Citrus Sinensis ID: 005492
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 694 | 2.2.26 [Sep-21-2011] | |||||||
| Q7X8C5 | 748 | Wall-associated receptor | yes | no | 0.949 | 0.881 | 0.423 | 1e-142 | |
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.938 | 0.904 | 0.427 | 1e-137 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.877 | 0.834 | 0.432 | 1e-136 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.890 | 0.812 | 0.416 | 1e-135 | |
| Q9LN59 | 788 | Putative wall-associated | no | no | 0.613 | 0.540 | 0.567 | 1e-135 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.517 | 0.453 | 0.622 | 1e-133 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.945 | 0.853 | 0.423 | 1e-133 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.479 | 0.443 | 0.628 | 1e-131 | |
| Q9LMT9 | 764 | Putative wall-associated | no | no | 0.550 | 0.5 | 0.579 | 1e-128 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.485 | 0.461 | 0.628 | 1e-126 |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 505 bits (1301), Expect = e-142, Method: Compositional matrix adjust.
Identities = 305/721 (42%), Positives = 434/721 (60%), Gaps = 62/721 (8%)
Query: 8 LPFGIG-KGCFLDKSFEVICNYSGKYPKAYLPGINNLELLDIDSYYEGTIRVNFPIISLK 66
PFGIG K C+L+ +EV+CN + P +L IN EL++I G + + P+ S
Sbjct: 46 FPFGIGGKDCYLNPWYEVVCNSTNSVP--FLSRINR-ELVNIS--LNGVVHIKAPVTSSG 100
Query: 67 NSSNAK--------GVNLLGSPFIFSNISNRFAAIGCDDYDTVDINNSTVSGGCLSISTC 118
S+ V GSP+ ++ N A+GC + S ++ S +
Sbjct: 101 CSTGTSQPLTPPPLNVAGQGSPYFLTD-KNLLVAVGCKFKAVMAGITSQITSCESSCNER 159
Query: 119 DPTSKRG----CYDFLCA---LSPNITHIFNADLSYFYSQNISQK--CRSVSVVEENWVG 169
+ +S+ G C + C + + + D+ N + + CR V+ + +
Sbjct: 160 NSSSQEGRNKICNGYKCCQTRIPEGQPQVISVDIEIPQGNNTTGEGGCR-VAFLTSDKYS 218
Query: 170 SKYLENPRVLKQQARGIPAM-LDW--------GEEIGSCFEEFSSYSTICGDRENGCSIK 220
S + P K G A+ L W + SC + S + D CS
Sbjct: 219 SLNVTEPE--KFHGHGYAAVELGWFFDTSDSRDTQPISC-KNASDTTPYTSDTRCSCSYG 275
Query: 221 LSSGYI---CRCDAGFYRPHGLCSGTLLCISGHNCSKCPYGYFRYPRNSTDCYGGTAYYS 277
SG+ C C++ Y+ + G C+ + +C R C ++
Sbjct: 276 YFSGFSYRDCYCNSPGYKGNPFLPGG--CV---DVDECKLDIGRNQCKDQSCVNLPGWFD 330
Query: 278 YFTRK-SRVKYIIIGCSGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQE 336
+K ++K +I G G LL GI+ LYKFV++R+++ +KFF+RNGG+LL+Q+
Sbjct: 331 CQPKKPEQLKRVIQGVLIGSALLLFAFGIFGLYKFVQKRRKLIRMRKFFRRNGGMLLKQQ 390
Query: 337 LSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD 396
L+ E N+E +++F+S +LEKATDN+N NR+LGQGGQGTVYKGML DGRIVAVK+SK VD
Sbjct: 391 LARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVD 450
Query: 397 ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPI 456
E VE+FINEVV+L+QINHRNIVKLLGCCLETEVP+LVYEF+PNG L + +H++ +++ +
Sbjct: 451 EDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTM 510
Query: 457 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516
TWE+ L IA+E++GAL YLHSAAS PIYHRDIK+ NILLD++ RAKVSDFGTSRSV +DQ
Sbjct: 511 TWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQ 570
Query: 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG 576
THLTT+V GTFGYVDPEYFQSS+FTEKSDVYSFGVVLVE+LTG+KP + ++E++ L
Sbjct: 571 THLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAA 630
Query: 577 YFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636
+F++A+ ENR+ +I+D R+ E + +M+VA LA+RCLN GK RP M+EV+ EL IR
Sbjct: 631 HFVEAVKENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIR 690
Query: 637 TS---TGASI-----LQQNCEEIDFVDGDISGHSLETGSSSTGMSILNSSSAFSIDAHPL 688
+S +G I E++F D + E G+++ S+ N++S S DA PL
Sbjct: 691 SSHYDSGIHIEDDDEEDDQAMELNFND------TWEVGATAPA-SMFNNASPTS-DAEPL 742
Query: 689 L 689
+
Sbjct: 743 V 743
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 488 bits (1257), Expect = e-137, Method: Compositional matrix adjust.
Identities = 302/707 (42%), Positives = 419/707 (59%), Gaps = 56/707 (7%)
Query: 9 PFGIGKGCFLDKSFEVICNYSG-KYPKAYLPGINN-LELLDIDSYYEGTIRVNFPIIS-L 65
PFGIGKGC+ +K FE++C S + P LP I + ++ + ++ F I S L
Sbjct: 45 PFGIGKGCYKNKWFEIVCKSSSDQQPILLLPRIRRAVTSFNLGDPFSISVYNKFYIQSPL 104
Query: 66 KNSS-------NAKGVNLLGSPFIFSNISNRFAAIGCDDYDTVDINNSTVSGGCLSISTC 118
K+S ++ +NL GSPF S +N+F A+GC++ +++ + G C +
Sbjct: 105 KHSGCPNRDGYSSSSLNLKGSPFFISE-NNKFTAVGCNNKAFMNVTGLQIVG-CETTCGN 162
Query: 119 DPTSKRG----CYDFLC---ALSPNIT-HIFNADLSYFYSQNISQKCRSVSVVEENWVGS 170
+ S +G C + C + P + +F+A + Q C+ + + GS
Sbjct: 163 EIRSYKGANTSCVGYKCCQMTIPPLLQLQVFDATVEKLEPNK--QGCQVAFLTQFTLSGS 220
Query: 171 KYLENPRVLKQQARGIPAMLDWGEEIGSCFEEFSSYSTICGDRENGCSIKLSSGYICRCD 230
+ P L + + L+W ++ +S +C + Y C C
Sbjct: 221 LF--TPPELMEYSEYTTIELEWRLDLSY----MTSKRVLCKG-----NTFFEDSYQCSCH 269
Query: 231 AGF----YRPHGLCSGTLLCISGHNCSKCPYGYFRYPRNSTDCYGGTAYYSYFTRKSRVK 286
G+ Y P G C C H +KC C Y R +
Sbjct: 270 NGYEGNPYIPGG-CQDIDECRDPH-LNKC---------GKRKCVNVLGSY----RCEKTW 314
Query: 287 YIIIGCSGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEK 346
I+ + GLL L+ G+W L K ++RK K K+KFF+RNGGLLLQQ+ S ++ +
Sbjct: 315 PAILSGTLSSGLLLLIFGMWLLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNR 374
Query: 347 TKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINE 406
TK+F+S DLE ATD +NA+RILGQGGQGTVYKGML DG IVAVKKSK + E N+E+FINE
Sbjct: 375 TKVFSSNDLENATDRFNASRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINE 434
Query: 407 VVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV 466
+++LSQINHRN+VK+LGCCLETEVP+LVYEFIPN L+ ++HN E+FP++WE+ L IA
Sbjct: 435 IILLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIAC 494
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 526
EV+ AL YLHSA SIPIYHRD+KS NILLD+K+RAKVSDFG SRSV +D THLTT VQGT
Sbjct: 495 EVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGT 554
Query: 527 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR 586
GYVDPEY QS+ FT KSDVYSFGV+L+E+LTG+KP+ + E + L YFL+A+ +R
Sbjct: 555 IGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDR 614
Query: 587 LFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS-TGASILQ 645
L EILDAR+ +E +E ++ VA LA+RCL+LN + RPTM++V EL +++ G
Sbjct: 615 LHEILDARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQSKRKGTQSQA 674
Query: 646 QNCEEIDFVDGDISGHSLETGSSSTGMSILNSSSAFSIDAHPLLSNK 692
QN EE + + S+ SS + + NSS FS+D PL+ +K
Sbjct: 675 QNGEEHAHIQIAMP-ESMSLSYSSPNIVVENSS--FSLDTKPLMPHK 718
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1252), Expect = e-136, Method: Compositional matrix adjust.
Identities = 293/678 (43%), Positives = 411/678 (60%), Gaps = 69/678 (10%)
Query: 8 LPFGIG-KGCFLDKSFEVICNYSGKYPKAYLPGIN-------NLELLDIDSYYEGTIRVN 59
PFGIG K C+L+ +EVICN + +P ++ N+ L D + Y G +++
Sbjct: 50 FPFGIGGKDCYLNGWYEVICNTTTSDSNTTVPLLSMINREVVNISLPDSNEPY-GLVQIK 108
Query: 60 FPIISLKNSSNAK----------GVNLLGSPFIFSNISNRFAAIGCDDYDTVDINNSTVS 109
P+ SL SSN V GSP+ ++ NR A+GC + S +
Sbjct: 109 GPVTSLGCSSNTSEGPQNSLPVLNVTGKGSPYFLTD-ENRLVAVGCGIKALMTDTESEIL 167
Query: 110 G---GCLSISTCDPTSKRGCYDFLC-----------ALSPNITHIFNADLSYFYSQNISQ 155
G C + + + C + C A++ NI + S +
Sbjct: 168 GCESSCEHRKSGEEVTNLICTGYRCCQARLPVGRPQAITVNIEN----------SSGGEE 217
Query: 156 KCRSVSVVEENWVGSKYLENPRVLKQQARGIPAMLDWGEEIGSCFEEFSSY-------ST 208
C+ + ++ + S E P +L+ G + F S
Sbjct: 218 TCKVAFLTDKRYSPSNVTE-PEQFHNNGY---VVLELGWYFATSNSRFKSLLGCTNMSRK 273
Query: 209 ICGDRENGCSIKLS--SGYICR---CDAGFY-RPH--GLCSGTLLCISGHNCSKCPYGYF 260
G ++ CS + SG R CD G+ P+ G C T C HNC + +
Sbjct: 274 GSGFSDDNCSCEYDYFSGMSYRNCYCDYGYTGNPYLRGGCVDTDSCEGNHNCGEDAH-CV 332
Query: 261 RYPRNSTDCYGGTAYYSYFTRKSRVKYIIIGCSGGLGLLFLLVGIWWLYKFVKRRKEIKL 320
P + C + T+ ++ I+IG SG L VG++WL+K +K+R+ I
Sbjct: 333 NMPGPMSMCRPNPK-ITKPTKPPVLQGILIGLSG----LVFFVGLFWLFKLIKKRRNINR 387
Query: 321 KQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM 380
+KFFKRNGGLLL+Q+L++ + N+E +K+F+SK+L KATDN++ +R+LGQGGQGTVYKGM
Sbjct: 388 SKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVLGQGGQGTVYKGM 447
Query: 381 LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN 440
L DG IVAVK+SK+VDE +E+FINE+V+LSQINHRNIVKLLGCCLETEVP+LVYE+IPN
Sbjct: 448 LVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPN 507
Query: 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR 500
G L++ +H++ +++ +TWE+ LRIA+E++GAL Y+HSAAS PI+HRDIK+ NILLD+KYR
Sbjct: 508 GDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYR 567
Query: 501 AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 560
AKVSDFGTSRSV +DQTHLTT V GTFGY+DPEYF SSQ+T KSDVYSFGVVLVE++TG+
Sbjct: 568 AKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGE 627
Query: 561 KPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGK 620
KP+ + ++E + L +FL+A+ ENR+ +I+D R+ E+K E +M VA LA++CLN GK
Sbjct: 628 KPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGK 687
Query: 621 MRPTMKEVAFELGGIRTS 638
RP MKEV+ EL IR+S
Sbjct: 688 NRPNMKEVSNELERIRSS 705
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 484 bits (1246), Expect = e-135, Method: Compositional matrix adjust.
Identities = 280/672 (41%), Positives = 395/672 (58%), Gaps = 54/672 (8%)
Query: 8 LPFGIG-KGCFLDKSFEVICNYSGKYPKAYLPGIN----NLELLDIDSYYE-GTIRVNFP 61
PFGIG K C+L+ +EV+CN + P +L IN N+ L D YY G + + P
Sbjct: 44 FPFGIGGKECYLNPWYEVVCNTTTSVP--FLSRINRELVNIYLPDPTEYYSNGVVHIKGP 101
Query: 62 IISLKNSSNAK--------GVNLLGSPFIFSNISNRFAAIGCD-DYDTVDINNSTVSGGC 112
+ S S+ V GSP+ ++ N A+GC+ +D+ + + GC
Sbjct: 102 VTSSGCSTGTSQPLTPQPLNVAGQGSPYFLTD-KNLLMAVGCNVKAVMMDVKSQII--GC 158
Query: 113 LSISTCDP--TSKRGCYDFLCA--------LSPNITHIFNADLSYFYSQNISQKCRSVSV 162
S +CD +S + + +C+ + + ++ ++N ++ V+
Sbjct: 159 ES--SCDERNSSSQVVRNKICSGNKCCQTRIPEGQPQVIGVNIEIPENKNTTEGGCKVAF 216
Query: 163 VEENWVGSKYLENPRVLKQQARGIPAMLDWGEEIGSCFEEFSSYSTICGDRENGCSIKLS 222
+ N S + P + E+G F+ S N
Sbjct: 217 LTSNKYSSLNVTEPEEFHSDGYAV-------VELGWYFDTSDSRVLSPIGCMNVSDASQD 269
Query: 223 SGY----ICRCDAGFY----------RPHGLCSGTLLCISGHNCSKCPYGYFRYPRNSTD 268
GY IC C G++ G L + +C R
Sbjct: 270 GGYGSETICVCSYGYFSGFSYRSCYCNSMGYAGNPFLPGGCVDIDECKLEIGRKRCKDQS 329
Query: 269 CYGGTAYYSYFTRKS-RVKYIIIGCSGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKR 327
C +++ +K ++K + G G LL GI+ LYKF+K+++ + FF+R
Sbjct: 330 CVNKPGWFTCEPKKPGQIKPVFQGVLIGSALLLFAFGIFGLYKFIKKQRRSSRMRVFFRR 389
Query: 328 NGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIV 387
NGG+LL+Q+L+ E N+E +K+F+S +LEKATDN+N NR+LGQGGQGTVYKGML DGRIV
Sbjct: 390 NGGMLLKQQLARKEGNVEMSKIFSSNELEKATDNFNTNRVLGQGGQGTVYKGMLVDGRIV 449
Query: 388 AVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI 447
AVK+SK +DE VE+FINEVV+L+QINHRNIVKLLGCCLETEVP+LVYEF+PNG L + +
Sbjct: 450 AVKRSKAMDEDKVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRL 509
Query: 448 HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 507
++ +++ +TWE+ L IA+E++GAL YLHSAAS PIYHRDIK+ NILLD+KY+ KVSDFG
Sbjct: 510 RDECDDYIMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDEKYQVKVSDFG 569
Query: 508 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 567
TSRSV +DQTHLTT+V GTFGYVDPEYFQSS+FT+KSDVYSFGVVLVE++TG+ P +
Sbjct: 570 TSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTDKSDVYSFGVVLVELITGKNPSSRVQ 629
Query: 568 TDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKE 627
++E++ +F+ A+ ENR +I+D R+ E + +M VA LAKRCLN GK RP M+E
Sbjct: 630 SEENRGFAAHFVAAVKENRFLDIVDERIKDECNLDQVMAVAKLAKRCLNRKGKKRPNMRE 689
Query: 628 VAFELGGIRTST 639
V+ EL IR+S+
Sbjct: 690 VSVELERIRSSS 701
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 482 bits (1241), Expect = e-135, Method: Compositional matrix adjust.
Identities = 251/442 (56%), Positives = 320/442 (72%), Gaps = 16/442 (3%)
Query: 227 CRCDAGF----YRPHGLCSGTLLCISGHNCSKCPYGYFRYPRNSTDCYGGTAYYSYFTRK 282
C C G+ Y P G C + C + YG + R S C ++ K
Sbjct: 321 CGCSQGYEGNPYLPGG-------CKDINECLRNSYGQRQNCRESDTCVNLPGTFNCIGNK 373
Query: 283 SRVKYIIIGCSGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNES 342
+RV +IG G+L L+VGIWWL KF+K+R+ K K+KFFKRNGGLLLQQ+L++N+
Sbjct: 374 TRV--TMIGVGSAFGILVLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKG 431
Query: 343 NIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQ 402
N+EKT++F+S++LEKATDN++ +RILGQGGQGTVYKGML DGR VAVKKSK+VDE +E+
Sbjct: 432 NVEKTRIFSSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEE 491
Query: 403 FINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLL 462
FINEVVILSQINHR++VKLLGCCLETEVP LVYEFIPNG L+Q+IH + +++ TW + L
Sbjct: 492 FINEVVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRL 551
Query: 463 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 522
RIAV+++GAL YLHSAAS PIYHRDIKS NILLD+KYR KVSDFGTSRSV +D TH TT
Sbjct: 552 RIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTV 611
Query: 523 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAI-NTDEDKSLVGYFLQA 581
+ GT GYVDPEY+ SSQ+T+KSDVYSFGVVLVE++TG+KP+ + N+ E + L +F A
Sbjct: 612 ISGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIRGLADHFRVA 671
Query: 582 INENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGA 641
+ ENR FEI+DAR+ K E +M VA LA+RCLN GK RP M++V +L I S
Sbjct: 672 MKENRFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILASQED 731
Query: 642 SILQQNCEEIDFVDGDISGHSL 663
S++ N E D D + G ++
Sbjct: 732 SLV--NIENDDGADDEEEGMTM 751
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 475 bits (1222), Expect = e-133, Method: Compositional matrix adjust.
Identities = 224/360 (62%), Positives = 291/360 (80%), Gaps = 1/360 (0%)
Query: 288 IIIGCSGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKT 347
+ IG G L +VGI+ LYKF+K+++++ K+KFFKRNGGLLLQQ+L S +EKT
Sbjct: 373 LAIGLGASFGSLIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKT 432
Query: 348 KLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEV 407
+F+S++LEKAT+N+++NRILGQGGQGTVYKGML DGRIVAVKKSK+VDE +E+FINEV
Sbjct: 433 IVFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEV 492
Query: 408 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEE-FPITWELLLRIAV 466
VILSQINHRNIVKLLGCCLET+VP+LVYEFIPNG L++++H++ +E TW + LRIA+
Sbjct: 493 VILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAI 552
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 526
+++GAL YLHS+AS PIYHRD+KS NI+LD+KYRAKVSDFGTSR+V VD THLTT V GT
Sbjct: 553 DIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGT 612
Query: 527 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR 586
GY+DPEYFQSSQFT+KSDVYSFGVVLVE++TG+K I + + E+++L YF+ A+ EN+
Sbjct: 613 VGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENK 672
Query: 587 LFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGASILQQ 646
LF+I+DAR+ + A +A++CLNL G+ RP+M+EV+ EL IR G LQ+
Sbjct: 673 LFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIRMPCGDMQLQE 732
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 474 bits (1221), Expect = e-133, Method: Compositional matrix adjust.
Identities = 319/754 (42%), Positives = 443/754 (58%), Gaps = 98/754 (12%)
Query: 9 PFGIGKGCFLDKSFEVICNYSGKYPKAYLPGINNLELLDI---DSYYE------GTIRVN 59
PFGIG GC+L+K +E+IC + P I N E++ I D Y G+IR+
Sbjct: 39 PFGIGTGCYLEKWYEIIC-VNNSVP---FLSIINREVVSISFSDMYRRFFNVGYGSIRIR 94
Query: 60 FPIISLKNSSNAKG----VNLLGSPFIFSNISNRFAAIGCDDYDTV-DINNSTVSGGCLS 114
PI S SS + +N+ G PF + +N A+GC++ ++ ++ S V GC S
Sbjct: 95 NPIASKGCSSGGQEFGSLLNMTGYPFYLGD-NNMLIAVGCNNTASLTNVEPSIV--GCES 151
Query: 115 ISTCDPTSKRGCYDFLCALSPNITH----------IFN-----------ADLSYFYSQNI 153
TC D+L L N + I N A L Y Q I
Sbjct: 152 --TCSTNQDIPINDYLGVLYCNARYGDSEYCKNISIMNDTSCNGIGCCKASLPARYQQII 209
Query: 154 ----------SQKCRSVSVVEENWVGSKYLENPRVLKQQARGIPAM-LDW------GEEI 196
S+ C+ + +E + S + R+ A G + L W I
Sbjct: 210 GVEIDDSNTESKGCKVAFITDEEYFLSNGSDPERL---HANGYDTVDLRWFIHTANHSFI 266
Query: 197 GSC-FEEFSSYSTICGD-RENGCSI-----KLSSGY-ICRCDAGF----YRPHGLCSGTL 244
GS + Y+ + D RE G ++GY C C +GF Y P G C
Sbjct: 267 GSLGCKSIDEYTILRRDNREYGIGCLCDYNSTTTGYATCSCASGFEGNPYIP-GECKDIN 325
Query: 245 LCISGHNCSK-CPYGYFRYPRNSTDCYGGTAYYSYFTRKSRVKYIIIGCSGGLGLLFLLV 303
C+ G + + C G + GG Y + + ++IG S L +
Sbjct: 326 ECVRGIDGNPVCTAG------KCVNLLGG-----YTCEYTNHRPLVIGLSTSFSTLVFIG 374
Query: 304 GIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYN 363
GI+WLYKF++R++ + K+KFFKRNGGLLLQQ+L++ E N++ T++F S++LEKAT+N++
Sbjct: 375 GIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELEKATENFS 434
Query: 364 ANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLG 423
RILG+GGQGTVYKGML DGRIVAVKKSK+VDE +E+FINEVVILSQINHRNIVKLLG
Sbjct: 435 LTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLG 494
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPI-TWELLLRIAVEVSGALFYLHSAASIP 482
CCLET+VP+LVYEFIPNG L++++H+ +++ + TWE+ LRIAV+++GAL YLHSAAS P
Sbjct: 495 CCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGALSYLHSAASSP 554
Query: 483 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 542
IYHRDIKS NI+LD+K+RAKVSDFGTSR+V VD THLTT V GT GY+DPEYFQSSQFT+
Sbjct: 555 IYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTD 614
Query: 543 KSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKE 602
KSDVYSFGVVL E++TG+K + + + E ++L YF A+ ENRL +I+DAR+ K
Sbjct: 615 KSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARIRDGCKLN 674
Query: 603 GIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGA----SILQQNCEEID--FVDG 656
+ A +A++CLN+ G+ RP+M++V+ EL IR+ + +N EE VD
Sbjct: 675 QVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSYSEDMQPYEYASENEEEKKETLVDV 734
Query: 657 DI-SGHSLETGSSSTGMSILNSSSAFSIDAHPLL 689
++ S + + ++S+ SI +SS+ S D PL
Sbjct: 735 NVESRNYVSVTAASSQYSIATTSSSRS-DVEPLF 767
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 470 bits (1209), Expect = e-131, Method: Compositional matrix adjust.
Identities = 223/355 (62%), Positives = 296/355 (83%)
Query: 284 RVKYIIIGCSGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESN 343
++K + G G LLFL++GIW L KFVK+R++I K+ FFKRNGGLLL+Q+L++ N
Sbjct: 343 KIKPLFPGLVLGFPLLFLVLGIWGLIKFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGN 402
Query: 344 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQF 403
++ +K+F+SK+LEKATDN+N NR+LGQGGQGTVYKGML DGRIVAVK+SK++DE VE+F
Sbjct: 403 VQSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEF 462
Query: 404 INEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLR 463
INEV +LSQINHRNIVKL+GCCLETEVP+LVYE IPNG L++ +H+ +++ +TW++ LR
Sbjct: 463 INEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLR 522
Query: 464 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 523
I+VE++GAL YLHSAAS P+YHRD+K+ NILLD+KYRAKVSDFGTSRS+ VDQTHLTT V
Sbjct: 523 ISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLV 582
Query: 524 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN 583
GTFGY+DPEYFQ+SQFT+KSDVYSFGVVLVE++TG+KP + +E++ LV +F +A+
Sbjct: 583 AGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMK 642
Query: 584 ENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638
+NR+ +I+D+R+ + E ++ VA LA+RCL+L GK RP M+EV+ EL IR+S
Sbjct: 643 QNRVLDIVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSS 697
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 458 bits (1178), Expect = e-128, Method: Compositional matrix adjust.
Identities = 222/383 (57%), Positives = 287/383 (74%), Gaps = 1/383 (0%)
Query: 284 RVKYIIIGCSGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESN 343
+ +++G G +L + GIWW K +++R+ K+KFFKRNGGLLLQQ+L++ +
Sbjct: 376 HIPEVMLGLGAGFFVLIVGGGIWWWRKLLRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGR 435
Query: 344 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQF 403
+EKTKLF+S++LEKATDN+N NR++GQGGQGTVYKGML DGR VAVKKS +VDE +++F
Sbjct: 436 VEKTKLFSSRELEKATDNFNDNRVIGQGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEF 495
Query: 404 INEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLR 463
INEV+ILSQINHR++VKLLGCCLETEVP+LVYEFIPNG L+Q++H + +++ W + +R
Sbjct: 496 INEVIILSQINHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMR 555
Query: 464 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 523
IAV++SGA YLH+AA PIYHRDIKS NILLD+KYRAKVSDFGTSRSV +D TH TT +
Sbjct: 556 IAVDISGAFSYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVI 615
Query: 524 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN-TDEDKSLVGYFLQAI 582
GT GYVDPEY+ SS FTEKSDVYSFGVVLVE++TG+KP+ ++ T E L YF A+
Sbjct: 616 SGTVGYVDPEYYGSSHFTEKSDVYSFGVVLVELITGEKPVITLSETQEITGLADYFRLAM 675
Query: 583 NENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGAS 642
ENRLFEI+DAR+ + K E ++ VA LA RCL GK RP M+EV+ L I ++
Sbjct: 676 RENRLFEIIDARIRNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTALERICSAPEDF 735
Query: 643 ILQQNCEEIDFVDGDISGHSLET 665
+Q +E D G+S T
Sbjct: 736 QVQIQIDEEDETTKLFRGYSGST 758
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 453 bits (1166), Expect = e-126, Method: Compositional matrix adjust.
Identities = 213/339 (62%), Positives = 283/339 (83%), Gaps = 2/339 (0%)
Query: 300 FLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKAT 359
F ++GI+ LYKF+++R+ I KFFKRNGGLLL+Q+L++ + ++E +K+F+S++LEKAT
Sbjct: 366 FFVIGIFGLYKFIRKRRRIIRSMKFFKRNGGLLLKQQLTTKDGSVEMSKIFSSRELEKAT 425
Query: 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 419
DN++ +R+LGQGGQGTVYK ML DG IVAVK+SK+VDE +E+FINE+V+LSQINHRNIV
Sbjct: 426 DNFSIDRVLGQGGQGTVYKRMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIV 485
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
KLLGCCLETEVP+LVYE+IPNG L++ +H++ +++ +TWE+ LRIAVE++GAL Y+HSAA
Sbjct: 486 KLLGCCLETEVPILVYEYIPNGDLFKRLHDEYDDYMMTWEVRLRIAVEIAGALSYMHSAA 545
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 539
S PI+HRDIK+ NILLD+KYRAK+SDFGTSRSV DQTHLTT V GTFGY+DPEYF SSQ
Sbjct: 546 SFPIFHRDIKTTNILLDEKYRAKISDFGTSRSVATDQTHLTTLVAGTFGYMDPEYFLSSQ 605
Query: 540 FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEA 599
+T KSDVYSFGVVLVE++TG+KP+ + ++E L YFL+A+ ENR +I+D R+ E+
Sbjct: 606 YTHKSDVYSFGVVLVELITGEKPMSRVRSEEGIGLATYFLEAMKENRAVDIIDIRIKDES 665
Query: 600 KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638
K+ +M VA LA+RCLN G RP M+EV+ +L IR+S
Sbjct: 666 KQ--VMAVAKLARRCLNRKGNKRPNMREVSIKLERIRSS 702
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 694 | ||||||
| 255545824 | 727 | kinase, putative [Ricinus communis] gi|2 | 0.943 | 0.900 | 0.562 | 0.0 | |
| 255545828 | 694 | kinase, putative [Ricinus communis] gi|2 | 0.894 | 0.894 | 0.556 | 0.0 | |
| 255541802 | 743 | kinase, putative [Ricinus communis] gi|2 | 0.881 | 0.823 | 0.545 | 1e-176 | |
| 359475622 | 867 | PREDICTED: wall-associated receptor kina | 0.906 | 0.725 | 0.498 | 1e-173 | |
| 359475620 | 822 | PREDICTED: wall-associated receptor kina | 0.907 | 0.766 | 0.505 | 1e-171 | |
| 147765961 | 679 | hypothetical protein VITISV_007744 [Viti | 0.899 | 0.918 | 0.500 | 1e-170 | |
| 224118592 | 642 | predicted protein [Populus trichocarpa] | 0.834 | 0.901 | 0.496 | 1e-164 | |
| 225455808 | 718 | PREDICTED: wall-associated receptor kina | 0.936 | 0.905 | 0.492 | 1e-162 | |
| 224053054 | 722 | predicted protein [Populus trichocarpa] | 0.946 | 0.909 | 0.487 | 1e-161 | |
| 224103351 | 685 | predicted protein [Populus trichocarpa] | 0.922 | 0.934 | 0.486 | 1e-161 |
| >gi|255545824|ref|XP_002513972.1| kinase, putative [Ricinus communis] gi|223547058|gb|EEF48555.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 681 bits (1757), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/706 (56%), Positives = 492/706 (69%), Gaps = 51/706 (7%)
Query: 8 LPFGIGKGCFLDKSFEVICNYSGKYPKAYLPGINNLELLDIDSYYEGTIRVNFPIISLK- 66
PFGIGKGC++ + FE++CN S PK +L IN +ELL S I VN P+IS
Sbjct: 43 FPFGIGKGCYMSEMFEIVCNDSFTPPKPFLTSIN-MELLHDPSIGSERITVNSPVISSNC 101
Query: 67 --NSSNAKGVNLLGSPFIFSNISNRFAAIGCDDYDTVDINNSTVSGGCLSISTCDPTSKR 124
SS + V+LLG+ F+FSN SNRF IGCD Y + + +TV GGCLSI C S
Sbjct: 102 SNKSSTSTEVSLLGTSFLFSNESNRFTTIGCDSYAMLTQSGNTV-GGCLSI--CRDNSSS 158
Query: 125 GCYDFLC----------ALSPNITHIFNADLSYFYSQNISQKCRSVSVVEENWVGSKYLE 174
GCY C + NIT+ FN+D + +C+S +V +NW+ SK
Sbjct: 159 GCYGLNCCQTTIPPYVQSFEVNITNPFNSD------GDGRDRCKSAFMVSQNWLASKSTN 212
Query: 175 NPRVLKQQARGIPAMLDWGEEIGSCFEEFSSYSTI-CGDRENGCSIKLSSGYICRC---- 229
V +Q +PA+LDW + G C + S I C R C +L+ C C
Sbjct: 213 LDEV--RQMDHVPAVLDWANDQGYC--DISKNPNITCTSRY--CWAQLTENQFCICRQCE 266
Query: 230 DAG-FYRPHGLCSGTLLCI---SGHNCSKCPYGYFRYPRNSTDCYGGTAYYSYFTRKSRV 285
D G P L C+ G+NC CP + + + CY +A F KSR+
Sbjct: 267 DVGKCTNPKNYYYCQLKCMYNRGGYNC-PCP---VEHHKEYSICYPDSA----FAGKSRI 318
Query: 286 KYIIIGCSGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIE 345
K I+IGC GLGLL L++GIW YK +KRR+ KLKQKFFKRNGGLLL+Q+LSS ES++E
Sbjct: 319 KTILIGCGSGLGLLLLIIGIWLSYKIIKRRRATKLKQKFFKRNGGLLLEQQLSSTESHVE 378
Query: 346 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFIN 405
+TK+FTSK+LEKATDNY+ +RILGQGGQGTVYKGMLTDGR+VA+KKSKLVDE ++QFIN
Sbjct: 379 QTKVFTSKELEKATDNYHTSRILGQGGQGTVYKGMLTDGRVVAIKKSKLVDEDKLDQFIN 438
Query: 406 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 465
EVVILSQINHRN+VKL GCCLETEVPLLVYEFIPNGTL+QYI N +EFPITWE+ LRIA
Sbjct: 439 EVVILSQINHRNVVKLTGCCLETEVPLLVYEFIPNGTLFQYIQNPNKEFPITWEMRLRIA 498
Query: 466 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 525
EV+GAL YLHSAAS+PIYHRDIKS+NILLD+KYRAKV+DFGTS+S+ ++QTH+TT VQG
Sbjct: 499 TEVAGALAYLHSAASMPIYHRDIKSSNILLDEKYRAKVADFGTSKSIAIEQTHVTTLVQG 558
Query: 526 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN 585
TFGY+DPEYFQSSQFTEKSDVYSFGVVLVE+LTGQKPI ++ + E++SL YFL + EN
Sbjct: 559 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSLRSVEERSLATYFLMTMEEN 618
Query: 586 RLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTG-ASIL 644
RLFEILDARVLKE +E I+ +A +A++CLNLNGK RP MK VA EL GIR+S G +S +
Sbjct: 619 RLFEILDARVLKEGGREEIIAMAKMAEKCLNLNGKKRPKMKTVAIELEGIRSSQGVSSTI 678
Query: 645 QQNCEEIDFVDGDISGHSLETGSSSTGMSILNSSSAFS-IDAHPLL 689
QQ+ EE+D+V GD + S + SSSTG LNS++ + D PLL
Sbjct: 679 QQDYEEVDYVVGDYTA-SWDVASSSTGS--LNSTTIRARFDVKPLL 721
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545828|ref|XP_002513974.1| kinase, putative [Ricinus communis] gi|223547060|gb|EEF48557.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 670 bits (1729), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/650 (55%), Positives = 464/650 (71%), Gaps = 29/650 (4%)
Query: 7 QLPFGIGKGCFLDKSFEVICNYSGKYPKAYLPGINNLELLDIDSYYEGTIRVNFPII--- 63
+ PFGIGKGC++D+SFEV CN S + PK +L IN +ELL++ S ++VN P+I
Sbjct: 42 EFPFGIGKGCYMDESFEVTCNSSSEPPKPFLTSIN-MELLEVLS--PNQVQVNNPVIYSN 98
Query: 64 SLKNSSNAKGVNLLGSPFIFSNISNRFAAIGCDDYDTVDINNSTVSGGCLSISTCDPTSK 123
+S A V+L G+PF FSN SNRF A GC++Y + + GGCLSI D +
Sbjct: 99 CSHKTSTASRVSLSGTPFTFSNASNRFTAKGCNNYAILMQDIGDTVGGCLSICR-DEANS 157
Query: 124 RGCYDFLCALS--PNITHIFNADLSYFYSQNISQKCRSVSVVEENWVGSKYLENPRVLKQ 181
GCY C + P F A+++ +S N + C+S +V+++W + + +
Sbjct: 158 SGCYGINCWQTTIPPYMKSFEANMTNPFSDN-TNNCKSAFMVDQSWFAFQSSSSRSLDDL 216
Query: 182 QARG-IPAMLDWGEEIGSCFEEFSSYSTI-CGDRENGCSIKLSSGYICRCDAGFYRPHGL 239
+ +PA+LDW G C + S Y I C + C +L+ +C C P+
Sbjct: 217 NYKDHVPAVLDWANYQGYC--DISEYYNITCTTDSSYCWKELNRSQVCICQCE--DPNKC 272
Query: 240 CSGT------LLCI---SGHNCSKCPYGYFRYPRNSTDCYGGTAYYSYFTRKSRVKYIII 290
+ L C+ G+NC CP G+ +Y NS CY + ++ +++ K III
Sbjct: 273 PDQSSNYNCRLFCMYRPGGYNCP-CPRGHGKY-ENSNRCYPNSVFWG--KSRTKTKSIII 328
Query: 291 GCSGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLF 350
GC G+G L LL+GIW LYK +KRR+ +KLKQ FFKRNGGLLL+Q+LSS E+ +E+TK+F
Sbjct: 329 GCGSGIGFLLLLIGIWSLYKIIKRRRAMKLKQNFFKRNGGLLLEQQLSSTENYVEQTKVF 388
Query: 351 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVIL 410
TSK+LEKATD+Y+ NRILGQGGQGTVYKGML DGR+VA+KKSK+VDE ++QFINEVVIL
Sbjct: 389 TSKELEKATDDYHTNRILGQGGQGTVYKGMLIDGRVVAIKKSKVVDEDKLDQFINEVVIL 448
Query: 411 SQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 470
SQINHRN+VKL+GCCLETEVPLLVYEFIPNGTLYQYIHN EEFP+TWE+ LRIA EV+G
Sbjct: 449 SQINHRNVVKLIGCCLETEVPLLVYEFIPNGTLYQYIHNPNEEFPVTWEMRLRIATEVAG 508
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 530
AL YLH+AAS+PIYHRDIKS+NILLD+KYRAKV+DFGTS+S+ +DQTH+TT+VQGTFGY+
Sbjct: 509 ALAYLHAAASMPIYHRDIKSSNILLDEKYRAKVADFGTSKSISIDQTHVTTRVQGTFGYL 568
Query: 531 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590
DPEYFQSSQFTEKSDVYSFGVVLVE+LTGQKPI + + E++SL YFL + E+RLFEI
Sbjct: 569 DPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSYRSVEERSLATYFLMTMEESRLFEI 628
Query: 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTG 640
LDARVLKE +E I+ +A LA++CLNLNGK RP MK VA EL GIR+S G
Sbjct: 629 LDARVLKEGGREEIIAMAKLAEKCLNLNGKKRPKMKTVAIELEGIRSSQG 678
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255541802|ref|XP_002511965.1| kinase, putative [Ricinus communis] gi|223549145|gb|EEF50634.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 626 bits (1614), Expect = e-176, Method: Compositional matrix adjust.
Identities = 356/653 (54%), Positives = 444/653 (67%), Gaps = 41/653 (6%)
Query: 9 PFGIGKGCFLDKSFEVICNYSGKYPKAYLPGINNLELLDIDSYYEGTIRVNFPIISLKNS 68
PFGIG+GC++D F V CN + + YL IN LELL + S +RVN P+++ N
Sbjct: 44 PFGIGEGCYMDSGFAVTCNKTSLPYRPYLTSIN-LELLRV-SLESTLVRVNNPVLN-SNC 100
Query: 69 SNAKGVNLLGSPFIFSNI--SNRFAAIGCDDYDTVDINNSTVSGGCLSISTCDPT-SKRG 125
+ V+ L + +NRF A+GC++ + V GGCLSI C+ T ++
Sbjct: 101 QDRPPVSDLSFSGSPFSFSDNNRFTALGCNNLALI-YRQDMVIGGCLSI--CNVTVTESS 157
Query: 126 CYDFLCALS--PNITHIFNADLSYFYSQNISQKCRSVSVVEENWVGSKYLENPRVLKQQA 183
CY C + P NA L ++CR +V+ W S +N L A
Sbjct: 158 CYGINCCQTSIPPYLKFINASLRSI-DPVPDEQCRVAFMVDREWFSSNASDNISAL-LGA 215
Query: 184 RGIPAMLDWGEEIGSCFEEFSSYST--ICGDRENGCSIKLSSGYICRCDAGFY-RPHGLC 240
+ +PA+L+WG G+C + + ++ ICG + CS+K+ Y C C+ G+ P+ C
Sbjct: 216 KQVPAVLEWGISNGTCADSPGAENSTDICGSNAS-CSVKVGINYQCSCNQGYEGNPYLSC 274
Query: 241 SG------------TLLCIS---GHNCSKCPYGYFRYPRNSTDCYGGTAYYSYFTRKSRV 285
+++C++ + CS CP GY N CY Y F
Sbjct: 275 QDINECEDSQKNKCSMICVNTPGSYKCS-CPDGYISMGNN---CYLTDGYTERFR----- 325
Query: 286 KYIIIGCSGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIE 345
I I S GLG+ FLL+G WWLYK KRRK+ KL+Q+FFKRNGGLLLQQ+LSS+ES+IE
Sbjct: 326 PVIAIVLSAGLGIPFLLIGTWWLYKVQKRRKDAKLRQRFFKRNGGLLLQQQLSSSESSIE 385
Query: 346 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFIN 405
KT +FT+K+LEKATD+YN NRILGQGGQGTVYKGMLTDG++VA+KKSK+ DE+ EQFIN
Sbjct: 386 KTNMFTAKELEKATDHYNENRILGQGGQGTVYKGMLTDGKVVAIKKSKIADESKTEQFIN 445
Query: 406 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 465
EVVILSQINHRN+VKLLGCCLETEVPLLVYEFIPNGTLYQ++H+ EEFPITWE+ LRIA
Sbjct: 446 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDPSEEFPITWEMRLRIA 505
Query: 466 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 525
+E AL YLHSAAS+PIYHRDIKS NILLDDKYRAKVSDFGTS+S+ VDQTH+TT+VQG
Sbjct: 506 IETGSALSYLHSAASVPIYHRDIKSTNILLDDKYRAKVSDFGTSKSIAVDQTHVTTRVQG 565
Query: 526 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN 585
TFGY+DPEYFQSSQFTEKSDVYSFGVVLVE+LTGQKPI + E++SL YFL ++ +N
Sbjct: 566 TFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSARAVEERSLAMYFLLSMEQN 625
Query: 586 RLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638
RLFEILDARVLKE KE I+ VA LA+RCLNLNGK RPTM+ V E+ IR S
Sbjct: 626 RLFEILDARVLKEGGKEEILAVAKLARRCLNLNGKKRPTMRTVVTEVERIRAS 678
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475622|ref|XP_003631717.1| PREDICTED: wall-associated receptor kinase-like 10-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 616 bits (1589), Expect = e-173, Method: Compositional matrix adjust.
Identities = 350/702 (49%), Positives = 448/702 (63%), Gaps = 73/702 (10%)
Query: 9 PFGIGK-GCFLDKSFEVICNYSGKYPKAYLPGINNLELLDIDSYYEGTIRVNFPIISLKN 67
PFGIG GC+ D+ FEV CN S PK +L G+N LE+L++ +GTIRVN P++ +N
Sbjct: 49 PFGIGSAGCYFDEWFEVTCNNSTDPPKPFLKGVN-LEVLNVS--LDGTIRVNNPVLLSQN 105
Query: 68 SSNAKGVNLL---GSPFIFSNISNRFAAIGCDDYDTVDINNSTVSGGCLSI--STCDPTS 122
S + G PF FSN RF A+GC + + + TV GGC++
Sbjct: 106 CSGKPSNDTQWWEGGPFSFSNTYTRFTAVGCSALVYI-MQDDTVIGGCMTFCKKDATAAK 164
Query: 123 KRGCYDFLCALS--PNITHIFNADLSYFY--SQNISQKCRSVSVVEENWVGSKYLENPRV 178
K CY C + P F A+L F S + ++C+ +V++ W S + +P
Sbjct: 165 KASCYGLECCQTQVPPGLLSFTANLGTFSDGSADEQEQCKFAFMVDQEWFISN-VPDPHT 223
Query: 179 LKQQARGIPAMLDWGEEIGSCFEEFSSYST---ICGDRENGCSIKLSSGYICRC----DA 231
+K +PA+LDW +C S+ +T CG+ + +S IC C +
Sbjct: 224 VKDMEY-VPAVLDWRIYNATCAASTSNLNTSTSFCGENTLCSTDTQTSSLICSCFPVYEG 282
Query: 232 GFYRPHGLCSGTLLCISGHNCSKCPYGYFRYPRNSTDCYGGTAYYSYFTRKSRVKYIIIG 291
Y P G C GT ++ DC I IG
Sbjct: 283 NPYLPQG-CQGT--------------------QSIEDC----------------AVITIG 305
Query: 292 CSGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFT 351
LG L L++ WWLY +KRRK+IK K+K F RNGGLLL+Q+LSS E NI+KTKLFT
Sbjct: 306 ---ALGTLLLVLCAWWLYIVLKRRKKIKYKEKCFNRNGGLLLEQQLSSTEGNIDKTKLFT 362
Query: 352 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILS 411
SK+LEKATD YN NR++GQGG+GTVYKGML DGRIVAVKK K++ ++ +EQFINEVVIL
Sbjct: 363 SKELEKATDRYNENRVIGQGGEGTVYKGMLMDGRIVAVKKLKIMSDSKLEQFINEVVILC 422
Query: 412 QINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 471
QINHRN+VKLLGCCLETEVPLLVYEFIPNGTL ++IH Q EEFPITWE+ LRIA EV+GA
Sbjct: 423 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLSEHIHGQNEEFPITWEIRLRIATEVAGA 482
Query: 472 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 531
L YLHSAAS+PIYHRDIKS NILLDDKYRAKV+DFG S+ V +DQTHLTT+VQGTFGY+D
Sbjct: 483 LSYLHSAASVPIYHRDIKSTNILLDDKYRAKVADFGISKFVAIDQTHLTTQVQGTFGYLD 542
Query: 532 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591
PEYFQSSQFTEKSDVYSFG+VL+E+LTG+KPI + ++E KSL YF+ ++NE+RL ++L
Sbjct: 543 PEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSTASEEGKSLASYFILSMNEDRLSDLL 602
Query: 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGASILQQNCEEI 651
DA+V+KE++KE I +A LA+RC+NLNGK RPTM EVA EL IR G Q+N EEI
Sbjct: 603 DAQVVKESRKEEINAIAFLARRCINLNGKKRPTMMEVAMELERIRKCQGDFGAQENSEEI 662
Query: 652 DFVDGDISG----------HSLETGSSSTGMSILNSSSAFSI 683
++ ++ G L T +SS+ IL+ F +
Sbjct: 663 EYNTIELIGPWDVTSISTDSCLNTNASSSSDLILDKQQRFRV 704
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475620|ref|XP_002266785.2| PREDICTED: wall-associated receptor kinase-like 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 609 bits (1570), Expect = e-171, Method: Compositional matrix adjust.
Identities = 341/675 (50%), Positives = 439/675 (65%), Gaps = 45/675 (6%)
Query: 9 PFGIGK-GCFLDKSFEVICNYS--GKYPKAYLPGINNLELLDIDSYYEGTIRVNFPIISL 65
PFGIG GC+ D+ FEV CN S PK +L I NLE+L++ S TIRVN P++
Sbjct: 165 PFGIGSAGCYFDEWFEVTCNNSIHPHIPKPFL-KILNLEVLNV-SLNRSTIRVNNPVLGY 222
Query: 66 KNSSNAK---GVNLLGSPFIFSNISNRFAAIGCDDYDTVDINNSTVSGGCLSISTCDPTS 122
N S + G PF FS+ RF A+GC + N+S + GGC+S T+
Sbjct: 223 MNCSGKPSNDAQSWEGGPFSFSDTYTRFTAVGCSTLAYITQNDSVI-GGCMSYCKQGTTA 281
Query: 123 KR--GCYDFLCALS--PNITHIFNADLSYFYSQNISQ-KCRSVSVVEENWVGSKYLENPR 177
+ CY C + P F L F S + Q +C+ +V++ W S ++P
Sbjct: 282 AKNGSCYGLKCCQTQFPPGLQYFTTMLGDFPSNSDDQDECKYAFMVDQEWFISME-QDPD 340
Query: 178 VLKQQARGIPAMLDWGEEIGSC-------FEEFSSYSTICGDRENGCSIKLSSGYICRCD 230
+K PA+LDW +C ++ ++ CG + + CRC
Sbjct: 341 KVKDVGHA-PAVLDWRIYNATCKSVGWNNTSTSNTSTSFCGANAICSADTQTPSLTCRCP 399
Query: 231 AGFYRPHGLCSGTLLCISGHNCSKCPYGYFRYPRNSTDCYGGTAYYSYFT---------- 280
G+ L G C ++ N T C A +S +
Sbjct: 400 RGYEGNPYLTEG------------CEGTNYKLYENGTVCINRNANFSCYPVDKLIVDPRP 447
Query: 281 RKSRVKYIIIGCSGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSN 340
R+ + I +G G+G L L++ WWLYK +KRR++IK K+K FKRNGGLLL+Q+LSS+
Sbjct: 448 RRMVLPGICVGILAGVGTLLLVICAWWLYKVLKRRQKIKYKEKCFKRNGGLLLEQQLSSS 507
Query: 341 ESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV 400
E N++KTKLFTSK+LEKATD YN NR++GQGGQGTVYKGML DGRIVAVKK K+V + V
Sbjct: 508 EGNVDKTKLFTSKELEKATDRYNENRVIGQGGQGTVYKGMLMDGRIVAVKKLKIVGDGKV 567
Query: 401 EQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL 460
EQFINEVVILSQINHRN+VKLLGCCLET VPLLVYEFIPNGTL ++IH+Q EEFPITWE+
Sbjct: 568 EQFINEVVILSQINHRNVVKLLGCCLETAVPLLVYEFIPNGTLSEHIHDQNEEFPITWEM 627
Query: 461 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520
LRIA+EV+GAL YLHSAASIPIYHRDIKS NILLDDKYRAKV+DFGTS+SV +DQTHLT
Sbjct: 628 RLRIAIEVAGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVADFGTSKSVAIDQTHLT 687
Query: 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ 580
T+VQGTFGY+DPEYFQSSQFTEKSDVYSFG+VL+E+LTG+KPI + ++E KSL YF+
Sbjct: 688 TQVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSTASEEGKSLASYFIL 747
Query: 581 AINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTG 640
++NE+RL ++LDA+V+KE KKE I +A LA+RC+NLNGK RPTM EVA EL ++T
Sbjct: 748 SMNEDRLSDLLDAQVVKEGKKEEINAIAFLARRCINLNGKKRPTMMEVAMELEILKTKKM 807
Query: 641 ASILQQNCEEIDFVD 655
+ + + +F++
Sbjct: 808 QKWVPEGKWQPNFIE 822
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147765961|emb|CAN70207.1| hypothetical protein VITISV_007744 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 605 bits (1559), Expect = e-170, Method: Compositional matrix adjust.
Identities = 346/691 (50%), Positives = 444/691 (64%), Gaps = 67/691 (9%)
Query: 9 PFGIGK-GCFLDKSFEVICNYSGKYPKAYLPGINNLELLDIDSYYEGTIRVNFPIISLKN 67
PFGIG GC+ D+ FEV CN S PK +L G+N LE+L++ + GT+RVN P++ +N
Sbjct: 42 PFGIGSSGCYFDEWFEVTCNNSTDPPKPFLKGVN-LEVLNVSLH--GTVRVNNPVLLSQN 98
Query: 68 SSNAKGVNLL---GSPFIFSNISNRFAAIGCDDYDTVDINNSTVSGGCLSISTCDPTS-- 122
S + G PF FSN RF A+GC + + TV GGC+++ D +
Sbjct: 99 CSGKPSNDTQWWEGGPFSFSNTYTRFTAVGCSAMAYF-MQDDTVIGGCMTLCKKDVATAA 157
Query: 123 -KRGCYDFLCALS--PNITHIFNADLSYFY--SQNISQKCRSVSVVEENWVGSKYLENPR 177
CY C + P F A+L F S + + C+ +V++ W S + +P
Sbjct: 158 KNASCYGLECCQTQVPPGLLSFTANLDTFPEGSADEQEPCKYAFMVDQEWFISN-VPDPH 216
Query: 178 VLKQQARGIPAMLDWGEEIGSCFEEFSSYST---ICGDRENGCSIKLSSGYICRCDAGFY 234
+K +PA+LDW +C S+ +T CG+ C D
Sbjct: 217 TVKDMEY-VPAVLDWRIYNATCDASTSNLNTSTSFCGENT-----------FCSTDTQ-- 262
Query: 235 RPHGLCSGTLLCISGHNCSKCPYGYFRYPRNSTDCYGGTAYYSYFTRKSRVKYIIIGCSG 294
+ +L C CP Y P Y + +V I G
Sbjct: 263 ------TSSLTC-------SCPLLYEGNP--------------YLPQGCQVITI-----G 290
Query: 295 GLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKD 354
LG L L++ WWLY +KRRK+IK K+K F RNGGLLL+Q+LSS+E NI+KTKLFTSK+
Sbjct: 291 SLGTLLLVLCAWWLYIXLKRRKKIKYKEKCFNRNGGLLLEQQLSSSEGNIDKTKLFTSKE 350
Query: 355 LEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN 414
LEKATD YN NR++GQG QGT YKGML DGRIVAVKK K++ ++ +EQFINEVVIL QIN
Sbjct: 351 LEKATDRYNENRVIGQGXQGTXYKGMLMDGRIVAVKKLKIMSDSKLEQFINEVVILCQIN 410
Query: 415 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 474
HRN+VKLLGCCLETEVPLLVYEFIPNGTL ++IH Q EEFPITWE+ LRIA EV GAL Y
Sbjct: 411 HRNVVKLLGCCLETEVPLLVYEFIPNGTLSEHIHGQNEEFPITWEMRLRIATEVXGALSY 470
Query: 475 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 534
LHS ASIPIYHRDIKS NILLBDKYRAKV+DFG S+ V +DQTHLTT+VQGTFGY+DPEY
Sbjct: 471 LHSXASIPIYHRDIKSTNILLBDKYRAKVADFGISKFVAIDQTHLTTQVQGTFGYLDPEY 530
Query: 535 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594
FQSSQFTEKSDVYSFG+VL+E+LTG+KPI +I ++E KSL YF+ ++NE+RL ++LDA+
Sbjct: 531 FQSSQFTEKSDVYSFGIVLIELLTGKKPILSIASEEGKSLASYFILSMNEDRLSDLLDAQ 590
Query: 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGASILQQNCEEIDFV 654
V+KE++KE I +A LA+RC+NLNGK RPTM EVA EL IR G Q+N EEI++
Sbjct: 591 VVKESRKEEINAIAFLARRCINLNGKKRPTMMEVAMELERIRKCQGDFRAQENFEEIEYN 650
Query: 655 DGDISGHSLETGSSSTGMSILNSSSAFSIDA 685
++ G + S ST S LN++++ S D
Sbjct: 651 TTELIG-PWDVTSISTD-SCLNTNASSSSDV 679
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224118592|ref|XP_002331400.1| predicted protein [Populus trichocarpa] gi|222873614|gb|EEF10745.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 583 bits (1504), Expect = e-164, Method: Compositional matrix adjust.
Identities = 321/646 (49%), Positives = 419/646 (64%), Gaps = 67/646 (10%)
Query: 9 PFGIGKGCFLDKSFEVICNYSGKYPKAYLPGINNLELLDIDSYYEGTIRVNFPIISLKNS 68
PFG+ +GC+LD+ F+++CN S PK + G +LE+ +I S + TI V FPI+ N
Sbjct: 18 PFGMKEGCYLDERFKILCNSSSGVPKLTVNG-TDLEVNNI-SVDDSTIAVMFPIV-FANC 74
Query: 69 SNAKG---VNLLGSPFIFSNISNRFAAIGCDDYDTVDINNSTVSGGCLSISTCDPTSKR- 124
S G V+L GSPF+FS+ N F A GC + ++ N S + GGC+S+ CD
Sbjct: 75 SGKDGNTVVDLEGSPFVFSS-ENYFIARGCGNLALMNQNQSAI-GGCVSL--CDKNRDSM 130
Query: 125 --GCYDFLCALS--PNITHIFNADLSYFYSQNISQ---KCRSVSVVEENWVGSKYLENPR 177
C C + P+ +FN + S+ +CR +++E W
Sbjct: 131 MASCSGIDCCQTRIPSFLKVFNVTMKGLEDGKGSRGENECRYAFLIDERWTNYGGYYYDY 190
Query: 178 VL---------KQQARGIPAMLDWGEEIGSCFEEFSSYSTICGDRENGCSIKLSSGYICR 228
K++ +P +LDWG + FE + +S Y
Sbjct: 191 YFGGNFDFYYDKRERDHVPVVLDWGID-RRVFESLVKNGSF-----------YNSSYTST 238
Query: 229 CDAGFYRPHGLCSGTLLCISGHNCSKCPYGYFRYPRNSTDCYGGTAYYSYFTRKSRVKYI 288
C G G+C G LL + + +P + + F +K
Sbjct: 239 CFEGNPYLSGICQGKLLIVVSQ--------FSSFP----------SMNNAFLKK------ 274
Query: 289 IIGCSGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTK 348
C GG G LFLL+G+WWLYK KR++ KLK+K+FKRNGGLLLQ++LSS E N+EK K
Sbjct: 275 ---CVGGFGALFLLIGLWWLYKVFKRKRSEKLKKKYFKRNGGLLLQEQLSSGEVNVEKIK 331
Query: 349 LFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVV 408
+F SK+L+KATD+YN NR LGQGGQGTVYKGML DG+IVAVKKSK +DE N+ QFINEVV
Sbjct: 332 MFPSKELDKATDHYNVNRTLGQGGQGTVYKGMLADGKIVAVKKSKEIDEGNLRQFINEVV 391
Query: 409 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 468
+LSQINHRN+VKLLGCCLETE+PLL+YEFIPNGTL+Q++H+ EEFP+TWE+ LRIA EV
Sbjct: 392 LLSQINHRNVVKLLGCCLETELPLLIYEFIPNGTLFQFLHDPNEEFPLTWEMRLRIAAEV 451
Query: 469 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 528
+GALFYLHSAAS+PI+HRDIKS NILLD++YRAKV+DFGTSRSV +DQTH+TT+VQGTFG
Sbjct: 452 AGALFYLHSAASLPIFHRDIKSTNILLDEEYRAKVADFGTSRSVSIDQTHVTTRVQGTFG 511
Query: 529 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED-KSLVGYFLQAINENRL 587
Y+DPEYFQSSQFT+KSDVYSFGVVLVE+LTGQKPI ++E +SL YF+ A+ N L
Sbjct: 512 YLDPEYFQSSQFTDKSDVYSFGVVLVELLTGQKPISFTRSEEQGRSLATYFIMAMESNCL 571
Query: 588 FEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633
F+ILD +V+K+ ++E ++ VA+LA+ CL LNGK RPTMK V G
Sbjct: 572 FDILDPQVVKQGEREDVLMVASLARSCLRLNGKERPTMKGVTMRSG 617
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455808|ref|XP_002274809.1| PREDICTED: wall-associated receptor kinase-like 9-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 578 bits (1491), Expect = e-162, Method: Compositional matrix adjust.
Identities = 347/704 (49%), Positives = 452/704 (64%), Gaps = 54/704 (7%)
Query: 9 PFGIGKGCFLDKSFEVICNYSGKYPKAYLPGINNLELLDID-SYYEGTIRVNFPIIS--- 64
PFG+GK C+ D+ F + C++S PK L +N LE+L I+ ++ ++ VN PI S
Sbjct: 46 PFGMGKSCYKDEWFSISCSHSFDPPKPILSKLN-LEVLSIEMDRFQKSVMVNSPIYSNCE 104
Query: 65 ----LKNSSNAKGVNLLGSPFIFSNISNRFAAIGCDDYDTVDINNSTVSGGCLSISTCDP 120
SS + +L GSPF++S + N +GC + D N + GC STCD
Sbjct: 105 NGEVEVTSSPWQSRDLWGSPFLYS-LHNDLVGVGCHNVLLRD-RNEEIMAGC--ASTCDK 160
Query: 121 T-SKRGC-YDFLCALSPNITHIFNADLSYF-YSQNISQKCRSVSVVEENWVGSKY--LEN 175
+ + +GC Y C L+ DL ++ S S R ++ Y + N
Sbjct: 161 SITTKGCLYGINCCLTR-----LQEDLDFYSLSTTASSSERGDPDCTYAFLAYNYNNVSN 215
Query: 176 PRVLKQQARGIPAMLDW--GEEIG--SCFEEFSSYSTICGDRENGCSIKLSSGYICRC-- 229
+ + A+ P ++ W E++ +C ++ T+ R N Y C C
Sbjct: 216 VTTIVRDAKYAPLLISWLIPEQVDPQNCVDD-----TVYTSRGN------YPNYRCACNW 264
Query: 230 --DAGFYRPHGLCSGTLLCISGHNCSKCPYGYFRYPRNSTDCYGGTAYYSYFTRKSRVKY 287
+ Y HG C C+ C +G +ST Y Y + K++ K
Sbjct: 265 AEEGNPYLAHG-------CQVVRECANCRWGCDGRYNSST-----YKYDFYCSTKNKSKA 312
Query: 288 IIIGCSGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKT 347
+I+GCS GLL LL+ + LYK V+++ +I++K++FFKRNGGLLLQQ++SS++ EKT
Sbjct: 313 LILGCSISGGLLLLLIFSFGLYKVVRKQLDIRVKKRFFKRNGGLLLQQQISSDKIAFEKT 372
Query: 348 KLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEV 407
K+FTS +LEKATDN+N NRILGQGGQGTVYKGML DGRIVAVKKSK+VDE +E FINE+
Sbjct: 373 KIFTSDELEKATDNFNKNRILGQGGQGTVYKGMLNDGRIVAVKKSKIVDENQLEHFINEI 432
Query: 408 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 467
VILSQINHRN+V +LGCCLETEVPLLVYEFI NGTL+Q IH+Q EFP++WE+ LRIA+E
Sbjct: 433 VILSQINHRNVVGILGCCLETEVPLLVYEFISNGTLFQLIHDQNSEFPLSWEMRLRIALE 492
Query: 468 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 527
VSGAL YLHSA SIPIYHRDIKS NILLDDKY+AKVSDFGTSRS+ +DQTHLTT VQGTF
Sbjct: 493 VSGALSYLHSACSIPIYHRDIKSTNILLDDKYKAKVSDFGTSRSISIDQTHLTTIVQGTF 552
Query: 528 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 587
GY+DPEYFQSSQFTEKSDVYSFGVVLVE+LTGQKPI + + E+KSL +F+ ++ E+RL
Sbjct: 553 GYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSTRSPEEKSLATHFILSLQESRL 612
Query: 588 FEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGASILQQN 647
F+ILDARV+KE +KE IMT A LA RCLNLNG+ RPTMKEV E+ IR S + QN
Sbjct: 613 FDILDARVVKEGRKEDIMTFAKLAGRCLNLNGRKRPTMKEVTTEIDNIRVSALHLNVDQN 672
Query: 648 CEEIDFVDGDISGHSLETGSSSTGMSILNSSSAFSIDAHPLLSN 691
+E V +I+ +S++ S L+ + S D PLL N
Sbjct: 673 FQENACVVTEITEFLDMDDTSTSRGSCLDDTKESSFDVQPLLFN 716
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053054|ref|XP_002297684.1| predicted protein [Populus trichocarpa] gi|222844942|gb|EEE82489.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 575 bits (1481), Expect = e-161, Method: Compositional matrix adjust.
Identities = 344/706 (48%), Positives = 457/706 (64%), Gaps = 49/706 (6%)
Query: 8 LPFGIGKGCFLDKSFEVICN-YSGKYP-KAYLPGINNLELLDIDSYYEGTIRVNFPIISL 65
PFGIG GC+++ F V CN + P +A+L IN +E+ I S +RVN PIIS
Sbjct: 43 FPFGIGTGCYMNDWFSVHCNETTADSPSRAFLSRIN-MEVFKI-SLESSVVRVNSPIISS 100
Query: 66 KNSSNAK--GVNLLGSPFIFSNISNRFAAIGCDDYDTVD-INNSTVSGGCLSISTCDPTS 122
S +N+ GSPF FS+ SN F A+GC++ ++ I V GC S
Sbjct: 101 GCSGRGANLAINMTGSPFSFSS-SNIFTAMGCNNRALLNGIEPEIV--GCTSTCGASTEG 157
Query: 123 KRGCY---DFLCALS-PNITHIFNADL---SYFYSQNISQKCRSVSVVEENWVGSKYLEN 175
K Y + C + P+ + NA L + + +C+ +V+E W + + +
Sbjct: 158 KENSYCSGNNCCQTTIPSSLQVVNASLGTPEHPINDQGRNQCKVAFIVQEKWFRNN-ISS 216
Query: 176 PRVLKQQARGIPAMLDWGEEIGSCFEEFSSYSTICGDRENGCSIKL-SSGYICRCDAGF- 233
P V+ Q + +P +LDW + C + S G R ++ L S+ IC C+ G+
Sbjct: 217 PEVV-QDMQYVPVILDWNSDAMYCDPPMNLTSGRSGLR----TVTLYSNSTICSCNWGYD 271
Query: 234 ---YRPHGLCSGTLLC--ISGHNCSKCPYGYFRYPRNSTDCYGGTAYYSYFTRKSRVKYI 288
Y P G C+ C G++CS T C + K+++ ++
Sbjct: 272 GNPYLPDG-CTDIDECKIPRGNSCS-----------GMTKCVNVPGGFKCELDKAKITFL 319
Query: 289 IIGCSGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTK 348
S GLL LLVGIW LYK VK+RK I+LK+KFFKRNGGLLLQQ+LSS++ +I+KTK
Sbjct: 320 ----SAATGLLLLLVGIWRLYKLVKKRKNIELKKKFFKRNGGLLLQQQLSSSDGSIQKTK 375
Query: 349 LFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVV 408
+FTSK+LEKATD +N NRILGQGGQGTVYKGM DG IVAVKKS LVDE +E+FINEVV
Sbjct: 376 IFTSKELEKATDRFNDNRILGQGGQGTVYKGMQADGMIVAVKKSILVDEEKLEEFINEVV 435
Query: 409 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 468
ILSQ+NHRN+VKLLGCCLETEVPLLVYEFIPNG L++YIH+Q EEF +WE+ LRIA EV
Sbjct: 436 ILSQVNHRNVVKLLGCCLETEVPLLVYEFIPNGNLFEYIHDQKEEFEFSWEMRLRIATEV 495
Query: 469 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 528
+ AL YLHSAASIP+YHRDIKS NI+LD+K+RAKVSDFGTSRS+ +DQTHLTT VQGTFG
Sbjct: 496 ARALSYLHSAASIPVYHRDIKSTNIMLDEKFRAKVSDFGTSRSIAIDQTHLTTHVQGTFG 555
Query: 529 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 588
Y+DPEYFQSSQFT KSDVYSFGVVL E+L+GQKPI ++E SL +F+ + EN++F
Sbjct: 556 YLDPEYFQSSQFTGKSDVYSFGVVLAELLSGQKPISYERSEERGSLATHFILLVEENKIF 615
Query: 589 EILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGASILQQNC 648
+ILD R++ + ++E ++ VA LA+RCLNL G+ RPTM+EVA EL IR S GA QQ
Sbjct: 616 DILDERLMGQDREEEVIAVANLARRCLNLIGRKRPTMREVAIELEQIRLSKGALHPQQCS 675
Query: 649 EEIDFVDGDISGHSLETGSSSTGMSI--LNSSSAFSIDAHPLLSNK 692
+E++ + ++ + E T ++I + +A S+D PL+S++
Sbjct: 676 KELENIWDEVP-NVWEIAGPPTSVTIGDFRNGTAPSLDVQPLISHE 720
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224103351|ref|XP_002334062.1| predicted protein [Populus trichocarpa] gi|222869636|gb|EEF06767.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 575 bits (1481), Expect = e-161, Method: Compositional matrix adjust.
Identities = 331/681 (48%), Positives = 444/681 (65%), Gaps = 41/681 (6%)
Query: 8 LPFGIGKGCFLDKSFEVICN--YSGKYPKAYLPGINNLELLDIDSYYEGTIRVNFPIISL 65
PFGIG GC+L+ F V CN + +A+L IN +E+L+I S +RVN PIIS
Sbjct: 17 FPFGIGTGCYLNYWFSVHCNKTTADSRSRAFLSSIN-MEVLEI-SLRRSVVRVNSPIISS 74
Query: 66 KNSSNAK--GVNLLGSPFIFSNISNRFAAIGCDDYDTVDINNSTVSGGCLSISTCDPTSK 123
S +++ GSPF FS+ SN F A+GC++ + + G + S+ +
Sbjct: 75 GCSGRGANISIDMTGSPFAFSS-SNIFIAMGCNNRALLSRIEPEIVGCTTTGSSTEGKEN 133
Query: 124 RGCYDFLCALS--PNITHIFNADL---SYFYSQNISQKCRSVSVVEENWVGSKYLENPRV 178
C C + P+ +FNA L + + +C+ +VEE W + + +P V
Sbjct: 134 SYCSGNNCCQTTIPSNLQVFNASLGTTEHPINDQGRNQCKVAFIVEEEWFRNN-ISSPEV 192
Query: 179 LKQQARGIPAMLDWGEEIGSCFEEFSSYSTICGDRENGCSIKLSSGYI-CRCDAGF---- 233
+ Q + +P +L W G+ E + + ++ L S I C C G+
Sbjct: 193 V-QDMQYVPVILRWLMYYGTDIPEGVTLWGLS-------TVTLYSNSITCWCSPGYDGHP 244
Query: 234 YRPHGLCSGTLLCISGHNCSKCPYGYFRYPRNSTDCYGGTAYYSYFTRKSRVKYIIIGCS 293
Y P G C+ + +C + T C +Y K+++ ++ S
Sbjct: 245 YLPDG-CT---------DIDQCKIPGVNWCSGMTKCVNVPGWYKCELDKAKITFL----S 290
Query: 294 GGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSK 353
GLL LLVGIW LYK VK+RK I+LK+KFFKRNGGLLLQQ+LSS++ +I+KTK+FTSK
Sbjct: 291 AATGLLLLLVGIWRLYKLVKKRKNIELKKKFFKRNGGLLLQQQLSSSDGSIQKTKIFTSK 350
Query: 354 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI 413
+LEKATD +N NRILGQGGQGTVYKGM DG IVAVKKS LVDE +E+FINEVVILSQ+
Sbjct: 351 ELEKATDRFNDNRILGQGGQGTVYKGMQADGMIVAVKKSILVDEEKLEEFINEVVILSQV 410
Query: 414 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 473
NHRN+VKLLGCCLETEVPLLVYEFIPNG L++YIH+Q EEF +WE+ LRIA EV+ AL
Sbjct: 411 NHRNVVKLLGCCLETEVPLLVYEFIPNGNLFEYIHDQKEEFEFSWEMRLRIATEVARALS 470
Query: 474 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 533
YLHSAASIP+YHRDIKS NI+LD+K+RAKVSDFGTSRS+ +DQTHLTT VQGTFGY+DPE
Sbjct: 471 YLHSAASIPVYHRDIKSTNIMLDEKFRAKVSDFGTSRSIAIDQTHLTTHVQGTFGYLDPE 530
Query: 534 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDA 593
YFQSSQFT KSDVYSFGVVL E+L+GQKPI ++ +SL +F+ + EN++F+ILD
Sbjct: 531 YFQSSQFTGKSDVYSFGVVLAELLSGQKPISYERPEDRRSLATHFILLMEENKIFDILDE 590
Query: 594 RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGASILQQNCEEIDF 653
R++ + ++E ++ VA LA+RCLNLNG+ RPTM+EVA EL IR S GA QQ+C++++
Sbjct: 591 RLMGQDREEEVIAVANLARRCLNLNGRKRPTMREVAIELEQIRVSKGAPHAQQSCKDLEN 650
Query: 654 VDGDISGHSLETGSSSTGMSI 674
+ ++ + E +T ++I
Sbjct: 651 IRDEVP-NVWEIAGPTTSVTI 670
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 694 | ||||||
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.659 | 0.581 | 0.510 | 1.9e-130 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.479 | 0.456 | 0.615 | 5.7e-127 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.553 | 0.533 | 0.561 | 7.1e-126 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.497 | 0.459 | 0.602 | 1.2e-125 | |
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.494 | 0.433 | 0.604 | 1e-124 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.805 | 0.726 | 0.429 | 9.2e-124 | |
| TAIR|locus:2030988 | 764 | AT1G17910 [Arabidopsis thalian | 0.518 | 0.471 | 0.576 | 1.9e-122 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.505 | 0.446 | 0.586 | 2.2e-122 | |
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.958 | 0.889 | 0.399 | 9.5e-121 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.548 | 0.480 | 0.549 | 1.8e-112 |
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1136 (405.0 bits), Expect = 1.9e-130, Sum P(3) = 1.9e-130
Identities = 243/476 (51%), Positives = 307/476 (64%)
Query: 227 CRCDAGFYRPHGLCSGTLLCISGHNCSKCPYGYFRYPRNSTDCYGGTAYYSYFTRKSRVK 286
C C G+ L G C + C + YG + R S C ++ K+RV
Sbjct: 321 CGCSQGYEGNPYLPGG---CKDINECLRNSYGQRQNCRESDTCVNLPGTFNCIGNKTRV- 376
Query: 287 YXXXXXXXXXXXXXXXXXXWWLYKFVKRRKEIKLKQKFFKRXXXXXXXXXXXXXXXXIEK 346
WWL KF+K+R+ K K+KFFKR +EK
Sbjct: 377 -TMIGVGSAFGILVLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEK 435
Query: 347 TKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINE 406
T++F+S++LEKATDN++ +RILGQGGQGTVYKGML DGR VAVKKSK+VDE +E+FINE
Sbjct: 436 TRIFSSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINE 495
Query: 407 VVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV 466
VVILSQINHR++VKLLGCCLETEVP LVYEFIPNG L+Q+IH + +++ TW + LRIAV
Sbjct: 496 VVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAV 555
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 526
+++GAL YLHSAAS PIYHRDIKS NILLD+KYR KVSDFGTSRSV +D TH TT + GT
Sbjct: 556 DIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGT 615
Query: 527 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAI-NTDEDKSLVGYFLQAINEN 585
GYVDPEY+ SSQ+T+KSDVYSFGVVLVE++TG+KP+ + N+ E + L +F A+ EN
Sbjct: 616 VGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKEN 675
Query: 586 RLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGASILQ 645
R FEI+DAR+ K E +M VA LA+RCLN GK RP M++V +L I S S++
Sbjct: 676 RFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILASQEDSLV- 734
Query: 646 QNCEEIDFVDGDISGHSL-ETGSSST------GMSILNSSSAFSIDAHPLLSNK-W 693
N E D D + G ++ S T SI+ SSS S D PL + W
Sbjct: 735 -NIENDDGADDEEEGMTMINIDDSQTIYVTAPAPSIVASSS--SSDVQPLFPHPTW 787
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1120 (399.3 bits), Expect = 5.7e-127, Sum P(3) = 5.7e-127
Identities = 205/333 (61%), Positives = 269/333 (80%)
Query: 306 WWLYKFVKRRKEIKLKQKFFKRXXXXXXXXXXXXXXXXIEKTKLFTSKDLEKATDNYNAN 365
+WL+K +K+R+ I +KFFKR +E +K+F+SK+L KATDN++ +
Sbjct: 373 FWLFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSID 432
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
R+LGQGGQGTVYKGML DG IVAVK+SK+VDE +E+FINE+V+LSQINHRNIVKLLGCC
Sbjct: 433 RVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCC 492
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
LETEVP+LVYE+IPNG L++ +H++ +++ +TWE+ LRIA+E++GAL Y+HSAAS PI+H
Sbjct: 493 LETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTYMHSAASFPIFH 552
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 545
RDIK+ NILLD+KYRAKVSDFGTSRSV +DQTHLTT V GTFGY+DPEYF SSQ+T KSD
Sbjct: 553 RDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSD 612
Query: 546 VYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIM 605
VYSFGVVLVE++TG+KP+ + ++E + L +FL+A+ ENR+ +I+D R+ E+K E +M
Sbjct: 613 VYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDESKLEQVM 672
Query: 606 TVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638
VA LA++CLN GK RP MKEV+ EL IR+S
Sbjct: 673 AVAKLARKCLNRKGKNRPNMKEVSNELERIRSS 705
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1104 (393.7 bits), Expect = 7.1e-126, Sum P(2) = 7.1e-126
Identities = 218/388 (56%), Positives = 281/388 (72%)
Query: 306 WWLYKFVKRRKEIKLKQKFFKRXXXXXXXXXXXXXXXXIEKTKLFTSKDLEKATDNYNAN 365
W L K ++RK K K+KFF+R + +TK+F+S DLE ATD +NA+
Sbjct: 334 WLLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNAS 393
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
RILGQGGQGTVYKGML DG IVAVKKSK + E N+E+FINE+++LSQINHRN+VK+LGCC
Sbjct: 394 RILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGCC 453
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
LETEVP+LVYEFIPN L+ ++HN E+FP++WE+ L IA EV+ AL YLHSA SIPIYH
Sbjct: 454 LETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYH 513
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 545
RD+KS NILLD+K+RAKVSDFG SRSV +D THLTT VQGT GYVDPEY QS+ FT KSD
Sbjct: 514 RDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSD 573
Query: 546 VYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIM 605
VYSFGV+L+E+LTG+KP+ + E + L YFL+A+ +RL EILDAR+ +E +E ++
Sbjct: 574 VYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEECDREEVL 633
Query: 606 TVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST-GASILQQNCEEIDFVDGDISGHSLE 664
VA LA+RCL+LN + RPTM++V EL +++ G QN EE + + S+
Sbjct: 634 AVAKLARRCLSLNSEHRPTMRDVFIELDRMQSKRKGTQSQAQNGEEHAHIQIAMP-ESMS 692
Query: 665 TGSSSTGMSILNSSSAFSIDAHPLLSNK 692
SS + + NSS FS+D PL+ +K
Sbjct: 693 LSYSSPNIVVENSS--FSLDTKPLMPHK 718
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1116 (397.9 bits), Expect = 1.2e-125, Sum P(2) = 1.2e-125
Identities = 209/347 (60%), Positives = 275/347 (79%)
Query: 306 WWLYKFVKRRKEIKLKQKFFKRXXXXXXXXXXXXXXXXIEKTKLFTSKDLEKATDNYNAN 365
W L KFVK+R++I K+ FFKR ++ +K+F+SK+LEKATDN+N N
Sbjct: 365 WGLIKFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMN 424
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
R+LGQGGQGTVYKGML DGRIVAVK+SK++DE VE+FINEV +LSQINHRNIVKL+GCC
Sbjct: 425 RVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCC 484
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
LETEVP+LVYE IPNG L++ +H+ +++ +TW++ LRI+VE++GAL YLHSAAS P+YH
Sbjct: 485 LETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYH 544
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 545
RD+K+ NILLD+KYRAKVSDFGTSRS+ VDQTHLTT V GTFGY+DPEYFQ+SQFT+KSD
Sbjct: 545 RDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSD 604
Query: 546 VYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIM 605
VYSFGVVLVE++TG+KP + +E++ LV +F +A+ +NR+ +I+D+R+ + E ++
Sbjct: 605 VYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTLEQVL 664
Query: 606 TVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGASILQQNCEEID 652
VA LA+RCL+L GK RP M+EV+ EL IR+S L+ + EE D
Sbjct: 665 AVAKLARRCLSLKGKKRPNMREVSVELERIRSSP--EDLELHIEEED 709
|
|
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1109 (395.4 bits), Expect = 1.0e-124, Sum P(2) = 1.0e-124
Identities = 208/344 (60%), Positives = 271/344 (78%)
Query: 308 LYKFVKRRKEIKLKQKFFKRXXXXXXXXXXXXXXXXIEKTKLFTSKDLEKATDNYNANRI 367
LYKF+K+++++ K+KFFKR +EKT +F+S++LEKAT+N+++NRI
Sbjct: 393 LYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVFSSRELEKATENFSSNRI 452
Query: 368 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 427
LGQGGQGTVYKGML DGRIVAVKKSK+VDE +E+FINEVVILSQINHRNIVKLLGCCLE
Sbjct: 453 LGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLE 512
Query: 428 TEVPLLVYEFIPNGTLYQYIHNQIEE-FPITWELLLRIAVEVSGALFYLHSAASIPIYHR 486
T+VP+LVYEFIPNG L++++H++ +E TW + LRIA++++GAL YLHS+AS PIYHR
Sbjct: 513 TKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIAGALSYLHSSASSPIYHR 572
Query: 487 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDV 546
D+KS NI+LD+KYRAKVSDFGTSR+V VD THLTT V GT GY+DPEYFQSSQFT+KSDV
Sbjct: 573 DVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDV 632
Query: 547 YSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMT 606
YSFGVVLVE++TG+K I + + E+++L YF+ A+ EN+LF+I+DAR+ +
Sbjct: 633 YSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDIIDARIRDGCMLSQVTA 692
Query: 607 VATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGASILQQNCEE 650
A +A++CLNL G+ RP+M+EV+ EL IR G LQ+ E
Sbjct: 693 TAKVARKCLNLKGRKRPSMREVSMELDSIRMPCGDMQLQECVSE 736
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1106 (394.4 bits), Expect = 9.2e-124, Sum P(2) = 9.2e-124
Identities = 260/605 (42%), Positives = 360/605 (59%)
Query: 112 CLSISTCDPTSKRGCYDFLCALSPNITHIFNADLSYFYSQNISQKCRSVSVVEENWVGSK 171
C +IS + TS G +L I ++ S S+ C+ + +E + S
Sbjct: 180 CKNISIMNDTSCNGIGCCKASLPARYQQIIGVEIDD--SNTESKGCKVAFITDEEYFLSN 237
Query: 172 YLENPRVLKQQARGIPAM-LDW------GEEIGS--CFEEFSSYSTICGD-RENG--CSI 219
+ R+ A G + L W IGS C + Y+ + D RE G C
Sbjct: 238 GSDPERL---HANGYDTVDLRWFIHTANHSFIGSLGC-KSIDEYTILRRDNREYGIGCLC 293
Query: 220 KLSS---GYI-CRCDAGFY-RPH--GLCSGTLLCISGHNCSK-CPYGYFRYPRNSTDCYG 271
+S GY C C +GF P+ G C C+ G + + C G + G
Sbjct: 294 DYNSTTTGYATCSCASGFEGNPYIPGECKDINECVRGIDGNPVCTAG------KCVNLLG 347
Query: 272 GTAYYSYFTRKSRVKYXXXXXXXXXXXXXXXXXXWWLYKFVKRRKEIKLKQKFFKRXXXX 331
G Y +T + +WLYKF++R++ + K+KFFKR
Sbjct: 348 G--YTCEYTNHRPL---VIGLSTSFSTLVFIGGIYWLYKFIRRQRRLNQKKKFFKRNGGL 402
Query: 332 XXXXXXXXXXXXIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKK 391
++ T++F S++LEKAT+N++ RILG+GGQGTVYKGML DGRIVAVKK
Sbjct: 403 LLQQQLTTTEGNVDSTRVFNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKK 462
Query: 392 SKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQI 451
SK+VDE +E+FINEVVILSQINHRNIVKLLGCCLET+VP+LVYEFIPNG L++++H+
Sbjct: 463 SKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDS 522
Query: 452 EEFPIT-WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510
+++ +T WE+ LRIAV+++GAL YLHSAAS PIYHRDIKS NI+LD+K+RAKVSDFGTSR
Sbjct: 523 DDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSR 582
Query: 511 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+V VD THLTT V GT GY+DPEYFQSSQFT+KSDVYSFGVVL E++TG+K + + + E
Sbjct: 583 TVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQE 642
Query: 571 DKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAF 630
++L YF A+ ENRL +I+DAR+ K + A +A++CLN+ G+ RP+M++V+
Sbjct: 643 YRTLATYFTLAMKENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSM 702
Query: 631 ELGGIRTSTGA----SILQQNCEEID--FVDGDISGHS-LETGSSSTGMSILNSSSAFSI 683
EL IR+ + +N EE VD ++ + + ++S+ SI +SS+ S
Sbjct: 703 ELEKIRSYSEDMQPYEYASENEEEKKETLVDVNVESRNYVSVTAASSQYSIATTSSSRS- 761
Query: 684 DAHPL 688
D PL
Sbjct: 762 DVEPL 766
|
|
| TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1076 (383.8 bits), Expect = 1.9e-122, Sum P(3) = 1.9e-122
Identities = 208/361 (57%), Positives = 263/361 (72%)
Query: 306 WWLYKFVKRRKEIKLKQKFFKRXXXXXXXXXXXXXXXXIEKTKLFTSKDLEKATDNYNAN 365
WW K +++R+ K+KFFKR +EKTKLF+S++LEKATDN+N N
Sbjct: 398 WWWRKLLRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSSRELEKATDNFNDN 457
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
R++GQGGQGTVYKGML DGR VAVKKS +VDE +++FINEV+ILSQINHR++VKLLGCC
Sbjct: 458 RVIGQGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIILSQINHRHVVKLLGCC 517
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
LETEVP+LVYEFIPNG L+Q++H + +++ W + +RIAV++SGA YLH+AA PIYH
Sbjct: 518 LETEVPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVDISGAFSYLHTAACSPIYH 577
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 545
RDIKS NILLD+KYRAKVSDFGTSRSV +D TH TT + GT GYVDPEY+ SS FTEKSD
Sbjct: 578 RDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFTEKSD 637
Query: 546 VYSFGVVLVEILTGQKPIRAIN-TDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGI 604
VYSFGVVLVE++TG+KP+ ++ T E L YF A+ ENRLFEI+DAR+ + K E +
Sbjct: 638 VYSFGVVLVELITGEKPVITLSETQEITGLADYFRLAMRENRLFEIIDARIRNDCKLEQV 697
Query: 605 MTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGASILQQNCEEIDFVDGDISGHSLE 664
+ VA LA RCL GK RP M+EV+ L I ++ +Q +E D G+S
Sbjct: 698 IAVANLALRCLKKTGKTRPDMREVSTALERICSAPEDFQVQIQIDEEDETTKLFRGYSGS 757
Query: 665 T 665
T
Sbjct: 758 T 758
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1074 (383.1 bits), Expect = 2.2e-122, Sum P(2) = 2.2e-122
Identities = 207/353 (58%), Positives = 267/353 (75%)
Query: 306 WWLYKFVKRRKEIKLKQKFFKRXXXXXXXXXXXXXXXXIEKTKLFTSKDLEKATDNYNAN 365
WWL KF+ +R+ K K+KFFKR +EK ++FTSK+LEKAT+N++ N
Sbjct: 388 WWLRKFLVKRRMAKRKKKFFKRNGGLLLQQELNTRQGVVEKARIFTSKELEKATENFSEN 447
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
R+LG GGQGTVYKGML DGR VAVKKSK++DE +++FINEVVILSQINHR++VKLLGCC
Sbjct: 448 RVLGHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCC 507
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
LETEVP+LVYEFI NG L+++IH + +++ + W + LRIAV+++GAL YLHSAAS PIY
Sbjct: 508 LETEVPILVYEFIINGNLFKHIHEEEADDYTMIWGMRLRIAVDIAGALSYLHSAASSPIY 567
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 544
HRDIKS NILLD+KYRAKV+DFGTSRSV +DQTH TT + GT GYVDPEY++SSQ+TEKS
Sbjct: 568 HRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQYTEKS 627
Query: 545 DVYSFGVVLVEILTGQKPIRAI-NTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEG 603
DVYSFGV+L E++TG KP+ + NT E +L +F A+ E RL +I+DAR+ ++K E
Sbjct: 628 DVYSFGVILAELITGDKPVIMVQNTQEIIALAEHFRVAMKERRLSDIMDARIRDDSKPEQ 687
Query: 604 IMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGASILQQNCEEIDFVDG 656
+M VA LA +CL+ G+ RP M+EV EL I TS S +Q +E + DG
Sbjct: 688 VMAVANLAMKCLSSRGRNRPNMREVFTELERICTSPEDSQVQNRIDEEEEEDG 740
|
|
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1188 (423.3 bits), Expect = 9.5e-121, P = 9.5e-121
Identities = 285/713 (39%), Positives = 410/713 (57%)
Query: 9 PFGIG-KGCFLDKSFEVICNYSGKYP--KAYLPGINNLELLDIDSYYEGTIRVNFPIISL 65
PFGIG K C+L+ +EV+CN + P + N+ L + + + + +
Sbjct: 47 PFGIGGKDCYLNPWYEVVCNSTNSVPFLSRINRELVNISLNGV-VHIKAPVTSSGCSTGT 105
Query: 66 KNSSNAKGVNLLG--SPFIFSNISNRFAAIGCDDYDTVDINNSTVSGGC-LSISTCDPTS 122
+N+ G SP+ ++ N A+GC + V ++ C S + + +S
Sbjct: 106 SQPLTPPPLNVAGQGSPYFLTD-KNLLVAVGCK-FKAVMAGITSQITSCESSCNERNSSS 163
Query: 123 KRG----CYDFLCA---LSPNITHIFNADLSYFYSQNISQK--CRSVSVVEENWVGSKYL 173
+ G C + C + + + D+ N + + CR + + + S +
Sbjct: 164 QEGRNKICNGYKCCQTRIPEGQPQVISVDIEIPQGNNTTGEGGCRVAFLTSDKY-SSLNV 222
Query: 174 ENPRVLKQQARGIPAM-LDWGEEIG--------SCFEEFSSYSTICGDRENGCSIKLSSG 224
P K G A+ L W + SC + S + D CS SG
Sbjct: 223 TEPE--KFHGHGYAAVELGWFFDTSDSRDTQPISC-KNASDTTPYTSDTRCSCSYGYFSG 279
Query: 225 YI---CRCDAGFYRPHGLCSGTLLCISGHNCSKCPYGYFRYPRNSTDCYGGTAYYSYFTR 281
+ C C++ Y+ + G C+ C K G R C ++ +
Sbjct: 280 FSYRDCYCNSPGYKGNPFLPGG--CVDVDEC-KLDIG--RNQCKDQSCVNLPGWFDCQPK 334
Query: 282 K-SRVKYXXXXXXXXXXXXXXXXXXWWLYKFV-KRRKEIKLKQKFFKRXXXXXXXXXXXX 339
K ++K + LYKFV KRRK I+++ KFF+R
Sbjct: 335 KPEQLKRVIQGVLIGSALLLFAFGIFGLYKFVQKRRKLIRMR-KFFRRNGGMLLKQQLAR 393
Query: 340 XXXXIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETN 399
+E +++F+S +LEKATDN+N NR+LGQGGQGTVYKGML DGRIVAVK+SK VDE
Sbjct: 394 KEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDR 453
Query: 400 VEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWE 459
VE+FINEVV+L+QINHRNIVKLLGCCLETEVP+LVYEF+PNG L + +H++ +++ +TWE
Sbjct: 454 VEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWE 513
Query: 460 LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519
+ L IA+E++GAL YLHSAAS PIYHRDIK+ NILLD++ RAKVSDFGTSRSV +DQTHL
Sbjct: 514 VRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHL 573
Query: 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL 579
TT+V GTFGYVDPEYFQSS+FTEKSDVYSFGVVLVE+LTG+KP + ++E++ L +F+
Sbjct: 574 TTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFV 633
Query: 580 QAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS- 638
+A+ ENR+ +I+D R+ E + +M+VA LA+RCLN GK RP M+EV+ EL IR+S
Sbjct: 634 EAVKENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSSH 693
Query: 639 --TGASILQQNCEEIDFVDGDISGHSLETGSSSTGMSILNSSSAFSIDAHPLL 689
+G I + E+ ++ + + + E G+++ S+ N++S S DA PL+
Sbjct: 694 YDSGIHIEDDDEEDDQAMELNFND-TWEVGATAPA-SMFNNASPTS-DAEPLV 743
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1060 (378.2 bits), Expect = 1.8e-112, Sum P(2) = 1.8e-112
Identities = 216/393 (54%), Positives = 282/393 (71%)
Query: 306 WWLYKFVKRRKEIKLKQKFFKRXXXXXXXXXXXXXXXXIEKTKLFTSKDLEKATDNYNAN 365
WWL KF+ +R+ K K+KFFKR +EKT++F S++LEKAT+N++ N
Sbjct: 397 WWLRKFLIKRRITKRKKKFFKRNGGLLLLQELNTREGYVEKTRVFNSRELEKATENFSEN 456
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
R+LG GGQGTVYKGML DGR VAVKKSK++DE +++FINEVVILSQINHR++VKLLGCC
Sbjct: 457 RVLGHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCC 516
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
LETEVP+LVYEFI NG L+++IH + +++ + W + LRIAV+++GAL YLHS+AS PIY
Sbjct: 517 LETEVPMLVYEFIINGNLFKHIHEEESDDYTMLWGMRLRIAVDIAGALSYLHSSASSPIY 576
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 544
HRDIKS NILLD+KYRAKV+DFGTSRSV +DQTH TT + GT GYVDPEY+QSSQ+TEKS
Sbjct: 577 HRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYQSSQYTEKS 636
Query: 545 DVYSFGVVLVEILTGQKPIRAI-NTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEG 603
DVYSFGV+L E++TG KP+ + NT E +L +F A+ E RL +I+DAR+ + K E
Sbjct: 637 DVYSFGVILAELITGDKPVIMVQNTQEIVALAEHFRVAMKEKRLTDIIDARIRNDCKPEQ 696
Query: 604 IMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGASIL-------QQNCEEIDFVDG 656
+M VA +A +CL+ GK RP M+EV EL I TS S + ++ EE + V
Sbjct: 697 VMAVAKVAMKCLSSKGKKRPNMREVFTELERICTSPEDSQVHNRIDEEEEEEEEEEEVVT 756
Query: 657 DIS-GHSLETGSSSTGMSILNSSSAFSIDAHPL 688
I+ G S ++ +SI+ SS S D PL
Sbjct: 757 TINRGDSWSISVTAPALSIVASSP--SSDVEPL 787
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q7X8C5 | WAKLB_ARATH | 2, ., 7, ., 1, 1, ., - | 0.4230 | 0.9495 | 0.8810 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 694 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-50 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-49 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-41 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-33 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-32 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-32 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-32 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-29 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-28 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-28 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-27 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-27 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-27 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-26 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-25 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-25 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-23 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-23 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-22 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-22 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-22 | |
| pfam13947 | 106 | pfam13947, GUB_WAK_bind, Wall-associated receptor | 1e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-21 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-20 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-19 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-16 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-13 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 7e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.004 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 1e-51
Identities = 92/271 (33%), Positives = 137/271 (50%), Gaps = 21/271 (7%)
Query: 362 YNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVE--QFINEVVILSQINHRNI 418
Y R LG G GTVYK G+IVAVK K E + + E+ IL +++H NI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 419 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 478
V+L+ + + LV E+ G L+ Y+ P++ + +IA+++ L YLHS
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQS 537
I HRD+K NILLD+ K++DFG ++ ++ + LTT V GT Y+ PE
Sbjct: 118 G---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGG 173
Query: 538 SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597
+ + K DV+S GV+L E+LTG+ P N + L+ L E E + +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLE--FDEPKWSSGSE 231
Query: 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
EAK L K+CLN + RPT +E+
Sbjct: 232 EAKD--------LIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 2e-51
Identities = 70/193 (36%), Positives = 105/193 (54%), Gaps = 10/193 (5%)
Query: 368 LGQGGQGTVYKGM-LTDGRIVAVKK-SKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
LG+GG GTVY G+ VA+K K + +E+ + E+ IL ++NH NIVKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
+ LV E+ G+L + E ++ + +LRI +++ L YLH S I H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 486 RDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQSSQFTEK 543
RD+K NILLD D + K++DFG S+ + L + GT Y+ PE ++EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKL-LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 544 SDVYSFGVVLVEI 556
SD++S GV+L E+
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 4e-51
Identities = 73/265 (27%), Positives = 118/265 (44%), Gaps = 23/265 (8%)
Query: 366 RILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETN-VEQFINEVVILSQINHRNIVKLLG 423
LG+G G VY G++VA+K K E+ + E+ IL ++ H NIV+L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 483
+ + LV E+ G L+ + + ++ + ++ AL YLHS I
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRG---RLSEDEARFYLRQILSALEYLHSK---GI 118
Query: 484 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 543
HRD+K NILLD+ K++DFG +R +D T GT Y+ PE + +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 544 SDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEG 603
D++S GV+L E+LTG+ P + + F + F + + EAK
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLE-----LFKKIGKPKPPFPPPEWDISPEAKD-- 229
Query: 604 IMTVATLAKRCLNLNGKMRPTMKEV 628
L ++ L + + R T +E
Sbjct: 230 ------LIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 1e-50
Identities = 82/283 (28%), Positives = 129/283 (45%), Gaps = 44/283 (15%)
Query: 365 NRILGQGGQGTVYKGMLTD-----GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNI 418
+ LG+G G VYKG L VAVK K E +E+F+ E I+ +++H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 419 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 478
VKLLG C E E +V E++ G L Y+ + ++ LL A++++ + YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE-- 119
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 538
S HRD+ + N L+ + K+SDFG SR + D + + ++ PE +
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 539 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597
+FT KSDV+SFGV+L EI T G++P Y + + VL+
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQP--------------Y----------PGMSNEEVLE 214
Query: 598 EAKKEGIMT--------VATLAKRCLNLNGKMRPTMKEVAFEL 632
K + + L +C + + RPT E+ L
Sbjct: 215 YLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 1e-50
Identities = 85/279 (30%), Positives = 132/279 (47%), Gaps = 43/279 (15%)
Query: 365 NRILGQGGQGTVYKGMLTDG-----RIVAVKKSKL-VDETNVEQFINEVVILSQINHRNI 418
+ LG+G G VYKG L VAVK K E +E+F+ E I+ +++H NI
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 419 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 478
VKLLG C E E ++V E++P G L Y+ + ++ LL A++++ + YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLE-- 120
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 538
S HRD+ + N L+ + K+SDFG SR + D + + ++ PE +
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 539 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597
+FT KSDV+SFGV+L EI T G++P Y + +A VL+
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEP--------------Y----------PGMSNAEVLE 215
Query: 598 EAKKEGIMT--------VATLAKRCLNLNGKMRPTMKEV 628
KK + + L +C + + RPT E+
Sbjct: 216 YLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 5e-50
Identities = 88/283 (31%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 366 RILGQGGQGTVYKGMLTDG----RIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVK 420
+ LG+G G VYKG L VAVK K E + F+ E ++ ++ H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 421 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAVEVSGALFY 474
LLG C E E LV E++ G L Y+ FP ++ + LL A++++ + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 475 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDP 532
L S HRD+ + N L+ + K+SDFG SR V D + K G ++ P
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-RKKTGGKLPIRWMAP 176
Query: 533 EYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINE-NRLFEI 590
E + FT KSDV+SFGV+L EI T G P ++ +E L+ + + RL
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYRL--- 226
Query: 591 LDARVLKEAKKEGIM-TVATLAKRCLNLNGKMRPTMKEVAFEL 632
K E + L C L+ + RPT E+ L
Sbjct: 227 --------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 82/278 (29%), Positives = 134/278 (48%), Gaps = 33/278 (11%)
Query: 365 NRILGQGGQGTVYKGMLTD-----GRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNI 418
+ LG+G G VYKG L VAVK K E E+F+ E I+ +++H NI
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 419 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 478
V+LLG C + E +V E++P G L ++ E+ + LL++A++++ + YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE-- 119
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG---YVDPEYF 535
S HRD+ + N L+ + K+SDFG SR + D + G ++ PE
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPESL 176
Query: 536 QSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594
+ +FT KSDV+SFGV+L EI T G++P ++ +E L+ + + +
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-------VLELLEDGYRLPRPE-- 227
Query: 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632
E + L +C + + RPT E+ +L
Sbjct: 228 ---NCPDE----LYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 1e-41
Identities = 65/208 (31%), Positives = 108/208 (51%), Gaps = 22/208 (10%)
Query: 366 RILGQGGQGTVYKGMLTD-GRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLL 422
+LG+G G+VY + D G ++AVK +L E +E E+ ILS + H NIV+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 423 GCCL-ETEVPLLVY-EFIPNGTLYQYIHN--QIEEFPI---TWELLLRIAVEVSGALFYL 475
G E + L ++ E++ G+L + ++ E I T ++L L YL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE--------GLAYL 117
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV-MVDQTHLTTKVQGTFGYVDPEY 534
HS I HRDIK ANIL+D K++DFG ++ + ++ T V+GT ++ PE
Sbjct: 118 HSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 535 FQSSQFTEKSDVYSFGVVLVEILTGQKP 562
+ ++ +D++S G ++E+ TG+ P
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 79/267 (29%), Positives = 124/267 (46%), Gaps = 24/267 (8%)
Query: 366 RILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLL 422
+ +G+G G VY +DG++ +K+ L + E E +NEV IL ++NH NI+K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 423 GCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGALFYLHSAASI 481
E +V E+ G L Q I Q +E P E +L V++ AL YLHS
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-- 123
Query: 482 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 541
I HRDIK NI L K+ DFG S+ + T V GT Y+ PE Q+ +
Sbjct: 124 -ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKPYN 181
Query: 542 EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKK 601
KSD++S G VL E+ T + P ++L+ L+ + + + ++ E
Sbjct: 182 YKSDIWSLGCVLYELCTLKHPFEG------ENLLELALKILKGQ--YPPIPSQYSSE--- 230
Query: 602 EGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ L L + + RP++ ++
Sbjct: 231 -----LRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 67/201 (33%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 368 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 426
+G+GG G VYK G+ VA+K KL + E+ INE+ IL + H NIVK G L
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 427 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV---EVSGALFYLHSAASIPI 483
+ + +V EF G+L + + + + IA E+ L YLHS I
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----IAYVCKELLKGLEYLHSNGII-- 120
Query: 484 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 543
HRDIK+ANILL K+ DFG S + T + GT ++ PE + K
Sbjct: 121 -HRDIKAANILLTSDGEVKLIDFGL--SAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 544 SDVYSFGVVLVEILTGQKPIR 564
+D++S G+ +E+ G+ P
Sbjct: 178 ADIWSLGITAIELAEGKPPYS 198
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 70/206 (33%), Positives = 109/206 (52%), Gaps = 12/206 (5%)
Query: 361 NYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRN 417
NY ++G+G G VYKG+ L G VA+K+ L + E ++ + E+ +L + H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 418 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV-EVSGALFYLH 476
IVK +G ++ ++ E+ NG+L Q I FP E L+ + V +V L YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKK-FGPFP---ESLVAVYVYQVLQGLAYLH 116
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 536
I HRDIK+ANIL K++DFG + + + D + V GT ++ PE +
Sbjct: 117 EQGVI---HRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIE 172
Query: 537 SSQFTEKSDVYSFGVVLVEILTGQKP 562
S + SD++S G ++E+LTG P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 3e-33
Identities = 81/280 (28%), Positives = 120/280 (42%), Gaps = 22/280 (7%)
Query: 361 NYNANRILGQGGQGTVYKGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH-R 416
+Y R LG+G G VY D ++VA+K K VE+F+ E+ IL+ +NH
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 476
NIVKL + LV E++ G+L + + P++ L I ++ AL YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 477 SAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTH-----LTTKVQGTFGYV 530
S I HRDIK NILLD D K+ DFG ++ + + L + GT GY+
Sbjct: 119 SKGII---HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 531 DPEYFQSSQF---TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 587
PE + SD++S G+ L E+LTG P S I
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ----TLKIILELP 231
Query: 588 FEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKE 627
L + + + + L K+ L + K R +
Sbjct: 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 77/287 (26%), Positives = 125/287 (43%), Gaps = 45/287 (15%)
Query: 366 RILGQGGQGTVYKGMLT------DGRIVAVKKSK-LVDETNVEQFINEVVILSQINHRNI 418
R LG+G G V+ G D +VAVK K + F E +L+ H NI
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 419 VKLLGCCLETEVPLLVYEFIPNGTLYQY-----------IHNQIEEFPITWELLLRIAVE 467
VK G C E + P++V+E++ +G L ++ +T LL+IAV+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 468 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT- 526
++ + YL AS HRD+ + N L+ K+ DFG SR V + +V G
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY---RVGGHT 184
Query: 527 ---FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAI 582
++ PE +FT +SDV+SFGVVL EI T G++P ++ +
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP--------------WY--GL 228
Query: 583 NENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVA 629
+ + E + L + + V + C + + R +K++
Sbjct: 229 SNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 8e-32
Identities = 74/208 (35%), Positives = 106/208 (50%), Gaps = 13/208 (6%)
Query: 368 LGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLG 423
LG+G G V D G++ A+K K K++ VE + E ILS+INH IVKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 424 CCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 482
+TE L LV E+ P G L+ ++ E + E A E+ AL YLHS
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG--- 113
Query: 483 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 542
I +RD+K NILLD K++DFG ++ + + + T GT Y+ PE + +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGK 172
Query: 543 KSDVYSFGVVLVEILTGQKPIRAINTDE 570
D +S GV+L E+LTG+ P A + E
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 9e-32
Identities = 72/259 (27%), Positives = 125/259 (48%), Gaps = 24/259 (9%)
Query: 368 LGQGGQGTVYKGML-TDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGC 424
+G+G G V+K + D R+ A+K+ L ++ E+ I+E +L++++ I++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 425 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
L+ +V E+ NG L++ + Q P+ + + R +++ L +LHS I
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSKK---IL 123
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 544
HRDIKS N+ LD K+ D G ++ ++ D T+ + GT Y+ PE + + EKS
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAK-LLSDNTNFANTIVGTPYYLSPELCEDKPYNEKS 182
Query: 545 DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGI 604
DV++ GVVL E TG+ P A N G + I F + ++
Sbjct: 183 DVWALGVVLYECCTGKHPFDANNQ-------GALILKIIRGV-FPPVSQMYSQQ------ 228
Query: 605 MTVATLAKRCLNLNGKMRP 623
+A L +CL + + RP
Sbjct: 229 --LAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 75/225 (33%), Positives = 122/225 (54%), Gaps = 18/225 (8%)
Query: 366 RILGQGGQGTVYKGMLTDG----RIVAVKK-SKLVDETNVEQFINEVVILSQINHRNIVK 420
R++G+G G VY G L D AVK +++ D VEQF+ E +I+ +H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 421 LLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
LLG CL +E PL+V ++ +G L +I + E T + L+ ++V+ + YL A
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRS--ETHNPTVKDLIGFGLQVAKGMEYL---A 115
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM---VDQTHLTTKVQGTFGYVDPEYFQ 536
S HRD+ + N +LD+ + KV+DFG +R + H T + ++ E Q
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 537 SSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQ 580
+ +FT KSDV+SFGV+L E++T G P +++ + + Y LQ
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYLLQ 217
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 9e-30
Identities = 79/269 (29%), Positives = 125/269 (46%), Gaps = 33/269 (12%)
Query: 368 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 427
+G+G G V G G+ VAVK K D T + F+ E +++ + H N+V+LLG L+
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 428 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 487
+V E++ G+L Y+ ++ IT L A++V + YL HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRD 127
Query: 488 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 547
+ + N+L+ + AKVSDFG ++ Q V+ T PE + +F+ KSDV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDVW 183
Query: 548 SFGVVLVEILT-GQKPIRAINTDE--DKSLVGYFLQAINENRLFEILDARVLKEAKKEGI 604
SFG++L EI + G+ P I + GY ++A EG
Sbjct: 184 SFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA-------------------PEGC 224
Query: 605 -MTVATLAKRCLNLNGKMRPTMKEVAFEL 632
V + K C L+ RPT K++ +L
Sbjct: 225 PPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 66/222 (29%), Positives = 116/222 (52%), Gaps = 12/222 (5%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVK--KSKLVDETNVEQFINEVVILSQINHRNIVKLLG 423
+G+G G VYKG+L VAVK +S L + +F+ E IL Q +H NIVKL+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIG 59
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 483
C++ + +V E +P G+L ++ + + + LL+++++ + + YL S I
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLESKNCI-- 115
Query: 484 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV-QGTFGYVDPEYFQSSQFTE 542
HRD+ + N L+ + K+SDFG SR ++ + Q + PE ++T
Sbjct: 116 -HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 543 KSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQA 581
+SDV+S+G++L E + G P ++ + + + GY + A
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA 216
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 22/219 (10%)
Query: 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRN 417
+ Y +G+G G VYK G+ VA+KK +L + N E INE++I+ H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPN 76
Query: 418 IVKLLGCCLETEVPLLVYEFIPNGTL----YQYIHNQIEEFPITWELLLRIAVEVSGALF 473
IV L + +V E++ G+L Q + + + EV L
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN------FVRMNEPQIAYVCREVLQGLE 130
Query: 474 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 533
YLHS I HRDIKS NILL K++DFG + + +++ + V GT ++ PE
Sbjct: 131 YLHSQNVI---HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPE 186
Query: 534 YFQSSQFTEKSDVYSFGVVLVEILTGQ------KPIRAI 566
+ + K D++S G++ +E+ G+ P+RA+
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 68/199 (34%), Positives = 105/199 (52%), Gaps = 16/199 (8%)
Query: 368 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRNIVKLLGCC 425
LG G G V+ G VA+K ++ E + + FI E ++ +++H N+V+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK---MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
+ +V E++ NG L Y+ + + E LL + +V A+ YL S I H
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGT--EWLLDMCSDVCEAMEYLESNGFI---H 123
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQSSQFTE 542
RD+ + N L+ + KVSDFG +R V+ DQ T QGT + PE F S+F+
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 543 KSDVYSFGVVLVEILTGQK 561
KSDV+SFGV++ E+ + K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 368 LGQGGQGTVYKG--MLTDGRIVAVKKSKLVDETNV---EQFINEVVILSQINHRNIVKLL 422
LG G G+V KG ++ G+ V V L E ++F+ E +++Q++H IV+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 423 GCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 482
G C E +LV E P G L +Y+ + E I L +A +V+ + YL S +
Sbjct: 63 GVCKG-EPLMLVMELAPLGPLLKYLKKRRE---IPVSDLKELAHQVAMGMAYLESKHFV- 117
Query: 483 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQF 540
HRD+ + N+LL ++++AK+SDFG SR++ + G + + PE +F
Sbjct: 118 --HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 541 TEKSDVYSFGVVLVEILT-GQKPIRAI 566
+ KSDV+S+GV L E + G KP +
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 68/235 (28%), Positives = 104/235 (44%), Gaps = 30/235 (12%)
Query: 360 DNYNANRILGQGGQGTVYKGML-TDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN- 414
D++ +I+G+G TV + A+K K +L+ E V+ E +L+++N
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 415 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 474
H I+KL + E V E+ PNG L QYI A E+ AL Y
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKCTRF--YAAEILLALEY 117
Query: 475 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ---------- 524
LHS I HRD+K NILLD K++DFGT++ + + + + K
Sbjct: 118 LHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 525 ---------GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
GT YV PE + SD+++ G ++ ++LTG+ P R N
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 75/288 (26%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 366 RILGQGGQGTVYKGMLT--DGRI--VAVKKSKL--VDETNVEQFINEVVILSQINHRNIV 419
+ILG+G G+V +G L+ DG VAVK KL + +E+F++E + +H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 420 KLLGCCLETE------VPLLVYEFIPNGTLYQYI-HNQIEEFP--ITWELLLRIAVEVSG 470
KL+G C E P+++ F+ +G L+ ++ ++++ P + + LL+ V+++
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD----QTHLTTKVQGT 526
+ YL + I HRD+ + N +L + V+DFG S+ + Q + +
Sbjct: 125 GMEYLSNRNFI---HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA---KMP 178
Query: 527 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINEN 585
++ E +T KSDV++FGV + EI T GQ P + E + + N
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL------RHGN 232
Query: 586 RLFEILDARVLKEAKKEGIMT-VATLAKRCLNLNGKMRPTMKEVAFEL 632
RL + E + + L C + K RPT ++ L
Sbjct: 233 RL-----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 8e-28
Identities = 69/212 (32%), Positives = 118/212 (55%), Gaps = 23/212 (10%)
Query: 367 ILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETN-------VEQFINEVVILSQINHR 416
++G G G+VY GM + G ++AVK+ +L V ++ ++ E+ +L ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV-EVSGALFYL 475
NIV+ LG L+ + + E++P G++ + N F E L+R V ++ L YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFE---ETLVRNFVRQILKGLNYL 122
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-----VQGTFGYV 530
H+ I HRDIK ANIL+D+K K+SDFG S+ + + T +QG+ ++
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 531 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
PE + + +T K+D++S G ++VE+LTG+ P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 76/269 (28%), Positives = 121/269 (44%), Gaps = 25/269 (9%)
Query: 367 ILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLG 423
+G+G GTV K +DG+I+ K+ + E +Q ++EV IL ++ H NIV+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 424 CCL--ETEVPLLVYEFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGALFYLH--SA 478
+ + +V E+ G L Q I +E I E + RI ++ AL+ H S
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 538
+ HRD+K ANI LD K+ DFG ++ + D + T V GT Y+ PE
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHM 185
Query: 539 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598
+ EKSD++S G ++ E+ P A N + L + F + R E
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASKIKEGK-----FRRIPYRYSSE 237
Query: 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKE 627
+ + K LN++ RP+ +E
Sbjct: 238 LNE--------VIKSMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 368 LGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVEQF--INEVVILSQINHRNIVK---- 420
LG+G G+VYK L+D + A+K+ L + E+ +NE+ IL+ +NH NI+
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 421 -LLGCCLETEVPLLVYEFIPNGTLYQYIHN-QIEEFPITWELLLRIAVEVSGALFYLHSA 478
L G L +V E+ P G L + I + + I + + RI +++ L LH
Sbjct: 68 FLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 538
I HRD+KSANILL K+ D G S+ V + ++ GT Y+ PE ++
Sbjct: 123 K---ILHRDLKSANILLVANDLVKIGDLGISK---VLKKNMAKTQIGTPHYMAPEVWKGR 176
Query: 539 QFTEKSDVYSFGVVLVEILTGQKPIRA 565
++ KSD++S G +L E+ T P A
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 83/270 (30%), Positives = 128/270 (47%), Gaps = 29/270 (10%)
Query: 368 LGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 426
LG G G VY+G+ VAVK K D VE+F+ E ++ +I H N+V+LLG C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 427 ETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
E P ++ EF+ G L Y+ + + +LL +A ++S A+ YL I H
Sbjct: 73 R-EPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKNFI---H 127
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFTEK 543
RD+ + N L+ + + KV+DFG SR +M T+ T F + PE ++F+ K
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSR-LMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 544 SDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKE 602
SDV++FGV+L EI T G P I+ + ++E+L+ E +
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLEKGYRMERPEG 229
Query: 603 GIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632
V L + C N RP+ E+
Sbjct: 230 CPPKVYELMRACWQWNPSDRPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 62/206 (30%), Positives = 108/206 (52%), Gaps = 6/206 (2%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
R LG G G V++G+ + VA+K K D + F EV L ++ H++++ L C
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
E ++ E + G+L ++ + E + L+ +A +V+ + YL SI H
Sbjct: 72 SVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQNSI---H 127
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 545
RD+ + NIL+ + KV+DFG +R ++ + +L++ + + + PE F+ KSD
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLAR-LIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSD 186
Query: 546 VYSFGVVLVEILT-GQKPIRAINTDE 570
V+SFG++L E+ T GQ P +N E
Sbjct: 187 VWSFGILLYEMFTYGQVPYPGMNNHE 212
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 68/198 (34%), Positives = 110/198 (55%), Gaps = 11/198 (5%)
Query: 368 LGQGGQGTVYKGMLTDGRIVAVK--KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
+G G G V+ G + R VA+K + + E E FI E ++ +++H +V+L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
E LV+EF+ +G L Y+ Q +F + E LL + ++V + YL S+ I H
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKF--SQETLLGMCLDVCEGMAYLESSNVI---H 123
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 545
RD+ + N L+ + KVSDFG +R V+ DQ +T + + PE F S+++ KSD
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 546 VYSFGVVLVEILT-GQKP 562
V+SFGV++ E+ + G+ P
Sbjct: 184 VWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 70/205 (34%), Positives = 108/205 (52%), Gaps = 14/205 (6%)
Query: 365 NRILGQGGQGTVYKGMLT---DGRI-VAVKKSKL-VDETNVEQFINEVVILSQINHRNIV 419
R +G+G G VY+G+ + +I VAVK K + E+F+ E I+ Q +H +IV
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 420 KLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 478
KL+G TE P+ +V E P G L Y+ Q+ ++ + L+ + ++S AL YL S
Sbjct: 71 KLIGVI--TENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES- 125
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 538
HRDI + N+L+ K+ DFG SR + + + +K + ++ PE
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 539 QFTEKSDVYSFGVVLVEILT-GQKP 562
+FT SDV+ FGV + EIL G KP
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 70/215 (32%), Positives = 108/215 (50%), Gaps = 18/215 (8%)
Query: 361 NYNANRILGQG--GQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHR 416
+Y R+LG+G G+ T+Y+ D +V K+ L + E +NE+VILS + H
Sbjct: 1 HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ----IEEFPITWELLLRIAVEVSGAL 472
NI+ ++ L+ E+ GTLY I Q EE + W L ++ A+
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF-----QIVSAV 114
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532
Y+H A I HRDIK+ NI L K+ DFG S+ ++ + + V GT Y+ P
Sbjct: 115 SYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAETVVGTPYYMSP 170
Query: 533 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 567
E Q ++ KSD+++ G VL E+LT ++ A N
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 77/281 (27%), Positives = 134/281 (47%), Gaps = 42/281 (14%)
Query: 366 RILGQGGQGTVYKGMLT-DGR----IVAVKKSKLVDET---NVEQFINEVVILSQINHRN 417
++LG G GTVYKG+ +G VA+K L +ET ++ ++E +++ ++H +
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKV--LREETSPKANKEILDEAYVMASVDHPH 70
Query: 418 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 477
+V+LLG CL + L+ + +P G L Y+ N + I + LL V+++ + YL
Sbjct: 71 VVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEE 127
Query: 478 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG---TFGYVDPEY 534
+ HRD+ + N+L+ K++DFG ++ + VD+ +G ++ E
Sbjct: 128 KR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMALES 182
Query: 535 FQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDA 593
+T KSDV+S+GV + E++T G KP I E L+ RL
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL------EKGERL------ 230
Query: 594 RVLKEAKKEGIMT--VATLAKRCLNLNGKMRPTMKEVAFEL 632
+ I T V + +C ++ + RPT KE+ E
Sbjct: 231 ------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 19/206 (9%)
Query: 368 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDET--NVEQFINEVVILSQINHRNIVKLLGC 424
+G G G VY + L G ++AVK+ ++ D +++ +E+ +L + H N+VK G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 425 CLETEVPLLVYEFIPNGTLYQYIHN-QIEEFPITWELLLRI-AVEVSGALFYLHSAASIP 482
+ E + E+ GTL + + + +I + E ++R+ +++ L YLHS
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILD-----EHVIRVYTLQLLEGLAYLHSHG--- 119
Query: 483 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG---YVDPEYFQSSQ 539
I HRDIK ANI LD K+ DFG + + + T + +VQ G Y+ PE +
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 540 FTEK---SDVYSFGVVLVEILTGQKP 562
+D++S G V++E+ TG++P
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 21/207 (10%)
Query: 368 LGQGGQGTVYKGMLTD--GRI--VAVK--KSKLVDETNVEQFINEVVILSQINHRNIVKL 421
LG G G V +G + G++ VAVK KS + + ++ F+ E I+ ++H N+++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD-IMDDFLKEAAIMHSLDHENLIRL 61
Query: 422 LGCCLETEVPLLVYEFIPNGTLYQYIH-NQIEEFPITWELLLRIAVEVSGALFYLHSAAS 480
G L T ++V E P G+L + + + F I+ L AV+++ + YL S
Sbjct: 62 YGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLIS--TLCDYAVQIANGMRYLESKRF 118
Query: 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT----KVQGTFGYVDPEYFQ 536
I HRD+ + NILL + K+ DFG R++ ++ H KV F + PE +
Sbjct: 119 I---HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173
Query: 537 SSQFTEKSDVYSFGVVLVEILT-GQKP 562
+ F+ SDV+ FGV L E+ T G++P
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 17/204 (8%)
Query: 366 RILGQGGQGTVYKGMLT-----DGRIVAVKKSKLVDETNVEQ-FINEVVILSQINHRNIV 419
+ LG+G G V G VAVK E F E+ IL ++H NIV
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 420 KLLGCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 477
K G C + L+ E++P+G+L Y+ ++ I + LL + ++ + YL S
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDYLGS 127
Query: 478 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG---TFGYVDPEY 534
I HRD+ + NIL++ + K+SDFG ++ + D+ + K G F Y PE
Sbjct: 128 QRYI---HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA-PEC 183
Query: 535 FQSSQFTEKSDVYSFGVVLVEILT 558
++S+F+ SDV+SFGV L E+ T
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 367 ILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVILSQINHRNIVKL 421
LG+G G VYK G IVA+KK +L +E E + E+ +L ++ H NIVKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKL 63
Query: 422 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAVEVSGALFYL 475
L LV+E+ L +Y+ + I ++LL L Y
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLR--------GLAYC 114
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 535
HS I HRD+K NIL++ K++DFG +R+ + T +V T Y PE
Sbjct: 115 HSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEIL 170
Query: 536 QSSQFTEKS-DVYSFGVVLVEILTGQKPI 563
S+ + D++S G + E++TG KP+
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITG-KPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 66/238 (27%), Positives = 117/238 (49%), Gaps = 38/238 (15%)
Query: 365 NRILGQGGQGTVYKGMLT----DGRIVAVK--KSKLVDETNVEQFINEVVILSQINHRNI 418
+++G G G V +G L VA+K K+ D+ ++ F+ E I+ Q +H NI
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNI 67
Query: 419 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 478
++L G ++ +++ E++ NG+L +++ +F T L+ + ++ + YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF--TVGQLVGMLRGIASGMKYLSEM 125
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-----VQGTFGYVDPE 533
+ HRD+ + NIL++ KVSDFG SR + + TTK ++ T PE
Sbjct: 126 NYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APE 178
Query: 534 YFQSSQFTEKSDVYSFGVVLVEILT-GQKP---------IRAINTDEDKSLVGYFLQA 581
+FT SDV+SFG+V+ E+++ G++P I+A+ GY L
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-------GYRLPP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 73/267 (27%), Positives = 120/267 (44%), Gaps = 30/267 (11%)
Query: 368 LGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVEQFI-NEVVILSQINHRNIVKLLGCC 425
LGQG G VYK G+I A+KK + + + + E+ L +VK G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLL-RIAVEVSGALFYLHSAASIPIY 484
+ +V E++ G+L + ++ + P E +L IA ++ L YLH+ I
Sbjct: 69 YKEGEISIVLEYMDGGSLAD-LLKKVGKIP---EPVLAYIARQILKGLDYLHTKRHI--I 122
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSV--MVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 542
HRDIK +N+L++ K K++DFG S+ + +DQ + T V GT Y+ PE Q ++
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPERIQGESYSY 179
Query: 543 KSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF--LQAINENRLFEILDARVLKEAK 600
+D++S G+ L+E G+ P +F +QAI + + E +
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQ------PSFFELMQAICDGPPPSLPAEEFSPEFR 233
Query: 601 KEGIMTVATLAKRCLNLNGKMRPTMKE 627
CL + K RP+ E
Sbjct: 234 --------DFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 70/219 (31%), Positives = 122/219 (55%), Gaps = 16/219 (7%)
Query: 366 RILGQGGQGTVYKGM-LTDGRIVAVKKS-KLVDET-----NVEQFINEVVILSQINHRNI 418
++LG G GTVYKG+ + +G V + + K+++ET NVE F++E +I++ ++H ++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHL 71
Query: 419 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 478
V+LLG CL + LV + +P+G L Y+H + I +LLL V+++ + YL
Sbjct: 72 VRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER 128
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQS 537
+ HRD+ + N+L+ K++DFG +R + D+ + ++ E
Sbjct: 129 R---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 538 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 575
+FT +SDV+S+GV + E++T G KP I T E L+
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 365 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 424
R LG G G V+ G VAVK K + E F+ E I+ ++ H +V+L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 425 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
C E E +V E++ G+L ++ + E + L+ +A +++ + YL S I
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRNYI--- 125
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFTE 542
HRD+ + NIL+ + K++DFG +R + D T + F + PE +FT
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDD--EYTAREGAKFPIKWTAPEAANYGRFTI 183
Query: 543 KSDVYSFGVVLVEILT-GQKP 562
KSDV+SFG++L EI+T G+ P
Sbjct: 184 KSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 6/198 (3%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
R LG G G V++G+ + VAVK K + + F+ E I+ ++ H +++L C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
E +V E + G+L +Y+ + L+ +A +V+ + YL + I H
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQNYI---H 126
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 545
RD+ + N+L+ + KV+DFG +R + D + + PE ++F+ KSD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 546 VYSFGVVLVEILT-GQKP 562
V+SFG++L EI+T G+ P
Sbjct: 187 VWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 62/213 (29%), Positives = 109/213 (51%), Gaps = 19/213 (8%)
Query: 367 ILGQGGQGTVYKGMLTDGRIVAVKK------SKLVDETNVEQFINEVVILSQINHRNIVK 420
+LG+G GTVY G+ G+++AVK+ + L E E+ EV +L + H NIV+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 421 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLL-RIAVEVSGALFYLHSAA 479
LG CL+ + EF+P G++ + N+ P E + + ++ + YLH+
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLP---EPVFCKYTKQILDGVAYLHNNC 122
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSR-----SVMVDQTHLTTKVQGTFGYVDPEY 534
+ HRDIK N++L K+ DFG +R + +++ + GT ++ PE
Sbjct: 123 VV---HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 535 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 567
S + KSD++S G + E+ TG+ P+ +++
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 60/189 (31%), Positives = 96/189 (50%), Gaps = 23/189 (12%)
Query: 385 RIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL 443
+VAVK + + E F+ EV ILS+++ NI +LLG C ++ E++ NG L
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 444 YQYIHNQIEE--------FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL 495
Q++ + E +++ LL +A +++ + YL S+ HRD+ + N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLV 163
Query: 496 DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP------EYFQSSQFTEKSDVYSF 549
Y K++DFG SR++ + +VQG P E +FT KSDV++F
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYY---RVQGR--APLPIRWMAWESVLLGKFTTKSDVWAF 218
Query: 550 GVVLVEILT 558
GV L EILT
Sbjct: 219 GVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 36/272 (13%)
Query: 366 RILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETN-----VEQFINEVVILSQINHRNIV 419
+LG G G+VY+G+ L DG AVK+ L D+ V+Q E+ +LS++ H NIV
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 420 KLLGCCLETEVPLLVY-EFIPNGTLYQYIHNQIEEFPITWELLLRIAVE--VSGALFYLH 476
+ LG E + L ++ E +P G+ + ++++ E ++R+ + G L YLH
Sbjct: 66 QYLGTEREED-NLYIFLELVPGGS----LAKLLKKYGSFPEPVIRLYTRQILLG-LEYLH 119
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF- 535
++ HRDIK ANIL+D K++DFG ++ V+ + K G+ ++ PE
Sbjct: 120 DRNTV---HRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK--GSPYWMAPEVIA 174
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595
Q + +D++S G ++E+ TG+ P V + L I D
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW------SQLEGVAAVFKIGRSKELPPIPDH-- 226
Query: 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKE 627
L + K+ I+ +CL + +RPT E
Sbjct: 227 LSDEAKDFIL-------KCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 62/194 (31%), Positives = 102/194 (52%), Gaps = 8/194 (4%)
Query: 367 ILGQGGQGTVYKGMLTDGRIVAVK--KSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 424
+LG+G G V+KG L D VAVK K L E + +F++E IL Q +H NIVKL+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKLIGV 60
Query: 425 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
C + + +V E +P G ++ + +E + L++ A++ + + YL S I
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKT--KQLVKFALDAAAGMAYLESKNCI--- 115
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 544
HRD+ + N L+ + K+SDFG SR + Q + PE +++ +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 545 DVYSFGVVLVEILT 558
DV+S+G++L E +
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 78/289 (26%), Positives = 130/289 (44%), Gaps = 55/289 (19%)
Query: 366 RILGQGGQGTVYKGML-------TDGRIVAVKKSKLVDETNVE--QFINEVVILSQINHR 416
R LGQG G VY+G+ + R VA+K + + + E +F+NE ++ + N
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETR-VAIK-TVNENASMRERIEFLNEASVMKEFNCH 69
Query: 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEE-------FPITWELLLRIAVEVS 469
++V+LLG + L+V E + G L Y+ ++ E P T + +++A E++
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 470 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFG 528
+ YL A+ HRD+ + N ++ + K+ DFG +R + D K
Sbjct: 130 DGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 529 YVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRL 587
++ PE + FT KSDV+SFGVVL E+ T ++P + ++ +E
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE----------------- 229
Query: 588 FEILDARVLKEAKKEGIMT--------VATLAKRCLNLNGKMRPTMKEV 628
VLK G + + L + C N KMRPT E+
Sbjct: 230 -------VLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 362 YNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFIN--EVVILSQINHRNI 418
Y +G+G G VYK G IVA+KK KL E+ E+ +L ++NH NI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 419 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAVEVSGAL 472
+KLL LV+EF+ + LY+ I ++ P ++LL +A
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA------- 112
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532
+ HS I HRD+K N+L++ + K++DFG +RS T V T Y P
Sbjct: 113 -FCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAP 167
Query: 533 E-YFQSSQFTEKSDVYSFGVVLVEILTGQ 560
E ++ D++S G + E+L+ +
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 78/271 (28%), Positives = 134/271 (49%), Gaps = 37/271 (13%)
Query: 367 ILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 426
I+G+G G V +G T G+ VAVK K + + F+ E ++++++H+N+V+LLG L
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 427 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 486
+ +V E + G L ++ + ++ LL+ +++V+ + YL S + HR
Sbjct: 70 HNGL-YIVMELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHR 124
Query: 487 DIKSANILLDDKYRAKVSDFGTSR--SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 544
D+ + NIL+ + AKVSDFG +R S+ VD + L K + PE + +F+ KS
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKS 178
Query: 545 DVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQAINENRLFEILDARVLKEAKK 601
DV+S+GV+L E+ + G+ P ++ E K V GY + E +
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM------------------EPPE 220
Query: 602 EGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632
V L C K RP+ ++ +L
Sbjct: 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 79/291 (27%), Positives = 132/291 (45%), Gaps = 47/291 (16%)
Query: 368 LGQGGQGTVYKGMLT------DGRIVAVKKSKLVDETNVEQ-FINEVVILSQINHRNIVK 420
LG+G G VYKG LT VA+K K E V+Q F E ++S + H NIV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 421 LLGCCLETEVPLLVYEFIPNGTLYQYI--HNQIEEFPITWEL-----------LLRIAVE 467
LLG C + + +++E++ +G L++++ ++ + L IA++
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 468 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT- 526
++ + YL +S HRD+ + N L+ + K+SDFG SR + + +VQ
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY---SADYYRVQSKS 186
Query: 527 ---FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAI 582
++ PE +FT +SD++SFGVVL EI + G +P Y+
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP--------------YY--GF 230
Query: 583 NENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633
+ + E++ +R L ++ V L C N RP K++ L
Sbjct: 231 SNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 81/228 (35%), Positives = 118/228 (51%), Gaps = 30/228 (13%)
Query: 366 RILGQGGQGTVYKGMLTD------GRI-VAVK--KSKLVDETNVEQFINEVVILSQINHR 416
LG G G VY+G TD G I VAVK + D+ E F+ E ++S NH
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-FLKEAHLMSNFNHP 59
Query: 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHN-QIEEFP---ITWELLLRIAVEVSGAL 472
NIVKLLG CL E ++ E + G L Y+ + ++E F +T + LL I ++V+
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 473 FYLHSAASIPIYHRDIKSANILLDDK-YRA----KVSDFGTSRSVMVDQTHLTTKVQG-- 525
YL I HRD+ + N L+ +K Y A K+ DFG +R + + + +G
Sbjct: 120 VYLEQMHFI---HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEG 173
Query: 526 --TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 570
++ PE +FT +SDV+SFGV++ EILT GQ+P A+N E
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 359 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSK---LVDETNVEQFINEVVILSQIN 414
N+ + +G+G VYK + L DGR+VA+KK + ++D + + E+ +L Q++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 415 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALF 473
H N++K L +E +V E G L + I H + ++ I + + V++ AL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 474 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 533
++HS I HRDIK AN+ + K+ D G R T + V GT Y+ PE
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 534 YFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
+ + KSD++S G +L E+ Q P
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 83/274 (30%), Positives = 127/274 (46%), Gaps = 24/274 (8%)
Query: 366 RILGQGGQGTV----YKGMLTD-GRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIV 419
R+LG+G G V Y G +VAVK K + N + E+ IL + H NIV
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 420 KLLGCCLET--EVPLLVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGALFYL 475
K GCC E + L+ E++P G+L Y+ H + LL A ++ + YL
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEGMAYL 123
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG---TFGYVDP 532
HS I HRD+ + N+LLD+ K+ DFG +++V + + G F Y
Sbjct: 124 HSQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-V 179
Query: 533 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592
E + ++F+ SDV+SFGV L E+LT ++ ++ ++G + RL E+L+
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLIELLE 238
Query: 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMK 626
+ K V L K C K RPT +
Sbjct: 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 84/287 (29%), Positives = 132/287 (45%), Gaps = 32/287 (11%)
Query: 368 LGQGGQGTVYK---GMLTD--GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLL 422
LG+G G+V L D G +VAVKK + ++ F E+ IL + H NIVK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 423 GCCLETEVP--LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 480
G C LV E++P G+L Y+ E + LL A ++ + YL S
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGMEYLGSKRY 129
Query: 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG---TFGYVDPEYFQS 537
+ HRD+ + NIL++ + R K+ DFG ++ + D+ + + G F Y PE
Sbjct: 130 V---HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PESLTE 185
Query: 538 SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR--------LFE 589
S+F+ SDV+SFGVVL E+ T +D+ S F++ + ++ L E
Sbjct: 186 SKFSVASDVWSFGVVLYELFT--------YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237
Query: 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636
+L A + + K C N + RP+ E+A ++ IR
Sbjct: 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 368 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 426
+GQG GTVY + + G+ VA+K+ L + E INE++++ + H NIV L L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 427 ETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
+ +V E++ G+L + ++E I + E AL +LHS I H
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSNQVI---H 138
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 545
RDIKS NILL K++DFG + +Q+ +T V GT ++ PE + K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197
Query: 546 VYSFGVVLVEILTGQKP 562
++S G++ +E++ G+ P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 78/301 (25%), Positives = 130/301 (43%), Gaps = 47/301 (15%)
Query: 361 NYNANRILGQGGQGTVYKGMLTD--GR----IVAVKKSKL-VDETNVEQFINEVVILSQI 413
N + LG+G G V K GR VAVK K + + ++E +L Q+
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 414 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH--NQIE------------------- 452
NH +++KL G C + LL+ E+ G+L ++ ++
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 453 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 512
E +T L+ A ++S + YL A + + HRD+ + N+L+ + + K+SDFG SR V
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 513 MVDQTHLT-TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 571
+ +++ +K + ++ E +T +SDV+SFGV+L EI+T
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------------- 224
Query: 572 KSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631
L G I RLF +L E + + L C RPT +++ E
Sbjct: 225 --LGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282
Query: 632 L 632
L
Sbjct: 283 L 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 69/211 (32%), Positives = 109/211 (51%), Gaps = 19/211 (9%)
Query: 368 LGQGGQGTVYKGML--TDGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGC 424
LG G G V K +L G+I+AVK +L ++E +Q + E+ IL + N IV G
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 425 CL-ETEVPLLVYEFIPNGTL---YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 480
++ + + E++ G+L + + +I E L +IAV V L YLH
Sbjct: 68 FYNNGDISICM-EYMDGGSLDKILKEVQGRIPERI-----LGKIAVAVLKGLTYLHEKHK 121
Query: 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF 540
I HRD+K +NIL++ + + K+ DFG S +V+ T GT Y+ PE Q + +
Sbjct: 122 I--IHRDVKPSNILVNSRGQIKLCDFGVSG-QLVNSLAKTFV--GTSSYMAPERIQGNDY 176
Query: 541 TEKSDVYSFGVVLVEILTGQKPIRAINTDED 571
+ KSD++S G+ L+E+ TG+ P N D
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPD 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-23
Identities = 68/208 (32%), Positives = 108/208 (51%), Gaps = 15/208 (7%)
Query: 368 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLGCC 425
LG G G V G VA+K ++ E ++ ++FI E ++ +++H +V+L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
+ +V E++ NG L Y+ + F LL + +V + YL S I H
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKRF--QPSQLLEMCKDVCEGMAYLESKQFI---H 123
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFTEK 543
RD+ + N L+DD+ KVSDFG SR V+ D+ T+ V F + PE S+F+ K
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 544 SDVYSFGVVLVEILT-GQKPIRAINTDE 570
SDV++FGV++ E+ + G+ P N E
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYERFNNSE 209
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 68/228 (29%), Positives = 121/228 (53%), Gaps = 22/228 (9%)
Query: 366 RILGQGGQGTVYKGML-TDGR---IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVK 420
+++G G G V++G+L GR VA+K K E + F++E I+ Q +H NI++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 421 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGALFYLHSAA 479
L G + + +++ E++ NG L +Y+ + EF +LR ++ + YL +
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL---S 124
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD--QTHLTTKVQGTFGYVDPEYFQS 537
+ HRD+ + NIL++ KVSDFG SR + D T+ T+ + + PE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 538 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINE 584
+FT SDV+SFG+V+ E+++ G++P ++ E ++AIN+
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAIND 225
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 68/207 (32%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTD---GRIVAVKKSKLVDETNVEQFINEVVILSQINHR 416
DN+ +G+G G V + TD GR VAVKK L + E NEVVI+ H
Sbjct: 22 DNFVK---IGEGSTGIVC--IATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHP 76
Query: 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYL 475
NIV++ L + +V EF+ G L + H ++ E E + + + V AL +L
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIATVCLAVLKALSFL 131
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 535
H+ I HRDIKS +ILL R K+SDFG V + + V GT ++ PE
Sbjct: 132 HAQGVI---HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVI 187
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKP 562
+ + D++S G++++E++ G+ P
Sbjct: 188 SRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 368 LGQGGQGTVYKGML------TDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKL 421
LG+G G V+ D +VAVK K E+ + F E +L+ + H++IV+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 422 LGCCLETEVPLLVYEFIPNGTLYQYIHNQ------IEEF------PITWELLLRIAVEVS 469
G C E L+V+E++ +G L +++ + + +T +L IA +++
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 470 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFG 528
+ YL AS+ HRD+ + N L+ K+ DFG SR + D + +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 529 YVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 562
++ PE +FT +SD++SFGVVL EI T G++P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 367 ILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
LG+G G+VYK + G++VA+K + E ++++ I E+ IL Q + IVK G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
+ +V E+ G++ + +I +T E + I + L YLHS I H
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHSNKKI---H 122
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 545
RDIK+ NILL+++ +AK++DFG S + D V GT ++ PE Q + K+D
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKAD 181
Query: 546 VYSFGVVLVEILTGQ------KPIRAI 566
++S G+ +E+ G+ P+RAI
Sbjct: 182 IWSLGITAIEMAEGKPPYSDIHPMRAI 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 19/214 (8%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRN 417
D+Y ++G G VY + L + VA+K+ L +T+V++ EV +SQ NH N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 418 IVKLLGCCLETEVPLLVYEFIPNGTLY---QYIHNQ--IEEFPITWELLLRIAVEVSGAL 472
+VK + + LV ++ G+L + + + ++E I +L+ EV L
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA--TVLK---EVLKGL 115
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM--VDQTHLTTK-VQGTFGY 529
YLHS I HRDIK+ NILL + K++DFG S S+ D+T K GT +
Sbjct: 116 EYLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172
Query: 530 VDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKP 562
+ PE + + K+D++SFG+ +E+ TG P
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 4e-23
Identities = 79/277 (28%), Positives = 137/277 (49%), Gaps = 39/277 (14%)
Query: 366 RILGQGGQGTVYKGMLTD--GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLG 423
+ +G+G G V ML D G VAVK K ++ + F+ E +++Q+ H N+V+LLG
Sbjct: 12 QTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 424 CCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 482
+E + L +V E++ G+L Y+ ++ + + LL+ +++V A+ YL + +
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANNFV- 124
Query: 483 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 542
HRD+ + N+L+ + AKVSDFG ++ Q V+ T PE + +F+
Sbjct: 125 --HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 178
Query: 543 KSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQAINENRLFEILDARVLKEA 599
KSDV+SFG++L EI + G+ P I + V GY + A
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA------------------ 220
Query: 600 KKEGI-MTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635
+G V + K+C +L+ RP+ ++ +L I
Sbjct: 221 -PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 4e-23
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 366 RILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINHRNIVKLL 422
+G+G G VYK G +VA+KK ++ +E I E+ +L ++ H NIV+L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 423 GCCLETEVP--LLVYEFIP---NGTL----YQYIHNQIEEFPITWELLLRIAVEVSGALF 473
+V+E++ G L ++ +QI+ +LL L
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKC--YMKQLLE--------GLQ 114
Query: 474 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDP 532
YLHS I HRDIK +NIL+++ K++DFG +R + T +V T Y P
Sbjct: 115 YLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170
Query: 533 E-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
E ++++ + D++S G +L E+ G KPI
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 5e-23
Identities = 65/216 (30%), Positives = 112/216 (51%), Gaps = 20/216 (9%)
Query: 361 NYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFI--------NEVVILSQ 412
Y R++G+G G V+ L + A +K ++ + VEQ NE +L
Sbjct: 1 KYEKIRVVGRGAFGIVH---LCRRK--ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKL 55
Query: 413 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 472
++H NI++ LE + ++V E+ P GTL +YI + + + +L V++ AL
Sbjct: 56 LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLAL 114
Query: 473 FYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 531
++H+ I HRD+K+ NILLD K K+ DFG S+ ++ ++ T V GT Y+
Sbjct: 115 HHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISK-ILSSKSKAYT-VVGTPCYIS 169
Query: 532 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 567
PE + + +KSD+++ G VL E+ + ++ A N
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 9e-23
Identities = 64/210 (30%), Positives = 117/210 (55%), Gaps = 13/210 (6%)
Query: 368 LGQGGQGTVYKGM--LTDGRI-VAVKKSKLVDETNV-EQFINEVVILSQINHRNIVKLLG 423
LG G G V KG+ + +I VA+K K +E +V ++ + E I+ Q+++ IV+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 483
C E E +LV E G L +++ + +E IT ++ + +VS + YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDE--ITVSNVVELMHQVSMGMKYLEGKNFV-- 117
Query: 484 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFT 541
HRD+ + N+LL +++ AK+SDFG S+++ D ++ + G + + PE +F+
Sbjct: 118 -HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 542 EKSDVYSFGVVLVEILT-GQKPIRAINTDE 570
+SDV+S+G+ + E + GQKP + + E
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 68/284 (23%), Positives = 128/284 (45%), Gaps = 38/284 (13%)
Query: 367 ILGQGGQGTVYKGMLT------DGRIVAVKKSKLVDETNVEQ-FINEVVILSQINHRNIV 419
LG+G G V+ +V VK + + N++ F E+ + +++H+N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYI------HNQIEEFPITWELLLRIAVEVSGALF 473
+LLG C E E ++ E+ G L Q++ +++ P++ + + + +++ +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 474 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 533
+L +A + HRD+ + N L+ + KVS S+ V + + ++ PE
Sbjct: 132 HLSNARFV---HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 534 YFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592
Q F+ KSDV+SFGV++ E+ T G+ P ++ +E L + +L
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAGKL----- 236
Query: 593 ARVLKEAKKEGIMTVATLAK---RCLNLNGKMRPTMKEVAFELG 633
L + + L K RC +N K RP+ E+ LG
Sbjct: 237 --ELPVPEG----CPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 70/224 (31%), Positives = 104/224 (46%), Gaps = 30/224 (13%)
Query: 356 EKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVK---KSKLVDETNVEQ----FINEVV 408
E D+ R LG G G VY+G+ AV+ K + E+ EQ F+ E +
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 409 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH----NQIEEFPITWELLLRI 464
I+S+ NH+NIV+L+G E ++ E + G L ++ +T + LL
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 465 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGTSRSVMV------- 514
A +V+ YL I HRDI + N LL K AK++DFG +R +
Sbjct: 122 ARDVAKGCKYLEENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 558
+ L K ++ PE F FT K+DV+SFGV+L EI +
Sbjct: 179 GRAMLPIK------WMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 16/211 (7%)
Query: 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET-----NVEQFINEVVILSQIN 414
N+ ++LGQG G VY D GR +AVK+ ++ V E+ +L +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 415 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGALF 473
H IV+ GC + E + E++P G+ + +Q++ + +T + + ++ +
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGS----VKDQLKAYGALTETVTRKYTRQILEGVE 118
Query: 474 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT--TKVQGTFGYVD 531
YLHS I HRDIK ANIL D K+ DFG S+ + + T V GT ++
Sbjct: 119 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 532 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
PE + K+DV+S G +VE+LT + P
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 12/228 (5%)
Query: 361 NYNANRILGQGGQGTVYKGMLTDGRIV-AVK---KSKLVDETNVEQFINEVVILSQINHR 416
++ R++G+G G V D + + A+K K K V++ +V +NE IL ++NH
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 476
+V L + E LV + + G L ++ ++ + E + E+ AL YLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLH 117
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 536
S I HRDIK NILLD++ ++DF + V LTT GT GY+ PE
Sbjct: 118 SKG---IIHRDIKPDNILLDEQGHVHITDFNIAT--KVTPDTLTTSTSGTPGYMAPEVLC 172
Query: 537 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE 584
++ D +S GV E L G++P R + + A
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVL 220
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 77/283 (27%), Positives = 144/283 (50%), Gaps = 35/283 (12%)
Query: 366 RILGQGGQGTVYKGMLT-DGRI--VAVKKSKLV--DETNVEQFINEVVILSQINHRNIVK 420
+ LG+G G+V +G L D I VAVK K+ + +E F++E V + + +H N+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 421 LLGCCLETE------VPLLVYEFIPNGTLYQY-IHNQIEEFP--ITWELLLRIAVEVSGA 471
L+G CL+T P+++ F+ +G L+ + +++++ + P + ++L++ +++
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 472 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV-QGTFGYV 530
+ YL S + I HRD+ + N +L++ V+DFG S+ + + ++ + ++
Sbjct: 125 MEYLSSKSFI---HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 531 DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFE 589
E +T KSDV+SFGV + EI T GQ P + E+ + Y Q NRL +
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV---ENSEIYDYLRQG---NRLKQ 235
Query: 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632
D + + +L C LN K RP+ + + EL
Sbjct: 236 PPDC----------LDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 66/211 (31%), Positives = 112/211 (53%), Gaps = 15/211 (7%)
Query: 368 LGQGGQGTVYKG---MLTDGRIVAVK--KSKLVDETNVEQFINEVVILSQINHRNIVKLL 422
LG G GTV KG M + VAVK K+ D ++ + E ++ Q+++ IV+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 423 GCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 482
G C E E +LV E G L +++ +T + + + +VS + YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKH---VTEKNITELVHQVSMGMKYLEETNFV- 117
Query: 483 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQF 540
HRD+ + N+LL ++ AK+SDFG S+++ D+ + K G + + PE +F
Sbjct: 118 --HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 541 TEKSDVYSFGVVLVEILT-GQKPIRAINTDE 570
+ KSDV+SFGV++ E + GQKP + + +E
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE 206
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-22
Identities = 62/200 (31%), Positives = 107/200 (53%), Gaps = 11/200 (5%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLG 423
+ LG G G V+ G VA+K ++E + E FI E ++ +++H +V+L G
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKA---INEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 483
C + + +V EF+ NG L Y+ + + + ++LL + +V + YL + I
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKL--SKDMLLSMCQDVCEGMEYLERNSFI-- 122
Query: 484 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 543
HRD+ + N L+ KVSDFG +R V+ D+ ++ + + PE F S+++ K
Sbjct: 123 -HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 544 SDVYSFGVVLVEILT-GQKP 562
SDV+SFGV++ E+ T G+ P
Sbjct: 182 SDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 70/227 (30%), Positives = 109/227 (48%), Gaps = 25/227 (11%)
Query: 354 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD--ETNVEQFINEVVILS 411
DLE +D LG G G+V K V KK + + +Q + E+ I+
Sbjct: 6 DLETISD-------LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMH 58
Query: 412 QINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQI--EEFPITWELLLRIAVEVS 469
+ IV G L + EF+ G+L ++I + PI E+L +IAV V
Sbjct: 59 ECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-----DRIYKKGGPIPVEILGKIAVAVV 113
Query: 470 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM--VDQTHLTTKVQGTF 527
L YL++ I HRDIK +NIL++ + + K+ DFG S ++ + T + GT
Sbjct: 114 EGLTYLYNVHRI--MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTS 166
Query: 528 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL 574
Y+ PE Q ++T KSDV+S G+ ++E+ G+ P N D+D
Sbjct: 167 TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD 213
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 6e-22
Identities = 78/303 (25%), Positives = 116/303 (38%), Gaps = 61/303 (20%)
Query: 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFIN-----EVVILSQIN 414
Y + LG+G VYK GRIVA+KK KL + + IN E+ +L ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 415 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF------PITWELLLRIAVEV 468
H NI+ LL LV+EF+ L + I ++ L
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLR------ 113
Query: 469 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 528
L YLHS I HRD+K N+L+ K++DFG +RS +T +V T
Sbjct: 114 --GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRW 167
Query: 529 YVDPE-YFQSSQFTEKSDVYSFGVVLVE------ILTGQKPIRAIN---------TDED- 571
Y PE F + + D++S G + E L G I + T+E+
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227
Query: 572 ---KSLVGY----FLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPT 624
SL Y ++F A + + L +R L LN R T
Sbjct: 228 PGVTSLPDYVEFKPFPPTPLKQIF--------PAASDDAL----DLLQRLLTLNPNKRIT 275
Query: 625 MKE 627
++
Sbjct: 276 ARQ 278
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 16/203 (7%)
Query: 367 ILGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNVEQFINEVVILSQINH---RNIVKL 421
++G+G G VY+G + GR+VA+K L + +V EV +LSQ+ NI K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 422 LGCCLETEVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSAAS 480
G L+ ++ E+ G++ + I E I+ +++R EV AL Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYIS--VIIR---EVLVALKYIHKV-- 120
Query: 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ- 539
+ HRDIK+ANIL+ + K+ DFG + + + + +T V GT ++ PE +
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 540 FTEKSDVYSFGVVLVEILTGQKP 562
+ K+D++S G+ + E+ TG P
Sbjct: 179 YDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 9e-22
Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 368 LGQGGQGTVYKG-MLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 426
+G G G VYK + G +VA+K KL + E E+ +L + H NIV G L
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 427 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 486
+ +V E+ G+L Q I+ P++ + + E L YLH I HR
Sbjct: 71 RRDKLWIVMEYCGGGSL-QDIYQVTRG-PLSELQIAYVCRETLKGLAYLHETGKI---HR 125
Query: 487 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ------GTFGYVDPEYFQ---S 537
DIK ANILL + K++DFG S LT + GT ++ PE
Sbjct: 126 DIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 538 SQFTEKSDVYSFGVVLVEILTGQKP 562
+ K D+++ G+ +E+ Q P
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 1e-21
Identities = 38/92 (41%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 9 PFGIGKGCFLDKSFEVICNYSGKYPKAYLPGINNLELLDIDSYYEGTIRVNFPIISLKNS 68
PFGIG GC D FE+ CN + P+ L N E+L I S GT+RV PI S +
Sbjct: 16 PFGIGPGCARDPGFELTCNNTTSPPRLLLGNG-NYEVLSI-SLANGTVRVLDPISSNCYN 73
Query: 69 SNAKGVN----LLGSPFIFSNISNRFAAIGCD 96
S+ K + LG PF FS+ N+F +GC+
Sbjct: 74 SSGKRTDNGSLSLGGPFFFSSSRNKFVVVGCN 105
|
This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 77/266 (28%), Positives = 122/266 (45%), Gaps = 32/266 (12%)
Query: 368 LGQGGQGTVYKGMLTDGRIVAVKKSKLVD----ETNVEQFINEVVILSQINHRNIVKLLG 423
+G+G G V+KG+ D R V K++D E +E E+ +LSQ + + K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIH-NQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 482
L+ ++ E++ G+ + +EF I L E+ L YLHS I
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML-----KEILKGLDYLHSEKKI- 123
Query: 483 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 542
HRDIK+AN+LL ++ K++DFG + + Q T V GT ++ PE Q S +
Sbjct: 124 --HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDS 180
Query: 543 KSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKE 602
K+D++S G+ +E+ G+ P N+D V + + N L ++ KE
Sbjct: 181 KADIWSLGITAIELAKGEPP----NSDMHPMRVLFLIPKNNPPTLTGEF-SKPFKE---- 231
Query: 603 GIMTVATLAKRCLNLNGKMRPTMKEV 628
CLN + RPT KE+
Sbjct: 232 -------FIDACLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 63/213 (29%), Positives = 110/213 (51%), Gaps = 26/213 (12%)
Query: 367 ILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETN----------VEQFINEVVILSQINH 415
++G+G G VY + +T G ++AVK+ +L V+ +E+ L ++H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 416 RNIVKLLGCCLETEVPLLVY-EFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGAL 472
NIV+ LG TE L ++ E++P G++ + + + EE +L+ +V L
Sbjct: 68 LNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-----QLVRFFTEQVLEGL 121
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR-SVMVDQTHLTTKVQGTFGYVD 531
YLHS I HRD+K+ N+L+D K+SDFG S+ S + +QG+ ++
Sbjct: 122 AYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 532 PEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKP 562
PE S ++ K D++S G V++E+ G++P
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-21
Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 39/288 (13%)
Query: 281 RKSRVKYIIIGCSGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSN 340
RK+ + I C+ G L+ LV + + F++ R ++LK+ N
Sbjct: 623 RKTPSWWFYITCTLGAFLVLALVA--FGFVFIRGRNNLELKR---------------VEN 665
Query: 341 ESNIEKTKLFTSKDLEKATDN-----YNANRILGQGGQGTVYKG-MLTDGRIVAVKKSKL 394
E + + F SK + T N ++ +G +G YKG + +G VK+
Sbjct: 666 EDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIND 725
Query: 395 VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF 454
V+ I + + ++ H NIVKL+G C + L++E+I L + + N
Sbjct: 726 VNSIP-SSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----- 776
Query: 455 PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514
++WE +IA+ ++ AL +LH S + ++ I++D K + +
Sbjct: 777 -LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834
Query: 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
D + YV PE ++ TEKSD+Y FG++L+E+LTG+ P
Sbjct: 835 DTKCFISS-----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 75/269 (27%), Positives = 118/269 (43%), Gaps = 39/269 (14%)
Query: 368 LGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCC 425
+G+G G VYK + ++VA+K L E +E E+ LSQ I K G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
L+ ++ E+ G+ + ++ + + I EV L YLH I H
Sbjct: 69 LKGSKLWIIMEYCGGGSCL----DLLKPGKLDETYIAFILREVLLGLEYLHEEGKI---H 121
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 545
RDIK+ANILL ++ K++DFG S + + T V GT ++ PE + S + EK+D
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKAD 180
Query: 546 VYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI-------LDARVLKE 598
++S G+ +E+ G+ P +D V LF I L+ +
Sbjct: 181 IWSLGITAIELAKGEPP----LSDLHPMRV-----------LFLIPKNNPPSLEGNKFSK 225
Query: 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKE 627
K+ + CLN + K RP+ KE
Sbjct: 226 PFKDFV-------SLCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 4e-21
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 10/214 (4%)
Query: 354 DLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQ 412
+ E D +LG+G G VY L+ +A+K+ D V+ E+ + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 413 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 472
+ HRNIV+ LG E + E +P G+L + ++ + ++ ++ L
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGL 121
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGTSRSVMVDQTHLTTKVQGTFGYV 530
YLH I HRDIK N+L+ + Y K+SDFGTS+ + T GT Y+
Sbjct: 122 KYLHDNQ---IVHRDIKGDNVLV-NTYSGVVKISDFGTSKR-LAGINPCTETFTGTLQYM 176
Query: 531 DPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKP 562
PE + +D++S G +VE+ TG+ P
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 5e-21
Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 368 LGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 426
+G+G G V + + G++VAVKK L + E NEVVI+ H N+V++ L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 427 ETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
+ +V EF+ G L + H ++ E E + + + V AL LH+ I H
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAAVCLAVLKALSVLHAQGVI---H 139
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 545
RDIKS +ILL R K+SDFG V + + V GT ++ PE + + D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVD 198
Query: 546 VYSFGVVLVEILTGQKP 562
++S G++++E++ G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 77/287 (26%), Positives = 132/287 (45%), Gaps = 41/287 (14%)
Query: 361 NYNANRILGQGGQGTVYKGMLTDG--RIVAVK----------KSKLVDETNVEQFINEVV 408
Y LG G G VYK + ++A+K K K + ++ ++EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 409 IL-SQINHRNIVKLLGCCLETEVPLLVYEFI---PNGTLYQYIHNQIEEFPITWELLLRI 464
I+ Q+ H NIV+ LE + +V + I P G + + + + F E + I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT--EERIWNI 118
Query: 465 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ 524
V++ AL YLH I HRD+ NI+L + + ++DFG ++ ++ LT+ V
Sbjct: 119 FVQMVLALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKLTSVV- 174
Query: 525 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE 584
GT Y PE ++ + EK+DV++FG +L ++ T Q P + N SL
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLA--------- 222
Query: 585 NRLFEILDARVLKEAKKEGIMT--VATLAKRCLNLNGKMRPTMKEVA 629
+I++A + E EG+ + V + CL + + RP + +V+
Sbjct: 223 ---TKIVEA--VYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-21
Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 21/223 (9%)
Query: 366 RILGQGGQGTVYKGML------TDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 419
R LG+G G V+ D +VAVK K + + F E +L+ + H +IV
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ-------IEEFP---ITWELLLRIAVEVS 469
K G C+E + ++V+E++ +G L +++ E +T +L IA +++
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 470 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFG 528
+ YL AS HRD+ + N L+ + K+ DFG SR V D +
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 529 YVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 570
++ PE +FT +SDV+S GVVL EI T G++P ++ +E
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 7e-21
Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTD----GRIVAVK---KSKLVDETNVEQFINEVVILSQ 412
D++ + LG G G V ML G+ A+K K+K+V VE +NE IL
Sbjct: 1 DDFEFIKTLGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 413 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 472
I H +V L G + LV E++P G L+ + + FP A +V AL
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSH-LRKSGRFPEPVARFY--AAQVVLAL 114
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532
YLHS I +RD+K N+LLD K++DFG ++ V +T+ GT Y+ P
Sbjct: 115 EYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTYTLC---GTPEYLAP 167
Query: 533 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
E S + + D ++ G+++ E+L G P N +
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 7e-21
Identities = 77/300 (25%), Positives = 121/300 (40%), Gaps = 51/300 (17%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNV--EQFINEVVILSQINHR 416
+ Y ++G+G G V K G IVA+KK K ++ + + EV +L Q+ H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP----------ITWELLLRIAV 466
NIV L LV+E++ + +E P W+LL
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERT-----LLELLEASPGGLPPDAVRSYIWQLL----- 110
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD-QTHLTTKVQG 525
A+ Y HS I HRDIK NIL+ + K+ DFG +R++ + LT V
Sbjct: 111 ---QAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-A 163
Query: 526 TFGYVDPEYF-QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK---------SLV 575
T Y PE + + + DV++ G ++ E+L G+ P+ ++D D+ L
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE-PLFPGDSDIDQLYLIQKCLGPLP 222
Query: 576 GYFLQAINEN------RLFEILDARVLKEAKKEGIM--TVATLAKRCLNLNGKMRPTMKE 627
+ + N E L E + G + K CL ++ K R T E
Sbjct: 223 PSHQELFSSNPRFAGVAFPEPSQPESL-ERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 7e-21
Identities = 77/265 (29%), Positives = 125/265 (47%), Gaps = 30/265 (11%)
Query: 368 LGQGGQGTVYKGMLTDGRIVAVKKSKLVD----ETNVEQFINEVVILSQINHRNIVKLLG 423
+G+G G VYKG+ D R V K++D E +E E+ +LSQ + I + G
Sbjct: 12 IGKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 483
L+ ++ E++ G+ + ++ P+ + I E+ L YLHS I
Sbjct: 70 SYLKGTKLWIIMEYLGGGSAL----DLLKPGPLEETYIATILREILKGLDYLHSERKI-- 123
Query: 484 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 543
HRDIK+AN+LL ++ K++DFG + + Q T V GT ++ PE + S + K
Sbjct: 124 -HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFK 181
Query: 544 SDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEG 603
+D++S G+ +E+ G+ P N+D V FL N E ++ KE
Sbjct: 182 ADIWSLGITAIELAKGEPP----NSDLHPMRV-LFLIPKNSPPTLEGQYSKPFKE----- 231
Query: 604 IMTVATLAKRCLNLNGKMRPTMKEV 628
+ CLN + + RPT KE+
Sbjct: 232 ------FVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 7e-21
Identities = 68/282 (24%), Positives = 124/282 (43%), Gaps = 35/282 (12%)
Query: 361 NYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQ------FINEVVILSQI 413
+ + LG G + Y+ + G ++AVK+ V T+ EQ E+ +++++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 414 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 473
NH +I+++LG E L E++ G++ + +++ ++ L
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLS 117
Query: 474 YLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGTSRSVMVDQT---HLTTKVQGTFGY 529
YLH I HRD+K AN+L+D R +++DFG + + T ++ GT +
Sbjct: 118 YLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 530 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589
+ PE + Q+ DV+S G V++E+ T + P A +L +F+
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL------------IFK 222
Query: 590 ILDARV---LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
I A + E G+ V RCL L + RP +E+
Sbjct: 223 IASATTAPSIPEHLSPGLRDVTL---RCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 9e-21
Identities = 76/288 (26%), Positives = 140/288 (48%), Gaps = 36/288 (12%)
Query: 366 RILGQGGQGTVYKGMLT----DGRIVAVK--KSKLVDETNVEQFINEVVILSQINHRNIV 419
R+LG+G G+V + L + VAVK K+ + +++E+F+ E + + +H N++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 420 KLLGCCLETE------VPLLVYEFIPNGTLYQY-IHNQIEEFPITWEL--LLRIAVEVSG 470
KL+G L + +P+++ F+ +G L+ + + ++I E P T L L+R ++++
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGY 529
+ YL S I HRD+ + N +L++ V+DFG S+ + D + +
Sbjct: 125 GMEYLSSKNFI---HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 530 VDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLF 588
+ E + +T SDV++FGV + EI+T GQ P + E+ + Y I NRL
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV---ENSEIYNYL---IKGNRLK 235
Query: 589 EILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636
+ D + V L +C + K RP+ + + +L I
Sbjct: 236 QPPDC----------LEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 77/290 (26%), Positives = 130/290 (44%), Gaps = 37/290 (12%)
Query: 356 EKATDNYNANRILGQGGQGTVYKGMLTD---GRIVAVKKSKLVDET-----NVEQFINEV 407
E + + R LGQG G VY+G D G K V+E+ +E F+NE
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEA 60
Query: 408 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-------HNQIEEFPITWEL 460
++ ++V+LLG + + L+V E + +G L Y+ N P T +
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 461 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHL 519
++++A E++ + YL++ + HRD+ + N ++ + K+ DFG +R + D
Sbjct: 121 MIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 177
Query: 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYF 578
K ++ PE + FT SD++SFGVVL EI + ++P + ++
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS----------- 226
Query: 579 LQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
NE L ++D L + V L + C N KMRPT E+
Sbjct: 227 ----NEQVLKFVMDGGYLDQPDN-CPERVTDLMRMCWQFNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 74/290 (25%), Positives = 138/290 (47%), Gaps = 37/290 (12%)
Query: 356 EKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE--------QFINEV 407
E A + +R LGQG G VY+G + G + ++++ +T E +F+NE
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60
Query: 408 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-------HNQIEEFPITWEL 460
++ + N ++V+LLG + + L++ E + G L Y+ N + P + +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 461 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHL 519
++++A E++ + YL++ + HRD+ + N ++ + + K+ DFG +R + D
Sbjct: 121 MIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYF 578
K ++ PE + FT SDV+SFGVVL EI T ++P + ++
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS----------- 226
Query: 579 LQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
NE L +++ +L + M + L + C N KMRP+ E+
Sbjct: 227 ----NEQVLRFVMEGGLLDKPDNCPDM-LFELMRMCWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 76/265 (28%), Positives = 121/265 (45%), Gaps = 30/265 (11%)
Query: 368 LGQGGQGTVYKGMLTDGRIVAVKKSKLVD----ETNVEQFINEVVILSQINHRNIVKLLG 423
+G+G G V+KG+ D R V K++D E +E E+ +LSQ + + K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 483
L+ ++ E++ G+ + +E P+ + I E+ L YLHS I
Sbjct: 70 SYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSEKKI-- 123
Query: 484 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 543
HRDIK+AN+LL + K++DFG + + Q T V GT ++ PE + S + K
Sbjct: 124 -HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSK 181
Query: 544 SDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEG 603
+D++S G+ +E+ G+ P E + FL N E ++ LKE
Sbjct: 182 ADIWSLGITAIELAKGEPP-----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKE----- 231
Query: 604 IMTVATLAKRCLNLNGKMRPTMKEV 628
+ CLN RPT KE+
Sbjct: 232 ------FVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 76/260 (29%), Positives = 122/260 (46%), Gaps = 31/260 (11%)
Query: 384 GRIVAVKKSKLVDETNVEQFIN---EVVILSQINHRNIVKLLGCCLET--EVPLLVYEFI 438
G VAVK K E+ + E+ IL + H NIVK G C E L+ EF+
Sbjct: 33 GEQVAVKSLK--PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90
Query: 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK 498
P+G+L +Y+ + I + L+ AV++ + YL S + HRD+ + N+L++ +
Sbjct: 91 PSGSLKEYLPRNKNK--INLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESE 145
Query: 499 YRAKVSDFGTSRSVMVDQTHLTTK---VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVE 555
++ K+ DFG ++++ D+ + T K F Y PE S+F SDV+SFGV L E
Sbjct: 146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA-PECLIQSKFYIASDVWSFGVTLYE 204
Query: 556 ILTGQKPIRAINTDEDKSLVGYFLQAI--NENRLFEILDARVLKEAKKEGI-----MTVA 608
+LT D + S + FL+ I ++ RVL+E K+ V
Sbjct: 205 LLT--------YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVY 256
Query: 609 TLAKRCLNLNGKMRPTMKEV 628
L ++C R T + +
Sbjct: 257 QLMRKCWEFQPSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 78/287 (27%), Positives = 133/287 (46%), Gaps = 35/287 (12%)
Query: 360 DNYNANRILGQGGQGTVYKGML-----TDGRI-VAVKKSK-LVDETNVEQFINEVVILSQ 412
+N + + LG G G V + +D + VAVK K + E ++E+ I+S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 413 I-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 471
+ NH NIV LLG C L++ E+ G L ++ + E F + LL + +V+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLED-LLSFSYQVAKG 153
Query: 472 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT----F 527
+ +L S I HRD+ + N+LL K+ DFG +R +M D ++ V+G
Sbjct: 154 MAFLASKNCI---HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLPV 207
Query: 528 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENR 586
++ PE + +T +SDV+S+G++L EI + G P + D F + I E
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKEG- 260
Query: 587 LFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633
+ + + A E + + K C + + RPT K++ +G
Sbjct: 261 -YRMAQP---EHAPAE----IYDIMKTCWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 59/199 (29%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 368 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 427
LG G G V+ G VA+K K + E F+ E ++ Q+ H +V+L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-- 70
Query: 428 TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 486
T+ P+ ++ E++ NG+L ++ E +T L+ +A +++ + ++ I HR
Sbjct: 71 TQEPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKNYI---HR 126
Query: 487 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFTEKS 544
D+++ANIL+ + K++DFG +R +++ T + F + PE FT KS
Sbjct: 127 DLRAANILVSETLCCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 545 DVYSFGVVLVEILT-GQKP 562
DV+SFG++L EI+T G+ P
Sbjct: 185 DVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 5e-20
Identities = 62/196 (31%), Positives = 97/196 (49%), Gaps = 9/196 (4%)
Query: 368 LGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 426
+G+G G V GR VAVK L + E NEVVI+ H+N+V++ L
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 427 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 486
E ++ EF+ G L + + + + E + + V AL YLHS I HR
Sbjct: 89 VGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQGVI---HR 141
Query: 487 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDV 546
DIKS +ILL R K+SDFG + D + V GT ++ PE + + + D+
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDI 200
Query: 547 YSFGVVLVEILTGQKP 562
+S G++++E++ G+ P
Sbjct: 201 WSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 71/220 (32%), Positives = 106/220 (48%), Gaps = 19/220 (8%)
Query: 367 ILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVE---QFINEVVILSQINHRNIVKLL 422
ILG G GTVYK L RI+AVK L + VE Q ++E+ IL + + I+
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 423 GCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 482
G + EF+ G+L Y +I E +L RIAV V L YL S +
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVY--RKIPE-----HVLGRIAVAVVKGLTYLWS---LK 115
Query: 483 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 542
I HRD+K +N+L++ + + K+ DFG S ++ + GT Y+ PE Q+
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYMAPERISGEQYGI 172
Query: 543 KSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 582
SDV+S G+ +E+ G+ P I ++ + LQ I
Sbjct: 173 HSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI 212
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 7e-20
Identities = 58/187 (31%), Positives = 103/187 (55%), Gaps = 20/187 (10%)
Query: 386 IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 444
+VAVK + V +T F+ E+ I+S++ + NI++LLG C+ + ++ E++ NG L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 445 QYI-HNQIEE-------FP-ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL 495
Q++ +IE P ++ LL +AV+++ + YL AS+ HRD+ + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 496 DDKYRAKVSDFGTSRSVMVDQTHLTTKVQG----TFGYVDPEYFQSSQFTEKSDVYSFGV 551
+ Y K++DFG SR++ + ++QG ++ E +FT SDV++FGV
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 552 VLVEILT 558
L E+ T
Sbjct: 220 TLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 9e-20
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 366 RILGQGGQGTV----YKGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNI 418
++LG+G G V KG TD + AVK K ++ + +VE + E +L+
Sbjct: 1 KVLGKGSFGKVLLAELKG--TD-ELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF 57
Query: 419 VKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLH 476
+ L C +T+ L V E++ G L +I + F E R A E+ L +LH
Sbjct: 58 LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFD---EPRARFYAAEIVLGLQFLH 113
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD-QTHLTTKVQGTFGYVDPEYF 535
I +RD+K N+LLD + K++DFG + ++ T T+ GT Y+ PE
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEIL 168
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+ D ++ GV+L E+L GQ P + DE
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 1e-19
Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 9/196 (4%)
Query: 368 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 426
+GQG GTVY + + G+ VA+K+ L + E INE++++ + + NIV L L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 427 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 486
+ +V E++ G+L + + E + + + E AL +LHS I HR
Sbjct: 87 VGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSNQVI---HR 139
Query: 487 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDV 546
DIKS NILL K++DFG + +Q+ +T V GT ++ PE + K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 547 YSFGVVLVEILTGQKP 562
+S G++ +E++ G+ P
Sbjct: 199 WSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 1e-19
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 13/218 (5%)
Query: 348 KLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD---GRIVAVKKSKLVDETNVEQFI 404
KL T + Y +GQG GTV+ D G+ VA+K+ L + E I
Sbjct: 7 KLRTIVSIGDPKKKYTRYEKIGQGASGTVFTA--IDVATGQEVAIKQINLQKQPKKELII 64
Query: 405 NEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI 464
NE++++ ++ + NIV L L + +V E++ G+L + + E + + +
Sbjct: 65 NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAV 120
Query: 465 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ 524
E AL +LH+ I HRDIKS N+LL K++DFG + +Q+ +T V
Sbjct: 121 CRECLQALEFLHANQVI---HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV- 176
Query: 525 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
GT ++ PE + K D++S G++ +E++ G+ P
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 11/213 (5%)
Query: 368 LGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVE-QFINEVVILSQINHRNIVKLLGCC 425
+G+G G V+ G L D VAVK + +++ +F+ E IL Q +H NIV+L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
+ + +V E + G ++ + + + L+++ + + YL S I H
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKV--KELIQMVENAAAGMEYLESKHCI---H 117
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK--VQGTFGYVDPEYFQSSQFTEK 543
RD+ + N L+ +K K+SDFG SR D + +T Q + PE +++ +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 544 SDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 575
SDV+SFG++L E + G P ++ + + +
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAI 209
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 73/289 (25%), Positives = 133/289 (46%), Gaps = 45/289 (15%)
Query: 368 LGQGGQGTVYKGML-----TDGRIVAVKKSKLVDETNVEQ---FINEVVILSQINHRNIV 419
LG+ G +YKG L ++VA+K K D N +Q F E ++++++H NIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYI-----HNQI-----EEFPITWEL----LLRIA 465
LLG + + +++E++ G L++++ H+ + E+ + L L IA
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 466 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQ 524
++++ + YL S + H+D+ + NIL+ ++ K+SD G SR + D + K
Sbjct: 131 IQIAAGMEYLSSHFFV---HKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 525 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAIN 583
++ PE +F+ SD++SFGVVL EI + G +P + E
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------------- 234
Query: 584 ENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632
+ E++ R L ++ + +L C RP K++ L
Sbjct: 235 ---VIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 66/209 (31%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 368 LGQGGQGTVY--KGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLL 422
+ +G G V+ K T G I A+K K+ ++ + V+Q + E ILSQ +VKL
Sbjct: 1 ISKGAYGRVFLAKKKST-GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 423 GCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAAS 480
+ + L LV E++P G L + N + E + RI E+ AL YLHS
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLEN-VGSLD---EDVARIYIAEIVLALEYLHS--- 111
Query: 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ-------THLTTKVQGTFGYVDPE 533
I HRD+K NIL+D K++DFG S+ +V + ++ GT Y+ PE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 534 YFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
++ D +S G +L E L G P
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 368 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 427
LG G G V+ G VAVK K + E F+ E I+ ++ H +V+L E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 428 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 487
+ +V E++ G+L ++ + E + L+ +A +V+ + Y+ I HRD
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMNYI---HRD 127
Query: 488 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFTEKSD 545
++SANIL+ D K++DFG +R +++ T + F + PE +FT KSD
Sbjct: 128 LRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 546 VYSFGVVLVEILT-GQKPIRAINTDE 570
V+SFG++L E++T G+ P +N E
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMNNRE 211
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 80/273 (29%), Positives = 128/273 (46%), Gaps = 37/273 (13%)
Query: 368 LGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 426
+G+G G V G+ VAVKK L + E NEVVI+ +H N+V + L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 427 ETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
+ +V EF+ G L + H ++ E E + + + V AL YLH+ I H
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIATVCLSVLRALSYLHNQGVI---H 141
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 545
RDIKS +ILL R K+SDFG V + + V GT ++ PE + + D
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVD 200
Query: 546 VYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF----LQAINENRLFEILDARVLKEAKK 601
++S G++++E++ G+ P YF LQA+ R+ + L R +K++ K
Sbjct: 201 IWSLGIMVIEMIDGEPP--------------YFNEPPLQAM--RRIRDNLPPR-VKDSHK 243
Query: 602 EGIMTVATLAKRCLNLNGKMRPTMKEVAFELGG 634
V+++ + L+L P+ + A EL
Sbjct: 244 -----VSSVLRGFLDLMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 80/291 (27%), Positives = 140/291 (48%), Gaps = 25/291 (8%)
Query: 339 SNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDE 397
S+E +EK + S + Y +GQG GTVY M + G+ VA+++ L +
Sbjct: 1 SDEEILEKLRSIVS--VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 398 TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPIT 457
E INE++++ + + NIV L L + +V E++ G+L + + E +
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMD 114
Query: 458 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517
+ + E AL +LHS I HRDIKS NILL K++DFG + +Q+
Sbjct: 115 EGQIAAVCRECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171
Query: 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY 577
+T V GT ++ PE + K D++S G++ +E++ G+ P +N + ++L
Sbjct: 172 KRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY--LNENPLRAL--- 225
Query: 578 FLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+L A N E+ + L ++ RCL+++ + R + KE+
Sbjct: 226 YLIATNGTP--ELQNPEKLSAIFRD-------FLNRCLDMDVEKRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 53/198 (26%), Positives = 100/198 (50%), Gaps = 6/198 (3%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
+ LG G G V+ G + VAVK K +V+ F+ E ++ + H +V+L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
+ E ++ E++ G+L ++ + E + L+ + +++ + Y+ I H
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKNYI---H 126
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 545
RD+++AN+L+ + K++DFG +R + ++ + + PE FT KSD
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 546 VYSFGVVLVEILT-GQKP 562
V+SFG++L EI+T G+ P
Sbjct: 187 VWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 26/227 (11%)
Query: 367 ILGQGGQGTVYKGML-----TDGRI-VAVKKSKL-VDETNVEQFINEVVILSQI-NHRNI 418
LG+G G V K + VAVK K E ++ ++E+ ++ I H+NI
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 419 VKLLGCCLETEVPLLVYEFI-------------PNGTLYQYIHNQIEEFPITWELLLRIA 465
+ LLG C + +V E+ P G + E +T + L+ A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 466 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQ 524
+V+ + +L S I HRD+ + N+L+ + + K++DFG +R + +D TT +
Sbjct: 139 YQVARGMEFLASKKCI---HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 525 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 570
++ PE +T +SDV+SFGV+L EI T G P I +E
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 56/198 (28%), Positives = 104/198 (52%), Gaps = 11/198 (5%)
Query: 368 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 427
LGQG G V+ G VA+K K + E F+ E ++ ++ H +V+L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 428 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 487
+ +V E++ G+L ++ ++ ++ + L+ +A +++ + Y+ + HRD
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 127
Query: 488 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFTEKSD 545
+++ANIL+ + KV+DFG +R +++ T + F + PE +FT KSD
Sbjct: 128 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 546 VYSFGVVLVEILT-GQKP 562
V+SFG++L E+ T G+ P
Sbjct: 186 VWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 20/214 (9%)
Query: 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET-----NVEQFINEVVILSQIN 414
N+ ++LGQG G VY D GR +AVK+ + E+ V E+ +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 415 HRNIVKLLGCCLET-EVPLLVY-EFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGA 471
H IV+ GC + E L ++ E +P G+ I +Q++ + +T + + ++
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQILEG 118
Query: 472 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR---SVMVDQTHLTTKVQGTFG 528
+ YLHS I HRDIK ANIL D K+ DFG S+ ++ + T + + V GT
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPY 174
Query: 529 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
++ PE + K+D++S G +VE+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 51/197 (25%), Positives = 91/197 (46%), Gaps = 10/197 (5%)
Query: 368 LGQGGQGTVYK-GMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHRNIVKLLGC 424
+G+G G V+K G VA+KK + ++ Q + E+ L H +VKLL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 425 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
+LV E++P L + + + EE P+ + + + Y+H+ I
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRD--EERPLPEAQVKSYMRMLLKGVAYMHANG---IM 121
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQSSQFTEK 543
HRD+K AN+L+ K++DFG +R ++ L + T Y PE + + ++
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181
Query: 544 SDVYSFGVVLVEILTGQ 560
D+++ G + E+L G
Sbjct: 182 VDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 6e-19
Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 16/212 (7%)
Query: 366 RILGQGGQGTVYKG-MLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKL 421
R+LG+G G V + GR+ AVK K ++ + +VE + E ILS + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 422 LGCCLET-EVPLLVYEFIPNGTLYQYIHN--QIEEFPITWELLLRIAVEVSGALFYLHSA 478
L CC +T + V EF+ G L +I + +E + A E++ AL +LH
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-----YAAEITSALMFLHDK 115
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 538
I +RD+K N+LLD + K++DFG + + + T+ GT Y+ PE Q
Sbjct: 116 G---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTSTFCGTPDYIAPEILQEM 171
Query: 539 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+ D ++ GV+L E+L G P A N D+
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 63/215 (29%), Positives = 110/215 (51%), Gaps = 18/215 (8%)
Query: 366 RILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNV-----EQFINEVVILSQINHRNIV 419
++LG G GTVYKG+ + DG V + + V N ++ ++E +++ + +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
+LLG CL + V L V + +P G L Y+ + I + LL V+++ + YL
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDR--IGSQDLLNWCVQIAKGMSYLEE-- 127
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT---KVQGTFGYVDPEYFQ 536
+ + HRD+ + N+L+ K++DFG +R + +D+T KV ++ E
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALESIL 184
Query: 537 SSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 570
+FT +SDV+S+GV + E++T G KP I E
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 73/229 (31%), Positives = 111/229 (48%), Gaps = 24/229 (10%)
Query: 350 FTSKDLEKATDNYNANRILGQGGQGTVYKGML--TDGRIVAVKKSKL-VDETNVEQFINE 406
FT++DL+ + +G+G GTV K ML G I+AVK+ + VDE ++ + +
Sbjct: 1 FTAEDLKDLGE-------IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMD 52
Query: 407 V-VILSQINHRNIVKLLGCCLETEVPLLVYEF--IPNGTLYQYIHNQIE-EFPITWELLL 462
+ V++ + IVK G + E I Y+Y++ ++ P E+L
Sbjct: 53 LDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIP--EEILG 110
Query: 463 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 522
+IAV AL YL + I HRD+K +NILLD K+ DFG S +VD T
Sbjct: 111 KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-GQLVDSIAKTRD 167
Query: 523 VQGTFGYVDPEYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAINT 568
G Y+ PE S + +SDV+S G+ L E+ TG+ P N+
Sbjct: 168 A-GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS 215
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 60/220 (27%), Positives = 113/220 (51%), Gaps = 18/220 (8%)
Query: 366 RILGQGGQGTVYKGM-LTDG---RI-VAVKKSKLVDETNVEQFI-NEVVILSQINHRNIV 419
++LG G GTVYKG+ + +G +I VA+K+ + + I +E +++ +++ ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
+LLG CL + V L + + +P G L Y+ + + LL V+++ + YL
Sbjct: 73 RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYLEERR 129
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT---KVQGTFGYVDPEYFQ 536
+ HRD+ + N+L+ K++DFG ++ + D+ KV ++ E
Sbjct: 130 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PIKWMALESIL 184
Query: 537 SSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 575
+T +SDV+S+GV + E++T G KP I E S++
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--EQFINEVVILSQINHRNIVKLLG 423
LG+G G+V K L + ++ K+ D +Q + E+ I IVK G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 424 CCL---ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWE-LLLRIAVEVSGALFYLHSAA 479
L + + + + E+ G+L + E +L +IA V L YLHS
Sbjct: 67 AFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG----YVDPEYF 535
I HRDIK +NILL K + K+ DFG S L + GTF Y+ PE
Sbjct: 126 II---HRDIKPSNILLTRKGQVKLCDFGVS-------GELVNSLAGTFTGTSFYMAPERI 175
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKPI 563
Q ++ SDV+S G+ L+E+ + P
Sbjct: 176 QGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 15/206 (7%)
Query: 367 ILGQGGQGTVYKGMLT-DGR---IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKL 421
++G G G V +G L G+ VA+K K E F++E I+ Q +H NI+ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 422 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASI 481
G ++ +++ EF+ NG L ++ +F + L+ + ++ + YL + +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ--LVGMLRGIAAGMKYL---SEM 125
Query: 482 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT-TKVQG---TFGYVDPEYFQS 537
HRD+ + NIL++ KVSDFG SR + D + T T G + PE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 538 SQFTEKSDVYSFGVVLVEILT-GQKP 562
+FT SDV+S+G+V+ E+++ G++P
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 59/209 (28%), Positives = 108/209 (51%), Gaps = 30/209 (14%)
Query: 386 IVAVKKSKLVDETNVEQ-FINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 444
+VAVK + N F+ EV ILS++ NI++LLG C++ + ++ E++ NG L
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 445 QYI-HNQIEE---------------FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDI 488
Q++ + +++ I++ LL +A++++ + YL +S+ HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164
Query: 489 KSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG----TFGYVDPEYFQSSQFTEKS 544
+ N L+ + K++DFG SR++ + ++QG ++ E +FT S
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTAS 221
Query: 545 DVYSFGVVLVEILT--GQKPIRAINTDED 571
DV++FGV L EIL ++P + TDE
Sbjct: 222 DVWAFGVTLWEILMLCKEQPYGEL-TDEQ 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL---VDETNVEQFIN----EVVILSQ 412
N+ ++LG+G G VY D GR +AVK+ ET+ E +N E+ +L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE--VNALECEIQLLKN 60
Query: 413 INHRNIVKLLGCCLE-TEVPLLVY-EFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVS 469
+ H IV+ GC + E L ++ E++P G+ I +Q++ + +T + R ++
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQIL 116
Query: 470 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT--TKVQGTF 527
+ YLHS I HRDIK ANIL D K+ DFG S+ + T V GT
Sbjct: 117 QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 528 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
++ PE + K+DV+S +VE+LT + P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 366 RILGQGGQGTVYKGM------LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 419
R LG+G G V+ D +VAVK K + F E +L+ + H +IV
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ-------IEEFPI--TWEL----LLRIAV 466
K G C + + ++V+E++ +G L +++ ++ P EL +L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQG 525
+++ + YL AS HRD+ + N L+ K+ DFG SR V D +
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 526 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 562
++ PE +FT +SDV+SFGV+L EI T G++P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 74/303 (24%), Positives = 136/303 (44%), Gaps = 51/303 (16%)
Query: 356 EKATDNYNANRILGQGGQGTVYK----GMLT--DGRIVAVK--KSKLVDETNVEQFINEV 407
E +N R +GQG G V++ G+L +VAVK K + + + F E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREA 59
Query: 408 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-----HNQ------------ 450
++++ +H NIVKLLG C + L++E++ G L +++ Q
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 451 --IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 508
+ P++ L IA +V+ + YL + HRD+ + N L+ + K++DFG
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGL 176
Query: 509 SRSV-MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAI 566
SR++ D + ++ PE +++T +SDV+++GVVL EI + G +P
Sbjct: 177 SRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP---- 232
Query: 567 NTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGI-MTVATLAKRCLNLNGKMRPTM 625
Y+ A +E ++ + D VL + + + + L + C + RP+
Sbjct: 233 ----------YYGMA-HEEVIYYVRDGNVL--SCPDNCPLELYNLMRLCWSKLPSDRPSF 279
Query: 626 KEV 628
+
Sbjct: 280 ASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 5e-18
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 368 LGQGGQGTVYKGM-LTDGRIVAVK--KSKLVDETNVEQFIN--EVVILSQIN-HRNIVKL 421
LG G G+VY G +VA+K K K + E+ +N EV L ++N H NIVKL
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKF---YSWEECMNLREVKSLRKLNEHPNIVKL 63
Query: 422 LGCCLETEVPLLVYEFIPNGTLYQYI-HNQIEEFP------ITWELLLRIAVEVSGALFY 474
E + V+E++ G LYQ + + + F I +++L L +
Sbjct: 64 KEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ--------GLAH 114
Query: 475 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 534
+H +HRD+K N+L+ K++DFG +R + + T V T Y PE
Sbjct: 115 IHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREI-RSRPPYTDYV-STRWYRAPEI 169
Query: 535 F-QSSQFTEKSDVYSFGVVLVEILTGQKPI 563
+S+ ++ D+++ G ++ E+ T +P+
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTL-RPL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 77/309 (24%), Positives = 134/309 (43%), Gaps = 44/309 (14%)
Query: 356 EKATDNYNANRILGQGGQGTVY--------KGMLTDGRIVAVKKSK-LVDETNVEQFINE 406
E + D + LG+G G V K + VAVK K E ++ ++E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 407 VVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------------NQIE 452
+ ++ I H+NI+ LLG C + ++ E+ G L +Y+ ++
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 453 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 512
+ +T++ L+ +V+ + YL S I HRD+ + N+L+ + K++DFG +R V
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 513 M-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 570
+D TT + ++ PE +T +SDV+SFGV++ EI T G P I +E
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247
Query: 571 DKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAF 630
LF++L + + + + C + RPT K++
Sbjct: 248 ----------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291
Query: 631 ELGGIRTST 639
+L I T T
Sbjct: 292 DLDRILTLT 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 7e-18
Identities = 63/280 (22%), Positives = 134/280 (47%), Gaps = 40/280 (14%)
Query: 366 RILGQGGQGTVYKGM-LTDGRIVAVKKS-KLVDETNVEQFINEV----VILSQINHRNIV 419
++LG G GTV+KG+ + +G + + + K + + + Q E+ + + ++H IV
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
+LLG C + L V + P G+L ++ + + + LL V+++ ++YL
Sbjct: 73 RLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLEEHR 129
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDPEYFQSS 538
+ HR++ + NILL +++DFG + + D+ + ++ + ++ E
Sbjct: 130 MV---HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 539 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597
++T +SDV+S+GV + E+++ G +P + R E+ D +L+
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGM-------------------RPHEVPD--LLE 225
Query: 598 EAKKEGIMTVATL-----AKRCLNLNGKMRPTMKEVAFEL 632
+ ++ + T+ +C ++ +RPT KE+A E
Sbjct: 226 KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEF 265
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 7e-18
Identities = 60/205 (29%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 366 RILGQGGQGTVYKGML-TDGR---IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVK 420
+++G G G V G L G+ VA+K K E F++E I+ Q +H NI+
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 421 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 480
L G +++ ++V E++ NG+L ++ +F + L+ + ++ + YL +
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQ--LVGMLRGIASGMKYL---SD 124
Query: 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSS 538
+ HRD+ + NIL++ KVSDFG SR + D T G + PE
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 539 QFTEKSDVYSFGVVLVEILT-GQKP 562
+FT SDV+S+G+V+ E+++ G++P
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 8e-18
Identities = 65/214 (30%), Positives = 108/214 (50%), Gaps = 20/214 (9%)
Query: 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET-----NVEQFINEVVILSQIN 414
N+ ++LGQG G VY D GR +A K+ + E+ V E+ +L +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 415 HRNIVKLLGCCLE-TEVPLLVY-EFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGA 471
H IV+ GC + E L ++ E++P G+ + +Q++ + +T + + ++
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGS----VKDQLKAYGALTESVTRKYTRQILEG 118
Query: 472 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR---SVMVDQTHLTTKVQGTFG 528
+ YLHS I HRDIK ANIL D K+ DFG S+ ++ + T + + V GT
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPY 174
Query: 529 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
++ PE + K+DV+S G +VE+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 9e-18
Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 47/227 (20%)
Query: 362 YNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNI 418
Y + +G G G V + GR VA+KK V D + ++ + E+ +L + H NI
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 419 VKLLGCCLETEVPL-----------LVYEFIPNGT-LYQYIHNQIEEFPITWEL------ 460
+ LL ++ +V E + T L++ I + P+T +
Sbjct: 62 IGLL------DILRPPSPEDFNDVYIVTELME--TDLHKVIKSPQ---PLTDDHIQYFLY 110
Query: 461 -LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519
+LR L YLHSA + HRD+K +NIL++ K+ DFG +R V D+
Sbjct: 111 QILR-------GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160
Query: 520 TTKVQG--TFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
+ T Y PE SS++T+ D++S G + E+LT KP+
Sbjct: 161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 36/210 (17%)
Query: 367 ILGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNVEQF-INEVVILSQI---NHRNIVK 420
+G+G GTVYK L GR VA+KK ++ + E + + E+ +L Q+ H NIV+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 421 LLGCC----LETEVPL-LVYEFIPNGTLYQYIHN---------QIEEFPITWELLLRIAV 466
LL C + E+ L LV+E + + L Y+ I++ + +LL
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKD--LMRQLL----- 117
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 526
+ +LHS I HRD+K NIL+ + K++DFG +R + + LT+ V T
Sbjct: 118 ---RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEMALTSVVV-T 169
Query: 527 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEI 556
Y PE S + D++S G + E+
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 9/207 (4%)
Query: 361 NYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSK---LVDETNVEQFINEVVILSQINHR 416
N+ + +G+G VY+ L DG VA+KK + L+D I E+ +L Q+NH
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYL 475
N++K +E +V E G L + I H + ++ I + + + V++ AL ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 535
HS + HRDIK AN+ + K+ D G R +T + GT Y+ PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPYYMSPERI 178
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKP 562
+ + KSD++S G +L E+ Q P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 78/298 (26%), Positives = 132/298 (44%), Gaps = 44/298 (14%)
Query: 367 ILGQGGQGTVYKGMLT-DGRIV--AVKKSK-LVDETNVEQFINEVVILSQI-NHRNIVKL 421
++G+G G V + M+ DG + A+K K E + F E+ +L ++ +H NI+ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 422 LGCCLETEVPLLVYEFIPNGTLYQYIHNQ--IEEFP-----------ITWELLLRIAVEV 468
LG C + E+ P G L ++ +E P +T + LL+ A +V
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 469 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR--SVMVDQTHLTTKVQGT 526
+ + YL I HRD+ + N+L+ + +K++DFG SR V V +T V+
Sbjct: 129 ATGMQYLSEKQFI---HRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR-- 183
Query: 527 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINEN 585
++ E S +T KSDV+SFGV+L EI++ G P + E
Sbjct: 184 --WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--------------- 226
Query: 586 RLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGASI 643
L+E L E + V L ++C RP +++ +L + + A +
Sbjct: 227 -LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV 283
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 15/214 (7%)
Query: 361 NYNANRILGQGGQGTVY--KGMLTDGRIVAVKKSKL----VDETNVEQFINEVVILSQIN 414
Y + +G+G G +Y K +D +K+ L V E + EV++L+++
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASK--KEVILLAKMK 57
Query: 415 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 474
H NIV E +V E+ G L + I+ Q + + +L V++S L +
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKH 116
Query: 475 LHSAASIPIYHRDIKSANILLDDKYR-AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 533
+H I HRDIKS NI L AK+ DFG +R + D L GT Y+ PE
Sbjct: 117 IHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPYYLSPE 172
Query: 534 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 567
Q+ + K+D++S G VL E+ T + P N
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 31/237 (13%)
Query: 343 NIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVE 401
+ E +LF+ D EK + R +G G G VY +VA+KK + + E
Sbjct: 1 DPEIAELFSKDDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE 57
Query: 402 QF---INEVVILSQINHRNIVKLLGCCLETEVPLLVYEF-IPNGTLYQYIHNQ-IEEFPI 456
++ I EV L Q+ H N ++ GC L LV E+ + + + +H + ++E
Sbjct: 58 KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQE--- 114
Query: 457 TWELLLRIAVEVSGAL---FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513
+ IA GAL YLHS I HRDIK+ NILL + K++DFG++ V
Sbjct: 115 -----VEIAAICHGALQGLAYLHSHERI---HRDIKAGNILLTEPGTVKLADFGSASLVS 166
Query: 514 VDQTHLTTKVQGTFGYVDPEY---FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 567
+ + GT ++ PE Q+ K DV+S G+ +E+ + P+ +N
Sbjct: 167 PANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 3e-17
Identities = 57/188 (30%), Positives = 89/188 (47%), Gaps = 22/188 (11%)
Query: 396 DETNVEQFINEVVILSQINHRNIVKLL--GCCLETEVPLL--VYEFIPNGTLYQYIHNQI 451
+E +F E + +++ H NIV LL G E LL V+E++P TL + +
Sbjct: 18 EEHQRARFRRETALCARLYHPNIVALLDSG---EAPPGLLFAVFEYVPGRTLREVLAAD- 73
Query: 452 EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGT 508
+ R+ ++V AL H+ I HRD+K NI++ + AKV DFG
Sbjct: 74 --GALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128
Query: 509 S------RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
R V TT+V GT Y PE + T SD+Y++G++ +E LTGQ+
Sbjct: 129 GTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRV 188
Query: 563 IRAINTDE 570
++ + E
Sbjct: 189 VQGASVAE 196
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 368 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 426
LG G G VYK G A K ++ E +E F+ E+ ILS+ H NIV L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 427 ETEVPLLVYEFIPNGTLYQYIHNQIEEF--PITWELLLRIAVEVSGALFYLHSAASIPIY 484
++ EF G L + + E +T + + ++ AL +LHS I
Sbjct: 73 YENKLWILIEFCDGGAL----DSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVI--- 125
Query: 485 HRDIKSANILLDDKYRAKVSDFGTS-RSVMVDQTHLTTKVQGTFGYVDPEY-----FQSS 538
HRD+K+ NILL K++DFG S ++ Q T GT ++ PE F+ +
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDN 183
Query: 539 QFTEKSDVYSFGVVLVEILTGQKPIRAIN 567
+ K+D++S G+ L+E+ + P +N
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 63/209 (30%), Positives = 109/209 (52%), Gaps = 11/209 (5%)
Query: 361 NYNANRILGQG--GQGTVYKGMLTDGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRN 417
YN R++G+G G+ + + + +D + A+K+ +L + VE E V+L+++ H N
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 418 IVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 476
IV E + L +V E+ G L Q I Q + + +L+ V++ + ++H
Sbjct: 60 IVAFKES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKL-FPEDTILQWFVQMCLGVQHIH 117
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 536
+ HRDIKS NI L + K+ DFG++R + + T V GT YV PE ++
Sbjct: 118 EKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWE 173
Query: 537 SSQFTEKSDVYSFGVVLVEILTGQKPIRA 565
+ + KSD++S G +L E+ T + P +A
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHPFQA 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 9/207 (4%)
Query: 361 NYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSK---LVDETNVEQFINEVVILSQINHR 416
N+ + +G+G VY+ L D + VA+KK + ++D + + E+ +L Q+NH
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYL 475
N++K L +E +V E G L Q I + + ++ I + + V++ A+ ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 535
HS + HRDIK AN+ + K+ D G R +T + GT Y+ PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPYYMSPERI 178
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKP 562
+ + KSD++S G +L E+ Q P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 7e-17
Identities = 59/198 (29%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 368 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 427
LGQG G V+ G VA+K K E F+ E I+ ++ H +V L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 428 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRD 487
+ +V EF+ G+L ++ ++ + L+ +A +++ + Y+ I HRD
Sbjct: 73 EPI-YIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIERMNYI---HRD 127
Query: 488 IKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFTEKSD 545
+++ANIL+ D K++DFG +R +++ T + F + PE +FT KSD
Sbjct: 128 LRAANILVGDNLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 546 VYSFGVVLVEILT-GQKP 562
V+SFG++L E++T G+ P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 368 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGC 424
+G G G VYK G ++AVK+ + E N ++ V+L + IVK G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 425 CL-ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL---HSAAS 480
+ +++V + E + T + +I+ PI ++L ++ V + AL YL H
Sbjct: 83 FITDSDV-FICMELM--STCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKHG--- 135
Query: 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF 540
+ HRD+K +NILLD K+ DFG S ++ + T+ G Y+ PE
Sbjct: 136 --VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDP 191
Query: 541 TEK----SDVYSFGVVLVEILTGQKPIRAINTD 569
K +DV+S G+ LVE+ TGQ P + T+
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQFPYKNCKTE 224
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 65/221 (29%), Positives = 114/221 (51%), Gaps = 31/221 (14%)
Query: 368 LGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCC 425
LG+G TVYKG T G IVA+K+ L +E I E+ ++ ++ H NIV+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV- 66
Query: 426 LETEVPL-LVYEFIPNGTLYQYIH----------NQIEEFPITWELLLRIAVEVSGALFY 474
+ TE L LV+E++ + L +Y+ N ++ F T++LL IA +
Sbjct: 67 IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSF--TYQLLKGIA--------F 115
Query: 475 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 534
H + HRD+K N+L++ + K++DFG +R+ + + +V T Y P+
Sbjct: 116 CHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV 171
Query: 535 FQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL 574
S+ ++ D++S G ++ E++TG +P+ +ED+ L
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLL 211
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 71/218 (32%), Positives = 113/218 (51%), Gaps = 17/218 (7%)
Query: 366 RILGQGGQGTVY---KGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNI 418
++LGQG G V+ K D G++ A+K K+ L V E IL+++NH I
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFI 60
Query: 419 VKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 477
VKL +TE L L+ +F+ G L+ + +E T E + E++ AL +LHS
Sbjct: 61 VKL-HYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHS 116
Query: 478 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS 537
+ I +RD+K NILLD++ K++DFG S+ +D GT Y+ PE
Sbjct: 117 ---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 538 SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 575
T+ +D +SFGV++ E+LTG P + + E +++
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 365 NRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF--INEVVILSQINHRNIVKL 421
NRI G+G G VY+ T G IVA+KK ++ +E + + E+ +L + H NIV+L
Sbjct: 13 NRI-GEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVEL 71
Query: 422 L----GCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 477
G L++ LV E+ L + N F + + + +++ L YLH
Sbjct: 72 KEVVVGKHLDS--IFLVMEYCEQ-DLASLLDNMPTPFSES--QVKCLMLQLLRGLQYLHE 126
Query: 478 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQ 536
I HRD+K +N+LL DK K++DFG +R+ + +T KV T Y PE
Sbjct: 127 NF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLG 182
Query: 537 SSQFTEKSDVYSFGVVLVEILTGQKPI 563
+ +T D+++ G +L E+L KP+
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAH-KPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 16/223 (7%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTDGR-IVAVKK---SKLVDETNVEQFINEVVILSQINH 415
D+ + +G G G V+ A+K +++ + NE +L +++H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 416 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 475
I++L + ++ E++P G L+ Y+ N F + L A E+ AL YL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFY--ASEIVCALEYL 117
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 535
HS I +RD+K NILLD + K++DFG ++ + D+T + GT Y+ PE
Sbjct: 118 HSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTW---TLCGTPEYLAPEVI 170
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE--DKSLVG 576
QS + D ++ G+++ E+L G P N +K L G
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG 213
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 28/240 (11%)
Query: 356 EKATDNYNANRILGQG--GQGTVYKGMLTD----GRI--VAVKKSKL-VDETNVEQFINE 406
E D + LG+G GQ + + + D R+ VAVK K E ++ I+E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 407 VVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------------NQIE 452
+ ++ I H+NI+ LLG C + ++ E+ G L +Y+ Q+
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 453 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 512
E ++++ L+ A +V+ + YL S I HRD+ + N+L+ + K++DFG +R +
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 513 M-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 570
+D TT + ++ PE +T +SDV+SFGV+L EI T G P + +E
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 66/262 (25%), Positives = 129/262 (49%), Gaps = 30/262 (11%)
Query: 386 IVAVKKSKLVDETNVEQ-FINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 444
+VAVK + N F+ E+ I+S++ NI++LL C+ ++ ++ E++ NG L
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 445 QYI-HNQIEEFP-------ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD 496
Q++ ++ +E I++ L+ +A +++ + YL +S+ HRD+ + N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164
Query: 497 DKYRAKVSDFGTSRSVMVDQTHLTTKVQG----TFGYVDPEYFQSSQFTEKSDVYSFGVV 552
Y K++DFG SR++ + ++QG ++ E +FT SDV++FGV
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221
Query: 553 LVEILT--GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATL 610
L EILT ++P ++ ++ G F + ++ R + + + ++ L
Sbjct: 222 LWEILTLCKEQPYSQLSDEQVIENTGEFFR--DQGRQVYLPKPALCPD-------SLYKL 272
Query: 611 AKRCLNLNGKMRPTMKEVAFEL 632
C N K RP+ +E+ L
Sbjct: 273 MLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 65/245 (26%), Positives = 122/245 (49%), Gaps = 25/245 (10%)
Query: 367 ILGQGGQGTVYKGMLTDG-----RIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNI 418
+L +G G ++ G+L D V VK + D E V + E +L ++H+NI
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKT--VKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 419 VKLLGCCLE-TEVPLLVYEFIPNGTLYQYIHN-----QIEEFPITWELLLRIAVEVSGAL 472
+ +L C+E E P ++Y ++ G L ++ ++ + L+ +A++++ +
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVD 531
YLH + H+DI + N ++D++ + K++D SR + H L ++
Sbjct: 131 SYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMA 187
Query: 532 PEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFL-QAIN-ENR 586
E + +++ SDV+SFGV+L E++T GQ P I+ E + + GY L Q IN +
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPDE 247
Query: 587 LFEIL 591
LF ++
Sbjct: 248 LFAVM 252
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 71/231 (30%), Positives = 110/231 (47%), Gaps = 39/231 (16%)
Query: 356 EKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQF----INEVVIL 410
++ D ++ +G+G G VYK D G +VA+KK +L +E E F I E+ IL
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60
Query: 411 SQINHRNIVKLLGCCLETEVPL----------LVYEFIPN-------GTLYQYIHNQIEE 453
Q+NHRNIV L + + L LV+E++ + L + + I+
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 454 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513
F + LL L Y H + HRDIK +NILL++K + K++DFG +R
Sbjct: 121 F---MKQLLE-------GLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYN 167
Query: 514 VDQTHLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPI 563
+++ T T Y PE + + DV+S G +L E+ T +KPI
Sbjct: 168 SEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 71/271 (26%), Positives = 124/271 (45%), Gaps = 38/271 (14%)
Query: 387 VAVK--KSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTL 443
VAVK K D+ ++ ++E+ ++ I H+NI+ LLG C + ++ E+ G L
Sbjct: 47 VAVKMLKDDATDK-DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL 105
Query: 444 YQYIHN-------------QIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKS 490
+Y+ ++ E +T++ L+ A +V+ + YL S I HRD+ +
Sbjct: 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI---HRDLAA 162
Query: 491 ANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSF 549
N+L+ + K++DFG +R V +D TT + ++ PE +T +SDV+SF
Sbjct: 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222
Query: 550 GVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVA 608
GV+L EI T G P I +E LF++L + +
Sbjct: 223 GVLLWEIFTLGGSPYPGIPVEE----------------LFKLLKEGHRMDKPANCTHELY 266
Query: 609 TLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639
+ + C + RPT K++ +L + T T
Sbjct: 267 MIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 387 VAVK--KSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLV-YEFIPNGT 442
VAVK K D+ ++ I+E+ ++ I H+NI+ LLG C + E PL V E+ G
Sbjct: 47 VAVKMLKDNATDK-DLADLISEMELMKLIGKHKNIINLLGVCTQ-EGPLYVIVEYAAKGN 104
Query: 443 LYQYIH-------------NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIK 489
L +++ ++ E ++++ L+ A +V+ + YL S I HRD+
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI---HRDLA 161
Query: 490 SANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 548
+ N+L+ + K++DFG +R V +D T+ + ++ PE +T +SDV+S
Sbjct: 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWS 221
Query: 549 FGVVLVEILT-GQKPIRAINTDE 570
FG+++ EI T G P I +E
Sbjct: 222 FGILMWEIFTLGGSPYPGIPVEE 244
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 74/284 (26%), Positives = 132/284 (46%), Gaps = 41/284 (14%)
Query: 367 ILGQGGQGTVYKGMLTD-GRIVAVKK------SKLVDETNVEQFINEVVILSQINHRNIV 419
++G+G G V K + G+IVA+KK K+V + + E+ +L Q+ H N+V
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR----EIRMLKQLRHENLV 63
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP--ITWELLLRIAVEVSGALFYLHS 477
L+ + LV+EF+ + L + +E++P + + + ++ + + HS
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 478 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF-Q 536
I HRDIK NIL+ K+ DFG +R++ T V T Y PE
Sbjct: 119 HN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVG 174
Query: 537 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK-----SLVGYFLQAINE----NRL 587
+++ D+++ G ++ E+LTG+ P+ ++D D+ +G + E N L
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233
Query: 588 FEILDARVLKEAK-------KEGIMTVATLAKRCLNLNGKMRPT 624
F + +KE + K + V LAK+CL ++ RP+
Sbjct: 234 FAGMRLPEVKEIEPLEKRFPKLSGL-VLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 11/209 (5%)
Query: 365 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 424
+ LG G G V+ VAVK K +VE F+ E ++ + H +VKL
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKL-HA 68
Query: 425 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
+ E ++ EF+ G+L ++ + E L+ + +++ + ++ I
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNYI--- 124
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFTE 542
HRD+++ANIL+ K++DFG +R +++ T + F + PE FT
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 182
Query: 543 KSDVYSFGVVLVEILT-GQKPIRAINTDE 570
KSDV+SFG++L+EI+T G+ P ++ E
Sbjct: 183 KSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 366 RILGQGGQGTVYKGMLTDGR-----IVAVKKSKLVDETNVEQFINEVVILSQINHRNIVK 420
++LG+G G V L G+ + A+KK ++ + +VE + E +L+ +
Sbjct: 1 KVLGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 421 LLGCCLETEVPLL-VYEFIPNGTLYQYIHNQ--IEEFPITWELLLRIAVEVSGALFYLHS 477
L C +T+ L V EF+ G L +I ++ + + T+ A E+ L +LHS
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGLQFLHS 114
Query: 478 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS 537
I +RD+K N++LD K++DFG + + +T GT Y+ PE Q
Sbjct: 115 KGII---YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQG 170
Query: 538 SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
++T D +SFGV+L E+L GQ P + DE
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 10/211 (4%)
Query: 368 LGQGGQGTVYKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
LG G G V K ++ +K + Q I E+ +L + N IV G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
+ E + G+L Q + E I E+L ++++ V L YL I H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKHQI--MH 127
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 545
RD+K +NIL++ + K+ DFG S ++D + GT Y+ PE Q + ++ +SD
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQ-LIDS--MANSFVGTRSYMSPERLQGTHYSVQSD 184
Query: 546 VYSFGVVLVEILTGQKPIRAINTDEDKSLVG 576
++S G+ LVE+ G+ PI + E +++ G
Sbjct: 185 IWSMGLSLVELAIGRYPIPPPDAKELEAIFG 215
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 372 GQGTVYKGML----TDGRIVAVKKSKLVDETNVE--QFINEVVILSQINHRNIVKLLGCC 425
G+G+ K +L DG+ +K+ + + E + EV +LS + H NIV+
Sbjct: 9 GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF 68
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
E +V ++ G LY+ I+ Q + +L V++ AL ++H I H
Sbjct: 69 EENGNLYIVMDYCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILH 124
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 545
RDIKS NI L K+ DFG +R V+ L GT Y+ PE ++ + KSD
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYYLSPEICENRPYNNKSD 183
Query: 546 VYSFGVVLVEILTGQKPIRAINTDEDKSLV 575
+++ G VL E+ T + A N K+LV
Sbjct: 184 IWALGCVLYEMCTLKHAFEAGNM---KNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 7e-16
Identities = 89/319 (27%), Positives = 144/319 (45%), Gaps = 40/319 (12%)
Query: 353 KDLEKATDNYNANRILGQGGQGTV----YKGMLTDGRIVAVKKSKLVDETNVEQFINEVV 408
+ L+ ++Y+ +++G+G G V +K + + K +++ ++ F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 409 ILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 467
I++ N +V+L C + + L +V E++P G L + N + P W E
Sbjct: 96 IMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFY--TAE 150
Query: 468 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT---HLTTKVQ 524
V AL +HS I HRD+K N+LLD K++DFGT + +D+T T V
Sbjct: 151 VVLALDAIHSMGLI---HRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVRCDTAV- 204
Query: 525 GTFGYVDPEYFQSS----QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ 580
GT Y+ PE +S + + D +S GV L E+L G P A SLVG + +
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA------DSLVGTYSK 258
Query: 581 AIN-ENRLFEILDARVLKEAKKEGIMTVATLAKRCLNL--NG----KMRPTMKEVAFELG 633
++ +N L D + K AK + A L R + L NG K P K +
Sbjct: 259 IMDHKNSLNFPEDVEISKHAKN---LICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWD 315
Query: 634 GIRTSTGASILQQNCEEID 652
IR T A ++ + +ID
Sbjct: 316 NIR-ETAAPVVPELSSDID 333
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 82/300 (27%), Positives = 130/300 (43%), Gaps = 44/300 (14%)
Query: 354 DLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL-VDETNVEQFINEVVILS 411
D EK + LG G G V K + G I+A K L + Q I E+ +L
Sbjct: 2 DFEKLGE-------LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLH 54
Query: 412 QINHRNIVKLLGCCL-ETEVPLLVYEFIPNGTLYQYIHN--QIEEFPITWELLLRIAVEV 468
+ N IV G + E+ + + E + G+L Q + +I E +L +I++ V
Sbjct: 55 ECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPE-----NILGKISIAV 108
Query: 469 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 528
L YL I HRD+K +NIL++ + K+ DFG S ++D + GT
Sbjct: 109 LRGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVS-GQLIDS--MANSFVGTRS 163
Query: 529 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR-- 586
Y+ PE Q + +T +SD++S G+ LVE+ G+ PI + E +++ G +
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223
Query: 587 ---------------LFEILDARVLKEAKK--EGIMT--VATLAKRCLNLNGKMRPTMKE 627
+FE+LD V + K G + +CL N K R +KE
Sbjct: 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKE 283
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 65/251 (25%), Positives = 99/251 (39%), Gaps = 59/251 (23%)
Query: 358 ATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVILSQ 412
+Y LG+G G VYK + GR+VA+KK + +E + F + E+ IL +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKK 63
Query: 413 INHRNIVKLLGCCLE-----TEVPLLVYEFIP------NGTLYQYIHNQIEEFPITWELL 461
+ H N+V L+ +E VY P +G L N
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL----ENP----------- 108
Query: 462 LRIAVEVSGA----------LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511
+ + S + YLH I HRDIK+ANIL+D++ K++DFG +R
Sbjct: 109 -SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARP 164
Query: 512 VMVDQTHLTTKVQG----------TFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 560
+ G T Y PE ++T D++ G V E+ T
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR- 223
Query: 561 KPIRAINTDED 571
+PI +D D
Sbjct: 224 RPILQGKSDID 234
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-16
Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 366 RILGQGGQGTVYKGMLTDGR-------IVAVKKSKLVDETNVEQFINEVVILSQINHRNI 418
++LG+G G V ML + + I +KK ++ + +V+ + E IL+
Sbjct: 1 KVLGKGSFGKV---MLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 419 VKLLGCCLETEVPLL-VYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLH 476
+ L CC +T+ L V E++ G L QI+ E R A EV+ AL +LH
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLM----FQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 536
I +RD+K NILLD + K++DFG + +++ TT GT Y+ PE Q
Sbjct: 114 RHGVI---YRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFCGTPDYIAPEILQ 169
Query: 537 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
++ D ++ GV++ E++ GQ P A N D+
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-16
Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 26/203 (12%)
Query: 368 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINHRNIVKLLGC 424
+G+G G VYK G +VA+KK +L ET I E+ +L ++NH NIVKLL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 425 CLETEVPL-LVYEFIPNGTLYQYIH-NQIEEFPI------TWELLLRIAVEVSGALFYLH 476
+ TE L LV+EF+ + L +++ + + P+ ++LL +A + H
Sbjct: 68 -IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA--------FCH 117
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 536
S + HRD+K N+L++ + K++DFG +R+ V T +V T Y PE
Sbjct: 118 SHRVL---HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 173
Query: 537 SSQF-TEKSDVYSFGVVLVEILT 558
++ + D++S G + E++T
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-16
Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 24/221 (10%)
Query: 361 NYNANRILGQGGQGTVYKGMLTDGR-------IVAVKKSKLVDETNVEQFINEVVILSQI 413
++N +LG+G G V ML + + I +KK ++ + +VE + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57
Query: 414 NHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEF--PITWELLLRIAVEVSG 470
+ L C +T L V E++ G L +I Q+ +F P + A E++
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPHA----VFYAAEIAI 112
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV-QGTFGY 529
LF+LHS I +RD+K N++LD + K++DFG + + TT+ GT Y
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDY 167
Query: 530 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+ PE + + D ++FGV+L E+L GQ P + DE
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 9e-16
Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 44/219 (20%)
Query: 368 LGQGGQGTVYKGMLTD-GRIVAVKK--SKLVDETNVEQFINEVVILSQI-NHRNIVKLLG 423
LG+G G V+K + +VA+KK + T+ ++ E++ L ++ +H NIVKLL
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74
Query: 424 C--------------CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVS 469
+ET++ + I L + +H + I ++LL
Sbjct: 75 VIKAENDKDIYLVFEYMETDL----HAVIRANIL-EDVHKRY----IMYQLL-------- 117
Query: 470 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ----G 525
AL Y+HS I HRD+K +NILL+ R K++DFG +RS+ + + V
Sbjct: 118 KALKYIHSGNVI---HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 526 TFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
T Y PE S+++T+ D++S G +L E+L G KP+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 77/288 (26%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 367 ILGQGGQGTVYKGMLT-DGRIV--AVKKSK-LVDETNVEQFINEVVILSQINHR-NIVKL 421
++G+G G V K + DG + A+K+ K + + F E+ +L ++ H NI+ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 422 LGCCLETEVPLLVYEFIPNGTLYQYIHNQ--IEEFP-----------ITWELLLRIAVEV 468
LG C L E+ P+G L ++ +E P ++ + LL A +V
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 469 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR--SVMVDQTHLTTKVQGT 526
+ + YL I HRD+ + NIL+ + Y AK++DFG SR V V +T V+
Sbjct: 122 ARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR-- 176
Query: 527 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINEN 585
++ E S +T SDV+S+GV+L EI++ G P + E
Sbjct: 177 --WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------------- 219
Query: 586 RLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633
L+E L E V L ++C RP+ ++ L
Sbjct: 220 -LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 266
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 10/200 (5%)
Query: 368 LGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNV-EQFINEVVILSQINHRNIVKLLGC 424
+G+G G VYKG G+IVA+KK +L +E V I E+ +L ++ H NIV L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 425 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
++ L++EF+ + L +Y+ + + + EL+ ++ + + HS +
Sbjct: 68 LMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VL 123
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ-FTEK 543
HRD+K N+L+D+K K++DFG +R+ + T +V T Y PE S ++
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYSTP 182
Query: 544 SDVYSFGVVLVEILTGQKPI 563
D++S G + E+ T +KP+
Sbjct: 183 VDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 63/230 (27%), Positives = 96/230 (41%), Gaps = 35/230 (15%)
Query: 355 LEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQI 413
L T + ++G+G G VYK G++VA+K ++ E E+ E IL +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKY 59
Query: 414 -NHRNIVKLLGCCLETEVPL------LVYEFIPNGT---LYQYIHNQIEEFPITWELLLR 463
NH NI G ++ P LV E G+ L + + + + + E +
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK--RLKEEWIAY 117
Query: 464 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 523
I E L YLH I HRDIK NILL K+ DFG S L + +
Sbjct: 118 ILRETLRGLAYLHENKVI---HRDIKGQNILLTKNAEVKLVDFGVSA-------QLDSTL 167
Query: 524 Q------GTFGYVDPEYFQSSQ-----FTEKSDVYSFGVVLVEILTGQKP 562
GT ++ PE + + +SDV+S G+ +E+ G+ P
Sbjct: 168 GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 368 LGQGGQGTVYKGMLTD-GRIVAVKK--SKLVDETNVEQF-INEVVILSQINHRNIVKLLG 423
LG+GG G V + G++ A KK K + + EQ +NE IL +++ R IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 424 CCLETEVPL-LVYEFIPNGTLYQYIHNQIEE-FPITWELLLRIAVEVSGALFYLHSAASI 481
ET+ L LV + G L +I+N E FP + A ++ L +LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFY--AAQIICGLEHLHQRR-- 115
Query: 482 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 541
I +RD+K N+LLDD ++SD G + + + GT GY+ PE Q +
Sbjct: 116 -IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYD 172
Query: 542 EKSDVYSFGVVLVEILTGQKPIRAINTDEDK 572
D ++ G L E++ G+ P R +K
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRKEKVEK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 14/216 (6%)
Query: 361 NYNANRILGQGGQGTVY----KGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHR 416
++N +LG+G G V KG I +KK ++ + +VE + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 417 NIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 475
+ L C +T L V E++ G L I Q+ F + A E++ LF+L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ-QVGRFKEPHAVFY--AAEIAIGLFFL 117
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV-QGTFGYVDPEY 534
HS I +RD+K N++LD + K++DFG + M D +TTK GT Y+ PE
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEI 172
Query: 535 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+ + D ++FGV+L E+L GQ P + DE
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 368 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETN--VEQFINEVVILSQINHRNIVKLLGC 424
+G+G G VYK G IVA+KK +L E I E+ +L ++NH NIV+LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 425 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
LV+EF+ + L +Y+ + + L+ ++ + Y HS +
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VL 121
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQSSQFTEK 543
HRD+K N+L+D + K++DFG +R+ V T +V T Y PE S Q++
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYSTP 180
Query: 544 SDVYSFGVVLVEILTGQKPI 563
D++S G + E++ ++P+
Sbjct: 181 VDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 18/218 (8%)
Query: 361 NYNANRILGQGGQGTVYKGMLTDGR-------IVAVKKSKLVDETNVEQFINEVVILSQI 413
++N +LG+G G V ML + + I +KK ++ + +VE + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQ 57
Query: 414 NHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 472
+ + L C +T L V E++ G L +I Q+ +F + A E+S L
Sbjct: 58 DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPQAVFY--AAEISVGL 114
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532
F+LH I +RD+K N++LD + K++DFG + MVD T GT Y+ P
Sbjct: 115 FFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-TTRTFCGTPDYIAP 170
Query: 533 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
E + + D +++GV+L E+L GQ P + DE
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 64/245 (26%), Positives = 113/245 (46%), Gaps = 27/245 (11%)
Query: 366 RILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKL--- 421
R LG G G V+ + +D + VAVKK L D +V+ + E+ I+ +++H NIVK+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 422 -----------LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 470
+G E +V E++ + N +E+ P++ E ++
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLSEEHARLFMYQLLR 125
Query: 471 ALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQG--TF 527
L Y+HSA + HRD+K AN+ ++ + K+ DFG +R V +H +G T
Sbjct: 126 GLKYIHSANVL---HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 528 GYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR 586
Y P + +T+ D+++ G + E+LTG+ + E L+ + + E
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242
Query: 587 LFEIL 591
E+L
Sbjct: 243 RNELL 247
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 49/234 (20%)
Query: 365 NRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV----DETNVEQFIN----------EVVI 409
LG+G G V K T G+IVA+KK K++ D T Q + E+ I
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 410 LSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQI-----EEFPITWELLLRI 464
+++I H NI+ L+ +E + LV + I L + + +I + I ++L +
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMD-IMASDLKKVVDRKIRLTESQVKCILLQILNGL 132
Query: 465 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS----VMVDQT--- 517
V LH HRD+ ANI ++ K K++DFG +R D
Sbjct: 133 NV--------LHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 518 -------HLTTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
+T+KV T Y PE + ++ D++S G + E+LTG KP+
Sbjct: 182 ETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233
|
Length = 335 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 72/237 (30%), Positives = 116/237 (48%), Gaps = 30/237 (12%)
Query: 367 ILGQGGQGTVYKGML-TDG-RI-VAVKKSK-LVDETNVEQFINEVVILSQIN-HRNIVKL 421
++G+G G V K + DG R+ A+K+ K + + F E+ +L ++ H NI+ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 422 LGCCLETEVPLLVYEFIPNGTLYQYIHNQ--IEEFP-----------ITWELLLRIAVEV 468
LG C L E+ P+G L ++ +E P ++ + LL A +V
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 469 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR--SVMVDQTHLTTKVQGT 526
+ + YL I HRD+ + NIL+ + Y AK++DFG SR V V +T V+
Sbjct: 134 ARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR-- 188
Query: 527 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE--DKSLVGYFLQ 580
++ E S +T SDV+S+GV+L EI++ G P + E +K GY L+
Sbjct: 189 --WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 243
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 368 LGQGGQGTVYKGML-TDGRIVAVK--KSKLVDETNVEQFI-NEVVILSQINHRNIVKLLG 423
LG GG G V + + R A+K K + + ET ++ I +E IL + NH IVKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASI 481
+ + ++ E+ G L+ + +E + IA V A YLH+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE----YTARFYIACVVL-AFEYLHN---R 112
Query: 482 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 541
I +RD+K N+LLD K+ DFG ++ + Q T GT YV PE + +
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPEIILNKGYD 170
Query: 542 EKSDVYSFGVVLVEILTGQKPIRAINTD 569
D +S G++L E+LTG+ P + D
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDED 198
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 366 RILGQGGQGTVYKGML-TDGRIVAVKK--SKLVDETNVEQF-INEVVILSQINHRNIVKL 421
R+LG+GG G V + G++ A K+ K + + E +NE IL ++N + +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 422 LGCCLETEVPLLVYEFIPNGTLYQYIHNQ----IEEFPITWELLLRIAVEVSGALFYLHS 477
+ LV + G L +I+N EE E L A E+ L LH
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE-----ERALFYAAEILCGLEDLHR 120
Query: 478 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS 537
++ +RD+K NILLDD ++SD G + V + + GT GY+ PE +
Sbjct: 121 ENTV---YRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNN 175
Query: 538 SQFTEKSDVYSFGVVLVEILTGQKPIRA 565
++T D + G ++ E++ GQ P R
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 71/220 (32%), Positives = 109/220 (49%), Gaps = 18/220 (8%)
Query: 366 RILGQGGQGTVYKGML-TDGRIVAVKK--SKLVDETNVEQF-INEVVILSQINHRNIVKL 421
R+LG+GG G V + G++ A KK K + + E +NE IL ++N R +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 422 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEE-FPITWELLLRIAVEVSGALFYLHSAA 479
ET+ L LV + G L +I++ E F + A E+ L LH
Sbjct: 66 -AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFY--AAEICCGLEDLHQER 122
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 539
I +RD+K NILLDD ++SD G + V QT + +V GT GY+ PE ++ +
Sbjct: 123 ---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNER 177
Query: 540 FTEKSDVYSFGVVLVEILTGQKPI----RAINTDEDKSLV 575
+T D ++ G +L E++ GQ P + I +E + LV
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 16/212 (7%)
Query: 366 RILGQGGQGTVYKGMLTDGR----IVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKL 421
++LG+G G V L I A+KK ++++ +VE + E +L+ +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 422 LGCCLETEVPLL-VYEFIPNGTLYQYIHN--QIEEFPITWELLLRIAVEVSGALFYLHSA 478
L C +T+ L V E++ G L +I + + +E + A E+ L +LH
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-----YAAEIICGLQFLHKK 115
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 538
I +RD+K N+LLD K++DFG + M + +T GT Y+ PE +
Sbjct: 116 GII---YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQ 171
Query: 539 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
++ E D +SFGV+L E+L GQ P + DE
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-15
Identities = 81/244 (33%), Positives = 117/244 (47%), Gaps = 42/244 (17%)
Query: 362 YNANRILGQGGQGTV-YKGMLTDGRIVAVKKSKLVD-ETNVEQFIN----EVVILSQINH 415
Y +R+LG G GTV ++DG AVK +VD E E N EV L +
Sbjct: 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVK---VVDMEGMSEADKNRAQAEVCCLLNCDF 90
Query: 416 RNIVKLLGCCLE------------TEVPLLVYEFIPNGTLYQYIHNQIEE---FPITWEL 460
+IVK C E + LV ++ G L Q I ++ + F
Sbjct: 91 FSIVK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAG 146
Query: 461 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520
LL I V + A+ ++HS I HRDIKSANILL K+ DFG S+ M T ++
Sbjct: 147 LLFIQVLL--AVHHVHSKHMI---HRDIKSANILLCSNGLVKLGDFGFSK--MYAAT-VS 198
Query: 521 TKVQGTFG----YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE--DKSL 574
V TF YV PE ++ +++K+D++S GV+L E+LT ++P N +E K+L
Sbjct: 199 DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258
Query: 575 VGYF 578
G +
Sbjct: 259 AGRY 262
|
Length = 496 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 78/274 (28%), Positives = 124/274 (45%), Gaps = 25/274 (9%)
Query: 366 RILGQGGQGTVY----KGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKL 421
++LG+G G V+ KG I A+KK ++ + +VE + E +LS +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 422 LGCCLETEVPLL-VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 480
L C +T+ L V E++ G L +I + +F + A E+ L +LHS
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQS-CHKFDLPRATFY--AAEIICGLQFLHSKG- 116
Query: 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF 540
I +RD+K NILLD K++DFG + M+ T GT Y+ PE ++
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQKY 173
Query: 541 TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL-KEA 599
D +SFGV+L E+L GQ P + +E Q+I R+ R L +EA
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-------LFQSI---RMDNPCYPRWLTREA 223
Query: 600 KKEGIMTVATLAKRCLNLNGKMR--PTMKEVAFE 631
K + +R L + G +R P +E+ +
Sbjct: 224 KDILVKLFVREPERRLGVKGDIRQHPFFREIDWS 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 74/243 (30%), Positives = 115/243 (47%), Gaps = 49/243 (20%)
Query: 338 SSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV- 395
S++ S K + +LE+ NRI G G GTVYK + GR+ A+K V
Sbjct: 61 SASGSAPSAAKSLS--ELERV------NRI-GSGAGGTVYKVIHRPTGRLYALK----VI 107
Query: 396 ----DETNVEQFINEVVILSQINHRNIVKLLGCCLET-----EVPLLVYEFIPNGTLYQY 446
++T Q E+ IL +NH N+VK C + E+ +L+ EF+ G+L +
Sbjct: 108 YGNHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSL-EG 161
Query: 447 IHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 506
H E+F L +A ++ + YLH I HRDIK +N+L++ K++DF
Sbjct: 162 THIADEQF------LADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADF 212
Query: 507 GTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQSSQFTEK-----SDVYSFGVVLVEILTG 559
G SR ++ QT + V GT Y+ PE + D++S GV ++E G
Sbjct: 213 GVSR--ILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269
Query: 560 QKP 562
+ P
Sbjct: 270 RFP 272
|
Length = 353 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 7e-15
Identities = 78/273 (28%), Positives = 122/273 (44%), Gaps = 37/273 (13%)
Query: 366 RILGQGGQGTV-YKGMLTDGRIVAVKKSKLVDETNVEQFI--NEVVILSQINHRNIVKLL 422
R++G+G G V TDG+ +KK L + + E+ E +LSQ+ H NIV
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 423 GCCLETEVPLL--VYEFIPNGTLYQYIHNQ-----IEEFPITWELLLRIAVEVSGALFYL 475
E E LL V F G LY + Q E + W V+++ AL YL
Sbjct: 66 ES-WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------FVQIAMALQYL 118
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 535
H I HRD+K+ N+ L KV D G +R V+ +Q + + + GT Y+ PE F
Sbjct: 119 HEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPELF 174
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595
+ + KSDV++ G + E+ T + A N + SLV + I++ +
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLK---HAFNAKDMNSLV------------YRIIEGK- 218
Query: 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
L K+ + L L+ + RP++K +
Sbjct: 219 LPPMPKDYSPELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 37/224 (16%)
Query: 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKK-SKLVDE-TNVEQFINEVVILSQINHR 416
Y +G G G V + T G+ VA+KK D T ++ + E+ IL H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 417 NIVKLLGCCLETEVPL-----LVYEFIPNGTLYQYIH-NQIEEFPITWEL-------LLR 463
NI+ + L +V + + + L+ IH +Q P+T E LLR
Sbjct: 65 NIIAIRDI-LRPPGADFKDVYVVMDLMES-DLHHIIHSDQ----PLTEEHIRYFLYQLLR 118
Query: 464 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM---VDQTHLT 520
L Y+HSA + HRD+K +N+L+++ ++ DFG +R + + +
Sbjct: 119 -------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 521 TKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
T+ T Y PE ++T D++S G + E+L G++ +
Sbjct: 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 9e-15
Identities = 71/257 (27%), Positives = 114/257 (44%), Gaps = 22/257 (8%)
Query: 353 KDLEKATDNYNANRILGQGGQGTV----YKGMLTDGRIVAVKKSKLVDETNVEQFINEVV 408
+DL ++Y +++G+G G V +K + + K +++ ++ F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 409 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 468
I++ N +V+L + +V E++P G L + N + P W EV
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFY--TAEV 151
Query: 469 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 528
AL +HS I HRD+K N+LLD K++DFGT + + GT
Sbjct: 152 VLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208
Query: 529 YVDPEYFQSS----QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN- 583
Y+ PE +S + + D +S GV L E+L G P A SLVG + + +N
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA------DSLVGTYSKIMNH 262
Query: 584 ENRLFEILDARVLKEAK 600
+N L D + KEAK
Sbjct: 263 KNSLTFPDDNDISKEAK 279
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 368 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 426
+G G G VYK + G + A+K KL + E++++ H NIV G L
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 427 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 486
+ + EF G+L H P++ + ++ E L+YLHS + HR
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKGKM---HR 130
Query: 487 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF---QSSQFTEK 543
DIK ANILL D K++DFG S + + + GT ++ PE + + +
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYNQL 189
Query: 544 SDVYSFGVVLVEILTGQKPI 563
D+++ G+ +E+ Q P+
Sbjct: 190 CDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 368 LGQGGQGTVYK-GMLTDGRIVAVKK---SKLVDETNVEQFINEVVILSQINHRNIVKLLG 423
LG+GG G V M G++ A KK +L E + E IL++++ R IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 424 CCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE--LLLRIAVEVSGALFYLHSAAS 480
+T+ L LV + G L +I+N EE P E A +SG L +LH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG-LEHLHQRR- 117
Query: 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF 540
I +RD+K N+LLD+ ++SD G + + Q+ T GT G++ PE Q ++
Sbjct: 118 --IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEY 174
Query: 541 TEKSDVYSFGVVLVEILTGQKPIRA 565
D ++ GV L E++ + P RA
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPFRA 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 36/223 (16%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNV-EQFINEVVILSQINHR 416
D Y +G+G G VYK G++VA+KK++L +DE + + E+ +L ++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 417 N-IVKLLGCCLETEVPL------LVYEFIPNGTLYQYI-------HNQIEEFPI---TWE 459
IV+LL E LV+E++ + L +++ + I ++
Sbjct: 61 IYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 460 LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTH 518
LL +A + H + HRD+K N+L+D K K++D G R+ +
Sbjct: 119 LLKGVA--------HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS 167
Query: 519 LTTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQ 560
T ++ T Y PE S+ ++ D++S G + E+ Q
Sbjct: 168 YTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 20/209 (9%)
Query: 366 RILGQGGQGTVYKGML-TDGRIVAVKK--SKLVDETNVEQF-INEVVILSQINHRNIVKL 421
R+LG+GG G V + G++ A KK K + + E +NE IL ++N R +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 422 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQ----IEEFPITWELLLRIAVEVSGALFYLH 476
ET+ L LV + G L +I+N +E E + A E++ L LH
Sbjct: 66 -AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE-----ERAVFYAAEITCGLEDLH 119
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 536
I +RD+K NILLDD ++SD G + + +T + +V GT GY+ PE +
Sbjct: 120 RER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVK 174
Query: 537 SSQFTEKSDVYSFGVVLVEILTGQKPIRA 565
+ ++T D + G ++ E++ G+ P R
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 368 LGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 426
LG G G VYK + G + A K + E +E ++ E+ IL+ NH IVKLLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 427 ETEVPLLVYEFIPNGT---LYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 483
++ EF P G + + + E I +++ R +E AL YLHS + I
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI--QVICRQMLE---ALQYLHS---MKI 131
Query: 484 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY-----FQSS 538
HRD+K+ N+LL K++DFG S + V GT ++ PE + +
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVS-AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 539 QFTEKSDVYSFGVVLVEILTGQKPIRAIN 567
+ K+D++S G+ L+E+ + P +N
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHELN 219
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 70/252 (27%), Positives = 109/252 (43%), Gaps = 49/252 (19%)
Query: 368 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF---INEVVILSQINHRNIVKLLG 423
+G G G VY +VAVKK + E++ I EV L Q+ H N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 424 CCLETEVPLLVYEF-IPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGAL---FYLHSA 478
C L+ LV E+ + + + +H + ++E + IA GAL YLHS
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQE--------VEIAAITHGALQGLAYLHSH 140
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY---F 535
I HRDIK+ NILL + + K++DFG++ + + GT ++ PE
Sbjct: 141 NMI---HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAM 192
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN---------------------TDEDKSL 574
Q+ K DV+S G+ +E+ + P+ +N TD +
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF 252
Query: 575 VGYFLQAINENR 586
V Y LQ I + R
Sbjct: 253 VDYCLQKIPQER 264
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 60/214 (28%), Positives = 89/214 (41%), Gaps = 28/214 (13%)
Query: 368 LGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLG 423
+GQGG G V+ D G IVA+K KS L V + E IL+ +VKLL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL-------H 476
+ E L E++P G ++N L + E A FY+
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNN------------LGVLSEDH-ARFYMAEMFEAVD 115
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 536
+ + HRD+K N L+D K++DFG S+ ++ V G+ Y+ PE +
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV----TYANSVVGSPDYMAPEVLR 171
Query: 537 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+ D +S G +L E L G P +E
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 70/237 (29%), Positives = 111/237 (46%), Gaps = 35/237 (14%)
Query: 345 EKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGR---IVAVKKSKLVDETNVE 401
E +LF +D EK + R +G G G VY D R +VA+KK + + E
Sbjct: 13 EIAELFFKEDPEKL---FTDLREIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNE 67
Query: 402 QF---INEVVILSQINHRNIVKLLGCCLETEVPLLVYEF-IPNGTLYQYIHNQ-IEEFPI 456
++ I EV L +I H N ++ GC L LV E+ + + + +H + ++E
Sbjct: 68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE--- 124
Query: 457 TWELLLRIAVEVSGAL---FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513
+ IA GAL YLHS I HRDIK+ NILL + + K++DFG++
Sbjct: 125 -----VEIAAITHGALQGLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFGSASIAS 176
Query: 514 VDQTHLTTKVQGTFGYVDPEY---FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 567
+ + GT ++ PE Q+ K DV+S G+ +E+ + P+ +N
Sbjct: 177 PANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 30/205 (14%)
Query: 368 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV-EQFINEVV-------ILSQINHRNIV 419
LG+G GTVY ++ D + VA ++ K++ E V E NE V +LS+++H IV
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 420 KLLGCCLETEVPLLVYEFIPNGTL----YQYIHNQIEEFP----ITWELLLRIAVEVSGA 471
K LE + ++ E+ L + H + W + L + V
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTG-KTLSENQVCEWFIQLLLGVH---- 120
Query: 472 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 531
Y+H I HRD+K+ NI L + K+ DFG SR +M L T GT Y+
Sbjct: 121 --YMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDLATTFTGTPYYMS 173
Query: 532 PEYFQSSQFTEKSDVYSFGVVLVEI 556
PE + + KSD++S G +L E+
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 10/223 (4%)
Query: 356 EKATDNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQI 413
E D++ LG G G V+K G I+A K L + + Q I E+ +L +
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 414 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 473
N IV G + E + G+L Q + I ++L ++++ V L
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLT 117
Query: 474 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 533
YL I HRD+K +NIL++ + K+ DFG S ++D + GT Y+ PE
Sbjct: 118 YLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDS--MANSFVGTRSYMSPE 172
Query: 534 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG 576
Q + ++ +SD++S G+ LVE+ G+ PI + E + + G
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFG 215
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 61/242 (25%), Positives = 109/242 (45%), Gaps = 30/242 (12%)
Query: 373 QGTVYKGMLTDGRIVA--VKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEV 430
G ++GM + R+V ++ S DE F+ EV ++NH N+++ LG C+E+
Sbjct: 13 LGEAHRGM-SKARVVVKELRASATPDEQ--LLFLQEVQPYRELNHPNVLQCLGQCIESIP 69
Query: 431 PLLVYEFIPNGTLYQYIHNQIEEFPITWE--LLLRIAVEVSGALFYLHSAASIPIYHRDI 488
LLV EF P G L Y+ + + +L R+A EV+ L +LH A I H D+
Sbjct: 70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI---HSDL 126
Query: 489 KSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG--YVDPEYFQSSQ------- 539
N L K+ D+G + + + TK ++ PE +
Sbjct: 127 ALRNCQLTADLSVKIGDYGLALE-QYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKD 185
Query: 540 FTEKSDVYSFGVVLVEI----------LTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589
T+KS+++S GV + E+ L+ ++ ++ + ++D L L +R +E
Sbjct: 186 QTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE 245
Query: 590 IL 591
++
Sbjct: 246 VM 247
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 368 LGQGGQGTVYKG--MLTDGRIVAVKKSKLVDETNVEQF----INEVVILSQIN---HRNI 418
+G+G G V+K + GR VA+K+ ++ +T E I EV +L + H N+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 419 VKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 472
V+L C ET++ L V+E + + L Y+ +++ E + E + + ++ L
Sbjct: 67 VRLFDVCTVSRTDRETKLTL-VFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGL 123
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532
+LHS + HRD+K NIL+ + K++DFG +R + T V T Y P
Sbjct: 124 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVVVTLWYRAP 178
Query: 533 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 572
E S + D++S G + E+ +KP+ ++D D+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 73/260 (28%), Positives = 118/260 (45%), Gaps = 26/260 (10%)
Query: 353 KDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIV-AVK---KSKLVDETNVEQFINEVV 408
L ++++ +++G+G G V + V A+K K +++ ++ F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 409 ILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 467
I++ N IV+L + + L +V E++P G L + N + P W E
Sbjct: 96 IMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFY--TAE 150
Query: 468 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD-QTHLTTKVQGT 526
V AL +HS I HRD+K N+LLD K++DFGT + + T V GT
Sbjct: 151 VVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GT 206
Query: 527 FGYVDPEYFQS----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 582
Y+ PE +S + + D +S GV L E+L G P A SLVG + + +
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA------DSLVGTYSKIM 260
Query: 583 N-ENRLFEILDARVLKEAKK 601
+ +N L D + K+AK
Sbjct: 261 DHKNSLTFPDDIEISKQAKD 280
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 53/186 (28%), Positives = 77/186 (41%), Gaps = 12/186 (6%)
Query: 386 IVAVKKSKLVDETNVEQFINEVVIL-SQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 444
I +KKS ++ + V E I+ Q + KL + LV E++ G
Sbjct: 26 IKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCA 85
Query: 445 QYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVS 504
I + P W + EV + LH I HRDIK N+L+D K++
Sbjct: 86 SLI-KTLGGLPEDW--AKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLT 139
Query: 505 DFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIR 564
DFG SR+ + ++ K GT Y+ PE + SD +S G V+ E L G P
Sbjct: 140 DFGLSRNGLENK-----KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
Query: 565 AINTDE 570
A D
Sbjct: 195 AETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 70/270 (25%), Positives = 113/270 (41%), Gaps = 46/270 (17%)
Query: 367 ILGQGGQGTVYKGMLTDGR-------IVAVKKSKLVDETNVEQFINEVVILSQIN---HR 416
+LG+G G V +L + + I A+KK ++ VE + E I N H
Sbjct: 6 VLGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 417 NIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 475
+V L C +TE + V E+ G L +IH + P + A V L YL
Sbjct: 63 FLVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA----VFYAACVVLGLQYL 117
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGTFGYVDPEY 534
H I +RD+K N+LLD + K++DFG + M T+ GT ++ PE
Sbjct: 118 HENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEV 172
Query: 535 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594
+ +T D + GV++ E+L G+ P DE+ E+ D+
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGESPFPG--DDEE-----------------EVFDSI 213
Query: 595 VLKEAKKEGIMTVATLA--KRCLNLNGKMR 622
V E + ++ ++ +R L N + R
Sbjct: 214 VNDEVRYPRFLSREAISIMRRLLRRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 64/242 (26%), Positives = 99/242 (40%), Gaps = 52/242 (21%)
Query: 360 DNYNANRILGQGGQGTVYKG-MLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
D++ +++G+G G V+ G++ A+K KS ++ + E IL+ +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 416 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQY--IHNQIEE----FPITWELLLRIAVEV 468
IVKL + E L LV E++P G L + E F I EL+L
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVL------ 112
Query: 469 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS--------RSVMVDQTHLT 520
AL +H I HRDIK NIL+D K++DFG R ++ +H
Sbjct: 113 --ALDSVHKLGFI---HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 521 TK--------------------VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 560
GT Y+ PE + + + + D +S GV+L E+L G
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227
Query: 561 KP 562
P
Sbjct: 228 PP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 62/230 (26%), Positives = 110/230 (47%), Gaps = 16/230 (6%)
Query: 366 RILGQGGQGTVYKGML--TDGRIVA---VKKSKLVDETNVEQFINEVVILSQINHRNIVK 420
R++G+G V L T+ RI A VKK + D+ +++ E + Q ++ +
Sbjct: 1 RVIGRGSYAKVLLVRLKKTE-RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59
Query: 421 LLGCCLETEVPLL-VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
L C +TE L V E++ G L ++ Q + P E + E+S AL YLH
Sbjct: 60 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLP--EEHARFYSAEISLALNYLHERG 116
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 539
I +RD+K N+LLD + K++D+G + + T+ GT Y+ PE +
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-RPGDTTSTFCGTPNYIAPEILRGED 172
Query: 540 FTEKSDVYSFGVVLVEILTGQKPIRAINTDE--DKSLVGYFLQAINENRL 587
+ D ++ GV++ E++ G+ P + + + D++ Y Q I E ++
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 12/204 (5%)
Query: 360 DNYNANRILGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVE-QFINEVVILSQINHRN 417
D+Y LG+G TVYKG +G++VA+K +L +E I E +L + H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 418 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGALFYLH 476
IV L E LV+E++ + L QY+ P +L L ++ L Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL---FQLLRGLSYIH 120
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YF 535
I HRD+K N+L+ D K++DFG +R+ V +H + T Y P+
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVLL 176
Query: 536 QSSQFTEKSDVYSFGVVLVEILTG 559
S++++ D++ G + VE++ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 25/212 (11%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLG 423
+ + K T +VAVKK L + +++ E++ Q+ H NI+ +
Sbjct: 8 KCFEDLMIVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIHNQIEE-FPITWELLLR-IAVEVSGALFYLHSAASI 481
+ +V + G+ + E P EL + I +V AL Y+HS I
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP---ELAIAFILKDVLNALDYIHSKGFI 123
Query: 482 PIYHRDIKSANILLDDKYRAKVSDFGTSRS---------VMVDQTHLTTKVQGTFGYVDP 532
HR +K+++ILL + +S S S V+ D + K ++ P
Sbjct: 124 ---HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP---WLSP 177
Query: 533 EYFQSS--QFTEKSDVYSFGVVLVEILTGQKP 562
E Q + + EKSD+YS G+ E+ G P
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 68/235 (28%), Positives = 108/235 (45%), Gaps = 31/235 (13%)
Query: 345 EKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF 403
+ +LF D EK + R +G G G VY + + +VA+KK + + E++
Sbjct: 3 DVAELFFKDDPEKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 404 ---INEVVILSQINHRNIVKLLGCCLETEVPLLVYEF-IPNGTLYQYIHNQ-IEEFPITW 458
I EV L ++ H N ++ GC L LV E+ + + + +H + ++E
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE----- 114
Query: 459 ELLLRIAVEVSGAL---FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515
+ IA GAL YLHS I HRD+K+ NILL + K+ DFG S S+M
Sbjct: 115 ---VEIAAVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFG-SASIMAP 167
Query: 516 QTHLTTKVQGTFGYVDPEY---FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 567
GT ++ PE Q+ K DV+S G+ +E+ + P+ +N
Sbjct: 168 ANXFV----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 368 LGQGGQGTVYKGMLTDGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGC 424
LG G G VYK + ++A +K++D E +E ++ E+ IL+ +H NIVKLL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 425 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
++ EF G + + ++E P+T + + + AL YLH I
Sbjct: 71 FYYENNLWILIEFCAGGAV-DAVMLELER-PLTEPQIRVVCKQTLEALNYLHENK---II 125
Query: 485 HRDIKSANILLDDKYRAKVSDFGTS----RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF 540
HRD+K+ NIL K++DFG S R++ + + T V E + +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 541 TEKSDVYSFGVVLVEILTGQKPIRAIN 567
K+DV+S G+ L+E+ + P +N
Sbjct: 186 DYKADVWSLGITLIEMAQIEPPHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 25/217 (11%)
Query: 368 LGQGGQGTVYKGML---TDG---RIVAVKKSKLVDETNV-EQFINEVVILSQINHRNIVK 420
LG+ G VYKG L G + VA+K K E + E+F +E ++ S++ H NIV
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 421 LLGCCLETEVPLLVYEFIPNGTLYQYI-----HNQI----EEFPITWEL----LLRIAVE 467
LLG + + +++ + + L++++ H+ + ++ + L + I +
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 468 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM-VDQTHLTTKVQGT 526
++ + +L S + H+D+ + N+L+ DK K+SD G R V D L
Sbjct: 133 IAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 527 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 562
++ PE +F+ SD++S+GVVL E+ + G +P
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 66/305 (21%), Positives = 133/305 (43%), Gaps = 37/305 (12%)
Query: 336 ELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIV--AVKKSK 393
+ S I K S D+ D Y + ++ + Q ++YKG+ + ++ KK
Sbjct: 1 QNIITRSYINDIKCIESDDI----DKYTS-VLIKENDQNSIYKGIFNNKEVIIRTFKKFH 55
Query: 394 LVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL----LVYEFIPNGTLYQYIHN 449
+ ++ NE+ L +I+ NI+K+ G ++ L L+ E+ G L + +
Sbjct: 56 KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK 115
Query: 450 QIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS 509
E ++++ L +A++ L+ L+ + P ++++ S + L+ + Y+ K+ G
Sbjct: 116 ---EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLE 170
Query: 510 RSVMVDQTHLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAIN 567
+ + K Y + S++T K D+YS GVVL EI TG+ P +
Sbjct: 171 KILSSP----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226
Query: 568 TDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKE 627
T E L+ IN+N ++ + + + + + C + + RP +KE
Sbjct: 227 TKEIYDLI------INKNNSLKL---------PLDCPLEIKCIVEACTSHDSIKRPNIKE 271
Query: 628 VAFEL 632
+ + L
Sbjct: 272 ILYNL 276
|
Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 362 YNANRILGQGGQGTVYKGMLTD-GRIVAVKK--SKLVDETNVEQFINEVVILSQINHRNI 418
Y + +G G QG V T G VAVKK ++T+ ++ E+V+L +NH+NI
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 419 VKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 472
+ LL E + LV E + + L Q IH +++ +++ LL ++ +
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY-LLYQMLCGIK--- 137
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532
+LHSA I HRD+K +NI++ K+ DFG +R+ + + T T Y P
Sbjct: 138 -HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAP 191
Query: 533 EYFQSSQFTEKSDVYSFGVVLVEILTG 559
E + E D++S G ++ E++ G
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 22/180 (12%)
Query: 389 VKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH 448
+KK +++ V+ E IL +++H IV ++ + + EF+ G L+ ++
Sbjct: 51 LKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR 110
Query: 449 ------NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAK 502
N + +F E+ A YLHS I +RD+K N+LLD+K K
Sbjct: 111 KAGRFPNDVAKF---------YHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVK 158
Query: 503 VSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
V+DFG ++ V T + GT Y+ PE QS + D ++ GV+L E + G P
Sbjct: 159 VTDFGFAKKV----PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 15/202 (7%)
Query: 368 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL 426
+G G G VYK L G + AVK KL + E+ ++ + H NIV G L
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 427 ETEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
E + E+ G+L H + E I + + E L YLHS +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-----VCRETLQGLAYLHSKGKM--- 128
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF---QSSQFT 541
HRDIK ANILL D K++DFG + + + + GT ++ PE ++ +
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYN 187
Query: 542 EKSDVYSFGVVLVEILTGQKPI 563
+ D+++ G+ +E+ Q P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 366 RILGQGGQGTVYKGML-TDGRIVAVKK--SKLVDETNVEQF-INEVVILSQINHRNIVKL 421
R+LG+GG G V + G++ A KK K + + E +NE IL ++N R +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 422 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQ-----IEEFPITWELLLRIAVEVSGALFYL 475
ET+ L LV + G L +I+N E+ I + A E+ L L
Sbjct: 66 -AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY------AAELCCGLEDL 118
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 535
I +RD+K NILLDD+ ++SD G + + +T + +V GT GY+ PE
Sbjct: 119 QRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVI 173
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKPIR 564
+ ++T D + G ++ E++ GQ P R
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 58/219 (26%), Positives = 113/219 (51%), Gaps = 28/219 (12%)
Query: 368 LGQGGQGTVYKGMLTD-GRIVAVKKS----KLVDETN---VEQFINEVVILSQINHRNIV 419
LGQG ++KG+ + G + K+ K++D+++ E F ++SQ++H+++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
G C+ + ++V E++ G+L Y+ I+W+ L +A +++ AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLEDKG 120
Query: 480 SIPIYHRDIKSANILL----DDKYRA----KVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 531
+ H ++ + N+LL D K K+SD G S +V+ + L ++ +V
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI-LLERIP----WVP 172
Query: 532 PEYFQSSQ-FTEKSDVYSFGVVLVEILTG-QKPIRAINT 568
PE ++ Q + +D +SFG L EI +G KP+ A+++
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 62/242 (25%), Positives = 106/242 (43%), Gaps = 17/242 (7%)
Query: 366 RILGQGGQGTVYKGMLTDGRIV----AVKKSKLVDETNVEQFINEVVILSQINHRNIVKL 421
R++G+G V L + VKK + D+ +++ E + Q + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 422 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 480
L C +T L LV E++ G L ++ Q + P E A E+ AL +LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLP--EEHARFYAAEICIALNFLHERG- 116
Query: 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF 540
I +RD+K N+LLD K++D+G + + T+ GT Y+ PE + ++
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 541 TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN-----RLFEILDARV 595
D ++ GV++ E++ G+ P I + D + Y Q I E R + + V
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHV 233
Query: 596 LK 597
LK
Sbjct: 234 LK 235
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-13
Identities = 59/234 (25%), Positives = 103/234 (44%), Gaps = 36/234 (15%)
Query: 362 YNANRILGQGGQGTVYKGMLTD---GRIVAVKKSK--LVDETNV-EQFINEVVILSQINH 415
Y+ R++G+GG G VY D R VA+KK + L + + ++F+ E I + + H
Sbjct: 4 YDIIRLIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61
Query: 416 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL--------LLRIAVE 467
IV + C + + +I TL + + ++ ++ EL L I +
Sbjct: 62 PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121
Query: 468 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT------ 521
+ + Y+HS + HRD+K NILL + D+G + +++ L
Sbjct: 122 ICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 522 -----------KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIR 564
K+ GT Y+ PE +E +D+Y+ GV+L ++LT P R
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232
|
Length = 932 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 14/211 (6%)
Query: 366 RILGQGGQGTVYKGMLT-DGRIVAVK--KSKLVDETNVEQFI--NEVVILSQINHRNIVK 420
+++G+G G V DG+ AVK + K+V ++ I V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 421 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAA 479
L TE V +F+ G L+ ++ + FP E R A E++ AL YLHS
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFP---EPRARFYAAEIASALGYLHS-- 114
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 539
I I +RD+K NILLD + ++DFG + + Q+ TT GT Y+ PE +
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 540 FTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+ D + G VL E+L G P + E
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 5e-13
Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 11/203 (5%)
Query: 366 RILGQGGQGTVYKG--MLTDGRIVAVKKSKLVDETNVEQ---FINEVVILSQINHRNIVK 420
RILG G G + +G L R + V L + +Q F+ E + L Q +H NIV+
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 421 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 480
L G ++V E++ NG L ++ E + L+ + ++ + YL
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMGY 128
Query: 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF 540
+ H+ + + +L++ K+S F + + + T + + PE Q F
Sbjct: 129 V---HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185
Query: 541 TEKSDVYSFGVVLVEILT-GQKP 562
+ SDV+SFG+V+ E+++ G++P
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 40/213 (18%)
Query: 366 RILGQGGQGT---VYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN------- 414
+ILG+ G+GT V K G+ A+K K + + +V L +I
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMK-----KHFKSLEQVNNLREIQALRRLSP 56
Query: 415 HRNIVKLLGCCLE--TEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAV 466
H NI++L+ + T LV+E + + LY+ I + P ++LL
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLK---- 111
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 526
+L ++H I+HRDIK NIL+ D K++DFG+ R + + T+ T
Sbjct: 112 ----SLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY--TEYIST 161
Query: 527 FGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILT 558
Y PE + + K D+++ G V EIL+
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 361 NYNANRILGQGGQGTVY----KGMLTDGRIVAVK---KSKLVDET-NVEQFINEVVILSQ 412
N+ R+LG G G V+ G G++ A+K K+ +V + E E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 413 INHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV-EVSG 470
+ + L +T+ L L+ +++ G L+ +++ Q E F E +R+ + E+
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFT---ESEVRVYIAEIVL 116
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 530
AL +LH + I +RDIK NILLD + ++DFG S+ + ++ GT Y+
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 531 DPEYFQ--SSQFTEKSDVYSFGVVLVEILTGQKP 562
PE + S + D +S GV+ E+LTG P
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 366 RILGQGGQGTVYKGMLTDG----RIVAVK---KSKLV-DETNVEQFINEVVILSQINHRN 417
++LG+GG G V++ G +I A+K K+ +V ++ + E IL + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 418 IVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV-EVSGALFYL 475
IV L+ +T L L+ E++ G L+ +E I E + E+S AL +L
Sbjct: 62 IVDLI-YAFQTGGKLYLILEYLSGGELFM----HLEREGIFMEDTACFYLSEISLALEHL 116
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 535
H I +RD+K NILLD + K++DFG + + + T +T GT Y+ PE
Sbjct: 117 HQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEIL 172
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 567
S + D +S G ++ ++LTG P A N
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 368 LGQGGQGTVYKGMLTD-GRIVAVKK---SKLVDETNVEQF-INEVVILSQINHRNIVKLL 422
+G+G G V+K + G+IVA+KK S+ D+ +++ + E+ +L Q+ H N+V L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESE--DDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 423 GCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP----------ITWELLLRIAVEVSGAL 472
LV+E+ + L N++E+ P I W+ L A+
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVL-----NELEKNPRGVPEHLIKKIIWQTLQ--------AV 113
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532
+ H I HRD+K NIL+ + + K+ DFG +R + T V T Y P
Sbjct: 114 NFCHKHNCI---HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAP 169
Query: 533 EYF-QSSQFTEKSDVYSFGVVLVEILTGQ 560
E +Q+ DV++ G V E+LTGQ
Sbjct: 170 ELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 9e-13
Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 31/222 (13%)
Query: 368 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVIL---SQINHRNIV 419
+G G GTVYK G VA+K ++ +TN + + EV +L +H NIV
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRV--QTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 420 KLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFP---ITWELLLRIAVEVSG 470
+L+ C ET+V L V+E + Q + +++ P + E + + +
Sbjct: 66 RLMDVCATSRTDRETKVTL-VFEHVD-----QDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 530
L +LH+ I HRD+K NIL+ + K++DFG +R + Q LT V T Y
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR-IYSCQMALTPVVV-TLWYR 174
Query: 531 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 572
PE S + D++S G + E+ +KP+ N++ D+
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 65/233 (27%), Positives = 104/233 (44%), Gaps = 36/233 (15%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVILSQIN 414
Y +GQG G V+K +IVA+KK + +E E F + E+ IL +
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLK 69
Query: 415 HRNIVKLLGCCLETEVP--------LLVYEFIPN---GTL-YQYIHNQIEEFPITWELLL 462
H N+V L+ C P LV+EF + G L + + + E ++LL
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 463 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV----DQTH 518
+G L+Y+H I HRD+K+ANIL+ K++DFG +R+ +
Sbjct: 130 ------NG-LYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 519 LTTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
T +V T Y PE + D++ G ++ E+ T + PI NT++
Sbjct: 180 YTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQ 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 15/220 (6%)
Query: 351 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRI--VAVK---KSKLVDETNVEQFIN 405
+ + +++N R LG G G V + VA+K KSK++ + V+ +
Sbjct: 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS 80
Query: 406 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 465
E IL+ INH V L G + LV EF+ G + ++ + FP ++ A
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPN--DVGCFYA 137
Query: 466 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 525
++ YL S+ I +RD+K N+LLD K++DFG ++ V T + G
Sbjct: 138 AQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCG 190
Query: 526 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 565
T Y+ PE + + +D ++ G+ + EIL G P A
Sbjct: 191 TPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230
|
Length = 340 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 361 NYNANRILGQGGQGTVY---------KGMLTDGRIVA----VKKSKLVDETNVEQFINEV 407
N+ ++LG G G V+ G L +++ V+K+K V+ T E+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTER----- 55
Query: 408 VILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV 466
+L + + L +TE L L+ +++ G ++ +++ Q + F E +R
Sbjct: 56 NVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFS---EDEVRFYS 111
Query: 467 -EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 525
E+ AL +LH + I +RDIK NILLD + ++DFG S+ + ++ T G
Sbjct: 112 GEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCG 168
Query: 526 TFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKP 562
T Y+ PE + K+ D +S G+++ E+LTG P
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 29/215 (13%)
Query: 367 ILGQGGQGTVYKGM-LTDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLG 423
++G G G VYKG + G++ A+K + +E ++Q IN + S +HRNI G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS--HHRNIATYYG 70
Query: 424 CCLETEVP------LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 477
++ P LV EF G++ I N + + E + I E+ L +LH
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ 129
Query: 478 AASIPIYHRDIKSANILLDDKYRAKVSDFGTS----RSVMVDQTHLTTKVQGTFGYVDPE 533
I HRDIK N+LL + K+ DFG S R+V T + GT ++ PE
Sbjct: 130 HKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPE 181
Query: 534 YFQSSQ-----FTEKSDVYSFGVVLVEILTGQKPI 563
+ + KSD++S G+ +E+ G P+
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 56/202 (27%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 368 LGQGGQGTVYKGML-TDGRIVAVKK---SKLVDETNVEQFINEVVILSQINHRNIVKLLG 423
LG+GG G V + G++ A KK +L ++ + + E IL ++N IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 424 CCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 482
E++ L LV + G L +I+N + E + E ++ + +++ + +LHS +
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---MD 115
Query: 483 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 542
I +RD+K N+LLDD+ ++SD G +V + T+ GT GY+ PE + ++
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGL--AVELKDGKTITQRAGTNGYMAPEILKEEPYSY 173
Query: 543 KSDVYSFGVVLVEILTGQKPIR 564
D ++ G + E++ G+ P +
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 44/225 (19%)
Query: 360 DNYNA-NRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVILSQI 413
D Y NRI +G G VY+ G IVA+KK K+ E E F + E+ IL ++
Sbjct: 5 DEYEKLNRI-EEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSLREINILLKL 61
Query: 414 NHRNIVKLLGCCLETEVPL--------LVYEFIPNGTLYQYIHNQIEEFPI------TWE 459
H NIV + EV + +V E++ + L + + F +
Sbjct: 62 QHPNIVTV------KEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQ 114
Query: 460 LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519
LL +A +LH I HRD+K++N+LL+++ K+ DFG +R
Sbjct: 115 LLSGVA--------HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163
Query: 520 TTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
T V T Y PE + +++ D++S G + E+LT +KP+
Sbjct: 164 TQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 24/203 (11%)
Query: 368 LGQGGQGTVYKG--MLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQINHRNIVKLLGC 424
LG+G TV+KG LT +VA+K+ +L E I EV +L + H NIV L
Sbjct: 13 LGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 425 CLETEVPL-LVYEFIPNGTLYQYIHN-----QIEEFPITWELLLRIAVEVSGALFYLHSA 478
+ TE L LV+E++ + L QY+ N + I LLR L Y H
Sbjct: 72 -IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLR-------GLSYCHKR 122
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQS 537
I HRD+K N+L+++K K++DFG +R+ V + +V T Y P+ S
Sbjct: 123 K---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGS 178
Query: 538 SQFTEKSDVYSFGVVLVEILTGQ 560
++++ D++ G +L E+ TG+
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 67/245 (27%), Positives = 115/245 (46%), Gaps = 21/245 (8%)
Query: 366 RILGQGGQGTVYKGML-TDGRIVAVK--KSKLV-DETNVEQFINEVVILSQINHRNIVKL 421
R++G+G V L RI A+K K +LV D+ +++ E + ++ +
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 422 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAA 479
L C +TE L V EF+ G L ++ Q + P E R + E+S AL +LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLP---EEHARFYSAEISLALNFLHERG 116
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 539
I +RD+K N+LLD + K++D+G + + T+ GT Y+ PE +
Sbjct: 117 ---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFCGTPNYIAPEILRGED 172
Query: 540 FTEKSDVYSFGVVLVEILTGQKP--IRAINTDEDKSLVGYFLQAINEN-----RLFEILD 592
+ D ++ GV++ E++ G+ P I ++ + D++ Y Q I E R +
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 232
Query: 593 ARVLK 597
+ VLK
Sbjct: 233 SSVLK 237
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 41/154 (26%), Positives = 77/154 (50%), Gaps = 12/154 (7%)
Query: 406 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP--NGTLYQYIHNQIEEFPITWELLLR 463
E ++L +NH +++++ + + +V +P + LY Y+ + PI L+
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALI-- 161
Query: 464 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 523
I ++ L YLH+ I HRD+K+ NI ++D + + D G ++ +V L +
Sbjct: 162 IEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL--GL 216
Query: 524 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 557
GT PE ++ K+D++S G+VL E+L
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 25/215 (11%)
Query: 368 LGQGGQGTVYKG--MLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQINHRNIVKLLGC 424
LG+G TVYKG LTD +VA+K+ +L E I EV +L + H NIV L
Sbjct: 14 LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 425 CLETEVPL-LVYEFIPNGTLYQYIH---NQIEEFPITWEL--LLRIAVEVSGALFYLHSA 478
+ TE L LV+E++ + L QY+ N I + L LLR L Y H
Sbjct: 73 -IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLR-------GLNYCHRR 123
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQS 537
+ HRD+K N+L++++ K++DFG +R+ + + +V T Y P+ S
Sbjct: 124 K---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGS 179
Query: 538 SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 572
+ ++ + D++ G + E+ TG +P+ +T E++
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTG-RPLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 359 TDNYNANRILGQGGQGTV--YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQIN 414
T+ Y + +G G G V + LT G+ VA+KK ++ E+ +L +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 415 HRNIVKLLGCCLE-TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 473
H NI+ L + E V E + GT +H + P+ + + ++ L
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELL--GT---DLHRLLTSRPLEKQFIQYFLYQILRGLK 122
Query: 474 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 533
Y+HSA + HRD+K +NIL+++ K+ DFG +R + +T GYV
Sbjct: 123 YVHSAGVV---HRDLKPSNILINENCDLKICDFGLAR---IQDPQMT-------GYVSTR 169
Query: 534 YFQSSQ-------FTEKSDVYSFGVVLVEILTGQKPI 563
Y+++ + + + D++S G + E+L G KP+
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 361 NYNANRILGQGGQGTVY---------KGMLTDGRIVA----VKKSKLVDETNVEQFINEV 407
N+ ++LG G G V+ G L +++ V+K+K + T E+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTER----- 55
Query: 408 VILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV 466
+L I + L +T+ L L+ ++I G L+ ++ +Q E F E+ +
Sbjct: 56 QVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFK-EQEVQIYSG- 112
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 526
E+ AL +LH + I +RDIK NILLD ++DFG S+ D+ GT
Sbjct: 113 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169
Query: 527 FGYVDPEYFQ--SSQFTEKSDVYSFGVVLVEILTGQKP 562
Y+ P+ + + D +S GV++ E+LTG P
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 360 DNYNANRILGQG--GQGTVYKGMLTDGRIVA---VKKSKLVDETNVEQFINEVVILSQIN 414
+++ ++G+G G+ V + T G I A +KKS L+ + V F E ILS N
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 415 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 474
I +L + + LV E+ P G L ++ ++F + A FY
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQF------------DEDMAQFY 107
Query: 475 L-------HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 527
L HS + HRDIK N+L+D K++DFG++ + ++ + GT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167
Query: 528 GYVDPEYFQSSQFTEKS------DVYSFGVVLVEILTGQKP 562
Y+ PE + K D +S GV+ E++ G+ P
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 368 LGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCC 425
LG+G G+VYK + G +A+K+ +L +DE+ Q I E+ IL + IV G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
+ E++ G+L + + I ++L RI V L +L +I H
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI--IH 126
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVM--VDQTHLTTKVQGTFGYVDPEYFQS------ 537
RD+K N+L++ + K+ DFG S +++ + +T++ G Y+ PE +S
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPNQN 181
Query: 538 SQFTEKSDVYSFGVVLVEILTGQKP 562
+T +SDV+S G+ ++E+ G+ P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 16/212 (7%)
Query: 366 RILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINE-VVILSQINHRNIVK 420
+++G+G G V DG+ AVK K ++ + + + E V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 421 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEE-FPITWELLLRI-AVEVSGALFYLHSA 478
L + V +++ G L+ H Q E FP E R A E++ AL YLHS
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELF--FHLQRERSFP---EPRARFYAAEIASALGYLHS- 114
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 538
+ I +RD+K NILLD + ++DFG + + + + T+ GT Y+ PE +
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI-EHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 539 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+ D + G VL E+L G P + +T E
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 33/213 (15%)
Query: 368 LGQGGQGTVYKGML--TDGRIVAVKKSKL-VDETNVEQFINEV-VILSQINHRNIVKLLG 423
LG+G G V K M G I+AVK+ + V+ ++ + ++ + + ++ V G
Sbjct: 9 LGRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67
Query: 424 C---------CLETEVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALF 473
C+E L +F Y I E ++L +IAV + AL
Sbjct: 68 ALFREGDVWICMEVMDTSL-DKFYKK----VYDKGLTIPE-----DILGKIAVSIVKALE 117
Query: 474 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 533
YLHS S+ HRD+K +N+L++ + K+ DFG S +VD T G Y+ PE
Sbjct: 118 YLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGIS-GYLVDSVAKTIDA-GCKPYMAPE 173
Query: 534 YF----QSSQFTEKSDVYSFGVVLVEILTGQKP 562
+ KSDV+S G+ ++E+ TG+ P
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 65/212 (30%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 368 LGQGGQGTVYKGMLTDG-RIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLG 423
+G+G G V + D RI A+K K+ +V + V + E +L+Q+N IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIH-----NQIEEFPITWELLLRIAVEVSGALFYLHSA 478
E LV FI G L+ ++ + T ELL AL LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLC--------ALENLHK- 111
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 538
+ +RD+K NILLD + + DFG + M D T GT Y+ PE
Sbjct: 112 --FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCGTPEYLAPELLLGH 168
Query: 539 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+T+ D ++ GV+L E+LTG P N +E
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE 200
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 36/221 (16%)
Query: 360 DNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINH 415
D Y +G+G G VYK +T+ +A+KK +L DE I E+ +L ++ H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 416 RNIVKLLGCCLETEVPLLVYEFI-----------PNGTLYQYIHNQIEEFPITWELLLRI 464
NIV+L + LV+E++ P+ + I+ + +++L I
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPD---FAKNPRLIKTY--LYQILRGI 115
Query: 465 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA-KVSDFGTSRSVMVDQTHLTTKV 523
A Y HS + HRD+K N+L+D + A K++DFG +R+ + T +V
Sbjct: 116 A--------YCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEV 164
Query: 524 QGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
T Y PE S ++ D++S G + E++ QKP+
Sbjct: 165 V-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203
|
Length = 294 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 8e-12
Identities = 57/187 (30%), Positives = 89/187 (47%), Gaps = 19/187 (10%)
Query: 387 VAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY 446
V K L DE +E+ L+ +H IVK + LL+ E+ G L +
Sbjct: 96 VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQ 155
Query: 447 IHNQIEEFPITWELLLRIAVEVSGALFY-----LHSAASIPIYHRDIKSANILLDDKYRA 501
I +++E L G LFY L S + HRD+KSANI L
Sbjct: 156 IKQRLKEH-------LPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGII 208
Query: 502 KVSDFGTSR----SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 557
K+ DFG S+ SV +D + + GT Y+ PE ++ ++++K+D++S GV+L E+L
Sbjct: 209 KLGDFGFSKQYSDSVSLD---VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265
Query: 558 TGQKPIR 564
T +P +
Sbjct: 266 TLHRPFK 272
|
Length = 478 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 23/214 (10%)
Query: 368 LGQGGQGTVYKG--MLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQINHRNIVKLLGC 424
LG+G TV+KG LT+ +VA+K+ +L E I EV +L + H NIV L
Sbjct: 14 LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 425 CLETEVPLLVYEFIPNGTLYQYIHN-----QIEEFPITWELLLRIAVEVSGALFYLHSAA 479
+ LV+E++ + L QY+ + + I +LR L Y H
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILR-------GLAYCHRRK 124
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQSS 538
+ HRD+K N+L++++ K++DFG +R+ V + +V T Y P+ SS
Sbjct: 125 ---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSS 180
Query: 539 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 572
+++ + D++ G + E+ +G +P+ +T ED+
Sbjct: 181 EYSTQIDMWGVGCIFFEMASG-RPLFPGSTVEDE 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 69/251 (27%), Positives = 127/251 (50%), Gaps = 27/251 (10%)
Query: 325 FKRNGGLLLQQELS--SNESNIEKTKLFTSKDLEKATD-NYNANRILGQGGQGTVYKGML 381
F+ N L ++E S +N E + D+ ++ + +Y I+G G G VY+ +
Sbjct: 28 FEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAIC 87
Query: 382 TD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHRNIVKL-----LGCCLETEVPL-- 432
D VA+KK L D Q+ N E++I+ +NH NI+ L C + E +
Sbjct: 88 IDTSEKVAIKKV-LQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142
Query: 433 -LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKS 490
+V EFIP T+++Y+ + L+++ + ++ AL Y+HS I HRD+K
Sbjct: 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKP 198
Query: 491 ANILLDDK-YRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YFQSSQFTEKSDVYS 548
N+L+D + K+ DFG++++++ Q ++ + F Y PE ++ +T D++S
Sbjct: 199 QNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY-ICSRF-YRAPELMLGATNYTTHIDLWS 256
Query: 549 FGVVLVEILTG 559
G ++ E++ G
Sbjct: 257 LGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 29/216 (13%)
Query: 366 RILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH-RNIVKLLG 423
++G G G VYKG + G++ A+K V E E+ E+ +L + +H RNI G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 424 CCLETEVP------LLVYEFIPNGTLYQYIHN-QIEEFPITWELLLRIAVEVSGALFYLH 476
++ P LV EF G++ + N + W + I E+ L +LH
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--IAYICREILRGLAHLH 138
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTS----RSVMVDQTHLTTKVQGTFGYVDP 532
+ I HRDIK N+LL + K+ DFG S R+V T + GT ++ P
Sbjct: 139 AHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAP 190
Query: 533 EYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPI 563
E + + +SD++S G+ +E+ G P+
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTDGRI-VAVKK--SKLVDETNVEQFINEVVILSQINHR 416
D Y +G G G V T VA+KK + ++ E+ +L ++H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 417 NIVKLLGC-----CLE--TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVS 469
N++ LL LE +V LV + L + Q ++ + + + ++
Sbjct: 75 NVIGLLDVFTPASSLEDFQDV-YLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQIL 128
Query: 470 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 529
L Y+HSA I HRD+K +NI +++ K+ DFG +R +T V T Y
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEMTGYVA-TRWY 181
Query: 530 VDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQ 560
PE + + D++S G ++ E+LTG+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 39/224 (17%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQ-FINEVVILSQINHRN 417
Y +G+G G V G VA+KK + Q + E+ IL + H N
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 418 IVKLLGC----CLET--EVPLLVYEFIPNGTLYQYIHNQ------IEEFPITWELLLRIA 465
I+ +L E+ +V +V E + LY+ I Q I+ F +++L R
Sbjct: 65 IIGILDIIRPPSFESFNDV-YIVQELMET-DLYKLIKTQHLSNDHIQYF--LYQIL-R-- 117
Query: 466 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH-----LT 520
L Y+HSA + HRD+K +N+LL+ K+ DFG +R D H LT
Sbjct: 118 -----GLKYIHSANVL---HRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLT 167
Query: 521 TKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
V T Y PE S +T+ D++S G +L E+L+ +P+
Sbjct: 168 EYV-ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 67/257 (26%), Positives = 110/257 (42%), Gaps = 51/257 (19%)
Query: 367 ILGQGGQGT---VYKGML---TDGRIVAVKKSKLVDETNVEQF-------INEVVILSQI 413
I G G+GT VYK DG+ A+KK K + EQ+ E+ +L ++
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFK----GDKEQYTGISQSACREIALLREL 59
Query: 414 NHRNIVKLLGCCLETEVPL--LVYEFIPNGTLYQYIH----NQIEEFP------ITWELL 461
H N+V L+ LE L++++ + L+Q I + P + W++L
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 462 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGTSRSVMVDQT 517
+G + YLHS + HRD+K ANIL+ ++ K+ D G +R
Sbjct: 119 -------NG-VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167
Query: 518 HLTT--KVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL 574
L V T Y PE ++ +T+ D+++ G + E+LT + + KS
Sbjct: 168 PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSN 227
Query: 575 VGYFLQAINENRLFEIL 591
Q R+FE+L
Sbjct: 228 PFQRDQLE---RIFEVL 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 362 YNANRILGQGGQGTVYKGM-LTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHRNI 418
Y + +G G QG V G+ VA+KK + T+ ++ E+V++ +NH+NI
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 419 VKLLGC-----CLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 471
+ LL LE +V LV E + + L Q I ++ E + + ++
Sbjct: 78 IGLLNVFTPQKSLEEFQDV-YLVMELM-DANLCQVIQMDLDH-----ERMSYLLYQMLCG 130
Query: 472 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 531
+ +LHSA I HRD+K +NI++ K+ DFG +R+ +T V T Y
Sbjct: 131 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVV-TRYYRA 185
Query: 532 PEYFQSSQFTEKSDVYSFGVVLVEILTGQ 560
PE + E D++S G ++ E++ G
Sbjct: 186 PEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 68/286 (23%), Positives = 126/286 (44%), Gaps = 49/286 (17%)
Query: 368 LGQGGQGTVYKGML---TDGRIVAVKKSKLV-------DETNVEQFINEVVILSQINHRN 417
LGQG +YKG+L +D IV + V D + F ++SQ++H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 418 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 477
+VKL G C+ E ++V E++ G L ++H + + W L +A +++ AL YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 478 AASIPIYHRDIKSANILL-----DDKYR--AKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 530
+ H ++ NIL+ ++ Y K+SD G +V+ + + ++
Sbjct: 120 KKLV---HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE-----ERVERIPWI 171
Query: 531 DPEYFQ--SSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRL 587
PE + + T +D +SFG L+EI + G++P+ +++ E + F Q
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER----FYQ------- 220
Query: 588 FEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633
D L +A L +C + RP+ + + +L
Sbjct: 221 ----DQHRLPMPD---CAELANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 367 ILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLL 422
I+G+GG G VY D G++ A+K K ++ + +NE ++LS ++ + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 423 GCCLETEVP---LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSA 478
P + + + G L H + + + E +R A E+ L ++H+
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDL----HYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS- 537
+ +RD+K ANILLD+ ++SD G + + H + GT GY+ PE Q
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKG 170
Query: 538 SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+ + +D +S G +L ++L G P R T +
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 14/229 (6%)
Query: 346 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYK-GMLTDGRIVAVKKSKLVDETNVEQFI 404
+ + + L TD + +G+G G VYK DG + AVK + + + E
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA 67
Query: 405 NEVVILSQINHRNIVKLLGCCLETEVPL-----LVYEFIPNGTLYQYIHNQIEEFPITWE 459
++ S NH N+VK G + + + LV E G++ + + + E
Sbjct: 68 EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE 127
Query: 460 LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519
+ I+ + GAL L + I HRD+K NILL + K+ DFG S + +
Sbjct: 128 AM--ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 185
Query: 520 TTKVQGTFGYVDPEYFQSSQ-----FTEKSDVYSFGVVLVEILTGQKPI 563
T V GT ++ PE Q + + DV+S G+ +E+ G P+
Sbjct: 186 NTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 366 RILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEV-VILSQINHRNIVK 420
+++G+G G V + + AVK K ++ + + ++E V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 421 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAA 479
L + V ++I G L+ ++ + E R A E++ AL YLHS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHS-- 114
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 539
+ I +RD+K NILLD + ++DFG + ++ T+ GT Y+ PE
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 540 FTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+ D + G VL E+L G P + NT E
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 52/208 (25%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 368 LGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETN-VEQF-INEVVILSQINHRNIVKLLGC 424
+G+G GTV+K + IVA+K+ +L D+ V + E+ +L ++ H+NIV+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 425 CLETEVPLLVYEFIPNGTLYQYI--------HNQIEEFPITWELLLRIAVEVSGALFYLH 476
+ LV+E+ + L +Y ++ F ++LL +A + H
Sbjct: 68 LHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSF--MFQLLKGLA--------FCH 116
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE-YF 535
S + HRD+K N+L++ K++DFG +R+ + + +V T Y P+ F
Sbjct: 117 SHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 172
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKPI 563
+ ++ D++S G + E+ +P+
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 30/206 (14%)
Query: 368 LGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVE-QFINEVVILSQINHRNIVKLLGCC 425
LG+G TVYKG+ +G++VA+K + E V I E +L + H NIV L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 426 LETEVPLLVYEFIPNGTLYQYI---------HNQIEEFPITWELLLRIAVEVSGALFYLH 476
E V+E++ + L QY+ +N + F LLR L Y+H
Sbjct: 73 HTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYN-VRLFMFQ---LLR-------GLAYIH 120
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDPEYF 535
I HRD+K N+L+ K++DFG +R+ + QT+ + V T Y P+
Sbjct: 121 GQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVL 175
Query: 536 Q-SSQFTEKSDVYSFGVVLVEILTGQ 560
++ ++ D++ G + +E+L GQ
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 38/119 (31%), Positives = 63/119 (52%), Gaps = 5/119 (4%)
Query: 455 PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514
P+T E L+ + +V+ + +L S I HRD+ + NILL + K+ DFG +R +
Sbjct: 169 PLTLEDLISYSFQVARGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYK 225
Query: 515 DQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDED 571
D ++ + ++ PE +T +SDV+SFGV+L EI + G P + DE+
Sbjct: 226 DPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 362 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 416
Y + +G G QG V Y +L R VA+KK ++T+ ++ E+V++ +NH+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 417 NIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 470
NI+ LL E + LV E + + L Q I +++ +++ LL ++ +
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-LLYQMLCGIK- 133
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 530
+LHSA I HRD+K +NI++ K+ DFG +R+ + + T T Y
Sbjct: 134 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 185
Query: 531 DPEYFQSSQFTEKSDVYSFGVVLVEIL 557
PE + E D++S G ++ E++
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 362 YNANRILGQGGQGTV---YKGMLTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 416
Y + +G G QG V Y +L R VA+KK ++T+ ++ E+V++ +NH+
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 417 NIVKLLGC-----CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 471
NI+ LL LE + + + + L Q I +++ +++ LL ++ +
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK-- 140
Query: 472 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 531
+LHSA I HRD+K +NI++ K+ DFG +R+ + + T T Y
Sbjct: 141 --HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRA 193
Query: 532 PEYFQSSQFTEKSDVYSFGVVLVEILTGQ 560
PE + E D++S G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 66/267 (24%), Positives = 106/267 (39%), Gaps = 68/267 (25%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
++++ +++G+G G V D G+I A+K KS++ + + E +L++ +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 416 RNIVKLLGCCLETEVPLLVYEFIPNGTL------YQYIHNQIEEFPITWELLLRIAVEVS 469
+V L + + L+ EF+P G L Y + F + E +L I
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA-ECVLAIEA--- 116
Query: 470 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS-------------------- 509
+H I HRDIK NIL+D K+SDFG S
Sbjct: 117 -----VHKLGFI---HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168
Query: 510 --------RSVMVDQTHLT--TKVQ----------------GTFGYVDPEYFQSSQFTEK 543
SV VD +LT +K Q GT Y+ PE F + ++
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228
Query: 544 SDVYSFGVVLVEILTGQKPIRAINTDE 570
D +S G ++ E L G P + N+ E
Sbjct: 229 CDWWSLGAIMFECLIGWPPFCSENSHE 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 38/223 (17%)
Query: 362 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRNI 418
Y ++G+G G V + T G VA+KK V E ++ + + E+ +L + H +I
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 419 VKLLGCCL-----ETEVPLLVYEFIPNGTLYQYI---------HNQIEEFPITWELLLRI 464
V++ L E + +V+E + L+Q I H+Q + LLR
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQ-----LLR- 114
Query: 465 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD--QTHLTTK 522
AL Y+H+A ++HRD+K NIL + + K+ DFG +R D T
Sbjct: 115 ------ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165
Query: 523 VQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPI 563
T Y PE S S++T D++S G + E+LTG KP+
Sbjct: 166 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 372 GQGTVYKGML----TDGRIVA---VKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 424
G+GT K +L G+ A +KK ++ + V + E +L H + L
Sbjct: 4 GKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYS 63
Query: 425 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
+ V E++ G L+ ++ E + + E+ AL YLHS I
Sbjct: 64 FQTKDRLCFVMEYVNGGELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IV 117
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 544
+RD+K N++LD K++DFG + + D + T GT Y+ PE + + +
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGRAV 176
Query: 545 DVYSFGVVLVEILTGQKPIRAINTDEDK 572
D + GVV+ E++ G+ P N D +K
Sbjct: 177 DWWGLGVVMYEMMCGRLPF--YNQDHEK 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 38/225 (16%)
Query: 348 KLFTSKDLEKATDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETNVE-QFI 404
KL T K L+K LG+G TVYKG LT ++VA+K+ +L E I
Sbjct: 3 KLETYKKLDK----------LGEGSYATVYKGRSKLTG-QLVALKEIRLEHEEGAPFTAI 51
Query: 405 NEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI--------HNQIEEFPI 456
E +L + H NIV L + LV+E++ + L QY+ + + F
Sbjct: 52 REASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLF 110
Query: 457 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516
LLR L Y H + HRD+K N+L+ ++ K++DFG +R+ V
Sbjct: 111 Q---LLR-------GLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157
Query: 517 THLTTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQ 560
+ +V T Y P+ S++++ D++ G + E+ TG+
Sbjct: 158 KTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 26/181 (14%)
Query: 455 PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514
P+ + LLR + +V+ + +L S I HRD+ + N+LL D AK+ DFG +R +M
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 515 DQTHLTTKVQGT----FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTD 569
D ++ V+G ++ PE +T +SDV+S+G++L EI + G+ P I +
Sbjct: 265 DSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN 321
Query: 570 EDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVA 629
F + + D A E + ++ K C NL RPT +++
Sbjct: 322 SK------FYKMVKRGYQMSRPDF-----APPE----IYSIMKMCWNLEPTERPTFSQIS 366
Query: 630 F 630
Sbjct: 367 Q 367
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 61/256 (23%), Positives = 103/256 (40%), Gaps = 71/256 (27%)
Query: 360 DNYNANRILGQGGQGTV-YKGMLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
D++ + +++G+G G V G I A+K KS+++++ V E IL++ ++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 416 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLR--IAVEVSGAL 472
+VKL + E L L+ E++P G + LL++ E
Sbjct: 61 PWVVKLY-YSFQDENYLYLIMEYLPGGDMMT--------------LLMKKDTFTE-EETR 104
Query: 473 FY-------LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ- 524
FY + S + HRDIK N+LLD K K+SDFG + ++H T +
Sbjct: 105 FYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTG--LKKSHRTEFYRI 162
Query: 525 --------------------------------------GTFGYVDPEYFQSSQFTEKSDV 546
GT Y+ PE F + + ++ D
Sbjct: 163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222
Query: 547 YSFGVVLVEILTGQKP 562
+S GV++ E+L G P
Sbjct: 223 WSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 65/226 (28%), Positives = 98/226 (43%), Gaps = 34/226 (15%)
Query: 368 LGQGGQGTVYKGMLTDGRIVA--VKKSKLVDETNVEQ--FINEVVILSQINHRNIVKLLG 423
+G G G V G + G A V K V + EQ F+ E + H N+++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL--LLRIAVEVSGALFYLHSAASI 481
C E LLV EF P G L Y+ + + +T + L R+A E++ L +LH I
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFI 122
Query: 482 PIYHRDIKSANILLDDKYRAKVSDFGTSRS-------VMVDQT---------HLTTKVQG 525
H D+ N LL K+ D+G S + V DQ L +V G
Sbjct: 123 ---HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 526 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 570
VD T++S+V+S GV + E+ G +P R ++ ++
Sbjct: 180 NLLVVDQ--------TKESNVWSLGVTIWELFELGSQPYRHLSDEQ 217
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 37/119 (31%), Positives = 63/119 (52%), Gaps = 5/119 (4%)
Query: 455 PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514
P+T E L+ + +V+ + +L S I HRD+ + NILL + K+ DFG +R +
Sbjct: 170 PLTMEDLICYSFQVARGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 515 DQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDED 571
D ++ + ++ PE +T +SDV+SFGV+L EI + G P + +E+
Sbjct: 227 DPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-10
Identities = 65/254 (25%), Positives = 110/254 (43%), Gaps = 44/254 (17%)
Query: 397 ETNVEQFINEVVILSQINHRNIVKLLGCCLE--TEVPLLVYEFIPNGTLYQYIHNQIEEF 454
E Q + EV ++ ++ H+NIV+ + L + ++ EF G L + I + F
Sbjct: 53 EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF 112
Query: 455 -PITWELLLRIAVEVSGALFYLHSAASIP----IYHRDIKSANILLDDKYR--------- 500
I ++ I ++ AL Y H+ P + HRD+K NI L R
Sbjct: 113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172
Query: 501 --------AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF--QSSQFTEKSDVYSFG 550
AK+ DFG S+++ ++ + GT Y PE ++ + +KSD+++ G
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230
Query: 551 VVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATL 610
++ E+ +G+ P N F Q I+E + L +K KE + L
Sbjct: 231 CIIYELCSGKTPFHKANN---------FSQLISELKRGPDLP---IKGKSKE----LNIL 274
Query: 611 AKRCLNLNGKMRPT 624
K LNL+ K RP+
Sbjct: 275 IKNLLNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 52/232 (22%)
Query: 361 NYNANRILGQGGQGTV----YKGMLTDGRIVAVKKSKLVDETNV-------EQFINEVVI 409
Y + LGQG G V ++ VA+KK TNV ++ + E+ +
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKI-----TNVFSKKILAKRALRELKL 54
Query: 410 LSQI-NHRNIVKLLGCCLETEVP-------LLVYEFIPNGTLYQYIHN--QIEEFPI--- 456
L H+NI C + ++ L +YE + L+Q I + + +
Sbjct: 55 LRHFRGHKNIT----CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSF 110
Query: 457 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD- 515
+++L L Y+HSA + HRD+K N+L++ K+ DFG +R +
Sbjct: 111 IYQILC--------GLKYIHSANVL---HRDLKPGNLLVNADCELKICDFGLARGFSENP 159
Query: 516 ---QTHLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPI 563
+T V T Y PE S Q +T+ DV+S G +L E+L G+KP+
Sbjct: 160 GENAGFMTEYV-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 37/119 (31%), Positives = 62/119 (52%), Gaps = 5/119 (4%)
Query: 455 PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514
+T E L+ + +V+ + +L S I HRD+ + NILL + K+ DFG +R +
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 515 DQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDED 571
D ++ + ++ PE +T +SDV+SFGV+L EI + G P + DE+
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 290
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 20/231 (8%)
Query: 346 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFI 404
KT +F S +D + +G+G G V+K + +G AVK + + + E+
Sbjct: 6 KTIIFDS--FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIE 62
Query: 405 NEVVILSQI-NHRNIVKLLGCCLETEVP-----LLVYEFIPNGTLYQYIHNQIEEFPITW 458
E IL + +H N+VK G + +V LV E G++ + ++
Sbjct: 63 AEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME 122
Query: 459 ELLLR-IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517
E ++ I E L +LH +I HRD+K NILL + K+ DFG S + +
Sbjct: 123 EPIIAYILHEALMGLQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179
Query: 518 HLTTKVQGTFGYVDPEYFQSSQ-----FTEKSDVYSFGVVLVEILTGQKPI 563
T V GT ++ PE Q + + DV+S G+ +E+ G P+
Sbjct: 180 RRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 14/198 (7%)
Query: 372 GQGTVYKGML----TDGRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 424
G+GT K +L GR A+K K ++ + V + E +L H + L
Sbjct: 4 GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 63
Query: 425 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
+ V E+ G L+ ++ E T E E+ AL YLHS +
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VV 117
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 544
+RDIK N++LD K++DFG + + D + T GT Y+ PE + + +
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAV 176
Query: 545 DVYSFGVVLVEILTGQKP 562
D + GVV+ E++ G+ P
Sbjct: 177 DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 59/200 (29%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 372 GQGTVYKGML----TDGRIVAVK----KSKLVDETNVEQFINEVVILSQINHRNIVKLLG 423
G+G+ K +L +DG AVK K+ L + V+L + H +V L
Sbjct: 4 GKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHY 63
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAASIP 482
E V +++ G L+ H Q E E R A EV+ A+ YLHS +
Sbjct: 64 SFQTAEKLYFVLDYVNGGELF--FHLQRER--CFLEPRARFYAAEVASAIGYLHS---LN 116
Query: 483 IYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 542
I +RD+K NILLD + ++DFG + + + T+ GT Y+ PE + +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGV-EPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 543 KSDVYSFGVVLVEILTGQKP 562
D + G VL E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 36/120 (30%), Positives = 60/120 (50%), Gaps = 11/120 (9%)
Query: 475 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 534
+HS + HRDIK N+LLD +++DFG+ + D T ++ GT Y+ PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 535 FQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589
Q+ ++ + D +S GV + E+L G+ P A +SLV + + +N F+
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNHEERFQ 228
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 2e-09
Identities = 39/159 (24%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 414 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 473
++ N +KL + +L+ ++I +G L+ + + ++ + +I ++ AL
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALN 123
Query: 474 YLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532
LH I H DIK N+L D K R + D+G + + + GT Y P
Sbjct: 124 DLHKHNII---HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSP 175
Query: 533 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 571
E + + D ++ GV+ E+LTG+ P + + DE+
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK-EDEDEE 213
|
Length = 267 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 366 RILGQGGQGTVYKGMLTD---GRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVK 420
R +G G G V+ +TD G+ VA+KK V + + ++ E+ +L H N++
Sbjct: 6 RPIGYGAFGVVWS--VTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63
Query: 421 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAA 479
L + ++ + +H I P++ + + ++ L YLHSA
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG 123
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSS 538
I HRDIK N+L++ K+ DFG +R D++ H+T +V + Y PE S
Sbjct: 124 ---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILMGS 179
Query: 539 Q-FTEKSDVYSFGVVLVEILTG------QKPIRAIN 567
+ +T D++S G + E+L Q PI+ ++
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD 215
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 43/163 (26%), Positives = 79/163 (48%), Gaps = 14/163 (8%)
Query: 402 QFINEVVILSQINHRNIVKL---LGCCLETEVPLLVYEFIPNGTLYQYIHN---QIEEFP 455
Q NE++ L ++NH NI+K+ L T + Y+F LY ++++ ++ P
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRP 264
Query: 456 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515
+ + I ++ A+ Y+H I HRDIK NI L+ + + DFGT+ +
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDKKLI---HRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 558
+ GT PE + E +D++S G++L+++L+
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 57/239 (23%), Positives = 107/239 (44%), Gaps = 37/239 (15%)
Query: 403 FINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLL 462
F ++ Q++H++IV L G C+ ++V EF+ G L ++H + + W+
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK--F 108
Query: 463 RIAVEVSGALFYLHSAASIPIYHRDIKSANILL-----DDKYRA--KVSDFGTSRSVMVD 515
++A +++ AL YL + H ++ + NILL D + K+SD G +V+
Sbjct: 109 KVAKQLASALSYLEDKDLV---HGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR 165
Query: 516 QTHLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEI-LTGQKPIRAINTDEDKS 573
Q + ++ PE + S+ + +D +SFG L EI G+ P++ DK+
Sbjct: 166 QECVE-----RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK------DKT 214
Query: 574 LVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632
L + R +E V K+ +A L C+N + RP + + ++
Sbjct: 215 L-------AEKERFYEGQCMLVTPSCKE-----LADLMTHCMNYDPNQRPFFRAIMRDI 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 367 ILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLL 422
I+G+GG G VY D G++ A+K K ++ + +NE ++LS ++ + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 423 GCCLETEVP---LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSA 478
P + + + G L H + + + E +R A E+ L ++H+
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 538
+ +RD+K ANILLD+ ++SD G + + H + GT GY+ PE Q
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKG 170
Query: 539 -QFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+ +D +S G +L ++L G P R T +
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 73/266 (27%), Positives = 104/266 (39%), Gaps = 49/266 (18%)
Query: 368 LGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLG 423
+G+G G VY+ D RI A+K K ++V + V I E RNI L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGE---------RNI---LV 48
Query: 424 CCLETEVPLLV---YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY------ 474
L E P +V + F + LY + + + + W L A FY
Sbjct: 49 RTLLDESPFIVGLKFSFQTDSDLY-LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL 107
Query: 475 -LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 533
L I +RD+K NILLD + DFG S++ + D T GT Y+ PE
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLAPE 166
Query: 534 -YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINT--------------------DEDK 572
+T+ D +S GV++ E+ G P A +T DE +
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGR 226
Query: 573 SLVGYFLQAINENRLFEILDARVLKE 598
V L ++RL DA LKE
Sbjct: 227 QFVKGLLNRNPQHRLGAHRDAVELKE 252
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 4e-09
Identities = 35/110 (31%), Positives = 57/110 (51%), Gaps = 11/110 (10%)
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-----SQ 539
HRDIK NIL+D +++DFG+ +M D T ++ GT Y+ PE Q+ +
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGK 184
Query: 540 FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589
+ + D +S GV + E+L G+ P A +SLV + + +N F+
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNHKERFQ 228
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 57/241 (23%), Positives = 100/241 (41%), Gaps = 44/241 (18%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
D++ + +++G+G G V D G I A+K K+ ++++ V E IL + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 416 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 475
+VK+ + L+ EF+P G + + +++ ++ E E A+ +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAETVLAIDAI 117
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFG---------------------------- 507
H I HRDIK N+LLD K K+SDFG
Sbjct: 118 HQLGFI---HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 508 ------TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK 561
+ + ++ L GT Y+ PE F + + + D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 562 P 562
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 29/217 (13%)
Query: 356 EKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH 415
EKAT Y A +IL KK +V + V + E +L H
Sbjct: 16 EKATGRYYAMKIL---------------------KKEVIVAKDEVAHTLTENRVLQNSRH 54
Query: 416 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 475
+ L + V E+ G L+ ++ E + + E+ AL YL
Sbjct: 55 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYL 111
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 535
HS ++ +RD+K N++LD K++DFG + + D + T GT Y+ PE
Sbjct: 112 HSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVL 168
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 572
+ + + D + GVV+ E++ G+ P N D +K
Sbjct: 169 EDNDYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHEK 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 16/208 (7%)
Query: 372 GQGTVYKGML----TDGRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 424
G+GT K +L G+ A+K K ++ + V + E +L H + L
Sbjct: 4 GKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS 63
Query: 425 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
+ V E+ G L+ ++ E + + E+ AL YLHS +
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VV 117
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 544
+RD+K N++LD K++DFG + + D + T GT Y+ PE + + +
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAV 176
Query: 545 DVYSFGVVLVEILTGQKPIRAINTDEDK 572
D + GVV+ E++ G+ P N D +K
Sbjct: 177 DWWGLGVVMYEMMCGRLPF--YNQDHEK 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 26/216 (12%)
Query: 366 RILGQGGQGTVY----KGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKL 421
+++ G G VY K + + K L+ ++Q E IL+ + +V +
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 422 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 480
C ET+ L +V E++ G + N I P+ ++ E AL YLH+
Sbjct: 67 F-CSFETKRHLCMVMEYVEGGDCATLLKN-IGALPV--DMARMYFAETVLALEYLHNYG- 121
Query: 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT--------------HLTTKVQGT 526
I HRD+K N+L+ K++DFG S+ ++ T L +V GT
Sbjct: 122 --IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 527 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
Y+ PE + + D ++ G++L E L G P
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 16/163 (9%)
Query: 406 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGT--LYQYIHNQIEEFPITWELLLR 463
E+ IL I+HR I+ L+ +V +P L+ Y+ P+ E +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRS---GPLPLEQAIT 189
Query: 464 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 523
I + AL YLH I HRD+K+ NI LD+ A + DFG + +D T +
Sbjct: 190 IQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA--ACKLDAHPDTPQC 244
Query: 524 QGTFGYVD---PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
G G ++ PE + K+D++S G+VL E+ +
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 79/320 (24%), Positives = 120/320 (37%), Gaps = 68/320 (21%)
Query: 366 RILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKL 421
+ LG G G V D + A+K K +++ V E IL++ ++ +VKL
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 422 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV-EVSGALFYLHSAAS 480
+ + V ++IP G + + ++E FP E+L R + E++ A+ +H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLL-IRMEVFP---EVLARFYIAELTLAIESVHKMGF 122
Query: 481 IPIYHRDIKSANILLDDKYRAKVSDFG--------------------------------- 507
I HRDIK NIL+D K++DFG
Sbjct: 123 I---HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 508 -------------TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLV 554
R+ Q L + GT Y+ PE +T+ D +S GV+L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 555 EILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRC 614
E+L GQ P A E + L+ IN I L + I + A+
Sbjct: 240 EMLVGQPPFLAPTPTETQ------LKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEER 293
Query: 615 LNLNG----KMRPTMKEVAF 630
L NG K P EV F
Sbjct: 294 LGRNGADDIKAHPFFSEVDF 313
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 34/213 (15%)
Query: 368 LGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVE--QFINEVVILSQINHRNIVKLLGC 424
+G+G G V ++ VA+KK + ++ + + E+ +L ++H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 425 CLET-----EVPLLVYEFIPNGTLYQYIH-NQIEEFPITWE-------LLLRIAVEVSGA 471
+VYE + + L+Q I +Q ++ + LLR
Sbjct: 73 MPPPHREAFNDVYIVYELM-DTDLHQIIRSSQ----TLSDDHCQYFLYQLLR-------G 120
Query: 472 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 531
L Y+HSA + HRD+K +N+LL+ K+ DFG +R+ +T V T Y
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRA 176
Query: 532 PE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
PE S++T DV+S G + E+L G+KP+
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 44/241 (18%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
+++ + +++G+G G V D G + A+K K+ ++++ V E IL + +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 416 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 475
+VK+ + L+ EF+P G + + +++ +T E E A+ +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAETVLAIDSI 117
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFG----------------TSRSVMVDQT-- 517
H I HRDIK N+LLD K K+SDFG + S+ D T
Sbjct: 118 HQLGFI---HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 518 ----------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK 561
L GT Y+ PE F + + + D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 562 P 562
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 44/143 (30%), Positives = 65/143 (45%), Gaps = 10/143 (6%)
Query: 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 476
N+V L + + LV + G L+ +I + I E + R A E+ AL LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN---IPEECVKRWAAEMVVALDALH 102
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 536
I RD+ NILLDD+ +++ F R V+ + V+ Y PE
Sbjct: 103 REG---IVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM--YCAPEVGG 155
Query: 537 SSQFTEKSDVYSFGVVLVEILTG 559
S+ TE D +S G +L E+LTG
Sbjct: 156 ISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 49/213 (23%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 362 YNANRILGQGGQGTVYKGM-LTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHRNI 418
Y + + +G G G+V + G VA+KK E ++ E+ +L + H N+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 419 VKLLGCCLETEVPLLVYEFIPNGTL---YQYIHNQ-IEEFPITWELLLRIAVEVSGALFY 474
+ LL + + + + L Y Q I P++ + + + ++ L Y
Sbjct: 77 IGLL----DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKY 132
Query: 475 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 534
+HSA I HRD+K N+ +++ K+ DFG +R + T GYV +
Sbjct: 133 IHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT----------GYVVTRW 179
Query: 535 FQSSQ-------FTEKSDVYSFGVVLVEILTGQ 560
+++ + + + D++S G ++ E+LTG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 9/197 (4%)
Query: 367 ILGQGGQGTVYKGMLTDGR-IVAVKKSKLVDETN--VEQFINEVVILSQINHRNIVKLLG 423
++G+G G V K + + IVA+KK K +E E + E+ +L + NIV+L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 483
LV+E++ L +EE P ++ + + +H I
Sbjct: 68 AFRRRGKLYLVFEYVEKNML-----ELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDI 121
Query: 484 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 543
HRDIK N+L+ K+ DFG +R++ T+ T Y PE + + +
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 544 SDVYSFGVVLVEILTGQ 560
D++S G +L E+ GQ
Sbjct: 182 VDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 43/144 (29%), Positives = 67/144 (46%), Gaps = 20/144 (13%)
Query: 471 ALFYL-------HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 523
A FYL S + HRDIK N+LLD +++DFG+ ++ D T +
Sbjct: 104 ARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA 163
Query: 524 QGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF 578
GT Y+ PE Q+ ++ + D +S GV + E+L G+ P A +SLV +
Sbjct: 164 VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETY 217
Query: 579 LQAIN-ENRL-FEILDARVLKEAK 600
+ +N + F V +EAK
Sbjct: 218 GKIMNHKEHFQFPPDVTDVSEEAK 241
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 46/242 (19%)
Query: 366 RILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKL 421
++LG+G G V+ L G++ A+K K +++ V++ + E IL+ ++H + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 422 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQ----IEEFPITWELLLRIAVEVSGALFYLH 476
+TE L LV ++ P G L++ + Q + E + A EV AL YLH
Sbjct: 67 Y-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF-----YAAEVLLALEYLH 120
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDF-------------------GTSRSVMVDQT 517
I +RD+K NILL + +SDF G+ RS +
Sbjct: 121 LLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 518 HLTTKVQ---------GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINT 568
T + GT Y+ PE D ++ G++L E+L G P + N
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237
Query: 569 DE 570
DE
Sbjct: 238 DE 239
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 34/112 (30%), Positives = 63/112 (56%), Gaps = 9/112 (8%)
Query: 451 IEEFP-ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS 509
I E P +++ L+ + +V+ + +L S + HRD+ + N+L+ + K+ DFG +
Sbjct: 230 INESPALSYMDLVGFSYQVANGMEFLASKNCV---HRDLAARNVLICEGKLVKICDFGLA 286
Query: 510 RSVMVDQTHLTTKVQGTF---GYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 558
R +M D +++ TF ++ PE ++ +T SDV+SFG++L EI T
Sbjct: 287 RDIMRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 67/300 (22%), Positives = 127/300 (42%), Gaps = 64/300 (21%)
Query: 368 LGQGGQGTVYKGML-----------------------TDGRIVAVKKSKLVDETNVE--- 401
LGQG + +Y G L +GR + V K++D ++ +
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVV-LKVLDPSHRDIAL 61
Query: 402 QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELL 461
F ++SQ++H ++ + G C+ ++V EF+ +G L + + P+ W++
Sbjct: 62 AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT 121
Query: 462 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA-------KVSDFGTSRSVMV 514
+A +++ AL YL + H ++ + NILL A K+SD G S + +
Sbjct: 122 --VAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS 176
Query: 515 DQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEI-LTGQKPIRAINTDEDK 572
+ + ++ PE + + +D +SFG L+EI G+ P++ E +
Sbjct: 177 REERVE-----RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231
Query: 573 SLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632
F + ++RL E + KE +ATL +CL RP+ + + +L
Sbjct: 232 ----RFYE--KKHRLPE--------PSCKE----LATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 14/155 (9%)
Query: 413 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLL-RIAVEVSGA 471
+ H NI++ LG C+E LLV+E+ G L Y+ + + LLL R+A E++
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 472 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT--KVQGTFGY 529
+ ++H + H D+ N L KV D+G S + ++ T +
Sbjct: 112 VTHMHKHNFL---HSDLALRNCFLTSDLTVKVGDYGIGPS-RYKEDYIETEDDKCVPLRW 167
Query: 530 VDPEY---FQ----SSQFTEKSDVYSFGVVLVEIL 557
+ PE F +++ T+ S+V++ GV L E+
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 59/248 (23%), Positives = 94/248 (37%), Gaps = 56/248 (22%)
Query: 366 RILGQGGQGTVYKGMLTDGRIV-AVK---KSKLVDETNVEQFINEVVILSQINHRNIVKL 421
+ +G G G V D + A+K K+ ++ E IL++ ++ +VKL
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 422 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLR--IAVEVSGALFYLHSAA 479
+ + V ++IP G + + ++ F E L R IA E++ A+ +H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLL-IRLGIFE---EDLARFYIA-ELTCAIESVHKMG 121
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFG-------------------------------- 507
I HRDIK NIL+D K++DFG
Sbjct: 122 FI---HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 508 ---------TSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 557
R + GT Y+ PE + +T+ D +S GV+L E+L
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 558 TGQKPIRA 565
GQ P A
Sbjct: 239 VGQPPFLA 246
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 45/160 (28%), Positives = 67/160 (41%), Gaps = 13/160 (8%)
Query: 404 INEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP--NGTLYQYIHNQIEEFPITWELL 461
E IL INH +I++L G + L+ +P LY Y+ + I +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAK-RNIAIC--DI 184
Query: 462 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS-RSVMVDQTHLT 520
L I V A+ YLH I HRDIK+ NI ++ + DFG + V ++
Sbjct: 185 LAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 560
GT PE + D++S G+VL E+ T
Sbjct: 242 GWA-GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 37/123 (30%), Positives = 63/123 (51%), Gaps = 11/123 (8%)
Query: 452 EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511
+E + E LL + +V+ + +L S I HRD+ + NILL K+ DFG +R
Sbjct: 207 DELALDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHGRITKICDFGLARD 263
Query: 512 VMVDQTHLTTKVQGT----FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAI 566
+ D ++ V+G ++ PE + +T +SDV+S+G++L EI + G P +
Sbjct: 264 IRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320
Query: 567 NTD 569
D
Sbjct: 321 PVD 323
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 31/101 (30%), Positives = 54/101 (53%), Gaps = 8/101 (7%)
Query: 461 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520
LL +V+ + +L S + HRD+ + N+LL K+ DFG +R +M D +++
Sbjct: 239 LLSFTYQVARGMEFLASKNCV---HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295
Query: 521 TKVQGTF---GYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 558
TF ++ PE + +T SDV+S+G++L EI +
Sbjct: 296 KG--STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 51/232 (21%), Positives = 103/232 (44%), Gaps = 48/232 (20%)
Query: 352 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVV 408
+K + + + Y +G G G+V T G VAVKK ++ + ++ E+
Sbjct: 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 68
Query: 409 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFP 455
+L + H N++ LL F P +L ++ ++N ++
Sbjct: 69 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 116
Query: 456 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515
+T + + + ++ L Y+HSA I HRD+K +N+ +++ K+ DFG +R +
Sbjct: 117 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 173
Query: 516 QTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 560
T GYV ++++ + + + D++S G ++ E+LTG+
Sbjct: 174 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 33/227 (14%)
Query: 352 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRI---VAVKK--SKLVDETNVEQFINE 406
+K + + D Y + +G G GTV + D R VA+KK E ++ E
Sbjct: 7 NKTIWEVPDRYRDLKQVGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRE 64
Query: 407 VVILSQINHRNIVKLLGCCLETEVPL-------LVYEFIPN--GTLYQYIHNQIEEFPIT 457
+ +L + H N++ LL ++ L LV F+ G L + H ++ E I
Sbjct: 65 LRLLKHMKHENVIGLLDV-FTPDLSLDRFHDFYLVMPFMGTDLGKLMK--HEKLSEDRIQ 121
Query: 458 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517
+ + ++ L Y+H+A I HRD+K N+ +++ K+ DFG +R + T
Sbjct: 122 F-----LVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT 173
Query: 518 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPI 563
T Y PE + +T+ D++S G ++ E+LTG KP+
Sbjct: 174 GYVV----TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPL 215
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 57/241 (23%), Positives = 113/241 (46%), Gaps = 25/241 (10%)
Query: 368 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQINHRNIVKLLGCCL 426
+G+G G VYK DG+ K ++ T + E+ +L ++ H N++ L L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 427 ---ETEVPLLVYEFIPNGTLYQYIH----NQIEEFPITWE--LLLRIAVEVSGALFYLHS 477
+ +V LL +++ + L+ I ++ + P+ ++ + ++ + YLH+
Sbjct: 69 SHADRKVWLL-FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 478 AASIPIYHRDIKSANILL----DDKYRAKVSDFGTSRSVMVDQTHLT--TKVQGTFGYVD 531
+ HRD+K ANIL+ ++ R K++D G +R L V TF Y
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 532 PEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590
PE ++ +T+ D+++ G + E+LT + PI ++ K+ Y + +R+F +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTSNPYHHDQL--DRIFNV 240
Query: 591 L 591
+
Sbjct: 241 M 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 53/213 (24%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 368 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVE-QFINEVVILSQINHRNIVKLLGCCL 426
+G+G G VYK DG+ K ++ T + E+ +L ++ H N++ L L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 427 ---ETEVPLLVYEFIPNGTLYQYIH----NQIEEFPITW--ELLLRIAVEVSGALFYLHS 477
+ +V LL +++ + L+ I ++ + P+ ++ + ++ + YLH+
Sbjct: 69 SHSDRKVWLL-FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 478 AASIPIYHRDIKSANILL----DDKYRAKVSDFGTSRSVMVDQTHLT--TKVQGTFGYVD 531
+ HRD+K ANIL+ ++ R K++D G +R L V TF Y
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 532 PEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPI 563
PE ++ +T+ D+++ G + E+LT + PI
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 59/258 (22%), Positives = 92/258 (35%), Gaps = 72/258 (27%)
Query: 366 RILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKL 421
+ LG G G V D + A+K K ++ V E IL++ ++ +V+L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 422 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV-EVSGALFYL----- 475
+ + V ++IP G + LL+R+ + A FY+
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMS--------------LLIRMGIFPEDLARFYIAELTC 112
Query: 476 --HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS------------------------ 509
S + HRDIK NIL+D K++DFG
Sbjct: 113 AVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172
Query: 510 ----------------------RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 547
R+ Q L + GT Y+ PE + +T+ D +
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232
Query: 548 SFGVVLVEILTGQKPIRA 565
S GV+L E+L GQ P A
Sbjct: 233 SVGVILYEMLVGQPPFLA 250
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 14/150 (9%)
Query: 370 QGGQGTVYKGML-TDGRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
+G G VY G + ++ AVK K+ ++++ V Q E L+ IV L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 426 LETEVPLLVYEFIPNGTLYQYIH--NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 483
LV E++ G + +H +E E+ ++ EV+ AL YLH I
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDE-----EMAVKYISEVALALDYLHRHG---I 125
Query: 484 YHRDIKSANILLDDKYRAKVSDFGTSRSVM 513
HRD+K N+L+ ++ K++DFG S+ +
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 15/157 (9%)
Query: 404 INEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP--NGTLYQYIHNQIEEFPITWELL 461
++E +L +++H ++ LL + + LV +P LY Y+ ++ P+ +
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLR--PLGLAQV 262
Query: 462 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT 521
+A ++ A+ Y+H I HRDIK+ N+L++ + DFG + + T
Sbjct: 263 TAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGA--ACFARGSWSTP 317
Query: 522 KVQGTFGYVD---PEYFQSSQFTEKSDVYSFGVVLVE 555
G G VD PE +T D++S G+V+ E
Sbjct: 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 58/235 (24%), Positives = 101/235 (42%), Gaps = 46/235 (19%)
Query: 350 FTSKDLEKAT----DNYNANRILGQGGQGTVYKGMLTDGR-IVAVKK--SKLVDETNVEQ 402
F ++L K + Y +G G G+V T R VAVKK + +
Sbjct: 1 FYRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARR 60
Query: 403 FINEVVILSQINHRNIVKLL-----GCCLE--TEVPL---LVYEFIPNGTLYQYIHNQIE 452
E+ +L + H N++ LL +E EV L L+ + N Q + ++
Sbjct: 61 TYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHV 120
Query: 453 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 512
+F I LLR L Y+HSA I HRD+K +N+ +++ ++ DFG +R
Sbjct: 121 QFLIYQ--LLR-------GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQA 168
Query: 513 MVDQTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 560
+ T GYV ++++ + + + D++S G ++ E+L G+
Sbjct: 169 DDEMT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 38/124 (30%), Positives = 61/124 (49%), Gaps = 8/124 (6%)
Query: 339 SNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYK----GMLTDGRI--VAVKKS 392
+N + I+ T+L ++ E DN + LG G G V + G+ + + VAVK
Sbjct: 17 NNYTFIDPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKML 76
Query: 393 KLVDETN-VEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ 450
K T+ E ++E+ ILS + H+NIV LLG C L++ E+ G L ++ +
Sbjct: 77 KASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136
Query: 451 IEEF 454
E F
Sbjct: 137 AETF 140
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 47/178 (26%), Positives = 72/178 (40%), Gaps = 38/178 (21%)
Query: 360 DNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVDETNVEQFINEVVILSQI 413
D++ + LG+G G VYK L +G+ V +KK+ + VE ++NE V +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV-LKKAT--EYGAVEIWMNERV---RR 185
Query: 414 NHRN-IVKLLGCCLET-----EVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE--LLLRI 464
N + LE E LV+ + TL + ++ EFP E LL ++
Sbjct: 186 ACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSK--EFPYNVEPYLLGKV 243
Query: 465 AVEVSGA--------------LFYLHSAASIPIYHRDIKSANILLDDKYRA-KVSDFG 507
G LF L S I HRD+K NI+ + + K+ D G
Sbjct: 244 QDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLG 301
|
Length = 566 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 46/215 (21%), Positives = 86/215 (40%), Gaps = 30/215 (13%)
Query: 365 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVI--------------- 409
++++G GG G VY+ + + ++ E + E ++
Sbjct: 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN 76
Query: 410 LSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY---QYIHNQIEEFPITWELLLRIAV 466
+ I+H I K GC + + Y FI L + I +I+ +L+ I
Sbjct: 77 IHNIDHLGIPKYYGCG-SFKRCRMYYRFILLEKLVENTKEIFKRIKCKNK--KLIKNIMK 133
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT-TKVQ- 524
++ L Y+H I H DIK NI++D R + D+G + ++ H+ +K Q
Sbjct: 134 DMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190
Query: 525 ----GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVE 555
GT Y + + T + D+ S G +++
Sbjct: 191 DLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 35/109 (32%), Positives = 48/109 (44%), Gaps = 11/109 (10%)
Query: 356 EKATDNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLVDETNVEQ--FINEV 407
E D + LG+G G V + R VAVK K T E + E+
Sbjct: 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLK-EGATASEYKALMTEL 61
Query: 408 VILSQI-NHRNIVKLLGCCLETEVPLLV-YEFIPNGTLYQYIHNQIEEF 454
IL I +H N+V LLG C + PL+V E+ G L Y+ ++ E F
Sbjct: 62 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 46/192 (23%), Positives = 78/192 (40%), Gaps = 20/192 (10%)
Query: 384 GRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG 441
G +V V+ + L E +++ NEVV+ H NI+ ++ F+ G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 442 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA 501
+ + E ++ L+ I L YLH I HR+IK+++IL+
Sbjct: 85 SANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQNGYI---HRNIKASHILISGDGLV 140
Query: 502 KVSDF---------GTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFG 550
+S G V+ D +T V ++ PE + + KSD+YS G
Sbjct: 141 SLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYGYNVKSDIYSVG 197
Query: 551 VVLVEILTGQKP 562
+ E+ TG+ P
Sbjct: 198 ITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 30/122 (24%), Positives = 51/122 (41%), Gaps = 22/122 (18%)
Query: 455 PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD----------------DK 498
P + L +I + AL Y H+ + + H D+K NIL++ D
Sbjct: 227 PFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284
Query: 499 YRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 558
R ++ D G D+ H T + T Y PE + +D++S G ++ E+ T
Sbjct: 285 CRVRICDLGGC----CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT 340
Query: 559 GQ 560
G+
Sbjct: 341 GK 342
|
Length = 467 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 35/119 (29%), Positives = 54/119 (45%), Gaps = 8/119 (6%)
Query: 344 IEKTKLFTSKDLEKATDNYNANRILGQGGQG-----TVYKGMLTDGRI-VAVKKSK-LVD 396
I+ T+L E + + + LG G G T Y +D + VAVK K
Sbjct: 19 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH 78
Query: 397 ETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF 454
T E ++E+ +LS + NH NIV LLG C L++ E+ G L ++ + + F
Sbjct: 79 LTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSF 137
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 35/109 (32%), Positives = 48/109 (44%), Gaps = 11/109 (10%)
Query: 356 EKATDNYNANRILGQGGQGTVYKGML------TDGRIVAVKKSKLVDETNVEQ--FINEV 407
E D ++LG G G V + + VAVK K T E ++E+
Sbjct: 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLK-EGATASEHKALMSEL 61
Query: 408 VILSQI-NHRNIVKLLGCCLETEVPLLV-YEFIPNGTLYQYIHNQIEEF 454
IL I NH N+V LLG C + PL+V EF G L ++ + E F
Sbjct: 62 KILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 366 RILGQGGQGTVYKGM---LTDGR---IVAVKKSKLVDETNVEQ-FINEVVILSQIN-HRN 417
RILG G G V +G L+ + VAVK K ++ +Q ++E+ I++ + H N
Sbjct: 43 RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLN 102
Query: 418 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF 454
IV LLG C ++ ++ E+ G L Y+H + F
Sbjct: 103 IVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNF 139
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 694 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PF13947 | 106 | GUB_WAK_bind: Wall-associated receptor kinase gala | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| PF08488 | 103 | WAK: Wall-associated kinase; InterPro: IPR013695 T | 99.54 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.25 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.05 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.05 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.87 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.69 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.66 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.62 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.51 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.48 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.36 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.35 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.29 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.2 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.17 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.14 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.1 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.04 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.96 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.92 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.91 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.87 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.77 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.76 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.71 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.66 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.59 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.49 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.31 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.26 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.25 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.15 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.12 | |
| KOG1219 | 4289 | consensus Uncharacterized conserved protein, conta | 97.08 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.94 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.92 | |
| PLN02236 | 344 | choline kinase | 96.88 | |
| PF12662 | 24 | cEGF: Complement Clr-like EGF-like | 96.84 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.74 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.63 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.19 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.15 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.14 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.04 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.74 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.72 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.63 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.52 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.27 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.02 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.65 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.65 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.63 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.58 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-56 Score=472.08 Aligned_cols=292 Identities=46% Similarity=0.747 Sum_probs=259.7
Q ss_pred cccccChhhHHHHhcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEE
Q 005492 346 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425 (694)
Q Consensus 346 ~~~~~~~~~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~ 425 (694)
..+.|++++|..||++|...++||+|+||.||+|.+.++..||||++.........+|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 57789999999999999999999999999999999999999999988764433155699999999999999999999999
Q ss_pred eeCCc-cEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEe
Q 005492 426 LETEV-PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVS 504 (694)
Q Consensus 426 ~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~ 504 (694)
.+.+. .+||||||++|+|.++|+..... +++|.+|++||.++|+||+|||+...++|+||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99994 99999999999999999986554 79999999999999999999999998899999999999999999999999
Q ss_pred ecCCccccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh
Q 005492 505 DFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE 584 (694)
Q Consensus 505 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 584 (694)
|||+|+.......+..+...||.+|+|||++..+..+.|+|||||||+|+||+||++|.+...+.....+..|+...+..
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 99999766541222221117999999999999999999999999999999999999998876656666799999999999
Q ss_pred cchhhhhhhhhh-hhhhH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 005492 585 NRLFEILDARVL-KEAKK-EGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 585 ~~~~~~~d~~~~-~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~ 638 (694)
+.+.+++|+.+. .+... .....+..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999987 45443 6788899999999999999999999999999665543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=395.74 Aligned_cols=260 Identities=34% Similarity=0.549 Sum_probs=215.5
Q ss_pred CCccceeeeeCcEEEEEEEEcCCcEEEEEEccccCh--hhHHHHHHHHHHHhhccCCcceeEEeEEeeCC-ccEEEEEeC
Q 005492 362 YNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRNIVKLLGCCLETE-VPLLVYEFI 438 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~-~~~lv~e~~ 438 (694)
+...+.||+|+||+||+|.++....||||++..... ...++|.+|+.+|++++|||||+++|+|.+.. ...|||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 344556999999999999998666699999876332 22669999999999999999999999999988 789999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCC-cEEEeecCCccccccCCc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~-~~kl~DFGla~~~~~~~~ 517 (694)
++|+|.++|+.. ....+++..+++|+.|||+||.|||+.+. ||||||||+||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999885 34469999999999999999999999984 99999999999999997 99999999998765332
Q ss_pred ceeeeeecCCCCCCCcccc--cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQ--SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~--~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
...+...||+.|||||++. ...|+.|+||||||++||||+||+.||....... .+......+ .
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~------~~~~v~~~~---------~ 263 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ------VASAVVVGG---------L 263 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcC---------C
Confidence 2233367999999999999 6699999999999999999999999998765421 111111121 1
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccccC
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTG 640 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~~ 640 (694)
+...+...+..+..|+.+||+.||..||++.+++..|+.+.....
T Consensus 264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 122233366778999999999999999999999999998876554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=395.51 Aligned_cols=256 Identities=31% Similarity=0.480 Sum_probs=222.7
Q ss_pred CCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCC
Q 005492 362 YNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG 441 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~g 441 (694)
+...+.||+|-||.||.|.++....||+|.++.. ....+.|++|+++|++|+|+|||+|+|+|..++..+||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 4456789999999999999998889999988754 445678999999999999999999999999999999999999999
Q ss_pred ChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcceee
Q 005492 442 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT 521 (694)
Q Consensus 442 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 521 (694)
+|.+||+.. .+..+...+++.++.|||+|++||++++ +|||||.++||||+++..+||+|||||+....+......
T Consensus 287 sLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 287 SLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred cHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 999999973 3346999999999999999999999999 999999999999999999999999999966666655555
Q ss_pred eeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhh
Q 005492 522 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAK 600 (694)
Q Consensus 522 ~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 600 (694)
...-...|.|||.+..+.++.|||||||||+||||+| |+.|+......+ +. +.++...+-..+
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-------v~---------~~le~GyRlp~P 426 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-------VL---------ELLERGYRLPRP 426 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-------HH---------HHHhccCcCCCC
Confidence 5666789999999999999999999999999999999 888887765543 22 333334444456
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 005492 601 KEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 601 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~ 638 (694)
..++..+.+|+..||+.+|++|||+..+...|+.+...
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 67888999999999999999999999999999877654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=373.00 Aligned_cols=250 Identities=28% Similarity=0.412 Sum_probs=210.0
Q ss_pred CCccceeeeeCcEEEEEEEEcC-CcEEEEEEccc-cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCc-cEEEEEeC
Q 005492 362 YNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEV-PLLVYEFI 438 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~-~~lv~e~~ 438 (694)
.+..+.||+|..|+|||+.++. ++.+|+|.+.. .++...+++.+|++++++.+||+||.++|.|..... ..|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 4457789999999999999875 88999999854 456678899999999999999999999999999995 99999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
++|+|++++...+ .+++..+.+|+.+|++||.|||+ ++ ||||||||+||||+.++.+||+|||.++.+...
T Consensus 161 DgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred CCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 9999999998652 49999999999999999999996 66 999999999999999999999999999876543
Q ss_pred ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
......||..|||||.+.+..|+.++||||||++|+|+.+|+.|+...... .......+ ..+++.. ..
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~~Ll---------~~Iv~~p-pP 300 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIFELL---------CAIVDEP-PP 300 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHHHHH---------HHHhcCC-CC
Confidence 455677999999999999999999999999999999999999999765211 11222211 1122211 11
Q ss_pred hhhH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 598 EAKK-EGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 598 ~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.++. ...++++.++..||++||.+||+++|++++
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2222 367789999999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=370.71 Aligned_cols=204 Identities=32% Similarity=0.524 Sum_probs=184.7
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
..+|...+.||+|+||+||+|++++ +..||||.+... .....+.+..|+.+|+.++|||||+|++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 4678889999999999999999865 899999987764 5667788899999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCC------CcEEEeecCCc
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK------YRAKVSDFGTS 509 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~------~~~kl~DFGla 509 (694)
|||.+|+|.+||+.+. .+++.....++.|||.||++||+++ ||||||||.||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999999764 4999999999999999999999999 9999999999999764 56899999999
Q ss_pred cccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCcc
Q 005492 510 RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570 (694)
Q Consensus 510 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~ 570 (694)
+.+. .........|++-|||||+++..+|+.|+|+||+|++||++++|+.||...+..+
T Consensus 163 R~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 163 RFLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred hhCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 9875 3334556789999999999999999999999999999999999999998665544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=386.70 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=214.2
Q ss_pred cCCCccceeeeeCcEEEEEEEE-cCCcEEEEEEccc---cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGML-TDGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
..|...+.||+|||+.+|+++. ..|+.||+|++.. ......+...+||+|.++|+|||||+++++|++.+..|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999998 6699999998764 35567788999999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
|+|++++|.++++.. .++++.+++.++.||+.||.|||+++ |+|||||..|+||++++++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999999843 36999999999999999999999999 999999999999999999999999999987644
Q ss_pred CcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
. .......|||.|+|||++.....+..+||||+|||||.||.|++||+..+..+ ....++.+..
T Consensus 172 ~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-------ty~~Ik~~~Y-------- 235 (592)
T KOG0575|consen 172 G-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-------TYNKIKLNEY-------- 235 (592)
T ss_pred c-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-------HHHHHHhcCc--------
Confidence 3 34456789999999999999999999999999999999999999997644332 2222222211
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..+.....+..+||.++|+.+|.+|||+.+|+.+
T Consensus 236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1122344567899999999999999999999975
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=404.05 Aligned_cols=264 Identities=30% Similarity=0.484 Sum_probs=228.5
Q ss_pred HHhcCCCccceeeeeCcEEEEEEEEc------CCcEEEEEEccccChh-hHHHHHHHHHHHhhccCCcceeEEeEEeeCC
Q 005492 357 KATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETE 429 (694)
Q Consensus 357 ~~~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~ 429 (694)
....+....+.||+|+||+||+|... +...||||.++..... ..++|.+|++++..++|||||+|+|+|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 33456677889999999999999853 3567999999986555 7889999999999999999999999999999
Q ss_pred ccEEEEEeCCCCChHHHHhcccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCC
Q 005492 430 VPLLVYEFIPNGTLYQYIHNQIE-----------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK 498 (694)
Q Consensus 430 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~ 498 (694)
..++|+|||..|+|.+||+.+.. ..+|+..+.+.||.|||.||.||-++. +|||||..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence 99999999999999999976321 234899999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCccccccCCcceee-eeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHH
Q 005492 499 YRAKVSDFGTSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVG 576 (694)
Q Consensus 499 ~~~kl~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~ 576 (694)
..|||+||||+|.+...+.+... ...-.++|||||.+..++||.+||||||||+|||+++ |+.|+.+...++
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E------ 713 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE------ 713 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH------
Confidence 99999999999988765554433 4456789999999999999999999999999999998 899999888776
Q ss_pred HHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccccc
Q 005492 577 YFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639 (694)
Q Consensus 577 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~ 639 (694)
+.+.++.+++ -+.+..++.++..|+..||+.+|.+||+++||-..|+......
T Consensus 714 -VIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 -VIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred -HHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 5555555554 2334577889999999999999999999999999998765443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=366.44 Aligned_cols=253 Identities=27% Similarity=0.369 Sum_probs=208.1
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccCh-------hhHHHHHHHHHHHhhccCCcceeEEeEEeeCCc
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE-------TNVEQFINEVVILSQINHRNIVKLLGCCLETEV 430 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~ 430 (694)
.+.|...+.||+|+||.|-+|..+ +|+.||||.++.... .......+|+++|++|+|||||++++++.+.+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 467888999999999999999965 599999998765211 123345799999999999999999999999999
Q ss_pred cEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCC---CcEEEeecC
Q 005492 431 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFG 507 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~---~~~kl~DFG 507 (694)
.||||||++||.|.+++-.+. .+.+..-..++.|++.||.|||+.| |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999999998754 3788888899999999999999999 9999999999999755 789999999
Q ss_pred CccccccCCcceeeeeecCCCCCCCcccccCC---CCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh
Q 005492 508 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE 584 (694)
Q Consensus 508 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 584 (694)
+|+... +...+....||+.|.|||++.+.. +..++|+|||||+||-+++|.+||.....+. . +.+.+..
T Consensus 325 lAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--s----l~eQI~~ 396 (475)
T KOG0615|consen 325 LAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--S----LKEQILK 396 (475)
T ss_pred hhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--c----HHHHHhc
Confidence 999765 455677789999999999997654 3458899999999999999999997654332 1 2223333
Q ss_pred cchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 585 NRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 585 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
++.... ........++..+||.+||..||++||++.|++++
T Consensus 397 G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 397 GRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred Cccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 332111 11224456678899999999999999999999876
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=354.98 Aligned_cols=257 Identities=28% Similarity=0.434 Sum_probs=210.6
Q ss_pred cCCCccceeeeeCcEEEEEEE-EcCCcEEEEEEccc--cChhhHHHHHHHHHHHhhccCCcceeEEe-EEeeCC-ccEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLG-CCLETE-VPLLV 434 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~g-~~~~~~-~~~lv 434 (694)
.+|++.++||+|.||+||++. ..+|..+|.|.++. .+....++...|+.+|++|+|||||++++ .+.++. ..+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457788999999999999998 45799999998774 45566788999999999999999999998 444444 48999
Q ss_pred EEeCCCCChHHHHhc-ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeecccccccEEECCCCcEEEeecCCcccc
Q 005492 435 YEFIPNGTLYQYIHN-QIEEFPITWELLLRIAVEVSGALFYLHSAAS-IPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 512 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~-~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~ 512 (694)
||++.+|+|...++. +..+..+++..+++++.|++.||..+|+.-. ..|+||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999976 2334469999999999999999999999321 13999999999999999999999999999987
Q ss_pred ccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhh
Q 005492 513 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592 (694)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 592 (694)
.... .......|||.||+||.+....|+.||||||+||++|||..-++||.+.+-.+ ..+.+..+...++.+
T Consensus 179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~-------L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 179 SSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS-------LCKKIEQGDYPPLPD 250 (375)
T ss_pred cchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-------HHHHHHcCCCCCCcH
Confidence 6443 33455779999999999999999999999999999999999999998763221 344444443332222
Q ss_pred hhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 593 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
...+..+.+||..|+..||+.||+.-.++..+
T Consensus 251 --------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 251 --------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred --------HHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 34566788999999999999999955544444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=356.72 Aligned_cols=242 Identities=29% Similarity=0.414 Sum_probs=206.3
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccc---cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv 434 (694)
.+.|+..++||+|+||+||+++.++ ++.+|+|.+++ ......+..++|..+|.+++||.||+|+..|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4679999999999999999999766 89999998775 3445678889999999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
+||+.||.|..+|.+.. .+++..+.-++.+|+.||.|||+++ ||||||||+|||||++|+++|+||||++....
T Consensus 104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999998654 4899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
. ...+....||+.|||||++.+..|+.++|+||||++||||++|.+||...+..+ +...+..+++
T Consensus 178 ~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-------~~~~I~~~k~------- 242 (357)
T KOG0598|consen 178 D-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-------MYDKILKGKL------- 242 (357)
T ss_pred C-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-------HHHHHhcCcC-------
Confidence 3 334555789999999999999999999999999999999999999998755432 2222222221
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCC
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRP 623 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP 623 (694)
...+.-...+..+++.++|..+|++|.
T Consensus 243 --~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 --PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred --CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 111222445678999999999999996
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=359.54 Aligned_cols=267 Identities=26% Similarity=0.344 Sum_probs=216.6
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeC--CccEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLL 433 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~l 433 (694)
.+.|+..++||+|.||.||+|+.. +|+.||+|++.... +.......+||.||++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 356778889999999999999965 59999999987643 45566778999999999999999999999887 68999
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
|+|||++ +|.-++... ...+++.++..++.||+.||.|+|..+ |+|||||.+|||||.+|.+||+|||||+.+.
T Consensus 196 VFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999988 888888653 335999999999999999999999999 9999999999999999999999999999887
Q ss_pred cCCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchh----
Q 005492 514 VDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF---- 588 (694)
Q Consensus 514 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 588 (694)
.......+..+-|..|.|||++.+ ..|+.+.|+||.||||.||+.|++.|.+.+..++...+..+.....+..+.
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 776666677778999999999886 579999999999999999999999998877655444433322222221111
Q ss_pred ---hhhhh-----hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 589 ---EILDA-----RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 589 ---~~~d~-----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..+.+ +...+.....+....+|+..+|..||.+|.|+.++++.
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 11111 11112233445668899999999999999999998863
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=340.23 Aligned_cols=264 Identities=24% Similarity=0.338 Sum_probs=209.1
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
+.|+...++|+|+||+|||.+.++ |+.||||++.... +...+-.++|+++|++++|+|+|.|+++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 457788899999999999999887 9999999986533 3345567899999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|++..-|.+ |...... ++.+.+.+++.|+++|+.|+|+++ ++||||||+||||+.++.+||+|||+|+.+..+
T Consensus 82 ~~dhTvL~e-Le~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHE-LERYPNG--VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHH-HHhccCC--CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 998855555 4443333 899999999999999999999999 999999999999999999999999999988643
Q ss_pred cceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHH--------HHHhhhcch
Q 005492 517 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF--------LQAINENRL 587 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~ 587 (694)
....+....|..|.|||++.+ .+|...+|||++||++.||++|.+-|.+.++-++..++... .+....+..
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 334455668999999999887 78999999999999999999999999876654432222211 112222221
Q ss_pred ------hhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005492 588 ------FEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAF 630 (694)
Q Consensus 588 ------~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 630 (694)
.+.-++...+...+.....+.+++..||+.||.+|++-+|++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111111122222333456889999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=354.03 Aligned_cols=255 Identities=31% Similarity=0.460 Sum_probs=208.6
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC--ccEEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETE--VPLLVY 435 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~--~~~lv~ 435 (694)
..++...+.||+|+||.||++...+ |+..|||.+...+....+.+.+|+.+|++++|||||+.+|.....+ .+.|.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3457788999999999999999875 8999999887654444778999999999999999999999865555 588999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECC-CCcEEEeecCCcccccc
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~-~~~~kl~DFGla~~~~~ 514 (694)
||+++|+|.+++.+... .+++..+..+++||++||+|||+++ |+|+||||+||||+. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999998654 5999999999999999999999999 999999999999999 79999999999987653
Q ss_pred --CCcceeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhh
Q 005492 515 --DQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591 (694)
Q Consensus 515 --~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (694)
..........||+.|||||++..+ ....++|||||||+++||+||++||... .....+..........
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~---- 241 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL---- 241 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC----
Confidence 222334457799999999999854 3446999999999999999999999764 1111122222222211
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
...+...+.+..+++.+|++.+|+.|||+.+++++.
T Consensus 242 -----P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 242 -----PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred -----CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 123334556788999999999999999999999874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=380.74 Aligned_cols=258 Identities=24% Similarity=0.419 Sum_probs=221.7
Q ss_pred CCCccceeeeeCcEEEEEEEEcC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
...+.++||.|.||.|++|.++- ...||||.++.. .+.+..+|+.|+.||.+++||||++|.|+.......+||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 34667899999999999999863 457999999974 4567789999999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
|||+||+|+.||+.+.. .+++.++..++++||.|++||.+.+ +|||||.++|||++.+...||+||||+|.+..+
T Consensus 710 EyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999999998754 4999999999999999999999999 999999999999999999999999999977654
Q ss_pred Ccceeee--eecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhh
Q 005492 516 QTHLTTK--VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592 (694)
Q Consensus 516 ~~~~~~~--~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 592 (694)
.....+. ..-..+|.|||.+...++|.+|||||||++|||.++ |.+|+-....++ +... ++
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-------VIka---------Ie 848 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VIKA---------IE 848 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-------HHHH---------HH
Confidence 4332222 233579999999999999999999999999999998 899987766554 2222 22
Q ss_pred hhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccccc
Q 005492 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639 (694)
Q Consensus 593 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~ 639 (694)
..++-..+++++..|.+|+..||++|-.+||++.||+.+|.++.+..
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 33344456788899999999999999999999999999998876543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=391.57 Aligned_cols=265 Identities=29% Similarity=0.503 Sum_probs=222.3
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC--Cc----EEEEEEccc-cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCcc
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD--GR----IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 431 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~--~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~ 431 (694)
..+....+.||+|+||.||.|...+ +. .||||.++. .+.....+|++|..+|+.++|||||+++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3456678899999999999999764 43 499998876 4667788999999999999999999999999999999
Q ss_pred EEEEEeCCCCChHHHHhcccC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecC
Q 005492 432 LLVYEFIPNGTLYQYIHNQIE----EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 507 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFG 507 (694)
+|++|||++|+|..||++... ...|+...++.++.|||+|+.||++++ +|||||..+|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999998521 235899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCcceeeee-ecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhc
Q 005492 508 TSRSVMVDQTHLTTKV-QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINEN 585 (694)
Q Consensus 508 la~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 585 (694)
||+.+...+....... .-...|||||.++.+.++.|+|||||||+|||++| |..||...+..+. +...+..+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~~~gg 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDVLEGG 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHHHhCC
Confidence 9996654444333322 34568999999999999999999999999999999 8899987665441 11223333
Q ss_pred chhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccccCCc
Q 005492 586 RLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGAS 642 (694)
Q Consensus 586 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~~~~ 642 (694)
+ -+.+..++..+.+|+..||+.+|++||++..+++.+..+.......
T Consensus 922 R----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 922 R----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred c----------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 2 2334567788999999999999999999999999988876655443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=359.14 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=215.9
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
...|...++||+|+.|.||.+... .++.||||++........+-+++|+.+|+..+|+|||.+++.+...+.+|.||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 346777889999999999999854 5889999999888778888899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
|++|+|.+.+... .+++.++..|++++++||+|||.++ |+|||||.+|||++.++.+||+|||++..+.....
T Consensus 352 m~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999998765 3999999999999999999999999 99999999999999999999999999988765554
Q ss_pred ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
......||+.|||||++....|++|.||||||++++||+-|.+||-..++-. +...+..+--.++
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-------AlyLIa~ng~P~l------- 489 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNGTPKL------- 489 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-------HHHHHhhcCCCCc-------
Confidence 3445679999999999999999999999999999999999999997644322 2222222211111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..+......+.+++.+||+.|+++||++.|+|++
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1223455679999999999999999999999975
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=352.15 Aligned_cols=251 Identities=30% Similarity=0.392 Sum_probs=211.2
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccc---cChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCccE
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL---VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPL 432 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~ 432 (694)
...+|...+.||+|+|++|++|..++ ++.+|||++.. ..+...+-+..|-.+|.+| .||.|++|+.-|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 34679999999999999999999765 89999998764 3344455677799999999 8999999999999999999
Q ss_pred EEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccc
Q 005492 433 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 512 (694)
Q Consensus 433 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~ 512 (694)
+|+||.++|+|.++|++.+ .+++.....++.||+.||+|||+.| ||||||||+|||||+++++||+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999999764 4999999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCcc----------e--eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHH
Q 005492 513 MVDQTH----------L--TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ 580 (694)
Q Consensus 513 ~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 580 (694)
...... . ...++||..|.+||++.....+..+|+|+|||+||+|+.|++||.+.+.-- .+..
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl------iFqk 298 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL------IFQK 298 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH------HHHH
Confidence 532211 1 144789999999999999999999999999999999999999998654321 1111
Q ss_pred HhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 581 AINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 581 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
. ++ +..+.+...++.+.+|+.+.|..||.+|+|.+||-++
T Consensus 299 I---------~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 299 I---------QA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred H---------HH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1 11 1123334445678899999999999999999998765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=361.55 Aligned_cols=262 Identities=28% Similarity=0.461 Sum_probs=207.9
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEc------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCC
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVD-ETNVEQFINEVVILSQI-NHRNIVKLLGCCLETE 429 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~ 429 (694)
..++|++.++||+|+||.||+|... +++.||||+++... ....+.+.+|+.++.++ +||||+++++++.+.+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3567999999999999999999742 25689999987532 34456799999999999 8999999999987654
Q ss_pred -ccEEEEEeCCCCChHHHHhcccC--------------------------------------------------------
Q 005492 430 -VPLLVYEFIPNGTLYQYIHNQIE-------------------------------------------------------- 452 (694)
Q Consensus 430 -~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 452 (694)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999975321
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc-eeeeeecCCC
Q 005492 453 ---EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFG 528 (694)
Q Consensus 453 ---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~ 528 (694)
..++++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++........ ......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 124888999999999999999999999 999999999999999999999999999865432221 1122345678
Q ss_pred CCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHH
Q 005492 529 YVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTV 607 (694)
Q Consensus 529 y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l 607 (694)
|+|||++.+..++.++||||||++||||++ |..||......+ .+...+..+... ..+...+..+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTRM---------RAPENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCCC---------CCCCCCCHHH
Confidence 999999999999999999999999999997 999997644321 111222222111 1112334568
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 005492 608 ATLAKRCLNLNGKMRPTMKEVAFELGGIRT 637 (694)
Q Consensus 608 ~~li~~cl~~~p~~RPt~~evl~~L~~l~~ 637 (694)
.+|+.+||+.+|.+||++.||++.|+.+..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=341.07 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=212.5
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
.+.|+...+||.|..++||+|... .++.||||++.... ....+.+.+|+..|+.++||||++++..|..+..+|+||+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 467999999999999999999954 57999999987643 2346889999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
||.+|++.+.++..... -+++..+..|.+++++||.|||.+| .||||||+.||||+.+|.+||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999886444 3999999999999999999999999 9999999999999999999999999887665433
Q ss_pred ccee---eeeecCCCCCCCccccc--CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhh
Q 005492 517 THLT---TKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591 (694)
Q Consensus 517 ~~~~---~~~~gt~~y~aPE~~~~--~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (694)
.... ....||+.|||||+++. ..|+.|+||||||++..||.+|..||....+-+ .....+. +......
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tLq-n~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTLQ-NDPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHhc-CCCCCcc
Confidence 2211 44579999999999643 469999999999999999999999998766532 1111111 1111111
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAF 630 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 630 (694)
-..+..+..+.....+.+++..||+.||.+|||+.++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111222333445568999999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.13 Aligned_cols=265 Identities=25% Similarity=0.301 Sum_probs=212.0
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChh--hHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDET--NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
++|...++||+|.||.||+|.+. .|+.||||+++..... -....++||+.|+.++|+||+.|++++...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46788899999999999999965 4999999998874332 24567899999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
||+. +|...+++.. ..++..++..++.++++||+|||.+. |+||||||.|+|+++++.+||+|||+++.+....
T Consensus 82 fm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9965 9999998754 36999999999999999999999999 9999999999999999999999999999887655
Q ss_pred cceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchh---hhhh
Q 005492 517 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF---EILD 592 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~d 592 (694)
...... .-|..|.|||.+.+ .+|+...||||.||++.||+-|.+-|.+.++-++...+..+........+. .+.|
T Consensus 156 ~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 156 RIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred cccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 443333 57899999999876 579999999999999999999998777766544333332222222221111 1111
Q ss_pred --------hhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 593 --------ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 593 --------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..............+.+|+..|+..||.+|+++.|++++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111111223345567899999999999999999999876
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=354.66 Aligned_cols=265 Identities=25% Similarity=0.357 Sum_probs=211.1
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChh-hHHHHHHHHHHHhhcc-CCcceeEEeEEeeCC-ccEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET-NVEQFINEVVILSQIN-HRNIVKLLGCCLETE-VPLLV 434 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~-~~~lv 434 (694)
.++|...++||.|.||.||+|+..+ +..||||+++..-.. +.-.=++|+..|++|+ |||||+|.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4678999999999999999999654 899999998753222 2223467999999998 999999999999998 99999
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
||||+. +|+++++.+ ...+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+||||||.+..
T Consensus 89 fE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 999965 999999887 347999999999999999999999999 99999999999999999999999999998754
Q ss_pred CCcceeeeeecCCCCCCCccc-ccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhh----
Q 005492 515 DQTHLTTKVQGTFGYVDPEYF-QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE---- 589 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~-~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 589 (694)
. ...+....|..|.|||++ +.+.|+.+.|||++|||++|+.+-++-|.+.+..++...+..++....+..+.+
T Consensus 163 k--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 163 K--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred C--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 3 234556789999999986 567899999999999999999999999987665443222222222111111111
Q ss_pred ---------hhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 590 ---------ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 590 ---------~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+.+.-...+......+..+||.+|+.+||.+|||+.|.+++
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111122223456788999999999999999999999986
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=360.13 Aligned_cols=265 Identities=29% Similarity=0.452 Sum_probs=217.4
Q ss_pred HHHHhcCCCccceeeeeCcEEEEEEEEcC--C--cE-EEEEEccc---cChhhHHHHHHHHHHHhhccCCcceeEEeEEe
Q 005492 355 LEKATDNYNANRILGQGGQGTVYKGMLTD--G--RI-VAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCL 426 (694)
Q Consensus 355 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~ 426 (694)
++...++....++||+|+||.||+|.++. + .. ||||..+. .......+|++|++++++++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 33334555667999999999999999764 2 23 89998875 45778899999999999999999999999999
Q ss_pred eCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeec
Q 005492 427 ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 506 (694)
Q Consensus 427 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DF 506 (694)
..+.++||||+++||+|.+||++... .++..+++.++.+.|.||+|||+++ ++||||.++|+|++.+..+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence 99999999999999999999998654 4999999999999999999999999 999999999999999999999999
Q ss_pred CCccccccCCcceee-eeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhh
Q 005492 507 GTSRSVMVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINE 584 (694)
Q Consensus 507 Gla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 584 (694)
||++... ...... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+....+ +...+.
T Consensus 307 GLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-------v~~kI~- 376 (474)
T KOG0194|consen 307 GLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-------VKAKIV- 376 (474)
T ss_pred ccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-------HHHHHH-
Confidence 9987543 111111 2235679999999999999999999999999999999 888998765542 222221
Q ss_pred cchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccccCC
Q 005492 585 NRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGA 641 (694)
Q Consensus 585 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~~~ 641 (694)
........+...+..+..++.+|+..+|++||+|.++.+.|+.+......
T Consensus 377 -------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 377 -------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 11111222234566788999999999999999999999999888766543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=342.47 Aligned_cols=259 Identities=22% Similarity=0.408 Sum_probs=206.6
Q ss_pred ccccChhhHHHHhcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhh---HHHHHHHHHHHhhccCCcceeEEe
Q 005492 347 TKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETN---VEQFINEVVILSQINHRNIVKLLG 423 (694)
Q Consensus 347 ~~~~~~~~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~g 423 (694)
.+.++.++++ ......||+|+++.||+|.+ +|+.||||+++...... .+.|.+|+.+|++++||||++++|
T Consensus 12 ~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 12 IKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred ceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 3445566653 23346899999999999998 58999999987643332 577889999999999999999999
Q ss_pred EEee----CCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecccccccEEECCC
Q 005492 424 CCLE----TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA-ASIPIYHRDIKSANILLDDK 498 (694)
Q Consensus 424 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~ivH~DIkp~NIll~~~ 498 (694)
++.+ ....++||||+++|+|.+++.... .+++...+.++.|++.||.|||+. + ++||||||+|||++++
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~ 159 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTEN 159 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCC
Confidence 9987 346789999999999999998642 589999999999999999999985 6 7899999999999999
Q ss_pred CcEEEeecCCccccccCCcceeeeeecCCCCCCCccccc--CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHH
Q 005492 499 YRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG 576 (694)
Q Consensus 499 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~ 576 (694)
+.+||+|||+++...... ....++..|+|||++.+ ..++.++||||||+++|||++|+.||...+..+ +
T Consensus 160 ~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~-- 230 (283)
T PHA02988 160 YKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---I-- 230 (283)
T ss_pred CcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---H--
Confidence 999999999987653221 22347899999999976 689999999999999999999999997654221 1
Q ss_pred HHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 005492 577 YFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636 (694)
Q Consensus 577 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~ 636 (694)
.......+.. ...+...+..+.+|+.+||+.||++|||+.||++.|+.++
T Consensus 231 -~~~i~~~~~~---------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 231 -YDLIINKNNS---------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -HHHHHhcCCC---------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1111111110 1111234567899999999999999999999999998765
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=355.11 Aligned_cols=269 Identities=26% Similarity=0.461 Sum_probs=218.3
Q ss_pred ChhhHHHHhcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeC
Q 005492 351 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLET 428 (694)
Q Consensus 351 ~~~~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~ 428 (694)
+.++++...+.+.+...||+|.||+||+|.+.. .||||.++.. ..++.+.|++|+.++++-+|.||+-+.|+|...
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 346677777888889999999999999999853 4999998763 456788999999999999999999999999998
Q ss_pred CccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCC
Q 005492 429 EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 508 (694)
Q Consensus 429 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGl 508 (694)
.. .||..++++-+|+.+||.... .+...+.+.||.|||+|+.|||.++ |||||||..||+|.++++|||+||||
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred ce-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence 88 999999999999999997643 5899999999999999999999999 99999999999999999999999999
Q ss_pred cccccc-CCcceeeeeecCCCCCCCccccc---CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh
Q 005492 509 SRSVMV-DQTHLTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE 584 (694)
Q Consensus 509 a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 584 (694)
+..-.. ..........|...|||||+++. .+|++.+||||||+++|||++|..||...+.+.. +-++..
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI-------ifmVGr 607 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI-------IFMVGR 607 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-------EEEecc
Confidence 864321 11122233447789999999864 5799999999999999999999999984333321 111222
Q ss_pred cchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccccc
Q 005492 585 NRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639 (694)
Q Consensus 585 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~ 639 (694)
+-+. +++ .......+.++.+|+..||..++++||.+.+|+..|+.+..+.
T Consensus 608 G~l~----pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 608 GYLM----PDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred cccC----ccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 2111 111 1122356678999999999999999999999999998887653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=320.80 Aligned_cols=236 Identities=28% Similarity=0.382 Sum_probs=203.6
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|+..+.||.|+||.|.+++.+. |..+|+|.+... ...+.+...+|..+|+.+.||.+++|.+.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 568889999999999999999765 889999998763 4456677889999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++|.|..+|++.. .++++.+.-+|.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||.|+....
T Consensus 124 eyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 9999999999998754 4999999999999999999999999 99999999999999999999999999987642
Q ss_pred CcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
.+-...||+.|+|||.++...+..++|.|+|||++|||+.|.+||...++.. +.+.+-++++
T Consensus 197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY~KI~~~~v-------- 258 (355)
T KOG0616|consen 197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IYEKILEGKV-------- 258 (355)
T ss_pred ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HHHHHHhCcc--------
Confidence 3567889999999999999999999999999999999999999998766522 2222222221
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCC
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMR 622 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~R 622 (694)
..+......+.+|+...|+.|-.+|
T Consensus 259 --~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 --KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1223344568899999999998888
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=347.81 Aligned_cols=244 Identities=32% Similarity=0.527 Sum_probs=205.3
Q ss_pred CccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCC
Q 005492 363 NANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGT 442 (694)
Q Consensus 363 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gs 442 (694)
...+-||.|+.|.||+|++. ++.||||+++...+ .+|+-|++|+||||+.+.|+|....-++|||||++.|-
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 34678999999999999996 68899998764332 36778999999999999999999999999999999999
Q ss_pred hHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcceeee
Q 005492 443 LYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 522 (694)
Q Consensus 443 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 522 (694)
|.+.|+... +++...+..|..+||.|+.|||.+. |||||||+-||||..+..+||+|||.++..... .....
T Consensus 199 L~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMS 270 (904)
T KOG4721|consen 199 LYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMS 270 (904)
T ss_pred HHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhh
Confidence 999998643 5899999999999999999999999 999999999999999999999999999876432 33445
Q ss_pred eecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHH
Q 005492 523 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKE 602 (694)
Q Consensus 523 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 602 (694)
+.||..|||||+++..+.++|+|||||||||||||||..||........ ..-+..+.+ .-..+..
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-------IwGVGsNsL--------~LpvPst 335 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-------IWGVGSNSL--------HLPVPST 335 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-------EEeccCCcc--------cccCccc
Confidence 7799999999999999999999999999999999999999976543221 111112222 2223446
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 005492 603 GIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRT 637 (694)
Q Consensus 603 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~ 637 (694)
++.-+.-|+++||+..|..||++.+++.+|+-...
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 66778899999999999999999999999975443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=347.60 Aligned_cols=247 Identities=28% Similarity=0.436 Sum_probs=210.8
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
++|.+.+.||+|.||.||||+.+. .+.||+|.+.+. .+.+.+.+.+|++|++.++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578888999999999999999775 789999987653 34567889999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|+.+ +|+.+|.... .++++.+..|+.|++.||.|||+.+ |+|||+||.||||+.++.+|++|||+|+.... .
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-N 153 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-C
Confidence 9977 9999998654 4999999999999999999999999 99999999999999999999999999997754 4
Q ss_pred cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhh
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 596 (694)
....+...||+-|||||++.+..|+..+|+|||||+|||+++|++||..... ...+ +.+.....
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~~Lv-~~I~~d~v--------- 217 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------TQLV-KSILKDPV--------- 217 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------HHHH-HHHhcCCC---------
Confidence 4566778899999999999999999999999999999999999999964321 1111 11111110
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 597 KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 597 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..+......+..++...|.+||..|.+..+++.+
T Consensus 218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1123556678999999999999999999998754
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=347.64 Aligned_cols=250 Identities=27% Similarity=0.383 Sum_probs=207.1
Q ss_pred HHhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc----Ch-hhHHHHHHHHHHHhhcc-CCcceeEEeEEeeCC
Q 005492 357 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV----DE-TNVEQFINEVVILSQIN-HRNIVKLLGCCLETE 429 (694)
Q Consensus 357 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~ 429 (694)
...++|...+.||+|+||+|++|... .++.||+|.+... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34578999999999999999999865 5899999965542 11 33556678999999998 999999999999999
Q ss_pred ccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCC-CcEEEeecCC
Q 005492 430 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGT 508 (694)
Q Consensus 430 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~-~~~kl~DFGl 508 (694)
..++||||+.+|+|.+++.+.. .+.+.....++.|++.|++|+|+++ |+||||||+|||+|.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999998732 4899999999999999999999999 9999999999999999 9999999999
Q ss_pred ccccccCCcceeeeeecCCCCCCCcccccCC-CC-ceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcc
Q 005492 509 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ-FT-EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR 586 (694)
Q Consensus 509 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 586 (694)
+.... ..........||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+.. . +...+..+.
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~-l~~ki~~~~ 239 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------N-LYRKIRKGE 239 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------H-HHHHHhcCC
Confidence 98764 2334456677999999999999877 75 8999999999999999999999863221 1 111122221
Q ss_pred hhhhhhhhhhhhhhHHH-HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005492 587 LFEILDARVLKEAKKEG-IMTVATLAKRCLNLNGKMRPTMKEVAF 630 (694)
Q Consensus 587 ~~~~~d~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~evl~ 630 (694)
+ ..+... ..++..|+.+||..+|.+|+++.++++
T Consensus 240 ~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 240 F----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred c----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1 111112 566889999999999999999999994
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=349.54 Aligned_cols=264 Identities=29% Similarity=0.468 Sum_probs=228.2
Q ss_pred hhHHHHhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCcc
Q 005492 353 KDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 431 (694)
Q Consensus 353 ~~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~ 431 (694)
++++-...+....++||-|-||.||.|+|+. .-.||||.++. +...+++|+.|+.+|+.++|||+|+|+|+|..+..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4444444556677899999999999999987 56799999874 455689999999999999999999999999999999
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
|||.|||..|+|.+||++. ++..++.-.++.++.||+.|+.||..++ +|||||.++|.|+.++..+||+||||+++
T Consensus 339 YIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999985 3446888899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhh
Q 005492 512 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590 (694)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (694)
+..+.........-.+.|.|||.+....++.|+|||+|||+|||+.| |..|+.+.... .+.++
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS----------------qVY~L 478 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------------QVYGL 478 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH----------------HHHHH
Confidence 87666555555556789999999999999999999999999999998 78888764432 23445
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 005492 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRT 637 (694)
Q Consensus 591 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~ 637 (694)
+....+.+.+..+++.+.+|+++||+++|.+||++.|+-+.++.+-.
T Consensus 479 LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 479 LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 55566666777889999999999999999999999999888875543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=335.22 Aligned_cols=269 Identities=27% Similarity=0.395 Sum_probs=204.5
Q ss_pred cCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhh--ccCCcceeEEeEEeeCC----ccEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQ--INHRNIVKLLGCCLETE----VPLL 433 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~g~~~~~~----~~~l 433 (694)
+..+..++||+|.||.||||++. ++.||||++. ..+.+.|.+|-+|++. ++|+||+++++.-.... .++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34455678999999999999997 5999999876 5667788888888877 48999999999877655 8899
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeeecccccccEEECCCCcEEEeecC
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA------ASIPIYHRDIKSANILLDDKYRAKVSDFG 507 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~------~~~~ivH~DIkp~NIll~~~~~~kl~DFG 507 (694)
|+||.++|+|.+||+.+ .++|....+|+..+++||+|||+. .+++|+|||||++||||..+++..|+|||
T Consensus 286 Vt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999999876 499999999999999999999985 35789999999999999999999999999
Q ss_pred CccccccCCcce-eeeeecCCCCCCCcccccCC-CC-----ceeeEEehhHHHHHHHhCCCCCccCCCcc-Ccc------
Q 005492 508 TSRSVMVDQTHL-TTKVQGTFGYVDPEYFQSSQ-FT-----EKSDVYSFGVVLVEILTGQKPIRAINTDE-DKS------ 573 (694)
Q Consensus 508 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-~t-----~~sDvwSlGvll~elltg~~p~~~~~~~~-~~~------ 573 (694)
||..+....... .....||.+|||||++.+.- +. .+.||||+|.|||||++.-.-+......+ ..-
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 998876443322 22366999999999997632 22 36899999999999999765443211111 000
Q ss_pred ---HHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccccc
Q 005492 574 ---LVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639 (694)
Q Consensus 574 ---~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~ 639 (694)
-.+.+...+-..+.+..+...... ...+..+.+.+..||..|++.|.|+.=|.+.+..+....
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 011122222222222222222221 134567899999999999999999999988887766543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=337.29 Aligned_cols=255 Identities=22% Similarity=0.376 Sum_probs=206.9
Q ss_pred cCCCccceeeeeCcEEEEEEEEc----CCcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv 434 (694)
++|++.+.||+|+||.||+|.++ .+..||+|.++... ......|.+|+.++++++||||+++++++...+..+||
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888999999999999999864 35689999987643 34456799999999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999997643 25899999999999999999999999 99999999999999999999999998765432
Q ss_pred CCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhh
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDA 593 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 593 (694)
..........++..|+|||.+....++.++||||||+++|||++ |+.||......+ +...+..+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~------ 226 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDGFR------ 226 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCC------
Confidence 22111122335678999999999999999999999999999875 999997654321 1222222211
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 594 RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 594 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
...+...+..+.+++.+||+.+|.+||++.+|++.|.++
T Consensus 227 ---~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 ---LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 111223456788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=341.28 Aligned_cols=253 Identities=25% Similarity=0.337 Sum_probs=206.3
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEE
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l 433 (694)
..++|+.+++||+|+||.||+++-++ |..+|+|+++.. ...+++..+.|-.+|...++|+||+|+..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45789999999999999999999776 999999998863 45567888999999999999999999999999999999
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
||||++||++..+|.... .|++......+.+++.|+.-||+.| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999998653 5999999999999999999999999 9999999999999999999999999975332
Q ss_pred c----C-------------------Ccc----e-------------------eeeeecCCCCCCCcccccCCCCceeeEE
Q 005492 514 V----D-------------------QTH----L-------------------TTKVQGTFGYVDPEYFQSSQFTEKSDVY 547 (694)
Q Consensus 514 ~----~-------------------~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~t~~sDvw 547 (694)
. + ... . .....|||.|||||++.+..|+...|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 0 000 0 0113599999999999999999999999
Q ss_pred ehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCC---
Q 005492 548 SFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPT--- 624 (694)
Q Consensus 548 SlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt--- 624 (694)
||||||||||.|.+||...++.+. ...+...+. . +..........+..+||.+||. ||++|..
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T-------~rkI~nwr~--~----l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQET-------YRKIVNWRE--T----LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHHhh--h----ccCCCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 999999999999999998776552 111111110 0 0011111223678899999998 9999976
Q ss_pred HHHHHH
Q 005492 625 MKEVAF 630 (694)
Q Consensus 625 ~~evl~ 630 (694)
+.||-+
T Consensus 439 ~~EIK~ 444 (550)
T KOG0605|consen 439 AEEIKK 444 (550)
T ss_pred HHHHhc
Confidence 555543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=343.02 Aligned_cols=264 Identities=24% Similarity=0.369 Sum_probs=216.8
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhh-HHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETN-VEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
.+...+.++||+|-||.|.+.....+.+||||.++...... ..+|.+|+++|.+++|||||+|+|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34556778999999999999999888999999998755544 48999999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
|++|+|.+||.++.... +.-....+|+.|||.||+||.+.+ +|||||.++|+|+|.++++||+|||++|.+...+.
T Consensus 617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999998874332 455667789999999999999999 99999999999999999999999999998776555
Q ss_pred ce-eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh--CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 518 HL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT--GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 518 ~~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
+. .....-.++|||||.+..++++.++|||+||++|||+++ ...||.....+.. ++.......... ..
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~------~~ 763 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQG------RQ 763 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCC------cc
Confidence 43 334556789999999999999999999999999999976 6789876654331 111111111111 11
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
.....+.-++..+.+++.+||..+-++||+++++...|.+.
T Consensus 764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11122445677889999999999999999999999988653
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=340.77 Aligned_cols=262 Identities=24% Similarity=0.404 Sum_probs=203.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-----------------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-----------------GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKL 421 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l 421 (694)
++|...++||+|+||.||++.+.+ +..||+|.+... ......+|.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999998542 346999988753 33446679999999999999999999
Q ss_pred EeEEeeCCccEEEEEeCCCCChHHHHhccc----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 005492 422 LGCCLETEVPLLVYEFIPNGTLYQYIHNQI----------------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485 (694)
Q Consensus 422 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH 485 (694)
++++.+.+..+|||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999986532 1124788999999999999999999999 999
Q ss_pred cccccccEEECCCCcEEEeecCCccccccCCcc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh--CCCC
Q 005492 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT--GQKP 562 (694)
Q Consensus 486 ~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt--g~~p 562 (694)
|||||+|||+++++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999765432221 1222345788999999998999999999999999999987 5567
Q ss_pred CccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 563 IRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
|......+ .............. . .....+...+..+.+|+.+||+.+|++|||+.+|.+.|+
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQ---VIENAGEFFRDQGR-Q-----VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHH---HHHHHHHHhhhccc-c-----ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 76543321 11111111111000 0 000011233457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=352.53 Aligned_cols=259 Identities=27% Similarity=0.429 Sum_probs=206.2
Q ss_pred HhcCCCccceeeeeCcEEEEEEEE------cCCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCC
Q 005492 358 ATDNYNANRILGQGGQGTVYKGML------TDGRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETE 429 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~ 429 (694)
..++|++.+.||+|+||.||++.. ..+..||||+++.. .....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345789999999999999999974 23568999998753 234456789999999999 8999999999999999
Q ss_pred ccEEEEEeCCCCChHHHHhcccC---------------------------------------------------------
Q 005492 430 VPLLVYEFIPNGTLYQYIHNQIE--------------------------------------------------------- 452 (694)
Q Consensus 430 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 452 (694)
..++||||+++|+|.++++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999975321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 453 ---------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 453 ---------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
...+++..++.++.||+.||+|||+.+ |+||||||+|||++++..+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 124789999999999999999999999 99999999999999999999999999986543322
Q ss_pred ce-eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhh
Q 005492 518 HL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 518 ~~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
.. .....++..|+|||.+.+..++.++||||||++||||++ |..||....... .+...+..+..
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~-------- 335 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGYR-------- 335 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCcc--------
Confidence 11 112234567999999999999999999999999999998 888986543221 11122222110
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGG 634 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 634 (694)
...+...+.++.+|+.+||+.+|++||++.||++.|++
T Consensus 336 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 336 -MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 01111224568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=342.89 Aligned_cols=245 Identities=26% Similarity=0.327 Sum_probs=202.3
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|++.+.||+|+||.||++.... ++.||+|.++.. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 578899999999999999999864 889999987642 2334567899999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999997643 4889999999999999999999999 999999999999999999999999999865322
Q ss_pred CcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
.....||+.|+|||++.+..++.++||||||++||||++|+.||......+ ....+..+.+
T Consensus 172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~i~~~~~-------- 232 (329)
T PTZ00263 172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-------IYEKILAGRL-------- 232 (329)
T ss_pred ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-------HHHHHhcCCc--------
Confidence 123468999999999999999999999999999999999999996543211 1112222111
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPT-----MKEVAFE 631 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 631 (694)
..+......+.+|+.+||+.||.+||+ +.+++.+
T Consensus 233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011112345789999999999999997 5666654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=354.21 Aligned_cols=254 Identities=26% Similarity=0.486 Sum_probs=213.7
Q ss_pred CccceeeeeCcEEEEEEEEc-CC----cEEEEEEccc-cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 363 NANRILGQGGQGTVYKGMLT-DG----RIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 363 ~~~~~LG~G~~g~Vy~~~~~-~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
...++||+|+||+||+|.+- +| -+||||.+.. .......++++|+-+|.+++|||+++|+|+|.... +.||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 44689999999999999963 33 4689998765 44556788999999999999999999999998777 889999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
||+.|+|.+|++.++. .+-.+.++.|..|||+||.|||.+. ++||||..+|||+..-..+||.|||+++.+..+.
T Consensus 778 ~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999998654 5999999999999999999999999 9999999999999999999999999999887665
Q ss_pred cceeee-eecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 517 THLTTK-VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 517 ~~~~~~-~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
...... ..-.+.|||-|.+....|+.++|||||||++|||+| |..|+++...++..+ ++...
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d----------------lle~g 916 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD----------------LLEKG 916 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH----------------HHhcc
Confidence 544332 234568999999999999999999999999999999 999998877665322 22222
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~ 638 (694)
.+-..++.....+..++.+||..|+..||+++++...+.+..+.
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 22233456677899999999999999999999999888765544
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=332.46 Aligned_cols=256 Identities=23% Similarity=0.418 Sum_probs=209.5
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
.++|+..++||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3578889999999999999999888889999987643 234678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++++|.++++... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999997642 235899999999999999999999998 999999999999999999999999999876433222
Q ss_pred eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
......++..|+|||++....++.++||||||+++|+|++ |+.||......+ ....+..... .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~---------~ 223 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGYR---------M 223 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCC---------C
Confidence 2223345678999999998899999999999999999998 999986543221 1111111110 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
......+..+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 01112345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=331.34 Aligned_cols=251 Identities=28% Similarity=0.453 Sum_probs=204.9
Q ss_pred cCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCC
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP 439 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~ 439 (694)
++|+..+.||+|+||.||++.++++..+|+|.+... ....++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457788999999999999999988889999987643 3335678999999999999999999999999999999999999
Q ss_pred CCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce
Q 005492 440 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519 (694)
Q Consensus 440 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 519 (694)
+|+|.++++.... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999976432 4899999999999999999999999 9999999999999999999999999987654332222
Q ss_pred eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 520 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
.....++..|+|||.+....++.++||||||+++|||++ |+.||......+ ....+..+.. ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~-------~~~~i~~~~~--~~------- 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-------VVEMISRGFR--LY------- 221 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCC--CC-------
Confidence 222335668999999998899999999999999999999 899986543221 1111211110 00
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
.+...+..+.+++.+||+.+|.+||++.++++.|
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1112235688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=351.86 Aligned_cols=260 Identities=28% Similarity=0.472 Sum_probs=206.4
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEc------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCC
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETE 429 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~ 429 (694)
..++|++.+.||+|+||.||++... ++..||||+++.. .....+.+.+|+.+++.+ +|+||+++++++.+..
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3457889999999999999998842 2457999998753 334466789999999999 8999999999999999
Q ss_pred ccEEEEEeCCCCChHHHHhcccC---------------------------------------------------------
Q 005492 430 VPLLVYEFIPNGTLYQYIHNQIE--------------------------------------------------------- 452 (694)
Q Consensus 430 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 452 (694)
..++||||+++|+|.++++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999999865321
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce-ee
Q 005492 453 ----------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TT 521 (694)
Q Consensus 453 ----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~ 521 (694)
..++++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......... ..
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 124788999999999999999999999 9999999999999999999999999997654332211 11
Q ss_pred eeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhh
Q 005492 522 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAK 600 (694)
Q Consensus 522 ~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 600 (694)
...++..|+|||++....++.++||||||+++|||++ |+.||....... . +...+..+. ....+
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~----~~~~~~~~~---------~~~~~ 337 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K----FYKMVKRGY---------QMSRP 337 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H----HHHHHHccc---------CccCC
Confidence 2234568999999999999999999999999999997 999997543221 0 111111110 00011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 601 KEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 601 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
...+..+.+++.+||+.+|.+||++.+|++.|+++
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11245688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=335.10 Aligned_cols=252 Identities=25% Similarity=0.324 Sum_probs=202.7
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
.|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3777899999999999999975 58999999876422 2334568899999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999998886542 235899999999999999999999999 9999999999999999999999999997653221
Q ss_pred cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhh
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 596 (694)
......||..|+|||++.+..++.++|||||||+||||++|+.||......... ......+... .
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~----------~ 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKED----------Q 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhcc----------c
Confidence 223346899999999999999999999999999999999999999765432211 1111111110 0
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005492 597 KEAKKEGIMTVATLAKRCLNLNGKMRPT-----MKEVAFE 631 (694)
Q Consensus 597 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 631 (694)
...+......+.+|+.+||+.+|.+||+ +.+++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1122234456889999999999999997 7777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=337.75 Aligned_cols=266 Identities=23% Similarity=0.265 Sum_probs=203.9
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
++|++.+.||+|+||.||++..+. ++.+|+|+++.. .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 468899999999999999999864 789999987653 23345678899999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|++++.|..+.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99988776554322 24899999999999999999999999 9999999999999999999999999998764333
Q ss_pred cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHH--------HHhhhc-ch
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL--------QAINEN-RL 587 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~-~~ 587 (694)
........|++.|+|||++.+..++.++|||||||+||||++|+.||......+......... ...... ..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 223334568999999999998899999999999999999999999997644322110000000 000000 00
Q ss_pred hhhhhhh------hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 588 FEILDAR------VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 588 ~~~~d~~------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.....+. .........+..+.+|+.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 0001111234568999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=331.58 Aligned_cols=255 Identities=29% Similarity=0.465 Sum_probs=208.2
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
.+|...+.||+|+||.||+|..++ ++.||+|.+... ....+++.+|++++++++|+||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 457788999999999999999765 888999987643 344678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999997643 235899999999999999999999998 999999999999999999999999999866433222
Q ss_pred eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
......++..|+|||.+.+..++.++||||||+++|||++ |..||.....++ ....+... ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~---------~~~ 224 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKG---------YRM 224 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCC---------CCC
Confidence 2222234668999999999999999999999999999998 899986543221 11111111 111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
+.+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 12223446788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=339.22 Aligned_cols=242 Identities=23% Similarity=0.322 Sum_probs=198.8
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCC
Q 005492 366 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG 441 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~g 441 (694)
+.||+|+||.||++... +++.||||.++.. .......+.+|+.++++++||||+++++++.+.+..+|||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999975 5899999987642 2344567889999999999999999999999999999999999999
Q ss_pred ChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcceee
Q 005492 442 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT 521 (694)
Q Consensus 442 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 521 (694)
+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~ 153 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccc
Confidence 9999997642 5899999999999999999999999 9999999999999999999999999987543221 2233
Q ss_pred eeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhH
Q 005492 522 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKK 601 (694)
Q Consensus 522 ~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 601 (694)
...||+.|+|||++.+..++.++|||||||+||||++|+.||...+... ....+..... ..+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~~~~~~~----------~~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEI----------RFPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCCC----------CCCC
Confidence 4569999999999999999999999999999999999999996533211 1111111110 1122
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005492 602 EGIMTVATLAKRCLNLNGKMRP-----TMKEVAFE 631 (694)
Q Consensus 602 ~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 631 (694)
.....+.+|+.+||+.||++|| ++.+++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 3345688999999999999999 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=343.14 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=205.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|++.+.||+|+||.||+|...+ ++.||||+++.. .......+.+|+.++.+++||||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 368899999999999999999875 889999988643 2234567889999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999997542 4899999999999999999999999 99999999999999999999999999976533
Q ss_pred CcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
......||+.|+|||++.+..++.++||||||++||||++|+.||...+..+. ...+... ...+....
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~--~~~~~~~~ 221 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-------WENLKYW--KETLQRPV 221 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-------HHHHHhc--cccccCCC
Confidence 22345689999999999999999999999999999999999999976543221 1111110 00000000
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
...........+.+++.+||..+|.+||++.+++++
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000011234568899999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=330.27 Aligned_cols=257 Identities=25% Similarity=0.434 Sum_probs=209.7
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
..++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 346789999999999999999998888899999886533 3457799999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999997653 235899999999999999999999999 99999999999999999999999999987653222
Q ss_pred ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 596 (694)
........+..|+|||++.+..++.++||||||++++||++ |+.||......+ ....+.... .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~---------~ 222 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQGY---------R 222 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC---------C
Confidence 21222223457999999999999999999999999999999 999986543221 111111110 0
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 597 KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 597 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
...+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 011123346788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=334.22 Aligned_cols=257 Identities=29% Similarity=0.474 Sum_probs=209.6
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC------CcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 432 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~ 432 (694)
++|+..+.||+|+||.||+|.... ...||+|.+.... ......|.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998653 2579999886533 344567899999999999999999999999999999
Q ss_pred EEEEeCCCCChHHHHhcccCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCC
Q 005492 433 LVYEFIPNGTLYQYIHNQIEE-------------FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY 499 (694)
Q Consensus 433 lv~e~~~~gsL~~~l~~~~~~-------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~ 499 (694)
++|||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 999999999999999764211 35889999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCccccccCCc-ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHH
Q 005492 500 RAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGY 577 (694)
Q Consensus 500 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~ 577 (694)
.+||+|||+++....... .......+++.|+|||.+....++.++||||||++||||++ |..||......+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999976543221 22233446788999999998999999999999999999998 999987654322
Q ss_pred HHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 578 FLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 578 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
....+..... ...+...+.++.+|+.+||+.+|.+||++.||+++|+.+
T Consensus 235 ~~~~i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 235 VIEMIRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1122222211 112334567899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=382.47 Aligned_cols=264 Identities=27% Similarity=0.441 Sum_probs=212.5
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
...|...++||+|+||.||+|... ++..||||+++..... ...|++++++++|||||+++|++.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 356778899999999999999974 6899999988653322 23468899999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++|+|.++++. ++|..+.+|+.|+|+||+|||....++|+||||||+||+++.++.+++. ||.......+
T Consensus 765 ~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 765 IEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 999999999962 8999999999999999999997655569999999999999999888875 6665433221
Q ss_pred ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
....+++.|+|||++.+..++.++|||||||++|||++|+.||..... ....+..|.............+|+.+..
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccC
Confidence 123578999999999999999999999999999999999999954332 2334555554444444445555555432
Q ss_pred h--hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccccc
Q 005492 598 E--AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639 (694)
Q Consensus 598 ~--~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~ 639 (694)
. ...+...++.+++.+||+.+|++||+|.||+++|+.+.+..
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 2 23455667899999999999999999999999998876543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.18 Aligned_cols=249 Identities=26% Similarity=0.397 Sum_probs=211.8
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccc-cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
..|...+.||+|.||.||+|.... ++.||+|.+.. ......+++.+|+.+|.+++++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 356777899999999999999765 88999999876 4456688899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+.+|++.+.|+... .+.+..+.-|+++++.||.|||.++ .+|||||+.|||+..++.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999997542 3588888899999999999999999 99999999999999999999999999987765444
Q ss_pred ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
.. ..+.||+.|||||++....|+.|+||||||++.+||.+|.+|+....+... .-++......
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv----------------lflIpk~~PP 229 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV----------------LFLIPKSAPP 229 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE----------------EEeccCCCCC
Confidence 43 667899999999999988999999999999999999999999987655321 1111112122
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+.......+.+++..||.++|+.||++.+++++
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2223455678999999999999999999998864
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=344.42 Aligned_cols=252 Identities=25% Similarity=0.321 Sum_probs=205.5
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|.+.+.||+|+||+||++... +++.||||+++.. .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999976 5899999988642 2245667899999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999865 35899999999999999999999999 999999999999999999999999999866433
Q ss_pred C----------------------------cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCC
Q 005492 516 Q----------------------------THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 567 (694)
Q Consensus 516 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~ 567 (694)
. ........||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 112233568999999999999999999999999999999999999997654
Q ss_pred CccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 005492 568 TDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPT-MKEVAFE 631 (694)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~~ 631 (694)
..+ ......... ...........+..+.+|+.+||. +|.+||+ +.+++++
T Consensus 235 ~~~------~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQE------TYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHH------HHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 221 111111100 000000001134668899999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=331.76 Aligned_cols=258 Identities=26% Similarity=0.455 Sum_probs=213.7
Q ss_pred HHhcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 357 KATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 357 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
....+|+..++||.|+||.||+|...++..+|+|.+.........++..|+.+++.++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567889999999999999999998899999999887666567789999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|+++++|.++++... ...+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999998643 235899999999999999999999999 9999999999999999999999999997654322
Q ss_pred cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhh
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
. ......++..|+|||.+....++.++||||||+++++|++ |+.||......+ ....+..+ .
T Consensus 159 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~---------~ 221 (261)
T cd05148 159 Y-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-------VYDQITAG---------Y 221 (261)
T ss_pred c-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHHhC---------C
Confidence 1 1223335678999999998899999999999999999998 899996544211 11111111 1
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
....+...+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1111223446688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=335.65 Aligned_cols=262 Identities=23% Similarity=0.318 Sum_probs=201.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
++|...++||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56899999999999999999976 48899999886532 23345778999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++ +|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 975 99999875432 4789999999999999999999999 99999999999999999999999999876532221
Q ss_pred ceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh------------
Q 005492 518 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE------------ 584 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 584 (694)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+... ........
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH---LIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChHHhhccccc
Confidence 1233457899999998865 568999999999999999999999997654332111 11111100
Q ss_pred cchhhhhhhhhh----hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 585 NRLFEILDARVL----KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 585 ~~~~~~~d~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..+.....+... .........++.+|+.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000100000 00011123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=337.87 Aligned_cols=245 Identities=26% Similarity=0.347 Sum_probs=202.4
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|+..+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999976 5899999987642 2234567889999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999997643 4899999999999999999999999 999999999999999999999999998765322
Q ss_pred CcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
.....|++.|+|||++.+..++.++||||||++||||++|+.||......+ ....+..+..
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~-------- 215 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-------IYEKILAGKL-------- 215 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCc--------
Confidence 223458999999999999999999999999999999999999997543221 1111111111
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPT-----MKEVAFE 631 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 631 (694)
..+......+.+|+.+||+.||.+||+ +.+++++
T Consensus 216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111222456889999999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.42 Aligned_cols=263 Identities=28% Similarity=0.408 Sum_probs=206.3
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
.++|+..+.||+|+||.||++.... +..+|+|.+... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4689999999999999999999764 888999987753 33445779999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+. |+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 999999999997643 48999999999999999999998632 999999999999999999999999998765322
Q ss_pred cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhh-------------
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN------------- 583 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------- 583 (694)
......|++.|+|||++.+..++.++||||||++||||++|+.||......+ +...+.....
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence 1233458999999999999999999999999999999999999996543221 1000000000
Q ss_pred -----------------hcchhhhhhhhhh----hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 584 -----------------ENRLFEILDARVL----KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 584 -----------------~~~~~~~~d~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
.....+..+.... .........++.+|+.+||+.||++|||+.|++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000011110000 000112346789999999999999999999999763
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=332.31 Aligned_cols=249 Identities=35% Similarity=0.599 Sum_probs=196.4
Q ss_pred ccceeeeeCcEEEEEEEEc-----CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 364 ANRILGQGGQGTVYKGMLT-----DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 364 ~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
..+.||.|.||.||+|.+. .+..|+||.++.. .....+.|.+|++++++++||||++++|++.+.+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 2568999999653 344588999999999999999999999999988889999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++|+|.++|+.. ....+++..++.|+.|++.||+|||+.+ ++|+||+++|||+++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999986 2335999999999999999999999998 99999999999999999999999999987632211
Q ss_pred -ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhh
Q 005492 518 -HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 518 -~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
...........|+|||.+....++.++||||||+++|||++ |+.||......+ +...+.++....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-------~~~~~~~~~~~~------ 225 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-------IIEKLKQGQRLP------ 225 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-------HHHHHHTTEETT------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccccccce------
Confidence 22233446778999999999999999999999999999999 678876543221 222222222111
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
.+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 226 ---~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ---IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1122345688999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=346.70 Aligned_cols=244 Identities=27% Similarity=0.389 Sum_probs=207.9
Q ss_pred HHhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccc---cChhhHHHHHHHHHHHhhcc-CCcceeEEeEEeeCCcc
Q 005492 357 KATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL---VDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVP 431 (694)
Q Consensus 357 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~ 431 (694)
...++|...++||+|.||+|+++..+. ++.+|||.+++ ...++++..+.|.+|+...+ ||-+++|+.++...++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 345789999999999999999999875 78999999886 35667888899999998885 99999999999999999
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
++||||+.||++..+.+.. .+++..+.-++..|+.||+|||+++ ||+||||.+|||||.+|.+||+||||++.
T Consensus 445 ~fvmey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999955554432 4999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhh
Q 005492 512 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591 (694)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (694)
.... ...+....||+.|||||++.+..|+.++|+|||||+|||||.|+.||.+.+.++. +...+...
T Consensus 518 ~m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------FdsI~~d~------ 584 (694)
T KOG0694|consen 518 GMGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------FDSIVNDE------ 584 (694)
T ss_pred cCCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHhcCC------
Confidence 5432 3357778999999999999999999999999999999999999999987665541 11111111
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTM 625 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 625 (694)
..++...+.+...|+.++|.++|++|..+
T Consensus 585 -----~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 -----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11234455678899999999999999877
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=342.89 Aligned_cols=248 Identities=26% Similarity=0.413 Sum_probs=210.9
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
.-|+.++.||.|+.|.|-+|++. .|+.+|||.+... .......+.+||.+|+-+.|||+++|++++.+...+|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45888999999999999999975 5999999987653 3344566888999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++|-|+++|..++ ++++.+..++++||+.|+.|+|..+ |+||||||+|+|||.++++||+|||+|..-.
T Consensus 92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~-- 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV-- 163 (786)
T ss_pred EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence 9999999999998654 5999999999999999999999999 9999999999999999999999999997643
Q ss_pred CcceeeeeecCCCCCCCcccccCCC-CceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
........+|.+.|.+||++.+.+| +.++||||.|||||.||+|+.||++.+.. ..+..++.|.+
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir-------~LLlKV~~G~f------- 229 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR-------VLLLKVQRGVF------- 229 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH-------HHHHHHHcCcc-------
Confidence 2334556679999999999999988 57999999999999999999999843322 13333444332
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
+.+...+.+.++|+.+||..||++|.|++||+++-
T Consensus 230 ---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 230 ---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred ---cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 12234456788999999999999999999998863
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.43 Aligned_cols=255 Identities=25% Similarity=0.436 Sum_probs=207.6
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv 434 (694)
++|+..+.||+|+||.||+|.+.. ...||||.++.. ......+|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568899999999999999999753 457999988653 344566799999999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
|||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999976433 5899999999999999999999998 99999999999999999999999999987652
Q ss_pred CCcc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhh
Q 005492 515 DQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592 (694)
Q Consensus 515 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 592 (694)
.... ......++..|+|||.+....++.++||||||+++|||++ |..||......+ ....+......
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~---- 227 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGYRL---- 227 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCC----
Confidence 2222 1222335678999999999999999999999999999998 999986533221 11111111100
Q ss_pred hhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 593 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
..+...+..+.+|+.+||+.+|++||++.+|+++|..+
T Consensus 228 -----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11123345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=309.26 Aligned_cols=265 Identities=25% Similarity=0.381 Sum_probs=213.2
Q ss_pred HhcCCCccceeeeeCcEEEEEEE-EcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC-----cc
Q 005492 358 ATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETE-----VP 431 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~-----~~ 431 (694)
..++|.+.+.||+|||+-||+++ ..+++.+|+|++.....++.+..++|++..++++|||+++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 35789999999999999999998 4568999999998888888999999999999999999999999876554 48
Q ss_pred EEEEEeCCCCChHHHHhcccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEE-FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~ 510 (694)
||+++|...|+|.+.+.....+ ..+++.++++|+.+|++||++||+..+ |++||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999874333 369999999999999999999999884 69999999999999999999999999987
Q ss_pred ccccCCccee--------eeeecCCCCCCCcccc---cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHH
Q 005492 511 SVMVDQTHLT--------TKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL 579 (694)
Q Consensus 511 ~~~~~~~~~~--------~~~~gt~~y~aPE~~~---~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~ 579 (694)
.....-.... ....-|..|.|||++. +...++++|||||||+||+|+.|..||+..-...+ ++.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-Sla---- 252 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-SLA---- 252 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-eEE----
Confidence 6543211111 1123588999999985 34578999999999999999999999975433211 110
Q ss_pred HHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 005492 580 QAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636 (694)
Q Consensus 580 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~ 636 (694)
..+....+...-....++.+.+||.+||+.||.+||++.+++..+..+.
T Consensus 253 --------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 --------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111111111111225677899999999999999999999999987653
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.38 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=204.4
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|++.+.||+|+||+||++... +++.||+|.++.. .....+.+.+|+.+++.++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999976 4889999988753 2334567889999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++|+|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999986522 5899999999999999999999999 999999999999999999999999999876544
Q ss_pred CcceeeeeecCCCCCCCcccc------cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQ------SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~------~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (694)
.........||+.|+|||++. ...++.++||||||++||||++|+.||......+ .+...+.......
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~ 229 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFLK 229 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCccC
Confidence 333334456899999999986 4567899999999999999999999997543321 1111111111111
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 590 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.. ........+.+|+..||+ +|.+||++.+++.+
T Consensus 230 ~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 230 FP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00 011234567899999997 99999999998864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=326.01 Aligned_cols=248 Identities=25% Similarity=0.417 Sum_probs=212.9
Q ss_pred hcCCCccceeeeeCcEEEEEEEE-cCCcEEEEEEccc---cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGML-TDGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv 434 (694)
..+|++.+.||+|.||.|-++.. ..|+.||||-++. .++.++-.+.+||+||+.|+||||++++.+|...+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35788899999999999999986 5699999997654 4566777889999999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
|||..+|.|++|+.+.. .|++.....+++||..|+.|.|.++ ++|||||.+|||||+|+++||+||||+.++..
T Consensus 132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999998754 4999999999999999999999999 99999999999999999999999999987643
Q ss_pred CCcceeeeeecCCCCCCCcccccCCC-CceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhh
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDA 593 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 593 (694)
. .....+.|++-|.+||.+.+.+| .+.+|-|||||+||.|+.|..||++.+... +...+..+..++.
T Consensus 206 ~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~-------lvrQIs~GaYrEP--- 273 (668)
T KOG0611|consen 206 K--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR-------LVRQISRGAYREP--- 273 (668)
T ss_pred c--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH-------HHHHhhcccccCC---
Confidence 2 33456789999999999999988 589999999999999999999998754321 3334444443332
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 594 RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 594 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
+.+....-||++||..+|++|.|+.+|..+-
T Consensus 274 --------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 --------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 2334566799999999999999999998764
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.77 Aligned_cols=263 Identities=26% Similarity=0.400 Sum_probs=209.1
Q ss_pred HHhcCCCccceeeeeCcEEEEEEEEcC------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcc-CCcceeEEeEEeeC
Q 005492 357 KATDNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLV-DETNVEQFINEVVILSQIN-HRNIVKLLGCCLET 428 (694)
Q Consensus 357 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~nIv~l~g~~~~~ 428 (694)
...++|.+.++||+|+||.||+|.... +..||||+++.. .....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 345688999999999999999998632 346999998753 3344567999999999996 99999999999999
Q ss_pred CccEEEEEeCCCCChHHHHhcccC--------------------------------------------------------
Q 005492 429 EVPLLVYEFIPNGTLYQYIHNQIE-------------------------------------------------------- 452 (694)
Q Consensus 429 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 452 (694)
+..+|||||+++|+|.++|+....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999999875321
Q ss_pred -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEE
Q 005492 453 -------------------------------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL 495 (694)
Q Consensus 453 -------------------------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll 495 (694)
...+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 124788899999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCccccccCCcc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCcc
Q 005492 496 DDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKS 573 (694)
Q Consensus 496 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~ 573 (694)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++||||++ |..||.......
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--- 347 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--- 347 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH---
Confidence 99999999999999865432221 1222346778999999999999999999999999999997 889986543221
Q ss_pred HHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 005492 574 LVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRT 637 (694)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~ 637 (694)
.+...+..+. ....+...+..+.+++.+||+.+|++||++.+|+++|+.+.+
T Consensus 348 ---~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 ---TFYNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ---HHHHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0111111111 011122345678899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=327.33 Aligned_cols=252 Identities=27% Similarity=0.432 Sum_probs=205.1
Q ss_pred cCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCC
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP 439 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~ 439 (694)
++|...+.||+|+||+||+|...++..+|+|.++.. ....++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 357788999999999999999877778999987743 2345679999999999999999999999999999999999999
Q ss_pred CCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce
Q 005492 440 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519 (694)
Q Consensus 440 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 519 (694)
+++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999976433 5899999999999999999999999 9999999999999999999999999987654332222
Q ss_pred eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 520 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
.....++..|+|||.+....++.++||||||+++|||++ |+.||...+..+ ....+..+... .
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~ 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGLRL---------Y 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCCCC---------C
Confidence 222335678999999998889999999999999999998 999986544321 11111111110 0
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
.+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11123457889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=333.14 Aligned_cols=239 Identities=26% Similarity=0.316 Sum_probs=194.6
Q ss_pred eeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCCh
Q 005492 368 LGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL 443 (694)
Q Consensus 368 LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gsL 443 (694)
||+|+||.||++...+ ++.||+|.+... .......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999999764 789999987642 344567788999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcceeeee
Q 005492 444 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 523 (694)
Q Consensus 444 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 523 (694)
.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 153 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTF 153 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccccc
Confidence 99997642 4899999999999999999999999 9999999999999999999999999987543222 223345
Q ss_pred ecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHH
Q 005492 524 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEG 603 (694)
Q Consensus 524 ~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 603 (694)
.||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+..... .. ...+...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~-~~----------~~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQ-EP----------LRFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHc-CC----------CCCCCcC
Confidence 68999999999999999999999999999999999999997543211 1111111 11 0112233
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005492 604 IMTVATLAKRCLNLNGKMRPTMKEVAF 630 (694)
Q Consensus 604 ~~~l~~li~~cl~~~p~~RPt~~evl~ 630 (694)
...+.+++.+||+.+|.+||++..+.+
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e 243 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQE 243 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence 456889999999999999986543333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.78 Aligned_cols=255 Identities=30% Similarity=0.511 Sum_probs=208.2
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC------CcEEEEEEccccChh-hHHHHHHHHHHHhhccCCcceeEEeEEeeCCccE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 432 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~ 432 (694)
++|.+.+.||+|+||.||+|...+ ++.||||.++..... ..+.+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 568888999999999999998643 478999998764443 5678999999999999999999999999999999
Q ss_pred EEEEeCCCCChHHHHhcccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcE
Q 005492 433 LVYEFIPNGTLYQYIHNQIE-----------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA 501 (694)
Q Consensus 433 lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~ 501 (694)
+||||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 99999999999999976421 235889999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccccCCc-ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHH
Q 005492 502 KVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFL 579 (694)
Q Consensus 502 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 579 (694)
||+|||+++....... .......+++.|+|||++....++.++||||||+++|||++ |..||......+ ..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-------~~ 234 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------VI 234 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HH
Confidence 9999999976533221 11223345788999999999999999999999999999998 999986544322 11
Q ss_pred HHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 580 QAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 580 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
..+..+... ..+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus 235 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 ECITQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 122222111 111233456889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=334.21 Aligned_cols=242 Identities=24% Similarity=0.329 Sum_probs=197.8
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCC
Q 005492 366 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG 441 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~g 441 (694)
+.||+|+||.||++... +++.||+|.++.. .......+.+|+.++++++||||+++++++...+..+|||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999975 5899999987642 3345567888999999999999999999999999999999999999
Q ss_pred ChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcceee
Q 005492 442 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT 521 (694)
Q Consensus 442 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 521 (694)
+|..++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~ 153 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccc
Confidence 9999987543 4899999999999999999999999 9999999999999999999999999987543222 1223
Q ss_pred eeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhH
Q 005492 522 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKK 601 (694)
Q Consensus 522 ~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 601 (694)
...||+.|+|||++.+..++.++||||||++||||++|+.||...+..+ ....+..... ..+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------~~~~~~~~~~----------~~p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI----------RFPR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCC----------CCCC
Confidence 3568999999999999999999999999999999999999996543221 1111111100 1112
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005492 602 EGIMTVATLAKRCLNLNGKMRP-----TMKEVAFE 631 (694)
Q Consensus 602 ~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 631 (694)
.....+.+++.+||+.+|.+|| ++.+++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 3345688999999999999998 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=335.92 Aligned_cols=258 Identities=24% Similarity=0.487 Sum_probs=206.2
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-Cc----EEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GR----IVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l 433 (694)
.+|+..+.||+|+||.||+|.+.. +. .||+|.++.. .....+++.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 468999999999999999998643 33 4899998753 344567899999999999999999999999764 5689
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
|+||+++|+|.++++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999987533 4889999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCccee-eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhh
Q 005492 514 VDQTHLT-TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591 (694)
Q Consensus 514 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (694)
....... ....++..|+|||++....++.++||||||++||||++ |+.||......+ +......+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~--- 230 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERL--- 230 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhCCCCC---
Confidence 4332221 12234678999999999999999999999999999998 999987543221 11111111100
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccccc
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~ 639 (694)
..+......+.+++.+||+.+|.+||++.+++..|..+....
T Consensus 231 ------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 231 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 001123346789999999999999999999999998775443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=306.51 Aligned_cols=249 Identities=27% Similarity=0.357 Sum_probs=209.5
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv 434 (694)
.++|++.+.||+|-||.||.|..+. +-.||+|++... .....+++.+|++|-+.|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 3678999999999999999999764 778999987652 233456889999999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
+||.++|+|...|..... ..+++.....++.|+|.||.|+|..+ ++||||||+|+|++.++.+||+|||-+-.-.
T Consensus 101 lEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999986432 25889999999999999999999999 9999999999999999999999999885432
Q ss_pred CCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
........||..|++||+..+...+.++|+|++|++.||++.|.+||......+ ..+.+..- ++.
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-------tYkrI~k~---~~~--- 240 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-------TYKRIRKV---DLK--- 240 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-------HHHHHHHc---ccc---
Confidence 334456779999999999999999999999999999999999999997655222 11222111 111
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+........++|.+|+..+|.+|.+..|++++
T Consensus 241 ----~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 241 ----FPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 123344568899999999999999999999876
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=350.88 Aligned_cols=263 Identities=23% Similarity=0.359 Sum_probs=216.3
Q ss_pred HHHhcCCCccceeeeeCcEEEEEEEEcCC-cEEEEEEccccChhhHHHHHHHHHHHhhcc-CCcceeEEe-EEeeC----
Q 005492 356 EKATDNYNANRILGQGGQGTVYKGMLTDG-RIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLG-CCLET---- 428 (694)
Q Consensus 356 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~g-~~~~~---- 428 (694)
.....++++.+.|.+|||+.||.|....+ ..+|+|++...++...+...+||++|++|+ |+|||.+++ .....
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 33456678889999999999999998876 999999998888999999999999999996 999999999 43322
Q ss_pred --CccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeec
Q 005492 429 --EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 506 (694)
Q Consensus 429 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DF 506 (694)
-+.+|.||||.+|.|-+++..+... .|++.++++|+.|+++|+++||... +||||||||.+||||+.+++.||+||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence 2568999999999999999876444 3999999999999999999999987 67999999999999999999999999
Q ss_pred CCccccccCCc-ce-------eeeeecCCCCCCCccc---ccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHH
Q 005492 507 GTSRSVMVDQT-HL-------TTKVQGTFGYVDPEYF---QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 575 (694)
Q Consensus 507 Gla~~~~~~~~-~~-------~~~~~gt~~y~aPE~~---~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~ 575 (694)
|.+.-...... .. .-...-|+-|.|||++ .+...++|+|||+|||+||-|.....||+....
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------- 263 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------- 263 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------
Confidence 98864432221 10 0112368999999986 467899999999999999999999999975422
Q ss_pred HHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccccc
Q 005492 576 GYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639 (694)
Q Consensus 576 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~ 639 (694)
..|++..............|.+||..||+.+|++||++-+|+..+..++...
T Consensus 264 ------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 ------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 2233333333333567788999999999999999999999999987766543
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=331.51 Aligned_cols=260 Identities=28% Similarity=0.482 Sum_probs=211.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEc------CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l 433 (694)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57888999999999999999852 245689998877666667789999999999999999999999999999999
Q ss_pred EEEeCCCCChHHHHhccc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEE
Q 005492 434 VYEFIPNGTLYQYIHNQI----------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV 503 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl 503 (694)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999997542 1234899999999999999999999999 999999999999999999999
Q ss_pred eecCCccccccCCcc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHH
Q 005492 504 SDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQA 581 (694)
Q Consensus 504 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 581 (694)
+|||+++........ ......++..|+|||++....++.++||||||++++||++ |..||......+ ....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence 999999865432211 1122335678999999998999999999999999999998 899986544321 1122
Q ss_pred hhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 005492 582 INENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 582 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~ 638 (694)
+..+.... .+...+..+.+|+.+||+.+|.+||++.+|++.|+++...
T Consensus 235 i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 22222111 1112335689999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=331.41 Aligned_cols=260 Identities=27% Similarity=0.447 Sum_probs=212.3
Q ss_pred cCCCccceeeeeCcEEEEEEEEc------CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l 433 (694)
.+|...+.||+|+||.||++... ++..+++|.++.......+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45778899999999999999853 345699999877666667789999999999999999999999999999999
Q ss_pred EEEeCCCCChHHHHhcccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCc
Q 005492 434 VYEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR 500 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~ 500 (694)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999976421 234899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccccCCc-ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHH
Q 005492 501 AKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYF 578 (694)
Q Consensus 501 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 578 (694)
+||+|||++........ .......++..|+|||++....++.++||||||+++|||++ |+.||......+ .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999976543221 11223346788999999999999999999999999999999 999986544322 1
Q ss_pred HHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 005492 579 LQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 579 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~ 638 (694)
...+..+.... .....+..+.+++.+||+.+|++||++.+|++.|+++.+.
T Consensus 235 ~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 IECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 12222221111 1122345688999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=323.97 Aligned_cols=254 Identities=26% Similarity=0.432 Sum_probs=205.6
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
.++|++.++||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++|+||+++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 356888999999999999999988888899998875332 3567999999999999999999999875 45679999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++++|.++++... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999997642 235899999999999999999999999 999999999999999999999999999765433222
Q ss_pred eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
......++..|+|||.+....++.++||||||+++|||++ |..||......+ ....+..+ ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~---------~~~ 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-------VLEQVERG---------YRM 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcC---------CCC
Confidence 2222335678999999988899999999999999999999 889986533211 11111111 011
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGG 634 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 634 (694)
..+...+..+.+|+.+||+.+|++|||+.++++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1122344678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=341.46 Aligned_cols=260 Identities=22% Similarity=0.280 Sum_probs=200.2
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
..+|++.+.||+|+||.||++... .++.||+|... ...+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999975 48899999643 24578899999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+. ++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 165 ~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 95 68988887542 4899999999999999999999999 99999999999999999999999999975432222
Q ss_pred ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCc----cHHHHHHHHhhhc--------
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK----SLVGYFLQAINEN-------- 585 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~----~~~~~~~~~~~~~-------- 585 (694)
.......||+.|+|||++.+..++.++||||||++||||++|+.||......... .....+.......
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 2333456999999999999999999999999999999999999887543321111 0111111111000
Q ss_pred --chhhhh---------hh--hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 586 --RLFEIL---------DA--RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 586 --~~~~~~---------d~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+.... .+ +.........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 00 00000011345578899999999999999999999864
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=336.04 Aligned_cols=242 Identities=23% Similarity=0.329 Sum_probs=198.3
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCC
Q 005492 366 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG 441 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~g 441 (694)
+.||+|+||.||++... +++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..+|||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999975 4899999988642 3345677889999999999999999999999999999999999999
Q ss_pred ChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcceee
Q 005492 442 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT 521 (694)
Q Consensus 442 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 521 (694)
+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 153 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMK 153 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccc
Confidence 9999987542 4899999999999999999999999 9999999999999999999999999987543221 2223
Q ss_pred eeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhH
Q 005492 522 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKK 601 (694)
Q Consensus 522 ~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 601 (694)
...||+.|+|||++.+..++.++|||||||+||||++|+.||......+ ....+..... ..+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-------~~~~~~~~~~----------~~p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEDI----------KFPR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-------HHHHhccCCc----------cCCC
Confidence 4568999999999999999999999999999999999999996543221 1111111100 1112
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005492 602 EGIMTVATLAKRCLNLNGKMRP-----TMKEVAFE 631 (694)
Q Consensus 602 ~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 631 (694)
.....+.+|+.+||+.+|.+|| ++.|++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2345678999999999999997 88888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=329.92 Aligned_cols=263 Identities=25% Similarity=0.309 Sum_probs=206.2
Q ss_pred hhhHHHHhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC--------------hhhHHHHHHHHHHHhhccCC
Q 005492 352 SKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--------------ETNVEQFINEVVILSQINHR 416 (694)
Q Consensus 352 ~~~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~ 416 (694)
..+-.+..++|++.+.||+|.||.|-+|+.. +++.||||.+.... ....+...+||.+|++++||
T Consensus 89 ~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~ 168 (576)
T KOG0585|consen 89 DDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHP 168 (576)
T ss_pred CcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCc
Confidence 3344455689999999999999999999965 58999999765321 12256889999999999999
Q ss_pred cceeEEeEEeeC--CccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEE
Q 005492 417 NIVKLLGCCLET--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANIL 494 (694)
Q Consensus 417 nIv~l~g~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIl 494 (694)
|||+|+++..+. +..|||+||+..|.+...=. ....+++.+.++++++++.||+|||.++ ||||||||+|+|
T Consensus 169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLL 242 (576)
T KOG0585|consen 169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLL 242 (576)
T ss_pred CeeEEEEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheE
Confidence 999999998765 58899999999888755322 2223999999999999999999999999 999999999999
Q ss_pred ECCCCcEEEeecCCccccccC----CcceeeeeecCCCCCCCcccccCC----CCceeeEEehhHHHHHHHhCCCCCccC
Q 005492 495 LDDKYRAKVSDFGTSRSVMVD----QTHLTTKVQGTFGYVDPEYFQSSQ----FTEKSDVYSFGVVLVEILTGQKPIRAI 566 (694)
Q Consensus 495 l~~~~~~kl~DFGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~t~~sDvwSlGvll~elltg~~p~~~~ 566 (694)
|++++++||+|||.+...... .........||+.|+|||...++. .+.+.||||+||+||-|+.|+.||.+.
T Consensus 243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 999999999999998755221 111223367999999999987633 367899999999999999999999754
Q ss_pred CCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 567 NTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
...+ .+ ..|+...+......+....+.+||+++|.+||+.|.+..+|..+.--.
T Consensus 323 ~~~~------l~---------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 323 FELE------LF---------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred hHHH------HH---------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 3221 11 222222222222234566789999999999999999999998876443
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.02 Aligned_cols=257 Identities=27% Similarity=0.481 Sum_probs=205.7
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEc------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCc
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEV 430 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~ 430 (694)
++++|+..+.||+|+||.||+|... .+..||||+.... ......++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999853 2467999987643 23345678999999999999999999999999999
Q ss_pred cEEEEEeCCCCChHHHHhcccC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEE
Q 005492 431 PLLVYEFIPNGTLYQYIHNQIE-------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV 503 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl 503 (694)
.++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999976322 224688899999999999999999998 999999999999999999999
Q ss_pred eecCCccccccCCcce-eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHH
Q 005492 504 SDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQA 581 (694)
Q Consensus 504 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 581 (694)
+|||+++......... .....+++.|+|||++....++.++||||||+++|||++ |..||......+ ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLRF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence 9999987654322211 112335678999999999999999999999999999999 688886543321 1122
Q ss_pred hhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 582 INENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 582 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
+....... .+...+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 234 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 21211111 11223456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.20 Aligned_cols=254 Identities=24% Similarity=0.315 Sum_probs=203.7
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEE
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l 433 (694)
..++|+..+.||+|+||.||++.... ++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+....+|
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 45689999999999999999999764 889999987642 23345567899999999999999999999999999999
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999998753 3888999999999999999999999 9999999999999999999999999997654
Q ss_pred cCCcceeeeeecCCCCCCCcccccC----CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhh
Q 005492 514 VDQTHLTTKVQGTFGYVDPEYFQSS----QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589 (694)
Q Consensus 514 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (694)
...........||+.|+|||++... .++.++|||||||+||||++|+.||....... .+...........
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~~~~ 267 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMDHKNSLT 267 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HHHHHHcCCCcCC
Confidence 3322223345699999999998653 47899999999999999999999997543211 1111111100000
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005492 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKM--RPTMKEVAFE 631 (694)
Q Consensus 590 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~ 631 (694)
+ ......+..+.+|+.+||+.+|.+ ||++.|++++
T Consensus 268 ~-------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 F-------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred C-------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 001123456889999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=324.98 Aligned_cols=250 Identities=29% Similarity=0.457 Sum_probs=203.6
Q ss_pred CCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 361 NYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
+|++.+.||+|+||.||++.++++..+|+|..... ......+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 47788999999999999999887788999987542 22346788999999999999999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..........
T Consensus 84 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 84 GCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999999976433 5899999999999999999999999 99999999999999999999999999876543222222
Q ss_pred eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEA 599 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 599 (694)
....++..|+|||.+....++.++||||||++||||++ |+.||......+ ....+.... ....
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~~~ 222 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-------VVESVSAGY---------RLYR 222 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-------HHHHHHcCC---------cCCC
Confidence 22224567999999999999999999999999999999 789987543321 111111110 0111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 600 KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 600 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
+...+..+.+|+.+||+.+|++||++.|+++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 122455789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=323.74 Aligned_cols=254 Identities=24% Similarity=0.421 Sum_probs=207.3
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
.+.|++.++||+|+||.||+|..++++.+|+|.+.... ...+++.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 46788999999999999999999889999999887433 34578999999999999999999999864 56789999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999987643 236899999999999999999999999 999999999999999999999999999766433222
Q ss_pred eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
......++..|+|||++....++.++||||||++++||++ |+.||......+ ....+..... .
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~ 222 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-------VIQNLERGYR---------M 222 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHHcCCC---------C
Confidence 2223345678999999998999999999999999999999 999997544221 1111111110 1
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGG 634 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 634 (694)
..+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1112234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=329.39 Aligned_cols=264 Identities=29% Similarity=0.462 Sum_probs=205.2
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-----CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeC--CccE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-----DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPL 432 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~ 432 (694)
++|++.+.||+|+||.||++..+ +++.||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888999999999999999753 4789999998877677778899999999999999999999987543 4678
Q ss_pred EEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccc
Q 005492 433 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 512 (694)
Q Consensus 433 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~ 512 (694)
+|+||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999999997643 24899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCccee--eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcc----
Q 005492 513 MVDQTHLT--TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR---- 586 (694)
Q Consensus 513 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 586 (694)
........ ....++..|+|||++.+..++.++||||||++++||++|..|+...... +...+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 230 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--------FMRMMGNDKQGQM 230 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--------hhhhccccccccc
Confidence 43322111 1122344699999999889999999999999999999987765432211 001100000
Q ss_pred ----hhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 005492 587 ----LFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636 (694)
Q Consensus 587 ----~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~ 636 (694)
+.+.+............+..+.+|+.+||+.+|++|||+.||++.|+.++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 01111111111111233457899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.24 Aligned_cols=262 Identities=24% Similarity=0.367 Sum_probs=197.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEc--CCcEEEEEEccccC--hhhHHHHHHHHHHHhhc---cCCcceeEEeEEee-----
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT--DGRIVAVKKSKLVD--ETNVEQFINEVVILSQI---NHRNIVKLLGCCLE----- 427 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~g~~~~----- 427 (694)
++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 36889999876432 22345567787777766 69999999999863
Q ss_pred CCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecC
Q 005492 428 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 507 (694)
Q Consensus 428 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFG 507 (694)
....++||||++ ++|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346789999996 699999876432 35899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhc--
Q 005492 508 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN-- 585 (694)
Q Consensus 508 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 585 (694)
+++..... .......|++.|+|||.+....++.++||||||+++|||++|+.||......+ ....+.......
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~ 230 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGE 230 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCCh
Confidence 99765432 22334568999999999998899999999999999999999999997654322 111111111000
Q ss_pred -chh-------hhhhhh---hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 586 -RLF-------EILDAR---VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 586 -~~~-------~~~d~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
... ..+... ............+.+|+.+||+.+|++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 000000 0011112234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.72 Aligned_cols=261 Identities=29% Similarity=0.474 Sum_probs=206.5
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeC-C
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVD-ETNVEQFINEVVILSQI-NHRNIVKLLGCCLET-E 429 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~-~ 429 (694)
.++|++.+.||+|+||.||+|... .++.||+|+++... ....+.+..|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457999999999999999999743 24789999887532 33456788999999999 899999999988755 4
Q ss_pred ccEEEEEeCCCCChHHHHhcccC---------------------------------------------------------
Q 005492 430 VPLLVYEFIPNGTLYQYIHNQIE--------------------------------------------------------- 452 (694)
Q Consensus 430 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 452 (694)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999999865321
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce-eeeeecCCCCC
Q 005492 453 -EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYV 530 (694)
Q Consensus 453 -~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~ 530 (694)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+....... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 125899999999999999999999998 9999999999999999999999999998764332221 22234567899
Q ss_pred CCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHH
Q 005492 531 DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVAT 609 (694)
Q Consensus 531 aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 609 (694)
|||++.+..++.++|||||||+||||++ |..||......+. +...+..+.. ...+.....++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTR---------MRAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCC---------CCCCccCCHHHHH
Confidence 9999999999999999999999999998 9999875433221 1111211111 1111233456889
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHhcccc
Q 005492 610 LAKRCLNLNGKMRPTMKEVAFELGGIRT 637 (694)
Q Consensus 610 li~~cl~~~p~~RPt~~evl~~L~~l~~ 637 (694)
++.+||+.+|++||++.||+++|+++..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=339.56 Aligned_cols=252 Identities=24% Similarity=0.308 Sum_probs=198.2
Q ss_pred CCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
.|+..+.||+|+||+||+|.... ++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58889999999999999998754 889999988642 33456678999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999997643 4899999999999999999999999 9999999999999999999999999976431100
Q ss_pred c----------------------------------------------ceeeeeecCCCCCCCcccccCCCCceeeEEehh
Q 005492 517 T----------------------------------------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFG 550 (694)
Q Consensus 517 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlG 550 (694)
. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001234699999999999988999999999999
Q ss_pred HHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHh--cccCCCCCCCHHHH
Q 005492 551 VVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRC--LNLNGKMRPTMKEV 628 (694)
Q Consensus 551 vll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~c--l~~~p~~RPt~~ev 628 (694)
|+||||++|+.||......+. ....+.......+ ........++.+|+.++ +..++..||++.++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~-------~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTET------QLKVINWENTLHI-------PPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHH------HHHHHccccccCC-------CCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 999999999999976443221 1111110000000 00012234577888884 45566669999999
Q ss_pred HHH
Q 005492 629 AFE 631 (694)
Q Consensus 629 l~~ 631 (694)
+.+
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=337.25 Aligned_cols=246 Identities=26% Similarity=0.323 Sum_probs=202.2
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC--CcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD--GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l 433 (694)
.++|+..+.||+|+||.||+|..++ +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568999999999999999998654 368999987542 23456678899999999999999999999999999999
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999997643 4899999999999999999999999 9999999999999999999999999997653
Q ss_pred cCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhh
Q 005492 514 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDA 593 (694)
Q Consensus 514 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 593 (694)
.. .....||+.|+|||++.+..++.++|||||||+||||++|+.||...+... ....+..+..
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~~~~i~~~~~------ 245 (340)
T PTZ00426 183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-------IYQKILEGII------ 245 (340)
T ss_pred CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCC------
Confidence 22 234568999999999999889999999999999999999999997543211 1111111110
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005492 594 RVLKEAKKEGIMTVATLAKRCLNLNGKMRP-----TMKEVAFE 631 (694)
Q Consensus 594 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 631 (694)
..+......+.+++.+||+.+|.+|+ ++++++++
T Consensus 246 ----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01112234577999999999999995 78887765
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=340.57 Aligned_cols=256 Identities=23% Similarity=0.324 Sum_probs=202.2
Q ss_pred HHHhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccc---cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCcc
Q 005492 356 EKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 431 (694)
Q Consensus 356 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~ 431 (694)
....++|+..+.||+|+||.||++.... ++.+|+|.+.. ......+.+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 3345789999999999999999999865 78999998754 2233455688999999999999999999999999999
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 9999999999999999653 3889999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCcceeeeeecCCCCCCCcccccC----CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcch
Q 005492 512 VMVDQTHLTTKVQGTFGYVDPEYFQSS----QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 587 (694)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (694)
.............||+.|+|||++... .++.++||||||++||||++|+.||......+ .+...+.....
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~~i~~~~~~ 265 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYSKIMDHKNS 265 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCcc
Confidence 643322223345699999999998754 37899999999999999999999997543211 11111111110
Q ss_pred hhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005492 588 FEILDARVLKEAKKEGIMTVATLAKRCLNLNGKM--RPTMKEVAFE 631 (694)
Q Consensus 588 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~ 631 (694)
..+ .........+.+++.+||..++.+ ||++.|++++
T Consensus 266 ~~~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 LNF-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cCC-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000 001123456778999999855544 8899998876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=329.24 Aligned_cols=262 Identities=28% Similarity=0.434 Sum_probs=209.9
Q ss_pred HHHhcCCCccceeeeeCcEEEEEEEEcC------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEee
Q 005492 356 EKATDNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLE 427 (694)
Q Consensus 356 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~ 427 (694)
+...++|+..+.||+|+||.||++...+ ...+|+|.+... ......++.+|+.+++++ +|+||+++++++.+
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3445678899999999999999998643 367999988753 334556789999999999 89999999999999
Q ss_pred CCccEEEEEeCCCCChHHHHhccc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEE
Q 005492 428 TEVPLLVYEFIPNGTLYQYIHNQI-------------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANIL 494 (694)
Q Consensus 428 ~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIl 494 (694)
.+..+++|||+++|+|.++++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 999999999999999999997531 2346899999999999999999999998 999999999999
Q ss_pred ECCCCcEEEeecCCccccccCCcc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCc
Q 005492 495 LDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDK 572 (694)
Q Consensus 495 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~ 572 (694)
+++++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++ |..||......+
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 242 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-- 242 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--
Confidence 999999999999999876432221 1222235678999999998999999999999999999998 889986543322
Q ss_pred cHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 005492 573 SLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636 (694)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~ 636 (694)
....+..+. ....+......+.+|+.+||+.+|++|||+.|+++.|+.+.
T Consensus 243 -----~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 -----LFKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -----HHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111221111 11112233456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=328.03 Aligned_cols=256 Identities=25% Similarity=0.459 Sum_probs=205.8
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-----CCcEEEEEEccc-cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-----DGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l 433 (694)
+.|++.+.||+|+||+||+|... .+..+|+|.++. ........+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 46788899999999999999852 467899999875 333445778999999999999999999999999999999
Q ss_pred EEEeCCCCChHHHHhcccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCC
Q 005492 434 VYEFIPNGTLYQYIHNQIE--------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY 499 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~ 499 (694)
||||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999964321 234789999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCccccccCCc-ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHH
Q 005492 500 RAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGY 577 (694)
Q Consensus 500 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~ 577 (694)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||++||||++ |..||......+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999976543221 12223335678999999998889999999999999999998 888986543221
Q ss_pred HHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005492 578 FLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGG 634 (694)
Q Consensus 578 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 634 (694)
....+...... ..+...+..+.+++.+||+.+|.+||++.+|+++|+.
T Consensus 235 ~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 12222221111 1112234568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=331.28 Aligned_cols=242 Identities=27% Similarity=0.373 Sum_probs=196.4
Q ss_pred ceeeeeCcEEEEEEEEc----CCcEEEEEEcccc----ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 366 RILGQGGQGTVYKGMLT----DGRIVAVKKSKLV----DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
+.||+|+||.||++... .++.||||.++.. .......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999853 4789999987642 223345678899999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++++|.+++.... .+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 99999999997643 4788999999999999999999999 9999999999999999999999999987543222
Q ss_pred ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
.......||+.|+|||++.+..++.++||||||++||||++|+.||......+ ....+..+..
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-------~~~~~~~~~~---------- 217 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-------TIDKILKGKL---------- 217 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC----------
Confidence 22334568999999999999899999999999999999999999997543211 1111111110
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRP-----TMKEVAFE 631 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 631 (694)
..+......+.+++.+||+.+|++|| ++.+++++
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11122345678999999999999999 78887764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.08 Aligned_cols=252 Identities=23% Similarity=0.299 Sum_probs=200.8
Q ss_pred CCCccceeeeeCcEEEEEEEEc----CCcEEEEEEcccc----ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCcc
Q 005492 361 NYNANRILGQGGQGTVYKGMLT----DGRIVAVKKSKLV----DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP 431 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~ 431 (694)
+|++.+.||+|+||.||++... +++.||+|.+... .....+.+..|+.+++++ +|+||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788999999999999998853 4789999987642 223456688899999999 599999999999999999
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999997542 4899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCcceeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhh
Q 005492 512 VMVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590 (694)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (694)
.............||+.|+|||++.+. .++.++||||||++||||++|+.||......... ..+...+...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~~----- 226 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILKC----- 226 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhcC-----
Confidence 544333334445699999999999865 4789999999999999999999999754332211 1111111100
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005492 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRP-----TMKEVAFE 631 (694)
Q Consensus 591 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 631 (694)
++ ..+......+.+++.+||+.||++|| ++.+++++
T Consensus 227 -~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 -DP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -CC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 01 11122345678999999999999999 66677754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=329.48 Aligned_cols=264 Identities=24% Similarity=0.344 Sum_probs=200.6
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
.++|++.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999986 58899999887533 2334567889999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 68888887543 24899999999999999999999999 9999999999999999999999999987543221
Q ss_pred cceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchh------h
Q 005492 517 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF------E 589 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 589 (694)
.......+++.|+|||++.+ ..++.++||||||++||||++|+.||....... ................ .
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhh
Confidence 12233457899999999865 458899999999999999999999997643211 1111111111000000 0
Q ss_pred --hhh---------hhhhhhhh-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 590 --ILD---------ARVLKEAK-KEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 590 --~~d---------~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..+ ..+..... ......+.+|+.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000 00000000 0112457899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=314.21 Aligned_cols=265 Identities=21% Similarity=0.242 Sum_probs=207.2
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChh--hHHHHHHHHHHHhhccCCcceeEEeEEeeC--CccEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET--NVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLV 434 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lv 434 (694)
++|+..+.|++|.||.||+|+++. ++.||+|+++..... ---..++||.+|.+.+|||||.+-.+..-. +..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 468889999999999999999764 889999998864322 123468999999999999999999887643 578999
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
|||++. +|..+++.-. .++...++.-++.|+++||+|||.+. |+|||||++|+|+...|.+||+||||||.+..
T Consensus 156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999987 8999998754 36899999999999999999999999 99999999999999999999999999998875
Q ss_pred CCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhh---
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI--- 590 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 590 (694)
... ..+...-|..|.|||++.+ ..|+.+.|+||+|||+.||+++++-|.+....++.+.+........+.-+..+
T Consensus 230 p~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 230 PLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred Ccc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 533 3455667999999999876 56999999999999999999999998877654433333222222111111100
Q ss_pred -----------hhhhhhhhhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 591 -----------LDARVLKEAKKE-GIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 591 -----------~d~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.-..+...+... ..+.-.+|+..+|..||.+|.|+.|.+++
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 001111111111 23567799999999999999999998875
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=337.22 Aligned_cols=264 Identities=26% Similarity=0.385 Sum_probs=198.2
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC-----ccE
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETE-----VPL 432 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~-----~~~ 432 (694)
+|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999976 5899999987642 2334567899999999999999999999986443 479
Q ss_pred EEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccc
Q 005492 433 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 512 (694)
Q Consensus 433 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~ 512 (694)
+||||+. ++|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68999887542 4899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCcc--eeeeeecCCCCCCCccccc--CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHH--------HHH
Q 005492 513 MVDQTH--LTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY--------FLQ 580 (694)
Q Consensus 513 ~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~--------~~~ 580 (694)
...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||.............. ...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 332211 1233568999999999876 6789999999999999999999999976432211000000 000
Q ss_pred Hhhhcchhhhhhh---hhh---hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 581 AINENRLFEILDA---RVL---KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 581 ~~~~~~~~~~~d~---~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+......+.+.. ... .+........+.+++.+||+.+|++||++.|++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000001000 000 00001223567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.33 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=200.1
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccc---cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|++.+.||+|+||+||++.... ++.||+|.+.. ......+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 468899999999999999999764 88999998764 22334566889999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++|+|.+++.+... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999976322 4899999999999999999999999 999999999999999999999999998765443
Q ss_pred CcceeeeeecCCCCCCCccccc-----CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (694)
.........||+.|+|||++.. ..++.++||||||++||||++|+.||......+ .....+.......+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~~ 229 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKEHFQF 229 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCcccC
Confidence 3333334569999999999863 457889999999999999999999996543221 11111111111111
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 005492 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGK--MRPTMKEVAFE 631 (694)
Q Consensus 591 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~--~RPt~~evl~~ 631 (694)
.. .....+..+.+++.+||..+++ .||++.+++++
T Consensus 230 ~~------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 PP------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CC------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 0112345678889888865443 37899998876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=322.67 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=205.7
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
.++|++.++||+|+||.||+|.+.+...||+|+++... ...+.|.+|+.++++++||||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35689999999999999999998777789999987532 23467899999999999999999999874 45679999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999997642 235899999999999999999999999 999999999999999999999999999766433322
Q ss_pred eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
......++..|+|||++....++.++||||||+++|||++ |+.||......+ ....+..+. ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-------~~~~~~~~~---------~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGY---------RM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-------HHHHHhcCC---------CC
Confidence 2223346678999999998899999999999999999999 888886543221 111111110 00
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
......+..+.+|+.+|++.+|++||++.++++.|+..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11223456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=338.21 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=198.2
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|.+.++||+|+||+||++... +++.||||.+... .....+.+.+|++++++++||||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999875 5889999987542 2334567889999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999997542 4899999999999999999999999 999999999999999999999999998633210
Q ss_pred Cc------------c----------------------------------eeeeeecCCCCCCCcccccCCCCceeeEEeh
Q 005492 516 QT------------H----------------------------------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSF 549 (694)
Q Consensus 516 ~~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSl 549 (694)
.. . ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0 0012358999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCC---CCHH
Q 005492 550 GVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMR---PTMK 626 (694)
Q Consensus 550 Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~ 626 (694)
||+||||++|+.||......+ .+...........+.+ .......+.+|+.+||. +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHE------TYRKIINWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHH------HHHHHHccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 999999999999997544321 1111111000000000 01123467899999997 66665 5999
Q ss_pred HHHHH
Q 005492 627 EVAFE 631 (694)
Q Consensus 627 evl~~ 631 (694)
|++++
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=331.55 Aligned_cols=252 Identities=29% Similarity=0.394 Sum_probs=215.1
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCc-cEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEV-PLLV 434 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~-~~lv 434 (694)
.++|...+++|+|+||.++..+.+ ++..+++|++.... ....+...+|+.++++++|||||.+.+.+.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367889999999999999998866 47889999877633 3344578899999999999999999999999998 8999
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
|+|++||+|.+.|.+.. ...++++.+..|+.|++.|+.|||+.. |+|||||+.|||++.+..+||+|||+|+.+..
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999998865 456999999999999999999999888 99999999999999999999999999998865
Q ss_pred CCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
+. .......||+.||.||.+.+.+|..|+|||||||++|||.+-+++|...+... ...+.. . .
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li~ki~-~---------~ 221 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LILKIN-R---------G 221 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------HHHHHh-h---------c
Confidence 54 34556779999999999999999999999999999999999999998755432 111111 1 1
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.....+.....++..|+..||+.+|..||++.+++.+
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1223345667789999999999999999999999976
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=350.38 Aligned_cols=251 Identities=25% Similarity=0.317 Sum_probs=205.5
Q ss_pred CCCccceeeeeCcEEEEEEEEcC--CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD--GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
.|...+.||+|+||.||+|.... ++.||+|............+.+|+.+++.++|||||++++++.+.+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 48889999999999999998643 5788999876666666677889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcc-cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 439 PNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 439 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
++|+|.++|+.. ....++++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999998753 23346899999999999999999999999 99999999999999999999999999986643221
Q ss_pred -ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhh
Q 005492 518 -HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596 (694)
Q Consensus 518 -~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 596 (694)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+..+...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-------~~~~~~~~~~~-------- 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-------IMQQVLYGKYD-------- 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC--------
Confidence 12334568999999999999999999999999999999999999996533211 11111111110
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005492 597 KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAF 630 (694)
Q Consensus 597 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 630 (694)
..+......+.+|+.+||+.+|++||++.+++.
T Consensus 290 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 111223456889999999999999999999875
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=328.44 Aligned_cols=261 Identities=26% Similarity=0.449 Sum_probs=207.0
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-C--cEEEEEEccc-cChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCccEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-G--RIVAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lv 434 (694)
++|++.+.||+|+||.||+|...+ + ..+++|.++. ......+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999999764 3 3478888774 3344567899999999999 799999999999999999999
Q ss_pred EEeCCCCChHHHHhcccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcE
Q 005492 435 YEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA 501 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~ 501 (694)
+||+++++|.++++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999976321 124889999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHH
Q 005492 502 KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQ 580 (694)
Q Consensus 502 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 580 (694)
||+|||++...... ........+..|+|||++....++.++||||||+++|||++ |..||......+ ...
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LYE 229 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHH
Confidence 99999998643211 11111223457999999998899999999999999999997 999996543321 111
Q ss_pred HhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccccCC
Q 005492 581 AINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGA 641 (694)
Q Consensus 581 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~~~ 641 (694)
.+..+ .....+...+..+.+|+.+||+.+|.+||++.++++.|+.+......
T Consensus 230 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 230 KLPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 11111 11111223345688999999999999999999999999887765543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=339.98 Aligned_cols=252 Identities=26% Similarity=0.369 Sum_probs=200.9
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|+..+.||+|+||+||++... +++.||||++... .......+.+|+.++..++||||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999976 4899999988642 2344567889999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999997643 4899999999999999999999999 999999999999999999999999998754321
Q ss_pred Ccc-------------------------------------eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh
Q 005492 516 QTH-------------------------------------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 558 (694)
Q Consensus 516 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt 558 (694)
... ......||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0012358999999999999999999999999999999999
Q ss_pred CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 005492 559 GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPT---MKEVAFE 631 (694)
Q Consensus 559 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~~ 631 (694)
|..||......+ .............+.. .......+.+|+.+|+. +|.+|++ +.|++++
T Consensus 235 G~~Pf~~~~~~~------~~~~i~~~~~~~~~~~-------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQE------TYRKIINWKETLQFPD-------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHH------HHHHHHcCCCccCCCC-------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999997544321 1111111000000000 01123467789999996 9999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.08 Aligned_cols=260 Identities=25% Similarity=0.363 Sum_probs=210.0
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|++.+.||+|+||.||+|... +++.||||.+.. ........+.+|+.++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999975 589999997654 23344567899999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 436 EFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999986432 2235899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ....+......
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~-~~~~~~~~~~~------ 226 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFS-LCQKIEQCDYP------ 226 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHH-HHHHHhcCCCC------
Confidence 221 122345788999999999888999999999999999999999998643321 111 11111111111
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~ 636 (694)
.......+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 227 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 --PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1111234466889999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=320.24 Aligned_cols=247 Identities=28% Similarity=0.440 Sum_probs=198.3
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCCh
Q 005492 366 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL 443 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gsL 443 (694)
+.||+|+||.||+|... +++.+|+|..... .......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999975 5889999986543 344567799999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee-ee
Q 005492 444 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT-TK 522 (694)
Q Consensus 444 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-~~ 522 (694)
.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......... ..
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 99997543 24899999999999999999999999 99999999999999999999999999875432111110 11
Q ss_pred eecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhH
Q 005492 523 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKK 601 (694)
Q Consensus 523 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 601 (694)
...+..|+|||.+....++.++||||||+++|||++ |..||......+ ....+... .....+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~---------~~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQG---------VRLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcC---------CCCCCcc
Confidence 123457999999999999999999999999999998 888886543221 11111111 1111122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 602 EGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 602 ~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
..+..+.+++.+||+.+|++||++.+|+++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 33457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.63 Aligned_cols=255 Identities=26% Similarity=0.462 Sum_probs=204.0
Q ss_pred CCccceeeeeCcEEEEEEEEcC----CcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCc-----
Q 005492 362 YNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEV----- 430 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~----- 430 (694)
|.+.+.||+|+||.||+|.... +..||+|+++.. .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998753 367999988753 33456789999999999999999999999876654
Q ss_pred -cEEEEEeCCCCChHHHHhccc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeec
Q 005492 431 -PLLVYEFIPNGTLYQYIHNQI---EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 506 (694)
Q Consensus 431 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DF 506 (694)
.++++||+++++|..++.... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999986532 2236899999999999999999999998 999999999999999999999999
Q ss_pred CCccccccCCcce-eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhh
Q 005492 507 GTSRSVMVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINE 584 (694)
Q Consensus 507 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 584 (694)
|+++......... .....++..|+|||.+....++.++||||||+++|||++ |..||......+ ....+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~-------~~~~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-------IYDYLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc
Confidence 9998664332221 112235678999999998999999999999999999999 889986543221 1111111
Q ss_pred cchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 585 NRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 585 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
+.. ...+...+..+.+++.+||+.+|++||++.||++.|+++
T Consensus 231 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 111223456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=333.22 Aligned_cols=260 Identities=27% Similarity=0.403 Sum_probs=203.8
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
.++|+..++||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++||||+++++++.+.+..+||||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999986 4788999987653 33445779999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
|+++++|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999997642 489999999999999999999985 5 999999999999999999999999998755322
Q ss_pred CcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh-----------
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE----------- 584 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 584 (694)
......|+..|+|||++.+..++.++||||||+++|||++|+.||......+. .. +......
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL---EL-MFGCPVEGDPAESETSPR 230 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH---HH-HhcCcccCCccccccCcc
Confidence 12234589999999999998999999999999999999999999965432110 00 0000000
Q ss_pred ------------------cchhhhhhhhhhhh---h-hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 585 ------------------NRLFEILDARVLKE---A-KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 585 ------------------~~~~~~~d~~~~~~---~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.....+.+...... . ......++.+|+.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00000000000000 0 00123568899999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=325.48 Aligned_cols=260 Identities=24% Similarity=0.424 Sum_probs=210.3
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEee-CCcc
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-----GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLE-TEVP 431 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~-~~~~ 431 (694)
.++|...+.||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.+ ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678899999999999999999876 688999987653 34556778999999999999999999998876 4678
Q ss_pred EEEEEeCCCCChHHHHhcccCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeec
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEE-----FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 506 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DF 506 (694)
++++||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999999764322 46899999999999999999999998 999999999999999999999999
Q ss_pred CCccccccCCcce-eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhh
Q 005492 507 GTSRSVMVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINE 584 (694)
Q Consensus 507 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 584 (694)
|+++.+....... .....++..|+|||++....++.++||||||+++||+++ |+.||...+..+ ....+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-------MAAYLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHc
Confidence 9998664333221 122345678999999998899999999999999999999 999997543321 1111111
Q ss_pred cchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 005492 585 NRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRT 637 (694)
Q Consensus 585 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~ 637 (694)
+. ........+..+.+++.+||+.+|++||++.+|++.|+.+.+
T Consensus 235 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 GY---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CC---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 10 000111234568899999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.73 Aligned_cols=237 Identities=24% Similarity=0.341 Sum_probs=189.0
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHH-HHhhccCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVV-ILSQINHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
++||+|+||.||++... +++.||+|.+... .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999986 4889999987642 2223445555654 67889999999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT 153 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence 9999988753 24889999999999999999999999 9999999999999999999999999987532222 223
Q ss_pred eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAK 600 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 600 (694)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+..+ +...+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~~----------~~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-------MYDNILHKP----------LQLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-------HHHHHhcCC----------CCCC
Confidence 34568999999999999999999999999999999999999997543211 111111111 0111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 005492 601 KEGIMTVATLAKRCLNLNGKMRPTMK 626 (694)
Q Consensus 601 ~~~~~~l~~li~~cl~~~p~~RPt~~ 626 (694)
......+.+++.+||+.+|.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 22345688999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=317.98 Aligned_cols=247 Identities=28% Similarity=0.458 Sum_probs=200.5
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCChH
Q 005492 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 444 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 444 (694)
++||+|+||.||+|...+++.+|+|...... ......+.+|++++++++||||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998889999999876543 333457899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcceeeeee
Q 005492 445 QYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ 524 (694)
Q Consensus 445 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 524 (694)
+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++...............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 9987643 24899999999999999999999999 999999999999999999999999998754322221222223
Q ss_pred cCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHH
Q 005492 525 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEG 603 (694)
Q Consensus 525 gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 603 (694)
++..|+|||++....++.++||||||+++|||++ |..||....... ....+..+. ....+...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~~~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGY---------RMSCPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCC---------CCCCCCCC
Confidence 4678999999999999999999999999999998 999986543221 111111111 00111223
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 604 IMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 604 ~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
+..+.+++.+||+.+|++||++.++++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=329.83 Aligned_cols=243 Identities=27% Similarity=0.415 Sum_probs=194.0
Q ss_pred ceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
+.||+|+||.||++.... ++.+|+|.++.. .....+.+..|+.++.++ +||||+++++++.+.+..+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 479999999999999764 789999988752 334456688899988877 899999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
|+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTT 153 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccc
Confidence 99999887542 4899999999999999999999999 9999999999999999999999999987543222 122
Q ss_pred eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCcc--CccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE--DKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......+....+..... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------C
Confidence 34568999999999999999999999999999999999999996432221 11112222222211111 1
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCH
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTM 625 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~ 625 (694)
.+......+.+++.+||+.||.+||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 122334567899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=325.34 Aligned_cols=257 Identities=28% Similarity=0.420 Sum_probs=204.7
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEcC------CcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCc
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEV 430 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~ 430 (694)
.+++|.+.+.||+|++|.||+|.+.+ +..||+|...... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678999999999999999999764 5679999876433 3345679999999999999999999999999999
Q ss_pred cEEEEEeCCCCChHHHHhcccC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCC---cEEE
Q 005492 431 PLLVYEFIPNGTLYQYIHNQIE----EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY---RAKV 503 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~---~~kl 503 (694)
.++||||+++++|.++++.... ...+++..+++++.||+.||+|||+.+ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976532 125899999999999999999999999 99999999999998654 6999
Q ss_pred eecCCccccccCCcce-eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHH
Q 005492 504 SDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQA 581 (694)
Q Consensus 504 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 581 (694)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||......+ ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-------~~~~ 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-------VMEF 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence 9999998663221111 111223568999999999999999999999999999997 999987544322 1111
Q ss_pred hhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 582 INENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 582 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
+.... ....+...+..+.+++.+||+.+|++||++.+|+++|.
T Consensus 234 ~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGGG---------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11110 01112233457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=329.95 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=199.8
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|++.+.||+|+||.||++.... ++.||+|.+... .......+.+|+.++..++|+||+++++++.+.+..+|||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 478899999999999999999764 788999987642 2334556888999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++|+|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999986422 4899999999999999999999999 999999999999999999999999999766543
Q ss_pred CcceeeeeecCCCCCCCccccc-----CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (694)
.........||+.|+|||++.. ..++.++||||||++||||++|+.||...+..+ .............
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~- 228 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEERFQ- 228 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCccc-
Confidence 3333334569999999999875 567899999999999999999999997543221 1111111110000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005492 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKM--RPTMKEVAFE 631 (694)
Q Consensus 591 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~ 631 (694)
+... ....+..+.+++.+||..++.+ |+++.+++++
T Consensus 229 ~p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 FPSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0000 1123456888999999866544 4678877754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.20 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=198.2
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
++||+|+||.||++... +++.||+|.++.. .....+.+..|..++.++ +||||+++++++.+.+..+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999976 4889999988752 233456688899999998 799999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTT 153 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccc
Confidence 99999987542 4999999999999999999999999 9999999999999999999999999987532221 223
Q ss_pred eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCcc--CccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE--DKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......+..+.+..... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------C
Confidence 34568999999999999999999999999999999999999997543222 11112222222222111 1
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPT------MKEVAFE 631 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt------~~evl~~ 631 (694)
.+......+.+++.+||+.+|.+||+ +.+++++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11223456889999999999999998 5666543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=324.62 Aligned_cols=267 Identities=29% Similarity=0.443 Sum_probs=203.7
Q ss_pred CCccceeeeeCcEEEEEEEE-----cCCcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC--ccEE
Q 005492 362 YNANRILGQGGQGTVYKGML-----TDGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETE--VPLL 433 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~--~~~l 433 (694)
|+..+.||+|+||+||++.. .+++.||+|..+... ......|.+|++++++++||||+++++++.+.+ ..++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988653 357889999887543 335677899999999999999999999987643 5789
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
||||+++++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999999999753 4999999999999999999999999 9999999999999999999999999998664
Q ss_pred cCCcc--eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhh
Q 005492 514 VDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591 (694)
Q Consensus 514 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (694)
..... ......++..|+|||.+....++.++||||||++++||++|..|+........ ..............+.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhh
Confidence 32211 11222356679999999988999999999999999999999999865432110 0000000000001111111
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~ 636 (694)
+.......+...+..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111111112234567999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.56 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=197.9
Q ss_pred CCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
+|++.+.||+|+||.||++.... ++.||||.+... .......+.+|+.++++++||||+++++.+.+.+..+||||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 68899999999999999999764 889999987642 22345678899999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999997642 4889999999999999999999999 9999999999999999999999999975321000
Q ss_pred ------------------------------------------cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHH
Q 005492 517 ------------------------------------------THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLV 554 (694)
Q Consensus 517 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ 554 (694)
........||+.|+|||++.+..++.++|||||||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00011246899999999999999999999999999999
Q ss_pred HHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 005492 555 EILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRP---TMKEVAFE 631 (694)
Q Consensus 555 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~evl~~ 631 (694)
||++|+.||......+. ............+ .........+.+++.+|+ .+|.+|+ ++.+++++
T Consensus 236 ell~G~~Pf~~~~~~~~------~~~i~~~~~~~~~-------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAET------QLKVINWETTLHI-------PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHH------HHHHhccCccccC-------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999976543221 1111100000000 001122345677888876 5999999 88888865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=331.27 Aligned_cols=245 Identities=25% Similarity=0.363 Sum_probs=195.3
Q ss_pred CCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHH---hhccCCcceeEEeEEeeCCccEEE
Q 005492 362 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVIL---SQINHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l---~~l~h~nIv~l~g~~~~~~~~~lv 434 (694)
|++.+.||+|+||.||++... +++.||||.++.. .....+.+.+|++++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999976 4899999998642 233445667776655 566899999999999999999999
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
|||+++++|..+++.. .+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999999988643 4899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
.. .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ....+.....
T Consensus 154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~~~------- 218 (324)
T cd05589 154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-------VFDSIVNDEV------- 218 (324)
T ss_pred CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC-------
Confidence 22 22334568999999999999999999999999999999999999997543221 1111111110
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPT-----MKEVAFE 631 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 631 (694)
..+...+..+.+++.+||+.+|.+||+ +.+++++
T Consensus 219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 011223456789999999999999994 5555543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=326.30 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=206.3
Q ss_pred CCCccceeeeeCcEEEEEEEEcC------CcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l 433 (694)
+|++.+.||+|+||.||+|.... ...+|+|.+.... ....+++.+|+.+++.++||||+++++.+.+.+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999998642 3568888876533 3446789999999999999999999999999999999
Q ss_pred EEEeCCCCChHHHHhccc---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccccccc
Q 005492 434 VYEFIPNGTLYQYIHNQI---------------------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSAN 492 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~N 492 (694)
|+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999987521 1135889999999999999999999998 9999999999
Q ss_pred EEECCCCcEEEeecCCccccccCCcce-eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCcc
Q 005492 493 ILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 570 (694)
Q Consensus 493 Ill~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~ 570 (694)
||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |..||......+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999997654322211 122335678999999988899999999999999999998 999986543221
Q ss_pred CccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 005492 571 DKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRT 637 (694)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~ 637 (694)
........ .....+...+..+.+++.+||+.+|++||++.++++.|+++..
T Consensus 238 -------~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 -------LFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -------HHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11121111 0111122334568899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=317.57 Aligned_cols=267 Identities=26% Similarity=0.343 Sum_probs=211.1
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcc--ccChhhHHHHHHHHHHHhhccCCcceeEEeEEee-----CC
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSK--LVDETNVEQFINEVVILSQINHRNIVKLLGCCLE-----TE 429 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~-----~~ 429 (694)
....|...+.||+|+||.|..+..+ +|+.||||++. .......++-++|+++|+.++|+||+.+++.+.- -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456666789999999999999976 48999999987 4566778889999999999999999999999875 34
Q ss_pred ccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCc
Q 005492 430 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS 509 (694)
Q Consensus 430 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla 509 (694)
..|+|+|+| ..+|...|+... .|+......++.|+++||.|+|+.+ |+||||||+|+|++.+..+||+|||||
T Consensus 100 DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 779999999 568999998653 3999999999999999999999999 999999999999999999999999999
Q ss_pred cccccC-CcceeeeeecCCCCCCCcccc-cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcch
Q 005492 510 RSVMVD-QTHLTTKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 587 (694)
Q Consensus 510 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (694)
+..... .....+....|..|.|||++. ...|+.+.||||.||+|.||++|++-|.+.+.-.+..++........+..+
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 987532 122345567899999999875 468999999999999999999999999877655444333322222211111
Q ss_pred hhhhhhh--------------hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 588 FEILDAR--------------VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 588 ~~~~d~~--------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..+-... ......+...+...+|+.+||..||.+|+|++|.+++
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111100 0111122334568899999999999999999999875
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=329.06 Aligned_cols=237 Identities=25% Similarity=0.371 Sum_probs=190.0
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHH-HHhhccCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVV-ILSQINHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
+.||+|+||+||++... +++.||+|.+... ......++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999986 5899999987642 2223345555555 56789999999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTT 153 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcc
Confidence 99999997542 5899999999999999999999999 999999999999999999999999998754222 1223
Q ss_pred eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAK 600 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 600 (694)
....||+.|+|||++.+..++.++||||||++||||++|+.||...+..+ ....+..... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~----------~~~ 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-------MYDNILNKPL----------RLK 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCCC----------CCC
Confidence 34568999999999999999999999999999999999999997543221 1111111110 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 005492 601 KEGIMTVATLAKRCLNLNGKMRPTMK 626 (694)
Q Consensus 601 ~~~~~~l~~li~~cl~~~p~~RPt~~ 626 (694)
......+.+++.+||+.+|.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 12345688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=324.06 Aligned_cols=258 Identities=23% Similarity=0.442 Sum_probs=203.4
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-Cc----EEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GR----IVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l 433 (694)
++|+..+.||+|+||+||+|.+.. ++ .+++|...... .....++..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 457778999999999999999743 44 47888775432 234567888999999999999999999875 455789
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
++||+++|+|.++++.... .+++..++.|+.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999976432 5899999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCcc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhh
Q 005492 514 VDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591 (694)
Q Consensus 514 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (694)
..... ......++..|+|||.+....++.++||||||+++|||++ |+.||......+ ....+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~-- 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERLA-- 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCC--
Confidence 33221 2233446778999999998999999999999999999998 999987543321 112222211110
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccccc
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~ 639 (694)
. +......+.+++.+||..+|++||++.|+++.|..+....
T Consensus 232 ~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 232 Q-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred C-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 0 1112345788999999999999999999999998866543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=332.43 Aligned_cols=253 Identities=24% Similarity=0.328 Sum_probs=197.2
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|+..+.||+|+||+||++.... ++.||||.+... .......+.+|+.++.+++|+||+++++.+.+....+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 468899999999999999998764 889999988642 2334567888999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999997642 5899999999999999999999999 999999999999999999999999998754321
Q ss_pred Cc----------------------------------ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCC
Q 005492 516 QT----------------------------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK 561 (694)
Q Consensus 516 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~ 561 (694)
.. .......||+.|+|||++.+..++.++|||||||+||||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 00 00123469999999999999999999999999999999999999
Q ss_pred CCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 005492 562 PIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLN--LNGKMRPTMKEVAFE 631 (694)
Q Consensus 562 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~--~~p~~RPt~~evl~~ 631 (694)
||......+ ....+......-.+.+. ......+.+++.+++. .++..||++.||+++
T Consensus 235 Pf~~~~~~~-------~~~~i~~~~~~~~~p~~------~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQE-------TYKKVMNWKETLIFPPE------VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHHH-------HHHHHHcCcCcccCCCc------CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 997644322 11111110000001110 0122346677777554 233456899999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.00 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=203.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC-----hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-----ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l 433 (694)
++|+..+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999975 48999999876432 2234678899999999999999999999999999999
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
|+||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999997643 4889999999999999999999999 9999999999999999999999999987654
Q ss_pred cCCccee--eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhh
Q 005492 514 VDQTHLT--TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591 (694)
Q Consensus 514 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (694)
....... ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+ ........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~------- 222 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA------AIFKIATQ------- 222 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH------HHHHHhcc-------
Confidence 3221111 23457789999999999999999999999999999999999986532211 01111111
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
......+......+.+++.+||..+|.+||++.+++++
T Consensus 223 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 --PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01111222344568899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=320.67 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=209.3
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
..++|.+.++||+|+||.||++..++++.+|||.+... ....+++.+|+.++++++|+||+++++++.+....++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 35789999999999999999999888889999988743 23457899999999999999999999999998999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999998753 235899999999999999999999999 99999999999999999999999999876643222
Q ss_pred ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 596 (694)
........+..|+|||.+.+..++.++||||||++++||++ |+.||....... ....+..+. .
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~~---------~ 222 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-------VLEQVERGY---------R 222 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC---------C
Confidence 22222335678999999998899999999999999999998 999986543211 111111110 0
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005492 597 KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGG 634 (694)
Q Consensus 597 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 634 (694)
...+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01111224568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.81 Aligned_cols=241 Identities=25% Similarity=0.369 Sum_probs=193.0
Q ss_pred ceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
+.||+|+||.||+|...+ ++.||+|.++.. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999764 789999987642 233455566777777654 899999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 99999997643 4899999999999999999999999 9999999999999999999999999997643322 223
Q ss_pred eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAK 600 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 600 (694)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+ ....+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~----------~~~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-------LFDSILNDR----------PHFP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC----------CCCC
Confidence 34568999999999999999999999999999999999999997644321 111111110 0111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 005492 601 KEGIMTVATLAKRCLNLNGKMRPTMK-EVAF 630 (694)
Q Consensus 601 ~~~~~~l~~li~~cl~~~p~~RPt~~-evl~ 630 (694)
......+.+++.+||+.+|.+||++. ++++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 22334578999999999999999975 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.84 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=204.5
Q ss_pred cCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCC
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP 439 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~ 439 (694)
++|.+.+.||+|++|.||++....+..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688889999999999999998877789999876432 33567899999999999999999999875 456799999999
Q ss_pred CCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce
Q 005492 440 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519 (694)
Q Consensus 440 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 519 (694)
+++|.++++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999997643 235899999999999999999999999 9999999999999999999999999997654332222
Q ss_pred eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 520 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
.....++..|+|||.+....++.++||||||+++|||++ |+.||......+ ....+..+. ...
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~---------~~~ 223 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-------VLEQVERGY---------RMP 223 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC---------CCC
Confidence 222345678999999998899999999999999999999 899987543221 111111110 001
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGG 634 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 634 (694)
.+...+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 112345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.88 Aligned_cols=246 Identities=30% Similarity=0.451 Sum_probs=198.4
Q ss_pred eeeeeCcEEEEEEEEc---CCcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCC
Q 005492 367 ILGQGGQGTVYKGMLT---DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG 441 (694)
Q Consensus 367 ~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~g 441 (694)
+||+|+||.||+|.++ ++..+|+|+++... ....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 47889999876432 345678999999999999999999999885 45678999999999
Q ss_pred ChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee-
Q 005492 442 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT- 520 (694)
Q Consensus 442 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~- 520 (694)
+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999997542 4899999999999999999999999 99999999999999999999999999987654332211
Q ss_pred -eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 521 -TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 521 -~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
....++..|+|||.+....++.++||||||+++|||++ |+.||......+ ....+..+.. ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~i~~~~~---------~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-------VTQMIESGER---------ME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCC---------CC
Confidence 12224578999999988889999999999999999998 999997543221 1222222111 11
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
.+...+..+.++|.+||+.+|++||++.+|.+.|++.
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1223446688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=337.28 Aligned_cols=248 Identities=25% Similarity=0.341 Sum_probs=195.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
++|+..++||+|+||.||++... +++.||||.+... .....+.+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45667889999999999999976 5899999988653 333456789999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++++|.+.. .+.+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999986532 2567888899999999999999999 9999999999999999999999999998654322
Q ss_pred ceeeeeecCCCCCCCccccc-----CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 592 (694)
.......||..|+|||++.. ...+.++|||||||+||||++|+.||......+ ........ ...
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~-~~~------- 291 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAI-CMS------- 291 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHH-hcc-------
Confidence 12233468999999998743 234568999999999999999999997432221 11111000 000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 593 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
...+........+.+|+.+||+.+|++||++.|++++
T Consensus 292 --~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 --QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011122344568899999999999999999999986
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=338.31 Aligned_cols=251 Identities=23% Similarity=0.291 Sum_probs=196.5
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
.|+..++||+|+||+||+|... +++.+|+|.+... .......+.+|+.++++++||||+++++++.+.+..+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999975 4889999987642 23445678899999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|+++|+|.+++.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999997642 4889999999999999999999999 9999999999999999999999999975321000
Q ss_pred ----------------------------------------------cceeeeeecCCCCCCCcccccCCCCceeeEEehh
Q 005492 517 ----------------------------------------------THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFG 550 (694)
Q Consensus 517 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlG 550 (694)
........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001124589999999999999999999999999
Q ss_pred HHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCC---HHH
Q 005492 551 VVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPT---MKE 627 (694)
Q Consensus 551 vll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~e 627 (694)
|+||||++|+.||...+..+. ............ .........++.+++.+++ .+|.+|++ +.+
T Consensus 236 vil~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~-------~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLET------QMKVINWQTSLH-------IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHH------HHHHHccCCCcC-------CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 999999999999976443210 111111000000 0001122345677888876 59999987 777
Q ss_pred HHHH
Q 005492 628 VAFE 631 (694)
Q Consensus 628 vl~~ 631 (694)
++++
T Consensus 302 i~~h 305 (382)
T cd05625 302 IKAH 305 (382)
T ss_pred HhcC
Confidence 6653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=332.70 Aligned_cols=258 Identities=29% Similarity=0.500 Sum_probs=219.0
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEcC---C--cEEEEEEccc-cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCcc
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLTD---G--RIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 431 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~~---~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~ 431 (694)
..+.....+.||+|-||.||+|.+.+ | -.||||..+. ...++.+.|++|..+|++++|||||+|+|+|.+. ..
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence 33445556789999999999999643 2 3589998887 5667789999999999999999999999999764 56
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
|||||.++-|.|.+||+.+.. .|+...+..++.||..||+|||+.. +|||||..+|||+....=+||+||||+|.
T Consensus 466 WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence 999999999999999998655 4999999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhh
Q 005492 512 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590 (694)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (694)
+..+.....+...-...|||||.+.-..++.+||||.|||.|||++. |.+||.+....+ +...+..+.
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-------VI~~iEnGe---- 609 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-------VIGHIENGE---- 609 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-------eEEEecCCC----
Confidence 87766665556666789999999999999999999999999999997 999998876544 112222221
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 005492 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRT 637 (694)
Q Consensus 591 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~ 637 (694)
+...++.+++.+..|+.+||..+|.+||.+.|+...|..+..
T Consensus 610 -----RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 610 -----RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -----CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 223355778889999999999999999999999988876654
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=328.86 Aligned_cols=244 Identities=27% Similarity=0.396 Sum_probs=203.7
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
.|...+.||.|+||.||-+... +.+.||||++.... ...+.+++.|+..|.+++|||+|.+-|||..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4667889999999999999964 57899999987643 3457789999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|| -|+-.++|.-+. .++.+..+..|..+.+.||+|||+++ .||||||+.||||.+.+.|||+|||.|.....
T Consensus 107 YC-lGSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HH-hccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 99 457777776543 36999999999999999999999999 99999999999999999999999999876533
Q ss_pred cceeeeeecCCCCCCCcccc---cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhh
Q 005492 517 THLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDA 593 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 593 (694)
...+.|||.|||||++. .++|+-|+||||||++..||.-.++|+..++.-. ++..+..+.-.-+-
T Consensus 179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-------ALYHIAQNesPtLq-- 246 (948)
T KOG0577|consen 179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNESPTLQ-- 246 (948)
T ss_pred ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-------HHHHHHhcCCCCCC--
Confidence 33467999999999874 5789999999999999999999999987655322 33444433221111
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005492 594 RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAF 630 (694)
Q Consensus 594 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 630 (694)
..+....+..++..||++-|.+|||..+++.
T Consensus 247 ------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 247 ------SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred ------CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 2456677999999999999999999988764
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.35 Aligned_cols=247 Identities=27% Similarity=0.434 Sum_probs=197.6
Q ss_pred eeeeeCcEEEEEEEEc---CCcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCC
Q 005492 367 ILGQGGQGTVYKGMLT---DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGT 442 (694)
Q Consensus 367 ~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gs 442 (694)
.||+|+||.||+|.+. .+..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 35579999887543 334567999999999999999999999875 457899999999999
Q ss_pred hHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee--
Q 005492 443 LYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT-- 520 (694)
Q Consensus 443 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-- 520 (694)
|.+++.... ..+++..+++++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++....+.....
T Consensus 81 L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999997543 25899999999999999999999999 99999999999999999999999999976543322211
Q ss_pred eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEA 599 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 599 (694)
....++..|+|||.+....++.++||||||+++|||++ |+.||......+ +...+..+.. ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKR---------LDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCC---------CCC
Confidence 11223578999999988889999999999999999996 999997544321 1112221111 111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 600 KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 600 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
+...+.++.+++.+||+.+|++||++.+|++.|+.+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 223456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.42 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=206.3
Q ss_pred cCCCccceeeeeCcEEEEEEEEc------CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l 433 (694)
.+|...++||+|+||.||++... ++..+|+|.+........+.+.+|+++++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999742 356899998887777777889999999999999999999999999999999
Q ss_pred EEEeCCCCChHHHHhcccC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcE
Q 005492 434 VYEFIPNGTLYQYIHNQIE------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA 501 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~ 501 (694)
+|||+++++|.++++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999976432 124889999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccccCCcc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHH
Q 005492 502 KVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFL 579 (694)
Q Consensus 502 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 579 (694)
||+|||+++........ ......+++.|+|||.+....++.++||||||+++|||++ |+.||......+ ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~ 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-------AI 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-------HH
Confidence 99999998765432211 1122335678999999999999999999999999999998 899986543221 11
Q ss_pred HHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 580 QAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 580 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
.....+.. ...+...+..+.+|+.+||+.+|.+||++.+|++.|+
T Consensus 235 ~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ECITQGRE---------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHcCcc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11111100 0111223456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.18 Aligned_cols=254 Identities=24% Similarity=0.415 Sum_probs=207.2
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
.++|+..+.||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++|+||+++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678999999999999999999877888999987643 3345789999999999999999999999887 7789999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999997643 235889999999999999999999998 999999999999999999999999998765433222
Q ss_pred eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
......++..|+|||++....++.++|+||||++++++++ |+.||....... +...+..+.. .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~---------~ 222 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYR---------M 222 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCCCC---------C
Confidence 2223345678999999998899999999999999999999 899986543211 1111111111 1
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGG 634 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 634 (694)
......+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112344568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=333.18 Aligned_cols=242 Identities=23% Similarity=0.325 Sum_probs=197.2
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCC
Q 005492 366 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG 441 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~g 441 (694)
+.||+|+||.||++... +++.||+|.++.. .......+..|+++++.++||||+++++++.+.+..+|||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999975 5889999987642 2344567888999999999999999999999999999999999999
Q ss_pred ChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 442 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 442 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
+|..++.... .+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TM 153 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cc
Confidence 9999987542 48999999999999999999997 67 99999999999999999999999999875432222 22
Q ss_pred eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAK 600 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 600 (694)
....||+.|+|||++.+..++.++||||||++||||++|+.||......+ ....+..... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-------~~~~i~~~~~----------~~p 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEI----------RFP 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-------HHHHHhcCCC----------CCC
Confidence 34569999999999999999999999999999999999999996543221 1111111100 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005492 601 KEGIMTVATLAKRCLNLNGKMRP-----TMKEVAFE 631 (694)
Q Consensus 601 ~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 631 (694)
......+.+|+.+||+.||++|+ ++.+++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 22345678999999999999996 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=339.41 Aligned_cols=264 Identities=26% Similarity=0.429 Sum_probs=209.0
Q ss_pred HHHHhcCCCccceeeeeCcEEEEEEEEc------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcc-CCcceeEEeEEe
Q 005492 355 LEKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVD-ETNVEQFINEVVILSQIN-HRNIVKLLGCCL 426 (694)
Q Consensus 355 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~g~~~ 426 (694)
++...++|.+.++||+|+||.||+|.+. .+..||||+++... ....+.+.+|+.+|.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4445567888999999999999999864 24679999987542 333557899999999997 999999999999
Q ss_pred eCCccEEEEEeCCCCChHHHHhcccC------------------------------------------------------
Q 005492 427 ETEVPLLVYEFIPNGTLYQYIHNQIE------------------------------------------------------ 452 (694)
Q Consensus 427 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 452 (694)
.....++||||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999975321
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccc
Q 005492 453 -----------------------------------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSA 491 (694)
Q Consensus 453 -----------------------------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~ 491 (694)
...+++..++.++.|++.||+|||+.+ |+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 124678889999999999999999988 999999999
Q ss_pred cEEECCCCcEEEeecCCccccccCCcc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCc
Q 005492 492 NILLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTD 569 (694)
Q Consensus 492 NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~ 569 (694)
|||+++++.+||+|||+++........ ......++..|+|||.+....++.++||||||++||||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 999999999999999999865432211 1122346788999999998899999999999999999998 88898654322
Q ss_pred cCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 005492 570 EDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636 (694)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~ 636 (694)
+ .....+..+. ....+......+.+|+.+||+.+|.+||++.+|++.|+++.
T Consensus 349 ~------~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 E------QFYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H------HHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 0111111110 01111223467889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.76 Aligned_cols=250 Identities=29% Similarity=0.464 Sum_probs=207.3
Q ss_pred cCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCC
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP 439 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~ 439 (694)
++|+..+.||+|+||.||++... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 56888999999999999999875 78899999876544 56789999999999999999999999999999999999999
Q ss_pred CCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce
Q 005492 440 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519 (694)
Q Consensus 440 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 519 (694)
+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999976532 25899999999999999999999999 99999999999999999999999999986632211
Q ss_pred eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 520 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
....+..|+|||.+....++.++||||||++++||++ |+.||......+ ....+..+. ...
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~~ 219 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGY---------RME 219 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCC---------CCC
Confidence 2234668999999998899999999999999999997 999986543221 111111110 111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
.+...+..+.+++.+||..+|++||++.+++++|+++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1223346788999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=329.21 Aligned_cols=262 Identities=27% Similarity=0.430 Sum_probs=209.2
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC--------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeC
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD--------GRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLET 428 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~ 428 (694)
.++|.+.+.||+|+||.||++.... ...+|+|.++.. ......++.+|+.+++.+ +||||+++++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3678999999999999999998532 357999988753 234566788999999999 799999999999999
Q ss_pred CccEEEEEeCCCCChHHHHhcccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEE
Q 005492 429 EVPLLVYEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL 495 (694)
Q Consensus 429 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll 495 (694)
+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999976432 135899999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeecCCccccccCCcc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCcc
Q 005492 496 DDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKS 573 (694)
Q Consensus 496 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~ 573 (694)
++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.....++
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--- 250 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 250 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---
Confidence 99999999999998765422111 1122224568999999998899999999999999999998 888886533221
Q ss_pred HHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccccc
Q 005492 574 LVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639 (694)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~ 639 (694)
+...+..... .+.+...+..+.+|+.+||+.+|.+||+|.+|++.|+.+....
T Consensus 251 ----~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 251 ----LFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred ----HHHHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1122222111 1112233457889999999999999999999999999876654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=316.98 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=211.3
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|+..+.||+|+||.||+|... +++.+|+|.++. ......+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999987 689999998753 23344678999999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 436 EFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
||+++++|.+++.... ....+++.+++.++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999987532 2345899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ... ....+..+.....
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~~~~~---- 228 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-LCKKIEKCDYPPL---- 228 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHH-HHhhhhcCCCCCC----
Confidence 221 123345888999999999889999999999999999999999998643311 111 1111111111110
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~ 636 (694)
.....+..+.+++.+||..+|++||++.+|++.|+.+.
T Consensus 229 ----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 ----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 01134457889999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=326.54 Aligned_cols=259 Identities=26% Similarity=0.441 Sum_probs=204.8
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-Cc--EEEEEEcccc-ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCccEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GR--IVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lv 434 (694)
++|++.+.||+|+||.||+|.+++ +. .+|+|+.+.. .......+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 578889999999999999999754 43 4688876643 344567889999999999 899999999999999999999
Q ss_pred EEeCCCCChHHHHhcccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcE
Q 005492 435 YEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA 501 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~ 501 (694)
|||+++++|.++++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999976421 125889999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHH
Q 005492 502 KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQ 580 (694)
Q Consensus 502 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 580 (694)
||+|||+++..... .......++..|+|||++....++.++||||||++|+||++ |..||......+ ...
T Consensus 164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~ 234 (303)
T cd05088 164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE 234 (303)
T ss_pred EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-------HHH
Confidence 99999998643211 11111224567999999988889999999999999999998 999996543321 111
Q ss_pred HhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccccc
Q 005492 581 AINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639 (694)
Q Consensus 581 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~ 639 (694)
.+... ...+.+...+..+.+|+.+||+.+|++||++.++++.|.++....
T Consensus 235 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 235 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111 000111123456889999999999999999999999998765443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.50 Aligned_cols=255 Identities=26% Similarity=0.487 Sum_probs=200.7
Q ss_pred CCccceeeeeCcEEEEEEEEcC-Cc--EEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeC------Cc
Q 005492 362 YNANRILGQGGQGTVYKGMLTD-GR--IVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLET------EV 430 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~------~~ 430 (694)
|.+.++||+|+||.||+|.+.+ +. .+|+|.++.. .....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999765 33 6899987653 345577899999999999999999999987543 24
Q ss_pred cEEEEEeCCCCChHHHHhccc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecC
Q 005492 431 PLLVYEFIPNGTLYQYIHNQI---EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 507 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFG 507 (694)
.+++|||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999885321 2235899999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCcce-eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhc
Q 005492 508 TSRSVMVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINEN 585 (694)
Q Consensus 508 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 585 (694)
+++......... .....+++.|+|||.+....++.++||||||+++|||++ |+.||......+ ....+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcC
Confidence 998764332211 122235678999999999999999999999999999999 788986533211 11222222
Q ss_pred chhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 586 RLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 586 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
.... .+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 231 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111 1112345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.64 Aligned_cols=261 Identities=25% Similarity=0.344 Sum_probs=205.5
Q ss_pred hhhHHHHhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccc---cChhhHHHHHHHHHHHhhccCCcceeEEeEEee
Q 005492 352 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLE 427 (694)
Q Consensus 352 ~~~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~ 427 (694)
..++....++|++.+.||+|+||.||++..+. ++.+|+|.+.. ......+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 44555566899999999999999999999864 78999998753 223345568889999999999999999999999
Q ss_pred CCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecC
Q 005492 428 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 507 (694)
Q Consensus 428 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFG 507 (694)
.+..++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999999999753 3888999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCcceeeeeecCCCCCCCcccccC----CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhh
Q 005492 508 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS----QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN 583 (694)
Q Consensus 508 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 583 (694)
+++..............||+.|+|||++... .++.++|||||||+||||++|+.||...+.. ..+...+.
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~ 261 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMN 261 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHc
Confidence 9987643333333455699999999998754 3789999999999999999999999754321 11112211
Q ss_pred hcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 005492 584 ENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKM--RPTMKEVAFEL 632 (694)
Q Consensus 584 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~L 632 (694)
......+.+ .......+.++|.+||...+.+ ||++.+++++.
T Consensus 262 ~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 262 HKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111111111 1123456788999999844433 78888888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.69 Aligned_cols=242 Identities=26% Similarity=0.366 Sum_probs=196.4
Q ss_pred ceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
++||+|+||.||+|.... ++.||||.++.. .....+.+..|.+++..+ +||||+++++++.+.+..+|||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999765 789999987642 234456778899999876 799999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
++|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTT 153 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-ccc
Confidence 99999987543 4899999999999999999999999 9999999999999999999999999987543222 223
Q ss_pred eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAK 600 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 600 (694)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+ ....+..... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-------~~~~i~~~~~----------~~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-------LFESILHDDV----------LYP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC----------CCC
Confidence 34568999999999999999999999999999999999999997654321 1111111110 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 005492 601 KEGIMTVATLAKRCLNLNGKMRP-------TMKEVAFE 631 (694)
Q Consensus 601 ~~~~~~l~~li~~cl~~~p~~RP-------t~~evl~~ 631 (694)
......+.+++.+||+.+|++|| ++.+++++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11235678999999999999999 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=349.26 Aligned_cols=259 Identities=27% Similarity=0.328 Sum_probs=207.4
Q ss_pred hHHHHhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC-
Q 005492 354 DLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETE- 429 (694)
Q Consensus 354 ~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~- 429 (694)
+.....++|.+.+.||+|+||+||++... +++.||||.+... .......+.+|+.++..++|+||+++++.+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 33445678999999999999999999865 5899999987643 3455677889999999999999999988775433
Q ss_pred -------ccEEEEEeCCCCChHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcE
Q 005492 430 -------VPLLVYEFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA 501 (694)
Q Consensus 430 -------~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~ 501 (694)
..++||||+++|+|.++|+... ....+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 2579999999999999997632 2346899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccccCC-cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHH
Q 005492 502 KVSDFGTSRSVMVDQ-THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ 580 (694)
Q Consensus 502 kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 580 (694)
||+|||+++...... ........||+.|+|||++.+..++.++||||||++||||++|+.||......+ .+ .
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------~~-~ 255 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------VM-H 255 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HH-H
Confidence 999999998654322 122334568999999999999999999999999999999999999996543211 11 1
Q ss_pred HhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 581 AINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 581 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
....+... ..+...+..+.+|+.+||+.+|.+||++.+++++
T Consensus 256 ~~~~~~~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 KTLAGRYD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHhcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111111 1122344678899999999999999999999864
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.37 Aligned_cols=260 Identities=25% Similarity=0.360 Sum_probs=209.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|++.+.||+|+||.||++... +++.+|||.+... ......++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888999999999999999964 6899999977642 3344568899999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 436 EFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999987522 2346899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
... ......++..|+|||.+.+..++.++||||||+++|+|++|..||....... .. ....+.... .+
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~-~~~~~~~~~-----~~- 226 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YS-LCKKIEQCD-----YP- 226 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HH-HhhhhhcCC-----CC-
Confidence 221 1223458889999999998899999999999999999999999986543211 00 111111110 00
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~ 636 (694)
..........+.+++.+||+.+|++||||.+|++.++++.
T Consensus 227 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 227 --PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0011234567889999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.09 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=206.3
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-C---cEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-G---RIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l 433 (694)
.++|+..+.||+|+||.||+|.... + ..+|+|..+.. .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3578888999999999999999753 3 37999988654 34456789999999999999999999999999999999
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999997643 35899999999999999999999999 9999999999999999999999999987664
Q ss_pred cCCcceee--eeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhh
Q 005492 514 VDQTHLTT--KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590 (694)
Q Consensus 514 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (694)
........ ....+..|+|||++....++.++||||||+++|||++ |+.||......+ +...+....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i~~~~---- 227 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAINDGF---- 227 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhcCC----
Confidence 32221111 1123457999999998899999999999999999997 999986543211 112221110
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 591 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
........+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 228 -----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 -----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011123345688999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=322.43 Aligned_cols=252 Identities=25% Similarity=0.340 Sum_probs=202.8
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
+|+..+.||+|+||+||++... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999975 58899999876422 2234567889999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999999887542 235899999999999999999999999 9999999999999999999999999987653222
Q ss_pred cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhh
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 596 (694)
. .....|++.|+|||++.+..++.++||||||+++|||++|+.||........ ...+...+... .
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~~----------~ 221 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKED----------Q 221 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhhc----------c
Confidence 1 2234589999999999989999999999999999999999999976433211 11111111110 1
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005492 597 KEAKKEGIMTVATLAKRCLNLNGKMRP-----TMKEVAFE 631 (694)
Q Consensus 597 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 631 (694)
...+...+..+.+|+.+||+.||.+|| ++.+++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 112233456688999999999999999 77787664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.08 Aligned_cols=258 Identities=28% Similarity=0.446 Sum_probs=207.2
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCc
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVD-ETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEV 430 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~ 430 (694)
.++|...+.||+|+||.||++... .+..+|+|+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357999999999999999999752 24579999877543 34456799999999999 79999999999999999
Q ss_pred cEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcc
Q 005492 431 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~ 510 (694)
.++||||+++|+|.++++.... ..+++.+++.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999976432 23899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCcc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchh
Q 005492 511 SVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLF 588 (694)
Q Consensus 511 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (694)
........ ......++..|+|||.+....++.++||||||+++|||++ |..||......+ .+......+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~--- 260 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEG--- 260 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcC---
Confidence 66433221 1122335678999999999999999999999999999998 999986544321 111111111
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 589 EILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 589 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
.....+...+..+.+++.+||+.+|++||++.||++.|+++
T Consensus 261 ------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 ------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 01111112345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=316.18 Aligned_cols=250 Identities=27% Similarity=0.436 Sum_probs=206.4
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
+|+..+.||+|++|.||++... +++.|++|.+.. ......+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999976 488999998764 2445677899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++++|.++++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999998752 336899999999999999999999998 99999999999999999999999999886643322
Q ss_pred ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
......+++.|+|||++.+..++.++||||||++++||++|+.||......+ .......+.. .
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~---------~ 219 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-------LILKIIRGVF---------P 219 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC---------C
Confidence 2233458889999999999999999999999999999999999997544211 1111111111 1
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.........+.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1112344568999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=324.43 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=204.4
Q ss_pred CCCccceeeeeCcEEEEEEEEcC------CcEEEEEEccccCh-hhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLVDE-TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l 433 (694)
.|+..+.||+|+||.||+|...+ +..||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46778899999999999998643 47899999875433 335678899999999999999999999999999999
Q ss_pred EEEeCCCCChHHHHhccc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCc
Q 005492 434 VYEFIPNGTLYQYIHNQI-------------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR 500 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~ 500 (694)
++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999986321 1234889999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccccCCc-ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHH
Q 005492 501 AKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYF 578 (694)
Q Consensus 501 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 578 (694)
+||+|||+++....... .......+++.|+|||.+....++.++||||||+++|||++ |..||......+ .
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~ 235 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------V 235 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-------H
Confidence 99999999886543221 11223345778999999988899999999999999999998 888886543221 1
Q ss_pred HHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005492 579 LQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGG 634 (694)
Q Consensus 579 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 634 (694)
...+...... ..+...+..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus 236 ~~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 2222222111 1122345668899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.51 Aligned_cols=241 Identities=26% Similarity=0.371 Sum_probs=195.9
Q ss_pred CCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCC-cceeEEeEEeeCCccEEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHR-NIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-nIv~l~g~~~~~~~~~lv~ 435 (694)
+|++.+.||+|+||.||+|...+ ++.||||.+... .....+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47889999999999999999765 789999987642 334567788999999999765 5888999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999997543 4899999999999999999999999 999999999999999999999999998753222
Q ss_pred CcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
. .......||+.|+|||++.+..++.++||||||++||||++|+.||......+ ....+....
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~~~--------- 217 (324)
T cd05587 155 G-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQSIMEHN--------- 217 (324)
T ss_pred C-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC---------
Confidence 2 22334568999999999999999999999999999999999999997543221 111111111
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTM 625 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 625 (694)
...+......+.+++.+||+.+|.+|++.
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 01112234567899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.42 Aligned_cols=237 Identities=30% Similarity=0.428 Sum_probs=193.4
Q ss_pred ceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
+.||+|+||.||++..+. ++.||||.+... .....+.+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999764 889999987642 234566778899998877 699999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTT 153 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccc
Confidence 99999987643 4899999999999999999999999 9999999999999999999999999987543222 223
Q ss_pred eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAK 600 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 600 (694)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+ ....+..+.. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~----------~~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEV----------VYP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCC----------CCC
Confidence 34568999999999999999999999999999999999999997644321 1111111111 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 005492 601 KEGIMTVATLAKRCLNLNGKMRPTMK 626 (694)
Q Consensus 601 ~~~~~~l~~li~~cl~~~p~~RPt~~ 626 (694)
......+.+++.+||+.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 12345678999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.69 Aligned_cols=256 Identities=28% Similarity=0.468 Sum_probs=207.4
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC------CcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCcc
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 431 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~ 431 (694)
.++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578889999999999999998753 3689999976532 34456789999999999999999999999999999
Q ss_pred EEEEEeCCCCChHHHHhcccC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEe
Q 005492 432 LLVYEFIPNGTLYQYIHNQIE-------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVS 504 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~ 504 (694)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999975322 224789999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccccCCc-ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHh
Q 005492 505 DFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAI 582 (694)
Q Consensus 505 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 582 (694)
|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |+.||......+ ....+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHHHH
Confidence 9999876543322 12223346789999999998899999999999999999998 899986543322 11111
Q ss_pred hhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 583 NENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 583 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
..+.... .+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111111 11223567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.44 Aligned_cols=261 Identities=27% Similarity=0.449 Sum_probs=206.6
Q ss_pred HHhcCCCccceeeeeCcEEEEEEEEcC------CcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC
Q 005492 357 KATDNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETE 429 (694)
Q Consensus 357 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~ 429 (694)
...++|++.+.||+|+||.||+|..++ +..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 346789999999999999999997542 4579999876433 234456889999999999999999999999999
Q ss_pred ccEEEEEeCCCCChHHHHhcccC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEE
Q 005492 430 VPLLVYEFIPNGTLYQYIHNQIE-------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAK 502 (694)
Q Consensus 430 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~k 502 (694)
..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+++ |+||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 99999999999999999975321 234678889999999999999999999 99999999999999999999
Q ss_pred EeecCCccccccCCcc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHH
Q 005492 503 VSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQ 580 (694)
Q Consensus 503 l~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 580 (694)
|+|||+++........ ......++..|+|||.+....++.++||||||+++|||++ |..||......+ ...
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-------~~~ 232 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLK 232 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH
Confidence 9999998865432211 1122235678999999999999999999999999999998 788886543221 111
Q ss_pred HhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 005492 581 AINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636 (694)
Q Consensus 581 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~ 636 (694)
.+..+... ..+...+..+.+++.+||+.+|++||++.++++.|+...
T Consensus 233 ~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 233 FVMDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111110 111123457899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=328.13 Aligned_cols=238 Identities=28% Similarity=0.359 Sum_probs=193.8
Q ss_pred ceeeeeCcEEEEEEEE----cCCcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCC
Q 005492 366 RILGQGGQGTVYKGML----TDGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP 439 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~ 439 (694)
+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999875 247899999886532 2234567889999999999999999999999999999999999
Q ss_pred CCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce
Q 005492 440 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519 (694)
Q Consensus 440 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 519 (694)
+|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~ 154 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KK 154 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cc
Confidence 999999997542 4899999999999999999999999 9999999999999999999999999987654322 22
Q ss_pred eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhh
Q 005492 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEA 599 (694)
Q Consensus 520 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 599 (694)
.....|++.|+|||.+....++.++||||||++||||++|+.||......+ ....+..... ..
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-------~~~~i~~~~~----------~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-------TMTMILKAKL----------GM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-------HHHHHHcCCC----------CC
Confidence 334568999999999998889999999999999999999999997543211 1111111110 11
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005492 600 KKEGIMTVATLAKRCLNLNGKMRPTMKE 627 (694)
Q Consensus 600 ~~~~~~~l~~li~~cl~~~p~~RPt~~e 627 (694)
+......+.+|+.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1223456789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=338.40 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=201.3
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC-----ccE
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETE-----VPL 432 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~-----~~~ 432 (694)
+|+..+.||+|+||.||++... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999975 5899999987642 3345567899999999999999999999998776 789
Q ss_pred EEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccc
Q 005492 433 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 512 (694)
Q Consensus 433 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~ 512 (694)
+|+||+. ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 5788887643 25899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCcceeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhh-
Q 005492 513 MVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI- 590 (694)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 590 (694)
............++..|+|||++.+. .++.++||||||+++|||++|+.||......+.. ..+..........++
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL---DLITDLLGTPSLEAMR 230 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCCCCHHHHH
Confidence 44333333344578999999998764 5799999999999999999999999765433211 111111111100000
Q ss_pred ---------hhhhh--------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 591 ---------LDARV--------LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 591 ---------~d~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+.... ...........+.+|+.+||+.||.+|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000 000111224568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=331.73 Aligned_cols=247 Identities=27% Similarity=0.418 Sum_probs=205.5
Q ss_pred ceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCChH
Q 005492 366 RILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 444 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 444 (694)
-+||+|.||+||.|++.+ ...+|||.+...+....+-+..||.+.++++|+|||+++|++.+++..-|.||-+|||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 479999999999999876 5579999988777777888999999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEEC-CCCcEEEeecCCccccccCCcceeeee
Q 005492 445 QYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKV 523 (694)
Q Consensus 445 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~ 523 (694)
++|+..=....-.+..+-.+.+||++||.|||+.. |||||||-+||||+ -.|.+||+|||.++.+.. -...+..+
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc-CCcccccc
Confidence 99987543322378899999999999999999999 99999999999996 678999999999987642 23455667
Q ss_pred ecCCCCCCCcccccC--CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhH
Q 005492 524 QGTFGYVDPEYFQSS--QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKK 601 (694)
Q Consensus 524 ~gt~~y~aPE~~~~~--~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 601 (694)
.||.-|||||++..+ .|..++|||||||++.||.||++||........ .+.+-+.. ..-...+.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGmy------KvHP~iPe 802 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGMY------KVHPPIPE 802 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhcce------ecCCCCcH
Confidence 799999999999875 489999999999999999999999976543220 11111111 01122345
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005492 602 EGIMTVATLAKRCLNLNGKMRPTMKEVAF 630 (694)
Q Consensus 602 ~~~~~l~~li~~cl~~~p~~RPt~~evl~ 630 (694)
+...+...+|.+|+.++|.+||+++++++
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 56677889999999999999999999986
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.07 Aligned_cols=255 Identities=26% Similarity=0.425 Sum_probs=205.9
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv 434 (694)
.+|++.+.||+|+||.||+|.... +..+|+|.++.. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 468889999999999999998642 347999988653 234467899999999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999997643 25899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCcceee--eeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhh
Q 005492 515 DQTHLTT--KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591 (694)
Q Consensus 515 ~~~~~~~--~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (694)
....... ...++..|+|||.+....++.++||||||+++||+++ |+.||......+ ....+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~---- 227 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-------VIKAIEEGYR---- 227 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-------HHHHHhCCCc----
Confidence 3322221 1223568999999998899999999999999999886 999987544321 1111111100
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
.......+..+.+++.+||+.+|.+||+|.++++.|..+
T Consensus 228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 -----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 011122345688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=329.69 Aligned_cols=263 Identities=27% Similarity=0.433 Sum_probs=209.3
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC--------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeC
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD--------GRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLET 428 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~ 428 (694)
..+|.+.+.||+|+||.||++.... ...||+|..+.. .....+++.+|+.+++++ +||||+++++++.+.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3568899999999999999997531 236899987753 334567899999999999 899999999999999
Q ss_pred CccEEEEEeCCCCChHHHHhccc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEE
Q 005492 429 EVPLLVYEFIPNGTLYQYIHNQI-------------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL 495 (694)
Q Consensus 429 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll 495 (694)
+..++++||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999997532 1235889999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCccccccCCcc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCcc
Q 005492 496 DDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKS 573 (694)
Q Consensus 496 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~ 573 (694)
++++.+||+|||+++........ ......++..|+|||++....++.++||||||++||||++ |..||.....++
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 244 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--- 244 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence 99999999999999765432211 1122234567999999999999999999999999999998 888886543222
Q ss_pred HHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccccC
Q 005492 574 LVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTG 640 (694)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~~ 640 (694)
+...+...... +.+...+..+.+++.+||+.+|.+||++.|+++.|+.+.....
T Consensus 245 ----~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 245 ----LFKLLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred ----HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 11222111111 1112334568899999999999999999999999998875544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=326.71 Aligned_cols=255 Identities=21% Similarity=0.312 Sum_probs=200.1
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|++.++||+|+||.||++..+. ++.+|+|.+... .......+.+|+.++..++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468899999999999999999865 788999987532 2333456888999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++|+|.+++.+... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999976422 4899999999999999999999999 999999999999999999999999998765443
Q ss_pred CcceeeeeecCCCCCCCcccc-----cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (694)
.........||+.|+|||++. ...++.++||||||++||||++|+.||......+ .............+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~~ 229 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKERFQF 229 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCccccC
Confidence 333333456999999999986 3468899999999999999999999997543221 11111111100000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005492 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKM--RPTMKEVAFE 631 (694)
Q Consensus 591 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~ 631 (694)
. .........+.+|+.+||..++.+ |+++.|++++
T Consensus 230 -p-----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 -P-----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -C-----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 001123456788999988665444 6889988876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.58 Aligned_cols=261 Identities=27% Similarity=0.434 Sum_probs=209.1
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeC
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT--------DGRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLET 428 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~ 428 (694)
.++|.+.+.||+|+||.||++... ++..||+|..... .......+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467888999999999999999742 2457999987643 344567899999999999 899999999999999
Q ss_pred CccEEEEEeCCCCChHHHHhcccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEE
Q 005492 429 EVPLLVYEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL 495 (694)
Q Consensus 429 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll 495 (694)
...++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999976421 235889999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCccccccCCcc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCcc
Q 005492 496 DDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKS 573 (694)
Q Consensus 496 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~ 573 (694)
++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||++||||++ |..||......+
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--- 247 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 247 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---
Confidence 99999999999999866432222 1222345678999999998899999999999999999998 788886543221
Q ss_pred HHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 005492 574 LVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~ 638 (694)
....+..+.. ...+...+..+.+|+.+||+.+|.+||++.||++.|+++...
T Consensus 248 ----~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 248 ----LFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ----HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1122222111 011123345688999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=317.48 Aligned_cols=260 Identities=25% Similarity=0.411 Sum_probs=206.9
Q ss_pred hHHHHhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccE
Q 005492 354 DLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 432 (694)
Q Consensus 354 ~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~ 432 (694)
|++.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||+++++++.+.+..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 45667788888899999999999999965 47889999887766667788999999999999999999999999999999
Q ss_pred EEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECC-CCcEEEeecCCccc
Q 005492 433 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGTSRS 511 (694)
Q Consensus 433 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~-~~~~kl~DFGla~~ 511 (694)
+|+||+++++|.++++........++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 99999999999999986433212388899999999999999999998 999999999999976 67999999999876
Q ss_pred cccCCcceeeeeecCCCCCCCcccccCC--CCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhh
Q 005492 512 VMVDQTHLTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589 (694)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (694)
...... ......++..|+|||++.... ++.++||||||+++|+|++|+.||......... .... . ..
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-----~~~~-~---~~- 227 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-----MFKV-G---MF- 227 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-----Hhhh-h---hh-
Confidence 542221 122335789999999986643 789999999999999999999998653321100 0000 0 00
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 590 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
......+......+.+++.+||+.+|.+||++.|++++
T Consensus 228 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 ----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111222344568899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.41 Aligned_cols=254 Identities=26% Similarity=0.372 Sum_probs=204.0
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 57999999999999999999974 58899999987655556677889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++++|.++++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...... .
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06646 89 GGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-A 161 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-c
Confidence 999999999754 25899999999999999999999998 9999999999999999999999999998653221 1
Q ss_pred eeeeeecCCCCCCCcccc---cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~---~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
......++..|+|||.+. ...++.++||||||+++|||++|+.||......+... .+....+ ..+..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~---~~~~~ 231 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSNF---QPPKL 231 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCCC---CCCCC
Confidence 122345888999999874 4557889999999999999999999986543221100 0000000 00000
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
. .....+..+.+++.+||+.+|++||++.+++++|
T Consensus 232 ~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 K--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred c--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 0112345788999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=326.46 Aligned_cols=244 Identities=26% Similarity=0.380 Sum_probs=196.9
Q ss_pred ceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
+.||+|+||.||++.... ++.+|+|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999764 789999988752 234456788999999988 699999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
|+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTT 153 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cce
Confidence 99999887542 4999999999999999999999999 9999999999999999999999999987532221 223
Q ss_pred eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAK 600 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 600 (694)
....||+.|+|||++.+..++.++||||||++||||++|+.||..................+..... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RIP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CCC
Confidence 3456899999999999999999999999999999999999999765443333333333332222111 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 005492 601 KEGIMTVATLAKRCLNLNGKMRPTMK 626 (694)
Q Consensus 601 ~~~~~~l~~li~~cl~~~p~~RPt~~ 626 (694)
...+..+.+++.+||+.||.+||++.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 22335578999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=315.69 Aligned_cols=262 Identities=25% Similarity=0.324 Sum_probs=198.8
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC-----ccEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETE-----VPLL 433 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~-----~~~l 433 (694)
-.|...+++|.|+||.||+|+..+ +..||||+.-...+. --+|+++|+.++|||||+|+.++.... ...|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 357778999999999999999765 689999987543321 235899999999999999999987543 2348
Q ss_pred EEEeCCCCChHHHHhcc-cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCC-CcEEEeecCCccc
Q 005492 434 VYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGTSRS 511 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~-~~~kl~DFGla~~ 511 (694)
||||||. +|.++++.. .....++...+.-+..||.+||+|||+.+ |+||||||.|+|+|.+ +.+||+|||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999987 899998752 12335788888889999999999999999 9999999999999965 8999999999998
Q ss_pred cccCCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchh--
Q 005492 512 VMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF-- 588 (694)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 588 (694)
+...+.. ....-|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.+..++...+..+........+.
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 8655544 44556889999999876 579999999999999999999999998855433222222221111111111
Q ss_pred -----hhhhhhhh----hh-hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 589 -----EILDARVL----KE-AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 589 -----~~~d~~~~----~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+...+.+. .. ......++..+|+.++|+.+|.+|.++.|++.+
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11111111 11 223455678999999999999999999998854
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=314.49 Aligned_cols=267 Identities=24% Similarity=0.315 Sum_probs=205.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhccCCc-ceeEEeEEeeCC------
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRN-IVKLLGCCLETE------ 429 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-Iv~l~g~~~~~~------ 429 (694)
..|...++||+|+||+||+|+.+ +|+.||+|++..... .......+|+.+|++++|+| ||+|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 44666778999999999999965 589999999876433 24556789999999999999 999999999877
Q ss_pred ccEEEEEeCCCCChHHHHhcccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCC
Q 005492 430 VPLLVYEFIPNGTLYQYIHNQIEE-FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 508 (694)
Q Consensus 430 ~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGl 508 (694)
..+||+||++. +|..++...... ..++...+..++.||+.||+|||+++ |+||||||.||||++.+.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 78899999955 999999875432 34777899999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcch
Q 005492 509 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 587 (694)
Q Consensus 509 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (694)
|+....+... .+...+|..|.|||++.+. .|+...||||+||+++||++++.-|.+....++...+........+..+
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 9976644433 3455689999999999876 7999999999999999999999988876653221111111111111111
Q ss_pred hh-------------hhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 588 FE-------------ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 588 ~~-------------~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.. .-.+.......+.......+++.+||+.+|.+|.+++.++++
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00 000000001011111468899999999999999999999986
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=323.87 Aligned_cols=263 Identities=25% Similarity=0.404 Sum_probs=203.3
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC---------------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD---------------GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLL 422 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~ 422 (694)
.++|++.+.||+|+||.||++...+ ...||+|..... .......|.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578999999999999999987542 235899988653 344556799999999999999999999
Q ss_pred eEEeeCCccEEEEEeCCCCChHHHHhcccC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccE
Q 005492 423 GCCLETEVPLLVYEFIPNGTLYQYIHNQIE---------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANI 493 (694)
Q Consensus 423 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NI 493 (694)
+++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999965321 124789999999999999999999999 99999999999
Q ss_pred EECCCCcEEEeecCCccccccCCcc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh--CCCCCccCCCcc
Q 005492 494 LLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT--GQKPIRAINTDE 570 (694)
Q Consensus 494 ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt--g~~p~~~~~~~~ 570 (694)
|+++++.+||+|||++......... ......++..|+|||.+....++.++||||||++++||++ +..||......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999998765432211 1122335678999999998899999999999999999998 566776543322
Q ss_pred CccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 571 DKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
......+..... ........+...+..+.+|+.+||+.+|++||++.+|++.|+
T Consensus 241 ---~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 ---VIENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ---HHHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111000 000001111123457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=327.55 Aligned_cols=241 Identities=27% Similarity=0.377 Sum_probs=195.6
Q ss_pred CCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCccEEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
+|+..+.||+|+||.||++.... ++.||||.+... .....+.+..|..++..+ +|++|+++++++.+.+..+|||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999764 789999987642 233445677788888887 5899999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999987543 4899999999999999999999999 999999999999999999999999998754322
Q ss_pred CcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
. .......||+.|+|||++....++.++|||||||++|||++|+.||......+ ....+.....
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-------~~~~i~~~~~-------- 218 (323)
T cd05616 155 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNV-------- 218 (323)
T ss_pred C-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC--------
Confidence 2 12234568999999999999999999999999999999999999997543321 1111111110
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTM 625 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 625 (694)
..+.....++.+++.+||+.+|.+|++.
T Consensus 219 --~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 --AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1112334567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=326.59 Aligned_cols=265 Identities=23% Similarity=0.328 Sum_probs=201.0
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56889999999999999999976 47889999887533 23345678899999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++ +|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 88888876432 4889999999999999999999999 99999999999999999999999999875432221
Q ss_pred ceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhh-----
Q 005492 518 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEIL----- 591 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 591 (694)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+...................+.
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1223457899999998865 568999999999999999999999997654332111111000000000000000
Q ss_pred -hhhhh-------hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 592 -DARVL-------KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 592 -d~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+.... ..........+.+|+.+||+.||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000 00011234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=321.94 Aligned_cols=263 Identities=26% Similarity=0.428 Sum_probs=206.1
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-----------------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCccee
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-----------------GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVK 420 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~ 420 (694)
.++|++.+.||+|+||.||++...+ +..||+|.+... .....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999988653 246899987753 3345678999999999999999999
Q ss_pred EEeEEeeCCccEEEEEeCCCCChHHHHhcccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccccccc
Q 005492 421 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIE--------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSAN 492 (694)
Q Consensus 421 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~N 492 (694)
+++++..++..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999976431 125899999999999999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCCccccccCCc-ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh--CCCCCccCCCc
Q 005492 493 ILLDDKYRAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT--GQKPIRAINTD 569 (694)
Q Consensus 493 Ill~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt--g~~p~~~~~~~ 569 (694)
|++++++.++|+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ +..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876543221 12223346778999999998899999999999999999998 66777544322
Q ss_pred cCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 570 EDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
+ .............. ......+...+.++.+++.+||+.+|.+||++.||++.|+
T Consensus 241 ~---~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 Q---VIENAGHFFRDDGR------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H---HHHHHHhccccccc------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 11111111111000 0001111223457899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=317.94 Aligned_cols=254 Identities=26% Similarity=0.450 Sum_probs=203.9
Q ss_pred CCCccceeeeeCcEEEEEEEEcC-C---cEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD-G---RIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
.|++.+.||+|+||.||+|.... + ..||||.++.. ......+|..|+.++++++||||+++++++.+....++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 47788999999999999999754 3 36999998753 4455678999999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++++|.+++..... .+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999976432 4899999999999999999999999 999999999999999999999999998765432
Q ss_pred Ccce--eeeee--cCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhh
Q 005492 516 QTHL--TTKVQ--GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590 (694)
Q Consensus 516 ~~~~--~~~~~--gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (694)
.... ..... .+..|+|||.+....++.++||||||+++|||++ |..||......+ +...+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-------~~~~i~~~~---- 228 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VINAIEQDY---- 228 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCC----
Confidence 2211 11111 2357999999999999999999999999999886 999986543221 111111110
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 591 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
....+.+.+..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus 229 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 -----RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011123345688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=322.93 Aligned_cols=240 Identities=26% Similarity=0.363 Sum_probs=193.1
Q ss_pred ceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
+.||+|+||.||++..+. ++.||+|.++.. .....+.+..|..++..+ +||||+++++++.+.+..+|||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999864 889999988642 123455677788888765 899999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence 99999987642 4899999999999999999999999 9999999999999999999999999987432211 223
Q ss_pred eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAK 600 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 600 (694)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+.... + ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-------~~~~~~~~~------~----~~~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-------LFESIRVDT------P----HYP 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCC------C----CCC
Confidence 34568999999999999999999999999999999999999997543221 111111110 0 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 005492 601 KEGIMTVATLAKRCLNLNGKMRPTMK-EVA 629 (694)
Q Consensus 601 ~~~~~~l~~li~~cl~~~p~~RPt~~-evl 629 (694)
......+.+++.+||+.||++||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 12334678999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=318.28 Aligned_cols=257 Identities=29% Similarity=0.460 Sum_probs=206.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC----CcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv 434 (694)
++|...+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 468888999999999999998654 2468999876544 4566789999999999999999999998875 557899
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
|||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999976432 4899999999999999999999999 99999999999999999999999999876644
Q ss_pred CCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhh
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDA 593 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 593 (694)
..........++..|+|||.+....++.++||||||++++||++ |..||......+ ....+..+...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~~~----- 227 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-------VIGRIENGERL----- 227 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHcCCcC-----
Confidence 32222223334568999999988889999999999999999996 999997554321 11111111100
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 005492 594 RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 594 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~ 638 (694)
..+...+..+.+++.+|+..+|.+|||+.++++.|+.+...
T Consensus 228 ----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 ----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11123345788999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=319.68 Aligned_cols=258 Identities=26% Similarity=0.482 Sum_probs=205.0
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCc----EEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGR----IVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l 433 (694)
++|+..++||+|+||+||+|.+. +++ .||+|.++.. .......+.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 56888899999999999999854 344 4899988653 34456778999999999999999999999975 45689
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
++||+++|+|.++++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 ~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999976432 4899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCcce-eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhh
Q 005492 514 VDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591 (694)
Q Consensus 514 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (694)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~--- 230 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-------IPDLLEKGERL--- 230 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcC---
Confidence 332221 112234678999999998999999999999999999998 899986543211 11111111110
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccccc
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~ 639 (694)
..+...+..+.+++.+||+.+|++||++.++++.|+.+....
T Consensus 231 ------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 ------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 111223456889999999999999999999999998775544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=317.51 Aligned_cols=249 Identities=27% Similarity=0.458 Sum_probs=197.4
Q ss_pred ceeeeeCcEEEEEEEEcC-Cc--EEEEEEcccc-ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQGGQGTVYKGMLTD-GR--IVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
+.||+|+||.||+|.+.+ +. .+|+|..+.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999865 33 5788887743 345567899999999999 899999999999999999999999999
Q ss_pred CChHHHHhcccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecC
Q 005492 441 GTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 507 (694)
Q Consensus 441 gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFG 507 (694)
++|.++++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999976421 124789999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcc
Q 005492 508 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENR 586 (694)
Q Consensus 508 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 586 (694)
++...... ........+..|+|||++....++.++||||||++++||++ |..||......+ ....+..+
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~- 227 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQG- 227 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-------HHHHHhCC-
Confidence 98632211 11111223567999999988899999999999999999997 999996543211 11111111
Q ss_pred hhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 587 LFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 587 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
...+.+......+.+|+.+||+.+|.+||++.+++..|+++
T Consensus 228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 01111122345688999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=326.27 Aligned_cols=243 Identities=26% Similarity=0.378 Sum_probs=192.4
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHH-HHhhccCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVV-ILSQINHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
+.||+|+||+||++... +++.+|+|.+... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999975 5899999987642 2233455666655 56779999999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
|+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~ 153 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTT 153 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCc
Confidence 99999887542 5899999999999999999999999 999999999999999999999999998754222 1223
Q ss_pred eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAK 600 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 600 (694)
....||+.|+|||++.+..++.++||||||++||||++|+.||......+ ....+....+ ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~~~~~~~----------~~~ 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-------MYDNILHKPL----------VLR 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-------HHHHHHcCCc----------cCC
Confidence 34568999999999999999999999999999999999999997543221 1111111110 001
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 601 KEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 601 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
......+.+++.+||+.+|.+||++.+.++.+
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 12334577999999999999999986544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=315.29 Aligned_cols=251 Identities=29% Similarity=0.503 Sum_probs=203.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCC
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP 439 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~ 439 (694)
.+|+..+.||+|+||.||++.+.+++.+|+|.+... .....+|.+|++++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 357788999999999999999877889999987643 2234678999999999999999999999999999999999999
Q ss_pred CCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce
Q 005492 440 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519 (694)
Q Consensus 440 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 519 (694)
+++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999976432 4899999999999999999999999 9999999999999999999999999987654332221
Q ss_pred eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 520 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+. ....
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~--~~~~------ 222 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VVETINAGF--RLYK------ 222 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHhCCC--CCCC------
Confidence 222235678999999998899999999999999999998 899986533211 111111110 0011
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
+...+..+.+|+.+||+.+|++||++.++++.|
T Consensus 223 -~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 -PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 111245688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=314.57 Aligned_cols=249 Identities=28% Similarity=0.470 Sum_probs=201.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEee-CCccEEEEEeC
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE-TEVPLLVYEFI 438 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~-~~~~~lv~e~~ 438 (694)
++|...+.||+|+||.||++... +..+|+|..+.. ...+.+.+|+.++++++|+|++++++++.+ .+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888999999999999999765 788999987642 335679999999999999999999998654 45789999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++++|.++++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999986432 35899999999999999999999999 9999999999999999999999999987543222
Q ss_pred eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
.....+..|+|||++....++.++||||||+++|||++ |+.||......+ ....+..+. ..
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~ 218 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGY---------KM 218 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCC---------CC
Confidence 12234568999999998899999999999999999998 999986432211 111111110 11
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
......+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11223456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=320.50 Aligned_cols=262 Identities=27% Similarity=0.402 Sum_probs=204.1
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-----CCcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeC--Ccc
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-----DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVP 431 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~ 431 (694)
..|+..+.||+|+||.||++... ++..||+|.++... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 45788899999999999999842 47889999987543 44457899999999999999999999999875 567
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 899999999999999976432 4899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCcc--eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCc--------cCccHHHHHHHH
Q 005492 512 VMVDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTD--------EDKSLVGYFLQA 581 (694)
Q Consensus 512 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~--------~~~~~~~~~~~~ 581 (694)
....... ......++..|+|||.+.+..++.++||||||+++|||++++.|....... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6533221 122344677899999998889999999999999999999987664321110 000001111111
Q ss_pred hhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 582 INENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 582 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
+..+. ....+...+..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 239 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111 0111123446789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=318.28 Aligned_cols=248 Identities=23% Similarity=0.302 Sum_probs=195.8
Q ss_pred eeeeCcEEEEEEEEcC-CcEEEEEEccccC---hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCCh
Q 005492 368 LGQGGQGTVYKGMLTD-GRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL 443 (694)
Q Consensus 368 LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gsL 443 (694)
||+|+||.||++..+. |+.+|+|++.... ......+..|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999999764 8999999876421 22334566799999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcceeeee
Q 005492 444 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 523 (694)
Q Consensus 444 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 523 (694)
.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++....... .....
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 99887543 235899999999999999999999999 9999999999999999999999999987654321 22334
Q ss_pred ecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHH
Q 005492 524 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEG 603 (694)
Q Consensus 524 ~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 603 (694)
.|+..|+|||++.+..++.++|||||||++|||++|+.||........ ... ........ .... .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~-~~~~~~~~--------~~~~-~~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEE-LKRRTLED--------EVKF-EHQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHH-HHHHhhcc--------cccc-ccccC
Confidence 589999999999998999999999999999999999999975432211 011 00110000 0000 01123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 604 IMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 604 ~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
..++.+|+.+||+.+|++||+++|+++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 456889999999999999999988775543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=325.18 Aligned_cols=261 Identities=26% Similarity=0.433 Sum_probs=207.6
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeC
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT--------DGRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCCLET 428 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~ 428 (694)
.++|.+.+.||+|+||.||++... ....+|+|.++.. .......+.+|+.+++++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356888999999999999999752 2457999987753 334567789999999999 699999999999999
Q ss_pred CccEEEEEeCCCCChHHHHhcccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEE
Q 005492 429 EVPLLVYEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL 495 (694)
Q Consensus 429 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll 495 (694)
...++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 999999999999999999976321 235899999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCccccccCCcc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCcc
Q 005492 496 DDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKS 573 (694)
Q Consensus 496 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~ 573 (694)
++++.+||+|||+++........ ......++..|+|||.+....++.++||||||+++|||++ |..||......+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--- 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--- 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 99999999999999865432211 1112224567999999999999999999999999999999 888886543321
Q ss_pred HHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 005492 574 LVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~ 638 (694)
+...+..+... +.+...+..+.+++.+||+.+|++||++.++++.|..+...
T Consensus 245 ----~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 245 ----LFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred ----HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 12222221111 11122345688999999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=324.92 Aligned_cols=241 Identities=27% Similarity=0.369 Sum_probs=193.8
Q ss_pred ceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
+.||+|+||.||+|...+ ++.||||.++.. .....+.+..|..++..+ +||||+++++++.+.+..+|||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999765 789999987653 223455677788888764 899999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKT 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cce
Confidence 99999997542 4899999999999999999999999 9999999999999999999999999987543222 123
Q ss_pred eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAK 600 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 600 (694)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+.... +. .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~~------~~----~~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-------LFQSIRMDN------PC----YP 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCC------CC----CC
Confidence 34568999999999999999999999999999999999999997543221 111111110 00 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 005492 601 KEGIMTVATLAKRCLNLNGKMRPTMK-EVAF 630 (694)
Q Consensus 601 ~~~~~~l~~li~~cl~~~p~~RPt~~-evl~ 630 (694)
......+.+++.+||+.+|.+||++. ++++
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 12334578999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=313.80 Aligned_cols=248 Identities=29% Similarity=0.455 Sum_probs=199.3
Q ss_pred ceeeeeCcEEEEEEEEcC----CcEEEEEEccccCh-hhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQGGQGTVYKGMLTD----GRIVAVKKSKLVDE-TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
++||+|+||.||+|.+.. +..+|+|....... ...+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998643 26899998775433 35678999999999999999999999875 4567999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999998653 5899999999999999999999999 99999999999999999999999999987654332221
Q ss_pred e--eeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 521 T--KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 521 ~--~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
. ...++..|+|||.+....++.++||||||+++|||++ |+.||......+ +...+..... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~ 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-------VIAMLESGER---------L 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCCc---------C
Confidence 1 1223568999999999999999999999999999998 999986543211 1122222111 1
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~ 636 (694)
..+...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 112233456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=321.59 Aligned_cols=250 Identities=26% Similarity=0.421 Sum_probs=205.9
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
.+|+..+.||+|+||.||+|... +++.+|+|.+........+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57888999999999999999965 58899999887766666788999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++++|.+++.+. .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 999999998653 4899999999999999999999999 99999999999999999999999999876543221
Q ss_pred eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
......+++.|+|||.+....++.++||||||+++|+|++|+.||........ ........ ... ..
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~~~~~~~-~~~-------~~ 237 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNG-TPE-------LQ 237 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HHHHhcCC-CCC-------CC
Confidence 12234588899999999988899999999999999999999999965433210 11111110 000 01
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+......+.+++.+||..+|++||++.+++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 122334568899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=319.15 Aligned_cols=247 Identities=24% Similarity=0.291 Sum_probs=195.9
Q ss_pred eeeeCcEEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCCh
Q 005492 368 LGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL 443 (694)
Q Consensus 368 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gsL 443 (694)
||+|+||+||++... +++.+|+|.+.... ....+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999975 58899999876422 22346678899999999999999999999999999999999999999
Q ss_pred HHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcceeee
Q 005492 444 YQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 522 (694)
Q Consensus 444 ~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 522 (694)
..++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 99886432 2346899999999999999999999999 99999999999999999999999999876543222 2233
Q ss_pred eecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHH
Q 005492 523 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKE 602 (694)
Q Consensus 523 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 602 (694)
..||+.|+|||++.+..++.++||||||+++|||++|+.||......... . ..... ++... ...+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~-~~~~~--------~~~~~--~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--K-ELKQR--------ILNDS--VTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--H-HHHHh--------hcccC--CCCccc
Confidence 46899999999999999999999999999999999999999754322110 0 00000 01000 011223
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005492 603 GIMTVATLAKRCLNLNGKMRP-----TMKEVAFE 631 (694)
Q Consensus 603 ~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 631 (694)
.+..+.+++.+||+.+|++|| ++.+++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 456688999999999999999 56666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=312.99 Aligned_cols=253 Identities=26% Similarity=0.305 Sum_probs=208.2
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
+.|+..+.||.|.-|+||++.+++ +..+|+|++... ......+...|-+||+.++||-++.|++.++.++..+|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 457778899999999999999886 589999988653 3445566777999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc-
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV- 514 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~- 514 (694)
|||+||+|...++++.. ..+++..+.-++.+|+-||+|||..| ||.|||||+||||.++|++-|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999999887644 46999999999999999999999999 99999999999999999999999998654311
Q ss_pred --------------------------------C-Cc---------------------ceeeeeecCCCCCCCcccccCCC
Q 005492 515 --------------------------------D-QT---------------------HLTTKVQGTFGYVDPEYFQSSQF 540 (694)
Q Consensus 515 --------------------------------~-~~---------------------~~~~~~~gt~~y~aPE~~~~~~~ 540 (694)
. .. ..+...+||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 00 01122458999999999999999
Q ss_pred CceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCC
Q 005492 541 TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGK 620 (694)
Q Consensus 541 t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~ 620 (694)
+.++|+|+|||+||||+.|..||.+.+..+ .+..++-..+.-....+....+.+||++.|.+||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~---------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchh---------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 999999999999999999999999877654 22333333322222224556788999999999999
Q ss_pred CCCC----HHHHHHH
Q 005492 621 MRPT----MKEVAFE 631 (694)
Q Consensus 621 ~RPt----~~evl~~ 631 (694)
+|.. +.||-++
T Consensus 378 kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhccccchHHhhcC
Confidence 9998 6666543
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=321.49 Aligned_cols=257 Identities=25% Similarity=0.443 Sum_probs=206.1
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCcc
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 431 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~ 431 (694)
.++|+..+.||+|+||.||++... ++..+|+|.+.... .....++.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999864 36789999887533 34456799999999999999999999999999999
Q ss_pred EEEEEeCCCCChHHHHhccc-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccccccc
Q 005492 432 LLVYEFIPNGTLYQYIHNQI-------------------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSAN 492 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~N 492 (694)
++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999997532 1124789999999999999999999998 9999999999
Q ss_pred EEECCCCcEEEeecCCccccccCCc-ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCcc
Q 005492 493 ILLDDKYRAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 570 (694)
Q Consensus 493 Ill~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~ 570 (694)
||+++++.+||+|||+++....... ........+..|+|||.+....++.++||||||+++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876533221 11122234667999999998999999999999999999998 888886543321
Q ss_pred CccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005492 571 DKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGG 634 (694)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 634 (694)
....+..+.... .+...+..+.+|+.+||+.+|.+||++.|+++.|++
T Consensus 241 -------~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 -------VIYYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -------HHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 112222221111 112234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=326.08 Aligned_cols=242 Identities=26% Similarity=0.371 Sum_probs=196.9
Q ss_pred ceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
+.||+|+||+||++.... ++.||||.++.. .......+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999764 789999988742 234456778899999888 799999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTT 153 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccc
Confidence 99999987643 4899999999999999999999999 9999999999999999999999999987532222 222
Q ss_pred eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAK 600 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 600 (694)
....|++.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..... ..+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-------~~~~i~~~~~----------~~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-------LFQSILEDEV----------RYP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCC----------CCC
Confidence 34568999999999999999999999999999999999999997543211 1111111110 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 005492 601 KEGIMTVATLAKRCLNLNGKMRPTM-----KEVAFE 631 (694)
Q Consensus 601 ~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~~ 631 (694)
...+..+.+|+.+||+.+|.+||++ .+++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 2234568899999999999999999 777654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=314.41 Aligned_cols=248 Identities=27% Similarity=0.444 Sum_probs=201.7
Q ss_pred ceeeeeCcEEEEEEEEcC--C--cEEEEEEccccCh-hhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQGGQGTVYKGMLTD--G--RIVAVKKSKLVDE-TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
++||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|+.++++++||||+++++.+.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999754 3 3699999876555 667789999999999999999999999988 888999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce-
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL- 519 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~- 519 (694)
++|.+++.+... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999987542 46899999999999999999999999 9999999999999999999999999998765432221
Q ss_pred -eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 520 -TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 520 -~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
.....++..|+|||.+....++.++||||||+++|||++ |+.||...+..+ . ......... ..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~---~~~~~~~~~---------~~ 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---I---LKKIDKEGE---------RL 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHHHHhcCC---------cC
Confidence 123446789999999999999999999999999999998 999986543321 1 111110000 00
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
..+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 111233467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.61 Aligned_cols=251 Identities=28% Similarity=0.420 Sum_probs=200.6
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
++|+..+.||+|+||.||+|... +++.+|+|..... .......+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35788899999999999999864 5889999987653 344456799999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999997653 3788899999999999999999999 999999999999999999999999998765322
Q ss_pred ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
......++..|+|||++.+..++.++||||||+++|+|++|+.||......+...........+.... .+.+
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-- 220 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL-- 220 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC--
Confidence 12334689999999999999999999999999999999999999975433221111111111111100 0000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
........+.+++.+||+.+|++||++.|++++
T Consensus 221 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 -PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011233568899999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=311.47 Aligned_cols=247 Identities=28% Similarity=0.480 Sum_probs=200.7
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEccccChh-hHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCChH
Q 005492 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 444 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 444 (694)
++||+|+||.||++...+++.||+|........ ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999987764333 5678999999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee-eee
Q 005492 445 QYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT-TKV 523 (694)
Q Consensus 445 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-~~~ 523 (694)
+++..... .+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++........... ...
T Consensus 81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99976433 4899999999999999999999999 99999999999999999999999999876532111111 112
Q ss_pred ecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHH
Q 005492 524 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKE 602 (694)
Q Consensus 524 ~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 602 (694)
..+..|+|||.+.+..++.++||||||++++||++ |..||....... ....+... .....+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~~---------~~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESG---------YRMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhcC---------CCCCCCcc
Confidence 23567999999998899999999999999999999 788886543221 11111111 00111223
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 603 GIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 603 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
.+..+.+++.+||+.+|.+||++.||++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 3457899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=317.74 Aligned_cols=255 Identities=26% Similarity=0.405 Sum_probs=201.6
Q ss_pred HHHhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeC-----
Q 005492 356 EKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLET----- 428 (694)
Q Consensus 356 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~----- 428 (694)
+.+++.|+..+.||+|+||.||+|...+ ++.+|+|...... .....+.+|+.+++++ +|+||+++++++.+.
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 3466789999999999999999999764 8899999876533 3456788999999998 799999999998764
Q ss_pred -CccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecC
Q 005492 429 -EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 507 (694)
Q Consensus 429 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFG 507 (694)
...++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence 35789999999999999998642 235899999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCcceeeeeecCCCCCCCcccc-----cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHh
Q 005492 508 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 582 (694)
Q Consensus 508 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 582 (694)
++....... .......|+..|+|||++. ...++.++||||||+++|||++|+.||........ ....
T Consensus 157 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-------~~~~ 228 (272)
T cd06637 157 VSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-------LFLI 228 (272)
T ss_pred Cceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-------HHHH
Confidence 987653222 1233456899999999986 34588899999999999999999999964332110 0000
Q ss_pred hhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 583 NENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 583 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
........ .....+..+.+|+.+||+.+|.+||++.+++++
T Consensus 229 ~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 229 PRNPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred hcCCCCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 11100001 111233568899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=319.69 Aligned_cols=264 Identities=25% Similarity=0.394 Sum_probs=204.1
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-----------------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCccee
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-----------------DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVK 420 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~ 420 (694)
.++|++.++||+|+||.||++... +...+|+|.+... ......+|.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356899999999999999998533 2346899988753 3445678999999999999999999
Q ss_pred EEeEEeeCCccEEEEEeCCCCChHHHHhcccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccccccc
Q 005492 421 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIE--------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSAN 492 (694)
Q Consensus 421 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~N 492 (694)
+++++.+.+..++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999976421 124788899999999999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCCccccccCCcce-eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh--CCCCCccCCCc
Q 005492 493 ILLDDKYRAKVSDFGTSRSVMVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT--GQKPIRAINTD 569 (694)
Q Consensus 493 Ill~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt--g~~p~~~~~~~ 569 (694)
||+++++.+||+|||+++.+....... .....++..|+|||....+.++.++||||||+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999987654322111 112234678999999888899999999999999999998 67888654432
Q ss_pred cCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005492 570 EDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGG 634 (694)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 634 (694)
+. ............. ......+...+..+.+|+.+||+.+|++||++.+|++.|++
T Consensus 241 ~~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QV---IENTGEFFRDQGR------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH---HHHHHHHHhhccc------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 21 1101010000000 00001112234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=312.52 Aligned_cols=249 Identities=32% Similarity=0.510 Sum_probs=205.1
Q ss_pred ceeeeeCcEEEEEEEEcC----CcEEEEEEccccChh-hHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQGGQGTVYKGMLTD----GRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
+.||+|+||.||++.... +..+|+|.+...... ..+.+.+|+++++.++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999764 788999998764433 378899999999999999999999999999999999999999
Q ss_pred CChHHHHhcccC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 441 GTLYQYIHNQIE------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 441 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999987521 246999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCc-ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhh
Q 005492 515 DQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592 (694)
Q Consensus 515 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 592 (694)
... .......++..|+|||.+....++.++||||||++++||++ |..||......+ +...+..+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~------ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGY------ 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC------
Confidence 321 12233457889999999998899999999999999999999 699997653221 112221111
Q ss_pred hhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 593 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
....+...+..+.+++.+||+.+|.+||++.|++++|+
T Consensus 225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11112233567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=328.97 Aligned_cols=261 Identities=28% Similarity=0.433 Sum_probs=203.8
Q ss_pred hcCCCccceeeeeCcEEEEEEEE------cCCcEEEEEEccccC-hhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCC-
Q 005492 359 TDNYNANRILGQGGQGTVYKGML------TDGRIVAVKKSKLVD-ETNVEQFINEVVILSQI-NHRNIVKLLGCCLETE- 429 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~- 429 (694)
.++|++.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46799999999999999999974 246889999987532 33456788999999999 6899999999887654
Q ss_pred ccEEEEEeCCCCChHHHHhcccC---------------------------------------------------------
Q 005492 430 VPLLVYEFIPNGTLYQYIHNQIE--------------------------------------------------------- 452 (694)
Q Consensus 430 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 452 (694)
..++||||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999999975321
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc-eeeeee
Q 005492 453 -------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQ 524 (694)
Q Consensus 453 -------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~ 524 (694)
...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 123788899999999999999999999 999999999999999999999999998765322211 111233
Q ss_pred cCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHH
Q 005492 525 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEG 603 (694)
Q Consensus 525 gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 603 (694)
++..|+|||.+....++.++||||||+++|||++ |..||......+ .+...+..+.... .+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~---------~~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMR---------APDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCCC---------CCCCC
Confidence 5678999999998999999999999999999997 899986543221 1111121111110 01112
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 005492 604 IMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRT 637 (694)
Q Consensus 604 ~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~ 637 (694)
...+.+++.+||+.+|++||++.||+++|+.+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3468899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=316.71 Aligned_cols=256 Identities=26% Similarity=0.425 Sum_probs=206.1
Q ss_pred cCCCccceeeeeCcEEEEEEEEc------CCcEEEEEEccccChh-hHHHHHHHHHHHhhccCCcceeEEeEEeeCCccE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 432 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~ 432 (694)
++|+..+.||+|+||.||+|..+ +.+.+++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999964 2467999987654433 4678999999999999999999999999999999
Q ss_pred EEEEeCCCCChHHHHhcccCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeec
Q 005492 433 LVYEFIPNGTLYQYIHNQIEE------FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 506 (694)
Q Consensus 433 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DF 506 (694)
+||||+++++|.++++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999865422 25899999999999999999999999 999999999999999999999999
Q ss_pred CCccccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhc
Q 005492 507 GTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINEN 585 (694)
Q Consensus 507 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 585 (694)
|+++..............++..|+|||.+.+...+.++||||||+++++|++ |..||....... .......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~~~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HHHHHHcC
Confidence 9987543332222233346778999999988889999999999999999999 788886543221 11112111
Q ss_pred chhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 586 RLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 586 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
.+.. ......+..+.+++.+||+.+|.+||++.|++..|.
T Consensus 235 ~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1110 011223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=314.67 Aligned_cols=253 Identities=34% Similarity=0.542 Sum_probs=201.3
Q ss_pred CCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHH--HHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 362 YNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVE--QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
|+..+.||+|+||+||++.... ++.+|+|........... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678899999999999999876 678999998875544333 3456999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++++|.+++... ..+++..++.++.|+++||++||+.+ |+|+||||+||++++++.++|+|||.+... .....
T Consensus 81 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNE 153 (260)
T ss_dssp TTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTS
T ss_pred cccccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc-ccccc
Confidence 999999999832 25899999999999999999999999 999999999999999999999999998754 12223
Q ss_pred eeeeeecCCCCCCCcccc-cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~-~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
......++..|+|||.+. ....+.++||||||+++++|++|..||........ ...+..... ... ......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~---~~~~~~~~~----~~~-~~~~~~ 225 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ---LEIIEKILK----RPL-PSSSQQ 225 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH---HHHHHHHHH----THH-HHHTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhh---hhhhhhccc----ccc-cccccc
Confidence 344556889999999998 88899999999999999999999999976521111 000101000 000 000000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.......+.+++.+||+.+|++||++.+++++
T Consensus 226 --~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 226 --SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00112679999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=318.02 Aligned_cols=270 Identities=26% Similarity=0.390 Sum_probs=207.3
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-----CCcEEEEEEccccChh-hHHHHHHHHHHHhhccCCcceeEEeEEee--CCcc
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-----DGRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLE--TEVP 431 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~g~~~~--~~~~ 431 (694)
+.|+..+.||+|+||.||++.+. .+..+|||.++..... ..+.|.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999864 3678999998764443 56789999999999999999999999887 5578
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999999986543 4999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCcce--eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhh
Q 005492 512 VMVDQTHL--TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589 (694)
Q Consensus 512 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (694)
........ .....++..|+|||.+....++.++||||||++++||++|+.|+............. .........+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLLE 237 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHHH
Confidence 65322211 112234567999999998899999999999999999999999986533221110000 000000000111
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 590 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
.+........+...+.++.+|+.+||+.+|++||+|.||+++|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111111223346789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.06 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=193.4
Q ss_pred ceeeeeCcEEEEEEEEcC---CcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCC
Q 005492 366 RILGQGGQGTVYKGMLTD---GRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG 441 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~g 441 (694)
+.||+|+||.||+|...+ +..+|+|+++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998654 4579999887543 234457899999999999999999999999999999999999999
Q ss_pred ChHHHHhcccC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce
Q 005492 442 TLYQYIHNQIE--EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519 (694)
Q Consensus 442 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 519 (694)
+|.++++.... ....++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999976422 234678888999999999999999999 9999999999999999999999999987543322211
Q ss_pred -eeeeecCCCCCCCcccccC-------CCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhh
Q 005492 520 -TTKVQGTFGYVDPEYFQSS-------QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590 (694)
Q Consensus 520 -~~~~~gt~~y~aPE~~~~~-------~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (694)
.....++..|+|||++... .++.++||||||+++|||++ |+.||......+. .. ..+. +....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~---~~~~-~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LT---YTVR-EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HH---HHhh-cccCCC
Confidence 1223467889999998642 35889999999999999996 9999965433221 00 0111 111111
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 591 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
.++.+. ......+.+++.+|+ .+|++|||+.||++.|+
T Consensus 231 ~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111 112345778999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=311.85 Aligned_cols=250 Identities=25% Similarity=0.362 Sum_probs=204.4
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
+|++.++||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999976 4889999987542 3445678889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++++|.+++.... ...+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++...... .
T Consensus 81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-A 155 (255)
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc-c
Confidence 9999999987542 235899999999999999999999999 9999999999999999999999999987654322 1
Q ss_pred eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
......+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+... ....+..+....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~--------- 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN-------LILKVCQGSYKP--------- 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH-------HHHHHhcCCCCC---------
Confidence 2233558899999999999899999999999999999999999996533211 111111111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+......+.+|+.+||+.+|++||++.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 112234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.91 Aligned_cols=251 Identities=28% Similarity=0.345 Sum_probs=200.8
Q ss_pred CCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 362 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677889999999999999976 48899999876422 22345678899999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999999865422 35899999999999999999999998 99999999999999999999999999875532221
Q ss_pred ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||........... ....... ...
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~~----------~~~ 222 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKE----------VQE 222 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhhh----------hhh
Confidence 1234589999999999999999999999999999999999999976432211000 0000000 001
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPT-----MKEVAFE 631 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 631 (694)
.........+.+|+.+||+.+|++||+ +.|++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 112233456889999999999999999 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=323.91 Aligned_cols=243 Identities=26% Similarity=0.350 Sum_probs=191.7
Q ss_pred ceeeeeCcEEEEEEEEcC-CcEEEEEEccccC---hhhHHHHHHHH-HHHhhccCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD---ETNVEQFINEV-VILSQINHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
+.||+|+||+||++.... ++.+|+|.+.... ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 479999999999999764 7889999876421 22233444444 456788999999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~ 153 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTT 153 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCc
Confidence 99999997642 4788899999999999999999999 9999999999999999999999999987543222 223
Q ss_pred eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAK 600 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 600 (694)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+..... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~~~----------~~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-------MYDNILNKPL----------QLK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-------HHHHHHhCCc----------CCC
Confidence 34569999999999999999999999999999999999999997543221 1111111110 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 601 KEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 601 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
......+.+++.+||+.+|.+||++.+.+..+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 12345678999999999999999987554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=322.06 Aligned_cols=260 Identities=29% Similarity=0.427 Sum_probs=203.0
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
++|++.+.||+|+||.||++... ++..+|+|.+... ......++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999976 4788999987653 334456789999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
+++++|.++++.. ..+++..+..++.|+++||.|||+ .+ ++|+||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999999764 248999999999999999999998 46 9999999999999999999999999987553221
Q ss_pred cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhc-----------
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN----------- 585 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 585 (694)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ...+.......
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL---EAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH---HHhhcCccccccccCCcccccC
Confidence 2234588999999999888899999999999999999999999865432211 10000000000
Q ss_pred ---------chhhhhhhhhh---hhh-hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 586 ---------RLFEILDARVL---KEA-KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 586 ---------~~~~~~d~~~~---~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
...+..+.... ... .......+.+++.+||+.+|++||++.+|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000 000 01134568899999999999999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=318.32 Aligned_cols=261 Identities=24% Similarity=0.345 Sum_probs=195.6
Q ss_pred CCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccC--hhhHHHHHHHHHHHhhc---cCCcceeEEeEEeeC-----C
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD--ETNVEQFINEVVILSQI---NHRNIVKLLGCCLET-----E 429 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~g~~~~~-----~ 429 (694)
+|+..+.||+|+||+||+|...+ ++.||+|.++... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47888999999999999999764 8899999876532 22234566777777665 799999999998653 3
Q ss_pred ccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCc
Q 005492 430 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS 509 (694)
Q Consensus 430 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla 509 (694)
..++||||+++ +|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999975 8999887643 235899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhc---c
Q 005492 510 RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN---R 586 (694)
Q Consensus 510 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~ 586 (694)
+...... ......++..|+|||++.+..++.++||||||+++|||++|++||......+. ........... .
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~ 230 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLIGLPPEDD 230 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH---HHHHHHHhCCCChhh
Confidence 7654221 22334578999999999989999999999999999999999999865433211 11111111000 0
Q ss_pred hhh-------hhh---hhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 587 LFE-------ILD---ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 587 ~~~-------~~d---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+.. ... ..............+.+|+.+||+.||++|||+.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 000 000011112334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=330.81 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=197.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|+..+.||+|+||.||++...+ ++.||||.+... .......+.+|+.++.+++||||+++++.+.+.+..+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468889999999999999999764 889999988642 2344667888999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++|+|.+++.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999997642 4899999999999999999999999 999999999999999999999999998754321
Q ss_pred Cc----------------------------------ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCC
Q 005492 516 QT----------------------------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK 561 (694)
Q Consensus 516 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~ 561 (694)
.. .......||+.|+|||++.+..++.++|||||||+||||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 00113458999999999999999999999999999999999999
Q ss_pred CCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 005492 562 PIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPT---MKEVAFE 631 (694)
Q Consensus 562 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~~ 631 (694)
||......+ ............. +.+. ......+.+++.+++ .+|.+|++ +.|++++
T Consensus 235 Pf~~~~~~~------~~~~i~~~~~~~~-~p~~------~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQE------TYRKVMNWKETLV-FPPE------VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHH------HHHHHHcCCCcee-cCCC------CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 997654322 1111111000000 0000 012345778888877 49999986 5555543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=324.04 Aligned_cols=242 Identities=26% Similarity=0.382 Sum_probs=195.5
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcc-CCcceeEEeEEeeCCccEEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lv~ 435 (694)
+|+..+.||+|+||.||++... +++.||+|.+... .....+.+..|+.++..+. |++|+++++++.+.+..+|||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999976 4889999987642 2344567888999998885 577888999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999987543 4899999999999999999999999 999999999999999999999999998754322
Q ss_pred CcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
. .......||+.|+|||++.+..++.++||||||++||||++|+.||....... ....+.....
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~~~~-------- 218 (323)
T cd05615 155 G-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-------LFQSIMEHNV-------- 218 (323)
T ss_pred C-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC--------
Confidence 2 12233458999999999999999999999999999999999999997643221 1111111110
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMK 626 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 626 (694)
..+......+.+++.+||+.+|.+|++..
T Consensus 219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 --SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred --CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 11122345678999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.04 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=202.3
Q ss_pred CCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 362 YNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
|++.+.||+|+||.||++.... +..+++|.+........+.+.+|+++++.++||||+++++++.+.+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5677889999999999999865 778899988766666778899999999999999999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
++|..++.... .++++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (282)
T cd06643 87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 160 (282)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence 99999887532 35899999999999999999999999 9999999999999999999999999987643221 122
Q ss_pred eeeecCCCCCCCcccc-----cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
....++..|+|||++. ...++.++|||||||++|||++|+.||......+ ........ ....+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~-~~~~~----- 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKS-EPPTL----- 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHHHhhc-CCCCC-----
Confidence 3345889999999984 4557889999999999999999999986543211 11111111 00000
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0112234568899999999999999999998865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=298.00 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=206.7
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccCh--------hhHHHHHHHHHHHhhc-cCCcceeEEeEEeeC
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDE--------TNVEQFINEVVILSQI-NHRNIVKLLGCCLET 428 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~ 428 (694)
.+.|...+.||+|..++|-+...+. |..+|+|++..... ...+.-++|+.||+++ .||||++|.+++..+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 4568888999999999999888654 78899997654211 1244557799999998 699999999999999
Q ss_pred CccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCC
Q 005492 429 EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 508 (694)
Q Consensus 429 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGl 508 (694)
...++|+|.|+.|.|++||.... .++++...+|++|+.+|+.|||..+ |+||||||+|||+|++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 99999999999999999998653 5999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeecCCCCCCCccccc------CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHh
Q 005492 509 SRSVMVDQTHLTTKVQGTFGYVDPEYFQS------SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 582 (694)
Q Consensus 509 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 582 (694)
+..+... .......||++|+|||.+.. ..|+...|+|++||+||.|+.|.+||..... ..++..+
T Consensus 170 a~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------mlMLR~I 240 (411)
T KOG0599|consen 170 ACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------MLMLRMI 240 (411)
T ss_pred eeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------HHHHHHH
Confidence 9876533 33456789999999999853 3578899999999999999999999965321 1244444
Q ss_pred hhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 583 NENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 583 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+++.. + ......+....+.+||.+||+.||.+|.|++|++++
T Consensus 241 meGkyq-F-----~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 241 MEGKYQ-F-----RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred Hhcccc-c-----CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 444331 1 112224556678899999999999999999999875
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.85 Aligned_cols=263 Identities=25% Similarity=0.375 Sum_probs=200.8
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
+|+..+.||+|++|.||+|... ++..||+|+++.. .....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999976 5889999987653 233456788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
++ ++|.+++........+++..++.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 689999876544456999999999999999999999999 99999999999999999999999999876543221
Q ss_pred ceeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh---c--------
Q 005492 518 HLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE---N-------- 585 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~-------- 585 (694)
......+++.|+|||.+.+. .++.++||||||++++||++|+.||....... ...... ..... .
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIF-RILGTPTEDVWPGVTSL 232 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH-HHhCCCChhhhhcchhh
Confidence 12233468899999988654 57899999999999999999999997543211 000000 00000 0
Q ss_pred -chhhhhhh---hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 586 -RLFEILDA---RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 586 -~~~~~~d~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
......+. ............++.+++.+||+.||.+|||+.+|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000 00001111234567899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=339.79 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=195.0
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeC--------
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLET-------- 428 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~-------- 428 (694)
..++|...++||+|+||.||+|... .++.||||++.... ....+|+.++++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3567999999999999999999975 48899999875321 2345799999999999999999987532
Q ss_pred CccEEEEEeCCCCChHHHHhcc-cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCC-cEEEeec
Q 005492 429 EVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDF 506 (694)
Q Consensus 429 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~-~~kl~DF 506 (694)
...++||||+++ +|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999985 777777542 22346899999999999999999999999 99999999999999664 7999999
Q ss_pred CCccccccCCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhc
Q 005492 507 GTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN 585 (694)
Q Consensus 507 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 585 (694)
|+++....... .....||+.|+|||++.+ ..++.++|||||||+||||++|.+||.+....+. .......+...
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~---~~~i~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ---LVRIIQVLGTP 290 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCC
Confidence 99986643222 223458999999999865 4689999999999999999999999976543221 11111111110
Q ss_pred chh---------------hhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 586 RLF---------------EILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 586 ~~~---------------~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
... .+....+....+...+.++.+|+.+||+.+|.+|||+.|++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000 0000111111122234678999999999999999999999864
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.40 Aligned_cols=252 Identities=28% Similarity=0.376 Sum_probs=214.1
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccCh---hhHHHHHHHHHHHhhcc-CCcceeEEeEEeeCCccE
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDE---TNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPL 432 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~ 432 (694)
....|+..+.||+|.||.||+++.+. |+.+|+|.+..... ...+.+.+|+.+|+++. |||||++.+.+.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34678889999999999999999876 99999998765333 34578999999999998 999999999999999999
Q ss_pred EEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECC----CCcEEEeecCC
Q 005492 433 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDFGT 508 (694)
Q Consensus 433 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~----~~~~kl~DFGl 508 (694)
||||++.+|.|.+.+... .+++.....++.|++.|++|||+.+ |+||||||+|+|+.. ++.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999876 2999999999999999999999999 999999999999953 35799999999
Q ss_pred ccccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchh
Q 005492 509 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 588 (694)
Q Consensus 509 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (694)
+..... ........||+.|+|||++....|+..+||||+||++|.|++|.+||...+..+. + ..+..+.+
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~------~-~~i~~~~~- 255 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI------F-LAILRGDF- 255 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH------H-HHHHcCCC-
Confidence 987755 4456678899999999999999999999999999999999999999987665431 1 12222222
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 589 EILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 589 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
....+........+.+++..+|..||.+|+|+.+++++
T Consensus 256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11222233456678899999999999999999999985
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.06 Aligned_cols=239 Identities=24% Similarity=0.405 Sum_probs=190.8
Q ss_pred ceeeeeCcEEEEEEEEcC-------------CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccE
Q 005492 366 RILGQGGQGTVYKGMLTD-------------GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 432 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~ 432 (694)
+.||+|+||.||+|.+.. ...||+|.+..........|.+|+.++++++||||+++++++.+....+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358899877655556678899999999999999999999999999999
Q ss_pred EEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCc-------EEEee
Q 005492 433 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR-------AKVSD 505 (694)
Q Consensus 433 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~-------~kl~D 505 (694)
+||||+++++|..+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999999987543 24899999999999999999999999 999999999999986654 89999
Q ss_pred cCCccccccCCcceeeeeecCCCCCCCcccc-cCCCCceeeEEehhHHHHHHH-hCCCCCccCCCccCccHHHHHHHHhh
Q 005492 506 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEIL-TGQKPIRAINTDEDKSLVGYFLQAIN 583 (694)
Q Consensus 506 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~sDvwSlGvll~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~ 583 (694)
||++...... ....++..|+|||.+. ...++.++||||||++||||+ +|..|+......+. .....
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~~ 223 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFYE 223 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHHh
Confidence 9998654322 2234788999999886 467899999999999999998 58888765332210 01000
Q ss_pred hcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 584 ENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 584 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
... .. .......+.+|+.+||+.+|.+||++.+|++.|
T Consensus 224 -~~~-~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 -GQC-ML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -cCc-cC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 00 011234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.24 Aligned_cols=250 Identities=30% Similarity=0.493 Sum_probs=194.9
Q ss_pred ceeeeeCcEEEEEEEEcC----CcEEEEEEccc-cChhhHHHHHHHHHHHhhccCCcceeEEeEEee-CCccEEEEEeCC
Q 005492 366 RILGQGGQGTVYKGMLTD----GRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLE-TEVPLLVYEFIP 439 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~-~~~~~lv~e~~~ 439 (694)
+.||+|+||.||+|.+.+ ...+|+|++.. ......+.+.+|+.+++.++||||+++++++.. +...++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 45799998754 334556789999999999999999999998764 556899999999
Q ss_pred CCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc-
Q 005492 440 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH- 518 (694)
Q Consensus 440 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~- 518 (694)
+++|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999976432 3678888999999999999999998 999999999999999999999999999765432111
Q ss_pred --eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhC-CCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhh
Q 005492 519 --LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTG-QKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 519 --~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
......++..|+|||.+....++.++||||||+++|||++| .+||......+ +. ..+..+...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~----~~~~~~~~~------- 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---IT----VYLLQGRRL------- 221 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHhcCCCC-------
Confidence 11123456789999999988999999999999999999995 55664332111 11 111111000
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~ 636 (694)
..+...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 222 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 --LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 001122356889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.74 Aligned_cols=260 Identities=25% Similarity=0.365 Sum_probs=198.7
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccc--cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC-----
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETE----- 429 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~----- 429 (694)
..++|+..+.||+|+||.||++.... ++.||+|++.. ........+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 35789999999999999999999754 88999998864 23445677889999999999999999999986543
Q ss_pred -ccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCC
Q 005492 430 -VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 508 (694)
Q Consensus 430 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGl 508 (694)
..++||||+++ +|.+.++. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999975 56666643 3788999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcc--
Q 005492 509 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR-- 586 (694)
Q Consensus 509 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 586 (694)
++..... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+. ...+........
T Consensus 170 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~ 244 (359)
T cd07876 170 ARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ---WNKVIEQLGTPSAE 244 (359)
T ss_pred ccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCcHH
Confidence 9754322 122334689999999999999999999999999999999999999976532210 000111000000
Q ss_pred --------hhhhhhhh---------------hh---hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 587 --------LFEILDAR---------------VL---KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 587 --------~~~~~d~~---------------~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
........ .. .+........+.+|+.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 00 00011123568899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=315.61 Aligned_cols=252 Identities=26% Similarity=0.377 Sum_probs=204.4
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
+.|++.++||+|+||.||+|.... ++.+|+|..........+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 568899999999999999999865 8899999988777777888999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++++|..++.+... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++...... ..
T Consensus 92 ~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~ 165 (292)
T cd06644 92 PGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQ 165 (292)
T ss_pred CCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-cc
Confidence 99999998865432 4899999999999999999999998 999999999999999999999999998754322 11
Q ss_pred eeeeeecCCCCCCCcccc-----cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDA 593 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 593 (694)
......++..|+|||++. ...++.++||||||+++|||++|+.||......+ ....... ......
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~-~~~~~~--- 235 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAK-SEPPTL--- 235 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHHhc-CCCccC---
Confidence 223445888999999984 3457889999999999999999999986543211 1111111 100000
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 594 RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 594 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..+......+.+++.+||+.+|++||++.+++++
T Consensus 236 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 ----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0112234568899999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.58 Aligned_cols=257 Identities=26% Similarity=0.486 Sum_probs=206.2
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-Cc----EEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GR----IVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l 433 (694)
.+|+..+.||+|+||.||+|..++ ++ .+|+|...... ......+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 457888999999999999999753 33 58999876543 3456789999999999999999999999987 78899
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999986533 4899999999999999999999988 9999999999999999999999999998765
Q ss_pred cCCccee-eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhh
Q 005492 514 VDQTHLT-TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591 (694)
Q Consensus 514 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (694)
....... ....++..|+|||.+....++.++||||||+++|||++ |+.||......+ +...+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~--- 230 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGERL--- 230 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhCCCCC---
Confidence 3322211 11223568999999988899999999999999999998 999997644322 11222111110
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~ 638 (694)
..+......+.+++.+||..+|.+||++.++++.|+.+.+.
T Consensus 231 ------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 231 ------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 01111234578999999999999999999999999987554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.30 Aligned_cols=251 Identities=26% Similarity=0.481 Sum_probs=202.5
Q ss_pred CCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccC------hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD------ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv 434 (694)
+|...+.||+|+||.||+|...+++.+|+|.++... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999876422 22345688999999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
+||+++++|.+++.+.. .+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999997642 4889999999999999999999999 99999999999999999999999999876532
Q ss_pred CC-----cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhh
Q 005492 515 DQ-----THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589 (694)
Q Consensus 515 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (694)
.. ........++..|+|||++.+..++.++||||||+++++|++|+.||......+. ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~~~~~-- 226 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA------MFYIGAHRGL-- 226 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH------HHHhhhccCC--
Confidence 11 1112234588999999999999999999999999999999999999965432110 0000000000
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 590 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
....+......+.+++.+||+.+|.+||++.+++++
T Consensus 227 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 227 ------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred ------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 011122344568899999999999999999998863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=321.35 Aligned_cols=262 Identities=24% Similarity=0.371 Sum_probs=201.0
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
++|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56889999999999999999976 47899999886532 33345678899999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
++ ++|.+++..... .+++..+..++.|+++||+|||+.+ |+|+||||+|||+++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 599998876433 4889999999999999999999999 99999999999999999999999999876433221
Q ss_pred ceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhh---hcchhhhhh-
Q 005492 518 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN---ENRLFEILD- 592 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d- 592 (694)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ...+...+. ...+..+++
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhcc
Confidence 1223346889999998865 4578999999999999999999999976543221 111111110 000000000
Q ss_pred --------hhhh----hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 593 --------ARVL----KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 593 --------~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+... ..........+.+||.+||+.||.+|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 00111234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=347.61 Aligned_cols=261 Identities=24% Similarity=0.349 Sum_probs=205.3
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|++.++||+|+||.||+|.... ++.||||++... .....+.|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 578999999999999999999764 899999988642 2234567999999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecC
Q 005492 436 EFIPNGTLYQYIHNQIE--------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 507 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFG 507 (694)
||+++++|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999875211 124667888999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCc-----------------ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCcc
Q 005492 508 TSRSVMVDQT-----------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570 (694)
Q Consensus 508 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~ 570 (694)
+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621110 01112458999999999999999999999999999999999999996533211
Q ss_pred CccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcccc
Q 005492 571 DKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRP-TMKEVAFELGGIRT 637 (694)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~l~~ 637 (694)
. . ... . +.++... ......+..+.+++.+||+.+|++|| +++++++.|+....
T Consensus 239 i---~--~~~-----~---i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 I---S--YRD-----V---ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred h---h--hhh-----h---ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 0 000 0 0000000 00123345688999999999999995 56777777776543
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.68 Aligned_cols=248 Identities=27% Similarity=0.411 Sum_probs=205.2
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
++|+..+.||.|++|.||+|... +++.+|+|.+.... ......+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999976 48899999876543 44567789999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999999764 5899999999999999999999999 9999999999999999999999999998765332
Q ss_pred ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
.......++..|+|||++.+..++.++||||||+++|+|++|+.||......+ ....+......
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-------~~~~~~~~~~~--------- 216 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-------VLFLIPKNNPP--------- 216 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-------HHHHhhhcCCC---------
Confidence 12233457889999999998889999999999999999999999996543211 11111111110
Q ss_pred hhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 598 EAKKE-GIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 598 ~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..... .+..+.+++.+||..+|++||++++++++
T Consensus 217 ~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 217 SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11111 34568899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.88 Aligned_cols=249 Identities=28% Similarity=0.503 Sum_probs=201.2
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccCh---------hhHHHHHHHHHHHhhccCCcceeEEeEEeeCCc
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE---------TNVEQFINEVVILSQINHRNIVKLLGCCLETEV 430 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~ 430 (694)
+|...+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999875 478999998764322 123568899999999999999999999999999
Q ss_pred cEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcc
Q 005492 431 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~ 510 (694)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999997642 4889999999999999999999998 9999999999999999999999999988
Q ss_pred ccccCCcc-----eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhc
Q 005492 511 SVMVDQTH-----LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN 585 (694)
Q Consensus 511 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 585 (694)
........ ......++..|+|||.+....++.++||||||+++|+|++|+.||....... ..... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~~~ 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ------AIFKI-GEN 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH------HHHHH-hcc
Confidence 76522111 1122447889999999998899999999999999999999999997543211 01010 000
Q ss_pred chhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 586 RLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 586 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.....+...+..+.+++.+||+.+|.+||++.||+++
T Consensus 228 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 228 ---------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ---------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0111222344678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.49 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=206.3
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
++|...+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 67999999999999999999974 58999999987666666678899999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++++|.+++.+. .+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred CCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence 999999998653 4899999999999999999999998 99999999999999999999999999876543322
Q ss_pred eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......... .....+ ... ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~-~~~-------~~ 236 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG-TPE-------LQ 236 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC-CCC-------CC
Confidence 1223457889999999999899999999999999999999999996544322100 000000 000 01
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+......+.+++.+||+.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112334567899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.35 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=202.8
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
++|...+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 56888899999999999999975 48899999987665556677889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++++|.+++.... .+++.+++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++...... ..
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~ 161 (267)
T cd06645 89 GGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IA 161 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-cc
Confidence 9999999987543 4899999999999999999999999 999999999999999999999999998765322 12
Q ss_pred eeeeeecCCCCCCCcccc---cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~---~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
......|+..|+|||++. ...++.++||||||+++|+|++|+.||........ .... ...... .+..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~-~~~~~~---~~~~ 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLM-TKSNFQ---PPKL 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhh-hccCCC---CCcc
Confidence 223346899999999874 45688999999999999999999999865432211 0000 000000 0000
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
. . ....+..+.+++.+||+.+|++||++.+|+++
T Consensus 232 ~-~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 K-D-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred c-c-cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0 0 01123457899999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=310.15 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=205.6
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
++|+..+.||+|+||.||+|...+ ++.+|+|.+..... .+++.+|++++++++||||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678999999999999999999876 78999998865322 778999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999999997543 35899999999999999999999999 99999999999999999999999999886643321
Q ss_pred eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
......++..|+|||++.+..++.++||||||+++|+|++|+.||......+.. ..+..... + ...
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~-----~--~~~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPNKPP-----P--TLS 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhccCCC-----C--CCC
Confidence 223344788999999999999999999999999999999999999754332210 00000000 0 001
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+......+.+++.+||+.+|++||++.||+++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 112234568899999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=325.64 Aligned_cols=249 Identities=25% Similarity=0.435 Sum_probs=211.2
Q ss_pred CccceeeeeCcEEEEEEEEcC--C--cEEEEEEccccChh-hHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 363 NANRILGQGGQGTVYKGMLTD--G--RIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 363 ~~~~~LG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
...++||+|.||.|++|.|+. | ..||||.++..... ...+|++|+.+|-+|+|+|+++|+|+..+ ....||+|+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 346789999999999999874 3 36899999875544 67899999999999999999999999988 778899999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
++.|+|.+.|++ ..+..+-...+..++.|||.||.||..++ +|||||..+|+||-....+||+||||.+.+...+.
T Consensus 192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999999998 34557889999999999999999999999 99999999999999999999999999999876655
Q ss_pred ceee--eeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 518 HLTT--KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 518 ~~~~--~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
.... ...-...|+|||.+....++.++|||+|||+||||+| |..||.+..... +.+.+|..
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~iD~~ 331 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNIDAG 331 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhcccc
Confidence 4322 2334668999999999999999999999999999998 789998765432 22333333
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
-+-..++.+++.+.++++.||..+|.+|||+..|.+.+
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 33344567888999999999999999999999997543
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=314.33 Aligned_cols=251 Identities=25% Similarity=0.315 Sum_probs=199.6
Q ss_pred CCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 362 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
|+..+.||+|+||+||++... +++.+|+|.+.... ......+.+|++++++++|+||+++++++.+++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999975 58899999876432 23345678899999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 999999999875432 35999999999999999999999999 9999999999999999999999999987653221
Q ss_pred ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
......|+..|+|||++.+..++.++|+||||+++|||++|+.||......... ..+...+.... .
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~~----------~ 222 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLETE----------E 222 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhccc----------c
Confidence 122346899999999999899999999999999999999999999754322110 00111111100 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPT-----MKEVAFE 631 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 631 (694)
.........+.+|+.+||+.+|++||+ +.+++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 111223456789999999999999999 5565543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=322.27 Aligned_cols=240 Identities=27% Similarity=0.314 Sum_probs=188.1
Q ss_pred eeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhc---cCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 368 LGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQI---NHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 368 LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l---~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
||+|+||+||+|.... ++.||||++... .......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999764 899999987542 222344556677777665 699999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~ 153 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTT 153 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCc
Confidence 99999987542 4899999999999999999999999 9999999999999999999999999987543222 223
Q ss_pred eeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEA 599 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 599 (694)
....||+.|+|||++.+. .++.++|||||||+||||++|+.||......+ ....+..+.. .+ ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~-~~-----~~-- 218 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKV-RF-----PK-- 218 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCC-CC-----CC--
Confidence 345689999999998764 48999999999999999999999997543221 1111111111 00 00
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 005492 600 KKEGIMTVATLAKRCLNLNGKMRPT----MKEVAF 630 (694)
Q Consensus 600 ~~~~~~~l~~li~~cl~~~p~~RPt----~~evl~ 630 (694)
......+.+++.+||+.+|.+||+ +.++++
T Consensus 219 -~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 -NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 112345779999999999999984 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=330.84 Aligned_cols=261 Identities=22% Similarity=0.342 Sum_probs=199.4
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
..+|.+.+.||+|+||.||++.... ++.||||... ...+.+|+++|++++|+|||++++++...+..+||||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999999865 7889999643 23467899999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+. ++|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 789998875432 5999999999999999999999999 99999999999999999999999999986543221
Q ss_pred c-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCc-cCccHHHHHHHHhhhcch-----hhh
Q 005492 518 H-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTD-EDKSLVGYFLQAINENRL-----FEI 590 (694)
Q Consensus 518 ~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~-----~~~ 590 (694)
. ......||..|+|||++.+..++.++|||||||+||||++|..|+...... ........+...+..... ...
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1 222356999999999999999999999999999999999988765433221 111111112222221110 000
Q ss_pred hhhhhhhhh-------------------hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 591 LDARVLKEA-------------------KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 591 ~d~~~~~~~-------------------~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
....+.... .......+.+|+.+||+.||.+|||+.|++++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000000 00122367899999999999999999999976
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=309.02 Aligned_cols=255 Identities=26% Similarity=0.395 Sum_probs=207.6
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
.++|+..+.||+|+||.||++... +++.+|+|..........+.+.+|+.++++++||||+++++++.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367899999999999999999975 4788999998876666778899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 99999999987642 25899999999999999999999999 9999999999999999999999999987654321
Q ss_pred ceeeeeecCCCCCCCcccccC---CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSS---QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~---~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
.......++..|+|||.+... .++.++||||||+++|||++|+.||......+. . .......+. ...
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~-~~~~~~~~~---~~~ 225 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------L-FLISKSNFP---PPK 225 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------H-HHHHhccCC---Ccc
Confidence 122334578899999999776 889999999999999999999999975442211 0 001111000 000
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+ ......+..+.+++.+||+.+|.+||++.+|+.+
T Consensus 226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 1122345678999999999999999999998853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.79 Aligned_cols=257 Identities=28% Similarity=0.526 Sum_probs=202.5
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-Cc----EEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GR----IVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l 433 (694)
++|+..+.||+|+||.||+|.+.. +. .+|+|.+.... .....++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 457788999999999999998643 43 57889876533 33345789999999999999999999998754 4679
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
++||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999976432 4899999999999999999999998 9999999999999999999999999998664
Q ss_pred cCCcc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhh
Q 005492 514 VDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591 (694)
Q Consensus 514 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (694)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~-- 231 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGERLP-- 231 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCCCC--
Confidence 32221 1122335678999999998999999999999999999997 889986543221 111121111100
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~ 638 (694)
.+......+.+++.+||..+|++||++.++++.|+.+...
T Consensus 232 -------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 232 -------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0112234678999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.87 Aligned_cols=239 Identities=23% Similarity=0.392 Sum_probs=189.7
Q ss_pred eeeeeCcEEEEEEEEcC-------------------------CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeE
Q 005492 367 ILGQGGQGTVYKGMLTD-------------------------GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKL 421 (694)
Q Consensus 367 ~LG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 421 (694)
.||+|+||.||+|.+.. ...||+|.+..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997521 13588998876555556788999999999999999999
Q ss_pred EeEEeeCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCC--
Q 005492 422 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-- 499 (694)
Q Consensus 422 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~-- 499 (694)
++++.+....+|||||+++|+|..++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999987543 25899999999999999999999998 99999999999997543
Q ss_pred -----cEEEeecCCccccccCCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHH-hCCCCCccCCCccCc
Q 005492 500 -----RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEIL-TGQKPIRAINTDEDK 572 (694)
Q Consensus 500 -----~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~ell-tg~~p~~~~~~~~~~ 572 (694)
.+|++|||++...... ....++..|+|||.+.. ..++.++||||||+++|||+ +|+.||......+..
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 3899999987644221 12346788999998865 56899999999999999995 689998765432210
Q ss_pred cHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 573 SLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
....... . .+......+.++|.+||+.+|++||++.+|++.|+
T Consensus 232 -------~~~~~~~-------~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 232 -------RFYEKKH-------R----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -------HHHHhcc-------C----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0111000 0 00111245889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.02 Aligned_cols=259 Identities=21% Similarity=0.352 Sum_probs=194.0
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
..+|++.+.||+|+||.||+|.... ++.||+|.... .....|+.++++++||||+++++++.+....++|+|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 4579999999999999999999864 77899997442 2235699999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+. ++|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 139 ~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 139 YS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred cC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 95 68988887543 35899999999999999999999999 999999999999999999999999998753221
Q ss_pred ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccH----HHHHHHHhhhcc-----h-
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL----VGYFLQAINENR-----L- 587 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~----~~~~~~~~~~~~-----~- 587 (694)
.......||..|+|||++.+..++.++||||||++||||+++..|+........... ...+...+.... +
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 122345689999999999999999999999999999999996655433222111110 011111111000 0
Q ss_pred --------hhhhhhhhhh---------hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 588 --------FEILDARVLK---------EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 588 --------~~~~d~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..+++..... .........+.+||.+||+.||.+|||+.||+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0000000000 0000123345679999999999999999999875
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=314.99 Aligned_cols=264 Identities=23% Similarity=0.346 Sum_probs=205.7
Q ss_pred cChhhHHHHhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhc-cCCcceeEEeEEee
Q 005492 350 FTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLE 427 (694)
Q Consensus 350 ~~~~~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~ 427 (694)
+.++.+..+.++|++.+.||+|+||.||++.... ++.+|+|...... ....++.+|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 3456677788999999999999999999999754 7899999876422 2346688899999999 69999999999853
Q ss_pred -----CCccEEEEEeCCCCChHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcE
Q 005492 428 -----TEVPLLVYEFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA 501 (694)
Q Consensus 428 -----~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~ 501 (694)
.+..++||||+++++|.++++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 346799999999999999986532 2345899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccccCCcceeeeeecCCCCCCCccccc-----CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHH
Q 005492 502 KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG 576 (694)
Q Consensus 502 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~ 576 (694)
||+|||+++....... ......|++.|+|||++.. ..++.++||||||+++|||++|+.||......+.
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~----- 237 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA----- 237 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-----
Confidence 9999999876543221 2233458999999999753 4578999999999999999999999875432210
Q ss_pred HHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 577 YFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 577 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
... ..........+ +......+.+|+.+||+.+|++||++.||++++
T Consensus 238 -~~~-~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 -LFK-IPRNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -Hhh-ccccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000 00110001111 111234588999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=307.93 Aligned_cols=251 Identities=30% Similarity=0.413 Sum_probs=206.3
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
+|+..+.||+|+||.||.+... +++.+++|++... ......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999865 4889999987653 345567889999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999998653 335899999999999999999999999 99999999999999999999999999876643332
Q ss_pred ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
......+++.|+|||.+.+..++.++||||||++++||++|+.||......+ .... +..+....
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~-~~~~~~~~-------- 220 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVK-IVQGNYTP-------- 220 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHH-HHcCCCCC--------
Confidence 2233458999999999998889999999999999999999999986533211 1111 11111111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
.....+..+.+++.+||+.+|.+||++.++++++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 -VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1123345688999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=328.16 Aligned_cols=261 Identities=23% Similarity=0.303 Sum_probs=201.5
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC---CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD---GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
..+|.+.+.||+|+||.||++...+ +..||+|.+... ..+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 4579999999999999999997543 578999987542 23568999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
|++. ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 166 e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9985 6888888432 35999999999999999999999999 999999999999999999999999999765433
Q ss_pred Ccc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchh------
Q 005492 516 QTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF------ 588 (694)
Q Consensus 516 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 588 (694)
... ......||+.|+|||++....++.++|||||||+||||++|+.||..............+...+......
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 221 2234569999999999999999999999999999999999999997765433222222222211111100
Q ss_pred ----hh---hhhhhhhhh--h-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 589 ----EI---LDARVLKEA--K-----KEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 589 ----~~---~d~~~~~~~--~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.. ......... + ......+.++|.+||..+|++||++.|++.+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000000000 0 0123467889999999999999999999976
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.14 Aligned_cols=250 Identities=26% Similarity=0.373 Sum_probs=202.5
Q ss_pred CCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC-ccEEEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETE-VPLLVYE 436 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~-~~~lv~e 436 (694)
+|++.+.||+|++|.||++.... ++.+|+|++... .....+.+.+|++++++++|+|++++++.+...+ ..+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47889999999999999999764 788999987643 3345667899999999999999999999876444 5789999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999998642 235899999999999999999999999 9999999999999999999999999987664322
Q ss_pred cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhh
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 596 (694)
. ......+++.|+|||++.+..++.++||||||+++++|++|+.||...+... ... .+..+.+
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~-~~~~~~~--------- 219 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVY-RIIEGKL--------- 219 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHH-HHHhcCC---------
Confidence 2 2234458899999999999999999999999999999999999986433211 111 1111111
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 597 KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 597 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
...+......+.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11122344678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=314.04 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=203.1
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
++|++.+.||+|+||.||++... .+..+|+|.+... .......+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999986 5899999987653 344567899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
+++++|..+++.......+++..+..++.|++.||.|||+. + |+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999997643334689999999999999999999974 6 999999999999999999999999998765322
Q ss_pred cceeeeeecCCCCCCCcccccC------CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhh
Q 005492 517 THLTTKVQGTFGYVDPEYFQSS------QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~------~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (694)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... ....+ ..+..+.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~-~~~~~~~---- 226 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQL-SAIVDGD---- 226 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHH-HHHhhcC----
Confidence 12233478899999998554 35889999999999999999999996533211 11111 1111111
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 591 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
....+......+.+++.+||+.+|++||++.+++++
T Consensus 227 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 -----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -----CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111223355678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=312.41 Aligned_cols=250 Identities=32% Similarity=0.495 Sum_probs=199.1
Q ss_pred ceeeeeCcEEEEEEEEcC-------CcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 366 RILGQGGQGTVYKGMLTD-------GRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
+.||+|+||.||+|...+ +..+|||.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998753 2579999875432 34567899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhccc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCC-----cEEEeecCC
Q 005492 438 IPNGTLYQYIHNQI----EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-----RAKVSDFGT 508 (694)
Q Consensus 438 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~-----~~kl~DFGl 508 (694)
+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997632 2234789999999999999999999998 99999999999999877 899999999
Q ss_pred ccccccCCcc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcc
Q 005492 509 SRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENR 586 (694)
Q Consensus 509 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 586 (694)
++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-------VLQHVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-------HHHHHhcCC
Confidence 8765432211 1122335678999999999999999999999999999998 999986443211 111111111
Q ss_pred hhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005492 587 LFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGG 634 (694)
Q Consensus 587 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 634 (694)
....+...+..+.+++.+||+.+|.+||++.+|++.|++
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 011122345678899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=308.24 Aligned_cols=238 Identities=24% Similarity=0.452 Sum_probs=191.7
Q ss_pred ceeeeeCcEEEEEEEEcCCc-----------EEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEE
Q 005492 366 RILGQGGQGTVYKGMLTDGR-----------IVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv 434 (694)
+.||+|+||.||+|.+.+.. .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999986533 5788876644333 6889999999999999999999999988 788999
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCC-------cEEEeecC
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-------RAKVSDFG 507 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~-------~~kl~DFG 507 (694)
|||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999986543 5899999999999999999999998 99999999999999887 79999999
Q ss_pred CccccccCCcceeeeeecCCCCCCCcccccC--CCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhh
Q 005492 508 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS--QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINE 584 (694)
Q Consensus 508 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 584 (694)
++..... .....++..|+|||++... .++.++||||||+++|||++ |..||......+... ....
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-------~~~~ 221 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-------FYQD 221 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-------HHhc
Confidence 9876543 2223467789999999876 78999999999999999999 577776654222110 0000
Q ss_pred cchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 585 NRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 585 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
.... +......+.+++.+||..+|.+||++.+|++.|+
T Consensus 222 ~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QHRL-----------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCC-----------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 0001156889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=309.15 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=196.9
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccC-----hhhHHHHHHHHHHHhhccCCcceeEEeEEeeC--Ccc
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD-----ETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVP 431 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~ 431 (694)
.+|+..+.||+|+||.||++...+ ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 468899999999999999999754 8899999875422 23456788999999999999999999998764 567
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
++++||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999997642 4889999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCc--ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhh
Q 005492 512 VMVDQT--HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589 (694)
Q Consensus 512 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (694)
...... .......++..|+|||.+.+..++.++||||||+++|||++|+.||......+ .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------~~~~~~~~~---- 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------AIFKIATQP---- 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------HHHHHhcCC----
Confidence 532111 11123457889999999999899999999999999999999999997542211 011111110
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 590 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
...+.+......+.+++ +||..+|++||+++||+++
T Consensus 226 -----~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 -----TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -----CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 01111222334566677 7888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=314.02 Aligned_cols=253 Identities=26% Similarity=0.359 Sum_probs=206.4
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
.++|++.+.||.|+||.||++... ++..+|+|..........+.|.+|+.++++++||||+++++.+.+....++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467889999999999999999975 5889999998877777778899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++++|.+++..... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 999999999876432 5899999999999999999999999 9999999999999999999999999987653322
Q ss_pred ceeeeeecCCCCCCCcccc-----cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 592 (694)
.......+++.|+|||.+. ...++.++||||||+++|||++|+.||......+ ..... ......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~~~~~~---- 226 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLKI-LKSEPP---- 226 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHHH-hcCCCC----
Confidence 2223456899999999975 3457889999999999999999999997543211 11111 111000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 593 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
. ...+......+.+++.+||+.+|.+||++.+++++
T Consensus 227 -~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 -T--LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -C--cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 00112234568899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.06 Aligned_cols=260 Identities=23% Similarity=0.321 Sum_probs=199.0
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC-----
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETE----- 429 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~----- 429 (694)
..++|+..+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999875 4889999988653 3345567889999999999999999999986443
Q ss_pred -ccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCC
Q 005492 430 -VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 508 (694)
Q Consensus 430 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGl 508 (694)
..++||||+++ +|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 46899999975 67776653 3889999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhc---
Q 005492 509 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN--- 585 (694)
Q Consensus 509 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 585 (694)
++..... .......+|..|+|||++.+..++.++||||||++||||++|+.||......+. .......+...
T Consensus 166 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~ 240 (355)
T cd07874 166 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ---WNKVIEQLGTPCPE 240 (355)
T ss_pred cccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHH
Confidence 9764322 222345689999999999999999999999999999999999999976432211 00000000000
Q ss_pred -------chhhhhhh---------------hhh---hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 586 -------RLFEILDA---------------RVL---KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 586 -------~~~~~~d~---------------~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.....++. ... ..........+.+|+.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 000 00111123567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=316.57 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=205.8
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
.+|+..+.||.|++|.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 56889999999999999999864 58999999887655566778899999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++++|.+++... .+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 999999998653 4899999999999999999999999 99999999999999999999999999876543322
Q ss_pred eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||......+. +.... ...... ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~~~-~~~~~~-------~~ 236 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIA-TNGTPE-------LQ 236 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-hcCCcc-------cC
Confidence 12234588899999999988899999999999999999999999966443211 11111 000000 01
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+...+..+.++|.+||..+|.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 112234568899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=313.36 Aligned_cols=258 Identities=28% Similarity=0.421 Sum_probs=206.4
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
++|++.+.||+|+||+||++... +++.+|+|.+... .....+.+.+|+++++.++||||+++++++......+|||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56888899999999999999976 4889999987653 234567899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
+++++|.+++.... .+++..+..++.|++.||.|||+ .+ ++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999987642 58999999999999999999997 46 9999999999999999999999999986543221
Q ss_pred cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCcc-----HHHHHHHHhhhcchhhhh
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKS-----LVGYFLQAINENRLFEIL 591 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 591 (694)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||......++.. ........+...
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 229 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------ 229 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------
Confidence 123458999999999988899999999999999999999999998655432111 111111111100
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
.+.+ .....+..+.+|+.+||+.+|++||++.|++++..-+
T Consensus 230 ~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 230 PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 0000 0112445788999999999999999999999875433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=313.53 Aligned_cols=264 Identities=24% Similarity=0.368 Sum_probs=207.3
Q ss_pred ccChhhHHHHhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-cCCcceeEEeEEe
Q 005492 349 LFTSKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCL 426 (694)
Q Consensus 349 ~~~~~~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~ 426 (694)
++..+++..++++|...+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 4556777788999999999999999999999975 48899999876432 2346678899999999 8999999999987
Q ss_pred eCC-----ccEEEEEeCCCCChHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCc
Q 005492 427 ETE-----VPLLVYEFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR 500 (694)
Q Consensus 427 ~~~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~ 500 (694)
..+ ..++||||+++++|.++++... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 543 5799999999999999987532 2335899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCccccccCCcceeeeeecCCCCCCCcccccC-----CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHH
Q 005492 501 AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS-----QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 575 (694)
Q Consensus 501 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~ 575 (694)
+||+|||+++........ .....++..|+|||.+... .++.++||||||+++|||++|+.||......+
T Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~----- 240 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK----- 240 (291)
T ss_pred EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-----
Confidence 999999998765432211 2234578899999998643 36899999999999999999999997543211
Q ss_pred HHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 576 GYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 576 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.... +.......+.+ +......+.++|.+||+.+|++||++.|++++
T Consensus 241 -~~~~-~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 241 -TLFK-IPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -HHHH-HhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0111 11111111111 11233568899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=325.89 Aligned_cols=260 Identities=23% Similarity=0.338 Sum_probs=199.0
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeC------
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLET------ 428 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~------ 428 (694)
..++|...+.||+|+||.||++.... ++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 45789999999999999999999754 889999988652 344566788999999999999999999987643
Q ss_pred CccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCC
Q 005492 429 EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 508 (694)
Q Consensus 429 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGl 508 (694)
...++||||+++ +|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 356899999975 77777753 3889999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhc--c
Q 005492 509 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN--R 586 (694)
Q Consensus 509 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 586 (694)
++..... .......+|..|+|||++.+..++.++||||||++||||++|+.||...+..+. ...+....... .
T Consensus 173 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~ 247 (364)
T cd07875 173 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQLGTPCPE 247 (364)
T ss_pred ccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHH
Confidence 9765322 222344689999999999999999999999999999999999999976543221 11111100000 0
Q ss_pred h--------hhhhhh--------------hhh----hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 587 L--------FEILDA--------------RVL----KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 587 ~--------~~~~d~--------------~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
. ...+.. ... .+........+.+|+.+||+.||.+|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 000000 000 00011123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=318.00 Aligned_cols=197 Identities=24% Similarity=0.396 Sum_probs=161.8
Q ss_pred cceeeeeCcEEEEEEEEc---CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeC--CccEEEEEeCC
Q 005492 365 NRILGQGGQGTVYKGMLT---DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLVYEFIP 439 (694)
Q Consensus 365 ~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lv~e~~~ 439 (694)
.++||+|+||+||+|... +++.+|+|.+... .....+.+|+.++++++||||+++++++... ...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999965 3678999987643 2234578899999999999999999998653 45789999986
Q ss_pred CCChHHHHhccc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEE----CCCCcEEEeecCCc
Q 005492 440 NGTLYQYIHNQI------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGTS 509 (694)
Q Consensus 440 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll----~~~~~~kl~DFGla 509 (694)
++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 48888875421 1235899999999999999999999999 9999999999999 45678999999999
Q ss_pred cccccCCcc--eeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCC
Q 005492 510 RSVMVDQTH--LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAIN 567 (694)
Q Consensus 510 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~ 567 (694)
+........ ......+|+.|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876432211 2234568999999999876 458999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=309.52 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=191.5
Q ss_pred ceeeeeCcEEEEEEEEcC---CcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCC
Q 005492 366 RILGQGGQGTVYKGMLTD---GRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG 441 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~g 441 (694)
+.||+|+||.||+|...+ ...+|+|.+.... ......|.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997643 3578888776432 334567899999999999999999999999999999999999999
Q ss_pred ChHHHHhcccCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce
Q 005492 442 TLYQYIHNQIEE--FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519 (694)
Q Consensus 442 sL~~~l~~~~~~--~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 519 (694)
+|.+++...... ...++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999764321 23568888999999999999999999 9999999999999999999999999987543222111
Q ss_pred -eeeeecCCCCCCCccccc-------CCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhh
Q 005492 520 -TTKVQGTFGYVDPEYFQS-------SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590 (694)
Q Consensus 520 -~~~~~gt~~y~aPE~~~~-------~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (694)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||......+ .....+.... ..+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~-~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQD-IKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhccC-ccC
Confidence 122335678999998743 456889999999999999999 778886543221 1111111111 111
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 591 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
.++.. .......+.+++..|+ .+|++||++.+|++.|.
T Consensus 231 ~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111 1223455677888888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=310.74 Aligned_cols=248 Identities=27% Similarity=0.419 Sum_probs=205.3
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
..|+..+.||.|+||.||+|... .+..||+|...... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999976 48899999876533 45567899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++++|.+++... ++++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06640 84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence 9999999998643 4889999999999999999999998 9999999999999999999999999997654322
Q ss_pred ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
.......++..|+|||++.+..++.++|+||||+++|||++|+.||........ ...+.. ....
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~---------~~~~ 219 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-------LFLIPK---------NNPP 219 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-------hhhhhc---------CCCC
Confidence 122334578899999999988999999999999999999999999875443211 011111 1111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
......+..+.+++.+||+.+|++||++.+++.+
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2233455678899999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=310.35 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=202.8
Q ss_pred CCCccceeeeeCcEEEEEEEEcC--CcEEEEEEcccc----------ChhhHHHHHHHHHHHhh-ccCCcceeEEeEEee
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD--GRIVAVKKSKLV----------DETNVEQFINEVVILSQ-INHRNIVKLLGCCLE 427 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~nIv~l~g~~~~ 427 (694)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999865 688999976532 23345667889998875 799999999999999
Q ss_pred CCccEEEEEeCCCCChHHHHhcc-cCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecccccccEEECCCCcEEEee
Q 005492 428 TEVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKYRAKVSD 505 (694)
Q Consensus 428 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivH~DIkp~NIll~~~~~~kl~D 505 (694)
.+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999998642 223458999999999999999999996 56 99999999999999999999999
Q ss_pred cCCccccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhc
Q 005492 506 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN 585 (694)
Q Consensus 506 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 585 (694)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ....+...
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-------~~~~~~~~ 228 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-------LATKIVEA 228 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-------HHHHHhhc
Confidence 99997654332 2334558899999999998889999999999999999999999986432211 11111111
Q ss_pred chhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 586 RLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 586 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
..... ........+.+++.+||+.+|++||++.||..+|+
T Consensus 229 ~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYEPL--------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCcC--------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11110 01123456889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=307.96 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=208.1
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
++|++.+.||.|+||+||+|... ++..+|+|++.... ......+.+|+.+++.++|+||+++++.+.+.+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999965 57899999886432 33667899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++++|.++++.......+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999987544346899999999999999999999999 99999999999999999999999999877654332
Q ss_pred c---eeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhh
Q 005492 518 H---LTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDA 593 (694)
Q Consensus 518 ~---~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 593 (694)
. ......++..|+|||++... .++.++|+||||++++||++|+.||......+ .+....... .+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~------~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQND------PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCC------CC
Confidence 2 22334588999999998877 78999999999999999999999997554322 011111110 00
Q ss_pred hhhhhh-hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 594 RVLKEA-KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 594 ~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
...... ....+..+.+++.+||+.+|++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 010100 12344668899999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=298.32 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=205.9
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
+++|++.+.||+|.|+.||+.... .|+.+|+|.+.. ......+++.+|++|.+.|+||||++|++.+.+....+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 467888899999999999998865 488888886543 34447888999999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEEC---CCCcEEEeecCCcccc
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGTSRSV 512 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~---~~~~~kl~DFGla~~~ 512 (694)
|+|.|++|..-|-.+ ...++..+-..++||++||.|.|..+ |+|||+||+|+||- ..--+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999998777544 34788889999999999999999999 99999999999994 3446899999999877
Q ss_pred ccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhh
Q 005492 513 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592 (694)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 592 (694)
. ....-....|||+|||||++...+|+..+|||+-||+||-|+.|.+||.+.+... ..+.+..+... ++
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-------lye~I~~g~yd--~~ 232 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYEQIKAGAYD--YP 232 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-------HHHHHhccccC--CC
Confidence 6 3344456779999999999999999999999999999999999999998644322 22333332211 11
Q ss_pred hhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 593 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+. ......++..+|+.+||..||.+|.|+.|.+.+
T Consensus 233 ~~----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 233 SP----EWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred Cc----ccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 11 112344567899999999999999999988754
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=307.18 Aligned_cols=251 Identities=32% Similarity=0.528 Sum_probs=203.8
Q ss_pred CCccceeeeeCcEEEEEEEEcC-----CcEEEEEEccccChh-hHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 362 YNANRILGQGGQGTVYKGMLTD-----GRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
|++.+.||+|+||.||++...+ +..+|+|.+...... ..+.+.+|+.++++++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999765 388999998764433 6778999999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++++|.+++...... .+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999764321 2899999999999999999999999 999999999999999999999999999876544
Q ss_pred CcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
.........+++.|+|||.+....++.++||||||+++++|++ |+.||......+ ....+......
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~------ 223 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE-------VLEYLKKGYRL------ 223 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCCCC------
Confidence 2222222336789999999988889999999999999999998 788886532211 11111111111
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
..+...+..+.+++.+||..+|++|||+.|+++.|
T Consensus 224 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11112455788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=307.28 Aligned_cols=248 Identities=27% Similarity=0.443 Sum_probs=202.5
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC-----hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-----ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv 434 (694)
+|+..+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.+++.++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999987 68999999876533 33567899999999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
+||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999997642 4899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCcceeeeeecCCCCCCCcccccCC-CCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhh
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDA 593 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 593 (694)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||......+ ...........
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~------ 220 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSKEL------ 220 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhcccC------
Confidence 22 223445888999999987776 8999999999999999999999986543111 11111110111
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 594 RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 594 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
...+......+.+++.+||+.+|.+||++.+++.+
T Consensus 221 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 ---PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ---CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11112234567899999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.24 Aligned_cols=247 Identities=27% Similarity=0.442 Sum_probs=202.0
Q ss_pred CCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
.|+..+.||+|+||.||+|.+.. ++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 46667889999999999998754 7889999876432 345667899999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLKPG----PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 999999998642 4899999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
......++..|+|||++.+..++.++||||||++++||++|+.|+....... ....+.... ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------~~~~~~~~~---------~~~ 220 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-------VLFLIPKNS---------PPT 220 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-------HHhhhhcCC---------CCC
Confidence 1223457889999999999899999999999999999999999986543221 111111110 111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.....+..+.+++.+||+.+|++||++.+|+++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 122334568899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=336.93 Aligned_cols=268 Identities=20% Similarity=0.270 Sum_probs=196.4
Q ss_pred hhhHHHHhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhccC------CcceeEEeE
Q 005492 352 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINH------RNIVKLLGC 424 (694)
Q Consensus 352 ~~~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~l~g~ 424 (694)
.+++...+++|++.++||+|+||+||+|.... ++.||||+++... .....+..|+.+++.++| .++++++++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 34555667899999999999999999999754 7889999986432 233456667777777754 458899998
Q ss_pred EeeC-CccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecccccccEEECCCC---
Q 005492 425 CLET-EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKY--- 499 (694)
Q Consensus 425 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivH~DIkp~NIll~~~~--- 499 (694)
+... ...+||||++ +++|.+++.+.. .+++..+..|+.||+.||+|||+ .+ |+||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccc
Confidence 8765 4678899987 778999887542 58999999999999999999998 47 99999999999998665
Q ss_pred -------------cEEEeecCCccccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccC
Q 005492 500 -------------RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAI 566 (694)
Q Consensus 500 -------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~ 566 (694)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 49999999875432 2233456899999999999999999999999999999999999999765
Q ss_pred CCccCccHHHHHHHH-----------------hh-hcchhhhhhhhhhhh-------hhHHHHHHHHHHHHHhcccCCCC
Q 005492 567 NTDEDKSLVGYFLQA-----------------IN-ENRLFEILDARVLKE-------AKKEGIMTVATLAKRCLNLNGKM 621 (694)
Q Consensus 567 ~~~~~~~~~~~~~~~-----------------~~-~~~~~~~~d~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~ 621 (694)
...+........... .. .+.+....++..... ........+.+||.+||+.||.+
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 432211111100000 00 000000000000000 00012345789999999999999
Q ss_pred CCCHHHHHHH
Q 005492 622 RPTMKEVAFE 631 (694)
Q Consensus 622 RPt~~evl~~ 631 (694)
|||+.|++++
T Consensus 429 R~ta~e~L~H 438 (467)
T PTZ00284 429 RLNARQMTTH 438 (467)
T ss_pred CCCHHHHhcC
Confidence 9999999975
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=307.95 Aligned_cols=247 Identities=28% Similarity=0.485 Sum_probs=199.8
Q ss_pred cCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCC
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP 439 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~ 439 (694)
++|++.+.||+|+||.||++.. .++.+|+|..... ...+.+.+|+.++++++||||+++++++.+. ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588899999999999999975 5788999987643 2346789999999999999999999998764 4799999999
Q ss_pred CCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce
Q 005492 440 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519 (694)
Q Consensus 440 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 519 (694)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999997643 235899999999999999999999998 999999999999999999999999998754321
Q ss_pred eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 520 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
......+..|+|||.+....++.++||||||+++|||++ |+.||......+ ....+..+. ...
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~~ 217 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGY---------RME 217 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCCC---------CCC
Confidence 112234567999999998899999999999999999998 999986544322 111111111 111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGG 634 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 634 (694)
.....+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 122334668899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=311.96 Aligned_cols=260 Identities=24% Similarity=0.388 Sum_probs=204.3
Q ss_pred ChhhHHHHhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-cCCcceeEEeEEee-
Q 005492 351 TSKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLE- 427 (694)
Q Consensus 351 ~~~~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~- 427 (694)
+..++..+.+.|+..+.||+|+||.||+|... +++.+|+|...... ....++..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45566667789999999999999999999975 48899999876432 3446788999999998 79999999999864
Q ss_pred -----CCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEE
Q 005492 428 -----TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAK 502 (694)
Q Consensus 428 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~k 502 (694)
.+..+++|||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 356799999999999999997643 235889999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccccCCcceeeeeecCCCCCCCcccc-----cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHH
Q 005492 503 VSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY 577 (694)
Q Consensus 503 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~ 577 (694)
|+|||++........ ......|+..|+|||.+. ...++.++||||||+++|||++|+.||......+..
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----- 235 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----- 235 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----
Confidence 999999875532211 123345889999999875 346788999999999999999999999654322110
Q ss_pred HHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 578 FLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 578 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.. ..... .. .......+..+.+|+.+||+.+|.+||++.|++++
T Consensus 236 -~~-~~~~~-----~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 -FL-IPRNP-----PP---KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred -hh-HhhCC-----CC---CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00 00000 00 01112344578999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=311.03 Aligned_cols=240 Identities=25% Similarity=0.449 Sum_probs=191.4
Q ss_pred ceeeeeCcEEEEEEEEcC--------CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 366 RILGQGGQGTVYKGMLTD--------GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
+.||+|+||.||+|.... ...+|+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998643 234888887655555667899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCc--------EEEeecCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR--------AKVSDFGTS 509 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~--------~kl~DFGla 509 (694)
+++|+|.++++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999986533 5899999999999999999999999 999999999999987665 699999988
Q ss_pred cccccCCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCC-CCCccCCCccCccHHHHHHHHhhhcch
Q 005492 510 RSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQ-KPIRAINTDEDKSLVGYFLQAINENRL 587 (694)
Q Consensus 510 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (694)
..... .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+....... ....... .
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-------~~~~~~~-~- 221 (258)
T cd05078 156 ITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-------KLQFYED-R- 221 (258)
T ss_pred cccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-------HHHHHHc-c-
Confidence 65432 123457889999999986 45899999999999999999985 5554332211 0001000 0
Q ss_pred hhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 588 FEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 588 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
...+.....++.+|+.+||+.+|++|||++++++.|+
T Consensus 222 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ---------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0111122346889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.78 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=191.3
Q ss_pred ceeeeeCcEEEEEEEEcCC---cEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCC
Q 005492 366 RILGQGGQGTVYKGMLTDG---RIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG 441 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~g 441 (694)
+.||+|+||.||++...++ ..+++|.+.... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999986543 356677665432 345678999999999999999999999999999999999999999
Q ss_pred ChHHHHhcccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC-cce
Q 005492 442 TLYQYIHNQIE-EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ-THL 519 (694)
Q Consensus 442 sL~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~-~~~ 519 (694)
+|.+++++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999986432 234677888999999999999999998 9999999999999999999999999986432211 112
Q ss_pred eeeeecCCCCCCCccccc-------CCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchhhhh
Q 005492 520 TTKVQGTFGYVDPEYFQS-------SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591 (694)
Q Consensus 520 ~~~~~gt~~y~aPE~~~~-------~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (694)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||......+ .+...+.. ......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~-~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIKD-QQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhh-cccccC
Confidence 223457889999998753 345789999999999999997 466775433211 11112221 112222
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
++.+.. .....+.+++..|| .+|++||++.+|++.|.
T Consensus 231 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222221 13356778999999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=324.77 Aligned_cols=246 Identities=26% Similarity=0.435 Sum_probs=197.8
Q ss_pred CccceeeeeCcEEEEEEEEcC-CcEEE---EEEccc-cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCc--cEEEE
Q 005492 363 NANRILGQGGQGTVYKGMLTD-GRIVA---VKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEV--PLLVY 435 (694)
Q Consensus 363 ~~~~~LG~G~~g~Vy~~~~~~-~~~va---vK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~--~~lv~ 435 (694)
+...+||+|+|-+||+|.+.. |-.|| ||.-+. ..+...+.|..|+.+|+.|+|||||+++.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 445789999999999999754 66666 332222 345567899999999999999999999999998765 67899
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECC-CCcEEEeecCCcccccc
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~-~~~~kl~DFGla~~~~~ 514 (694)
|.+..|+|..|+++... ++...+..|++||++||.|||++. |||+|||||-+||+|+. .|.|||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999998753 889999999999999999999987 67999999999999974 57899999999987653
Q ss_pred CCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
.. ...+.|||.|||||+.. ..|.+.+||||||+.|+||+|+..||..-.. ... +.+.+..|....-+.
T Consensus 199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----~AQ-IYKKV~SGiKP~sl~-- 266 (632)
T KOG0584|consen 199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----PAQ-IYKKVTSGIKPAALS-- 266 (632)
T ss_pred cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----HHH-HHHHHHcCCCHHHhh--
Confidence 32 23378999999999998 8999999999999999999999999965432 222 222222222211111
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+-..+++.++|.+||.. ..+||++.|+|..
T Consensus 267 ------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 267 ------KVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ------ccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 11124688999999999 8999999999864
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=317.87 Aligned_cols=257 Identities=20% Similarity=0.300 Sum_probs=195.7
Q ss_pred ccceeeee--CcEEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 364 ANRILGQG--GQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 364 ~~~~LG~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
+.++||+| +|++||++..+ +++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999875 5899999998753 2334566778999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++|+|.+++..+.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999999976432 24899999999999999999999999 999999999999999999999999865433211110
Q ss_pred ------eeeeeecCCCCCCCccccc--CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhh
Q 005492 519 ------LTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590 (694)
Q Consensus 519 ------~~~~~~gt~~y~aPE~~~~--~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (694)
......++..|+|||++.. ..++.++||||||+++|||++|+.||........ ..... .+.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~-~~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM------LLEKL-NGTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH------HHHHh-cCCcccc
Confidence 1112346778999999876 4689999999999999999999999975432210 00000 0000000
Q ss_pred hh------------------------------------hhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 591 LD------------------------------------ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 591 ~d------------------------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
++ ..............+.+|+.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00 000001112334578899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=305.82 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=204.1
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
+|+..+.||+|+||.||++... +++.+|+|++... .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788999999999999999975 5889999987642 334556899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++++|.+++..... ..+++.+++.++.|++.||+|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999999976422 24799999999999999999999998 99999999999999999999999999876543221
Q ss_pred ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
......+++.|+|||++.+..++.++|+||||+++++|++|+.||...... ........ +.. .
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~-~~~---------~ 219 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKIIR-GSY---------P 219 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHhc-CCC---------C
Confidence 122345788999999999999999999999999999999999998643221 11111111 110 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..+......+.++|.+||+.+|.+||++.+|+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1122334568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=306.34 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=198.1
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccC-----hhhHHHHHHHHHHHhhccCCcceeEEeEEeeC--Ccc
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD-----ETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVP 431 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~ 431 (694)
++|+..+.||+|+||.||++...+ ++.||||.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 478899999999999999999754 8999999875321 23456788999999999999999999998764 457
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
++||||+++++|.+++.... .+++...++++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 79999999999999997542 4789999999999999999999999 99999999999999999999999999876
Q ss_pred cccCCc--ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhh
Q 005492 512 VMVDQT--HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589 (694)
Q Consensus 512 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (694)
...... .......++..|+|||.+.+..++.++||||||+++|||++|+.||....... . ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~-~~~~~~~~---- 225 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----A-IFKIATQP---- 225 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----H-HHHHhcCC----
Confidence 532111 11223458889999999988889999999999999999999999996432111 0 11111100
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 590 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.....+......+.+++.+|+ .+|++||++.+|+++
T Consensus 226 -----~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 -----TNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRH 261 (265)
T ss_pred -----CCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence 011122334456788999999 499999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=347.14 Aligned_cols=257 Identities=24% Similarity=0.382 Sum_probs=200.8
Q ss_pred HHHhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeC--Cc
Q 005492 356 EKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLET--EV 430 (694)
Q Consensus 356 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~ 430 (694)
+...++|.+.+.||+|+||+||++.... +..+|+|.+... .......|..|+.++++++|||||++++++.+. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3445789999999999999999999765 778999987642 344567899999999999999999999988654 46
Q ss_pred cEEEEEeCCCCChHHHHhcccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeeecccccccEEECC--------
Q 005492 431 PLLVYEFIPNGTLYQYIHNQIE-EFPITWELLLRIAVEVSGALFYLHSAAS----IPIYHRDIKSANILLDD-------- 497 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~----~~ivH~DIkp~NIll~~-------- 497 (694)
++|||||+++|+|.++|..... ...+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 8899999999999999976322 2369999999999999999999998542 23999999999999964
Q ss_pred ---------CCcEEEeecCCccccccCCcceeeeeecCCCCCCCccccc--CCCCceeeEEehhHHHHHHHhCCCCCccC
Q 005492 498 ---------KYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAI 566 (694)
Q Consensus 498 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDvwSlGvll~elltg~~p~~~~ 566 (694)
...+||+|||++....... ......||+.|+|||++.. ..++.++||||||||||||++|+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2358999999998654322 2234568999999999854 45899999999999999999999999653
Q ss_pred CCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005492 567 NTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAF 630 (694)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 630 (694)
.... .+...+....... ....+..+.+||.+||+.+|.+||++.|++.
T Consensus 247 ~~~~------qli~~lk~~p~lp----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFS------QLISELKRGPDLP----------IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHH------HHHHHHhcCCCCC----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 3211 1111111111000 0122456889999999999999999999984
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=305.86 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=210.7
Q ss_pred CCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCC
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP 439 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~ 439 (694)
-|.++.+||+|+||.||++.+++ |+.+|||++.. ..+++++.+|+.++++.+.|++|+++|.+.....++||||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 36778899999999999999876 99999998765 5578899999999999999999999999999999999999999
Q ss_pred CCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce
Q 005492 440 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519 (694)
Q Consensus 440 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 519 (694)
.|++.+.++.+. .+|++..+..+++..++||+|||... -+|||||+.||||+-++.+||+|||.+-.+.. ....
T Consensus 112 AGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAK 185 (502)
T KOG0574|consen 112 AGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAK 185 (502)
T ss_pred CCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh-hHHh
Confidence 999999998653 36999999999999999999999998 89999999999999999999999999976642 2233
Q ss_pred eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhh
Q 005492 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEA 599 (694)
Q Consensus 520 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 599 (694)
...+.||+.|||||+++.-.|..++||||||++..||.-|++|+....+-.. .-++..++ ..--..
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-------IFMIPT~P-------PPTF~K 251 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-------IFMIPTKP-------PPTFKK 251 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-------eEeccCCC-------CCCCCC
Confidence 4557799999999999999999999999999999999999999976543221 00111111 011122
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 600 KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 600 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+.....++.++++.||-++|++|-|+.+++++
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 34566789999999999999999999998775
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=322.47 Aligned_cols=258 Identities=22% Similarity=0.326 Sum_probs=196.4
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeC------
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLET------ 428 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~------ 428 (694)
..++|...+.||+|+||+||++... +++.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999975 5789999987643 223456688999999999999999999988643
Q ss_pred CccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCC
Q 005492 429 EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 508 (694)
Q Consensus 429 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGl 508 (694)
...++++|++ +++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3468999987 78998887542 4899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcch
Q 005492 509 SRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 587 (694)
Q Consensus 509 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (694)
++..... .....||+.|+|||++.+ ..++.++||||||++||+|++|+.||......+ ....+....... .
T Consensus 165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~-~ 236 (343)
T cd07878 165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVGTP-S 236 (343)
T ss_pred ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCC-C
Confidence 9865322 223458999999999876 578999999999999999999999996543211 111111100000 0
Q ss_pred hhhhhh-----------hh-------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 588 FEILDA-----------RV-------LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 588 ~~~~d~-----------~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+.+.. .+ .........+.+.+|+.+||+.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00 000001122357899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.25 Aligned_cols=266 Identities=25% Similarity=0.385 Sum_probs=211.8
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhh--ccCCcceeEEeEEeeCC----ccE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQ--INHRNIVKLLGCCLETE----VPL 432 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~g~~~~~~----~~~ 432 (694)
.++....+.||+|.||.||+|.++ |+.||||.+.. .+...+.+|.+|++. |+|+||+.+++.-..+. .++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 456788899999999999999997 88999999874 344677888888887 49999999999876553 678
Q ss_pred EEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeeecccccccEEECCCCcEEEeecC
Q 005492 433 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-----AASIPIYHRDIKSANILLDDKYRAKVSDFG 507 (694)
Q Consensus 433 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-----~~~~~ivH~DIkp~NIll~~~~~~kl~DFG 507 (694)
||.+|.++|||+|||... .++....++++..+|.||++||. +|.|.|.|||||+.|||+..++..-|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 999999999999999764 59999999999999999999997 467889999999999999999999999999
Q ss_pred CccccccCCcc---eeeeeecCCCCCCCcccccCC----C--CceeeEEehhHHHHHHHhC----------CCCCccCCC
Q 005492 508 TSRSVMVDQTH---LTTKVQGTFGYVDPEYFQSSQ----F--TEKSDVYSFGVVLVEILTG----------QKPIRAINT 568 (694)
Q Consensus 508 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~--t~~sDvwSlGvll~elltg----------~~p~~~~~~ 568 (694)
||-....+... ......||.+|||||++...- + -..+||||||.||||+... +.||.+..+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99876544322 233466999999999986532 2 2368999999999999752 357765544
Q ss_pred ccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 005492 569 DEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRT 637 (694)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~ 637 (694)
.+.. ...+...+-..++++.++.+... .+....+.+|++.||..+|..|.|+-.+-+.|.++..
T Consensus 442 ~DPs--~eeMrkVVCv~~~RP~ipnrW~s---~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 442 SDPS--FEEMRKVVCVQKLRPNIPNRWKS---DPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCC--HHHHhcceeecccCCCCCccccc---CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 3211 22244444455555555544432 3567789999999999999999999999998877654
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=311.72 Aligned_cols=262 Identities=24% Similarity=0.346 Sum_probs=201.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
++|+..+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++.+....++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999986 48999999876432 2234568899999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|+++++|..++.... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998888875432 4899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh-----------
Q 005492 517 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE----------- 584 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 584 (694)
. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+.... .......
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYL---IRKTLGDLIPRHQQIFST 230 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCChHHhhhccc
Confidence 1 1223347889999999876 5688999999999999999999999976543221100 0000000
Q ss_pred cchh-h--hhhhhhh---hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 585 NRLF-E--ILDARVL---KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 585 ~~~~-~--~~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.... . ..++... .......+..+.+|+.+||+.+|++||++.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000 0 0000000 00011234668899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=315.45 Aligned_cols=252 Identities=26% Similarity=0.359 Sum_probs=207.4
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccc--cChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCccEEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
...|++.++||+||.+.||++...+.+.+|+|++.. .+...+.-|.+|+..|.+| .|.+||+|++|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 467999999999999999999998889999997654 5667788999999999999 5999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
|+= ..+|..+|.+.... ++...+..+..|++.|+.++|+++ |||-||||.|+|+-. |.+||+|||+|..+..+
T Consensus 440 E~G-d~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred ecc-cccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 986 45999999876433 333377889999999999999999 999999999999965 48999999999988766
Q ss_pred Ccce-eeeeecCCCCCCCcccccCC-----------CCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhh
Q 005492 516 QTHL-TTKVQGTFGYVDPEYFQSSQ-----------FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN 583 (694)
Q Consensus 516 ~~~~-~~~~~gt~~y~aPE~~~~~~-----------~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 583 (694)
.... .....||+.||+||.+.... .++++|||||||+||+|+.|+.||..... .
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--------------~ 578 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--------------Q 578 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--------------H
Confidence 5543 34456999999999986433 46799999999999999999999964321 1
Q ss_pred hcchhhhhhhhhhhhhhHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 584 ENRLFEILDARVLKEAKKEG-IMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 584 ~~~~~~~~d~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..++..+.++....+++..- ..++.++++.||++||++||+..|+|++
T Consensus 579 ~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 579 IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 12455666665544443221 1238999999999999999999999875
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=316.19 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=202.3
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccCh---hhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDE---TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|+..+.||+|++|.||++...+ ++.+|+|.+..... ...+.+.+|+++++.++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468889999999999999999865 89999998765332 35567899999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+.+++|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999987542 236899999999999999999999999 999999999999999999999999998755322
Q ss_pred Ccc----------------------------eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCC
Q 005492 516 QTH----------------------------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 567 (694)
Q Consensus 516 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~ 567 (694)
... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 0112357889999999999899999999999999999999999997544
Q ss_pred CccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 005492 568 TDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPT----MKEVAF 630 (694)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt----~~evl~ 630 (694)
..+ .+.... +...........+..+.+++.+||+.+|++||+ +.|++.
T Consensus 237 ~~~------~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDE------TFSNIL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHH------HHHHHh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 321 011111 111111111124567899999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=310.99 Aligned_cols=262 Identities=23% Similarity=0.312 Sum_probs=204.1
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
+|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999975 58999999887543 34457899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+ +++|.+++.... ..+++.+++.++.||+.||+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999997643 35999999999999999999999999 99999999999999999999999999887654332
Q ss_pred ceeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcch---h-----
Q 005492 518 HLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL---F----- 588 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~----- 588 (694)
.......++..|+|||.+.+. .++.++||||||++++||++|++||......+ .............. .
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCc
Confidence 223344588999999998654 46899999999999999999988876543211 11111111110000 0
Q ss_pred ----hhh----hhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 589 ----EIL----DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 589 ----~~~----d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+. ......+...+....+.+++.+||+.+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0000011112334678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=312.20 Aligned_cols=263 Identities=25% Similarity=0.324 Sum_probs=204.3
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
++|+..+.||+|+||.||+|...+ ++.||+|+++.. .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368889999999999999999864 889999987643 33445789999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|++++.|..++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99987777665432 24899999999999999999999999 9999999999999999999999999988765444
Q ss_pred cceeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhh-----------h
Q 005492 517 THLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN-----------E 584 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~ 584 (694)
........++..|+|||++.+. .++.++||||||++||+|++|+.||......+. ......... .
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ---LYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHhhhccc
Confidence 3233345578899999999888 889999999999999999999999975432210 000000000 0
Q ss_pred -c-----chhhhhhhhh-hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 585 -N-----RLFEILDARV-LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 585 -~-----~~~~~~d~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
. .+.+..++.. ....+...+.++.+||.+||+.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 0000000000 011112235779999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.11 Aligned_cols=197 Identities=23% Similarity=0.404 Sum_probs=161.4
Q ss_pred cceeeeeCcEEEEEEEEcC---CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEee--CCccEEEEEeCC
Q 005492 365 NRILGQGGQGTVYKGMLTD---GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE--TEVPLLVYEFIP 439 (694)
Q Consensus 365 ~~~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~--~~~~~lv~e~~~ 439 (694)
.++||+|+||.||+|...+ +..||+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 4689999999999999754 5789999876432 33467889999999999999999999864 456789999987
Q ss_pred CCChHHHHhccc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEE----CCCCcEEEeecCCc
Q 005492 440 NGTLYQYIHNQI------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGTS 509 (694)
Q Consensus 440 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll----~~~~~~kl~DFGla 509 (694)
+ +|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 7888775321 2235889999999999999999999999 9999999999999 56679999999999
Q ss_pred cccccCCcc--eeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCC
Q 005492 510 RSVMVDQTH--LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAIN 567 (694)
Q Consensus 510 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~ 567 (694)
+........ ......+|+.|+|||++.+ ..++.++||||||++||||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 866433221 1234568999999999876 458999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.31 Aligned_cols=252 Identities=25% Similarity=0.442 Sum_probs=203.2
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
+|+..+.||+|+||.||+|... +++.+|+|.++.... ...+.+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999975 588999998876444 3678899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999997642 4889999999999999999999999 99999999999999999999999999887654332
Q ss_pred ceee---eeecCCCCCCCcccccCC---CCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhh
Q 005492 518 HLTT---KVQGTFGYVDPEYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591 (694)
Q Consensus 518 ~~~~---~~~gt~~y~aPE~~~~~~---~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (694)
.... ...++..|+|||++.... .+.++||||||++++||++|+.||....... .... .+....... +
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~-~~~~~~~~~-~ 227 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMF-HVGAGHKPP-I 227 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHH-HHhcCCCCC-C
Confidence 2211 345788999999998766 8999999999999999999999996543111 0000 011110000 0
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
. ........+.+++.+||+.+|.+||++.+++.+
T Consensus 228 ~------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 228 P------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred C------cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 011224567899999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=302.86 Aligned_cols=249 Identities=27% Similarity=0.432 Sum_probs=202.4
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
+|+..+.||+|++|.||++... +++.+|+|.+... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999975 4889999987643 334567899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCC-CcEEEeecCCccccccCC
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~-~~~kl~DFGla~~~~~~~ 516 (694)
+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++++ ..+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999997643 235899999999999999999999999 9999999999999854 468999999998664322
Q ss_pred cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhh
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 596 (694)
......++..|+|||.+....++.++||||||+++|+|++|+.||...+... ...... ......
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~~~-~~~~~~------- 220 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLKIM-SGTFAP------- 220 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHHHH-hcCCCC-------
Confidence 1223457889999999998889999999999999999999999986543221 111111 111111
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 597 KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 597 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+......+.+++.+||+.+|++|||+.|++++
T Consensus 221 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 --ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.66 Aligned_cols=251 Identities=29% Similarity=0.442 Sum_probs=203.5
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeC--CccEEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLVY 435 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lv~ 435 (694)
+|+..+.||.|+||.||++... +++.+|+|.+.. ......+.+.+|+.++++++||||+++++++... ...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999865 578999998764 2344567789999999999999999999988643 4578999
Q ss_pred EeCCCCChHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeeecccccccEEECCCCcEEEeecCCc
Q 005492 436 EFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLH-----SAASIPIYHRDIKSANILLDDKYRAKVSDFGTS 509 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH-----~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla 509 (694)
||+++++|.+++.... ...++++..++.++.|++.||+||| +.+ ++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999997632 2346899999999999999999999 666 999999999999999999999999999
Q ss_pred cccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhh
Q 005492 510 RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589 (694)
Q Consensus 510 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (694)
........ ......+++.|+|||.+....++.++||||||+++++|++|+.||......+ +...+..+..
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~-- 227 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-------LASKIKEGKF-- 227 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-------HHHHHhcCCC--
Confidence 87653332 1233458999999999999889999999999999999999999997543211 1222222211
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 590 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
...+...+..+.+++.+||+.+|++||++.+|+++
T Consensus 228 -------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 -------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11222345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=304.83 Aligned_cols=253 Identities=25% Similarity=0.446 Sum_probs=202.8
Q ss_pred CCCccceeeeeCcEEEEEEEE-cCCcEEEEEEccccC------hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEE
Q 005492 361 NYNANRILGQGGQGTVYKGML-TDGRIVAVKKSKLVD------ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l 433 (694)
+|+..+.||+|++|.||++.. .+++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999986 458899999876432 1235778999999999999999999999999999999
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCC-cEEEeecCCcccc
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRSV 512 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~-~~kl~DFGla~~~ 512 (694)
|+||+++++|.+++.+.. ++++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999997542 5899999999999999999999999 99999999999998775 6999999998766
Q ss_pred ccCCcc---eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhh
Q 005492 513 MVDQTH---LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589 (694)
Q Consensus 513 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (694)
...... ......++..|+|||.+....++.++||||||+++++|++|+.||........ ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~------- 224 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIA------- 224 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHh-------
Confidence 433211 12234578899999999888899999999999999999999999965432211 11111100
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 590 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
......+.+......+.+++.+||+.+|.+||++.+++++
T Consensus 225 --~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 225 --SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred --ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0001112233445678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=312.80 Aligned_cols=262 Identities=24% Similarity=0.373 Sum_probs=201.3
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
++|+..++||+|+||.||++..++ ++.+|+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 468889999999999999999864 8999999876432 2245678899999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|+++++|.++.... ..+++..++.++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 99999998877643 23899999999999999999999998 9999999999999999999999999987654332
Q ss_pred cceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh--cchhhhhhh
Q 005492 517 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE--NRLFEILDA 593 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~d~ 593 (694)
.......++..|+|||++.+ ..++.++||||||+++|||++|++||......+ ........... .......+.
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhcc
Confidence 22233457889999999875 457889999999999999999999986543211 00000000000 000000000
Q ss_pred h----------h-----hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 594 R----------V-----LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 594 ~----------~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
. . ........+..+.+|+.+||+.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0 0 000112335678999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.78 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=200.1
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccCh----------hhHHHHHHHHHHHhhccCCcceeEEeEEeeCC
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE----------TNVEQFINEVVILSQINHRNIVKLLGCCLETE 429 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~ 429 (694)
+|...+.||+|+||.||+|... +++.+|+|.++.... ...+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999865 588999998753211 12356888999999999999999999999999
Q ss_pred ccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCc
Q 005492 430 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS 509 (694)
Q Consensus 430 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla 509 (694)
..++||||+++++|.++++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999999765 25899999999999999999999998 999999999999999999999999998
Q ss_pred cccccCCcc-eeeeeecCCCCCCCcccccCC--CCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcc
Q 005492 510 RSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR 586 (694)
Q Consensus 510 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 586 (694)
+........ ......++..|+|||.+.... ++.++|+||||+++|||++|..||......+ . ..... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~-~~~~~-~~~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----A-MFKLG-NKR 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----H-HHHhh-ccc
Confidence 765322111 123345889999999987654 8999999999999999999999985432211 0 11111 011
Q ss_pred hhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 587 LFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 587 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
....++ .+.....+..+.+++.+||+.+|.+||++.+|+++
T Consensus 229 ~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111 11112345678899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=311.65 Aligned_cols=262 Identities=23% Similarity=0.327 Sum_probs=198.1
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
+|+..+.||+|+||.||++... +|+.+|+|+++.. .......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999986 4889999987643 223345678899999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
++ ++|.+++.... ..+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 58888876543 24899999999999999999999999 99999999999999999999999999876543222
Q ss_pred ceeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcc------hhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR------LFEI 590 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 590 (694)
. .....++..|+|||.+.+. .++.++||||||+++|||++|..|+......+ .............. +...
T Consensus 155 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred C-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhc
Confidence 1 2233478899999998764 47899999999999999999998864332211 11111111100000 0000
Q ss_pred hhhh---------hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 591 LDAR---------VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 591 ~d~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+.. ...+........+.+++.+||+.+|.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000 0011112234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.98 Aligned_cols=255 Identities=25% Similarity=0.485 Sum_probs=200.3
Q ss_pred CCccceeeeeCcEEEEEEEEc----CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC------
Q 005492 362 YNANRILGQGGQGTVYKGMLT----DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETE------ 429 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~------ 429 (694)
|.+.+.||+|+||.||+|.+. .++.+|||.+... .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999864 3688999987642 3455778999999999999999999999887543
Q ss_pred ccEEEEEeCCCCChHHHHhccc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeec
Q 005492 430 VPLLVYEFIPNGTLYQYIHNQI---EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 506 (694)
Q Consensus 430 ~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DF 506 (694)
..++++||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999999875421 2235899999999999999999999998 999999999999999999999999
Q ss_pred CCccccccCCcc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhh
Q 005492 507 GTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINE 584 (694)
Q Consensus 507 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 584 (694)
|+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.||......+ + ...+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---I----YNYLIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---H----HHHHHc
Confidence 999866432211 1122335678999999998899999999999999999999 888886543221 1 111111
Q ss_pred cchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 585 NRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 585 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
.... ......+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 231 ~~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRL---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1100 00112345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=310.86 Aligned_cols=263 Identities=24% Similarity=0.352 Sum_probs=198.6
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccCh-hhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE-TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
++|+..+.||+|++|.||+|..+ +++.||||.+..... .....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999976 589999998765322 2335577899999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++ +|.+++..... .+++..+..++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 99999876533 5899999999999999999999999 99999999999999999999999999875432221
Q ss_pred ceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh---cchhh----
Q 005492 518 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE---NRLFE---- 589 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~---- 589 (694)
. .....++..|+|||++.+ ..++.++||||||+++|||++|+.||....... .........+.. .....
T Consensus 159 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 T-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred c-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhc
Confidence 1 122346789999999875 458999999999999999999999996543211 001101111000 00000
Q ss_pred ---------hhhhhhhhhhh--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 590 ---------ILDARVLKEAK--KEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 590 ---------~~d~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
...+....... ......+.+++.+||+.+|.+||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000000000 0112567899999999999999999998763
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=312.77 Aligned_cols=249 Identities=27% Similarity=0.396 Sum_probs=202.2
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCC
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP 439 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~ 439 (694)
.|.....||+|+||.||++... ++..||||++........+.+.+|+.+++.++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444567999999999999875 488999999876656667789999999999999999999999999999999999999
Q ss_pred CCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce
Q 005492 440 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519 (694)
Q Consensus 440 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 519 (694)
+++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++........ .
T Consensus 103 ~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 174 (292)
T cd06658 103 GGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K 174 (292)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence 99999988543 4899999999999999999999999 99999999999999999999999999876543222 2
Q ss_pred eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhh
Q 005492 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEA 599 (694)
Q Consensus 520 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 599 (694)
.....++..|+|||.+....++.++||||||+++|||++|+.||....... .+ ..+. ..+.+....
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~-~~~~-----~~~~~~~~~-- 240 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ------AM-RRIR-----DNLPPRVKD-- 240 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHH-----hcCCCcccc--
Confidence 233568999999999998899999999999999999999999986533211 01 1111 111111110
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 600 KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 600 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.......+.+++.+||..+|.+|||+.+++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234468899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.04 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=195.5
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHH-HhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVI-LSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
++|++.+.||+|+||.||++... +|+.||+|+++... .....++..|+.+ ++.++||||+++++++.+....++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999976 48999999887532 2334556667665 566789999999999999999999999
Q ss_pred eCCCCChHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 437 FIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
|++ ++|.+++.... ....+++..++.++.|++.||+|||++ + ++||||||+|||+++++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 68988886532 234689999999999999999999987 7 99999999999999999999999999876532
Q ss_pred CCcceeeeeecCCCCCCCccccc----CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhh
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQS----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~----~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (694)
.. ......++..|+|||.+.. ..++.++|+||||+++|||++|+.||...... ......... +....+
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~-~~~~~~ 228 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVVE-EPSPQL 228 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHHh-cCCCCC
Confidence 21 1223457889999998864 45689999999999999999999998643211 011111111 100000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 591 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
. ....+..+.+++.+||+.+|.+||++.+++++
T Consensus 229 ~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 229 P--------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred C--------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 11234568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.70 Aligned_cols=253 Identities=29% Similarity=0.414 Sum_probs=205.4
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
++|+..+.||+|++|.||++..+ +++.+|+|++.... ....+++.+|++++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999986 48899999876542 34567799999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999998653 358999999999999999999999 88 9999999999999999999999999987654322
Q ss_pred cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhh
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 596 (694)
.. ...++..|+|||.+.+..++.++||||||+++++|++|+.||....... ......+........
T Consensus 156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~---------- 221 (265)
T cd06605 156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEPP---------- 221 (265)
T ss_pred hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCCC----------
Confidence 11 1568889999999999999999999999999999999999996543211 111111111111100
Q ss_pred hhhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 597 KEAKKE-GIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 597 ~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
...+.. ....+.++|.+||..+|++||++.+++.+
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 011111 45568899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.47 Aligned_cols=256 Identities=26% Similarity=0.409 Sum_probs=202.6
Q ss_pred HHhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCC-----
Q 005492 357 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETE----- 429 (694)
Q Consensus 357 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~----- 429 (694)
.++++|+..+.||+|++|.||+|..+ +++.+++|....... ..+++.+|+.+++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45689999999999999999999986 478999998765433 456799999999999 7999999999997655
Q ss_pred -ccEEEEEeCCCCChHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecC
Q 005492 430 -VPLLVYEFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 507 (694)
Q Consensus 430 -~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFG 507 (694)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4799999999999999987632 2346899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCcceeeeeecCCCCCCCccccc-----CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHh
Q 005492 508 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 582 (694)
Q Consensus 508 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 582 (694)
++....... .......++..|+|||++.. ..++.++||||||++|++|++|+.||....... .... +
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~-~ 230 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------ALFK-I 230 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------HHHH-h
Confidence 987653222 22233458899999998753 347889999999999999999999996432211 0111 1
Q ss_pred hhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 583 NENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 583 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.......+ ..+......+.+|+.+||..||++|||+.+++++
T Consensus 231 ~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 PRNPPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hccCCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111010 1112345678899999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.33 Aligned_cols=263 Identities=23% Similarity=0.368 Sum_probs=203.1
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
+|+..+.||+|++|.||+|... +++.||||.++... ....+.+.+|+.++++++|+||+++++++.+.+..+|||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999986 48899999887643 334567889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++ +|.+++........+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 89999876554456999999999999999999999999 99999999999999999999999999876543221
Q ss_pred eeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhh---hcchhhhh---
Q 005492 519 LTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN---ENRLFEIL--- 591 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--- 591 (694)
......++..|++||.+.+. .++.++||||||+++|+|++|+.||......+... ....... ...+..+.
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL---KIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHHHhCCCChhhHHHHhcCc
Confidence 11223468899999988654 57899999999999999999999997654332111 1111000 00000000
Q ss_pred ------h---hhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 592 ------D---ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 592 ------d---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
. ..............+.+++.+||+.+|.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 000011112335678899999999999999999998853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=302.44 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=208.5
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccCh-hhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDE-TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
++|+..+.||+|++|.||++...+ ++.+|+|++..... .....+.+|+.++.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999999875 89999998876443 4567899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
+++++|.+++... ..+++..++.++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999764 358999999999999999999999 88 9999999999999999999999999988664333
Q ss_pred cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhh
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 596 (694)
.. .....++..|+|||.+....++.++||||||+++|+|++|+.||....... ..... ..+.....
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~-~~~~~~~~--------- 220 (264)
T cd06623 155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELM-QAICDGPP--------- 220 (264)
T ss_pred Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHH-HHHhcCCC---------
Confidence 22 224458899999999999999999999999999999999999997654311 11111 11111111
Q ss_pred hhhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 597 KEAKKE-GIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 597 ~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
...+.. .+..+.+++.+||+.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111122 45678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.81 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=201.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccC---hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|+..+.||+|+||.||++.... ++.||+|.+.... ....+.+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468889999999999999999765 7899999876532 234567889999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999997642 4899999999999999999999998 999999999999999999999999998642111
Q ss_pred Cc--------------ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHH
Q 005492 516 QT--------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQA 581 (694)
Q Consensus 516 ~~--------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 581 (694)
.. .......++..|+|||.+....++.++||||||+++|||++|+.||......+ +...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-------~~~~ 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-------LFGQ 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH
Confidence 00 01112347889999999988889999999999999999999999996543221 1111
Q ss_pred hhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005492 582 INENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGG 634 (694)
Q Consensus 582 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 634 (694)
....... .+. .....+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 228 ~~~~~~~---~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDDIE---WPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhcccC---CCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1111100 000 011234568899999999999999997666666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=305.37 Aligned_cols=247 Identities=27% Similarity=0.444 Sum_probs=202.3
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
-|+..+.||+|+||.||+|... ++..+|+|...... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4677889999999999999875 58899999876432 344567899999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06641 85 GGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I 156 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-h
Confidence 999999998643 4899999999999999999999999 9999999999999999999999999987654322 1
Q ss_pred eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
......++..|+|||.+....++.++||||||+++|+|++|..||....... ....+.... ...
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~---------~~~ 220 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLFLIPKNN---------PPT 220 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-------HHHHHhcCC---------CCC
Confidence 1223457889999999998889999999999999999999999986533211 111111110 111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.....+..+.+++.+||+.+|.+||++.+++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 122334568899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=312.50 Aligned_cols=248 Identities=26% Similarity=0.391 Sum_probs=201.4
Q ss_pred CCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 362 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
|+....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334557999999999999975 5899999998765555667789999999999999999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........ ..
T Consensus 103 ~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 174 (297)
T cd06659 103 GALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KR 174 (297)
T ss_pred CCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cc
Confidence 9999987542 4899999999999999999999999 99999999999999999999999999875543221 22
Q ss_pred eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAK 600 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 600 (694)
....++..|+|||++.+..++.++||||||++++||++|+.||......+ ....+...... . ....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~-----~--~~~~ 240 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-------AMKRLRDSPPP-----K--LKNA 240 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhccCCC-----C--cccc
Confidence 33568999999999998899999999999999999999999997533221 11111111000 0 0001
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 601 KEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 601 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
......+.+++.+||+.+|.+||++.+++++
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1223457899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=308.95 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=205.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
++|...+.||+|+||.||++... +++.+|+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67899999999999999999865 57899999987655556678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 999999999753 3789999999999999999999999 99999999999999999999999999876543322
Q ss_pred eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
......+++.|+|||.+....++.++||||||+++|+|++|+.||...+..+... ....... ....
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~~--------~~~~ 236 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGT--------PELQ 236 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCCC--------CCCC
Confidence 1223458889999999988889999999999999999999999997644322110 0000000 0001
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
........+.+++.+||..+|++||++.+++.+
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112234568899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.40 Aligned_cols=262 Identities=24% Similarity=0.353 Sum_probs=199.0
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
+|+..+.||.|++|.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4888999999999999999976 58899999876432 23346789999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+. ++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 68999987643 235899999999999999999999999 99999999999999999999999999876543221
Q ss_pred ceeeeeecCCCCCCCcccccCC-CCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhc--ch----hhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN--RL----FEI 590 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~-~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~----~~~ 590 (694)
. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||......+ ...... ...... .. ..+
T Consensus 156 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 T-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIF-RTLGTPDEVVWPGVTSL 231 (284)
T ss_pred c-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH-HHhCCCChhhhhhhhHH
Confidence 1 22234688999999887644 6889999999999999999999997543211 111100 000000 00 000
Q ss_pred ------hhh---hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 591 ------LDA---RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 591 ------~d~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+.. .............+.+++.+||+.||.+||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000 00001111233567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=304.16 Aligned_cols=261 Identities=27% Similarity=0.317 Sum_probs=203.4
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC--ccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETE--VPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~--~~~lv~ 435 (694)
++|+..+.||.|++|.||++...+ ++.+|+|.+.... .....++.+|++++++++||||+++++++.+.. ..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 468888999999999999999854 8899999877532 345677999999999999999999999986543 679999
Q ss_pred EeCCCCChHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 436 EFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999886522 2345899999999999999999999999 99999999999999999999999999875532
Q ss_pred CCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ...... ...+.......+ ...
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~-~~~~~~~~~~~~-~~~ 231 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIEL-LSYIVNMPNPEL-KDE 231 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHH-HHHHhcCCchhh-ccC
Confidence 22 123447889999999999999999999999999999999999997653311 111111 111111111111 100
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.. ........+.+++.+||+.+|.+|||+.||+++
T Consensus 232 ~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 232 PG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 00 001234578899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.07 Aligned_cols=245 Identities=27% Similarity=0.362 Sum_probs=201.6
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|+..+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999976 4899999987642 2344677899999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999999765 25899999999999999999999999 999999999999999999999999998876433
Q ss_pred CcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
.....+++.|+|||.+.....+.++||||||+++++|++|+.||......+ ....+..+..
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~-------- 215 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-------IYEKILEGKV-------- 215 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCc--------
Confidence 233458899999999988889999999999999999999999996544211 1111111110
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRP-----TMKEVAFE 631 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 631 (694)
..+......+.+++.+||+.+|.+|| +++|++++
T Consensus 216 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 216 --RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred --cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 11122345688999999999999998 66666543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=308.77 Aligned_cols=247 Identities=27% Similarity=0.388 Sum_probs=198.4
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
+.|+..+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888999999999999999976 5899999987643 2334567899999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||++ |+|.+++..... .+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 578777764332 5899999999999999999999999 999999999999999999999999998754322
Q ss_pred CcceeeeeecCCCCCCCcccc---cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 592 (694)
....++..|+|||.+. ...++.++||||||+++|||++|+.||....... ....+......
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-------~~~~~~~~~~~---- 232 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNDSP---- 232 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-------HHHHHhcCCCC----
Confidence 2235788999999874 4668899999999999999999999986543211 00011111000
Q ss_pred hhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 593 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
..........+.+++.+||+.+|++||++.+|+.+.
T Consensus 233 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 233 ----TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred ----CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 001122445689999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=304.94 Aligned_cols=265 Identities=23% Similarity=0.321 Sum_probs=198.5
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++++|...+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999875 58899999876533 233446789999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+. ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 67877775432 24788899999999999999999999 999999999999999999999999998764322
Q ss_pred CcceeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhc---------
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN--------- 585 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 585 (694)
... .....+++.|+|||.+.+. .++.++||||||++||||++|+.||....... .........+...
T Consensus 157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhhh
Confidence 211 2233468899999998754 57899999999999999999999997544321 0000011100000
Q ss_pred ch----hhhhh---hhhhhhh--hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 586 RL----FEILD---ARVLKEA--KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 586 ~~----~~~~d---~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+ .+... +...... .......+.+++.+|++.+|.+|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00 00000 0000000 00113567899999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=305.63 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=211.5
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
..-|...+.||+|.|+.|-++++- .|.+||||++... +.....++.+|++.|+-++|||||+|+++......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 345777889999999999999854 5999999998764 3344567899999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEE-CCCCcEEEeecCCcccccc
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL-DDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll-~~~~~~kl~DFGla~~~~~ 514 (694)
|+=++|+|++||-++... +.++...+++.||+.|+.|.|+.+ +|||||||+||.+ ...|.+||.|||++-.+..
T Consensus 97 ELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999999887554 999999999999999999999999 9999999999876 5678999999999976643
Q ss_pred CCcceeeeeecCCCCCCCcccccCCCC-ceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhh
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDA 593 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 593 (694)
. ...+...|.+.|-|||++.+..|+ +++|||||||+||.|++|++||+..+..| .+.-++|-
T Consensus 172 G--~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------TLTmImDC 234 (864)
T KOG4717|consen 172 G--KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------TLTMIMDC 234 (864)
T ss_pred c--chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------hhhhhhcc
Confidence 3 234556799999999999998885 68999999999999999999998776654 23334443
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005492 594 RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAF 630 (694)
Q Consensus 594 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 630 (694)
. ...+.....+..+||..||..||.+|.+.+||+.
T Consensus 235 K--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 K--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred c--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 2 3345566778899999999999999999999864
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=305.35 Aligned_cols=249 Identities=27% Similarity=0.392 Sum_probs=202.9
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCC
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP 439 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~ 439 (694)
.|...+.||+|++|.||++... +++.+|+|++........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3555679999999999999964 588999998876655666778999999999999999999999999999999999999
Q ss_pred CCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce
Q 005492 440 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519 (694)
Q Consensus 440 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 519 (694)
+++|.+++... .+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||++........ .
T Consensus 100 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 100 GGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred CCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 99999999762 4899999999999999999999999 99999999999999999999999998876543222 2
Q ss_pred eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhh
Q 005492 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEA 599 (694)
Q Consensus 520 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 599 (694)
.....|+..|+|||.+.+..++.++||||||++++||++|+.||...+..+ .. ..+.... .+... .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~------~~-~~~~~~~-----~~~~~--~ 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ------AM-KRIRDNL-----PPKLK--N 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH------HH-HHHHhcC-----CCCCc--c
Confidence 223458899999999998889999999999999999999999986533211 11 1111110 00000 0
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 600 KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 600 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
....+..+.+++.+||+.+|++||++.+++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 11234568999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=296.70 Aligned_cols=250 Identities=30% Similarity=0.447 Sum_probs=206.6
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCC
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP 439 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~ 439 (694)
.|...+.||+|++|.||++... +++.+++|+.........+.+.+|++++++++|+||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3777899999999999999986 588999999877655577889999999999999999999999999999999999999
Q ss_pred CCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce
Q 005492 440 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519 (694)
Q Consensus 440 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 519 (694)
+++|.+++.... ..+++..+..++.|++.||+|||..+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999997653 35899999999999999999999988 99999999999999999999999999877654332
Q ss_pred eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhh
Q 005492 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEA 599 (694)
Q Consensus 520 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 599 (694)
.....++..|+|||.+....++.++||||||+++++|++|+.||......+ ...............
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~------- 219 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-------ALFKIATNGPPGLRN------- 219 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH-------HHHHHHhcCCCCcCc-------
Confidence 344568899999999998889999999999999999999999987543211 000111110011100
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 600 KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 600 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.......+.+++.+||+.+|++|||+.+++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01124568899999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=310.09 Aligned_cols=261 Identities=27% Similarity=0.341 Sum_probs=200.3
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChh-----hHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDET-----NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv 434 (694)
+|+..+.||+|++|.||+|... +++.||||++...... ....+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999976 5899999988754322 345677899999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
|||+ +++|.+++.... ..+++..++.++.||++||+|||+.+ |+|+||||+|||++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999997643 25999999999999999999999999 99999999999999999999999999987643
Q ss_pred CCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhc--------
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN-------- 585 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 585 (694)
.... .....++..|+|||.+.+ ..++.++||||||++++||++|.+||......+ ............
T Consensus 155 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhhc
Confidence 3221 222346788999998864 467899999999999999999987776543221 111111110000
Q ss_pred -chhhhhhhh-----hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 586 -RLFEILDAR-----VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 586 -~~~~~~d~~-----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+....... ............+.+++.+||+.+|++||++.||+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000 0001112234678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=304.96 Aligned_cols=253 Identities=27% Similarity=0.429 Sum_probs=207.0
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
.+++|+..+.||+|++|.||++... ++..+|+|.+..... ..+.+.+|++++++++|+||+++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888999999999999999987 588999999876544 56788999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999998754 35999999999999999999999998 9999999999999999999999999886554322
Q ss_pred cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhh
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 596 (694)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... .... +.........
T Consensus 171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~~~----- 237 (286)
T cd06614 171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ALFL-ITTKGIPPLK----- 237 (286)
T ss_pred h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHhcCCCCCc-----
Confidence 1 2223347889999999998889999999999999999999999986543221 0111 1111111100
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 597 KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 597 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.....+..+.+++.+||+.+|.+||++.+++++
T Consensus 238 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 238 --NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred --chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111234568899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=304.31 Aligned_cols=248 Identities=27% Similarity=0.439 Sum_probs=201.2
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcc---CCcceeEEeEEeeCCccEEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQIN---HRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~nIv~l~g~~~~~~~~~lv~ 435 (694)
.|+..+.||+|+||.||+|... +++.+|+|.+... .....+++.+|+.++++++ |||++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4778889999999999999974 5899999987653 3445677889999999997 999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999998653 5899999999999999999999999 999999999999999999999999998876543
Q ss_pred CcceeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
.. ......|+..|+|||.+..+ .++.++||||||+++|+|++|+.||........ . ..+... ..+.
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~-~~~~~~-----~~~~ 221 (277)
T cd06917 155 SS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------M-MLIPKS-----KPPR 221 (277)
T ss_pred cc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------h-hccccC-----CCCC
Confidence 32 22334588899999998754 478999999999999999999999975432211 0 001110 0011
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+..+ ..+..+.+++.+||+.+|++||++.+++++
T Consensus 222 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 LEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1111 134568899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=319.18 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=207.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
+.|+++..||-|+||.||+++.++ +...|-|.+.......+++|+-||+||+...||+||+|++.|.-++.++|++|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 446677789999999999999887 4455678777778888999999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
.||..+..+-.-.. .|++.++..++.|++.||.|||+.. |||||||+.|||++-+|.++|+|||.+..... ...
T Consensus 112 ~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~q 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQ 185 (1187)
T ss_pred CCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh-HHh
Confidence 99999999877543 5999999999999999999999999 99999999999999999999999999865432 222
Q ss_pred eeeeeecCCCCCCCcccc-----cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDA 593 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 593 (694)
....+.||+.|||||+.. ..+|+.++||||||++|.||..+.+|-...++- ..++... ...-..++.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------RVllKia-KSePPTLlq- 257 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIA-KSEPPTLLQ- 257 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------HHHHHHh-hcCCCcccC-
Confidence 345577999999999864 568999999999999999999999997554432 1122221 111112222
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 594 RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 594 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+......+.+++.+||..||..||++.+++++
T Consensus 258 ------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 258 ------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 23445678899999999999999999999864
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=305.89 Aligned_cols=261 Identities=24% Similarity=0.328 Sum_probs=201.3
Q ss_pred CCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeC--CccEEEEE
Q 005492 362 YNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLVYE 436 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lv~e 436 (694)
|++.+.||+|++|.||+|...+ ++.+|+|++... .......+.+|+.++++++|+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5678899999999999999765 889999998764 234456788999999999999999999999988 78999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|+++ +|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 8998887642 35899999999999999999999999 9999999999999999999999999998765443
Q ss_pred cceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh---cch-----
Q 005492 517 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE---NRL----- 587 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~----- 587 (694)
........++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .......... ...
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhcccccc
Confidence 222333456888999998764 4689999999999999999999999976543211 1111110000 000
Q ss_pred ---------hhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 588 ---------FEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 588 ---------~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.......+........+..+.+++.+||+.+|.+||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000001111111125678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=307.51 Aligned_cols=262 Identities=21% Similarity=0.304 Sum_probs=200.6
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeC--CccEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLV 434 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lv 434 (694)
++|+..+.||+|+||.||+|... +++.+|+|.++... ......+.+|+.++++++||||+++++++... ...+||
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999986 48899999887533 22344678899999999999999999999877 889999
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
|||+++ +|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||+++....
T Consensus 85 ~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999974 99999876433 5899999999999999999999999 99999999999999999999999999886654
Q ss_pred CCcceeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh---------
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE--------- 584 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 584 (694)
... ......+++.|+|||.+.+. .++.++||||||++++||++|..||......+. ..........
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 159 PLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ---LNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred Ccc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchHHHHHh
Confidence 321 12234478899999998754 468999999999999999999999976443211 1000000000
Q ss_pred --------cchhhhhhhhhhhhhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 585 --------NRLFEILDARVLKEAKKE-GIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 585 --------~~~~~~~d~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..........+....+.. ....+.+++.+||+.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000111111111 25568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=308.68 Aligned_cols=267 Identities=23% Similarity=0.330 Sum_probs=200.0
Q ss_pred CCCccceeeeeCcEEEEEEEEcC---CcEEEEEEccccC---hhhHHHHHHHHHHHhhccCCcceeEEeEEeeC--CccE
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD---GRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPL 432 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~ 432 (694)
+|+..+.||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788999999999999999754 7899999887632 44456788999999999999999999999988 7899
Q ss_pred EEEEeCCCCChHHHHhcccC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECC----CCcEEEeec
Q 005492 433 LVYEFIPNGTLYQYIHNQIE--EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDF 506 (694)
Q Consensus 433 lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~----~~~~kl~DF 506 (694)
+||||+++ +|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 67777754322 236899999999999999999999999 999999999999999 999999999
Q ss_pred CCccccccCCc--ceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccH------HHH
Q 005492 507 GTSRSVMVDQT--HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL------VGY 577 (694)
Q Consensus 507 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~------~~~ 577 (694)
|+++....... .......++..|+|||.+.+ ..++.++||||||++|++|++|+.||........... ...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986643222 12233457889999998866 4589999999999999999999999976554331100 000
Q ss_pred HHHHhhhc------------chhhh--------hh-hhhhhhhhH--HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 578 FLQAINEN------------RLFEI--------LD-ARVLKEAKK--EGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 578 ~~~~~~~~------------~~~~~--------~d-~~~~~~~~~--~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+...+... ..... .. ..+...... .....+.+++.+||+.+|++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00111000 00000 00 000000011 233568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=301.28 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=202.3
Q ss_pred CCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
+|+..+.||+|+||.||++..+. +..+|+|.+... .....+.+.+|+.++++++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47888999999999999999864 888999987643 223456788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCC-cEEEeecCCccccccCC
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~-~~kl~DFGla~~~~~~~ 516 (694)
+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999976432 35899999999999999999999999 99999999999999875 56999999987664322
Q ss_pred cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhh
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 596 (694)
.......|++.|+|||.+....++.++||||||++++||++|+.||...+.. ....... ......
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~------- 221 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKIC-QGYFAP------- 221 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHh-cccCCC-------
Confidence 2223345889999999998888999999999999999999999998653321 1111111 111111
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 597 KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 597 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
........+.+++.+||+.+|++||++.+++++
T Consensus 222 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 --ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111233568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=315.16 Aligned_cols=261 Identities=27% Similarity=0.347 Sum_probs=203.7
Q ss_pred CCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhcc-C-----CcceeEEeEEeeCCccEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQIN-H-----RNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~l~g~~~~~~~~~l 433 (694)
+|.+.+.||+|.||.|-++.+.. ++.||||+++.. ..-..+-..|+.+|..|+ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78999999999999999999765 899999998853 445567788999999997 4 489999999999999999
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCC--CcEEEeecCCccc
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK--YRAKVSDFGTSRS 511 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~--~~~kl~DFGla~~ 511 (694)
|+|.+. -+|.++|+.+... .++...+..|+.||+.||.+||+.+ |||+||||+||||.+. ..+||+|||.+..
T Consensus 266 VfELL~-~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999995 4999999987544 5999999999999999999999999 9999999999999643 3799999999975
Q ss_pred cccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh-----c-
Q 005492 512 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE-----N- 585 (694)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----~- 585 (694)
... . ......+..|.|||++.+.+|+.+.||||||||++||++|.+-|.+.+..++...+..+...... +
T Consensus 341 ~~q---~-vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 341 ESQ---R-VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred cCC---c-ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 432 1 12455788999999999999999999999999999999998888776654433222211111000 0
Q ss_pred chhhhhhh--------------------------------h-hh------h-hhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 005492 586 RLFEILDA--------------------------------R-VL------K-EAKKEGIMTVATLAKRCLNLNGKMRPTM 625 (694)
Q Consensus 586 ~~~~~~d~--------------------------------~-~~------~-~~~~~~~~~l~~li~~cl~~~p~~RPt~ 625 (694)
+....++. . .. . ......-..+.+++.+||..||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 00000000 0 00 0 0111233568999999999999999999
Q ss_pred HHHHHH
Q 005492 626 KEVAFE 631 (694)
Q Consensus 626 ~evl~~ 631 (694)
.|.+++
T Consensus 497 ~qal~H 502 (586)
T KOG0667|consen 497 AQALNH 502 (586)
T ss_pred HHHhcC
Confidence 999876
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=306.64 Aligned_cols=264 Identities=22% Similarity=0.307 Sum_probs=198.6
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcc-CCcceeEEeEEeeCCc-----
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEV----- 430 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~----- 430 (694)
++|+..+.||+|+||.||+|... +++.||||...... ......+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999976 58999999876532 223467889999999995 6999999999987766
Q ss_pred cEEEEEeCCCCChHHHHhcccC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECC-CCcEEEeecC
Q 005492 431 PLLVYEFIPNGTLYQYIHNQIE--EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFG 507 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~-~~~~kl~DFG 507 (694)
.++||||+++ +|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 89998875432 246899999999999999999999999 999999999999998 8899999999
Q ss_pred CccccccCCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcc
Q 005492 508 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR 586 (694)
Q Consensus 508 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 586 (694)
+++........ .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......+. +.. +...+....
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~-~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLH-IFKLLGTPT 232 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHH-HHHHhCCCC
Confidence 98765332211 122346888999998865 4579999999999999999999999975432210 110 111110000
Q ss_pred hh------h--------hhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 587 LF------E--------ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 587 ~~------~--------~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.. . ...+.............+.++|.+||+.+|.+||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0 000000011112345678899999999999999999998864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=301.41 Aligned_cols=247 Identities=26% Similarity=0.338 Sum_probs=203.6
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
+|+..+.||.|+||.||++... ++..+|+|.+... .....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999986 4889999987643 22456789999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|+++++|.+++... .++++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999999765 35899999999999999999999999 9999999999999999999999999987654332
Q ss_pred cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhh
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 596 (694)
......++..|+|||.+....++.++|+||||+++|+|++|+.||....... ...+...... ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~----------~~ 218 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET----------AD 218 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------cc
Confidence 2233458889999999998889999999999999999999999997655321 1111111111 00
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 005492 597 KEAKKEGIMTVATLAKRCLNLNGKMRPTM--KEVA 629 (694)
Q Consensus 597 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~--~evl 629 (694)
...+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11122334678899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=312.76 Aligned_cols=262 Identities=24% Similarity=0.366 Sum_probs=198.6
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC-----cc
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETE-----VP 431 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~-----~~ 431 (694)
+++|++.++||+|+||.||+|... +++.||||.+... .......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999865 5899999988643 2334567889999999999999999999876543 47
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
++|+||+++ +|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999975 888877543 4899999999999999999999999 99999999999999999999999999876
Q ss_pred cccCCcc--eeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhc---
Q 005492 512 VMVDQTH--LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN--- 585 (694)
Q Consensus 512 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 585 (694)
....... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ....+...+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHH
Confidence 5432211 1123457899999998754 568999999999999999999999996543211 111111111100
Q ss_pred chhhhhhhhh--------------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 586 RLFEILDARV--------------LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 586 ~~~~~~d~~~--------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+..+.+... ...........+.+++.+||+.+|++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0011110000 000111234568899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.92 Aligned_cols=250 Identities=27% Similarity=0.391 Sum_probs=199.2
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
.|+..+.||+|+||.||++... ++..+|+|++... .......+.+|++++++++|||++++++++.+.+..+||||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3777889999999999999975 5889999987643 23345678999999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|++ |+|.+++.... .++++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 997 58888776543 35899999999999999999999999 999999999999999999999999998654321
Q ss_pred cceeeeeecCCCCCCCcccc---cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhh
Q 005492 517 THLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDA 593 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 593 (694)
....++..|+|||++. ...++.++||||||+++|||++|+.||....... ....+.....
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-------~~~~~~~~~~------ 241 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNES------ 241 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHhccC------
Confidence 2335788999999974 4678999999999999999999999986532211 0111111100
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 005492 594 RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636 (694)
Q Consensus 594 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~ 636 (694)
...........+.+++.+||+.+|.+||++.+|++++-.+.
T Consensus 242 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 242 --PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred --CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 00111233456889999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=295.74 Aligned_cols=251 Identities=27% Similarity=0.439 Sum_probs=206.9
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeC--CccEEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLVY 435 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lv~ 435 (694)
+|...+.||+|++|.||+|... +++.+++|...... ....+.+.+|+.++++++||||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999987 58899999876543 25678899999999999999999999999988 8899999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999998653 5999999999999999999999998 999999999999999999999999998876543
Q ss_pred Ccc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 516 QTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 516 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
... ......++..|+|||.+.....+.++||||||+++++|++|+.||..... .......... ..
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~---------~~ 220 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGS---------SG 220 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccc---------cC
Confidence 321 12334588899999999988899999999999999999999999976541 1111111110 00
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.....+...+..+.+++.+||+.+|++||++.+++.+
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1111222335678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=298.03 Aligned_cols=265 Identities=24% Similarity=0.394 Sum_probs=221.3
Q ss_pred hHHHHhcCCCccceeeeeCcEEEEEEEEcC------CcEEEEEEccc-cChhhHHHHHHHHHHHhhccCCcceeEEeEEe
Q 005492 354 DLEKATDNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCL 426 (694)
Q Consensus 354 ~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~ 426 (694)
++.....+++....+-+|.||.||.|.+.+ .+.|-+|.++. .++-+...++.|.-++..+.|||++++.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 445556778888899999999999997754 34566777664 55667888999999999999999999999987
Q ss_pred eC-CccEEEEEeCCCCChHHHHh-----cccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCc
Q 005492 427 ET-EVPLLVYEFIPNGTLYQYIH-----NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR 500 (694)
Q Consensus 427 ~~-~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~ 500 (694)
++ +.++.+|.++.-|+|..||. +......++..++..++.|++.|++|||+++ ++|.||..+|.+||+..+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence 65 57899999999999999998 3334456888999999999999999999999 999999999999999999
Q ss_pred EEEeecCCccccccCCcc-eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHH
Q 005492 501 AKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYF 578 (694)
Q Consensus 501 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 578 (694)
+||+|-.++|.+...+.+ ..........||+||.+....|+.++|||||||+||||+| |+.|+...++.| +
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------m 507 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------M 507 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------H
Confidence 999999999987655444 3344456789999999999999999999999999999998 899998776655 3
Q ss_pred HHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 005492 579 LQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRT 637 (694)
Q Consensus 579 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~ 637 (694)
...++++ .+...+.+++.++..++.-||...|++||+++|++.-|.+...
T Consensus 508 ~~ylkdG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 508 EHYLKDG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred HHHHhcc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 3333332 2333456788899999999999999999999999998876543
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=307.07 Aligned_cols=265 Identities=26% Similarity=0.358 Sum_probs=201.0
Q ss_pred HHhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC----
Q 005492 357 KATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETE---- 429 (694)
Q Consensus 357 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~---- 429 (694)
...++|++.+.||+|+||.||+|..+. ++.||+|+++... ......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 456789999999999999999999864 8899999886532 233456788999999999999999999987655
Q ss_pred ------ccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEE
Q 005492 430 ------VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV 503 (694)
Q Consensus 430 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl 503 (694)
..+||+||+++ +|..++.... ..+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 7777776542 35899999999999999999999999 999999999999999999999
Q ss_pred eecCCccccccCCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHh
Q 005492 504 SDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 582 (694)
Q Consensus 504 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 582 (694)
+|||++...............++..|+|||.+.+ ..++.++||||||++++||++|+.||......+ ....+....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~---~~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA---QLELISRLC 234 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHh
Confidence 9999998765433222223346788999998865 457899999999999999999999997543211 111111111
Q ss_pred hhcc---hhhh--------hhh------hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 583 NENR---LFEI--------LDA------RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 583 ~~~~---~~~~--------~d~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.... ...+ .+. ..... ....+..+.+++.+||+.+|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1000 0000 000 00000 11234678999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=297.29 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=199.2
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeC--Ccc
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-----DETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVP 431 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~ 431 (694)
.+|+..+.||+|+||.||+|... +++.+|+|.+... .......+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999975 4889999986432 233456789999999999999999999998765 357
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
++|+||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999997542 4889999999999999999999999 99999999999999999999999999986
Q ss_pred cccCC--cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhh
Q 005492 512 VMVDQ--THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589 (694)
Q Consensus 512 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (694)
..... ........++..|+|||.+.+..++.++||||||++++||++|+.||......+ .+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~----- 224 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------AIFKIATQ----- 224 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------HHHHHHcC-----
Confidence 53211 111223458899999999998889999999999999999999999996532211 11111111
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 590 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
......+......+.+++.+||+ +|..||+..+++.+
T Consensus 225 ----~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 225 ----PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ----CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11112233445678899999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=300.85 Aligned_cols=258 Identities=23% Similarity=0.305 Sum_probs=194.9
Q ss_pred CCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcc-CCcceeEEeEEeeC--CccEEEEE
Q 005492 362 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQIN-HRNIVKLLGCCLET--EVPLLVYE 436 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~g~~~~~--~~~~lv~e 436 (694)
|+..+.||+|+||.||+|... +++.+|+|+.+... ........+|+.++.++. |+||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999975 58899999876532 223334567899999985 99999999999987 88999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
|++ ++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||+|+||++++ +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 58888887543 25899999999999999999999999 999999999999999 999999999998664322
Q ss_pred cceeeeeecCCCCCCCcccc-cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh-----------
Q 005492 517 THLTTKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE----------- 584 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~-~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 584 (694)
. .....++..|+|||.+. ...++.++||||||+++|||++|..||...+..+ ...........
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcc
Confidence 2 12234788999999765 4567899999999999999999999997644321 11111111100
Q ss_pred cchhhhhhhh----hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 585 NRLFEILDAR----VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 585 ~~~~~~~d~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
........+. .........+..+.+|+.+||+.+|++||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000 0001112345789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=303.68 Aligned_cols=261 Identities=25% Similarity=0.355 Sum_probs=198.4
Q ss_pred CCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 362 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
|+..+.||.|++|.||+|... +|..||+|++.... ......+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999975 58999999876532 233467889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
+ ++|.+++..... ..+++..++.++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||++.........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 699999876532 35899999999999999999999998 999999999999999999999999998765432221
Q ss_pred eeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh-c--c---hh---
Q 005492 519 LTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE-N--R---LF--- 588 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~--~---~~--- 588 (694)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||........ +...+ ..... . . ..
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIF-RTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHhCCCChHHhhhhhhch
Confidence 1223468899999988654 578999999999999999999999965432210 11100 00000 0 0 00
Q ss_pred hh---hh---hhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 589 EI---LD---ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 589 ~~---~d---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+. +. ..............+.+++.+||+.+|.+||+++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 00 000001111233568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=324.85 Aligned_cols=268 Identities=20% Similarity=0.295 Sum_probs=191.7
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEcC--CcEEEEE------------------EccccChhhHHHHHHHHHHHhhccCCc
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLTD--GRIVAVK------------------KSKLVDETNVEQFINEVVILSQINHRN 417 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n 417 (694)
..++|++.+.||+|+||+||++..+. +...++| ++. ........+.+|+.+|++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 35789999999999999999987543 2222222 111 12234556889999999999999
Q ss_pred ceeEEeEEeeCCccEEEEEeCCCCChHHHHhcccC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEE
Q 005492 418 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIE--EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL 495 (694)
Q Consensus 418 Iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll 495 (694)
|+++++++.+.+..++|+|++. ++|.+++..... ........+..|+.||+.||+|||+++ |+||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999985 577777754321 112346677889999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCccccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCC-CCccCCCccCccH
Q 005492 496 DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK-PIRAINTDEDKSL 574 (694)
Q Consensus 496 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~-p~~~~~~~~~~~~ 574 (694)
+.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||+||||++|.. |+..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999998765443333344569999999999999999999999999999999999875 4433222211111
Q ss_pred HHHHHHHhh--hc-------chhhhhhhhhhh----hh-----hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 575 VGYFLQAIN--EN-------RLFEILDARVLK----EA-----KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 575 ~~~~~~~~~--~~-------~~~~~~d~~~~~----~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
...+ ..+. .. .+.+.++..... .. .......+.+++.+||+.||.+||++.|++++
T Consensus 381 ~~~~-~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKII-DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHH-HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111 1000 00 011111100000 00 00122356788999999999999999999875
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=299.91 Aligned_cols=242 Identities=24% Similarity=0.305 Sum_probs=188.3
Q ss_pred eeeeeCcEEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhh---ccCCcceeEEeEEeeCCccEEEEEeCC
Q 005492 367 ILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQ---INHRNIVKLLGCCLETEVPLLVYEFIP 439 (694)
Q Consensus 367 ~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~---l~h~nIv~l~g~~~~~~~~~lv~e~~~ 439 (694)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..+++. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 48899999875421 1222334455544443 479999999999999999999999999
Q ss_pred CCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce
Q 005492 440 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519 (694)
Q Consensus 440 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 519 (694)
+++|.+++..+. .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999999987543 4999999999999999999999999 9999999999999999999999999987543221
Q ss_pred eeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 520 TTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 520 ~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
.....|+..|+|||.+.. ..++.++||||||++++||++|+.||.......... ...... .....
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~----------~~~~~ 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTL----------TVNVE 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhh----------cCCcC
Confidence 123458999999999864 568999999999999999999999997554322110 101000 00111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRP-----TMKEVAFE 631 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 631 (694)
.+...+..+.+++.+||+.+|.+|| +++|++++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2233456788999999999999999 59888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=307.00 Aligned_cols=263 Identities=25% Similarity=0.338 Sum_probs=198.6
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeC--CccEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLL 433 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~l 433 (694)
.++|+..+.||+|+||.||+|.... ++.||+|.++... ......+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4679999999999999999999764 8999999876432 22234567899999999999999999998765 46799
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
||||+.+ +|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 8988887543 35899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh--cchhh-
Q 005492 514 VDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE--NRLFE- 589 (694)
Q Consensus 514 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~- 589 (694)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+. ...+...... .....
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPNESIWPG 235 (309)
T ss_pred CccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChhhchh
Confidence 3321 1222335788999999865 5689999999999999999999999975443221 1111111100 00000
Q ss_pred --------h--hhhhhh---hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 590 --------I--LDARVL---KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 590 --------~--~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
. +..... ..........+.++|.+||+.||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 000000 00001124567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=297.08 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=205.5
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
+|++.+.||+|++|.||++... +++.+|+|.+... .......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999865 5789999987653 334566788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 438 IPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 438 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999987632 2245899999999999999999999999 999999999999999999999999999776543
Q ss_pred cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhh
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 596 (694)
......++..|+|||.+.+..++.++|+||||++++||++|+.||......+ +.........
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~--------- 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGKY--------- 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCC---------
Confidence 2223457889999999999999999999999999999999999996543221 1111111111
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 597 KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 597 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
...+......+.+++.+||+.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11222445668999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=296.30 Aligned_cols=242 Identities=27% Similarity=0.317 Sum_probs=196.0
Q ss_pred eeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCCh
Q 005492 368 LGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL 443 (694)
Q Consensus 368 LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gsL 443 (694)
||.|++|.||++.... ++.+|+|.+... .....+.+.+|+.++++++||||+++++.+.+....++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999864 889999987642 223457799999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcceeeee
Q 005492 444 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 523 (694)
Q Consensus 444 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 523 (694)
.+++.+.. .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....... .....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 99997642 4899999999999999999999998 9999999999999999999999999998664332 22234
Q ss_pred ecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHH
Q 005492 524 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEG 603 (694)
Q Consensus 524 ~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 603 (694)
.++..|++||.+....++.++|+||||+++|+|++|..||.....+. ......... .......+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~---------~~~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILK---------GNGKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhc---------cCCCCCCCccc
Confidence 57889999999988889999999999999999999999997654211 111111110 00011112222
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005492 604 IMTVATLAKRCLNLNGKMRPT-----MKEVAF 630 (694)
Q Consensus 604 ~~~l~~li~~cl~~~p~~RPt-----~~evl~ 630 (694)
...+.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 567899999999999999999 566655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=310.26 Aligned_cols=265 Identities=21% Similarity=0.316 Sum_probs=201.6
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC-----c
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETE-----V 430 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~-----~ 430 (694)
.++|...+.||+|+||+||++... +++.||||.+... .......+.+|+.+++.++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999975 4899999987642 3334567788999999999999999999886543 4
Q ss_pred cEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcc
Q 005492 431 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~ 510 (694)
.+||+||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 6899888754 25999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhh------
Q 005492 511 SVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN------ 583 (694)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 583 (694)
...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...+..+ ..........
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEED 232 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChHH
Confidence 654322 22233457889999998765 568999999999999999999999997543211 1111111100
Q ss_pred -----hcchhhhhh-------hhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhcc
Q 005492 584 -----ENRLFEILD-------ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE--LGGI 635 (694)
Q Consensus 584 -----~~~~~~~~d-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~l 635 (694)
.......+. ... .......+..+.+++.+||+.+|++||++.+++++ +..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000000 000 01112345678899999999999999999999987 5444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=300.71 Aligned_cols=259 Identities=19% Similarity=0.288 Sum_probs=187.4
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcCC----cEEEEEEccccChhhH-----------HHHHHHHHHHhhccCCcceeEEe
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTDG----RIVAVKKSKLVDETNV-----------EQFINEVVILSQINHRNIVKLLG 423 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~nIv~l~g 423 (694)
.++|.+.++||+|+||+||+|...++ ..+|+|.......... .....++..+..++|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36799999999999999999997653 4566665433222110 11233445566678999999999
Q ss_pred EEeeCC----ccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCC
Q 005492 424 CCLETE----VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY 499 (694)
Q Consensus 424 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~ 499 (694)
++.... ..++++|++.. ++.+.+.... ..++..+..|+.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876554 23677777643 6666665431 3678889999999999999999998 99999999999999999
Q ss_pred cEEEeecCCccccccCCcc------eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCcc
Q 005492 500 RAKVSDFGTSRSVMVDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKS 573 (694)
Q Consensus 500 ~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~ 573 (694)
.+||+|||+++....+... ......||+.|+|||++.+..++.++||||||++|+||++|+.||........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-- 241 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-- 241 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH--
Confidence 9999999999876432211 11234599999999999999999999999999999999999999987633221
Q ss_pred HHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 574 LVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
.. .......+..+...... ....+..+.+++..|++.+|++||++.++++.|+
T Consensus 242 ~~----~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LI----HAAKCDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HH----HHhHHHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11 00011111111111110 1123467889999999999999999999998763
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.09 Aligned_cols=267 Identities=23% Similarity=0.346 Sum_probs=196.2
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCc-----
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEV----- 430 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~----- 430 (694)
.++|+..+.||+|+||.||++... +++.||||.+.... ......+.+|+.++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999976 48999999876432 2234456789999999999999999999876554
Q ss_pred ---cEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecC
Q 005492 431 ---PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 507 (694)
Q Consensus 431 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFG 507 (694)
.++||||+.+ +|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 4999999965 8888886542 24899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCcc---eeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhh
Q 005492 508 TSRSVMVDQTH---LTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN 583 (694)
Q Consensus 508 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 583 (694)
++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||..............+...+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99866432221 11234578899999988664 478999999999999999999999976543221111111100000
Q ss_pred hcch-----hhhhh----h-----hhhhhh-hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 584 ENRL-----FEILD----A-----RVLKEA-KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 584 ~~~~-----~~~~d----~-----~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.... .+..+ + ...... .......+.+||.+||+.+|.+||++.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000 00000 0 000000 00012456799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.06 Aligned_cols=260 Identities=23% Similarity=0.337 Sum_probs=199.8
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeC------
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLET------ 428 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~------ 428 (694)
..++|+..+.||+|+||.||++... +++.||||.+.. ........+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999975 589999998764 2344556788999999999999999999998644
Q ss_pred CccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCC
Q 005492 429 EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 508 (694)
Q Consensus 429 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGl 508 (694)
...++||||+. ++|.+++... +++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 34689999996 4888887643 889999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhc---
Q 005492 509 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN--- 585 (694)
Q Consensus 509 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 585 (694)
++...... ......++..|+|||.+.+..++.++||||||+++++|++|+.||...+.... ...+...+...
T Consensus 165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~ 239 (353)
T cd07850 165 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ---WNKIIEQLGTPSDE 239 (353)
T ss_pred ceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhcCCCCHH
Confidence 98654322 12334578899999999999999999999999999999999999975432110 00000000000
Q ss_pred ----------------------chhhhhhhhh----hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 586 ----------------------RLFEILDARV----LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 586 ----------------------~~~~~~d~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+.++..... ...........+.+++.+||+.||++||++.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 000011335568899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=293.93 Aligned_cols=251 Identities=32% Similarity=0.437 Sum_probs=206.7
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
+|+..+.||+|+||.||++... +++.+|+|++.... ......+.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999976 48899999987643 35667889999999999999999999999999999999999
Q ss_pred CCCCChHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCC
Q 005492 438 IPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 438 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~ 516 (694)
+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999998742 1246999999999999999999999998 9999999999999999999999999987664432
Q ss_pred cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhh
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 596 (694)
.......+++.|+|||.+....++.++||||||+++++|++|+.||......+ .... .......
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~-------- 221 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALK-ILKGQYP-------- 221 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHH-HhcCCCC--------
Confidence 22334468889999999998899999999999999999999999986543211 1111 1111111
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 597 KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 597 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..+......+.+++.+||..+|++||++.+++++
T Consensus 222 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 222 -PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1112334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.28 Aligned_cols=253 Identities=27% Similarity=0.387 Sum_probs=195.3
Q ss_pred CCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccC-hhhHHHHHHHHHHHhhcc-CCcceeEEeEEeeCCccEEEEEe
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD-ETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
+|...+.||+|+||.||++.... ++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 45567789999999999999764 8999999876532 345667899999999996 99999999999999999999999
Q ss_pred CCCCChHHHHh---cccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 438 IPNGTLYQYIH---NQIEEFPITWELLLRIAVEVSGALFYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 438 ~~~gsL~~~l~---~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
++. +|.++.. .. ....+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 864 5555432 22 224699999999999999999999975 6 9999999999999999999999999987654
Q ss_pred cCCcceeeeeecCCCCCCCcccccC---CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhh
Q 005492 514 VDQTHLTTKVQGTFGYVDPEYFQSS---QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590 (694)
Q Consensus 514 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (694)
.... .....++..|+|||++... .++.++||||||+++|||++|+.||.... .............
T Consensus 160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~----- 227 (288)
T cd06616 160 DSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGD----- 227 (288)
T ss_pred cCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCC-----
Confidence 3221 2233578899999998776 68999999999999999999999986533 1111111111110
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 591 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+.+........+..+.+|+.+||+.+|++||++.+|+++
T Consensus 228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111112345678999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=301.09 Aligned_cols=245 Identities=27% Similarity=0.410 Sum_probs=199.3
Q ss_pred cceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCCh
Q 005492 365 NRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL 443 (694)
Q Consensus 365 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gsL 443 (694)
..+||+|+||.||++... +++.||||++..........+.+|+.+++.++|+||+++++++.+.+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 467999999999999875 5899999988765555667899999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcceeeee
Q 005492 444 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 523 (694)
Q Consensus 444 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 523 (694)
.+++... .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........ .....
T Consensus 105 ~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 105 TDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 9988543 4899999999999999999999999 99999999999999999999999999876543221 12334
Q ss_pred ecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHH
Q 005492 524 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEG 603 (694)
Q Consensus 524 ~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 603 (694)
.++..|+|||.+....++.++|+||||+++|+|++|+.||......+ ....+... +..... . ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~-------~~~~~~~~-----~~~~~~-~-~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDN-----LPPKLK-N-LHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhh-----CCcccC-C-cccC
Confidence 57899999999988889999999999999999999999987533221 11111110 000100 0 0123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 604 IMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 604 ~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
...+.+++.+||+.+|.+||++.+++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 3457889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.55 Aligned_cols=266 Identities=27% Similarity=0.363 Sum_probs=200.2
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCC--cc
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETE--VP 431 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~--~~ 431 (694)
..++|+..+.||+|+||.||+|... +++.+|+|++.. ........+.+|+.+++++ +||||+++++++...+ ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567899999999999999999976 488999998754 2334456678899999999 9999999999987543 67
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
++||||++ ++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5999988754 4889999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCc----ceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHH--------
Q 005492 512 VMVDQT----HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF-------- 578 (694)
Q Consensus 512 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~-------- 578 (694)
...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||......+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 643322 12233458899999998765 56789999999999999999999999654332110000000
Q ss_pred HHHhhhcchhhhhhh------hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 579 LQAINENRLFEILDA------RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 579 ~~~~~~~~~~~~~d~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
...+.......+++. ....+.....+..+.+++.+||+.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000001100 00001111235678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.33 Aligned_cols=245 Identities=28% Similarity=0.375 Sum_probs=197.7
Q ss_pred eeeeCcEEEEEEEEcC-CcEEEEEEccccCh---hhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCCh
Q 005492 368 LGQGGQGTVYKGMLTD-GRIVAVKKSKLVDE---TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL 443 (694)
Q Consensus 368 LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gsL 443 (694)
||+|+||.||++...+ ++.+|+|.+..... ...+.+.+|++++++++||||+++++.+......++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999875 89999998765332 4567889999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc------
Q 005492 444 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT------ 517 (694)
Q Consensus 444 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~------ 517 (694)
.+++.... .+++..++.++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99998643 5899999999999999999999999 99999999999999999999999999876543321
Q ss_pred -ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhh
Q 005492 518 -HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596 (694)
Q Consensus 518 -~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 596 (694)
.......++..|+|||.+.....+.++||||||+++++|++|+.||......+ ....+..+.... .
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~------~ 221 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-------IFQNILNGKIEW------P 221 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCcCC------C
Confidence 12233457889999999988889999999999999999999999996544221 111111111100 0
Q ss_pred hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 597 KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 597 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
.. ...+..+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 222 ~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 ED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00 012467889999999999999999966666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=309.52 Aligned_cols=266 Identities=23% Similarity=0.347 Sum_probs=200.7
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEee----CCcc
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLE----TEVP 431 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~----~~~~ 431 (694)
.++|+..+.||+|+||.||++... +++.||+|++... .......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999976 4899999987653 22345678889999999999999999998763 3467
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
++||||+. ++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999995 68999886542 4899999999999999999999999 99999999999999999999999999876
Q ss_pred cccCCcc---eeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHH--------H
Q 005492 512 VMVDQTH---LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF--------L 579 (694)
Q Consensus 512 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~--------~ 579 (694)
....... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||............... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432211 1123468889999999865 56899999999999999999999999764332111000000 0
Q ss_pred HHhhhcchhhhhhhh------hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 580 QAINENRLFEILDAR------VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 580 ~~~~~~~~~~~~d~~------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.......+....+.. ...+.....+..+.+++.+||+.+|.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000111111000 0011112345679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=292.26 Aligned_cols=247 Identities=28% Similarity=0.461 Sum_probs=204.0
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
+|+..+.||+|++|.||++... +++.+|+|....... ...+.+.+|++++++++|+|++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999876 478999998876543 4667899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999999765 35899999999999999999999999 99999999999999999999999999987654332
Q ss_pred ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
. .....++..|+|||.+.....+.++|||+||+++++|++|+.||....... ...... .... .
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~------~~~~~~-~~~~---------~ 217 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA------ALFRIV-QDDH---------P 217 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHh-ccCC---------C
Confidence 1 233457889999999988889999999999999999999999986543211 011111 1100 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAF 630 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 630 (694)
..+......+.+++.+||..+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111223456889999999999999999999885
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=297.83 Aligned_cols=244 Identities=26% Similarity=0.303 Sum_probs=193.7
Q ss_pred eeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCCh
Q 005492 368 LGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL 443 (694)
Q Consensus 368 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gsL 443 (694)
||+|+||+||++... +++.+|+|.+... .......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 4889999987542 223355678899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcceeeee
Q 005492 444 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 523 (694)
Q Consensus 444 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 523 (694)
.+++..... ..+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++...... ......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGR 154 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC--Cccccc
Confidence 999976533 35899999999999999999999999 999999999999999999999999998765431 122234
Q ss_pred ecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHH
Q 005492 524 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEG 603 (694)
Q Consensus 524 ~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 603 (694)
.++..|+|||.+.+..++.++||||||+++++|++|+.||.......... .+...... .....+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~----------~~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKRRTLE----------MAVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHhcccc----------ccccCCccC
Confidence 57889999999988889999999999999999999999997654321110 01000000 011112233
Q ss_pred HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005492 604 IMTVATLAKRCLNLNGKMRP-----TMKEVAF 630 (694)
Q Consensus 604 ~~~l~~li~~cl~~~p~~RP-----t~~evl~ 630 (694)
...+.+++.+||+.+|.+|| ++.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 55688999999999999999 5555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=299.89 Aligned_cols=260 Identities=25% Similarity=0.333 Sum_probs=202.1
Q ss_pred CCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 362 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
|+..+.||+|++|.||++... +++.+++|++..... .....+.+|+.++++++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999975 588999998765332 34677889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
++ +|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 75 8888887643 35899999999999999999999999 9999999999999999999999999987765433 1
Q ss_pred eeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhc---chhhhhh--
Q 005492 519 LTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN---RLFEILD-- 592 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d-- 592 (694)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+. .......+... .+..+.+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhhh
Confidence 12224478889999998876 789999999999999999999999865443221 11111110000 0000000
Q ss_pred -----------hhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 593 -----------ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 593 -----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.....+........+.++|.+||+.+|.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000011223456779999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=327.90 Aligned_cols=264 Identities=29% Similarity=0.443 Sum_probs=217.3
Q ss_pred hHHHHhcCCCccceeeeeCcEEEEEEEEcC--------CcEEEEEEccc-cChhhHHHHHHHHHHHhhc-cCCcceeEEe
Q 005492 354 DLEKATDNYNANRILGQGGQGTVYKGMLTD--------GRIVAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLLG 423 (694)
Q Consensus 354 ~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g 423 (694)
.++...++..+.+.||+|.||.|++|.... ...||||.++. ....+.+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 455556666777799999999999998541 34699999886 4446788899999999999 6999999999
Q ss_pred EEeeCCccEEEEEeCCCCChHHHHhccc-----CC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccccc
Q 005492 424 CCLETEVPLLVYEFIPNGTLYQYIHNQI-----EE--------FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKS 490 (694)
Q Consensus 424 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp 490 (694)
+|.+....++|+||+..|+|.+||+... .. ..++...++.++.|||.|++||++.. ++||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999998865 00 13899999999999999999999998 99999999
Q ss_pred ccEEECCCCcEEEeecCCccccccCCcceeeeeec--CCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCC
Q 005492 491 ANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG--TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAIN 567 (694)
Q Consensus 491 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~ 567 (694)
+|||+.++..+||+|||+++..............+ ...|||||.+....|+.|+|||||||+||||+| |..|+.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999776555444333333 456999999999999999999999999999999 788986633
Q ss_pred CccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 005492 568 TDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l 635 (694)
..+ .+.+.++++ .+.+.+..+..++.++++.||+.+|++||++.++.+.|+.+
T Consensus 527 ~~~------~l~~~l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 PTE------ELLEFLKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred cHH------HHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 111 112233333 23344556677899999999999999999999999999874
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=301.34 Aligned_cols=262 Identities=22% Similarity=0.310 Sum_probs=198.0
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
++|+..+.||+|++|+||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57889999999999999999976 58899999876532 2345678899999999999999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECC-CCcEEEeecCCccccccC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~-~~~~kl~DFGla~~~~~~ 515 (694)
|++ ++|.+++.... ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++. +..+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 58888876542 224688899999999999999999998 999999999999985 567999999999765432
Q ss_pred CcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhh---
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEIL--- 591 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 591 (694)
.. ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+ ....+....... .....
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~---~~~~~~~~~~~~-~~~~~~~~ 231 (294)
T PLN00009 157 VR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID---ELFKIFRILGTP-NEETWPGV 231 (294)
T ss_pred cc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCC-Chhhcccc
Confidence 21 1223346889999998866 457899999999999999999999997543221 111111111000 00000
Q ss_pred -------------hhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 592 -------------DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 592 -------------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
...............+.+++.+||+.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000001112234568899999999999999999999864
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.10 Aligned_cols=261 Identities=26% Similarity=0.370 Sum_probs=203.7
Q ss_pred CCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC-----ccE
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETE-----VPL 432 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~-----~~~ 432 (694)
+|++.+.||+|++|.||++...+ ++.+|||++.... ....+.+.+|+.++++++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 57888999999999999999765 8999999887543 445678999999999999999999999998775 789
Q ss_pred EEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccc
Q 005492 433 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 512 (694)
Q Consensus 433 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~ 512 (694)
+||||++ ++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 48999887543 5999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCc--ceeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh-----
Q 005492 513 MVDQT--HLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE----- 584 (694)
Q Consensus 513 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 584 (694)
..... .......++..|+|||.+.+. .++.++||||||+++++|++|+.||......+.... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL---IVEVLGTPSEED 230 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHhcCCCChhH
Confidence 54321 122334578899999999887 899999999999999999999999976553221110 0000000
Q ss_pred ------cchhhhhh------hhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 585 ------NRLFEILD------ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 585 ------~~~~~~~d------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
......+. ...........+..+.+++.+||+.+|.+||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000 000011112245678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=293.66 Aligned_cols=260 Identities=26% Similarity=0.362 Sum_probs=197.9
Q ss_pred CCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccC--hhhHHHHHHHHHHHhhc---cCCcceeEEeEEeeCCc-----
Q 005492 362 YNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD--ETNVEQFINEVVILSQI---NHRNIVKLLGCCLETEV----- 430 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~g~~~~~~~----- 430 (694)
|++.+.||+|+||.||+|..+. ++.+|+|++.... ......+.+|+.+++++ +|+||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999999875 8999999887432 22344567788877766 59999999999998876
Q ss_pred cEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcc
Q 005492 431 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~ 510 (694)
.+++|||+++ +|.+++..... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 89998876432 35899999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcch---
Q 005492 511 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL--- 587 (694)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 587 (694)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+. ...+.........
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---LDKIFDVIGLPSEEEW 230 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---HHHHHHHcCCCChHhc
Confidence 7643321 1223478899999999999999999999999999999999999876443221 1111111100000
Q ss_pred -------hhhhhhh---hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 588 -------FEILDAR---VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 588 -------~~~~d~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
....... ...+........+.+++.+||+.+|.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000 0011122345678899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=300.39 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=197.5
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
+.|...+.||+|+||.||+|... ++..+|+|.+.. .......++.+|+++++.++|+|++++++++.+....++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34667789999999999999976 478899998754 23344567889999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+. |+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 68888776433 24899999999999999999999998 999999999999999999999999998765322
Q ss_pred CcceeeeeecCCCCCCCcccc---cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 592 (694)
....++..|+|||.+. ...++.++||||||+++|+|++|+.||......+ ....+..+....
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~--- 233 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNESPA--- 233 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-------HHHHHhhcCCCC---
Confidence 2345788999999974 3568899999999999999999999986533211 111111111100
Q ss_pred hhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005492 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 593 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
.........+.+||.+||+.+|++||++.+++++..
T Consensus 234 -----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 234 -----LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -----cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 011233456889999999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=292.22 Aligned_cols=243 Identities=26% Similarity=0.295 Sum_probs=190.1
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEccccCh---hhHHHHHHHHHHH-hhccCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE---TNVEQFINEVVIL-SQINHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
+.||+|+||.||+|... +++.||+|....... .....+..|..++ ...+|+||+++++++.+.+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999975 488999998764322 2233445555444 455899999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.... .
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 99999997542 4899999999999999999999998 99999999999999999999999999875432 2
Q ss_pred eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAK 600 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 600 (694)
....++..|+|||.+.+..++.++||||||+++|||++|..||......+ ....+...... ......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------~~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRIN------WPEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcccC------CCCccc
Confidence 23357889999999988889999999999999999999999996543221 11111111110 001111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 601 KEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 601 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
...+..+.+++.+||+.+|++||++.++.+.|
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 13346788999999999999999887665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=301.41 Aligned_cols=256 Identities=21% Similarity=0.321 Sum_probs=194.4
Q ss_pred ceeeee--CcEEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQG--GQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
..||+| +||+||++... +++.||+|..... .....+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999975 5899999987643 334467889999999999999999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce-
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL- 519 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~- 519 (694)
++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999999886532 24899999999999999999999998 9999999999999999999999998654332111110
Q ss_pred -----eeeeecCCCCCCCcccccC--CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcc------
Q 005492 520 -----TTKVQGTFGYVDPEYFQSS--QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR------ 586 (694)
Q Consensus 520 -----~~~~~gt~~y~aPE~~~~~--~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 586 (694)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||......+. ....+....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~ 233 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM------LLQKLKGPPYSPLDI 233 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH------HHHHhcCCCCCCccc
Confidence 0112245679999998763 478999999999999999999999975432110 000000000
Q ss_pred ------------------------------hhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 587 ------------------------------LFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 587 ------------------------------~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.....+..+...........+.+|+.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000111111112233456778999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.83 Aligned_cols=203 Identities=32% Similarity=0.526 Sum_probs=176.8
Q ss_pred CCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccc-cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeC------CccE
Q 005492 361 NYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLET------EVPL 432 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~------~~~~ 432 (694)
.|...+.||+||||.||+|+.+ .|+.||||.... ......+...+|+++|++++|+|||++++.-.+. ..+.
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3556788999999999999965 499999998775 3345567788999999999999999999986544 4678
Q ss_pred EEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEEC----CCCcEEEeecCC
Q 005492 433 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD----DKYRAKVSDFGT 508 (694)
Q Consensus 433 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~----~~~~~kl~DFGl 508 (694)
+|||||.+|+|...|.+-.+..-|++.+++.+..+++.||.|||+++ |+||||||.||++- .....||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999998666667999999999999999999999999 99999999999993 344579999999
Q ss_pred ccccccCCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCC
Q 005492 509 SRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINT 568 (694)
Q Consensus 509 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~ 568 (694)
|+.+..+ .......||..|++||++.. ..|+..+|.|||||++||.+||..||.....
T Consensus 171 Arel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 171 ARELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 9977543 36677889999999999995 8899999999999999999999999975543
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=306.13 Aligned_cols=261 Identities=22% Similarity=0.350 Sum_probs=195.6
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC------
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETE------ 429 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~------ 429 (694)
.++|...+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999975 5899999987642 2233456889999999999999999999987553
Q ss_pred ccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCc
Q 005492 430 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS 509 (694)
Q Consensus 430 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla 509 (694)
..++|+||+.. +|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 45899999964 7776653 14899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHH-------
Q 005492 510 RSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQA------- 581 (694)
Q Consensus 510 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~------- 581 (694)
+..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ........
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~ 237 (342)
T cd07879 165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGPE 237 (342)
T ss_pred cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHH
Confidence 764321 123457889999999876 568999999999999999999999997543211 01000000
Q ss_pred ----hhhcchhhhhhh---hhhhh---hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhcc
Q 005492 582 ----INENRLFEILDA---RVLKE---AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE--LGGI 635 (694)
Q Consensus 582 ----~~~~~~~~~~d~---~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~l 635 (694)
............ ..... ........+.+++.+||+.+|.+||++.+++.+ ++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000000000000 00000 001233568899999999999999999999865 4444
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=301.80 Aligned_cols=260 Identities=19% Similarity=0.278 Sum_probs=193.7
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCC
Q 005492 365 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGT 442 (694)
Q Consensus 365 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gs 442 (694)
.+.+|.|+++.||++.. +++.||||++... .....+.+.+|+.++++++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455555655555554 5899999998653 45567789999999999999999999999999999999999999999
Q ss_pred hHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc-----
Q 005492 443 LYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT----- 517 (694)
Q Consensus 443 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~----- 517 (694)
|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999986532 25889999999999999999999999 99999999999999999999999998865532111
Q ss_pred -ceeeeeecCCCCCCCccccc--CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHh----hhcc----
Q 005492 518 -HLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI----NENR---- 586 (694)
Q Consensus 518 -~~~~~~~gt~~y~aPE~~~~--~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~---- 586 (694)
.......++..|+|||++.. ..++.++||||||+++|||++|+.||....... .......... ....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhh
Confidence 11123346788999999876 358899999999999999999999997543221 1111000000 0000
Q ss_pred ---hhh----hhhh----hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 587 ---LFE----ILDA----RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 587 ---~~~----~~d~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
... ..++ .............+.+++.+||+.+|++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 0000 00111223344678899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=290.40 Aligned_cols=247 Identities=21% Similarity=0.290 Sum_probs=190.8
Q ss_pred HHHhcCCCcccee--eeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCcc
Q 005492 356 EKATDNYNANRIL--GQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP 431 (694)
Q Consensus 356 ~~~~~~f~~~~~L--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~ 431 (694)
....++|++.+.+ |+|+||.||++..+ +++.+|+|.......... |+.....+ +||||+++++++...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3334567776666 99999999999975 478899998764321111 22222222 799999999999999999
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCC-cEEEeecCCcc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSR 510 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~-~~kl~DFGla~ 510 (694)
++||||+++++|.+++.... .+++..+..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||+++
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 99999999999999997653 5999999999999999999999999 99999999999999988 99999999987
Q ss_pred ccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhh
Q 005492 511 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590 (694)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (694)
..... ....++..|+|||++.+..++.++||||||++++||++|+.||......+ .....+. ... ..
T Consensus 159 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~-~~~-~~----- 225 (267)
T PHA03390 159 IIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLL-KRQ-QK----- 225 (267)
T ss_pred ecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHH-Hhh-cc-----
Confidence 65322 12357899999999999999999999999999999999999997443221 1111111 100 00
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 005492 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPT-MKEVAFE 631 (694)
Q Consensus 591 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~~ 631 (694)
...........+.+++.+||+.+|.+||+ +++++++
T Consensus 226 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 226 -----KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -----cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 00111234566889999999999999996 6888753
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=296.48 Aligned_cols=255 Identities=23% Similarity=0.280 Sum_probs=201.3
Q ss_pred CCCccceeeeeCcEEEEEEEEc----CCcEEEEEEccccC----hhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCcc
Q 005492 361 NYNANRILGQGGQGTVYKGMLT----DGRIVAVKKSKLVD----ETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP 431 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~ 431 (694)
+|+..+.||+|++|.||++... +++.+|||.++... ....+.+.+|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999998853 46889999876422 22345688999999999 599999999999999999
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999998754 24899999999999999999999998 99999999999999999999999999877
Q ss_pred cccCCcceeeeeecCCCCCCCcccccCC--CCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhh
Q 005492 512 VMVDQTHLTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589 (694)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (694)
.............++..|+|||.+.+.. .+.++||||||++++||++|..||....... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~----- 227 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS----- 227 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc-----
Confidence 6544333333455889999999987655 7889999999999999999999986432211 111111111100
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005492 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGG 634 (694)
Q Consensus 590 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 634 (694)
....+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 228 ------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 ------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 011112234567899999999999999999888877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=335.68 Aligned_cols=256 Identities=25% Similarity=0.373 Sum_probs=206.6
Q ss_pred HHHHhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCcc
Q 005492 355 LEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 431 (694)
Q Consensus 355 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~ 431 (694)
+...+-++....+||.|.||.||-+... +|...|+|.++..+ ......+.+|+.++..++|||+|+.+|+-.+.+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 3445678888999999999999999965 49999999776533 34456788999999999999999999999999999
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
+|.||||++|+|.+.+.... -+++.....+..|++.||+|||++| ||||||||.||||+.++.+|++|||.|..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 99999999999999987543 2667777778899999999999999 99999999999999999999999999988
Q ss_pred cccCCc---ceeeeeecCCCCCCCcccccCC---CCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhc
Q 005492 512 VMVDQT---HLTTKVQGTFGYVDPEYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN 585 (694)
Q Consensus 512 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~---~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 585 (694)
+..... .......||+.|||||++.+.. -..++||||||||++||+||+.||...+.+- .+ ...+..+
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aI---My~V~~g 1457 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AI---MYHVAAG 1457 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HH---HhHHhcc
Confidence 764421 1223456999999999997643 5679999999999999999999997654431 11 1112222
Q ss_pred chhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 586 RLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 586 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
... ..+.....+-.+++.+||+.||++|.++.|++++
T Consensus 1458 h~P---------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 HKP---------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCC---------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 211 2222345566799999999999999999888876
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=295.69 Aligned_cols=251 Identities=24% Similarity=0.310 Sum_probs=197.1
Q ss_pred CCCccceeeeeCcEEEEEEEEc----CCcEEEEEEccccC----hhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCcc
Q 005492 361 NYNANRILGQGGQGTVYKGMLT----DGRIVAVKKSKLVD----ETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP 431 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~ 431 (694)
+|++.+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4778899999999999999863 68899999876422 23346788899999999 599999999999999999
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
++||||+++++|.+++.... .+++..+..++.|+++||.|||+.+ ++||||+|+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999997642 4889999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCcceeeeeecCCCCCCCcccccC--CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhh
Q 005492 512 VMVDQTHLTTKVQGTFGYVDPEYFQSS--QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589 (694)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (694)
.............|+..|+|||.+... .++.++||||||+++|+|++|+.||....... .............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~---- 228 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE---- 228 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccC----
Confidence 543332223345588999999998753 47889999999999999999999986432211 1111111111100
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005492 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRP-----TMKEVAF 630 (694)
Q Consensus 590 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 630 (694)
...+......+.+++.+||+.+|++|| ++.+++.
T Consensus 229 -------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 -------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 011122345688999999999999997 5565554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=297.67 Aligned_cols=244 Identities=26% Similarity=0.402 Sum_probs=194.5
Q ss_pred CCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 362 YNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
|...+.||+|+||+||+|... +++.+|+|++... .....+.+.+|+++++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666778999999999999975 4889999987642 233456788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+. ++|.+++.... .++++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 57888876543 35899999999999999999999999 99999999999999999999999999864321
Q ss_pred ceeeeeecCCCCCCCcccc---cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~---~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
.....|+..|+|||++. ...++.++||||||+++|||++|..||....... ..... ........
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~-~~~~~~~~---- 240 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHI-AQNDSPTL---- 240 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHH-HhcCCCCC----
Confidence 12345888999999984 4668899999999999999999999986543211 01111 11111110
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
........+.+++.+||+.+|.+||++.+++.+
T Consensus 241 ----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 ----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223458899999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=301.54 Aligned_cols=263 Identities=24% Similarity=0.314 Sum_probs=196.1
Q ss_pred hcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC------
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETE------ 429 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~------ 429 (694)
.++|+..+.||+|+||.||+|... +++.+|||++.... ......+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999976 48899999875432 222356788999999999999999999876544
Q ss_pred --ccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecC
Q 005492 430 --VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 507 (694)
Q Consensus 430 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFG 507 (694)
..++|+||+.. +|...+.... ..+++..+..++.|+++||+|||+.+ |+|+||||+|||+++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999975 6777776532 35999999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCcc----------eeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHH
Q 005492 508 TSRSVMVDQTH----------LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG 576 (694)
Q Consensus 508 la~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~ 576 (694)
+++........ ..+...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+..... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~---~ 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL---H 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence 99765432211 1123457888999998765 45899999999999999999999999754432211 1
Q ss_pred HHHHHhhhcc---------hhh--------hhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 577 YFLQAINENR---------LFE--------ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 577 ~~~~~~~~~~---------~~~--------~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.......... +.. ...+.+ .+........+.+++.+||+.+|.+|||+.|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTL-EERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccH-HHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1111110000 000 000000 00111223568899999999999999999998764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.95 Aligned_cols=245 Identities=27% Similarity=0.339 Sum_probs=205.3
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv 434 (694)
.+.|..-++||+||||.||..+.++ |+.+|.|++... ........++|-.+|.+++.+-||.|-..+...+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 3568889999999999999998765 899999977542 233345578899999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
+..|.||+|.-+|.+..+ ..+++..++-.+.+|+-||++||... ||.||+||+|||||+.|+++|+|+|||..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999987654 46999999999999999999999999 99999999999999999999999999987765
Q ss_pred CCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
... .....||.+|||||++.++.|+...|+|||||+||||+.|+.||........ .+-+|.+
T Consensus 340 g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----------------~eEvdrr 401 (591)
T KOG0986|consen 340 GKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----------------REEVDRR 401 (591)
T ss_pred CCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----------------HHHHHHH
Confidence 443 3344799999999999999999999999999999999999999975433211 1222333
Q ss_pred hh---hhhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 005492 595 VL---KEAKKEGIMTVATLAKRCLNLNGKMRPTM 625 (694)
Q Consensus 595 ~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 625 (694)
.. .+++....++...|.+..|++||.+|..-
T Consensus 402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 22 23445566778899999999999999643
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=302.95 Aligned_cols=250 Identities=25% Similarity=0.354 Sum_probs=207.9
Q ss_pred HHhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEE
Q 005492 357 KATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 357 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l 433 (694)
.....|.+.+.||+|.|++|.++.... +..||||.+... +....+.+.+|+++|+.++|||||+|+.+......+++
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 345779999999999999999999764 899999987753 33445668999999999999999999999999999999
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
||||..+|.+++||.++.. +.+.....++.|+..|++|||++. |+|||||++||||+.+.++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999998754 666888999999999999999999 9999999999999999999999999998764
Q ss_pred cCCcceeeeeecCCCCCCCcccccCCC-CceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhh
Q 005492 514 VDQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592 (694)
Q Consensus 514 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 592 (694)
.........|++.|.|||++.+.+| ++.+|+||+|++||.|+.|..||++.+..+-+.- .-.++
T Consensus 207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r-------vl~gk------ 271 (596)
T KOG0586|consen 207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR-------VLRGK------ 271 (596)
T ss_pred --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch-------heeee------
Confidence 3445566789999999999998776 6899999999999999999999987654432110 00010
Q ss_pred hhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 593 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+ ..+.-...+..++++++|.++|.+|+++.++.+.
T Consensus 272 --~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 272 --Y--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred --e--cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 0 1111222346689999999999999999988643
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=293.35 Aligned_cols=260 Identities=25% Similarity=0.351 Sum_probs=197.5
Q ss_pred CCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccCh-hhHHHHHHHHHHHhhcc-CCcceeEEeEEeeCCccEEEEEeC
Q 005492 362 YNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDE-TNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
|++.+.||+|++|+||+|...+ ++.||||++..... .......+|+..+++++ |+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5678899999999999999865 78899998765322 23334567999999999 999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
+|+|.+++.... ...+++..++.++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889999987653 235899999999999999999999999 99999999999999999999999999876543221
Q ss_pred eeeeeecCCCCCCCcccc-cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhh-------------h
Q 005492 519 LTTKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN-------------E 584 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~-~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------------~ 584 (694)
.....++..|+|||.+. ...++.++|+||||++++||++|+.||......+.. ......+. .
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQL---YKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHH---HHHHHhcCCCChhhhhhHhhhh
Confidence 22345788999999875 456899999999999999999999998655432110 00000000 0
Q ss_pred cchhhhhhhhh---hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 585 NRLFEILDARV---LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 585 ~~~~~~~d~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..+...+.... ..+........+.+++.+||+.+|++||+++|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000000 011111124668899999999999999999998864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=297.11 Aligned_cols=252 Identities=24% Similarity=0.417 Sum_probs=195.3
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccC-hhhHHHHHHHHHHHhhcc-CCcceeEEeEEeeCCccEEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD-ETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lv~ 435 (694)
.++|+..+.||+|+||.||+|..++ ++.||||.++... .....++..|+.++.+.. ||||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3668889999999999999999876 8999999987532 334556777887777764 999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
||++ ++|.+++..... .+++..+..++.|++.||+|||+ .+ |+||||+|+||++++++.+||+|||++.....
T Consensus 94 e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 477777655322 68999999999999999999997 46 99999999999999999999999999876532
Q ss_pred CCcceeeeeecCCCCCCCcccccCC----CCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhh
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQ----FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~----~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (694)
... .....++..|+|||.+.... ++.++||||||+++|||++|+.||....... .......... ...+
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~-~~~~ 239 (296)
T cd06618 168 SKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLTKILQEE-PPSL 239 (296)
T ss_pred CCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHHHHHhcCC-CCCC
Confidence 221 22234788999999987554 7899999999999999999999986432210 1111111111 0000
Q ss_pred hhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 591 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
. .......++.+++.+||+.+|.+||++.+++++
T Consensus 240 ~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 P-------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 001234568899999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=303.05 Aligned_cols=266 Identities=22% Similarity=0.333 Sum_probs=200.4
Q ss_pred ChhhHHHHhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEee
Q 005492 351 TSKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLE 427 (694)
Q Consensus 351 ~~~~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~ 427 (694)
...++..++++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 34566777899999999999999999999864 5889999988653 23345678899999999999999999998864
Q ss_pred C------CccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcE
Q 005492 428 T------EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA 501 (694)
Q Consensus 428 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~ 501 (694)
. ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence 3 2357778776 78998887643 4899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccccCCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHH
Q 005492 502 KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ 580 (694)
Q Consensus 502 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 580 (694)
||+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .......
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~ 232 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILR 232 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHH
Confidence 99999998754321 223457889999999866 568899999999999999999999996543221 1110100
Q ss_pred Hhhh--cchhhhhhhh----hh-----------hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 581 AINE--NRLFEILDAR----VL-----------KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 581 ~~~~--~~~~~~~d~~----~~-----------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.... ..+...+... .. .+........+.+++.+||+.+|.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 0000000000 00 00001124568899999999999999999999876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=290.99 Aligned_cols=242 Identities=23% Similarity=0.302 Sum_probs=187.5
Q ss_pred eeeeeCcEEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHH---HHhhccCCcceeEEeEEeeCCccEEEEEeCC
Q 005492 367 ILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVV---ILSQINHRNIVKLLGCCLETEVPLLVYEFIP 439 (694)
Q Consensus 367 ~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~---~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~ 439 (694)
.||+|+||.||++... +++.||+|.+.... ......+..|.. +++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 48899999875422 122223444444 4444579999999999999999999999999
Q ss_pred CCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce
Q 005492 440 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519 (694)
Q Consensus 440 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 519 (694)
+++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 99999998754 25999999999999999999999998 9999999999999999999999999987553222
Q ss_pred eeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 520 TTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 520 ~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
.....|+..|+|||.+..+ .++.++||||||+++|||++|+.||.......... ....... .. .+
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~------~~----~~ 217 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------MA----VE 217 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhc------cC----CC
Confidence 1234589999999998754 68999999999999999999999997653322111 1011100 00 11
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRP-----TMKEVAFE 631 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 631 (694)
.+...+..+.+++.+||..+|.+|| ++.+++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1122345788999999999999999 89998864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=324.79 Aligned_cols=254 Identities=27% Similarity=0.413 Sum_probs=192.3
Q ss_pred HHhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeC------
Q 005492 357 KATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLET------ 428 (694)
Q Consensus 357 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~------ 428 (694)
+-..+|++.+.||+||||.||+++.+ ||+.+|||++... .......+.+|+..|++|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567999999999999999999976 7999999998764 344566789999999999999999987532110
Q ss_pred --------------------------------------------------------------------------------
Q 005492 429 -------------------------------------------------------------------------------- 428 (694)
Q Consensus 429 -------------------------------------------------------------------------------- 428 (694)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHH
Q 005492 429 ---------------------------------EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 475 (694)
Q Consensus 429 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yL 475 (694)
..+||-||||+..+|.++++.+... -.....+++++||++||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence 0136778999998888888765321 14678899999999999999
Q ss_pred HhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc-----------------CCcceeeeeecCCCCCCCcccccC
Q 005492 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV-----------------DQTHLTTKVQGTFGYVDPEYFQSS 538 (694)
Q Consensus 476 H~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~-----------------~~~~~~~~~~gt~~y~aPE~~~~~ 538 (694)
|+.+ ||||||||.||+||++..+||+|||+|..... ......+...||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 99999999999999999999999999987220 011123456799999999999764
Q ss_pred ---CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhc
Q 005492 539 ---QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCL 615 (694)
Q Consensus 539 ---~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl 615 (694)
.|+.|+|+|||||||+||+. ||.... +. ...+..++.+.+... .++.....+.-..+|.+|+
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-ER-----a~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM-ER-----ASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchH-HH-----HHHHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 49999999999999999996 553211 10 012222333332221 1122233344568999999
Q ss_pred ccCCCCCCCHHHHHH
Q 005492 616 NLNGKMRPTMKEVAF 630 (694)
Q Consensus 616 ~~~p~~RPt~~evl~ 630 (694)
+.||.+|||+.|+|.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999875
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=295.43 Aligned_cols=248 Identities=29% Similarity=0.400 Sum_probs=202.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcc-CCcceeEEeEEeeCCccEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lv 434 (694)
++|...+.||+|+||.||++... +++.+|+|..... .....+.+.+|+.++++++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999976 5899999987642 2344567889999999998 99999999999999999999
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
|||+++++|.+++.+.. .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999997643 5999999999999999999999999 99999999999999999999999999876543
Q ss_pred CCc-------------------ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHH
Q 005492 515 DQT-------------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 575 (694)
Q Consensus 515 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~ 575 (694)
... .......++..|+|||.+....++.++||||||+++++|++|+.||.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----- 229 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----- 229 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-----
Confidence 221 11223457889999999988889999999999999999999999997544211
Q ss_pred HHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 005492 576 GYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTM----KEVAF 630 (694)
Q Consensus 576 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~----~evl~ 630 (694)
.+.... . .....+...+..+.+++.+||+.+|.+||++ .++++
T Consensus 230 -~~~~~~-~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 -TFQKIL-K----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -HHHHHH-h----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 011111 0 0111122335668899999999999999999 66664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=302.19 Aligned_cols=261 Identities=25% Similarity=0.338 Sum_probs=196.7
Q ss_pred cCCC-ccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhh--------------HHHHHHHHHHHhhccCCcceeEEe
Q 005492 360 DNYN-ANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETN--------------VEQFINEVVILSQINHRNIVKLLG 423 (694)
Q Consensus 360 ~~f~-~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~nIv~l~g 423 (694)
++|. ..+.||+|+||+||+|... +++.||||.++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4555 3577999999999999976 58999999876432211 125788999999999999999999
Q ss_pred EEeeCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEE
Q 005492 424 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV 503 (694)
Q Consensus 424 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl 503 (694)
++...+..++||||++ ++|.+++... ..+++.....++.|++.||+|||+.+ |+|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 6999998653 24899999999999999999999999 999999999999999999999
Q ss_pred eecCCccccccCC-------------cceeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCc
Q 005492 504 SDFGTSRSVMVDQ-------------THLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTD 569 (694)
Q Consensus 504 ~DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~ 569 (694)
+|||+++...... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999987654111 1111223467889999998764 4789999999999999999999999765432
Q ss_pred cCccHHHHHHHHhhhcchh---h------------hhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 570 EDKSLVGYFLQAINENRLF---E------------ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~---~------------~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+ ....+.......... . ...... ..........+.+++.+||+.+|++||++.|++.+
T Consensus 241 ~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 D---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred H---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccH-HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 2 111111111110000 0 000000 01111234568899999999999999999999974
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=299.71 Aligned_cols=263 Identities=21% Similarity=0.324 Sum_probs=200.0
Q ss_pred hHHHHhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhccCCcceeEEeEEee-CC
Q 005492 354 DLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLE-TE 429 (694)
Q Consensus 354 ~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~-~~ 429 (694)
++...+++|+..+.||+|+||.||++... +++.||+|++.. ......+.+.+|+.++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34456789999999999999999999866 589999998753 223345678899999999999999999999876 45
Q ss_pred ccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCc
Q 005492 430 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS 509 (694)
Q Consensus 430 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla 509 (694)
..++|+||+ +++|.++++.. .+++..+..++.|+++||+|||+.+ |+||||+|+|||+++++.+||+|||++
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence 788999998 56898888643 4788899999999999999999999 999999999999999999999999998
Q ss_pred cccccCCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhh-----
Q 005492 510 RSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN----- 583 (694)
Q Consensus 510 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 583 (694)
...... .....++..|+|||.+.+ ..++.++||||||+++++|++|+.||........ .........
T Consensus 156 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~ 228 (328)
T cd07856 156 RIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ---FSIITDLLGTPPDD 228 (328)
T ss_pred cccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHH
Confidence 754321 122346889999998766 5689999999999999999999999965432110 000001000
Q ss_pred ------hcchhhhhhhh-h-----hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 584 ------ENRLFEILDAR-V-----LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 584 ------~~~~~~~~d~~-~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.....+++... . ..+........+.++|.+||+.+|++||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 0 000111234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=293.64 Aligned_cols=260 Identities=27% Similarity=0.376 Sum_probs=201.0
Q ss_pred CCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccC--hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 362 YNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
|+..+.||+|++|.||+|...+ ++.+|+|...... ....+.+..|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5667889999999999999865 8999999887642 344567889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 518 (694)
+ ++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 59999998653 25999999999999999999999999 99999999999999999999999999876643322
Q ss_pred eeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh---cch-------
Q 005492 519 LTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE---NRL------- 587 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~------- 587 (694)
......++..|+|||.+... .++.++||||||++++||++|+.||......+. ...+...... ...
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhcccc
Confidence 12223457789999998776 789999999999999999999999966442211 1111111000 000
Q ss_pred -----hhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 588 -----FEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 588 -----~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+........+........+.+++.+||+.+|++||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000001111224578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=274.83 Aligned_cols=248 Identities=25% Similarity=0.431 Sum_probs=196.5
Q ss_pred ccceeeeeCcEEEEEEEEcC-CcEEEEEEccc-cChhhHHHHHHHHHHHhhcc-CCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 364 ANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL-VDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 364 ~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
....||.|..|.|++...+. |...|||.+.. .+.+..+.++..+.++..-+ .|.||+.+|+|..+...++.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 35569999999999999765 89999998765 45566777888887776654 8999999999999999999999983
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
..++.+|+.-. .++++..+-++...+++||.||.+++. |+|||+||+|||+|+.|++||+|||++-.+-... ..
T Consensus 175 ~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Ah 248 (391)
T KOG0983|consen 175 TCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AH 248 (391)
T ss_pred HHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeeccc--cc
Confidence 35555555432 359999999999999999999999874 9999999999999999999999999997664333 34
Q ss_pred eeeecCCCCCCCccccc---CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~---~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
+...|-+.|||||.+.- ..|+.++||||||+.|+||.||+.||.+.+.+-. .+...+.+. ...++..
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-----~ltkvln~e--PP~L~~~--- 318 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-----VLTKVLNEE--PPLLPGH--- 318 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-----HHHHHHhcC--CCCCCcc---
Confidence 45568999999999863 4689999999999999999999999987655421 011111111 1111111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
......+.+++..||.+|+.+||.+.+++++
T Consensus 319 ---~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 319 ---MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ---cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1256779999999999999999999999875
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=304.04 Aligned_cols=261 Identities=26% Similarity=0.394 Sum_probs=196.2
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeC----------
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLET---------- 428 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~---------- 428 (694)
.+|...+.||+|+||.||+|.... +..||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 679999999999999999999764 889999998776666778899999999999999999999876654
Q ss_pred ----CccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEEC-CCCcEEE
Q 005492 429 ----EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKV 503 (694)
Q Consensus 429 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~-~~~~~kl 503 (694)
...++||||++ ++|.+++... .+++..++.++.||++||.|||+.+ |+||||||+||+++ ++..+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 34689999997 5898888642 4899999999999999999999999 99999999999997 5567899
Q ss_pred eecCCccccccCCcc--eeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHH
Q 005492 504 SDFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ 580 (694)
Q Consensus 504 ~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 580 (694)
+|||+++........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||......+... ....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~---~~~~ 233 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ---LILE 233 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHH
Confidence 999998765322111 1122347889999998654 568899999999999999999999997544321100 0000
Q ss_pred Hhhh------cchhhhhhhhh----------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 581 AINE------NRLFEILDARV----------LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 581 ~~~~------~~~~~~~d~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.... ........... ..........++.+++.+||+.+|.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 00000000000 001111234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=289.64 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=196.0
Q ss_pred CCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc-----ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV-----DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv 434 (694)
+|.+.+.||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999998754 444555544321 223445677899999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhcc-cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 435 YEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
|||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999998752 22346999999999999999999999999 999999999999986 469999999987654
Q ss_pred cCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhh
Q 005492 514 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDA 593 (694)
Q Consensus 514 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 593 (694)
... .......++..|+|||.+....++.++|+||||+++|+|++|..||..... ........ .+.
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~-~~~------- 221 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIV-EGP------- 221 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHH-cCC-------
Confidence 322 222334578899999999888899999999999999999999999854221 11111111 110
Q ss_pred hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 594 RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 594 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
....+...+..+.+++.+||+.+|++||++.|++++
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 --TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111223445678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=300.27 Aligned_cols=263 Identities=22% Similarity=0.346 Sum_probs=198.4
Q ss_pred HHHHhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC--
Q 005492 355 LEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETE-- 429 (694)
Q Consensus 355 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~-- 429 (694)
+....++|+..+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445678999999999999999999865 5899999987542 2333457889999999999999999999987654
Q ss_pred ----ccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEee
Q 005492 430 ----VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 505 (694)
Q Consensus 430 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~D 505 (694)
..++||||+ +++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 348999998 77998888642 4899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccccCCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHH-------
Q 005492 506 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY------- 577 (694)
Q Consensus 506 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~------- 577 (694)
||++...... .....+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||........ ....
T Consensus 162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~ 235 (343)
T cd07880 162 FGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--LMEIMKVTGTP 235 (343)
T ss_pred cccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCC
Confidence 9998765322 123357889999999876 4588999999999999999999999975432110 0000
Q ss_pred ---HHHHhhhcchhhhhhh------hhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 578 ---FLQAINENRLFEILDA------RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 578 ---~~~~~~~~~~~~~~d~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+...+........... .............+.+++.+||+.+|.+|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000000 00001111234468899999999999999999999853
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=303.63 Aligned_cols=259 Identities=23% Similarity=0.348 Sum_probs=198.5
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCc----
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEV---- 430 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~---- 430 (694)
..++|+..+.||+|++|.||+|.... ++.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 46789999999999999999999864 789999987642 23345678889999999999999999998876654
Q ss_pred --cEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCC
Q 005492 431 --PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 508 (694)
Q Consensus 431 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGl 508 (694)
.++|+||+ +++|.+++... .+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 79999998 66999988752 4899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhh----
Q 005492 509 SRSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN---- 583 (694)
Q Consensus 509 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 583 (694)
+...... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||......+ ..........
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~~ 237 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPDE 237 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCH
Confidence 8765332 223357889999999865 467899999999999999999999996543221 0110100000
Q ss_pred -------hcchhhhhhh---hh---hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 584 -------ENRLFEILDA---RV---LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 584 -------~~~~~~~~d~---~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.......+.. .. ..+........+.+++.+||+.+|.+|||+.+|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000000 00 000111235678899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=287.77 Aligned_cols=258 Identities=28% Similarity=0.416 Sum_probs=200.5
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccC---hh----hHHHHHHHHHHHhhccCCcceeEEeEEe-eC
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ET----NVEQFINEVVILSQINHRNIVKLLGCCL-ET 428 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~----~~~~~~~E~~~l~~l~h~nIv~l~g~~~-~~ 428 (694)
..++|-..+.||+|||+.||++.+- ..+.||+|.-.... .+ -.+...+|.+|.+.|.||.||++++++. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3467888899999999999999854 57889999754321 11 1334567999999999999999999986 56
Q ss_pred CccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEEC---CCCcEEEee
Q 005492 429 EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD---DKYRAKVSD 505 (694)
Q Consensus 429 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~---~~~~~kl~D 505 (694)
+.++-|+||++|.+|+-||+.+. .+++..+..|+.||+.||.||.+.. +||||-||||.||||- .-|.+||.|
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 78889999999999999998764 4899999999999999999999876 6799999999999995 457899999
Q ss_pred cCCccccccCCc------ceeeeeecCCCCCCCccccc----CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHH
Q 005492 506 FGTSRSVMVDQT------HLTTKVQGTFGYVDPEYFQS----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 575 (694)
Q Consensus 506 FGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~----~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~ 575 (694)
|||++.+..+.. ..+....||..|++||.+.- ...+.|+||||.||++|..+.|++||.......
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ----- 691 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ----- 691 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-----
Confidence 999998764322 24556779999999998753 357889999999999999999999998654432
Q ss_pred HHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005492 576 GYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAF 630 (694)
Q Consensus 576 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 630 (694)
..+.++.+...-.-. ....+....+...+|++||+..-++|.+..++..
T Consensus 692 ----dILqeNTIlkAtEVq--FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 ----DILQENTILKATEVQ--FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ----HHHhhhchhcceecc--CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 122222221111000 0111233456789999999999999998877654
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=279.45 Aligned_cols=241 Identities=24% Similarity=0.344 Sum_probs=202.4
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccc---cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv 434 (694)
.++|+..++||+|.||+|.+.+-+. ++.+|||.++. ...+....-+.|-++|+.-+||.+..|...+...+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4789999999999999999998764 89999998876 3455566678899999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~ 514 (694)
|||..||.|.-+|.... .+++....-...+|+.||.|||+.+ ||.||||.+|.|||.+|++||+||||.+.-.
T Consensus 247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence 99999999999987642 4888888889999999999999999 9999999999999999999999999998643
Q ss_pred CCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
.....+....||+.|+|||++....|..++|+|.+||+||||++|+.||.....+. +++++-..
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k----------------LFeLIl~e 383 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK----------------LFELILME 383 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH----------------HHHHHHhh
Confidence 33445667889999999999999999999999999999999999999997644332 22211110
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCC
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRP 623 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP 623 (694)
....+....++...|+...|.+||.+|.
T Consensus 384 -d~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 -DLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 0112334445677899999999999995
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=297.31 Aligned_cols=261 Identities=24% Similarity=0.333 Sum_probs=193.2
Q ss_pred CCCccceeeeeCcEEEEEEEEcC---CcEEEEEEcccc--ChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeC----Cc
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD---GRIVAVKKSKLV--DETNVEQFINEVVILSQI-NHRNIVKLLGCCLET----EV 430 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~----~~ 430 (694)
+|+..+.||+|+||.||++.... +..+|+|++... .....+.+.+|+.+++++ +||||++++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47788999999999999999753 678999987642 223456788999999999 599999999976433 35
Q ss_pred cEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcc
Q 005492 431 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~ 510 (694)
.++++||+. ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888886 6899988653 25899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCcc---eeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh--
Q 005492 511 SVMVDQTH---LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE-- 584 (694)
Q Consensus 511 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 584 (694)
........ ......|+..|+|||++.+ ..++.++||||||+++++|++|+.||....... ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 230 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPD 230 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCC
Confidence 65432211 1223458899999998765 468999999999999999999999987543211 11111110000
Q ss_pred -cchhhhhhhh--------------hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 585 -NRLFEILDAR--------------VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 585 -~~~~~~~d~~--------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..+..+..+. ............+.+++.+||+.+|.+|||+.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 0000001124568899999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=277.07 Aligned_cols=262 Identities=23% Similarity=0.340 Sum_probs=206.5
Q ss_pred hhhHHHHhcCCCccceeeeeCcEEEEEEE-EcCCcEEEEEEccccChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCC
Q 005492 352 SKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETE 429 (694)
Q Consensus 352 ~~~l~~~~~~f~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~ 429 (694)
++|+-+.|+ +.||+|+++.|-..+ +..|..+|||++.+..........+|++++.+. .|+||++|+++|+++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 566666665 689999999999887 567999999999887777788999999999998 5999999999999999
Q ss_pred ccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCC---cEEEeec
Q 005492 430 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY---RAKVSDF 506 (694)
Q Consensus 430 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~---~~kl~DF 506 (694)
..|||||-|.||+|..+|+++. -+++.+..++.++|+.||.|||.++ |.||||||+|||..+.. -+||+||
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred eEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999998764 3899999999999999999999999 99999999999996544 4899999
Q ss_pred CCccccccCC--c----ceeeeeecCCCCCCCcccc-----cCCCCceeeEEehhHHHHHHHhCCCCCccCCCcc-----
Q 005492 507 GTSRSVMVDQ--T----HLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE----- 570 (694)
Q Consensus 507 Gla~~~~~~~--~----~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~----- 570 (694)
.|..-+.... + .......|+..|||||+.. ...|+.+.|.||||||||-||+|.+||.+.-..+
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 9876543221 1 1122355888999999863 3468899999999999999999999998764322
Q ss_pred Ccc---HHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005492 571 DKS---LVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAF 630 (694)
Q Consensus 571 ~~~---~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 630 (694)
.+. -.....+.+.++.. ++.| ........+..+++...|..++.+|.++.+++.
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkY-eFPd-----kdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKY-EFPD-----KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccHHHHHHHHHHHhccCC-cCCh-----hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111 11122223333321 1111 112344566789999999999999999999887
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=285.55 Aligned_cols=250 Identities=28% Similarity=0.385 Sum_probs=204.8
Q ss_pred cChhhHHHHhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccc---cChhhHHHHHHHHHHHhhc-cCCcceeEEeE
Q 005492 350 FTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL---VDETNVEQFINEVVILSQI-NHRNIVKLLGC 424 (694)
Q Consensus 350 ~~~~~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~ 424 (694)
.+..+..++ .+|+...+||+|+||.|.++..+. .+.+|||.++. ...++.+--+.|-++|+-. +-|-+++|+.+
T Consensus 340 ~~~~d~i~~-tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 340 SSKRDRIKA-TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred CCcccceee-cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH
Confidence 334443344 459999999999999999999775 67899998875 2334455556777888776 56889999999
Q ss_pred EeeCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEe
Q 005492 425 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVS 504 (694)
Q Consensus 425 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~ 504 (694)
+..-+.+|+||||+.+|+|--++++-. .+.+..+.-+|.+||-||-+||+++ |+.||||.+|||||.++++||+
T Consensus 419 FQTmDRLyFVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~ 492 (683)
T KOG0696|consen 419 FQTMDRLYFVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIA 492 (683)
T ss_pred hhhhhheeeEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEee
Confidence 999999999999999999999998754 3788889999999999999999999 9999999999999999999999
Q ss_pred ecCCccccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh
Q 005492 505 DFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE 584 (694)
Q Consensus 505 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 584 (694)
|||+++.-..+ ...+....||+.|+|||.+...+|+.++|+|||||+||||+.|++||++...++ ..+.+.+
T Consensus 493 DFGmcKEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-------lF~aI~e 564 (683)
T KOG0696|consen 493 DFGMCKENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQAIME 564 (683)
T ss_pred ecccccccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHH
Confidence 99999864332 334566889999999999999999999999999999999999999998866544 2222222
Q ss_pred cchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCC
Q 005492 585 NRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPT 624 (694)
Q Consensus 585 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 624 (694)
.. -.+++..+.+...+....|.+.|.+|..
T Consensus 565 --------hn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 565 --------HN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred --------cc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 11 2244556667888999999999999954
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=318.30 Aligned_cols=260 Identities=25% Similarity=0.344 Sum_probs=215.7
Q ss_pred hhhHHHHhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccc---cChhhHHHHHHHHHHHhhccCCcceeEEeEEee
Q 005492 352 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLE 427 (694)
Q Consensus 352 ~~~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~ 427 (694)
..+++...++|.+.++||+|+||.|..++.+. ++.+|+|++.. ........|..|-.+|..-+.+.|++|+..|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 34556667889999999999999999999875 88999998876 445667789999999999999999999999999
Q ss_pred CCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecC
Q 005492 428 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 507 (694)
Q Consensus 428 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFG 507 (694)
+..+|||||||+||+|..+|.+.. .++++.+.-++.+|+.||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999998754 4999999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCcceeeeeecCCCCCCCccccc-----CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHh
Q 005492 508 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 582 (694)
Q Consensus 508 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 582 (694)
.+-.+..+..-.....+|||.|++||++.. +.|++..|+||+||++|||+.|..||...+ ++.-....+
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm 294 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIM 294 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHh
Confidence 988877777667777889999999999853 578999999999999999999999997543 232233333
Q ss_pred hhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 005492 583 NENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPT---MKEVAFE 631 (694)
Q Consensus 583 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~~ 631 (694)
.......+.+. ...+....+||.+.+ -+|+.|.. +.++-.+
T Consensus 295 ~hk~~l~FP~~-------~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 295 NHKESLSFPDE-------TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred chhhhcCCCcc-------cccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 33222222211 234566788998888 56777877 7777654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=275.03 Aligned_cols=270 Identities=21% Similarity=0.303 Sum_probs=201.2
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-----CcEEEEEEccccCh--hhHHHHHHHHHHHhhccCCcceeEEeEEee-CCc
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-----GRIVAVKKSKLVDE--TNVEQFINEVVILSQINHRNIVKLLGCCLE-TEV 430 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~-~~~ 430 (694)
...|+....||+|.||.||+|+..+ ...+|||+++.... .--....+|+.+++.++||||+.|..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568999999999999999997543 23689998875422 223456789999999999999999999988 678
Q ss_pred cEEEEEeCCCCChHHHHhccc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCC----CcEEEe
Q 005492 431 PLLVYEFIPNGTLYQYIHNQI--EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK----YRAKVS 504 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~----~~~kl~ 504 (694)
.+|++||.+. +|.+.|+-+. ....++...+..|+.||+.|+.|||+.- |+||||||.||||..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 8999999987 8888886532 2346899999999999999999999999 9999999999999766 899999
Q ss_pred ecCCccccccCCcc--eeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCcc------HH
Q 005492 505 DFGTSRSVMVDQTH--LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKS------LV 575 (694)
Q Consensus 505 DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~------~~ 575 (694)
|||++|.+...-.. ....+.-|..|.|||++.+ ..||.+.|||+.||++.||++-++-|......-... ..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999988644322 2345667999999999876 579999999999999999999998887654322111 11
Q ss_pred HHHHHHhhhc---chh---hhhhh-hhhhhhh----------------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 576 GYFLQAINEN---RLF---EILDA-RVLKEAK----------------KEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 576 ~~~~~~~~~~---~~~---~~~d~-~~~~~~~----------------~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
+.+...+... .+. ...+- ....+.. ....+...+|+.++|..||.+|.|+.+.+++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 1111221111 000 00000 0000000 00112367899999999999999999998764
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=280.64 Aligned_cols=236 Identities=31% Similarity=0.375 Sum_probs=193.1
Q ss_pred eeeeCcEEEEEEEEcC-CcEEEEEEccccC---hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCCh
Q 005492 368 LGQGGQGTVYKGMLTD-GRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL 443 (694)
Q Consensus 368 LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gsL 443 (694)
||+|+||.||++...+ ++.+|+|.+.... ......+..|+.++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999764 8899999876532 23566889999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcceeeee
Q 005492 444 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 523 (694)
Q Consensus 444 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 523 (694)
.+++.... .+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF 153 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence 99997653 4899999999999999999999998 9999999999999999999999999987654322 123344
Q ss_pred ecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHH
Q 005492 524 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEG 603 (694)
Q Consensus 524 ~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 603 (694)
.++..|+|||.+.+...+.++|+||||+++|+|++|+.||......+ ....+.... ...+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~----------~~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE-------IYEKILKDP----------LRFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHhcCC----------CCCCCCC
Confidence 57889999999998889999999999999999999999996543211 111111110 0111122
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHH
Q 005492 604 IMTVATLAKRCLNLNGKMRPTMKE 627 (694)
Q Consensus 604 ~~~l~~li~~cl~~~p~~RPt~~e 627 (694)
+..+.+++.+||..+|++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 456889999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=252.32 Aligned_cols=264 Identities=22% Similarity=0.337 Sum_probs=200.6
Q ss_pred CCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
+|...++||+|.+|+||+|+.++ ++.||+|++... ++......++|+-+|+.++|+|||+++++...+....||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46677899999999999999765 889999987763 344467789999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+.. +|..|...... .++.+....++.|+++||.+.|+++ +.|||+||.|.||+.++.+|++|||+++.+...-.
T Consensus 83 cdq-dlkkyfdslng--~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 955 78888776433 4899999999999999999999999 99999999999999999999999999998765443
Q ss_pred ceeeeeecCCCCCCCcccccC-CCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHHHHhhhcchh---hhhh
Q 005492 518 HLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLF---EILD 592 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~d 592 (694)
.. ....-|..|.+|.++.+. -|+...|+||-||++.|+.. |++.|.+...+++...+.+......+..+. .+.|
T Consensus 157 cy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 157 CY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred ee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 32 234468999999998875 58999999999999999998 555555443332222222222222222211 1111
Q ss_pred hhh---------hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 593 ARV---------LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 593 ~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
-.. +.+.-+.....=.+|+...|.-+|..|.++++.+++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111 111112222345688889999999999999987764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=313.47 Aligned_cols=145 Identities=28% Similarity=0.377 Sum_probs=131.6
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
++|.+.++||+|+||+||+|... +++.||||+++.. .......+..|+.+++.++||||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67899999999999999999987 5889999987643 2334577889999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcc
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~ 510 (694)
||+++++|.++++... .+++..++.|+.||+.||+|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997542 4889999999999999999999998 9999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-34 Score=271.26 Aligned_cols=263 Identities=26% Similarity=0.365 Sum_probs=199.6
Q ss_pred ccccChhhHHHHhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccC-hhhHHHHHHHHHHHhhc-cCCcceeEEe
Q 005492 347 TKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD-ETNVEQFINEVVILSQI-NHRNIVKLLG 423 (694)
Q Consensus 347 ~~~~~~~~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~g 423 (694)
...|+.++|+. ...||.|+||+|+|-..+. |+..|||++.... ....++++.|.+...+- +.||||+++|
T Consensus 58 ~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 58 LHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 44566555543 5679999999999998765 9999999988744 45677888888865554 7899999999
Q ss_pred EEeeCCccEEEEEeCCCCChHHHHhc--ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcE
Q 005492 424 CCLETEVPLLVYEFIPNGTLYQYIHN--QIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA 501 (694)
Q Consensus 424 ~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~ 501 (694)
.+..++..||.||.|+ .||+.+.+. ......+++..+-.|....+.||.||..... ||||||||+|||||..|.+
T Consensus 131 a~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 131 ALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCE
Confidence 9999999999999994 476665443 1123359999999999999999999998753 9999999999999999999
Q ss_pred EEeecCCccccccCCcceeeeeecCCCCCCCccccc--CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHH
Q 005492 502 KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL 579 (694)
Q Consensus 502 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~ 579 (694)
||+|||++-.+. ++-..+.-.|-..|||||.+.. ..|+.+|||||||++|+|+.||+.|+..-+. ..+.+.
T Consensus 208 KLCDFGIcGqLv--~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~ 280 (361)
T KOG1006|consen 208 KLCDFGICGQLV--DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLC 280 (361)
T ss_pred eeecccchHhHH--HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHH
Confidence 999999987553 2233444568889999999864 3489999999999999999999999864221 222222
Q ss_pred HHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 580 QAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 580 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+.+. +... ++.. .....+....+..+|.-||-+|-++||.+.+++++
T Consensus 281 ~Vv~-gdpp-~l~~---~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 281 QVVI-GDPP-ILLF---DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHc-CCCC-eecC---cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2221 1111 1111 01113456678999999999999999999998764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=294.24 Aligned_cols=262 Identities=19% Similarity=0.248 Sum_probs=184.7
Q ss_pred HhcCCCccceeeeeCcEEEEEEEE-----------------cCCcEEEEEEccccChhhHHHH--------------HHH
Q 005492 358 ATDNYNANRILGQGGQGTVYKGML-----------------TDGRIVAVKKSKLVDETNVEQF--------------INE 406 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E 406 (694)
..++|++.++||+|+||+||+|.+ .+++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999964 2356899999876443333334 346
Q ss_pred HHHHhhccCCcc-----eeEEeEEee--------CCccEEEEEeCCCCChHHHHhcccC---------------------
Q 005492 407 VVILSQINHRNI-----VKLLGCCLE--------TEVPLLVYEFIPNGTLYQYIHNQIE--------------------- 452 (694)
Q Consensus 407 ~~~l~~l~h~nI-----v~l~g~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------- 452 (694)
+.++.+++|.++ +++++++.. .+..+|||||+++++|.++|+....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 677888753 3567999999999999999975321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcceeeeeecCCCCCCC
Q 005492 453 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532 (694)
Q Consensus 453 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aP 532 (694)
...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 113567889999999999999999998 99999999999999999999999999976543222222223357899999
Q ss_pred cccccCCC----------------------CceeeEEehhHHHHHHHhCCC-CCccCCCccCc-----cHHHHHHHHhhh
Q 005492 533 EYFQSSQF----------------------TEKSDVYSFGVVLVEILTGQK-PIRAINTDEDK-----SLVGYFLQAINE 584 (694)
Q Consensus 533 E~~~~~~~----------------------t~~sDvwSlGvll~elltg~~-p~~~~~~~~~~-----~~~~~~~~~~~~ 584 (694)
|.+..... ..+.||||+||+|+||++|.. |+......... .... .+.....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~-~~r~~~~ 458 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLN-RWRMYKG 458 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHH-HHHhhcc
Confidence 98754321 235799999999999999875 66432211100 0000 0011111
Q ss_pred cchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 005492 585 NRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNG---KMRPTMKEVAFE 631 (694)
Q Consensus 585 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPt~~evl~~ 631 (694)
.. ..............+|+.++|..+| .+|+|+.|++++
T Consensus 459 ~~--------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QK--------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cC--------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11 0011112234567899999999766 689999999976
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=273.00 Aligned_cols=220 Identities=24% Similarity=0.221 Sum_probs=176.9
Q ss_pred eCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCChHHHHhc
Q 005492 371 GGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHN 449 (694)
Q Consensus 371 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 449 (694)
|.+|.||++... +++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999975 48899999886532 234455566667899999999999999999999999999999999976
Q ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcceeeeeecCCCC
Q 005492 450 QIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 529 (694)
Q Consensus 450 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y 529 (694)
.. .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||++...... .....++..|
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 43 4899999999999999999999999 999999999999999999999999987654321 1223356789
Q ss_pred CCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHH
Q 005492 530 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVAT 609 (694)
Q Consensus 530 ~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 609 (694)
+|||.+....++.++||||||+++|||++|+.|+........ .. . ..+.+......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~--~-------~~~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------TH--T-------TLNIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------cc--c-------ccCCcccCCHHHHH
Confidence 999999888899999999999999999999988653221100 00 0 00111223456889
Q ss_pred HHHHhcccCCCCCCCHH
Q 005492 610 LAKRCLNLNGKMRPTMK 626 (694)
Q Consensus 610 li~~cl~~~p~~RPt~~ 626 (694)
++.+||+.||++||++.
T Consensus 208 li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 208 LLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHccCCHHHhcCCC
Confidence 99999999999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=299.35 Aligned_cols=259 Identities=20% Similarity=0.286 Sum_probs=172.4
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEcC-----CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeE------Ee
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLTD-----GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGC------CL 426 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~------~~ 426 (694)
..++|+..++||+|+||.||+|.+.+ +..||||++..... .+.+..| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999999754 68999998764221 1112211 1122222333222221 24
Q ss_pred eCCccEEEEEeCCCCChHHHHhcccCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccc
Q 005492 427 ETEVPLLVYEFIPNGTLYQYIHNQIEE-----------------FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIK 489 (694)
Q Consensus 427 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIk 489 (694)
+....+|||||+++++|.++++..... .......+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 556789999999999999998754211 01123456689999999999999998 9999999
Q ss_pred cccEEECC-CCcEEEeecCCccccccCCcceeeeeecCCCCCCCcccccC----------------------CCCceeeE
Q 005492 490 SANILLDD-KYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS----------------------QFTEKSDV 546 (694)
Q Consensus 490 p~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~~sDv 546 (694)
|+|||+++ ++.+||+|||+++.+............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 67999999999987654444444556789999999965322 23456799
Q ss_pred EehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhc-----chhhhhhhhhhhh------hhHHHHHHHHHHHHHhc
Q 005492 547 YSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN-----RLFEILDARVLKE------AKKEGIMTVATLAKRCL 615 (694)
Q Consensus 547 wSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~d~~~~~~------~~~~~~~~l~~li~~cl 615 (694)
|||||+||||+++..|+... +.. +...+... .+...+.+....+ ..........+|+.+||
T Consensus 363 wSlGviL~el~~~~~~~~~~-------~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN-------LIQ-FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH-------HHH-HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 99999999999976654211 111 11111110 0111111110000 00011223558999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 005492 616 NLNGKMRPTMKEVAFE 631 (694)
Q Consensus 616 ~~~p~~RPt~~evl~~ 631 (694)
+.||++|||+.|++++
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999986
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=263.93 Aligned_cols=254 Identities=23% Similarity=0.285 Sum_probs=199.3
Q ss_pred HhcCCCcc-ceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeC----Cc
Q 005492 358 ATDNYNAN-RILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLET----EV 430 (694)
Q Consensus 358 ~~~~f~~~-~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~----~~ 430 (694)
.+++|.+. ++||-|-.|.|-....+. ++.+|+|.+... ...++|+++.=.. .|||||.+++++... ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35666654 579999999999988764 889999987632 3456788766555 699999999998643 45
Q ss_pred cEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEEC---CCCcEEEeecC
Q 005492 431 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFG 507 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~---~~~~~kl~DFG 507 (694)
+++|||.|+||.|++.+.++.. ..+++.++..|++||..|+.|||+.+ |.||||||+|+|.. .|-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 6799999999999999988744 47999999999999999999999999 99999999999996 45679999999
Q ss_pred CccccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcch
Q 005492 508 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 587 (694)
Q Consensus 508 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (694)
+|+.-.. ........-|+.|.|||++...+|+...|+||+||+||-|++|.+||....-. .+..-+...++.+..
T Consensus 210 FAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 210 FAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQY 284 (400)
T ss_pred cccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccCc
Confidence 9986432 22334456799999999999999999999999999999999999999764321 111113333333321
Q ss_pred hhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 588 FEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 588 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
++.+ +-....++...++|+.+|..+|.+|.|+.++.++
T Consensus 285 -~FP~-----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 -EFPE-----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -cCCC-----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1111 1123456678899999999999999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=268.19 Aligned_cols=238 Identities=29% Similarity=0.396 Sum_probs=194.3
Q ss_pred CcEEEEEEEEcC-CcEEEEEEccccChhh-HHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCChHHHHhc
Q 005492 372 GQGTVYKGMLTD-GRIVAVKKSKLVDETN-VEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHN 449 (694)
Q Consensus 372 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 449 (694)
+||.||++...+ ++.+|+|+........ .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999875 8999999987654444 78899999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcceeeeeecCCCC
Q 005492 450 QIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 529 (694)
Q Consensus 450 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y 529 (694)
... +++..++.++.+++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++....... ......++..|
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 432 899999999999999999999998 9999999999999999999999999998765432 23344578899
Q ss_pred CCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHH
Q 005492 530 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVAT 609 (694)
Q Consensus 530 ~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 609 (694)
++||.+....++.++|||+||+++++|++|..||......+ ............. .......+..+.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~------~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL------ELFKKIGKPKPPF-------PPPEWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH------HHHHHHhccCCCC-------ccccccCCHHHHH
Confidence 99999998889999999999999999999999986532111 1111111111100 0000003457889
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 005492 610 LAKRCLNLNGKMRPTMKEVAF 630 (694)
Q Consensus 610 li~~cl~~~p~~RPt~~evl~ 630 (694)
++.+||..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=279.90 Aligned_cols=243 Identities=27% Similarity=0.361 Sum_probs=194.7
Q ss_pred cceeeeeCcEEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCC
Q 005492 365 NRILGQGGQGTVYKGMLT-DGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG 441 (694)
Q Consensus 365 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~g 441 (694)
.++||.|-||+||-|+.+ .|+.||||.+.+ ....+..++++|+.||++++||.||.|.-.|+..+..+.|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 478999999999999975 599999998765 344566889999999999999999999999999999999999994 5
Q ss_pred ChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCC---CcEEEeecCCccccccCCcc
Q 005492 442 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 442 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~---~~~kl~DFGla~~~~~~~~~ 518 (694)
++.+.|... ++..|++..-.-++.||+.||.|||.++ |+|.||||+||||... ..+||+|||+||.+... .
T Consensus 648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--s 721 (888)
T KOG4236|consen 648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--S 721 (888)
T ss_pred hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh--h
Confidence 665555443 2335999999999999999999999999 9999999999999643 47999999999987543 3
Q ss_pred eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhh
Q 005492 519 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
....+.||+.|+|||+++...|...-|+||.||++|--++|..||....+- .+ .+....+ +..+..+
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI-----nd----QIQNAaF--MyPp~PW-- 788 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI-----ND----QIQNAAF--MYPPNPW-- 788 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch-----hH----Hhhcccc--ccCCCch--
Confidence 445677999999999999999999999999999999999999999653321 11 1111111 1111222
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVA 629 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl 629 (694)
.+......+||...|+..-.+|-+..+-+
T Consensus 789 --~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 789 --SEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred --hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 33445677899999999999998876654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=290.29 Aligned_cols=260 Identities=24% Similarity=0.375 Sum_probs=210.2
Q ss_pred hhhHHHHhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-cCCcceeEEeEEee--
Q 005492 352 SKDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLE-- 427 (694)
Q Consensus 352 ~~~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~-- 427 (694)
++.+...++-|++.+.||+|.+|.||++... +++..|+|+.... .+..+++..|.++|+.+ .|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 4444556788999999999999999999964 5888999987643 44456778899999998 69999999999873
Q ss_pred ---CCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEe
Q 005492 428 ---TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVS 504 (694)
Q Consensus 428 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~ 504 (694)
++.+|||||||.+||..+++++.. ...+.|..+..|++.++.||.+||... ++|||||-.||||+.++.+||.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 468899999999999999998865 557999999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccccCCcceeeeeecCCCCCCCcccccC-----CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHH
Q 005492 505 DFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS-----QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL 579 (694)
Q Consensus 505 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~ 579 (694)
|||++..+... ........||+.|||||++... .|+..+|+||||++..||--|.+|+.++-+-. .+.
T Consensus 166 DFGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------aLF 238 (953)
T KOG0587|consen 166 DFGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------ALF 238 (953)
T ss_pred eeeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh------hhc
Confidence 99999876432 2334456699999999998643 47789999999999999999999987654322 111
Q ss_pred HHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 580 QAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 580 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
. +..++ ......+.....++.++|..||.+|..+||++.+++++
T Consensus 239 ~-IpRNP-------PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 239 L-IPRNP-------PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred c-CCCCC-------CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1 11111 11111234566789999999999999999999988764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=287.22 Aligned_cols=240 Identities=25% Similarity=0.293 Sum_probs=195.3
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCccEEEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lv~e 436 (694)
++.|.....+|.|+|+.|-.+.... ++..++|++... ..+-.+|+.++... +||||+++.+.+.+....++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 6778888899999999999988654 788999987654 12234566555555 79999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEE-CCCCcEEEeecCCccccccC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL-DDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll-~~~~~~kl~DFGla~~~~~~ 515 (694)
.+.++-|.+.+.... .....+..|+.+|+.|+.|||.+| ++||||||+|||+ ++.++++|+|||.++....+
T Consensus 397 ~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999888887643 233778889999999999999999 9999999999999 58899999999999876544
Q ss_pred CcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
.....-|..|.|||++....|++++||||||++||+||+|+.||.....+. .+...+..++..
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------ei~~~i~~~~~s------- 532 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------EIHTRIQMPKFS------- 532 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH------HHHHhhcCCccc-------
Confidence 223346889999999999999999999999999999999999997665441 122222222211
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
...+....+|+.+||+.+|.+||+|.++..+
T Consensus 533 -----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 -----ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -----cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 3344567899999999999999999998875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-33 Score=265.75 Aligned_cols=266 Identities=23% Similarity=0.364 Sum_probs=200.2
Q ss_pred CCCccceeeeeCcEEEEEEEEcC-CcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeC--------C
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLET--------E 429 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~--------~ 429 (694)
.|+...+||+|.||.||+|..++ |+.||+|+.... ...--...++|+++|..++|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 46667789999999999999765 788999875432 222345678899999999999999999887532 3
Q ss_pred ccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCc
Q 005492 430 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS 509 (694)
Q Consensus 430 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla 509 (694)
..+||+++++. +|.-.|.+.. ..++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 47899999976 7888886543 34899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcc---eeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhc
Q 005492 510 RSVMVDQTH---LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN 585 (694)
Q Consensus 510 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 585 (694)
+.+...... ..+...-|..|.+||.+.+ ..|+++.|||.-||+|.||+++.+-+++........++......+...
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 876543322 2344556999999999876 579999999999999999999998887766554433333332222211
Q ss_pred --------chhhhhhhh-hhh-h--hhHHH------HHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 586 --------RLFEILDAR-VLK-E--AKKEG------IMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 586 --------~~~~~~d~~-~~~-~--~~~~~------~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
.+.+.+... +.+ . .-.+. .....+|+..+|..||.+|+++.+++.+-
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 111111000 000 0 00111 12577999999999999999999998764
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=263.08 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=206.9
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccc---cChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCccEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL---VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~l 433 (694)
.++|...++||+|+|++|.++.++. .+.+|+|.++. .+.+++.....|-.+..+. +||.+|-|+.++..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 4679999999999999999999765 78899998775 4455667777788888876 79999999999999999999
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
|.||+++|+|.-+++++. .|+++.+.-+..+|..||.|||+.| |+.||||.+|+|||..+++||.|+|+.+...
T Consensus 329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999988887654 4999999999999999999999999 9999999999999999999999999998643
Q ss_pred cCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCc-cCccHHHHHHHHhhhcchhhhhh
Q 005492 514 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTD-EDKSLVGYFLQAINENRLFEILD 592 (694)
Q Consensus 514 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d 592 (694)
. ....+....||+.|.|||.+++..|....|+|+|||+|+||+.|+.||+....+ .+.+-.++..+.+-+..+
T Consensus 403 ~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi----- 476 (593)
T KOG0695|consen 403 G-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI----- 476 (593)
T ss_pred C-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-----
Confidence 3 334566788999999999999999999999999999999999999999865433 234445555555433221
Q ss_pred hhhhhhhhHHHHHHHHHHHHHhcccCCCCCCC
Q 005492 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPT 624 (694)
Q Consensus 593 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 624 (694)
..+.........+++.-|.+||.+|..
T Consensus 477 -----riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 477 -----RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred -----cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 122233445668899999999999853
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=268.53 Aligned_cols=263 Identities=22% Similarity=0.320 Sum_probs=201.4
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhccC--C----cceeEEeEEeeCCcc
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINH--R----NIVKLLGCCLETEVP 431 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----nIv~l~g~~~~~~~~ 431 (694)
+++|.+...+|+|.||.|-+..+.. +..||||+++..... .+.-+-|+++|.++.+ | -+|++.+++.-.+..
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 6889999999999999999998765 689999988765433 3556779999999943 3 388899999999999
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEEC---------------
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD--------------- 496 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~--------------- 496 (694)
+||+|.+ |-|+.++|..+. -.+++..++..|+.|++++++|||+.+ ++|-||||+|||+.
T Consensus 167 Civfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999998 559999998763 347999999999999999999999999 99999999999992
Q ss_pred -----CCCcEEEeecCCccccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccC
Q 005492 497 -----DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 571 (694)
Q Consensus 497 -----~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~ 571 (694)
.+..+||+|||.|....... .....|..|.|||++.+-.++..+||||+||||+||.+|...|+.....|.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 13458999999997643322 455689999999999999999999999999999999999999987653331
Q ss_pred ccHHHHHHH--------Hh------hhcch-----------hhhhhhhh----hhhhhHHHHHHHHHHHHHhcccCCCCC
Q 005492 572 KSLVGYFLQ--------AI------NENRL-----------FEILDARV----LKEAKKEGIMTVATLAKRCLNLNGKMR 622 (694)
Q Consensus 572 ~~~~~~~~~--------~~------~~~~~-----------~~~~d~~~----~~~~~~~~~~~l~~li~~cl~~~p~~R 622 (694)
..+.+.+.+ .. ..+++ ....++-. .......+...|.+|+++||..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 111111110 00 00000 00000000 001123445679999999999999999
Q ss_pred CCHHHHHHH
Q 005492 623 PTMKEVAFE 631 (694)
Q Consensus 623 Pt~~evl~~ 631 (694)
+|+.|++.+
T Consensus 398 iTl~EAL~H 406 (415)
T KOG0671|consen 398 ITLREALSH 406 (415)
T ss_pred ccHHHHhcC
Confidence 999999865
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=271.91 Aligned_cols=206 Identities=26% Similarity=0.383 Sum_probs=176.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccC---hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
.-|-.++.||-|+||+|.++.-.| ...+|+|.+.+.+ ..+....+.|-.||...+.+.||+|+..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 457888999999999999998655 6679999887643 445667888999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcccccc-
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV- 514 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~- 514 (694)
||++||++-.+|-+.. .+.+..+.-++.++.-|+++.|..| +|||||||+|||||.+|++||.||||+.-+.-
T Consensus 709 dYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999987643 4788888889999999999999999 99999999999999999999999999653310
Q ss_pred -------CCcce---------------------------------eeeeecCCCCCCCcccccCCCCceeeEEehhHHHH
Q 005492 515 -------DQTHL---------------------------------TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLV 554 (694)
Q Consensus 515 -------~~~~~---------------------------------~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ 554 (694)
...+. .....||+.|+|||++....++...|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 00000 01245999999999999999999999999999999
Q ss_pred HHHhCCCCCccCCCccC
Q 005492 555 EILTGQKPIRAINTDED 571 (694)
Q Consensus 555 elltg~~p~~~~~~~~~ 571 (694)
||+.|+.||-...+.+.
T Consensus 863 em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHhhCCCCccCCCCCcc
Confidence 99999999988777653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-31 Score=285.33 Aligned_cols=247 Identities=26% Similarity=0.409 Sum_probs=190.0
Q ss_pred CCCccceeeeeCcEE-EEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCccEEEEEeC
Q 005492 361 NYNANRILGQGGQGT-VYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
-|...+++|.|..|+ ||+|... ++.||||++- .+...-..+|+..|+.- +|||||++++.-.+....||..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 355567889999876 7999985 8899999875 23334557899999988 6999999999999999999999999
Q ss_pred CCCChHHHHhcccCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECC-----CCcEEEeecCCcccc
Q 005492 439 PNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-----KYRAKVSDFGTSRSV 512 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~-~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~-----~~~~kl~DFGla~~~ 512 (694)
. .+|.+++....... .......+.+..|++.||++||+.+ ||||||||.||||+. ..+++|+|||+++.+
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 4 59999998741111 1222456788999999999999999 999999999999965 357999999999988
Q ss_pred ccCCcce--eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhC-CCCCccCCCccCccHHHHHHHHhhhcchhh
Q 005492 513 MVDQTHL--TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTG-QKPIRAINTDEDKSLVGYFLQAINENRLFE 589 (694)
Q Consensus 513 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (694)
..+.... .....||.+|+|||++....-+.++||||||||+|+.++| ..||...-..+ .++. .....+..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl------~~~~~L~~ 734 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANIL------TGNYTLVH 734 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhh------cCccceee
Confidence 7655443 3456699999999999998888999999999999999996 89997543221 1100 00111111
Q ss_pred hhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 590 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+ .. ..+. +..+||.+|++.+|..||++.+|+.+
T Consensus 735 L------~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 L------EP-LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred e------cc-CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1 00 0111 67799999999999999999999865
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-31 Score=272.19 Aligned_cols=242 Identities=25% Similarity=0.312 Sum_probs=201.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEcCCc-EEEEEEcc---ccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTDGR-IVAVKKSK---LVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~~~-~vavK~~~---~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
.+++..-.||-||||.|=++..+... .+|+|.++ ..+..+.+.+..|-++|.+.+.|.||+|+--|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34555667999999999999876543 47777655 366777888999999999999999999999999999999999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
|-|-||.|...|+++. .++.....-++..+++|++|||.++ ||.|||||+|.|||.+|-+||.|||+|+.+...
T Consensus 500 EaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999998754 4888899999999999999999999 999999999999999999999999999987643
Q ss_pred CcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhh
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
..+-.+.||+.|.|||++.+...+.++|.||||++++||++|.+||.+.++-...+++ +.-+ -
T Consensus 574 --~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I---LkGi------------d 636 (732)
T KOG0614|consen 574 --RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI---LKGI------------D 636 (732)
T ss_pred --CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH---Hhhh------------h
Confidence 3456688999999999999999999999999999999999999999876653321111 1111 1
Q ss_pred hhhhhHHHHHHHHHHHHHhcccCCCCCCC
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPT 624 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt 624 (694)
..+.+........+||++....+|.+|..
T Consensus 637 ~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 12233344456778999999999999975
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=239.21 Aligned_cols=257 Identities=23% Similarity=0.346 Sum_probs=196.3
Q ss_pred hcCCCccceeeeeCcEEEEEEEE-cCCcEEEEEEccccChhhHHHHHHHHHHHhhcc-CCcceeEEeEEeeC--CccEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLET--EVPLLV 434 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~g~~~~~--~~~~lv 434 (694)
.++|++.+++|+|.++.||.|.. .+.++++||.++ +...+.+.+|+.+|..|. ||||++|++...+. ..+.||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK---PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK---PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec---hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46799999999999999999984 568899999988 445678899999999997 99999999998865 467899
Q ss_pred EEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECC-CCcEEEeecCCccccc
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGTSRSVM 513 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~-~~~~kl~DFGla~~~~ 513 (694)
+||+.+.+...+.. .++...+...+.|++.||.|+|+.| |+|||+||.|++||. .-.++|+|+|||..+.
T Consensus 114 FE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99999988766553 3788889999999999999999999 999999999999995 4579999999998875
Q ss_pred cCCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhh--
Q 005492 514 VDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI-- 590 (694)
Q Consensus 514 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 590 (694)
..... .....+..|.-||++.. ..|+-.-|+|||||+|..|+..+.||.......+ .++. +...+....+...
T Consensus 185 p~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVk-IakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 185 PGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVK-IAKVLGTDELYAYLN 260 (338)
T ss_pred CCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHH-HHHHhChHHHHHHHH
Confidence 44332 12335667889999865 5588899999999999999999999876544322 1221 1111111111111
Q ss_pred -----hhhhhh--------hh-------hh-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 591 -----LDARVL--------KE-------AK-KEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 591 -----~d~~~~--------~~-------~~-~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+|++.. .. .. .-..++..+|+.+.|..|..+|||++|...+
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 111111 00 00 1123678899999999999999999998764
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-31 Score=252.83 Aligned_cols=264 Identities=23% Similarity=0.313 Sum_probs=201.8
Q ss_pred CCccceeeeeCcEEEEEEEE-cCCcEEEEEEcccc--ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCC-----ccEE
Q 005492 362 YNANRILGQGGQGTVYKGML-TDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETE-----VPLL 433 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~-----~~~l 433 (694)
.+..+-||.|+||.||...+ ++|+.||+|++... +...-+.+.+|+++|.-++|.|++..++...-.. +.|.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34467899999999999986 46999999987652 3345678899999999999999999988765442 4567
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
+.|.|.. +|...|-. ...++.+.+.-+..||++||+|||+.+ |+||||||.|.|++.|..+||+|||+++...
T Consensus 135 ~TELmQS-DLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHh-hhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 7787743 66666543 346889999999999999999999999 9999999999999999999999999999887
Q ss_pred cCCcceeeeeecCCCCCCCccccc-CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHh--------hh
Q 005492 514 VDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI--------NE 584 (694)
Q Consensus 514 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~--------~~ 584 (694)
.++...++...-|..|.|||.+++ ..|+.+.||||.||++.||+..+..|+..++.++..++...+... .+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 777777777778999999999987 569999999999999999999998888776655544443322111 11
Q ss_pred cchhhhhhhhhhh---------hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 585 NRLFEILDARVLK---------EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 585 ~~~~~~~d~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
+....++...... ..+.....+...+...++..+|+.|.+..+.+.++
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111111111100 11122334566788899999999999998887664
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=235.78 Aligned_cols=206 Identities=27% Similarity=0.400 Sum_probs=169.4
Q ss_pred HHHHhcCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccc-cChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCcc
Q 005492 355 LEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP 431 (694)
Q Consensus 355 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~ 431 (694)
++...+.......||+|++|.|-+-++. +|...|+|++.. ......++.+.|+.+..+- .+|.+|.++|...+....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 4444555666778999999999888864 599999999876 3445566788888876664 799999999999999999
Q ss_pred EEEEEeCCCCChHHHHhcc-cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcc
Q 005492 432 LLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~ 510 (694)
+|.||.|+ .||+.+.++- .....+++..+-+|+..+..||.|||++-+ ++|||+||+||||+..|++|++|||++-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccce
Confidence 99999994 4888876652 233469999999999999999999999864 9999999999999999999999999987
Q ss_pred ccccCCcceeeeeecCCCCCCCccccc----CCCCceeeEEehhHHHHHHHhCCCCCcc
Q 005492 511 SVMVDQTHLTTKVQGTFGYVDPEYFQS----SQFTEKSDVYSFGVVLVEILTGQKPIRA 565 (694)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~~sDvwSlGvll~elltg~~p~~~ 565 (694)
.+... -..+...|-..|||||.+.. ..|+-|+||||||+.+.||.+++.|+..
T Consensus 198 ~L~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 198 YLVDS--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eehhh--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 65322 22222447789999998753 4789999999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=237.95 Aligned_cols=211 Identities=36% Similarity=0.583 Sum_probs=184.5
Q ss_pred eeeeCcEEEEEEEEcC-CcEEEEEEccccChh-hHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCChHH
Q 005492 368 LGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQ 445 (694)
Q Consensus 368 LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~ 445 (694)
||+|.+|.||++...+ ++.+++|........ ..+.+.+|+..++.++|++|+++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 899999988754332 45789999999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECC-CCcEEEeecCCccccccCCcceeeeee
Q 005492 446 YIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGTSRSVMVDQTHLTTKVQ 524 (694)
Q Consensus 446 ~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~ 524 (694)
++.... ..+++..++.++.+++++|++||+.+ ++|+||+|.||++++ +..++|+|||.+........ ......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 997642 35899999999999999999999998 999999999999999 89999999999876543321 123345
Q ss_pred cCCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHH
Q 005492 525 GTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEG 603 (694)
Q Consensus 525 gt~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 603 (694)
+...|++||.+... ..+.+.|+|+||+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78899999999887 889999999999999999
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 604 IMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 604 ~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
..+.+++.+|++.+|++||++.++++.|
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3477899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=235.59 Aligned_cols=199 Identities=36% Similarity=0.536 Sum_probs=175.0
Q ss_pred CCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChh-hHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCC
Q 005492 362 YNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP 439 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~ 439 (694)
|...+.||+|++|.||++...+ ++.+|+|........ ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999876 889999998765444 67889999999999999999999999999999999999999
Q ss_pred CCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce
Q 005492 440 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519 (694)
Q Consensus 440 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 519 (694)
+++|.+++...... +++..+..++.+++.+|.+||+.+ ++|+||+|.||+++.++.++|+|||++..........
T Consensus 81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 99999999865321 889999999999999999999998 9999999999999999999999999988765443112
Q ss_pred eeeeecCCCCCCCccc-ccCCCCceeeEEehhHHHHHHHhCCCCCcc
Q 005492 520 TTKVQGTFGYVDPEYF-QSSQFTEKSDVYSFGVVLVEILTGQKPIRA 565 (694)
Q Consensus 520 ~~~~~gt~~y~aPE~~-~~~~~t~~sDvwSlGvll~elltg~~p~~~ 565 (694)
.....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 3345578899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-29 Score=242.51 Aligned_cols=260 Identities=24% Similarity=0.312 Sum_probs=194.5
Q ss_pred cCCCccceeeeeCcEEEEEEEE-cCCcEEEEEEccc--cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeC------Cc
Q 005492 360 DNYNANRILGQGGQGTVYKGML-TDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLET------EV 430 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~------~~ 430 (694)
.+|...+.+|.|.- .|-.+.+ -.++.||+|++.. ......+...+|..++..++|+||++++.++.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777788888887 5555543 2488999998654 3345567778899999999999999999998743 35
Q ss_pred cEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcc
Q 005492 431 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~ 510 (694)
.++|||+|. .+|.+.++. .++...+..|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+++
T Consensus 96 ~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 689999995 489998873 3888999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhh------
Q 005492 511 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE------ 584 (694)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 584 (694)
.-..+ ...+....|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+...-++-............
T Consensus 167 ~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 167 TEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred ccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 65433 4566777899999999999988999999999999999999999888754322111111000000000
Q ss_pred ---c-------------chhhhhhhhh-h--hhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 585 ---N-------------RLFEILDARV-L--KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 585 ---~-------------~~~~~~d~~~-~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
. ...+.+...+ . .+.++.....+.+++.+||..+|++|.+++++|++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 0000110000 0 01111223457899999999999999999999876
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=254.59 Aligned_cols=196 Identities=24% Similarity=0.369 Sum_probs=167.8
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccC--------hhhHHHHHHHHHHHhhcc---CCcceeEEeEEee
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD--------ETNVEQFINEVVILSQIN---HRNIVKLLGCCLE 427 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~nIv~l~g~~~~ 427 (694)
..|...+.||+|+||.|+++.++. ...|+||.+++.. ...+-..-.||.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 347888999999999999999876 5678999776421 111223456999999997 9999999999999
Q ss_pred CCccEEEEEeC-CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeec
Q 005492 428 TEVPLLVYEFI-PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 506 (694)
Q Consensus 428 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DF 506 (694)
++.+||+||-. ++-+|+++|..+. .+++....-|++||+.|+++||+.+ |+|||||-+|+.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999965 4668999998654 4999999999999999999999999 999999999999999999999999
Q ss_pred CCccccccCCcceeeeeecCCCCCCCcccccCCC-CceeeEEehhHHHHHHHhCCCCCc
Q 005492 507 GTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIR 564 (694)
Q Consensus 507 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDvwSlGvll~elltg~~p~~ 564 (694)
|.+.... ......+.||.+|.|||++.+.+| ...-|||+||++||.++....||.
T Consensus 715 gsaa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9987653 334556789999999999999886 567899999999999999988875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=261.25 Aligned_cols=253 Identities=27% Similarity=0.387 Sum_probs=207.2
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
.++|+....+|.|.+|.|||+++.. ++..|+|.++....++..-..+|+-+++.-+|||||.++|.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 4678999999999999999999764 899999999998888888899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
+.+|+|++..+-.. ++++.++..++++.++||+|||+.+ =+|||||-.|||+++.+.+|++|||.+..+...-
T Consensus 94 cgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred cCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-
Confidence 99999999887543 6999999999999999999999999 7899999999999999999999999987664321
Q ss_pred ceeeeeecCCCCCCCccc---ccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhh
Q 005492 518 HLTTKVQGTFGYVDPEYF---QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~---~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
.....+.||+.|||||+. +.+.|..++|||++|+...|+---++|....-+.. +...+.... .++.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~l~LmTkS~----~qpp 235 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------ALFLMTKSG----FQPP 235 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------HHHHhhccC----CCCC
Confidence 233456799999999986 45789999999999999999988787754432221 111221111 1111
Q ss_pred hhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAF 630 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 630 (694)
-+++ .....+.+-++++.+|.++|++||+++.++.
T Consensus 236 ~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111 2234456789999999999999999987654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=227.95 Aligned_cols=253 Identities=23% Similarity=0.306 Sum_probs=188.9
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhc-cCCcceeEEeEE-eeCCccEEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCC-LETEVPLLVY 435 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~-~~~~~~~lv~ 435 (694)
.+.|.+.+.||+|.||.+-++.++. .+.+++|.+.. ......+|.+|..---.| .|.||+.-+++. +..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4679999999999999999999876 66788887653 344578899998766666 589999888764 4556777999
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEE-C-CCCcEEEeecCCccccc
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL-D-DKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll-~-~~~~~kl~DFGla~~~~ 513 (694)
||+|.|+|.+-+... .+.+..-.+++.|++.||.|||+++ +||||||.+|||| + +..++||+|||+.+...
T Consensus 102 E~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999999987653 3888889999999999999999999 9999999999999 2 44589999999987543
Q ss_pred cCCcceeeeeecCCCCCCCcccccC-----CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchh
Q 005492 514 VDQTHLTTKVQGTFGYVDPEYFQSS-----QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 588 (694)
Q Consensus 514 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (694)
.......-+..|.+||..... ...+.+|||.||++++.++||..||+.. ...+.....|....-+.+.
T Consensus 175 ----~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w~~rk~~-- 247 (378)
T KOG1345|consen 175 ----TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQWLKRKNP-- 247 (378)
T ss_pred ----ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHHhcccCc--
Confidence 222333456789999987542 3467899999999999999999999843 3334444443322211111
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005492 589 EILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 589 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 632 (694)
.+. .......+.+..+.++-|..++++|=...++.++.
T Consensus 248 -----~~P-~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 248 -----ALP-KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred -----cCc-hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 111 11122345677889999999999995555555443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=246.10 Aligned_cols=263 Identities=20% Similarity=0.257 Sum_probs=204.6
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhcc------CCcceeEEeEEeeCCc
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQIN------HRNIVKLLGCCLETEV 430 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~l~g~~~~~~~ 430 (694)
.-.+|.+....|+|-|++|.+|.... |..||||++... +...+.=+.|+++|++|+ .-|.++|+-.|....+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 35678888889999999999999765 889999998753 334455678999999995 4589999999999999
Q ss_pred cEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCC-CcEEEeecCCc
Q 005492 431 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGTS 509 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~-~~~kl~DFGla 509 (694)
++||+|-+ ..+|.+.|++.+...-|....+..++.|+..||..|...+ |+|.||||.|||+++. ..+||+|||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999987 5699999998777777999999999999999999999999 9999999999999865 56899999998
Q ss_pred cccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHH--------HH
Q 005492 510 RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL--------QA 581 (694)
Q Consensus 510 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~--------~~ 581 (694)
.....++. +...-+..|.|||++.+..|+...|+||.||.||||.||+..|.+.+... +..++. .+
T Consensus 585 ~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~---MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 585 SFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ---MLRLFMELKGKFPNKM 658 (752)
T ss_pred cccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH---HHHHHHHhcCCCcHHH
Confidence 76654332 22334567999999999999999999999999999999999998765432 111111 11
Q ss_pred hhhcchh---------------------------hhhhh------hh-----hhhhhHHHHHHHHHHHHHhcccCCCCCC
Q 005492 582 INENRLF---------------------------EILDA------RV-----LKEAKKEGIMTVATLAKRCLNLNGKMRP 623 (694)
Q Consensus 582 ~~~~~~~---------------------------~~~d~------~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RP 623 (694)
+..+.+. ..+.| .+ ..+........|.+|+..||.+||++|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 1111100 00001 00 0111233456788999999999999999
Q ss_pred CHHHHHHH
Q 005492 624 TMKEVAFE 631 (694)
Q Consensus 624 t~~evl~~ 631 (694)
|..+.|.+
T Consensus 739 t~nqAL~H 746 (752)
T KOG0670|consen 739 TVNQALKH 746 (752)
T ss_pred CHHHHhcC
Confidence 99998865
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=234.97 Aligned_cols=131 Identities=28% Similarity=0.407 Sum_probs=110.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcc-----C---CcceeEEeEEeeC--
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQIN-----H---RNIVKLLGCCLET-- 428 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~l~g~~~~~-- 428 (694)
.+|.+.++||-|.|++||++.+. +.+.||+|+.+.. ..-.+..+.||++|++++ | .+||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 67889999999999999999865 4788999998753 233466788999999983 3 4699999999754
Q ss_pred --CccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEE
Q 005492 429 --EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL 495 (694)
Q Consensus 429 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll 495 (694)
.+.+||+|++ |.+|..+|....-+ -++...+.+|+.||+.||.|||.... |||-||||+||||
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence 5789999999 66888888775333 49999999999999999999999874 9999999999999
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-27 Score=238.35 Aligned_cols=265 Identities=25% Similarity=0.357 Sum_probs=198.2
Q ss_pred HHHHhcCCCccceeeeeCcEEEEEEEEcC----CcEEEEEEccccChhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCC
Q 005492 355 LEKATDNYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETE 429 (694)
Q Consensus 355 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~ 429 (694)
+....+.|..+++||+|.|++||++.+.. .+.||+|.+.... ....+.+|+++|..+ .+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34445678899999999999999998643 6789999876543 345688999999999 5899999999999999
Q ss_pred ccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECC-CCcEEEeecCC
Q 005492 430 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGT 508 (694)
Q Consensus 430 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~-~~~~kl~DFGl 508 (694)
...+|+||+++....+++.. ++...+...++.++.||+++|..| ||||||||+|+|.+. -++-.|.||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999999998864 778999999999999999999999 999999999999974 46789999999
Q ss_pred ccccccCC------c-------------------------------------ceeeeeecCCCCCCCccccc-CCCCcee
Q 005492 509 SRSVMVDQ------T-------------------------------------HLTTKVQGTFGYVDPEYFQS-SQFTEKS 544 (694)
Q Consensus 509 a~~~~~~~------~-------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~t~~s 544 (694)
|....... . .......||++|.|||++.. ...+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 87211000 0 00112459999999999865 5578999
Q ss_pred eEEehhHHHHHHHhCCCCCccCCCccCccHHHHHH----HHhh-----hcc--h------h---------hhhh-hhhhh
Q 005492 545 DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL----QAIN-----ENR--L------F---------EILD-ARVLK 597 (694)
Q Consensus 545 DvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~----~~~~-----~~~--~------~---------~~~d-~~~~~ 597 (694)
||||.||+++.+++++.||.....+-+ .+...+. ..+. .++ + . +-++ ..+.+
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred ceeeccceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 999999999999999999965544322 1111110 0000 011 0 0 0010 00000
Q ss_pred ---------hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 598 ---------EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 598 ---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
......+..+.+|+.+||+.||.+|.|+++.|++
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0111123468899999999999999999999875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=270.34 Aligned_cols=197 Identities=18% Similarity=0.220 Sum_probs=140.8
Q ss_pred hhccC-CcceeEEeEE-------eeCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 005492 411 SQINH-RNIVKLLGCC-------LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 482 (694)
Q Consensus 411 ~~l~h-~nIv~l~g~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ 482 (694)
+.++| +||+++++++ .+.+.+++++|++ +++|.++|.... ..+++.+++.++.||++||+|||+++
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 34556 6888888887 3334667888987 569999997532 35999999999999999999999999
Q ss_pred eeecccccccEEECC-------------------CCcEEEeecCCccccccCC---------------cceeeeeecCCC
Q 005492 483 IYHRDIKSANILLDD-------------------KYRAKVSDFGTSRSVMVDQ---------------THLTTKVQGTFG 528 (694)
Q Consensus 483 ivH~DIkp~NIll~~-------------------~~~~kl~DFGla~~~~~~~---------------~~~~~~~~gt~~ 528 (694)
|+||||||+||||+. ++.+||+|||+++...... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 4456666666665321100 000111347888
Q ss_pred CCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHH
Q 005492 529 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVA 608 (694)
Q Consensus 529 y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~ 608 (694)
|||||++.+..++.++|||||||+||||++|..|+..... . + ..+.. ..+.+.. ........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~---~-~~~~~----~~~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----T---M-SSLRH----RVLPPQI-----LLNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----H---H-HHHHH----hhcChhh-----hhcCHHHH
Confidence 9999999999999999999999999999999887642110 0 0 00000 0111111 11123456
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 005492 609 TLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 609 ~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.++.+||+.+|.+||+|.||+++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 88899999999999999999864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=214.16 Aligned_cols=265 Identities=18% Similarity=0.234 Sum_probs=211.8
Q ss_pred hcCCCccceeeeeCcEEEEEEE-EcCCcEEEEEEccccChhhHHHHHHHHHHHhhcc-CCcceeEEeEEeeCCccEEEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lv~e 436 (694)
.-+|.+.++||+|.||.++.|+ +-+++.||||.-.. ....-++..|.+..+.|. .++|..++-+..++..-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3479999999999999999998 45799999997543 334567888999999985 6999999999999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEEC-----CCCcEEEeecCCccc
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-----DKYRAKVSDFGTSRS 511 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~-----~~~~~kl~DFGla~~ 511 (694)
.+ |-+|++++.-... .++.++++.+|.|++.-++|+|++. +|.|||||+|+||. +...+.|+|||+|+.
T Consensus 105 LL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 98 7799998876544 4999999999999999999999999 99999999999995 344689999999998
Q ss_pred cccCCcce------eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhc
Q 005492 512 VMVDQTHL------TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN 585 (694)
Q Consensus 512 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 585 (694)
+....... .....||.+||+-..+.+.+.+++.|+-|||-++++.|.|..||++......+.....+-..-...
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 87554332 234569999999999999999999999999999999999999999987765443332221111111
Q ss_pred chhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccccC
Q 005492 586 RLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTG 640 (694)
Q Consensus 586 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~~ 640 (694)
. ..++....+.++..-+.-.-.++..+-|+..-+...+..+....+
T Consensus 259 ~---------i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 259 P---------IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred C---------HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 1 123334456677788888888899999999887777766655443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=226.53 Aligned_cols=263 Identities=22% Similarity=0.264 Sum_probs=200.9
Q ss_pred CCCccceeeeeCcEEEEEEEEcCC--cEEEEEEccccChhhHHHHHHHHHHHhhccC----CcceeEEeEE-eeCCccEE
Q 005492 361 NYNANRILGQGGQGTVYKGMLTDG--RIVAVKKSKLVDETNVEQFINEVVILSQINH----RNIVKLLGCC-LETEVPLL 433 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~l~g~~-~~~~~~~l 433 (694)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997663 4788887665433333377889999999873 6899999999 47778899
Q ss_pred EEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCC-----CcEEEeecCC
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-----YRAKVSDFGT 508 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~-----~~~kl~DFGl 508 (694)
||+.+ +.+|.++..... ...++..++++|+.|++.+|++||+.| ++||||||.|+++... ..++|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 779999876654 446999999999999999999999999 9999999999999754 4699999999
Q ss_pred cc--ccccCCcc----e---eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHH
Q 005492 509 SR--SVMVDQTH----L---TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL 579 (694)
Q Consensus 509 a~--~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~ 579 (694)
++ ........ . .....||..|.+++.+.+...+++.|+||++.++.||+.|..||........... +
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~---~- 249 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK---F- 249 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH---H-
Confidence 99 33222211 1 2235599999999999999999999999999999999999999976554322111 1
Q ss_pred HHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccccC
Q 005492 580 QAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTG 640 (694)
Q Consensus 580 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~~~ 640 (694)
........... .....+..+.++...+-..+..++|....+...|+......+
T Consensus 250 ---~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~ 302 (322)
T KOG1164|consen 250 ---EKDPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG 302 (322)
T ss_pred ---HHHhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence 11111111110 111223456666666667999999999999999887766553
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-25 Score=210.74 Aligned_cols=168 Identities=22% Similarity=0.236 Sum_probs=126.6
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
|+|.++++... ..+++..++.|+.|++.||+|||+.+ ||+|||+++++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 78999998643 25999999999999999999999876 999999999999999 99987654322
Q ss_pred eeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAK 600 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 600 (694)
..||+.|+|||++.+..++.++||||||+++|||++|+.||....... ............. ++... ...
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~------~~~~~-~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPAD------DPRDR-SNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccC------Ccccc-ccH
Confidence 258899999999999999999999999999999999999986533211 1111111111100 00000 001
Q ss_pred HHHH--HHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 005492 601 KEGI--MTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636 (694)
Q Consensus 601 ~~~~--~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~ 636 (694)
.... ..+.+++.+||+.+|.+||++.|+++++..+.
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 1122 26899999999999999999999999986654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=205.46 Aligned_cols=263 Identities=19% Similarity=0.250 Sum_probs=208.7
Q ss_pred hcCCCccceeeeeCcEEEEEEEE-cCCcEEEEEEccccChhhHHHHHHHHHHHhhccC-CcceeEEeEEeeCCccEEEEE
Q 005492 359 TDNYNANRILGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVEQFINEVVILSQINH-RNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~g~~~~~~~~~lv~e 436 (694)
...|..+++||.|+||.+|.|.. .+|..||||.-.. .....++..|..+...|+| ..|..+..+..+.+.-.||||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 46799999999999999999994 5699999997553 2334567889999999976 778888899999999999999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEEC---CCCcEEEeecCCccccc
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~---~~~~~kl~DFGla~~~~ 513 (694)
.+ +.+|.+++.-... .++..+++.++-|++.-++|+|.++ ++||||||+|+|.. ....+.|+|||||+.+.
T Consensus 92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 7799998875433 3889999999999999999999999 99999999999995 44579999999999876
Q ss_pred cCCcc------eeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcch
Q 005492 514 VDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 587 (694)
Q Consensus 514 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (694)
..... ......||.+|.+-..+.+.+.+.+.|+-|+|.+|.++..|..||++............+.+. ++
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek----K~ 241 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK----KM 241 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh----hc
Confidence 43222 234466999999999988889999999999999999999999999988765543333222111 11
Q ss_pred hhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 005492 588 FEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 588 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~ 638 (694)
....+.+....+.++...+..|-....++-|+..-+.+.++-+...
T Consensus 242 -----s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 242 -----STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred -----CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 1112223345567788899999999999999988777776655433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=220.27 Aligned_cols=177 Identities=18% Similarity=0.118 Sum_probs=135.4
Q ss_pred HHHHhcCCCccceeeeeCcEEEEEEEEc--CCcEEEEEEcccc-----ChhhHHHHHHHHHHHhhccCCcceeEEeEEee
Q 005492 355 LEKATDNYNANRILGQGGQGTVYKGMLT--DGRIVAVKKSKLV-----DETNVEQFINEVVILSQINHRNIVKLLGCCLE 427 (694)
Q Consensus 355 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~ 427 (694)
.....++|...+.||+|+||+||+|..+ +++.+|||+.... .....+.|.+|+++|++++|+|+++.+..
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 3445678999999999999999999875 4778899986532 22345679999999999999999853322
Q ss_pred CCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccc-ccccEEECCCCcEEEeec
Q 005492 428 TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDI-KSANILLDDKYRAKVSDF 506 (694)
Q Consensus 428 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DI-kp~NIll~~~~~~kl~DF 506 (694)
.+..+|||||+++++|... .. .. ...++.|+++||.|||+.+ |+|||| ||+|||++.++.+||+||
T Consensus 90 ~~~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred cCCcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 2467999999999999632 11 11 1467899999999999999 999999 999999999999999999
Q ss_pred CCccccccCCcc-------eeeeeecCCCCCCCcccccCC------CCceeeEE
Q 005492 507 GTSRSVMVDQTH-------LTTKVQGTFGYVDPEYFQSSQ------FTEKSDVY 547 (694)
Q Consensus 507 Gla~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~------~t~~sDvw 547 (694)
|+++.+...... ..+...+++.|+|||++...+ .+..+|-|
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 999876532211 113456888999999986432 23346666
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8e-24 Score=202.78 Aligned_cols=250 Identities=20% Similarity=0.316 Sum_probs=191.3
Q ss_pred CccceeeeeCcEEEEEEEEcCCcEEEEEEccc--cChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 363 NANRILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 363 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
....+|.+...|..|+|++..+ .+++|.++. .......+|..|.-.|+-+.||||++++|.|.....+.++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 3445688899999999999744 455565543 2333456788999999999999999999999999999999999999
Q ss_pred CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCccee
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 520 (694)
|+|+..||+.. ...++..+..+++.++|+|++|||+.... |----|.+..++||++.+++|+-=. .+. +...
T Consensus 272 gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad-~kf-----sfqe 343 (448)
T KOG0195|consen 272 GSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMAD-TKF-----SFQE 343 (448)
T ss_pred hHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheeccc-cee-----eeec
Confidence 99999999864 34578889999999999999999998742 3334689999999999998875211 111 1111
Q ss_pred eeeecCCCCCCCcccccCCC---CceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhh
Q 005492 521 TKVQGTFGYVDPEYFQSSQF---TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 521 ~~~~gt~~y~aPE~~~~~~~---t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
....-.+.||+||.++..+. -+++|+|||.++||||.|...||....+-+..- .+--..++.
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---------------kialeglrv 408 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---------------KIALEGLRV 408 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---------------hhhhccccc
Confidence 12224678999999987664 358999999999999999999998776654221 111122333
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~ 636 (694)
..++.....+.+|+.-|+..||.+||.+..|+-.|+.++
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 344555667889999999999999999999998887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-21 Score=200.82 Aligned_cols=261 Identities=31% Similarity=0.393 Sum_probs=198.5
Q ss_pred CCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChh---hHHHHHHHHHHHhhccCC-cceeEEeEEeeCCccEEEEEe
Q 005492 362 YNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET---NVEQFINEVVILSQINHR-NIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-nIv~l~g~~~~~~~~~lv~e~ 437 (694)
|...+.||.|+|+.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +|+++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999987 78899987753332 477899999999999988 799999999777778999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCC-cEEEeecCCccccccCC
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~-~~kl~DFGla~~~~~~~ 516 (694)
+.+++|.+++........+.......++.|++.+|.|+|..+ ++||||||+||+++... .+++.|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977765421125899999999999999999999999 99999999999999988 79999999998554333
Q ss_pred cc-----eeeeeecCCCCCCCccccc---CCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchh
Q 005492 517 TH-----LTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 588 (694)
Q Consensus 517 ~~-----~~~~~~gt~~y~aPE~~~~---~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (694)
.. ......|+..|+|||.+.. .......|+|++|++++++++|..||...... .........+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 22 2355679999999999987 57899999999999999999999996554431 0011111111111100
Q ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 589 EILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 589 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.................+.+++.+++..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223467899999999999999998887654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-22 Score=224.20 Aligned_cols=254 Identities=20% Similarity=0.260 Sum_probs=190.5
Q ss_pred CccceeeeeCcEEEEEEEEcC-CcEEEEEEcc-----ccChhh-HHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 363 NANRILGQGGQGTVYKGMLTD-GRIVAVKKSK-----LVDETN-VEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 363 ~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~-----~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
...+.+|.|++|.|+...... ....+.|... ...... ...+..|+.+-..++|+|++..+....+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456789999999887776432 3333333221 111111 122666888888899999998888877777666669
Q ss_pred EeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
||+++ +|..++... ..++...+..++.|++.||.|||+.+ |.|||||++|+++..++.+||+|||.+.....+
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 999999764 24888899999999999999999999 999999999999999999999999998876543
Q ss_pred Cc---ceeeeeecCCCCCCCcccccCCCCc-eeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhh
Q 005492 516 QT---HLTTKVQGTFGYVDPEYFQSSQFTE-KSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591 (694)
Q Consensus 516 ~~---~~~~~~~gt~~y~aPE~~~~~~~t~-~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (694)
.. .......|...|+|||.+...+|.+ ..||||.|+++..|++|+.||......++.. ....... +.-
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~---~~~ 545 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSD---QRN 545 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcccc---ccc
Confidence 33 4556678999999999999998875 6799999999999999999998766554332 0000000 000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
...-........+.+...++.+||+.+|.+|.|+++|++.
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0111122334555677899999999999999999999863
|
|
| >PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-21 Score=169.96 Aligned_cols=92 Identities=43% Similarity=0.690 Sum_probs=78.7
Q ss_pred cceeecCCCCCCCCCCCCCceeeeCCCCCCCccccCCCCcceEEeeecCCccEEEEeeceeecccCCC-----Ccceeec
Q 005492 3 KYQHQLPFGIGKGCFLDKSFEVICNYSGKYPKAYLPGINNLELLDIDSYYEGTIRVNFPIISLKNSSN-----AKGVNLL 77 (694)
Q Consensus 3 ~v~ipyPFGig~~C~~~~~F~l~C~~~~~pp~~~l~~~~~~~v~~is~~~~~~~~v~~~~~~~~~~~~-----~~~~~~~ 77 (694)
||+||||||||++|++++||+|+|++++++|+|++.+. +++|++|++++ ++++|..++.+.+.... ...+++.
T Consensus 10 nv~IpYPFgi~~~C~~~~~F~L~C~~~~~~~~l~l~~~-~~~V~~I~~~~-~~i~v~~~~~~~~~~~~~~~~~~~~~~~~ 87 (106)
T PF13947_consen 10 NVSIPYPFGIGPGCGRDPGFELTCNNNTSPPKLLLSSG-NYEVLSISYEN-GTIRVSDPISSNCYSSSSSNSSNSNLSLN 87 (106)
T ss_pred CEeecCCCccCCCCCCCCCcEEECCCCCCCceeEecCC-cEEEEEEecCC-CEEEEEeccccceecCCCCcccccEEeec
Confidence 79999999999999996699999999988899999777 89999999988 99999999876532211 2345666
Q ss_pred CCceEeccCCcEEEEEcCCc
Q 005492 78 GSPFIFSNISNRFAAIGCDD 97 (694)
Q Consensus 78 ~~pf~~s~~~N~~~~~GC~~ 97 (694)
+ ||++|+++|+|+++||++
T Consensus 88 ~-~~~~s~~~N~~~~~GC~t 106 (106)
T PF13947_consen 88 G-PFFFSSSSNKFTVVGCNT 106 (106)
T ss_pred C-CceEccCCcEEEEECCCC
Confidence 6 899999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-21 Score=187.63 Aligned_cols=172 Identities=12% Similarity=0.137 Sum_probs=134.7
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhh---HHH------HHHHHHHHhhccCCcceeEEeEEeeC
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETN---VEQ------FINEVVILSQINHRNIVKLLGCCLET 428 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~------~~~E~~~l~~l~h~nIv~l~g~~~~~ 428 (694)
..++|+..++||.|+||.||+... ++..+|||.+....... .+. +.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 368899999999999999999655 57789999886432222 222 67899999999999999999887644
Q ss_pred --------CccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCc
Q 005492 429 --------EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR 500 (694)
Q Consensus 429 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~ 500 (694)
...+|||||++|.+|.++.. ++. ....+++.+|..||..+ ++||||||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 25789999999999988732 332 24569999999999999 99999999999999888
Q ss_pred EEEeecCCccccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh
Q 005492 501 AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 558 (694)
Q Consensus 501 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt 558 (694)
++|+|||.......+... ..+.....+..++|+|+||++|..+..
T Consensus 173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999999987654321111 013344557789999999999887653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-20 Score=181.03 Aligned_cols=139 Identities=19% Similarity=0.162 Sum_probs=108.6
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEccccChh--h-------H-----------------HHHHHHHHHHhhccCCcc
Q 005492 365 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--N-------V-----------------EQFINEVVILSQINHRNI 418 (694)
Q Consensus 365 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~nI 418 (694)
...||+|+||.||+|...+|+.||||.++..... . . .....|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999987653211 1 1 122349999999988876
Q ss_pred eeEEeEEeeCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecccccccEEECC
Q 005492 419 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL-HSAASIPIYHRDIKSANILLDD 497 (694)
Q Consensus 419 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~ivH~DIkp~NIll~~ 497 (694)
.....+. ....+|||||+++++|...+... ..+++..+..++.|++.+|.|| |+.+ |+||||||+|||+++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~ 153 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD 153 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC
Confidence 4433322 22348999999998776553322 2588999999999999999999 6888 999999999999984
Q ss_pred CCcEEEeecCCcccc
Q 005492 498 KYRAKVSDFGTSRSV 512 (694)
Q Consensus 498 ~~~~kl~DFGla~~~ 512 (694)
+.++|+|||++...
T Consensus 154 -~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 -GKLYIIDVSQSVEH 167 (190)
T ss_pred -CcEEEEEccccccC
Confidence 78999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.5e-21 Score=215.25 Aligned_cols=250 Identities=20% Similarity=0.237 Sum_probs=180.8
Q ss_pred CCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccC-hhhHHHHHHHHHH--HhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 361 NYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD-ETNVEQFINEVVI--LSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
++...+.||.+.|=+|.+++.++|. |+||++-..+ ....+.|.++++- ...++|||.+++.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6778899999999999999999888 8888765433 4445555554443 4456899999998887677777888888
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccc--cC
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM--VD 515 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~--~~ 515 (694)
+.+ +|+|.|..+ .-+..-+...|+.|++.||...|..+ |+|||||.+||||+.-.-+.|+||..-+... .+
T Consensus 103 vkh-nLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 855 888887643 23777888899999999999999999 9999999999999999999999998655433 22
Q ss_pred Ccceeee----eecCCCCCCCccccc----------CC-CCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHHH
Q 005492 516 QTHLTTK----VQGTFGYVDPEYFQS----------SQ-FTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFL 579 (694)
Q Consensus 516 ~~~~~~~----~~gt~~y~aPE~~~~----------~~-~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 579 (694)
.....+. ...-..|+|||.+.. .. ++++.||||+||+++||++ |++||... .+..+
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aY-- 247 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAY-- 247 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhH--
Confidence 2222222 223457999998743 12 6889999999999999998 67777421 11111
Q ss_pred HHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005492 580 QAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGG 634 (694)
Q Consensus 580 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 634 (694)
+.+. ......+.+.. +...+++|+..|++.||.+|.+++++|+.-++
T Consensus 248 ---r~~~--~~~~e~~Le~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 248 ---RSGN--ADDPEQLLEKI---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred ---hccC--ccCHHHHHHhC---cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 1110 00000111111 11257899999999999999999999987443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-19 Score=174.22 Aligned_cols=139 Identities=21% Similarity=0.197 Sum_probs=111.1
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEccccChh--------------------------hHHHHHHHHHHHhhccCCcc
Q 005492 365 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--------------------------NVEQFINEVVILSQINHRNI 418 (694)
Q Consensus 365 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~nI 418 (694)
...||+|++|.||+|...+|+.||||........ ....+..|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999888999999987653211 01234578999999999987
Q ss_pred eeEEeEEeeCCccEEEEEeCCCCChHHH-HhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecccccccEEEC
Q 005492 419 VKLLGCCLETEVPLLVYEFIPNGTLYQY-IHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLD 496 (694)
Q Consensus 419 v~l~g~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivH~DIkp~NIll~ 496 (694)
.....+... ..+|||||++++++... +.. ..++......++.|++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence 554444333 34899999998865443 332 247888999999999999999999 88 99999999999999
Q ss_pred CCCcEEEeecCCccccc
Q 005492 497 DKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 497 ~~~~~kl~DFGla~~~~ 513 (694)
++.++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 7899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=195.36 Aligned_cols=218 Identities=24% Similarity=0.455 Sum_probs=166.6
Q ss_pred HhhccCCcceeEEeEEeeCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-eeccc
Q 005492 410 LSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI-YHRDI 488 (694)
Q Consensus 410 l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~i-vH~DI 488 (694)
|+++.|.|+.+++|.+.+....++|.+|+..|+|.+.+... ...+++.....++++|+.||+|||+.. | .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 45789999999999999999999999999999999999873 345999999999999999999999876 5 99999
Q ss_pred ccccEEECCCCcEEEeecCCcccccc-CCcceeeeeecCCCCCCCcccccC-------CCCceeeEEehhHHHHHHHhCC
Q 005492 489 KSANILLDDKYRAKVSDFGTSRSVMV-DQTHLTTKVQGTFGYVDPEYFQSS-------QFTEKSDVYSFGVVLVEILTGQ 560 (694)
Q Consensus 489 kp~NIll~~~~~~kl~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-------~~t~~sDvwSlGvll~elltg~ 560 (694)
+++|.++|....+||+|||+...... ..........-..-|.|||.+... ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999876642 111111112245579999998763 2477899999999999999999
Q ss_pred CCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 005492 561 KPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 561 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~~~ 638 (694)
.||......+.. ...+.. ++.+ ....+.|.+... .+..+.+..++.+||..+|.+||++.+|-..++.+.+.
T Consensus 156 ~~~~~~~~~~~~--~eii~~-~~~~-~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDP--DEIILR-VKKG-GSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCCh--HHHHHH-HHhc-CCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 999876554433 111111 2220 111111111111 13444788999999999999999999999988877664
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-19 Score=171.09 Aligned_cols=188 Identities=16% Similarity=0.043 Sum_probs=140.9
Q ss_pred CCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChh----hHHHHHHHHHHHhhcc-CCcceeEEeEEeeCCccEEEEE
Q 005492 362 YNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET----NVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lv~e 436 (694)
+.+...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|++++ |+++++++++ +..+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34567899999999997765 5778887776653321 1225789999999995 5889999886 44699999
Q ss_pred eCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccc-ccccEEECCCCcEEEeecCCccccccC
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDI-KSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DI-kp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
|+.+.+|...+.. . ...++.|++.+|.++|.++ |+|||| ||+|||+++++.++|+|||++......
T Consensus 79 yI~G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 79 YLAGAAMYQRPPR---------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred eecCccHHhhhhh---------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 9999998754321 1 1357889999999999999 999999 799999999999999999999854322
Q ss_pred Ccc----e--------eeeeecCCCCCCCccccc--CCCCceeeEEehhHHHHHHHhCCCCCccCC
Q 005492 516 QTH----L--------TTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAIN 567 (694)
Q Consensus 516 ~~~----~--------~~~~~gt~~y~aPE~~~~--~~~t~~sDvwSlGvll~elltg~~p~~~~~ 567 (694)
... . ......++.|++|+...- ..--...+.++.|..+|.++|++.+.-...
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 210 0 111235778888876432 222357789999999999999998765443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.1e-19 Score=180.58 Aligned_cols=232 Identities=21% Similarity=0.296 Sum_probs=151.5
Q ss_pred CCccceeeeeCcEEEEEEEEcC-CcEEEEEEccc---cChhhHHHHHHHHHHHhhcc----------CCcceeEEeEEe-
Q 005492 362 YNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL---VDETNVEQFINEVVILSQIN----------HRNIVKLLGCCL- 426 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~----------h~nIv~l~g~~~- 426 (694)
....+.||.|+++.||.+++.+ ++.+|||.... ......+++++|.-....+. |-.++.-++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4457889999999999999876 89999997543 22335677777776655532 222332222221
Q ss_pred --------eC---C-----ccEEEEEeCCCCChHHHHhc---ccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 005492 427 --------ET---E-----VPLLVYEFIPNGTLYQYIHN---QIE-EFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 486 (694)
Q Consensus 427 --------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~ 486 (694)
.. . ..+++|+-+ .++|.+++.. ... ...+....++.+..|+++.+++||..| ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 11 1 225677777 5688887653 111 123556667888899999999999999 9999
Q ss_pred ccccccEEECCCCcEEEeecCCccccccCCcceeeeeecCCCCCCCccccc--------CCCCceeeEEehhHHHHHHHh
Q 005492 487 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS--------SQFTEKSDVYSFGVVLVEILT 558 (694)
Q Consensus 487 DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~~sDvwSlGvll~ellt 558 (694)
||+|+|++++++|.++|+||+........ ... ...+..|.+||.... -.++.+.|.|+||+++|.|.+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEE---EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCce---eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999876544321 111 234578999997643 247889999999999999999
Q ss_pred CCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCC
Q 005492 559 GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMR 622 (694)
Q Consensus 559 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 622 (694)
++.||........... ...... +.++.+..||..+|+.+|.+|
T Consensus 246 ~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999987654432211 111222 667789999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.6e-20 Score=196.34 Aligned_cols=225 Identities=25% Similarity=0.323 Sum_probs=178.3
Q ss_pred eeeeeCcEEEEEEE----EcCCcEEEEEEccccChh--hHHHHHHHHHHHhhcc-CCcceeEEeEEeeCCccEEEEEeCC
Q 005492 367 ILGQGGQGTVYKGM----LTDGRIVAVKKSKLVDET--NVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEFIP 439 (694)
Q Consensus 367 ~LG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lv~e~~~ 439 (694)
.+|+|.||.|++.. .+.+..+|+|.++..... .......|..++...+ ||.+|++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999999754 234778898877653221 1125566888888886 9999999999999999999999999
Q ss_pred CCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcce
Q 005492 440 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519 (694)
Q Consensus 440 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 519 (694)
+|.|...+.+.. ...+.........++-+++++|+.+ |+|||+|++||+++.+|.+|+.|||+++..-..+..
T Consensus 81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999988886543 3667777778889999999999999 999999999999999999999999999876433322
Q ss_pred eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhh
Q 005492 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEA 599 (694)
Q Consensus 520 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 599 (694)
.||..|||||++. ....++|.||||++++||++|..||.. + .+...++. .-..
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~------~~~~Il~~-----------~~~~ 206 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----D------TMKRILKA-----------ELEM 206 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----H------HHHHHhhh-----------ccCC
Confidence 7899999999998 667899999999999999999999975 1 01111110 1122
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCH
Q 005492 600 KKEGIMTVATLAKRCLNLNGKMRPTM 625 (694)
Q Consensus 600 ~~~~~~~l~~li~~cl~~~p~~RPt~ 625 (694)
+.+.......++..++..+|..|.-.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 34556667889999999999999765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3e-18 Score=167.95 Aligned_cols=137 Identities=16% Similarity=0.167 Sum_probs=107.8
Q ss_pred CCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhc-----cCCcceeEEeEEeeCC---c-cE
Q 005492 362 YNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-----NHRNIVKLLGCCLETE---V-PL 432 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~g~~~~~~---~-~~ 432 (694)
....+.||+|+||.||. ..+....+||+.........+.+.+|+.+++++ +||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34467899999999996 433333479987765455667899999999999 5799999999998874 3 33
Q ss_pred EEEEe--CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeecccccccEEECC----CCcEEEee
Q 005492 433 LVYEF--IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL-FYLHSAASIPIYHRDIKSANILLDD----KYRAKVSD 505 (694)
Q Consensus 433 lv~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL-~yLH~~~~~~ivH~DIkp~NIll~~----~~~~kl~D 505 (694)
+|+|| .++++|.+++.+. .+++. ..++.|++.++ +|||+++ |+||||||+|||++. +.+++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 6689999999653 25555 35678888777 9999999 999999999999973 34899999
Q ss_pred cCCc
Q 005492 506 FGTS 509 (694)
Q Consensus 506 FGla 509 (694)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=198.98 Aligned_cols=201 Identities=22% Similarity=0.310 Sum_probs=163.7
Q ss_pred hhhHHHHhcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcc---CCcceeEEeEEeeC
Q 005492 352 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN---HRNIVKLLGCCLET 428 (694)
Q Consensus 352 ~~~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~g~~~~~ 428 (694)
..+++.....|.+.+.||+|+||+||+|...+|+.||+|.-+.... -+|.--.+++.+|+ -+.|+.+..++.-.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 4456666778999999999999999999998899999998664332 23333344445554 34555666666667
Q ss_pred CccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEEC-------CCCcE
Q 005492 429 EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-------DKYRA 501 (694)
Q Consensus 429 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~-------~~~~~ 501 (694)
+.-+||+||.+.|+|.+++... ..++|..++.++.|++..+..||..+ |||+||||+|+||. +..-+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~---~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTN---KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred CcceeeeeccccccHHHhhccC---CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccce
Confidence 7889999999999999999833 35999999999999999999999999 99999999999993 34468
Q ss_pred EEeecCCccccccC-CcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCC
Q 005492 502 KVSDFGTSRSVMVD-QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK 561 (694)
Q Consensus 502 kl~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~ 561 (694)
+|+|||.+-.+..- +.......++|-.+--+|+..+..++...|.|.|+.+++-||.|+.
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999998766532 2234566778999999999999999999999999999999999985
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.4e-17 Score=160.97 Aligned_cols=134 Identities=22% Similarity=0.285 Sum_probs=113.9
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEccccCh--------hhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDE--------TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
+.||+|++|.||+|.. ++..+++|+...... .....+.+|+.++..++|++|+....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 577899997543211 1234678899999999999998888888788889999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998643 22 78899999999999999999 99999999999999 78899999998864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.8e-18 Score=181.99 Aligned_cols=241 Identities=21% Similarity=0.319 Sum_probs=160.5
Q ss_pred CCccceeeeeCcEEEEEEEEcCC----cEEEEEEccccChhhHHHHHHHHHHHhhc-cCCcceeEEe-------EEee--
Q 005492 362 YNANRILGQGGQGTVYKGMLTDG----RIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLG-------CCLE-- 427 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g-------~~~~-- 427 (694)
..+.+..+..+++.+......++ ..++-++.+...........+++..+... .|++.+ +.+ ....
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~-~~d~~~s~~~~~~~~~ 324 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSI-LEDLRPSLFESSKRNK 324 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCccc-ccCCCCchhhhccccc
Confidence 34445566666666665553322 33444444433312222233344444444 344333 222 1111
Q ss_pred ---CCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEe
Q 005492 428 ---TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVS 504 (694)
Q Consensus 428 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~ 504 (694)
...++|.|+++...+|.+||.........++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.
T Consensus 325 v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 325 VGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred cccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhh
Confidence 23478999999999999999876555678999999999999999999 67 8999999999999999999999
Q ss_pred ecCCccccccCC-----cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHh-CCCCCccCCCccCccHHHHH
Q 005492 505 DFGTSRSVMVDQ-----THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYF 578 (694)
Q Consensus 505 DFGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 578 (694)
|||+........ ....+...||..||+||.+.+..|+.|+||||||++|+||+. -..++.-.. +
T Consensus 399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t 468 (516)
T KOG1033|consen 399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------T 468 (516)
T ss_pred hhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------h
Confidence 999987665443 223445669999999999999999999999999999999998 222221110 1
Q ss_pred HHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005492 579 LQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628 (694)
Q Consensus 579 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev 628 (694)
..-++.+. +++....+++ .-..|+.+++.+.|.+||++.++
T Consensus 469 ~~d~r~g~----ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 469 LTDIRDGI----IPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hhhhhcCC----CChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHH
Confidence 11122222 2222222222 23479999999999999955443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.2e-17 Score=162.15 Aligned_cols=143 Identities=17% Similarity=0.121 Sum_probs=112.1
Q ss_pred cCCCccceeeeeCcEEEEEEE--EcCCcEEEEEEccccChh------------------------hHHHHHHHHHHHhhc
Q 005492 360 DNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDET------------------------NVEQFINEVVILSQI 413 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 413 (694)
..|.+.+.||+|++|.||+|. ..+|+.||||........ ....+..|+.++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 347888999999999999998 567999999987643210 112356899999999
Q ss_pred cCC--cceeEEeEEeeCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccc
Q 005492 414 NHR--NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSA 491 (694)
Q Consensus 414 ~h~--nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~ 491 (694)
.+. .+.++++. ...+|||||+++.+|..++... ..+.......++.|++.+|++||+.+. |+||||||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChh
Confidence 763 34455543 2358999999998887765322 235666778999999999999999874 999999999
Q ss_pred cEEECCCCcEEEeecCCcccc
Q 005492 492 NILLDDKYRAKVSDFGTSRSV 512 (694)
Q Consensus 492 NIll~~~~~~kl~DFGla~~~ 512 (694)
||+++ ++.++|+|||++...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 789999999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=156.63 Aligned_cols=144 Identities=22% Similarity=0.206 Sum_probs=112.3
Q ss_pred hHHHHhcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccCh----------------------hhHHHHHHHHHHHh
Q 005492 354 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDE----------------------TNVEQFINEVVILS 411 (694)
Q Consensus 354 ~l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~ 411 (694)
++......|...+.||+|+||.||++...+|+.||||+...... .....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 33333344778899999999999999988899999997543210 01123677899999
Q ss_pred hccCCc--ceeEEeEEeeCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccc
Q 005492 412 QINHRN--IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIK 489 (694)
Q Consensus 412 ~l~h~n--Iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIk 489 (694)
.+.|++ +++.++ ....++||||+++++|.+.... .....++.+++.++.++|+.+ |+|||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 998874 444543 3456899999999999775421 234678899999999999998 9999999
Q ss_pred cccEEECCCCcEEEeecCCccccc
Q 005492 490 SANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 490 p~NIll~~~~~~kl~DFGla~~~~ 513 (694)
|+||++++++.++|+|||++....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=180.89 Aligned_cols=138 Identities=19% Similarity=0.259 Sum_probs=112.8
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccc-cC------hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCcc
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKL-VD------ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 431 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~-~~------~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~ 431 (694)
...|...++||+|+||+||+|.+.+...++.++... .. ....+.+.+|++++++++|++++....+..+....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 445567899999999999999876544333222221 11 12245688999999999999999888888888888
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
+|||||+++++|.+++. ....++.|++++|.|||+.+ ++||||||+|||+ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999885 34678999999999999999 9999999999999 677999999999875
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.8e-17 Score=163.69 Aligned_cols=196 Identities=23% Similarity=0.252 Sum_probs=138.1
Q ss_pred cCCcceeEEeEEeeC---------------------------CccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHH
Q 005492 414 NHRNIVKLLGCCLET---------------------------EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV 466 (694)
Q Consensus 414 ~h~nIv~l~g~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 466 (694)
+|||||+++++|.+. ...||||.-.+. +|.+|+..+ ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence 599999999877532 245788887755 899998764 366777788999
Q ss_pred HHHHHHHHHHhcCCCCeeecccccccEEE--CCC--CcEEEeecCCcccccc-----CCcceeeeeecCCCCCCCccccc
Q 005492 467 EVSGALFYLHSAASIPIYHRDIKSANILL--DDK--YRAKVSDFGTSRSVMV-----DQTHLTTKVQGTFGYVDPEYFQS 537 (694)
Q Consensus 467 qia~aL~yLH~~~~~~ivH~DIkp~NIll--~~~--~~~kl~DFGla~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~ 537 (694)
|+++|+.|||.++ |.|||+|++|||| |++ ..+.|+|||.+-.-.. +........-|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999999 333 3579999997642211 11111222347778999999865
Q ss_pred CC------CCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHH
Q 005492 538 SQ------FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLA 611 (694)
Q Consensus 538 ~~------~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li 611 (694)
.+ --.|+|.|+.|.+.||+++...||.....- +.+ .....+ .-....+...+..+.+|+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem----~L~-------~r~Yqe----~qLPalp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM----LLD-------TRTYQE----SQLPALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh----eec-------hhhhhh----hhCCCCcccCChHHHHHH
Confidence 32 235899999999999999999999762211 000 000011 011222344556788999
Q ss_pred HHhcccCCCCCCCHHHHHHHH
Q 005492 612 KRCLNLNGKMRPTMKEVAFEL 632 (694)
Q Consensus 612 ~~cl~~~p~~RPt~~evl~~L 632 (694)
...|+.||++|++..-....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 999999999999876554443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=155.98 Aligned_cols=130 Identities=21% Similarity=0.303 Sum_probs=107.3
Q ss_pred eeeeeCcEEEEEEEEcCCcEEEEEEccccC--------hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeC
Q 005492 367 ILGQGGQGTVYKGMLTDGRIVAVKKSKLVD--------ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 367 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~ 438 (694)
.||+|+||.||+|.+ ++..+++|...... .....++.+|++++..++|+++.....++...+..+|||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 57889999754321 112356788999999999987666665666777789999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
++++|.+++.... . .++.|++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999875421 0 78999999999999999 99999999999999 78999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=8e-17 Score=180.76 Aligned_cols=208 Identities=27% Similarity=0.406 Sum_probs=145.7
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
..+|+.++.|..|++|.||...++. .+.+|+|.-+.. .|+ +||+.+ .+.++.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------------lil-----Rnilt~------a~npfvv--- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------------LIL-----RNILTF------AGNPFVV--- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc------------hhh-----hccccc------cCCccee---
Confidence 3679999999999999999998875 566787533211 011 112211 1222222
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~ 517 (694)
|+-...++.. .+++... +.+++|||+.+ |+|||+||+|.||+.-+++|+.|||+++.......
T Consensus 136 ---gDc~tllk~~---g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKNI---GPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcccC---CCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 3333334332 1233332 78999999999 99999999999999999999999999876532111
Q ss_pred --------------ceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhh
Q 005492 518 --------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN 583 (694)
Q Consensus 518 --------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 583 (694)
.....+.||+.|.|||++....|...+|+|++|+++||.+-|..||.+..+++- +.+.+.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------fg~vis 272 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQVIS 272 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------Hhhhhh
Confidence 112346799999999999999999999999999999999999999998877651 112221
Q ss_pred hcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCC
Q 005492 584 ENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRP 623 (694)
Q Consensus 584 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 623 (694)
.. ....+.....+.+++++|.+.|+.+|..|-
T Consensus 273 d~--------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 DD--------IEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hh--------ccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 11 111111233456788999999999999994
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=7.3e-15 Score=136.69 Aligned_cols=135 Identities=23% Similarity=0.211 Sum_probs=115.1
Q ss_pred ccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccC--CcceeEEeEEeeCCccEEEEEeCCCC
Q 005492 364 ANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFIPNG 441 (694)
Q Consensus 364 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~g~~~~~~~~~lv~e~~~~g 441 (694)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999865 7899998765433 5678999999999977 58999999988888899999999987
Q ss_pred ChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 442 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 442 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
.+..+ +......++.+++++|++||......++|+|++|+||++++.+.++++|||+++.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77653 4566778899999999999997544599999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.3e-15 Score=143.19 Aligned_cols=136 Identities=21% Similarity=0.246 Sum_probs=99.2
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEccccCh--hhHHHH----------------------HHHHHHHhhccCCc--c
Q 005492 365 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDE--TNVEQF----------------------INEVVILSQINHRN--I 418 (694)
Q Consensus 365 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~----------------------~~E~~~l~~l~h~n--I 418 (694)
.+.||+|+||+||+|...+++.||||....... .....+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 468999999999999988899999998654221 111111 35666666665443 4
Q ss_pred eeEEeEEeeCCccEEEEEeCCCCChHHH-HhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecccccccEEEC
Q 005492 419 VKLLGCCLETEVPLLVYEFIPNGTLYQY-IHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLD 496 (694)
Q Consensus 419 v~l~g~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivH~DIkp~NIll~ 496 (694)
.+.+++ ...+|||||++++++... +... . .. .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-h---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence 455543 346899999999554321 1111 0 11 5678899999999999999 88 99999999999999
Q ss_pred CCCcEEEeecCCccccc
Q 005492 497 DKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 497 ~~~~~kl~DFGla~~~~ 513 (694)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.9e-14 Score=143.58 Aligned_cols=135 Identities=19% Similarity=0.278 Sum_probs=106.1
Q ss_pred cceee-eeCcEEEEEEEEcCCcEEEEEEcccc-------------ChhhHHHHHHHHHHHhhccCCcc--eeEEeEEeeC
Q 005492 365 NRILG-QGGQGTVYKGMLTDGRIVAVKKSKLV-------------DETNVEQFINEVVILSQINHRNI--VKLLGCCLET 428 (694)
Q Consensus 365 ~~~LG-~G~~g~Vy~~~~~~~~~vavK~~~~~-------------~~~~~~~~~~E~~~l~~l~h~nI--v~l~g~~~~~ 428 (694)
...|| .||.|+||++... +..++||+.... .......+.+|+.++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 8999999999875 677888876421 11234567889999999998875 7777775543
Q ss_pred Cc----cEEEEEeCCC-CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEE
Q 005492 429 EV----PLLVYEFIPN-GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV 503 (694)
Q Consensus 429 ~~----~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl 503 (694)
.. .+||||++++ .+|.+++... +++.. .+.|++.+|.+||+.+ |+||||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 32 3599999997 6999988642 35544 3568999999999999 999999999999999889999
Q ss_pred eecCCccc
Q 005492 504 SDFGTSRS 511 (694)
Q Consensus 504 ~DFGla~~ 511 (694)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.4e-16 Score=175.36 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=189.7
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC--CcEEEEEEccccC--hhhHHHHHHHHHHHhhcc-CCcceeEEeEEeeCCccEEE
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD--GRIVAVKKSKLVD--ETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lv 434 (694)
..|...+.||+|+|+.|-...... ...+|+|...... ....+....|..+-+.+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 457777889999999998887643 4556777655432 333445556788877886 99999999999999999999
Q ss_pred EEeCCCCChHHHH-hcccCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeecccccccEEECCCC-cEEEeecCCccc
Q 005492 435 YEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALFYLH-SAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRS 511 (694)
Q Consensus 435 ~e~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~ivH~DIkp~NIll~~~~-~~kl~DFGla~~ 511 (694)
.+|..++++.+.+ +... ...+....-..+.|+..+|.|+| ..+ +.|+||||+|.+++..+ ..|++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999988 4332 13666677789999999999999 888 99999999999999999 999999999988
Q ss_pred ccc-CC-cceeeeeec-CCCCCCCcccccC-CCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcch
Q 005492 512 VMV-DQ-THLTTKVQG-TFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 587 (694)
Q Consensus 512 ~~~-~~-~~~~~~~~g-t~~y~aPE~~~~~-~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (694)
+.. +. ........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......... ...|. +.+.
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~-----~~~~ 248 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWK-----SNKG 248 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeec-----cccc
Confidence 765 22 233345568 9999999999874 5678899999999999999999999765543311 11110 0000
Q ss_pred hhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005492 588 FEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVA 629 (694)
Q Consensus 588 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl 629 (694)
... ............+++.+++..+|..|.+.+++.
T Consensus 249 --~~~----~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 249 --RFT----QLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred --ccc----cCccccCChhhhhcccccccCCchhcccccccc
Confidence 000 001112223466788889999999999987754
|
|
| >PF08488 WAK: Wall-associated kinase; InterPro: IPR013695 This domain is found together with the eukaryotic protein kinase domain IPR000719 from INTERPRO in plant wall-associated kinases (WAKs) and related proteins | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.6e-14 Score=122.07 Aligned_cols=97 Identities=23% Similarity=0.467 Sum_probs=70.7
Q ss_pred CCcccccccCC--CCc-ceeEEeeeeecccc-ccccceeEEEEeecccccccccCChhhhhcccCcccEEEEEEeeecCc
Q 005492 124 RGCYDFLCALS--PNI-THIFNADLSYFYSQ-NISQKCRSVSVVEENWVGSKYLENPRVLKQQARGIPAMLDWGEEIGSC 199 (694)
Q Consensus 124 ~~C~g~gCC~~--~~~-~~~~~~~~~~~~~~-~~~~~c~~a~~~e~~~~~~~~~~~~~~~~~~~~~vp~vldW~i~~~~C 199 (694)
..|+|++|||+ |.+ ++.+.+++...+.. ....+|++|||+|++||.++ +.+++. .+..+.|||+|+|+|...++
T Consensus 2 ~~CsG~~CCQt~iP~~~~qv~~~~i~~~~~~~~~~~~Ck~AFL~d~~~~~~n-~t~p~~-~~~~~y~pv~L~W~i~t~~~ 79 (103)
T PF08488_consen 2 SSCSGIGCCQTSIPSGLLQVFNVTIESTDGNNQTSNGCKVAFLVDEDWFSSN-ITDPED-FHAMGYVPVVLDWFIDTSDS 79 (103)
T ss_pred CccCCcceeccCCCCCCceEEEEEeEecCCCcccCCCceEEEEecccccccc-CCChHH-hccCCeeEEEEEEEEecCCc
Confidence 46999999999 665 67899998876553 34589999999999999766 555553 45678899999999975433
Q ss_pred ccccCCCccccCCCCCcccccCCCceEEEcc
Q 005492 200 FEEFSSYSTICGDRENGCSIKLSSGYICRCD 230 (694)
Q Consensus 200 ~~~~~~~~~aC~~~~s~c~~~~~~gy~C~C~ 230 (694)
. ...+++|..+. . .+ ...+|.|.
T Consensus 80 ~---~~~s~~C~~~~-~-y~---~~~~C~C~ 102 (103)
T PF08488_consen 80 S---FSNSLACKNNT-E-YS---SSNRCSCS 102 (103)
T ss_pred C---cCcCccCCCce-e-cc---CCCcEeCC
Confidence 2 22358898766 2 11 12389986
|
WAKs are serine-threonine kinases which might be involved in signalling to the cytoplasm and are required for cell expansion []. ; GO: 0004674 protein serine/threonine kinase activity, 0016021 integral to membrane |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=6.7e-14 Score=138.77 Aligned_cols=205 Identities=19% Similarity=0.262 Sum_probs=142.8
Q ss_pred HHHHHhhccCCcceeEEeEEeeCC-----ccEEEEEeCCCCChHHHHhcc-cCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 005492 406 EVVILSQINHRNIVKLLGCCLETE-----VPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYLHSAA 479 (694)
Q Consensus 406 E~~~l~~l~h~nIv~l~g~~~~~~-----~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~ 479 (694)
-+..|-++-|.|||+++.|+.+.. +..++.|||..|+|..+|++. .....+......+|+.||+.||.|||+..
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 345566778999999999987543 467899999999999999873 33446888899999999999999999986
Q ss_pred CCCeeecccccccEEECCCCcEEEeecCCccccccC---CcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHH
Q 005492 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD---QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEI 556 (694)
Q Consensus 480 ~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~el 556 (694)
|||+|+++..+-|++..++-+|+.----......- .........+-++|.+||+=.....+-++|||+||+..+||
T Consensus 197 -PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 -PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred -CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 67999999999999999998888432111000000 00011123367899999998888888999999999999999
Q ss_pred HhCCCC-CccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005492 557 LTGQKP-IRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 557 ltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.-+..- -......+...-.. +.+...- ...-+.++..|++..|..||+|++++.+
T Consensus 276 ailEiq~tnseS~~~~ee~ia--------~~i~~le------------n~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIA--------NVIIGLE------------NGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHheeccCCCcceeehhhhhh--------hheeecc------------CccccCcCcccccCCCCCCcchhhhhcC
Confidence 876532 11111111000000 0000000 0112357889999999999999988654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.6e-13 Score=145.23 Aligned_cols=141 Identities=19% Similarity=0.166 Sum_probs=101.5
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEccccChhh----------------------------------------HHHHH
Q 005492 365 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETN----------------------------------------VEQFI 404 (694)
Q Consensus 365 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~ 404 (694)
.+.||.|++|.||+|++++|+.||||..+...... .-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999865421111 01245
Q ss_pred HHHHHHhhcc----CCcceeEEeEEe-eCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHH-HHHHHHhc
Q 005492 405 NEVVILSQIN----HRNIVKLLGCCL-ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG-ALFYLHSA 478 (694)
Q Consensus 405 ~E~~~l~~l~----h~nIv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-aL~yLH~~ 478 (694)
+|+..+.+++ |.+-+.+-.++. .....+|||||++|++|.+++...... . .+..++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhC
Confidence 5666666652 333233323332 245679999999999999887542111 2 23456666666 47889999
Q ss_pred CCCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 479 ~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
+ ++|+|++|.||+++++++++|+|||++..+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 9999999999999999999999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=9.2e-13 Score=142.00 Aligned_cols=248 Identities=22% Similarity=0.282 Sum_probs=181.6
Q ss_pred cCCCccceeee--eCcEEEEEEEE---cCCcEEEEEEccccC--hhhHHHHHHHHHHHhhc-cCCcceeEEeEEeeCCcc
Q 005492 360 DNYNANRILGQ--GGQGTVYKGML---TDGRIVAVKKSKLVD--ETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP 431 (694)
Q Consensus 360 ~~f~~~~~LG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~ 431 (694)
..|...+.+|. |.+|.||.+.. .++..+|+|+-+.-. ......=++|+.....+ .|+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45677888999 99999999987 348899999855422 23333345566666666 499999988888899999
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeecccccccEEECCC-CcEEEeec
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG----ALFYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDF 506 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----aL~yLH~~~~~~ivH~DIkp~NIll~~~-~~~kl~DF 506 (694)
++-+|++. .+|.++.+.... .++...++....+..+ ||.++|... ++|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999885 788888876543 2677778888888888 999999999 9999999999999999 88999999
Q ss_pred CCccccccCCcce----eeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHh
Q 005492 507 GTSRSVMVDQTHL----TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 582 (694)
Q Consensus 507 Gla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 582 (694)
|+...+....-.. .....|...|++||... +.++.++|+|+||.++++..++..+........ +..+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W~~~ 338 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS--------WSQL 338 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC--------cccc
Confidence 9998876544221 12225788999999875 677899999999999999999876543221110 0001
Q ss_pred hhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005492 583 NENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAF 630 (694)
Q Consensus 583 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 630 (694)
+... +..++......++..++..+++.+|..|++.+.+..
T Consensus 339 r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 RQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1100 111122222334555899999999999998877654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.4e-11 Score=117.57 Aligned_cols=130 Identities=22% Similarity=0.129 Sum_probs=97.4
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcce-eEEeEEeeCCccEEEEEeCCCCCh
Q 005492 365 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV-KLLGCCLETEVPLLVYEFIPNGTL 443 (694)
Q Consensus 365 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~g~~~~~~~~~lv~e~~~~gsL 443 (694)
.+.|+.|.++.||++... +..+++|....... ....+..|+.+++.+.+.+++ +++.+. .+..++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 457889999999999875 77899998654321 234567899999998765554 454443 3446899999999887
Q ss_pred HHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecccccccEEECCCCcEEEeecCCcc
Q 005492 444 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA--SIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 444 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~ivH~DIkp~NIll~~~~~~kl~DFGla~ 510 (694)
.+.. . ....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6530 1 11245679999999999987 22359999999999999 5689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5e-11 Score=129.73 Aligned_cols=165 Identities=19% Similarity=0.210 Sum_probs=127.8
Q ss_pred cCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHH
Q 005492 382 TDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELL 461 (694)
Q Consensus 382 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~ 461 (694)
.++.+|.|...+.......+...+-++.|+.++||||++++....++...|||+|-+ ..|..++.+ +....+
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHHH
Confidence 357778887776655555667788899999999999999999999999999999988 467778765 346667
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcceeeeeecCCCCCCCcccccCCCC
Q 005492 462 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 541 (694)
Q Consensus 462 ~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t 541 (694)
...+.||+.||.|||+.+. ++|++|.-..|++++.|..||++|.++........ ......--..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence 7789999999999997664 99999999999999999999999988754321111 111111223466676554322
Q ss_pred ceeeEEehhHHHHHHHhC
Q 005492 542 EKSDVYSFGVVLVEILTG 559 (694)
Q Consensus 542 ~~sDvwSlGvll~elltg 559 (694)
-..|.|.||++++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 456999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.7e-11 Score=133.05 Aligned_cols=144 Identities=17% Similarity=0.166 Sum_probs=96.0
Q ss_pred cCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccChh------------------------------h----HH---
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET------------------------------N----VE--- 401 (694)
Q Consensus 360 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~------------------------------~----~~--- 401 (694)
..|+. +.||.|++|.||+|.+++ |+.||||.....-.. . .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 789999999999999988 999999987632110 0 11
Q ss_pred ---HHHHHHHHHhhcc----CCcceeEEeEEee-CCccEEEEEeCCCCChHHHH--hccc-CCCCCCHHHHHHHHHHHHH
Q 005492 402 ---QFINEVVILSQIN----HRNIVKLLGCCLE-TEVPLLVYEFIPNGTLYQYI--HNQI-EEFPITWELLLRIAVEVSG 470 (694)
Q Consensus 402 ---~~~~E~~~l~~l~----h~nIv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~-~~~~l~~~~~~~i~~qia~ 470 (694)
+|.+|+..+.+++ +.+.+.+=.++.+ ....+|||||++|+.|.++- .... +...+....+..++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 2344555555542 3444444444433 45678999999999998753 2211 1112333333333344
Q ss_pred HHHHHHhcCCCCeeecccccccEEECCCC----cEEEeecCCcccccc
Q 005492 471 ALFYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFGTSRSVMV 514 (694)
Q Consensus 471 aL~yLH~~~~~~ivH~DIkp~NIll~~~~----~~kl~DFGla~~~~~ 514 (694)
++..| ++|+|+||.||+++.++ ++++.|||++..+..
T Consensus 276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34567 99999999999999887 999999999887643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.6e-10 Score=107.13 Aligned_cols=135 Identities=16% Similarity=0.135 Sum_probs=98.7
Q ss_pred ceeeeeCcEEEEEEEEcC-------CcEEEEEEcccc-------------C---------hhhHHHHH----HHHHHHhh
Q 005492 366 RILGQGGQGTVYKGMLTD-------GRIVAVKKSKLV-------------D---------ETNVEQFI----NEVVILSQ 412 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~~----~E~~~l~~ 412 (694)
..||.|--+.||.|...+ +..+|||..+.. + ....+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 478999953211 0 11122333 79999999
Q ss_pred ccC--CcceeEEeEEeeCCccEEEEEeCCCCChHH-HHhcccCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeccc
Q 005492 413 INH--RNIVKLLGCCLETEVPLLVYEFIPNGTLYQ-YIHNQIEEFPITWELLLRIAVEVSGALFYL-HSAASIPIYHRDI 488 (694)
Q Consensus 413 l~h--~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~ivH~DI 488 (694)
+.. -++.+++++ ..-+|||||+.+..+.. .+++ ..++......+..+++.+|..| |..+ |+|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 853 566777764 56789999997754422 2222 1355566778889999999999 8888 999999
Q ss_pred ccccEEECCCCcEEEeecCCcccc
Q 005492 489 KSANILLDDKYRAKVSDFGTSRSV 512 (694)
Q Consensus 489 kp~NIll~~~~~~kl~DFGla~~~ 512 (694)
++.|||+++ +.++|+|||.+-..
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeC
Confidence 999999974 57999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.8e-10 Score=112.50 Aligned_cols=143 Identities=19% Similarity=0.219 Sum_probs=112.3
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEccccCh-hhHHHHHHHHHHHhhccC--CcceeEEeEEeeCC---ccEEEEEeC
Q 005492 365 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDE-TNVEQFINEVVILSQINH--RNIVKLLGCCLETE---VPLLVYEFI 438 (694)
Q Consensus 365 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~nIv~l~g~~~~~~---~~~lv~e~~ 438 (694)
.+.|+.|..+.||++...+|+.+++|....... .....+..|+.+++.+++ .++.+++.+..+.. ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 357899999999999987778999998764322 245678899999999976 44677887776543 568999999
Q ss_pred CCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA--------------------------------------- 479 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--------------------------------------- 479 (694)
++.+|.+.+.. ..++...+..++.+++++|..||+..
T Consensus 83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99988876532 13777888888999999999998531
Q ss_pred --------------CCCeeecccccccEEECC--CCcEEEeecCCccc
Q 005492 480 --------------SIPIYHRDIKSANILLDD--KYRAKVSDFGTSRS 511 (694)
Q Consensus 480 --------------~~~ivH~DIkp~NIll~~--~~~~kl~DFGla~~ 511 (694)
...++|+|++|.||++++ +..+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234799999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.4e-10 Score=116.94 Aligned_cols=167 Identities=23% Similarity=0.368 Sum_probs=128.7
Q ss_pred EEEEEEEE-cCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcceeEEeEEe----eCCccEEEEEeCCC-CChHHHH
Q 005492 374 GTVYKGML-TDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCL----ETEVPLLVYEFIPN-GTLYQYI 447 (694)
Q Consensus 374 g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~----~~~~~~lv~e~~~~-gsL~~~l 447 (694)
.+.|++.. .||..|++||++............-+++++++.|+|||++.+++. .+..++|||+|.|+ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 57788884 479999999995443333334455688999999999999999887 33467899999986 5787765
Q ss_pred hcccC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 448 HNQIE------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 448 ~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
..... ...+++..+|.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 43211 124678999999999999999999999 888999999999999999999999887665443
Q ss_pred CcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCC
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK 561 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~ 561 (694)
.. |.+.. -.+-|.=.||.+++.|.||..
T Consensus 447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 447 PT---------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC---------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 31 11111 235677789999999999964
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.3e-11 Score=131.27 Aligned_cols=261 Identities=19% Similarity=0.223 Sum_probs=184.9
Q ss_pred cccccChhh-HHHHhcCCCccceeeeeCcEEEEEEEEc--CCcEEEEEEccccChhhHHH--HHHHHHHHhhc-cCCcce
Q 005492 346 KTKLFTSKD-LEKATDNYNANRILGQGGQGTVYKGMLT--DGRIVAVKKSKLVDETNVEQ--FINEVVILSQI-NHRNIV 419 (694)
Q Consensus 346 ~~~~~~~~~-l~~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~nIv 419 (694)
..++|..++ ....+.+|..+..||.|.|+.|++...+ ++..+++|.+.........+ -+.|+.+...+ .|.+++
T Consensus 250 p~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 250 PANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred hhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccC
Confidence 345555555 4455678999999999999999987754 47789999876533332222 24566666666 589999
Q ss_pred eEEeEEeeCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCC-
Q 005492 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK- 498 (694)
Q Consensus 420 ~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~- 498 (694)
.....+...+..++=.||++++++...+.- ...+.+..++++..|++.++.++|+.. ++|+|+||+||++..+
T Consensus 330 g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~ 403 (524)
T KOG0601|consen 330 GKNSSWSQLRQGYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDG 403 (524)
T ss_pred CCCCCccccccccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccch
Confidence 988888888888899999999988777632 234788889999999999999999988 9999999999999875
Q ss_pred CcEEEeecCCccccccCCcceeeeeecCCCC-CCCcccccCCCCceeeEEehhHHHHHHHhCCCC-CccCCCccCccHHH
Q 005492 499 YRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY-VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP-IRAINTDEDKSLVG 576 (694)
Q Consensus 499 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p-~~~~~~~~~~~~~~ 576 (694)
+..++.|||.+..+.... ......+..| .+|+......+-.+.|++|||.-+.|.+++..- ......
T Consensus 404 ~~~~~~~~~~~t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-------- 472 (524)
T KOG0601|consen 404 FFSKLGDFGCWTRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-------- 472 (524)
T ss_pred hhhhccccccccccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc--------
Confidence 888999999886422111 1111122334 366667778889999999999999999998642 111111
Q ss_pred HHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 005492 577 YFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636 (694)
Q Consensus 577 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~l~ 636 (694)
..+..+.. ...+ .....+..+.+.++..++..||.+.++..+.+..+
T Consensus 473 ---~~i~~~~~---------p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 473 ---LTIRSGDT---------PNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ---eeeecccc---------cCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 01111111 0111 11245677888999999999999988776655443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=5.3e-11 Score=134.71 Aligned_cols=251 Identities=23% Similarity=0.269 Sum_probs=171.3
Q ss_pred HHHhcCCCccceeeeeCcEEEEEEEEcC-CcEEEEEEccccC---hhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCcc
Q 005492 356 EKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 431 (694)
Q Consensus 356 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~ 431 (694)
....+.|.+.+-+-+|.++.++.+.-.. |...++|...... ..+.+..+.+-.++-..+||-++...--+.-....
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 3445778888888999999999876432 5445555433221 11222222222222222334444443334456678
Q ss_pred EEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
.||++|..+++|...|+... .++..........+..+++|||... +.|+|++|.|+|+..++..+++|||+...
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred chhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence 89999999999999998754 3555556667778889999999987 89999999999999999999999984332
Q ss_pred cccC-----C-------------------------cceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCC
Q 005492 512 VMVD-----Q-------------------------THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK 561 (694)
Q Consensus 512 ~~~~-----~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~ 561 (694)
...- . ........+|+.|.+||.+.+......+|+|++|+.++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 2100 0 001123458999999999999999999999999999999999999
Q ss_pred CCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005492 562 PIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMK 626 (694)
Q Consensus 562 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 626 (694)
||.....+.. + +-+-...+ .+...+.+...+..+++.+.+..+|.+|-.|.
T Consensus 1034 p~na~tpq~~------f-~ni~~~~~-------~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQI------F-ENILNRDI-------PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchhhh------h-hccccCCC-------CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9987665431 1 11100000 01222334455678899999999999997776
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.8e-09 Score=97.71 Aligned_cols=143 Identities=22% Similarity=0.267 Sum_probs=108.4
Q ss_pred ccceeeeeCcEEEEEEEEcCCcEEEEEEccc--c------ChhhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEE
Q 005492 364 ANRILGQGGQGTVYKGMLTDGRIVAVKKSKL--V------DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 364 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~--~------~~~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~ 435 (694)
....|-+|+-+.|+++.+. |+...||.-.. . ..-....-++|+++|.++.--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999885 77777774221 1 1122456788999999987656555555667777778999
Q ss_pred EeCCC-CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCC---cEEEeecCCccc
Q 005492 436 EFIPN-GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY---RAKVSDFGTSRS 511 (694)
Q Consensus 436 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~---~~kl~DFGla~~ 511 (694)
||+++ .++.+++....... ........++.+|-+.+.-||..+ |+|+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 57889988765432 333334788999999999999999 99999999999996443 468999999853
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.7e-09 Score=98.40 Aligned_cols=131 Identities=22% Similarity=0.269 Sum_probs=100.8
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEE-ccc-cCh------hhHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEe
Q 005492 366 RILGQGGQGTVYKGMLTDGRIVAVKK-SKL-VDE------TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~~~~vavK~-~~~-~~~------~~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~ 437 (694)
..+++|+-+.+|.+.+. |..+++|. ..+ ... -..+.-.+|+.++.+++--.|.-..=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999775 44466663 222 111 1234457799999999766665555566778888999999
Q ss_pred CCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccc
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
+++..|.+++... ...++..+-..+.-||..+ |+|+||.++||++.... +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999998754 2457777888888899999 99999999999998775 99999999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=5.1e-08 Score=99.43 Aligned_cols=140 Identities=15% Similarity=0.095 Sum_probs=100.2
Q ss_pred eeeeeCcEEEEEEEEcCCcEEEEEEccccChh-----------hHHHHHHHHHHHhhccCCc--ceeEEeEEeeC-----
Q 005492 367 ILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET-----------NVEQFINEVVILSQINHRN--IVKLLGCCLET----- 428 (694)
Q Consensus 367 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n--Iv~l~g~~~~~----- 428 (694)
.+-.-....|++..+ +|+.+.||+....... ....+.+|...+.++...+ .++++++....
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333344667655 5778999965432211 1124778999998885433 34556665432
Q ss_pred CccEEEEEeCCCC-ChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECC-------CCc
Q 005492 429 EVPLLVYEFIPNG-TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-------KYR 500 (694)
Q Consensus 429 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~-------~~~ 500 (694)
..-+||+|++++. +|.+++..... .+.+......++.+++..+.-||..| |+|+|++++|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 3468999999986 89999864321 23566778899999999999999999 999999999999975 578
Q ss_pred EEEeecCCccc
Q 005492 501 AKVSDFGTSRS 511 (694)
Q Consensus 501 ~kl~DFGla~~ 511 (694)
+.|+||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.6e-08 Score=97.16 Aligned_cols=125 Identities=26% Similarity=0.271 Sum_probs=83.3
Q ss_pred EEEEEEEcCCcEEEEEEcccc--------------Ch------------hhHHHHHHHHHHHhhccCC--cceeEEeEEe
Q 005492 375 TVYKGMLTDGRIVAVKKSKLV--------------DE------------TNVEQFINEVVILSQINHR--NIVKLLGCCL 426 (694)
Q Consensus 375 ~Vy~~~~~~~~~vavK~~~~~--------------~~------------~~~~~~~~E~~~l~~l~h~--nIv~l~g~~~ 426 (694)
.||.|...+|..+|||.-+.. .. .......+|++.|.++... ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999999999999953321 00 0123457799999999765 566776552
Q ss_pred eCCccEEEEEeCC--CCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeeecccccccEEECCCCcEEE
Q 005492 427 ETEVPLLVYEFIP--NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY-LHSAASIPIYHRDIKSANILLDDKYRAKV 503 (694)
Q Consensus 427 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~y-LH~~~~~~ivH~DIkp~NIll~~~~~~kl 503 (694)
.-.|||||++ +..+..+.... ++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 4579999998 65555443322 2234456677788885555 57888 9999999999999988 9999
Q ss_pred eecCCcccc
Q 005492 504 SDFGTSRSV 512 (694)
Q Consensus 504 ~DFGla~~~ 512 (694)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.4e-07 Score=97.64 Aligned_cols=265 Identities=18% Similarity=0.179 Sum_probs=159.0
Q ss_pred CccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhc-cCCcceeEEeE------Ee-eCCccEEE
Q 005492 363 NANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGC------CL-ETEVPLLV 434 (694)
Q Consensus 363 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~g~------~~-~~~~~~lv 434 (694)
...+.||+|+-+.+|..--- +. -+-|+...-......+.. ..|... .||-+-.-+.+ .- .....-++
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchh-hc-hhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 34678999999999964321 11 223433332222222222 222222 45533221111 01 11225577
Q ss_pred EEeCCCCC-hHHHHhc---ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCcc
Q 005492 435 YEFIPNGT-LYQYIHN---QIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 435 ~e~~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~ 510 (694)
|+.+++.- +..++.- ...-....|+.+++.++.+|.+.+-||..| .+-+|+.++|+|+.++..+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 77776642 3333322 222234789999999999999999999999 8889999999999999999999854332
Q ss_pred ccccCCcceeeeeecCCCCCCCcccc-----cCCCCceeeEEehhHHHHHHHhC-CCCCccCCCccCccHHHHHHHHhhh
Q 005492 511 SVMVDQTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTG-QKPIRAINTDEDKSLVGYFLQAINE 584 (694)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~ 584 (694)
.. .......-..|...|++||... +..-+...|-|.||+++++|+.| +.||.+.....+.--. ....+..
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p--~E~~Ia~ 241 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP--LETDIAH 241 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc--chhhhhc
Confidence 22 2222333456889999999764 34457789999999999999996 9999875432111000 0011122
Q ss_pred cchhhhhhhhh-----hhhh-hHHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHhcccccc
Q 005492 585 NRLFEILDARV-----LKEA-KKEGIMTVATLAKRCLNLN--GKMRPTMKEVAFELGGIRTST 639 (694)
Q Consensus 585 ~~~~~~~d~~~-----~~~~-~~~~~~~l~~li~~cl~~~--p~~RPt~~evl~~L~~l~~~~ 639 (694)
+.+...-+.+. ..+. ....++.+..|..+|+... +.-||+++.++..|..++.+.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 22211111111 0011 1233456788888888654 568999999998887776654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=6.7e-09 Score=113.88 Aligned_cols=152 Identities=24% Similarity=0.300 Sum_probs=104.0
Q ss_pred HHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCc--------ceeeeeecCCCCCCCcccc
Q 005492 465 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT--------HLTTKVQGTFGYVDPEYFQ 536 (694)
Q Consensus 465 ~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~--------~~~~~~~gt~~y~aPE~~~ 536 (694)
+.+++.||.|+|...+ +||++|.|++|.++.++..||..|+.+........ ...........|.|||++.
T Consensus 105 l~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3445699999998764 99999999999999999999999998654432111 1111233567899999999
Q ss_pred cCCCCceeeEEehhHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcc
Q 005492 537 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLN 616 (694)
Q Consensus 537 ~~~~t~~sDvwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~ 616 (694)
....+.++|+||||+++|.+..|..+........ +. +... ...+..-........+.++.+=+.+++.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~---~~-~~~~--------~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL---LS-YSFS--------RNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCc---ch-hhhh--------hcccccccccccccCcHHHHHHHHHHhc
Confidence 9999999999999999999996555432221111 00 0000 0000000111123556778888999999
Q ss_pred cCCCCCCCHHHHHH
Q 005492 617 LNGKMRPTMKEVAF 630 (694)
Q Consensus 617 ~~p~~RPt~~evl~ 630 (694)
.++..||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998877653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.3e-07 Score=89.52 Aligned_cols=107 Identities=19% Similarity=0.203 Sum_probs=86.1
Q ss_pred HHHHHHHHHHHhhccC--CcceeEEeEEeeCC----ccEEEEEeCCCC-ChHHHHhcccCCCCCCHHHHHHHHHHHHHHH
Q 005492 400 VEQFINEVVILSQINH--RNIVKLLGCCLETE----VPLLVYEFIPNG-TLYQYIHNQIEEFPITWELLLRIAVEVSGAL 472 (694)
Q Consensus 400 ~~~~~~E~~~l~~l~h--~nIv~l~g~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL 472 (694)
.....+|...+..+.. -..++.+++..... ..+||+|++++. +|.+++..... ++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 4567888888888853 34566777766543 347999999984 89999876322 56677889999999999
Q ss_pred HHHHhcCCCCeeecccccccEEECCCC---cEEEeecCCcccc
Q 005492 473 FYLHSAASIPIYHRDIKSANILLDDKY---RAKVSDFGTSRSV 512 (694)
Q Consensus 473 ~yLH~~~~~~ivH~DIkp~NIll~~~~---~~kl~DFGla~~~ 512 (694)
+-||..+ |+|+|+++.|||++.+. .+.|+||+.++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 99999999999998876 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=9.3e-07 Score=87.47 Aligned_cols=134 Identities=22% Similarity=0.208 Sum_probs=95.7
Q ss_pred CCccceeeeeCcEEEEEEEEcCCcEEEEEEccccC----------------------hhhHHHHHHHHHHHhhccCC--c
Q 005492 362 YNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD----------------------ETNVEQFINEVVILSQINHR--N 417 (694)
Q Consensus 362 f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--n 417 (694)
..+..+||.|--+.||.|...+|.++|||.-+... ........+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45668999999999999999999999999422110 01123456799999998654 6
Q ss_pred ceeEEeEEeeCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECC
Q 005492 418 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD 497 (694)
Q Consensus 418 Iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~ 497 (694)
+.+.+++ +.-.+||||+++-.|...- ++....-.++..|++-+.-+-..| |+|+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 6666543 4557999999986665532 122333344444444444444677 999999999999999
Q ss_pred CCcEEEeecCCcc
Q 005492 498 KYRAKVSDFGTSR 510 (694)
Q Consensus 498 ~~~~kl~DFGla~ 510 (694)
++.+.++||--+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999997554
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.2e-06 Score=81.85 Aligned_cols=139 Identities=17% Similarity=0.123 Sum_probs=103.5
Q ss_pred eeeeCcEEEEEEEEcCCcEEEEEEccc-c-----ChhhHHHHHHHHHHHhhccC--CcceeEEeEEeeCC----ccEEEE
Q 005492 368 LGQGGQGTVYKGMLTDGRIVAVKKSKL-V-----DETNVEQFINEVVILSQINH--RNIVKLLGCCLETE----VPLLVY 435 (694)
Q Consensus 368 LG~G~~g~Vy~~~~~~~~~vavK~~~~-~-----~~~~~~~~~~E~~~l~~l~h--~nIv~l~g~~~~~~----~~~lv~ 435 (694)
-|+||-+.|+..... |..+-+|+-.. . -+-....|.+|+..|.++.. -.+.+++.+..... .-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467899999997765 44788887542 1 13356789999999999953 33555552222221 357999
Q ss_pred EeCCC-CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCc--EEEeecCCccc
Q 005492 436 EFIPN-GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR--AKVSDFGTSRS 511 (694)
Q Consensus 436 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~--~kl~DFGla~~ 511 (694)
|-+++ -+|.+++.+.. ..+.+...+..+..+++..|+-||+.+ +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 58999886542 224677888899999999999999999 999999999999986666 99999976654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.2e-06 Score=94.66 Aligned_cols=140 Identities=19% Similarity=0.207 Sum_probs=91.9
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEccccChhh------------------------------HH----------HHHH
Q 005492 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETN------------------------------VE----------QFIN 405 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~----------~~~~ 405 (694)
+-|+.++-|.||+|++++|+.||||.....-... .+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6789999999999999999999999644321100 11 2344
Q ss_pred HHHHHhhcc-----CCcceeEEeEEe-eCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 005492 406 EVVILSQIN-----HRNIVKLLGCCL-ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479 (694)
Q Consensus 406 E~~~l~~l~-----h~nIv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~ 479 (694)
|...+.+++ .++| ++=.++. -.....|+|||++|..+.+...-... .++.+.+.....++. +..+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~ia~~~~~~f--~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKELAELLVRAF--LRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHHHHHHHHHHH--HHHHHhcC
Confidence 555555552 2332 2222333 35677899999999999888432221 244333332222221 22333356
Q ss_pred CCCeeecccccccEEECCCCcEEEeecCCccccc
Q 005492 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 480 ~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~ 513 (694)
++|.|.+|.||+++.++++-+.|||+...+.
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999987664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.35 E-value=6.9e-06 Score=82.05 Aligned_cols=138 Identities=17% Similarity=0.156 Sum_probs=85.3
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCc--ceeEEeEEeeCCccEEEEEeCCCCC-
Q 005492 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRN--IVKLLGCCLETEVPLLVYEFIPNGT- 442 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~g~~~~~~~~~lv~e~~~~gs- 442 (694)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++..+.+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999983 24567788765422 3455788999999986544 4677888877778889999999963
Q ss_pred hHHHH---------------------hcccCCCCCCHHHHH-HHHH----------HHHH-HHHHHHhc-CCCCeeeccc
Q 005492 443 LYQYI---------------------HNQIEEFPITWELLL-RIAV----------EVSG-ALFYLHSA-ASIPIYHRDI 488 (694)
Q Consensus 443 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~----------qia~-aL~yLH~~-~~~~ivH~DI 488 (694)
+...+ |.. ........... ++-. .+.+ ...+|... ..+.++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~-~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHST-KCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCC-CCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 22111 110 00001111100 0000 0111 12222211 1234789999
Q ss_pred ccccEEECCCCcEEEeecCCcc
Q 005492 489 KSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 489 kp~NIll~~~~~~kl~DFGla~ 510 (694)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.2e-05 Score=78.15 Aligned_cols=137 Identities=18% Similarity=0.215 Sum_probs=90.5
Q ss_pred hcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHH---------HHHHHHHhhccC---CcceeEEeEEe
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQF---------INEVVILSQINH---RNIVKLLGCCL 426 (694)
Q Consensus 359 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h---~nIv~l~g~~~ 426 (694)
..+|...+++-......|.+-.. +|..+++|..........+.| .+++..+..++. ..+..++-+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 46777777777777666766655 478899997665333322222 233444444432 23333333322
Q ss_pred -----eCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcE
Q 005492 427 -----ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA 501 (694)
Q Consensus 427 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~ 501 (694)
-....+|+|||++|..|.++.. +++ .++..++++|.-||..| ++|+|..|.|+++++++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence 2234568999999988877542 222 35566778899999999 99999999999999664 9
Q ss_pred EEeecCCccc
Q 005492 502 KVSDFGTSRS 511 (694)
Q Consensus 502 kl~DFGla~~ 511 (694)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.8e-05 Score=79.31 Aligned_cols=143 Identities=22% Similarity=0.242 Sum_probs=85.6
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCC--cceeEEeEEeeC---CccEEEEEeCC
Q 005492 365 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHR--NIVKLLGCCLET---EVPLLVYEFIP 439 (694)
Q Consensus 365 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~g~~~~~---~~~~lv~e~~~ 439 (694)
.+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++...... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4679999999999999887 68999986543 4567788899999888543 356777655333 34689999999
Q ss_pred CCChHH----------------HHh---ccc-CCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 005492 440 NGTLYQ----------------YIH---NQI-EEFPITWEL---------LLRI------------AVEVSG-ALFYLHS 477 (694)
Q Consensus 440 ~gsL~~----------------~l~---~~~-~~~~l~~~~---------~~~i------------~~qia~-aL~yLH~ 477 (694)
+..+.. .+. ... ......+.. .... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988887 111 110 000111100 0000 111222 2333332
Q ss_pred c----CCCCeeecccccccEEEC-CCCcEEEeecCCcc
Q 005492 478 A----ASIPIYHRDIKSANILLD-DKYRAKVSDFGTSR 510 (694)
Q Consensus 478 ~----~~~~ivH~DIkp~NIll~-~~~~~kl~DFGla~ 510 (694)
. ....++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1 334599999999999999 66667899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.17 E-value=8.6e-06 Score=78.66 Aligned_cols=105 Identities=25% Similarity=0.324 Sum_probs=82.8
Q ss_pred HHHHHHHhhccC-CcceeEEeEEeeCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 005492 404 INEVVILSQINH-RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 482 (694)
Q Consensus 404 ~~E~~~l~~l~h-~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ 482 (694)
.+|.-+++.+++ +++++++|+| ..++|.||.+.+++...-..-..-...+|..+.+||.++++.+.+|++...-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999976 6999999999 44789999988766432100001113789999999999999999999965555
Q ss_pred eeecccccccEEECCCCcEEEeecCCcccc
Q 005492 483 IYHRDIKSANILLDDKYRAKVSDFGTSRSV 512 (694)
Q Consensus 483 ivH~DIkp~NIll~~~~~~kl~DFGla~~~ 512 (694)
+.-.|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.7e-05 Score=78.88 Aligned_cols=139 Identities=15% Similarity=0.112 Sum_probs=85.8
Q ss_pred eeeeCc-EEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcc-CCcceeEEeEEeeCCccEEEEEeCCCCChHH
Q 005492 368 LGQGGQ-GTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQ 445 (694)
Q Consensus 368 LG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~ 445 (694)
|-.|.. ..||+.... +..+.||+..... ..++.+|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 789998764 4778888875432 345678999888884 4446678888777777899999999988765
Q ss_pred HH-------------------hccc-CCCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----cC
Q 005492 446 YI-------------------HNQI-EEFPIT--WELLLRIAV--------------------EVSGALFYLHS----AA 479 (694)
Q Consensus 446 ~l-------------------~~~~-~~~~l~--~~~~~~i~~--------------------qia~aL~yLH~----~~ 479 (694)
.. |... ...+.. ....+.... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 42 1100 000111 000010000 01111222211 12
Q ss_pred CCCeeecccccccEEECCCCcEEEeecCCcc
Q 005492 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 480 ~~~ivH~DIkp~NIll~~~~~~kl~DFGla~ 510 (694)
.+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2448999999999999998778999998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.4e-05 Score=74.47 Aligned_cols=151 Identities=21% Similarity=0.241 Sum_probs=99.0
Q ss_pred ChhhHHHHhcCCCcccee---eeeCcEEEEEEEEcCCcEEEEEEccccChh-------------------h-----HHHH
Q 005492 351 TSKDLEKATDNYNANRIL---GQGGQGTVYKGMLTDGRIVAVKKSKLVDET-------------------N-----VEQF 403 (694)
Q Consensus 351 ~~~~l~~~~~~f~~~~~L---G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~-----~~~~ 403 (694)
+.+.|.....+..+.... ..|--+.||+|...++..+|||+.+..... . ....
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 445555555666555554 456667899999888999999975532111 0 1123
Q ss_pred HHHHHHHhhcc--CCcceeEEeEEeeCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCC
Q 005492 404 INEVVILSQIN--HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AAS 480 (694)
Q Consensus 404 ~~E~~~l~~l~--h~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~ 480 (694)
.+|+..|+++. +-.+.+-+++. .-.|||||+...-+- .-.....++.......+..++++.+.-|-. .+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~p---AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~- 187 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLP---APRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG- 187 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCC---CCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC-
Confidence 45777777774 33444444443 347999999654110 001111234444677778888888888877 66
Q ss_pred CCeeecccccccEEECCCCcEEEeecCCcccc
Q 005492 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 512 (694)
Q Consensus 481 ~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~ 512 (694)
+||+||..-|||+. ++.+.|+|||-|-..
T Consensus 188 --LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 188 --LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred --cccccchhhheEEE-CCeEEEEECcccccc
Confidence 99999999999999 779999999987544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.04 E-value=6.5e-07 Score=97.34 Aligned_cols=189 Identities=18% Similarity=0.139 Sum_probs=135.2
Q ss_pred HhcCCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCc-ceeEEeEEeeCCccEEEEE
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRN-IVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 358 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~g~~~~~~~~~lv~e 436 (694)
.+.-+..-+.++++++++++|.+....+....+.+... ....-++++|.+++||| .+..++-+..++..+++++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 34445555678899999999987544443444443321 44566899999999999 7777777777788899999
Q ss_pred eCCCC-ChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccC
Q 005492 437 FIPNG-TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 437 ~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~ 515 (694)
++..+ +-..-.. .....+...+...+.+.-+++|++||+.- =+|+| ||+..+ ...|..||+....+...
T Consensus 315 i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 315 ICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 99877 2111111 11112445556677778888999999875 57998 777766 57899999988766432
Q ss_pred CcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHHhCCCCC
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~elltg~~p~ 563 (694)
. ......+++.++|||+.....+..+.|+|++|+--.++--|-+|-
T Consensus 385 ~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 385 M--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred c--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 2 234456899999999999999999999999998777776666553
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.96 E-value=8.3e-05 Score=88.62 Aligned_cols=148 Identities=14% Similarity=0.226 Sum_probs=92.9
Q ss_pred cceeeeeCcEEEEEEEEcCC---cEEEEEEccccC-hhhHHHHHHHHHHHhhcc-CCcc--eeEEeEEeeC---CccEEE
Q 005492 365 NRILGQGGQGTVYKGMLTDG---RIVAVKKSKLVD-ETNVEQFINEVVILSQIN-HRNI--VKLLGCCLET---EVPLLV 434 (694)
Q Consensus 365 ~~~LG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nI--v~l~g~~~~~---~~~~lv 434 (694)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999887654 467777754322 223457889999999995 6665 7888888765 467999
Q ss_pred EEeCCCCChHH--------------------H---HhcccC-C-------CCCCH--HHHHHHH---------------H
Q 005492 435 YEFIPNGTLYQ--------------------Y---IHNQIE-E-------FPITW--ELLLRIA---------------V 466 (694)
Q Consensus 435 ~e~~~~gsL~~--------------------~---l~~~~~-~-------~~l~~--~~~~~i~---------------~ 466 (694)
|||+++..+.+ . ||.... . .+..+ .++..|. .
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99999865321 1 111000 0 00011 1121111 1
Q ss_pred HHHHHHHHHHhcCC--------CCeeecccccccEEECC-CCc-EEEeecCCcccc
Q 005492 467 EVSGALFYLHSAAS--------IPIYHRDIKSANILLDD-KYR-AKVSDFGTSRSV 512 (694)
Q Consensus 467 qia~aL~yLH~~~~--------~~ivH~DIkp~NIll~~-~~~-~kl~DFGla~~~ 512 (694)
.+...+.+|..+-. +.++|+|+++.|||++. +.. +-|.||.++...
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 23334566654321 24999999999999985 333 579999987643
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.92 E-value=5.2e-05 Score=83.64 Aligned_cols=141 Identities=17% Similarity=0.125 Sum_probs=89.1
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEccccChhh-------------------------------------HHHHHHHHH
Q 005492 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETN-------------------------------------VEQFINEVV 408 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~E~~ 408 (694)
+-||.-+.|.||+|++++|+.||||.-+..-+.. .-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999644311110 112445555
Q ss_pred HHhhc----cCCcc---eeEEeEEe-eCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 005492 409 ILSQI----NHRNI---VKLLGCCL-ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 480 (694)
Q Consensus 409 ~l~~l----~h~nI---v~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~ 480 (694)
...+. .|-++ |.+=.++. -.....|+||||+|..+.+.-.-... .++...+..-+.+... .-|-..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~--~qIf~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYL--EQIFKTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHH--HHHHhcC-
Confidence 44443 35441 11112222 23467899999999877765322111 2555544443333322 2222345
Q ss_pred CCeeecccccccEEECC----CCcEEEeecCCccccc
Q 005492 481 IPIYHRDIKSANILLDD----KYRAKVSDFGTSRSVM 513 (694)
Q Consensus 481 ~~ivH~DIkp~NIll~~----~~~~kl~DFGla~~~~ 513 (694)
++|.|-.|.||+++. ++.+.+-|||+...+.
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999983 6789999999987654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00024 Score=69.05 Aligned_cols=129 Identities=22% Similarity=0.260 Sum_probs=91.3
Q ss_pred ccceeeeeCcEEEEEEEEcCCcEEEEEEccccC----------------hhhHHHHHHHHHHHhhcc------CCcceeE
Q 005492 364 ANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD----------------ETNVEQFINEVVILSQIN------HRNIVKL 421 (694)
Q Consensus 364 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~nIv~l 421 (694)
....||+|+.-.||. +.+.....||...... .....+..+|+.-..++. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356799999999996 3444556677665433 223566777777766665 7899999
Q ss_pred EeEEeeCCccEEEEEeCCC------CChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEE
Q 005492 422 LGCCLETEVPLLVYEFIPN------GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL 495 (694)
Q Consensus 422 ~g~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll 495 (694)
+|+...+..+-+|+|.+.+ -+|.+++.+. .++. ...+.+. +-..||-+.+ |+.+|++|.||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEE
Confidence 9999999999999998653 3688888543 2454 3333333 4455677777 9999999999999
Q ss_pred CCC---C-cEEEee
Q 005492 496 DDK---Y-RAKVSD 505 (694)
Q Consensus 496 ~~~---~-~~kl~D 505 (694)
..+ . .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 532 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.0001 Score=68.60 Aligned_cols=128 Identities=17% Similarity=0.215 Sum_probs=88.9
Q ss_pred CccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCccee-EEeEEeeCCccEEEEEeCCCC
Q 005492 363 NANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVK-LLGCCLETEVPLLVYEFIPNG 441 (694)
Q Consensus 363 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-l~g~~~~~~~~~lv~e~~~~g 441 (694)
+..+.|++|.+|.||++.+. |..+|+|.-.. +.....+..|+++|..+.-.++-+ ++.|.. .++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 44678999999999999987 45788887553 344577889999999988766654 443332 24559999998
Q ss_pred ChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccc-cccEEECCCCcEEEeecCCcc
Q 005492 442 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIK-SANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 442 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIk-p~NIll~~~~~~kl~DFGla~ 510 (694)
.|.+.-... +-+ -...++++---|...| |-|+.|. |..++|-.+..+.|+||.-|.
T Consensus 98 ~L~~~~~~~------~rk----~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 98 PLGKLEIGG------DRK----HLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred chhhhhhcc------cHH----HHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 887765421 122 2344555544566667 9999987 444444444499999999886
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00018 Score=72.54 Aligned_cols=73 Identities=19% Similarity=0.243 Sum_probs=46.5
Q ss_pred ceeeeeCcE-EEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCC---cceeEEeEEeeCC---ccEEEEEeC
Q 005492 366 RILGQGGQG-TVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHR---NIVKLLGCCLETE---VPLLVYEFI 438 (694)
Q Consensus 366 ~~LG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~g~~~~~~---~~~lv~e~~ 438 (694)
+.|+.||.. .||+. +..+++|.... ......+.+|++++..+... -+.++++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457767766 58875 23467776543 22345788999999888532 3445555443322 358899999
Q ss_pred CCCChH
Q 005492 439 PNGTLY 444 (694)
Q Consensus 439 ~~gsL~ 444 (694)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.0004 Score=72.50 Aligned_cols=77 Identities=9% Similarity=0.040 Sum_probs=57.5
Q ss_pred ccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccC---CcceeEEeEEeeC---CccEEEEEe
Q 005492 364 ANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH---RNIVKLLGCCLET---EVPLLVYEF 437 (694)
Q Consensus 364 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~g~~~~~---~~~~lv~e~ 437 (694)
..+.||.|..+.||+....+++ +++|..+. ......|..|...|+.+.. -.+.++++++... +..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 3567999999999998766664 56666432 1133578899999999853 4688889887643 568999999
Q ss_pred CCCCCh
Q 005492 438 IPNGTL 443 (694)
Q Consensus 438 ~~~gsL 443 (694)
++++++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00039 Score=69.90 Aligned_cols=75 Identities=23% Similarity=0.188 Sum_probs=48.8
Q ss_pred cceeeeeCcEEEEEEEEcC--CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcc-eeEEeEEeeCCccEEEEEeCCCC
Q 005492 365 NRILGQGGQGTVYKGMLTD--GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVYEFIPNG 441 (694)
Q Consensus 365 ~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~g~~~~~~~~~lv~e~~~~g 441 (694)
.+.|..|-...+|+....+ +..+++|....... ......+|+.+++.+...++ +++++... ..+||||+++.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567778888999988764 67888887653222 11233468888888854444 34444332 24899999987
Q ss_pred ChH
Q 005492 442 TLY 444 (694)
Q Consensus 442 sL~ 444 (694)
++.
T Consensus 78 ~l~ 80 (235)
T cd05157 78 TLE 80 (235)
T ss_pred cCC
Confidence 763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00063 Score=65.59 Aligned_cols=125 Identities=30% Similarity=0.475 Sum_probs=90.6
Q ss_pred cCCCccceeeeeCc-EEEEEEEEcCCcEEEEEEccc---cCh------------------hhHHHHHHHHHHHhhcc---
Q 005492 360 DNYNANRILGQGGQ-GTVYKGMLTDGRIVAVKKSKL---VDE------------------TNVEQFINEVVILSQIN--- 414 (694)
Q Consensus 360 ~~f~~~~~LG~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 414 (694)
..++..+.||.|.. |.||++... |+.+|+|..+. ... ....-|..|-+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78899999999999 999999985 77999998221 100 11235778888888774
Q ss_pred CCcc--eeEEeEEeeCC------------------ccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHH
Q 005492 415 HRNI--VKLLGCCLETE------------------VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 474 (694)
Q Consensus 415 h~nI--v~l~g~~~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~y 474 (694)
+.++ |+.+||..-.. ...||.||++... .+. ..-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 4566 89999874321 1257888876533 122 2345677778899
Q ss_pred HHhcCCCCeeecccccccEEECCCCcEEEeecCCc
Q 005492 475 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS 509 (694)
Q Consensus 475 LH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla 509 (694)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99999 999999999976 3589999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00034 Score=71.40 Aligned_cols=137 Identities=15% Similarity=0.136 Sum_probs=77.5
Q ss_pred eeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCcc-eeEEeEEeeCCccEEEEEeCCCCChHHH
Q 005492 368 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVYEFIPNGTLYQY 446 (694)
Q Consensus 368 LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~g~~~~~~~~~lv~e~~~~gsL~~~ 446 (694)
+..|-.+.+|+.. .++..+++|..........-...+|..+++.+....+ .++++... .++||||++|..+..-
T Consensus 4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 4557778899887 4567788887543222211235778889988864433 34444332 3799999998765421
Q ss_pred -----------------Hhccc-CCCCCCHHH-HHHHHH---------HHHHHHHHHHhc-----CCCCeeecccccccE
Q 005492 447 -----------------IHNQI-EEFPITWEL-LLRIAV---------EVSGALFYLHSA-----ASIPIYHRDIKSANI 493 (694)
Q Consensus 447 -----------------l~~~~-~~~~l~~~~-~~~i~~---------qia~aL~yLH~~-----~~~~ivH~DIkp~NI 493 (694)
||... ...+++... +..... .+...+..+... ..+.++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11111 011122211 111111 111222222221 123489999999999
Q ss_pred EECCCCcEEEeecCCcc
Q 005492 494 LLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 494 ll~~~~~~kl~DFGla~ 510 (694)
++++++ ++|+||..+.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999876 7899998875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0016 Score=70.24 Aligned_cols=76 Identities=20% Similarity=0.239 Sum_probs=55.7
Q ss_pred cceeeeeCcEEEEEEEEcCC-cEEEEEEcccc-----C--hhhHHHHHHHHHHHhhcc---CCcceeEEeEEeeCCccEE
Q 005492 365 NRILGQGGQGTVYKGMLTDG-RIVAVKKSKLV-----D--ETNVEQFINEVVILSQIN---HRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 365 ~~~LG~G~~g~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~nIv~l~g~~~~~~~~~l 433 (694)
.+.||.|.+..||++...+| +.++||..... . +...+.+..|.+.|..+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35789999999999999877 58999974311 1 234567788888888863 2457777777 4466789
Q ss_pred EEEeCCCCC
Q 005492 434 VYEFIPNGT 442 (694)
Q Consensus 434 v~e~~~~gs 442 (694)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0015 Score=68.34 Aligned_cols=140 Identities=26% Similarity=0.363 Sum_probs=83.3
Q ss_pred ceeeeeCcEEEEEEEEcC-------CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcc-eeEEeEEeeCCccEEEEEe
Q 005492 366 RILGQGGQGTVYKGMLTD-------GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~g~~~~~~~~~lv~e~ 437 (694)
+.|..|-...+|+....+ ++.+++|...... ....+..+|+++++.+....+ .++++++. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 456667777899988665 4788888855432 233456778888888854333 34555543 2368999
Q ss_pred CCCCChHHH-----------------HhcccCCC--------CCCHHHHHH--------------------------HHH
Q 005492 438 IPNGTLYQY-----------------IHNQIEEF--------PITWELLLR--------------------------IAV 466 (694)
Q Consensus 438 ~~~gsL~~~-----------------l~~~~~~~--------~l~~~~~~~--------------------------i~~ 466 (694)
++|.++... ||...... +.-+..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776431 11111110 000111111 112
Q ss_pred HHHHHHHHHHh------cCCCCeeecccccccEEECCC----CcEEEeecCCcc
Q 005492 467 EVSGALFYLHS------AASIPIYHRDIKSANILLDDK----YRAKVSDFGTSR 510 (694)
Q Consensus 467 qia~aL~yLH~------~~~~~ivH~DIkp~NIll~~~----~~~kl~DFGla~ 510 (694)
++...+.+|.. .....++|+|+.+.|||++++ +.++|+||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22233344432 133458999999999999984 789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0064 Score=64.20 Aligned_cols=156 Identities=15% Similarity=0.208 Sum_probs=82.7
Q ss_pred ChhhHHHHhcCCCc-----cceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCc--ceeEEe
Q 005492 351 TSKDLEKATDNYNA-----NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRN--IVKLLG 423 (694)
Q Consensus 351 ~~~~l~~~~~~f~~-----~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~g 423 (694)
+.+++......|.. .+.|+.|....+|+....+| .+++|+.... ..+....|+.++..|...+ +.+.+.
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCccee
Confidence 34444444444543 34566777789999887655 6888876522 2233444555555553222 333332
Q ss_pred ------EEeeCCccEEEEEeCCCCChH-----------HH---HhcccCCC--------CCCH-HHHHH-----------
Q 005492 424 ------CCLETEVPLLVYEFIPNGTLY-----------QY---IHNQIEEF--------PITW-ELLLR----------- 463 (694)
Q Consensus 424 ------~~~~~~~~~lv~e~~~~gsL~-----------~~---l~~~~~~~--------~l~~-~~~~~----------- 463 (694)
+....+..++++||++|..+. +. +|...... .+.| .....
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 122345678999999987542 11 12111110 1111 11111
Q ss_pred -HH-HHHHHHHHHHHhc----CCCCeeecccccccEEECCCCcEEEeecCCcc
Q 005492 464 -IA-VEVSGALFYLHSA----ASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 464 -i~-~qia~aL~yLH~~----~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~ 510 (694)
.. ..+...++.+... -...++|+|+.|.|||++++...-|+||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 11 1111122333211 12349999999999999977666899999774
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.00063 Score=79.60 Aligned_cols=198 Identities=18% Similarity=0.189 Sum_probs=136.9
Q ss_pred HHHHHHHHHHhhccCCcceeEEeEEeeCCccE----EEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH
Q 005492 401 EQFINEVVILSQINHRNIVKLLGCCLETEVPL----LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 476 (694)
Q Consensus 401 ~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH 476 (694)
.....|+..+..+.|+|++.+++|-.+....- +.-|++..-++...+... ..++....+.+..++.+||+|+|
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v---~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV---GSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc---cccCHHHHHHHHHHHhhhHHHHH
Confidence 33455777888889999999999987665333 345677777887777643 25889999999999999999999
Q ss_pred hcCCCCeeecccccc---cEEECCCCcEEEe--ecCCccccccCCcceeeeeecCCCCCCCcccccCCCC--ceeeEEeh
Q 005492 477 SAASIPIYHRDIKSA---NILLDDKYRAKVS--DFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT--EKSDVYSF 549 (694)
Q Consensus 477 ~~~~~~ivH~DIkp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t--~~sDvwSl 549 (694)
+.. ..|.-+..+ +-..+..+.+.++ ||+.++......... ...-+..+.+||......+. ...|+|.+
T Consensus 304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHH
Confidence 986 666555554 4555666777777 888887665333221 12234567788877665554 45799999
Q ss_pred hHHHHHHHhCCCCCccCCCccCccHHHHHHHHhhhcchhhhhhhhhhhhhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005492 550 GVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVA 629 (694)
Q Consensus 550 Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl 629 (694)
|.++..+..|..+-.... ....+++.. ....+.+...+|+..++++|+.+.+++
T Consensus 379 gll~~~~~~~~~i~~~~~------------------~~~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA------------------VPVSLLDVL--------STSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCccccccc------------------chhhhhccc--------cchhhhhhhhhhcchhhhhccchhhhh
Confidence 999999998875421100 001111111 011466788999999999999999998
Q ss_pred HHH
Q 005492 630 FEL 632 (694)
Q Consensus 630 ~~L 632 (694)
.+.
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 763
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.007 Score=63.15 Aligned_cols=142 Identities=15% Similarity=0.141 Sum_probs=85.4
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCc--ceeEEeE------EeeCCccEEEEE
Q 005492 365 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRN--IVKLLGC------CLETEVPLLVYE 436 (694)
Q Consensus 365 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~g~------~~~~~~~~lv~e 436 (694)
.+.|..|....+|+....+ ..+++|.... ........|+.++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567777778999987654 4688887654 23456677888888875433 4454432 223456689999
Q ss_pred eCCCCChHH----H----------HhcccCC--------CCCCHHHHH----------HHHHHHHHHHHHHHhc----CC
Q 005492 437 FIPNGTLYQ----Y----------IHNQIEE--------FPITWELLL----------RIAVEVSGALFYLHSA----AS 480 (694)
Q Consensus 437 ~~~~gsL~~----~----------l~~~~~~--------~~l~~~~~~----------~i~~qia~aL~yLH~~----~~ 480 (694)
|++|..+.. . ||..... ....|.... .....+..++.++... -.
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 1 1111100 011221110 1112233445555541 12
Q ss_pred CCeeecccccccEEECCCCcEEEeecCCcc
Q 005492 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 481 ~~ivH~DIkp~NIll~~~~~~kl~DFGla~ 510 (694)
..++|+|+.|.|||++++..+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 348999999999999998778999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0094 Score=62.61 Aligned_cols=143 Identities=17% Similarity=0.221 Sum_probs=81.3
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCCc--ceeEEeE------EeeCCccEEEEE
Q 005492 365 NRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRN--IVKLLGC------CLETEVPLLVYE 436 (694)
Q Consensus 365 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~g~------~~~~~~~~lv~e 436 (694)
.+.++.|-...+|+....++ .+++|...... ..+....|++++..|.... +.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45566777789999876555 57788654321 2334556677777764322 3444432 122456789999
Q ss_pred eCCCCChHH--------------HHhcccCCC---------CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 005492 437 FIPNGTLYQ--------------YIHNQIEEF---------PITWELLL------------RIAVEVSGALFYLHS---- 477 (694)
Q Consensus 437 ~~~~gsL~~--------------~l~~~~~~~---------~l~~~~~~------------~i~~qia~aL~yLH~---- 477 (694)
|++|..+.. .+|...... .-.|.... .....+.+.+++|..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 998865321 122211110 01111110 011223345555543
Q ss_pred cCCCCeeecccccccEEECCCCcEEEeecCCcc
Q 005492 478 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 478 ~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~ 510 (694)
.....++|+|+.+.||+++++....|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 122459999999999999988777899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1219 consensus Uncharacterized conserved protein, contains laminin, cadherin and EGF domains [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.00038 Score=84.28 Aligned_cols=22 Identities=18% Similarity=0.259 Sum_probs=14.0
Q ss_pred ccccccCCCCCCC---CCCCccccCC
Q 005492 242 GTLLCISGHNCSK---CPYGYFRYPR 264 (694)
Q Consensus 242 ~~~~c~~~~~c~~---c~n~~g~y~~ 264 (694)
||+||. +..|-. |.|.+|.|-|
T Consensus 3941 Gi~eCs-~n~C~~gg~C~n~~gsf~C 3965 (4289)
T KOG1219|consen 3941 GISECS-KNVCGTGGQCINIPGSFHC 3965 (4289)
T ss_pred cccccc-cccccCCceeeccCCceEe
Confidence 466774 345643 8888888733
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0073 Score=62.84 Aligned_cols=130 Identities=15% Similarity=0.214 Sum_probs=79.2
Q ss_pred EEEEEEEEcCCcEEEEEEcc-ccChhhHHHHHHHHHHHhhccC--CcceeEEeEEeeCC--ccEEEEEeCCCCChHHHHh
Q 005492 374 GTVYKGMLTDGRIVAVKKSK-LVDETNVEQFINEVVILSQINH--RNIVKLLGCCLETE--VPLLVYEFIPNGTLYQYIH 448 (694)
Q Consensus 374 g~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~g~~~~~~--~~~lv~e~~~~gsL~~~l~ 448 (694)
-.+|..... ++++++.+.. ...........+|+.+++.+.- --+...+++|.++. .++.||+|+++..+.+.+.
T Consensus 39 n~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~ 117 (321)
T COG3173 39 NDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP 117 (321)
T ss_pred cceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence 344444443 6677777332 2333455667778888888743 33455677777766 7799999998843322221
Q ss_pred cccCCCCCCHHHHHHHH-HHHHHHH--------------------------------------------------HHHHh
Q 005492 449 NQIEEFPITWELLLRIA-VEVSGAL--------------------------------------------------FYLHS 477 (694)
Q Consensus 449 ~~~~~~~l~~~~~~~i~-~qia~aL--------------------------------------------------~yLH~ 477 (694)
... .. .+++ ..+++.| .||+.
T Consensus 118 ~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~ 189 (321)
T COG3173 118 PES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA 189 (321)
T ss_pred ccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence 100 00 0111 1333333 34443
Q ss_pred cC-----CCCeeecccccccEEECCCCcEEEeecCCcccc
Q 005492 478 AA-----SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 512 (694)
Q Consensus 478 ~~-----~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~ 512 (694)
+. .+.++|+|+++.|++++++..+=|.||+++...
T Consensus 190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 32 346999999999999999888999999998653
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0072 Score=62.33 Aligned_cols=31 Identities=23% Similarity=0.486 Sum_probs=25.5
Q ss_pred CCeeecccccccEEECCCCc-EEEeecCCccc
Q 005492 481 IPIYHRDIKSANILLDDKYR-AKVSDFGTSRS 511 (694)
Q Consensus 481 ~~ivH~DIkp~NIll~~~~~-~kl~DFGla~~ 511 (694)
+.++|+|+++.|||++++++ .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999997554 57999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0088 Score=63.80 Aligned_cols=140 Identities=21% Similarity=0.215 Sum_probs=80.5
Q ss_pred ceeeeeCcEEEEEEEEcC-----CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcce-eEEeEEeeCCccEEEEEeCC
Q 005492 366 RILGQGGQGTVYKGMLTD-----GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV-KLLGCCLETEVPLLVYEFIP 439 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~g~~~~~~~~~lv~e~~~ 439 (694)
+.|-.|-...+|+....+ ++.+++|........... -.+|..+++.+...++. ++++.+.. . .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 345457777889887542 367888876543322222 36788898888655544 45555532 2 5899998
Q ss_pred CCChHHH-----------------HhcccC---CCCCCHHHHHHHHHHH-----------------HHHHHHHH----h-
Q 005492 440 NGTLYQY-----------------IHNQIE---EFPITWELLLRIAVEV-----------------SGALFYLH----S- 477 (694)
Q Consensus 440 ~gsL~~~-----------------l~~~~~---~~~l~~~~~~~i~~qi-----------------a~aL~yLH----~- 477 (694)
+.+|... +|+..- .....+..+.++..++ ...+..|. .
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 121110 0011233333332221 11122222 1
Q ss_pred cCCCCeeecccccccEEECC-CCcEEEeecCCcc
Q 005492 478 AASIPIYHRDIKSANILLDD-KYRAKVSDFGTSR 510 (694)
Q Consensus 478 ~~~~~ivH~DIkp~NIll~~-~~~~kl~DFGla~ 510 (694)
.....++|+|+++.|||+++ +..++|+||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 12335899999999999986 4689999998875
|
|
| >PF12662 cEGF: Complement Clr-like EGF-like | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.00078 Score=40.72 Aligned_cols=22 Identities=32% Similarity=0.827 Sum_probs=17.5
Q ss_pred ceEEEccCcccc-CCCc-cccccc
Q 005492 224 GYICRCDAGFYR-PHGL-CSGTLL 245 (694)
Q Consensus 224 gy~C~C~~g~y~-~~g~-c~~~~~ 245 (694)
+|+|.|+.||.+ ++|. |+||||
T Consensus 1 sy~C~C~~Gy~l~~d~~~C~DIdE 24 (24)
T PF12662_consen 1 SYTCSCPPGYQLSPDGRSCEDIDE 24 (24)
T ss_pred CEEeeCCCCCcCCCCCCccccCCC
Confidence 599999999965 3443 999986
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.013 Score=60.54 Aligned_cols=74 Identities=22% Similarity=0.253 Sum_probs=49.0
Q ss_pred ccceeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcc---CCcceeEEeEEeeCCccEEEEEeCCC
Q 005492 364 ANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN---HRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 364 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
..+.|+.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+++++++....+..+||+||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 35678888899999977 568889999765 333456788888888883 45688899998888888999999987
Q ss_pred C
Q 005492 441 G 441 (694)
Q Consensus 441 g 441 (694)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.0021 Score=65.55 Aligned_cols=133 Identities=17% Similarity=0.198 Sum_probs=90.7
Q ss_pred CCCccceeeeeCcEEEEEEEEcCCcEEEEEEccccC-----------------hh-----hHHHHHHHHHHHhhccC--C
Q 005492 361 NYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD-----------------ET-----NVEQFINEVVILSQINH--R 416 (694)
Q Consensus 361 ~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~-----~~~~~~~E~~~l~~l~h--~ 416 (694)
-+...++||-|--+.||.+...+|++.++|.-.... .. ..-...+|+..|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 367789999999999999999999999998322110 00 01123457788887743 2
Q ss_pred cceeEEeEEeeCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEEC
Q 005492 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD 496 (694)
Q Consensus 417 nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~ 496 (694)
-+.+.++ ...-++|||++.+-.|...-+- .+..+ +...+..-+--|-.+| +||+|..--||+++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v------~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV------EDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeec------CChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 2444443 3455789999988777664321 22222 3333444455566778 99999999999999
Q ss_pred CCCcEEEeecCCc
Q 005492 497 DKYRAKVSDFGTS 509 (694)
Q Consensus 497 ~~~~~kl~DFGla 509 (694)
++..++++||--.
T Consensus 237 dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 237 DDDKIVVIDFPQM 249 (465)
T ss_pred cCCCEEEeechHh
Confidence 9999999999654
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.00025 Score=84.43 Aligned_cols=160 Identities=13% Similarity=0.007 Sum_probs=115.0
Q ss_pred HHHHHHHHhhccCCcceeEEeEEee--CCccEEEEEeCCCCChHHHHhcccCC-CCCCHHHHHHHHHHHHHHHHHHHhcC
Q 005492 403 FINEVVILSQINHRNIVKLLGCCLE--TEVPLLVYEFIPNGTLYQYIHNQIEE-FPITWELLLRIAVEVSGALFYLHSAA 479 (694)
Q Consensus 403 ~~~E~~~l~~l~h~nIv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~ 479 (694)
.+.|...++...|+++.....-... ....+.+++|+..|.+.+.|-+..++ .++...-+.....+...+..-.|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 4445555566788888765544432 34568899999999999998764333 34444444444444466666655543
Q ss_pred --CCCeeecccccccEEECCCCcEEEeecCCccccccCCcceeeeeecCCCCCCCcccccCCCCceeeEEehhHHHHHHH
Q 005492 480 --SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 557 (694)
Q Consensus 480 --~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGvll~ell 557 (694)
....+|+++|+-|.+|..+.++|+.++|+.+... ..........+++.|+.|+....-.++.++|+|..|+.+|++-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccC-chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 2347899999999999999999999999998322 2222233345677889999998889999999999999999998
Q ss_pred hCCCCC
Q 005492 558 TGQKPI 563 (694)
Q Consensus 558 tg~~p~ 563 (694)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 888775
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.1 Score=54.82 Aligned_cols=29 Identities=34% Similarity=0.395 Sum_probs=24.8
Q ss_pred CCeeecccccccEEECCCCcEEEeecCCcc
Q 005492 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 481 ~~ivH~DIkp~NIll~~~~~~kl~DFGla~ 510 (694)
..++|+|+.+.||++++ +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 34899999999999988 578999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.068 Score=57.57 Aligned_cols=80 Identities=14% Similarity=0.151 Sum_probs=53.4
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEccc----cCh---hhHHHHHHHHHHHhhcc---CCcceeEEeEEeeCCccEEE
Q 005492 365 NRILGQGGQGTVYKGMLTDGRIVAVKKSKL----VDE---TNVEQFINEVVILSQIN---HRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 365 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~----~~~---~~~~~~~~E~~~l~~l~---h~nIv~l~g~~~~~~~~~lv 434 (694)
.+.||.|....||+.... +..++||+... ... .....-..|+..|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 567899999999998764 55688997541 111 13444455667776653 357888888876 456789
Q ss_pred EEeCCC--CChHHHH
Q 005492 435 YEFIPN--GTLYQYI 447 (694)
Q Consensus 435 ~e~~~~--gsL~~~l 447 (694)
||++++ ..|.+.+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999977 3454444
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.022 Score=56.23 Aligned_cols=30 Identities=27% Similarity=0.433 Sum_probs=21.2
Q ss_pred CeeecccccccEEE-CCCCcEEEeecCCccc
Q 005492 482 PIYHRDIKSANILL-DDKYRAKVSDFGTSRS 511 (694)
Q Consensus 482 ~ivH~DIkp~NIll-~~~~~~kl~DFGla~~ 511 (694)
.+.|+|+.+.|||+ +.++.++|+||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 37899999999999 8889999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.076 Score=56.33 Aligned_cols=140 Identities=18% Similarity=0.222 Sum_probs=77.8
Q ss_pred ceeeeeCcEEEEEEEEcC----CcEEEEEEccccChhhHHHHHHHHHHHhhccCCcce-eEEeEEeeCCccEEEEEeCCC
Q 005492 366 RILGQGGQGTVYKGMLTD----GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV-KLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~g~~~~~~~~~lv~e~~~~ 440 (694)
+.|..|=...+|+....+ +..|++|....... ..-.-.+|..+++.+...++- ++++++. .. +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 345556677788886543 23788887654322 222235788888888765554 4565552 22 58999977
Q ss_pred CChHH-------H----------Hhccc-C--CCCCCHHHHHHHHHHH----------------------HHHHHH----
Q 005492 441 GTLYQ-------Y----------IHNQI-E--EFPITWELLLRIAVEV----------------------SGALFY---- 474 (694)
Q Consensus 441 gsL~~-------~----------l~~~~-~--~~~l~~~~~~~i~~qi----------------------a~aL~y---- 474 (694)
.+|.. . ||... . ..+--|..+.++..++ ..-+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 66532 1 11111 0 0011233322222221 111222
Q ss_pred HHhcC-CCCeeecccccccEEECC-CCcEEEeecCCcc
Q 005492 475 LHSAA-SIPIYHRDIKSANILLDD-KYRAKVSDFGTSR 510 (694)
Q Consensus 475 LH~~~-~~~ivH~DIkp~NIll~~-~~~~kl~DFGla~ 510 (694)
+...+ ...++|+|+.+.|||+++ ++.++++||..|.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 21112 223789999999999975 5689999999874
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.086 Score=55.81 Aligned_cols=79 Identities=16% Similarity=0.162 Sum_probs=50.9
Q ss_pred eeeeeCcEEEEEEEEcCC-cEEEEEEccc-------cChhhHHHHHHHHHHHhhcc--CC-cceeEEeEEeeCCccEEEE
Q 005492 367 ILGQGGQGTVYKGMLTDG-RIVAVKKSKL-------VDETNVEQFINEVVILSQIN--HR-NIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 367 ~LG~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~-nIv~l~g~~~~~~~~~lv~ 435 (694)
.||-|....||++...+| +.|+||.... .-+...++...|...|+... -| .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 578999999999998754 6899996331 11334556667878887663 24 34445433 455667999
Q ss_pred EeCCCC-ChHHHH
Q 005492 436 EFIPNG-TLYQYI 447 (694)
Q Consensus 436 e~~~~g-sL~~~l 447 (694)
|+++.. .|...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 998653 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.15 Score=53.64 Aligned_cols=30 Identities=13% Similarity=0.241 Sum_probs=27.0
Q ss_pred CeeecccccccEEECCCCcEEEeecCCccc
Q 005492 482 PIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 482 ~ivH~DIkp~NIll~~~~~~kl~DFGla~~ 511 (694)
.++|+|+.++|||+++++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.21 Score=49.01 Aligned_cols=119 Identities=20% Similarity=0.269 Sum_probs=76.7
Q ss_pred CCcEEEEEEccccChhhHHHHHHHHHHHhhc---cCCcceeEEeEEeeCCccEEEEEeCCCCChHH-----------HHh
Q 005492 383 DGRIVAVKKSKLVDETNVEQFINEVVILSQI---NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQ-----------YIH 448 (694)
Q Consensus 383 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~-----------~l~ 448 (694)
+..++.||+-. ......|..|+.-|..| +.-++.+++.+..+....+||+||++-+.+.. .||
T Consensus 38 g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d~~~~~~~GqqLA~LH 114 (286)
T COG3001 38 GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLDAHSAFILGQQLARLH 114 (286)
T ss_pred CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCCchhHHHHHHHHHHHH
Confidence 35678888643 45567788888877777 44668889999999999999999999876651 123
Q ss_pred cccCCC---------------CCC----H-----HHHHHHHHHHH--------------HHHHHHHhcC--CCCeeeccc
Q 005492 449 NQIEEF---------------PIT----W-----ELLLRIAVEVS--------------GALFYLHSAA--SIPIYHRDI 488 (694)
Q Consensus 449 ~~~~~~---------------~l~----~-----~~~~~i~~qia--------------~aL~yLH~~~--~~~ivH~DI 488 (694)
...... +-+ | ++|+-+..|+| ..+.-+=... .|..+|+||
T Consensus 115 ~~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~FfaeqRig~qlqlar~rg~~f~did~~~~~v~elL~~hqpqPsLlHGDL 194 (286)
T COG3001 115 QWGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAEQRIGWQLQLARERGLTFGDIDAIVEKIQELLADHQPQPSLLHGDL 194 (286)
T ss_pred hhcCccccCcccccccCCCCCCCCCcchHHHHHHHhhhhHHHHHHHHhCCCccCHHHHHHHHHHHHhcCCCCcceeeccc
Confidence 211110 111 2 22333333332 2333333333 266999999
Q ss_pred ccccEEECCCCcEEEee
Q 005492 489 KSANILLDDKYRAKVSD 505 (694)
Q Consensus 489 kp~NIll~~~~~~kl~D 505 (694)
...|.++..++ +.+.|
T Consensus 195 W~gN~a~~~~G-Pv~fD 210 (286)
T COG3001 195 WSGNCAFGKDG-PVIFD 210 (286)
T ss_pred ccccccccCCC-Ceeec
Confidence 99999999888 66655
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.14 Score=53.56 Aligned_cols=141 Identities=19% Similarity=0.217 Sum_probs=93.2
Q ss_pred CccceeeeeCcEEEEEEEEcCCcEEEEEEcccc-----Chh--------------------h-HHHHHHHHHHHhhccCC
Q 005492 363 NANRILGQGGQGTVYKGMLTDGRIVAVKKSKLV-----DET--------------------N-VEQFINEVVILSQINHR 416 (694)
Q Consensus 363 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~-----~~~--------------------~-~~~~~~E~~~l~~l~h~ 416 (694)
++...|..|--+-||.+.-.+|..+|||+.+.. +.+ . .-....|++.|++|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 344568888899999999999999999964421 000 0 11234588888888654
Q ss_pred cceeEEeEEeeCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecccccccEEEC
Q 005492 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD 496 (694)
Q Consensus 417 nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIll~ 496 (694)
.|.-.--... ..-.|||+|+.... |-.-......++...+..+-.|++.-+.-|.+... +||.||.--|+|+.
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE
Confidence 4331111111 12369999985321 11111122357777888888888888888877764 99999999999986
Q ss_pred CCCcEEEeecCCccc
Q 005492 497 DKYRAKVSDFGTSRS 511 (694)
Q Consensus 497 ~~~~~kl~DFGla~~ 511 (694)
+. .+.|+|.+-+-.
T Consensus 300 dG-~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 DG-KLYIIDVSQSVE 313 (520)
T ss_pred CC-EEEEEEcccccc
Confidence 54 899999876643
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.099 Score=50.84 Aligned_cols=136 Identities=15% Similarity=0.135 Sum_probs=80.8
Q ss_pred EEEEEccccChh-hHHHHHHHHHHHhhccCCcceeEEeEEeeCCccEEEEEeCCCCChHHHHhcccCCCCCCHHHHHHHH
Q 005492 387 VAVKKSKLVDET-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIA 465 (694)
Q Consensus 387 vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 465 (694)
..+|++....-. ...-|.++.+++++++ .|++|..= +.-..-+++|++-... ... ..++
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~---------------i~~-~N~i 147 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK---------------INF-SNFI 147 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc---------------cch-hHHH
Confidence 445555443333 4556788999998875 56777611 2234458888873311 111 1122
Q ss_pred HHHHHHHHHHHhcCCCCeeecccccccEEECCCCcEEEeecCCccccccCCcceeeeeecCCCCCCCcccccCCCCceee
Q 005492 466 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 545 (694)
Q Consensus 466 ~qia~aL~yLH~~~~~~ivH~DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sD 545 (694)
.-=+++|.-.|+... ..+|+|-.|+||+-|..|.+||.|-+..-.- +..|.- ......|.++.
T Consensus 148 ~agi~~L~~fH~~~~-~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~-------------~V~~vN---~~Y~~lT~~aE 210 (308)
T PF07387_consen 148 TAGIKDLMDFHSENQ-HCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN-------------QVNMVN---IEYESLTQEAE 210 (308)
T ss_pred HHhHHHHHHhhccCC-CeecCCCChhheeecCCCCEEecChhhhhhh-------------eeeEEe---eeccccChHHH
Confidence 222467888886542 3899999999999999999999997643110 111111 11234566666
Q ss_pred EEehhHHHHHHHhC
Q 005492 546 VYSFGVVLVEILTG 559 (694)
Q Consensus 546 vwSlGvll~elltg 559 (694)
+-+|=.-+++++..
T Consensus 211 ~~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 211 VKVFVKSCLKLVEK 224 (308)
T ss_pred HHHHHHHHHHHHHH
Confidence 66666666666654
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.65 E-value=1.1 Score=47.51 Aligned_cols=93 Identities=16% Similarity=0.116 Sum_probs=53.0
Q ss_pred ccChhhHHHHhcCCCcc---c-eeeeeCcEEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhccCC--cceeEE
Q 005492 349 LFTSKDLEKATDNYNAN---R-ILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHR--NIVKLL 422 (694)
Q Consensus 349 ~~~~~~l~~~~~~f~~~---~-~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~ 422 (694)
.++.+.+..+...+... + ..=.+.-..||+....++..+++|..... .....++..|++.+..|... .++..+
T Consensus 10 ~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~ 88 (325)
T PRK11768 10 TLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPL 88 (325)
T ss_pred CCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCc
Confidence 34455555554444221 1 12234556799998888888999976522 22456667788777776321 122211
Q ss_pred ---e--EEeeCCccEEEEEeCCCCC
Q 005492 423 ---G--CCLETEVPLLVYEFIPNGT 442 (694)
Q Consensus 423 ---g--~~~~~~~~~lv~e~~~~gs 442 (694)
| ....++..+.++++++|..
T Consensus 89 ~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 89 AFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cCCCCEEEEECCEEEEEEeeeCCCC
Confidence 1 1222456778999998764
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.28 Score=53.03 Aligned_cols=74 Identities=22% Similarity=0.266 Sum_probs=43.9
Q ss_pred ceeeeeCcEEEEEEEEcCC--cE-----EEEEEccccChhhHHHHHHHHHHHhhccCCccee-EEeEEeeCCccEEEEEe
Q 005492 366 RILGQGGQGTVYKGMLTDG--RI-----VAVKKSKLVDETNVEQFINEVVILSQINHRNIVK-LLGCCLETEVPLLVYEF 437 (694)
Q Consensus 366 ~~LG~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-l~g~~~~~~~~~lv~e~ 437 (694)
+.|..|-...+|++...++ .. |.++... ......-+-.+|+++++.+...++-+ +++.+. -.+++||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence 4455577788998875443 12 3333321 11111122356899999997666554 555553 2699999
Q ss_pred CCCCChH
Q 005492 438 IPNGTLY 444 (694)
Q Consensus 438 ~~~gsL~ 444 (694)
+++.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987764
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.63 E-value=0.041 Score=59.73 Aligned_cols=50 Identities=18% Similarity=0.248 Sum_probs=39.6
Q ss_pred HHHHHHHHHHHhhccCCcceeEEeEEeeC-CccEEEEEeCCCCChHHHHhcc
Q 005492 400 VEQFINEVVILSQINHRNIVKLLGCCLET-EVPLLVYEFIPNGTLYQYIHNQ 450 (694)
Q Consensus 400 ~~~~~~E~~~l~~l~h~nIv~l~g~~~~~-~~~~lv~e~~~~gsL~~~l~~~ 450 (694)
..+++-...+++.+.|+|+.+.+++-... ....+|+|++ +.+|.+++..+
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 45667788899999999999999887644 3467888988 66999988754
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.16 Score=54.45 Aligned_cols=81 Identities=15% Similarity=0.085 Sum_probs=52.8
Q ss_pred cceeeeeCcEEEEEEEEcC-CcEEEEEEccc------cChhhHHHHHHHHHHHhhcc--CC-cceeEEeEEeeCCccEEE
Q 005492 365 NRILGQGGQGTVYKGMLTD-GRIVAVKKSKL------VDETNVEQFINEVVILSQIN--HR-NIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 365 ~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--h~-nIv~l~g~~~~~~~~~lv 434 (694)
.+.||-|.-..||++.+.+ ++.|+||.... .-+-..++..-|.+.|+.+. -| ++++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4678999999999999853 56799995321 11334666777888888763 24 45555543 45556788
Q ss_pred EEeCCCC-ChHHHH
Q 005492 435 YEFIPNG-TLYQYI 447 (694)
Q Consensus 435 ~e~~~~g-sL~~~l 447 (694)
||+++.. .|.+.|
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 8888542 244443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 694 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-47 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-46 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-46 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-45 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-31 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-27 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-27 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-27 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-26 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-26 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-26 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-26 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-26 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-26 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-26 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-26 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-26 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-26 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-26 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-26 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-26 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-26 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-26 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-26 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-25 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-25 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-25 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-24 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-24 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-24 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-24 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-24 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-24 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-24 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-24 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-23 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-23 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-23 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-23 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-23 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-23 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-23 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-23 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-23 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-23 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-23 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-23 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-23 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-23 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-23 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-23 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-23 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-23 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-22 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-21 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-21 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-21 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-20 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-20 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-20 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-20 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-19 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-19 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-19 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-19 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-19 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-19 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-19 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-19 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-19 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-18 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-18 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-18 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-18 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-18 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-18 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-18 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-18 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-18 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-18 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-18 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-18 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-18 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-17 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-17 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-17 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-17 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-17 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-16 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-16 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-16 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-16 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-16 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-16 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-15 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-14 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-14 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-05 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 342 bits (879), Expect = e-113
Identities = 110/298 (36%), Positives = 175/298 (58%), Gaps = 5/298 (1%)
Query: 337 LSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD 396
LSS+ ++ DLE+AT+N++ ++G G G VYKG+L DG VA+K+
Sbjct: 16 LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES 75
Query: 397 ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-NQIEEFP 455
+E+F E+ LS H ++V L+G C E +L+Y+++ NG L ++++ + +
Sbjct: 76 SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 456 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV- 514
++WE L I + + L YLH+ I HRD+KS NILLD+ + K++DFG S+
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL 574
DQTHL+T V+GT GY+DPEYF + TEKSDVYSFGVVL E+L + I E +L
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 575 VGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632
+ +++ N +L +I+D + + + E + A +CL L+ + RP+M +V ++L
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 326 bits (839), Expect = e-107
Identities = 106/292 (36%), Positives = 171/292 (58%), Gaps = 4/292 (1%)
Query: 341 ESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV 400
E ++ + K F+ ++L+ A+DN++ ILG+GG G VYKG L DG +VAVK+ K
Sbjct: 11 EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG 70
Query: 401 E-QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIE-EFPITW 458
E QF EV ++S HRN+++L G C+ LLVY ++ NG++ + + E + P+ W
Sbjct: 71 ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 459 ELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518
RIA+ + L YLH I HRD+K+ANILLD+++ A V DFG ++ + TH
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 190
Query: 519 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI--RAINTDEDKSLVG 576
+TT V+GT G++ PEY + + +EK+DV+ +GV+L+E++TGQ+ + D+D L+
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 577 YFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ + E +L ++D + K E + + +A C + RP M EV
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 318 bits (818), Expect = e-104
Identities = 97/317 (30%), Positives = 167/317 (52%), Gaps = 23/317 (7%)
Query: 334 QQELSSNESNIEKTKLFTSKDLEKATDN------YNANRILGQGGQGTVYKGMLTDGRIV 387
+ L +++ F+ +L+ T+N +G+GG G VYKG + + V
Sbjct: 2 NKSLEVSDTR---FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTV 57
Query: 388 AVKKSKLVDETNVEQ----FINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL 443
AVKK + + E+ F E+ ++++ H N+V+LLG + + LVY ++PNG+L
Sbjct: 58 AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
Query: 444 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV 503
+ P++W + +IA + + +LH I HRDIKSANILLD+ + AK+
Sbjct: 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKI 174
Query: 504 SDFGTSRSVMV-DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
SDFG +R+ QT +T+++ GT Y+ PE + T KSD+YSFGVVL+EI+TG
Sbjct: 175 SDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPA 233
Query: 563 IRAINTDEDKSLVGYFLQAINENR-LFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKM 621
+ E + L+ + +E + + + +D + + +A + + ++A +CL+
Sbjct: 234 VD--EHREPQLLLDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNK 290
Query: 622 RPTMKEVAFELGGIRTS 638
RP +K+V L + S
Sbjct: 291 RPDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 2e-74
Identities = 69/334 (20%), Positives = 128/334 (38%), Gaps = 41/334 (12%)
Query: 333 LQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKS 392
+ + S ++ +++L + + +G G V+K L VAVK
Sbjct: 1 MGHHHHHHSSGVD----LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF 55
Query: 393 KLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP----LLVYEFIPNGTLYQYIH 448
+ D+ + Q EV L + H NI++ +G L+ F G+L ++
Sbjct: 56 PIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114
Query: 449 NQIEEFPITWELLLRIAVEVSGALFYLHSAASI-------PIYHRDIKSANILLDDKYRA 501
++W L IA ++ L YLH I HRDIKS N+LL + A
Sbjct: 115 AN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170
Query: 502 KVSDFGTSRSVMVDQTHLTTKVQ-GTFGYVDPEYFQSS-----QFTEKSDVYSFGVVLVE 555
++DFG + ++ T Q GT Y+ PE + + + D+Y+ G+VL E
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230
Query: 556 ILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE----------AKKEGIM 605
+ + + F + I ++ E + V+ + K G+
Sbjct: 231 LASRCTAADGPV----DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMA 286
Query: 606 TVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639
+ + C + + + R + V + ++ T
Sbjct: 287 MLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 9e-72
Identities = 83/275 (30%), Positives = 128/275 (46%), Gaps = 20/275 (7%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--NVEQFINEVVILSQINHRNIVKLLG 423
+G G GTV++ G VAVK D V +F+ EV I+ ++ H NIV +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 483
+ +V E++ G+LY+ +H + L +A +V+ + YLH+ + PI
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160
Query: 484 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 543
HR++KS N+L+D KY KV DFG SR + + GT ++ PE + EK
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 544 SDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEG 603
SDVYSFGV+L E+ T Q+P +N + + VG+ RL E +
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF-----KCKRL----------EIPRNL 264
Query: 604 IMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638
VA + + C RP+ + L + S
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 6e-71
Identities = 81/279 (29%), Positives = 137/279 (49%), Gaps = 26/279 (9%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
++G+G G V K + VA+K+ + E+ + FI E+ LS++NH NIVKL G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 426 LETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
L P+ LV E+ G+LY +H T + ++ S + YLHS +
Sbjct: 71 LN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 485 HRDIKSANILLDDKYR-AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 543
HRD+K N+LL K+ DFGT+ + QTH+T G+ ++ PE F+ S ++EK
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK-GSAAWMAPEVFEGSNYSEK 183
Query: 544 SDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEG 603
DV+S+G++L E++T +KP I + + A++ + +K K
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFR-----IMWAVHNGTRPPL-----IKNLPKP- 232
Query: 604 IMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGAS 642
+ +L RC + + RP+M+E+ + + +
Sbjct: 233 ---IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 2e-67
Identities = 81/286 (28%), Positives = 130/286 (45%), Gaps = 43/286 (15%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETN----VEQFINEVVILSQINHRNIVKL 421
I+G GG G VY+ G VAVK ++ + + +E E + + + H NI+ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 422 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASI 481
G CL+ LV EF G L + + + I ++L+ AV+++ + YLH A +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 482 PIYHRDIKSANILLDDKYR--------AKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 533
PI HRD+KS+NIL+ K K++DFG +R +T + G + ++ PE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSAA-GAYAWMAPE 184
Query: 534 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI----NENRLFE 589
++S F++ SDV+S+GV+L E+LTG+ P R I+ L
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID----------GLAVAYGVAMNKLALP 234
Query: 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635
I A L + C N + RP+ + +L I
Sbjct: 235 IP---------STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 3e-67
Identities = 82/282 (29%), Positives = 134/282 (47%), Gaps = 37/282 (13%)
Query: 366 RILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETN-------VEQFINEVVILSQINHRN 417
+ +G+GG G V+KG + D +VA+K L D ++F EV I+S +NH N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 418 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 477
IVKL G P +V EF+P G LY + ++ PI W + LR+ ++++ + Y+ +
Sbjct: 85 IVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 478 AASIPIYHRDIKSANILLDDK-----YRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532
+ PI HRD++S NI L AKV+DFG S+ H + + G F ++ P
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAP 195
Query: 533 EYF--QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590
E + +TEK+D YSF ++L ILTG+ P + + + + E I
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEGLRPTI 251
Query: 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632
++ + + + C + + K RP + EL
Sbjct: 252 P---------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-63
Identities = 59/275 (21%), Positives = 109/275 (39%), Gaps = 33/275 (12%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDET--NVEQFINEVVILSQINHRNIVKLLG 423
L + G ++KG G + VK K+ D + F E L +H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 424 CCLETEVPLL--VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASI 481
C P + ++P G+LY +H F + ++ A++++ + +LH+
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTL-EP 132
Query: 482 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ-- 539
I + S ++++D+ A++S S + +V PE Q
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPED 186
Query: 540 -FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598
+D++SF V+L E++T + P ++ E +G + E I
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFADLSNME----IGM--KVALEGLRPTI-------- 232
Query: 599 AKKEGIMT-VATLAKRCLNLNGKMRPTMKEVAFEL 632
GI V+ L K C+N + RP + L
Sbjct: 233 --PPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 4e-60
Identities = 55/282 (19%), Positives = 108/282 (38%), Gaps = 38/282 (13%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLG 423
++G+G G VY G G VA++ + +E ++ F EV+ Q H N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 483
C+ ++ TLY + + + + +IA E+ + YLH + I
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 484 YHRDIKSANILLDDKYRAKVSDFGTSR----SVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 539
H+D+KS N+ D+ + ++DFG + G ++ PE +
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 540 ---------FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590
F++ SDV++ G + E+ + P + + + + +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-------IIWQMGTGMKPNL 263
Query: 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632
+ KE ++ + C + RPT ++ L
Sbjct: 264 SQIGMGKE--------ISDILLFCWAFEQEERPTFTKLMDML 297
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-59
Identities = 65/292 (22%), Positives = 117/292 (40%), Gaps = 33/292 (11%)
Query: 366 RILGQGGQGTVYKGML-TDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 424
+LG+G G K G ++ +K+ DE F+ EV ++ + H N++K +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 425 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
+ + + E+I GTL I + + W + A +++ + YLH S+ I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLH---SMNII 130
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT-------------TKVQGTFGYVD 531
HRD+ S N L+ + V+DFG +R ++ ++T V G ++
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 532 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591
PE + EK DV+SFG+VL EI+ D + + L
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP----DYLPRTMDFGLNVRGFLDR---- 242
Query: 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGASI 643
+ + RC +L+ + RP+ ++ L +R +
Sbjct: 243 ------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 3e-58
Identities = 77/274 (28%), Positives = 126/274 (45%), Gaps = 27/274 (9%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLG 423
+ +G G GTVYKG VAVK + ++ F NEV +L + H NI+ +G
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 424 CCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIP 482
T L +V ++ +LY ++H E + L+ IA + + + YLH+
Sbjct: 88 YS--TAPQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHA---KS 140
Query: 483 IYHRDIKSANILLDDKYRAKVSDFGTSR-SVMVDQTHLTTKVQGTFGYVDPE---YFQSS 538
I HRD+KS NI L + K+ DFG + +H ++ G+ ++ PE S+
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 539 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598
++ +SDVY+FG+VL E++TGQ P IN + ++ + L L ++V
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVGRGSLSPDL-SKVRSN 253
Query: 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632
K + L CL RP+ + E+
Sbjct: 254 CPKR----MKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 5e-58
Identities = 72/328 (21%), Positives = 124/328 (37%), Gaps = 48/328 (14%)
Query: 350 FTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVI 409
+ + DN ++G+G G VYKG L D R VAVK N + FINE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKV---FSFANRQNFINEKNI 58
Query: 410 --LSQINHRNIVKLLGCCLETEVP-----LLVYEFIPNGTLYQYIHNQIEEFPITWELLL 462
+ + H NI + + LLV E+ PNG+L +Y+ W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSC 114
Query: 463 RIAVEVSGALFYLHSAASI------PIYHRDIKSANILLDDKYRAKVSDFGTSR------ 510
R+A V+ L YLH+ I HRD+ S N+L+ + +SDFG S
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 511 -SVMVDQTHLTTKVQGTFGYVDPEYFQSS-------QFTEKSDVYSFGVVLVEILTGQKP 562
++ + GT Y+ PE + + ++ D+Y+ G++ EI
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 563 IRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE-----------AKKEGIMTVATLA 611
+ + + + F + + FE + V +E + ++
Sbjct: 235 LFPGESVPEYQMA--FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 612 KRCLNLNGKMRPTMKEVAFELGGIRTST 639
+ C + + + R T + + +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIW 320
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-53
Identities = 62/298 (20%), Positives = 110/298 (36%), Gaps = 45/298 (15%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVI--LSQINHRNIVKLLG 423
+G+G G V++G G VAVK + + + E + + H NI+ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKI---FSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 424 CCLETEVP----LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
+ + L+ + G+LY Y+ + LRI + ++ L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 480 SI-----PIYHRDIKSANILLDDKYRAKVSDFGTSR----SVMVDQTHLTTKVQGTFGYV 530
I HRD+KS NIL+ + ++D G + S +V GT Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYM 184
Query: 531 DPE------YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE 584
PE ++ D+++FG+VL E+ R ++ + F +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-----RMVSNGIVEDYKPPFYDVVPN 239
Query: 585 NRLFEILDARVLKE----------AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632
+ FE + V + + ++A L K C N R T + L
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-52
Identities = 62/304 (20%), Positives = 112/304 (36%), Gaps = 43/304 (14%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINE--VVILSQINHRNIVKLLG 423
+ +G+G G V+ G G VAVK +E + E + + H NI+ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIA 98
Query: 424 CCLETEVP----LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
++ L+ ++ NG+LY Y+ + + + +L++A L +LH+
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 480 SI-----PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL---TTKVQGTFGYVD 531
I HRD+KS NIL+ ++D G + + D + GT Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 532 PE------YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN 585
PE Q +D+YSFG++L E+ + + + + +
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP-----YHDLVPSD 269
Query: 586 RLFEILDARVLKE----------AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635
+E + V + + E + + L C N R T V L +
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
Query: 636 RTST 639
S
Sbjct: 330 SESQ 333
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 4e-51
Identities = 59/307 (19%), Positives = 116/307 (37%), Gaps = 43/307 (14%)
Query: 367 ILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINE--VVILSQINHRNIVKLLGC 424
+G+G G V++G G VAVK + E + + H NI+ +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKI---FSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 425 CLETEVP----LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 480
+ LV ++ +G+L+ Y++ +T E ++++A+ + L +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 481 -----IPIYHRDIKSANILLDDKYRAKVSDFGTSR----SVMVDQTHLTTKVQGTFGYVD 531
I HRD+KS NIL+ ++D G + + +V GT Y+
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYMA 219
Query: 532 PE------YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN 585
PE + + +++D+Y+ G+V EI + + Y+ ++
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI----GGIHEDYQLPYYDLVPSDP 275
Query: 586 RLFEILDARVLKE---------AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636
+ E+ ++ E + +A + + C NG R T + L +
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335
Query: 637 TSTGASI 643
G +
Sbjct: 336 QQEGIKM 342
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-47
Identities = 76/277 (27%), Positives = 123/277 (44%), Gaps = 25/277 (9%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHR 416
++Y +G G G K +DG+I+ K+ + E + ++EV +L ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 417 NIVKLLGCCLETEVPLL--VYEFIPNGTLYQYIHNQIEE-FPITWELLLRIAVEVSGALF 473
NIV+ ++ L V E+ G L I +E + E +LR+ +++ AL
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 474 YLHS--AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 531
H + HRD+K AN+ LD K K+ DFG +R + D + T V GT Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 532 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591
PE + EKSD++S G +L E+ P A + E L I E + F +
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LA----GKIREGK-FRRI 236
Query: 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
R E + + R LNL RP+++E+
Sbjct: 237 PYRYSDELNE--------IITRMLNLKDYHRPSVEEI 265
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 71/274 (25%), Positives = 118/274 (43%), Gaps = 22/274 (8%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK---SKLVDETNVEQFINEVVILSQINH 415
N+ + +G+G VY+ L DG VA+KK L+D I E+ +L Q+NH
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 416 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGALFY 474
N++K +E +V E G L + I + ++ I + + V++ AL +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 475 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 534
+HS + HRDIK AN+ + K+ D G R T + V GT Y+ PE
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 535 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594
+ + KSD++S G +L E+ Q P + SL + I + +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLC----KKIEQCDYPPLPSDH 262
Query: 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+E ++ L C+N + + RP + V
Sbjct: 263 YSEELRQ--------LVNMCINPDPEKRPDVTYV 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-45
Identities = 66/272 (24%), Positives = 115/272 (42%), Gaps = 24/272 (8%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHR 416
+ Y + +G+G G DGR +K+ + + E+ EV +L+ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 476
NIV+ E +V ++ G L++ I+ Q + + +L V++ AL ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVH 142
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 536
I HRDIKS NI L ++ DFG +R V+ L GT Y+ PE +
Sbjct: 143 DRK---ILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACIGTPYYLSPEICE 198
Query: 537 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596
+ + KSD+++ G VL E+ T + A + K+LV I F +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNLV----LKIISGS-FPPVSLHYS 250
Query: 597 KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ + L + N + RP++ +
Sbjct: 251 YDLRS--------LVSQLFKRNPRDRPSVNSI 274
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 6e-44
Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 362 YNANRILGQGGQGTVYKGMLTD---GRIVAVK--KSKLV-DETNVEQFINEVVILSQINH 415
Y LG GG TVY D VA+K E +++F EV SQ++H
Sbjct: 13 YKIVDKLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 416 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 475
+NIV ++ E + LV E+I TL +YI P++ + + ++ + +
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHA 127
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT--KVQGTFGYVDPE 533
H I HRDIK NIL+D K+ DFG +++ + +T LT V GT Y PE
Sbjct: 128 HDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPE 182
Query: 534 YFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
+ E +D+YS G+VL E+L G+ P
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 60/294 (20%), Positives = 117/294 (39%), Gaps = 46/294 (15%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRN 417
++ + LG+GG G V++ D A+K+ +L + E E+ + EV L+++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 418 IVKLLGCCLE---------TEVPLLVY---EFIPNGTLYQYIHNQIEEFPITWELLLRIA 465
IV+ LE + + +Y + L +++ + + L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 466 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ- 524
++++ A+ +LHS + HRD+K +NI KV DFG ++ D+ T
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 525 ----------GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL 574
GT Y+ PE + ++ K D++S G++L E+L +T ++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------PFSTQMERVR 235
Query: 575 VGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
L + + F L + + + L+ + RP +
Sbjct: 236 T---LTDVRNLK-FPPLFTQKYPCEYV--------MVQDMLSPSPMERPEAINI 277
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 6e-42
Identities = 64/305 (20%), Positives = 115/305 (37%), Gaps = 36/305 (11%)
Query: 350 FTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVV 408
F + +Y + LG+GG V L DG A+K+ ++ + E+ E
Sbjct: 19 FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREAD 78
Query: 409 ILSQINHRNIVKLLGCCLETEVP----LLVYEFIPNGTLYQYI-HNQIEEFPITWELLLR 463
+ NH NI++L+ CL L+ F GTL+ I + + +T + +L
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138
Query: 464 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG---------TSRSVMV 514
+ + + L +H+ HRD+K NILL D+ + + D G +
Sbjct: 139 LLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195
Query: 515 DQTHLTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 571
+ T Y PE F E++DV+S G VL ++ G+ P +
Sbjct: 196 TLQDWAAQR-CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY------DM 248
Query: 572 KSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631
G + +N+L R + L + ++ RP + + +
Sbjct: 249 VFQKGDSVALAVQNQLSIPQSPRHSSALWQ--------LLNSMMTVDPHQRPHIPLLLSQ 300
Query: 632 LGGIR 636
L ++
Sbjct: 301 LEALQ 305
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-42
Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 418
++ ++G GG G V+K DG+ +K+ K N E+ EV L++++H NI
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAEREVKALAKLDHVNI 66
Query: 419 VKLLGCCLETEVPL----------------LVYEFIPNGTLYQYIHNQIEEFPITWELLL 462
V GC + + EF GTL Q+I + E + L L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLAL 125
Query: 463 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 522
+ +++ + Y+HS + +RD+K +NI L D + K+ DFG + T+
Sbjct: 126 ELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT--SLKNDGKRTR 180
Query: 523 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 582
+GT Y+ PE S + ++ D+Y+ G++L E+L A T + F +
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--AFETSK-------FFTDL 231
Query: 583 NENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ I+ K+ K L ++ L+ + RP E+
Sbjct: 232 RDG----IISDIFDKKEKT--------LLQKLLSKKPEDRPNTSEI 265
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-42
Identities = 68/213 (31%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 362 YNANRILGQGGQGTVYKGMLTD---GRIVAVK--KSKLV-DETNVEQFINEVVILSQINH 415
Y ILG GG V+ D R VAVK ++ L D + +F E + +NH
Sbjct: 14 YELGEILGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 416 RNIVKLL--GC--CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 471
IV + G +P +V E++ TL +H E P+T + + + + A
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQA 128
Query: 472 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT--KVQGTFGY 529
L + H I HRD+K ANI++ KV DFG +R++ +T V GT Y
Sbjct: 129 LNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 530 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
+ PE + +SDVYS G VL E+LTG+ P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 8e-42
Identities = 56/209 (26%), Positives = 85/209 (40%), Gaps = 18/209 (8%)
Query: 362 YNANRILGQGGQGTVYKGMLTD---GRIVAVK--KSKLV-DETNVEQFINEVVILSQINH 415
Y R++G+GG G VY+ D RIVA+K L D + E ++
Sbjct: 36 YRLRRLVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE 93
Query: 416 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 475
++V + + I L + + P+ + I ++ AL
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAA 150
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT--KVQGTFGYVDPE 533
H+A HRD+K NIL+ A + DFG + + LT GT Y+ PE
Sbjct: 151 HAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPE 205
Query: 534 YFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
F S T ++D+Y+ VL E LTG P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 70/310 (22%), Positives = 123/310 (39%), Gaps = 73/310 (23%)
Query: 359 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRN 417
++ +LGQG G V K D R A+KK + E + ++EV++L+ +NH+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 418 IVKLLGCCLETEVPL-------------LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI 464
+V+ LE + + E+ NGTLY IH++ + R+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR--DEYWRL 121
Query: 465 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV------------ 512
++ AL Y+HS I HRD+K NI +D+ K+ DFG +++V
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 513 --MVDQTHLTTKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTD 569
+LT+ + GT YV E + + EK D+YS G++ E++
Sbjct: 179 NLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---------- 227
Query: 570 EDKSLVGYFLQAINENRLFEIL-----------DARVLKEAKKEGIMTVATLAKRCLNLN 618
F + + + L D +K KK + + ++ +
Sbjct: 228 --------FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKK--------IIRLLIDHD 271
Query: 619 GKMRPTMKEV 628
RP + +
Sbjct: 272 PNKRPGARTL 281
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 52/207 (25%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 366 RILGQGGQGTVYKGMLTDGR-----IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIV 419
++LG G GTVYKG+ VA+K+ + ++ ++E +++ +++ ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
+LLG CL + V L+ + +P G L Y+ + + LL V+++ + YL
Sbjct: 81 RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYLEDRR 137
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQ 536
+ HRD+ + N+L+ K++DFG ++ + ++ +G ++ E
Sbjct: 138 LV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESIL 192
Query: 537 SSQFTEKSDVYSFGVVLVEILT-GQKP 562
+T +SDV+S+GV + E++T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-41
Identities = 77/291 (26%), Positives = 129/291 (44%), Gaps = 31/291 (10%)
Query: 366 RILGQGGQGTVYKGMLTDGRI-VAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 424
LG G G VY+G+ + VAVK K D VE+F+ E ++ +I H N+V+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 425 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
C ++ EF+ G L Y+ ++ +LL +A ++S A+ YL I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFI--- 340
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 544
HR++ + N L+ + + KV+DFG SR + D + + PE ++F+ KS
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 545 DVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQAINE--NRLFEILDARVLKEA 599
DV++FGV+L EI T G P I+ + L+ Y ++ +++E
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE---------- 450
Query: 600 KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGASILQQNCEE 650
+M + C N RP+ E+ + + S +
Sbjct: 451 ----LM------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 491
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-41
Identities = 69/280 (24%), Positives = 118/280 (42%), Gaps = 35/280 (12%)
Query: 366 RILGQGGQGTVYKGMLTDGRI-VAVKKSK-LVDETNVEQFINEVVILSQINHRNIVKLLG 423
+G+G G V+ G L VAVK + + +F+ E IL Q +H NIV+L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 483
C + + +V E + G ++ + + + LL++ + + + YL S I
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGMEYLESKCCI-- 235
Query: 484 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSSQFT 541
HRD+ + N L+ +K K+SDFG SR D + + PE +++
Sbjct: 236 -HRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 542 EKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQAINE--NRLFEILDARVL 596
+SDV+SFG++L E + G P ++ + + V G L + +F
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFR------- 346
Query: 597 KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636
+M +C RP+ + EL IR
Sbjct: 347 -------LME------QCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-41
Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 11/200 (5%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
+ LG G G V G VAVK K + ++F E + +++H +VK G C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
+ +V E+I NG L Y+ + + + LL + +V + +L S I H
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQ--LLEMCYDVCEGMAFLESHQFI---H 127
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSSQFTEK 543
RD+ + N L+D KVSDFG +R V+ DQ + V F PE F +++ K
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 544 SDVYSFGVVLVEILT-GQKP 562
SDV++FG+++ E+ + G+ P
Sbjct: 186 SDVWAFGILMWEVFSLGKMP 205
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 79/291 (27%), Positives = 135/291 (46%), Gaps = 30/291 (10%)
Query: 366 RILGQGGQGTVYKGMLT-----DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVK 420
+ LG+G G+V G +VAVKK + E ++ F E+ IL + H NIVK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 421 LLGCCLET-EVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 478
G C L L+ E++P G+L Y+ E LL+ ++ + YL +
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK--LLQYTSQICKGMEYLGTK 164
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQ 536
I HRD+ + NIL++++ R K+ DFG ++ + D+ + K G + PE
Sbjct: 165 RYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 537 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596
S+F+ SDV+SFGVVL E+ T ++ KS F++ I ++ +++ ++
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTY--------IEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273
Query: 597 KEAKKEGIM--------TVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639
+ K G + + + C N N RP+ +++A + IR
Sbjct: 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 75/300 (25%), Positives = 116/300 (38%), Gaps = 50/300 (16%)
Query: 366 RILGQGGQGTVYKGMLTD-----GRIVAVKKSK-LVDETNVEQFINEVVILSQINHRNIV 419
R LG+G G V G +VAVK K + + E+ IL + H +I+
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 420 KLLGCCLETEVP--LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 477
K GCC + LV E++P G+L Y+ I LL A ++ + YLH+
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHA 152
Query: 478 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYF 535
I HRD+ + N+LLD+ K+ DFG +++V + + G + PE
Sbjct: 153 QHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 536 QSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594
+ +F SDV+SFGV L E+LT + + + RL E+L
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ--GQMTVLRLTELL--- 264
Query: 595 VLKEAKKEG---------------IMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639
+ G +M K C RPT + + L +
Sbjct: 265 ------ERGERLPRPDKCPAEVYHLM------KNCWETEASFRPTFENLIPILKTVHEKY 312
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 73/313 (23%), Positives = 137/313 (43%), Gaps = 52/313 (16%)
Query: 365 NRILGQGGQGTVYKGMLTDG----RIVAVK--KSKLVDETNVEQFINEVVILSQINHRNI 418
R+LG+G G+V + L VAVK K+ ++ +++E+F+ E + + +H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 419 VKLLGCCLETE------VPLLVYEFIPNGTLYQYIHN---QIEEFPITWELLLRIAVEVS 469
KL+G L + +P+++ F+ +G L+ ++ F + + L+R V+++
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 470 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 529
+ YL +S HRD+ + N +L + V+DFG SR + + QG
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASK 200
Query: 530 V-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQA 581
+ E + +T SDV++FGV + EI+T GQ P I E + + G L+
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ 260
Query: 582 INE--NRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639
E +++ +M +C + + K RP+ + EL I
Sbjct: 261 PPECMEEVYD--------------LM------YQCWSADPKQRPSFTCLRMELENILGHL 300
Query: 640 GASILQQNCEEID 652
Q+ I+
Sbjct: 301 SVLSTSQDPLYIN 313
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 12/229 (5%)
Query: 338 SSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVD 396
S+ E + E L + D +LG+G G VY G L++ +A+K+ D
Sbjct: 4 STEEGDCESDLLEYDYEY----DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD 59
Query: 397 ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPI 456
+ E+ + + H+NIV+ LG E + E +P G+L + ++
Sbjct: 60 SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKD 119
Query: 457 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRSVMVD 515
+ + ++ L YLH I HRDIK N+L++ K+SDFGTS+ +
Sbjct: 120 NEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176
Query: 516 QTHLTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKP 562
T GT Y+ PE + + +D++S G ++E+ TG+ P
Sbjct: 177 NPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 68/305 (22%), Positives = 135/305 (44%), Gaps = 37/305 (12%)
Query: 334 QQELSSNESNIEKTKLFTSKDLEKATDN--YNANRILGQGGQGTVYKGM-LTDGRIVAVK 390
Q+E + + +IE+ + +K + + D + +G+G TVYKG+ VA
Sbjct: 1 QEERNQQQDDIEELE---TKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWC 57
Query: 391 KSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP----LLVYEFIPNGTLY 444
+ + ++ ++F E +L + H NIV+ T +LV E + +GTL
Sbjct: 58 ELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117
Query: 445 QYIHNQIEEF-PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAK 502
Y ++ F + ++L ++ L +LH+ + PI HRD+K NI + K
Sbjct: 118 TY----LKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVK 172
Query: 503 VSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
+ D G + + + V GT ++ PE ++ ++ E DVY+FG+ ++E+ T + P
Sbjct: 173 IGDLGLAT---LKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYP 228
Query: 563 IRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMR 622
E ++ + + + + D + E K+ + + C+ N R
Sbjct: 229 Y-----SECQNAAQIYRRVTSGVKP-ASFDKVAIPEVKE--------IIEGCIRQNKDER 274
Query: 623 PTMKE 627
++K+
Sbjct: 275 YSIKD 279
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 79/293 (26%), Positives = 135/293 (46%), Gaps = 30/293 (10%)
Query: 366 RILGQGGQGTVYKGMLT-----DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVK 420
+ LG+G G+V G +VAVKK + E ++ F E+ IL + H NIVK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 421 LLGCCLET-EVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 478
G C L L+ E++P G+L Y+ E LL+ ++ + YL +
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK--LLQYTSQICKGMEYLGTK 133
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQ 536
I HRD+ + NIL++++ R K+ DFG ++ + D+ K G + PE
Sbjct: 134 RYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 537 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596
S+F+ SDV+SFGVVL E+ T ++ KS F++ I ++ +++ ++
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTY--------IEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242
Query: 597 KEAKKEGIM--------TVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGA 641
+ K G + + + C N N RP+ +++A + IR +
Sbjct: 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 295
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 5e-40
Identities = 67/200 (33%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
+ +G G G V+ G + VA+K + + E FI E ++ +++H +V+L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
LE LV EF+ +G L Y+ Q F LL + ++V + YL A I H
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAET--LLGMCLDVCEGMAYLEEACVI---H 127
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSSQFTEK 543
RD+ + N L+ + KVSDFG +R V+ DQ T+ F PE F S+++ K
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 544 SDVYSFGVVLVEILT-GQKP 562
SDV+SFGV++ E+ + G+ P
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP 205
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-40
Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
LG G G V+ G VAVK K + + F+ E ++ Q+ H+ +V+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 426 LETEVPLL-VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
T+ P+ + E++ NG+L ++ +T LL +A +++ + ++ I
Sbjct: 78 --TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYI--- 131
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSSQFTE 542
HRD+++ANIL+ D K++DFG +R + ++ T + F PE FT
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTI 189
Query: 543 KSDVYSFGVVLVEILT-GQKP 562
KSDV+SFG++L EI+T G+ P
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-40
Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
+ LG G G V G VA+K K + ++FI E ++ ++H +V+L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 426 LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
+ ++ E++ NG L Y+ F LL + +V A+ YL S + H
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ--LLEMCKDVCEAMEYLESKQFL---H 143
Query: 486 RDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSSQFTEK 543
RD+ + N L++D+ KVSDFG SR V+ D+ T+ V F PE S+F+ K
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 544 SDVYSFGVVLVEILT-GQKP 562
SD+++FGV++ EI + G+ P
Sbjct: 202 SDIWAFGVLMWEIYSLGKMP 221
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 69/201 (34%), Positives = 103/201 (51%), Gaps = 11/201 (5%)
Query: 366 RILGQGGQGTVYKGMLTDGRI-VAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGC 424
LG G G VY+G+ + VAVK K D VE+F+ E ++ +I H N+V+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 425 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
C ++ EF+ G L Y+ ++ +LL +A ++S A+ YL I
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFI--- 133
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSSQFTE 542
HRD+ + N L+ + + KV+DFG SR + D T F PE ++F+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 543 KSDVYSFGVVLVEILT-GQKP 562
KSDV++FGV+L EI T G P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP 212
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-39
Identities = 70/207 (33%), Positives = 107/207 (51%), Gaps = 15/207 (7%)
Query: 366 RILGQGGQGTVYKGMLTDGR----IVAVKKSK-LVDETNVEQFINEVVILSQINHRNIVK 420
++G+G G VY G L D AVK + D V QF+ E +I+ +H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 421 LLGCCLETEVPLL-VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
LLG CL +E L V ++ +G L +I N E T + L+ ++V+ + +L A
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD---PEYFQ 536
S HRD+ + N +LD+K+ KV+DFG +R + + G V E Q
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 537 SSQFTEKSDVYSFGVVLVEILT-GQKP 562
+ +FT KSDV+SFGV+L E++T G P
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 70/207 (33%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 366 RILGQGGQGTVYKGMLTDGR----IVAVKKSK-LVDETNVEQFINEVVILSQINHRNIVK 420
++G+G G VY G L D AVK + D V QF+ E +I+ +H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 421 LLGCCLETEVPLL-VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
LLG CL +E L V ++ +G L +I N E T + L+ ++V+ + YL S
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD---PEYFQ 536
+ HRD+ + N +LD+K+ KV+DFG +R + + + G V E Q
Sbjct: 149 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 537 SSQFTEKSDVYSFGVVLVEILT-GQKP 562
+ +FT KSDV+SFGV+L E++T G P
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 365 NRILGQGGQGTVYKGMLTDGR----IVAVK--KSKLVDETNVEQFINEVVILSQINHRNI 418
+ILG+G G+V +G L VAVK K + +E+F++E + +H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 419 VKLLGCCLETE-----VPLLVYEFIPNGTLYQYIHN---QIEEFPITWELLLRIAVEVSG 470
++LLG C+E P+++ F+ G L+ Y+ + I + LL+ V+++
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 530
+ YL ++ HRD+ + N +L D V+DFG S+ + + QG +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKM 211
Query: 531 -----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 562
E +T KSDV++FGV + EI T G P
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 71/299 (23%), Positives = 125/299 (41%), Gaps = 47/299 (15%)
Query: 366 RILGQGGQGTVYKGMLT-----DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVK 420
LG+G G+V G +VAVK+ + F E+ IL ++ IVK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 421 LLGCCLET-EVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 478
G L LV E++P+G L ++ + LL + ++ + YL S
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGMEYLGSR 146
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQ 536
+ HRD+ + NIL++ + K++DFG ++ + +D+ + + G + PE
Sbjct: 147 RCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 537 SSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595
+ F+ +SDV+SFGVVL E+ T K + E ++G +RL E+L
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELL---- 257
Query: 596 LKEAKKEG---------------IMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639
+EG +M K C + + RP+ + +L + + +
Sbjct: 258 -----EEGQRLPAPPACPAEVHELM------KLCWAPSPQDRPSFSALGPQLDMLWSGS 305
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 51/207 (24%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 366 RILGQGGQGTVYKGMLTDGR-----IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIV 419
++LG G GTVYKG+ VA+K+ + ++ ++E +++ +++ ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
+LLG CL L+ + +P G L Y+ + + LL V+++ + YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYLEDRR 137
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQ 536
+ HRD+ + N+L+ K++DFG ++ + ++ +G ++ E
Sbjct: 138 LV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESIL 192
Query: 537 SSQFTEKSDVYSFGVVLVEILT-GQKP 562
+T +SDV+S+GV + E++T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 366 RILGQGGQGTVYKGMLTDGR-----IVAVKKSK-LVDETNVEQFINEVVILSQINHRNIV 419
++LG G GTV+KG+ V +K + + + + ++ + ++H +IV
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
+LLG C LV +++P G+L ++ +LLL V+++ ++YL
Sbjct: 79 RLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGVQIAKGMYYLEEHG 135
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQ 536
+ HR++ + N+LL + +V+DFG + + D ++ E
Sbjct: 136 MV---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ--LLYSEAKTPIKWMALESIH 190
Query: 537 SSQFTEKSDVYSFGVVLVEILT-GQKP 562
++T +SDV+S+GV + E++T G +P
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 365 NRILGQGGQGTVYKGMLTDGRI---VAVK--KSKLVDETNVEQFINEVVILSQINHRNIV 419
++ LG G GTV KG ++ VAVK K++ D ++ + E ++ Q+++ IV
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
+++G C E +LV E G L +Y+ + + ++ + +VS + YL +
Sbjct: 82 RMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 137
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQS 537
+ HRD+ + N+LL ++ AK+SDFG S+++ D+ + + G + + PE
Sbjct: 138 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 538 SQFTEKSDVYSFGVVLVEILT-GQKP 562
+F+ KSDV+SFGV++ E + GQKP
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 62/207 (29%), Positives = 110/207 (53%), Gaps = 15/207 (7%)
Query: 366 RILGQGGQGTVYKGMLTDGR----IVAVKKSK-LVDETNVEQFINEVVILSQINHRNIVK 420
R++G+G G VY G D A+K + + VE F+ E +++ +NH N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 421 LLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
L+G L E +P ++ ++ +G L Q+I + + T + L+ ++V+ + YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD---PEYFQ 536
+ HRD+ + N +LD+ + KV+DFG +R ++ + + + + V E Q
Sbjct: 145 FV---HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 537 SSQFTEKSDVYSFGVVLVEILT-GQKP 562
+ +FT KSDV+SFGV+L E+LT G P
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-39
Identities = 73/323 (22%), Positives = 141/323 (43%), Gaps = 33/323 (10%)
Query: 323 KFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLT 382
++ ++ L + + ++ +T+ E ++ LGQG G V+ G
Sbjct: 147 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 206
Query: 383 DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNG 441
VA+K K + E F+ E ++ ++ H +V+L +E P+ +V E++ G
Sbjct: 207 GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKG 263
Query: 442 TLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA 501
+L ++ + ++ + L+ +A +++ + Y+ + HRD+++ANIL+ +
Sbjct: 264 SLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRDLRAANILVGENLVC 319
Query: 502 KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQ 560
KV+DFG +R + ++ + + PE +FT KSDV+SFG++L E+ T G+
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379
Query: 561 KPIRAINTDEDKSLV--GYFLQAINE--NRLFEILDARVLKEAKKEGIMTVATLAKRCLN 616
P + E V GY + E L + +M +C
Sbjct: 380 VPYPGMVNREVLDQVERGYRMPCPPECPESLHD--------------LM------CQCWR 419
Query: 617 LNGKMRPTMKEVAFELGGIRTST 639
+ RPT + + L TST
Sbjct: 420 KEPEERPTFEYLQAFLEDYFTST 442
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-39
Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 366 RILGQGGQGTVYKGMLTDGRI----VAVKKSK---LVDETNVEQFINEVVILSQINHRNI 418
LG G G V +G VAVK K L ++ FI EV + ++HRN+
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 419 VKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 477
++L G L P+ +V E P G+L + F + L R AV+V+ + YL S
Sbjct: 84 IRLYGVVLTP--PMKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGMGYLES 139
Query: 478 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYF 535
I HRD+ + N+LL + K+ DFG R++ + H + + PE
Sbjct: 140 KRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 536 QSSQFTEKSDVYSFGVVLVEILT-GQKP 562
++ F+ SD + FGV L E+ T GQ+P
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 6e-39
Identities = 70/280 (25%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
LGQG G V+ G VA+K K + E F+ E ++ ++ H +V+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 426 LETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
+E P+ +V E++ G+L ++ + ++ + L+ +A +++ + Y+ +
Sbjct: 332 --SEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV--- 385
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 544
HRD+++ANIL+ + KV+DFG +R + ++ + + PE +FT KS
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 545 DVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQAINE--NRLFEILDARVLKEA 599
DV+SFG++L E+ T G+ P + E V GY + E L +
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD---------- 495
Query: 600 KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639
+M +C + RPT + + L TST
Sbjct: 496 ----LM------CQCWRKEPEERPTFEYLQAFLEDYFTST 525
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-39
Identities = 62/201 (30%), Positives = 109/201 (54%), Gaps = 17/201 (8%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
+ +G+G G V G G VAVK K ++ + F+ E +++Q+ H N+V+LLG
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 426 LETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
+E + L +V E++ G+L Y+ ++ + + LL+ +++V A+ YL +
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFV--- 139
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSSQFTE 542
HRD+ + N+L+ + AKVSDFG ++ +T+ G PE + +F+
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPVKWTAPEALREKKFST 193
Query: 543 KSDVYSFGVVLVEILT-GQKP 562
KSDV+SFG++L EI + G+ P
Sbjct: 194 KSDVWSFGILLWEIYSFGRVP 214
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 75/317 (23%), Positives = 134/317 (42%), Gaps = 59/317 (18%)
Query: 365 NRILGQGGQGTVYKGMLTDGR------IVAVKKSK-LVDETNVEQFINEVVILSQINHRN 417
+R LGQG G VY+G+ VA+K +F+NE ++ + N +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 418 IVKLLGCCLETEVPLLVYEFIPNGTLYQY-------IHNQIEEFPITWELLLRIAVEVSG 470
+V+LLG + + L++ E + G L Y + N P + ++++A E++
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 530
+ YL + HRD+ + N ++ + + K+ DFG +R + + +G G +
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLL 202
Query: 531 -----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQAI 582
PE + FT SDV+SFGVVL EI T ++P + ++ ++ V G L
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 262
Query: 583 NE--NRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTG 640
+ + LFE +M + C N KMRP+ E+ +
Sbjct: 263 DNCPDMLFE--------------LM------RMCWQYNPKMRPSFLEIISSIK------- 295
Query: 641 ASILQQNCEEIDFVDGD 657
++ E+ F +
Sbjct: 296 -EEMEPGFREVSFYYSE 311
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-38
Identities = 72/263 (27%), Positives = 125/263 (47%), Gaps = 21/263 (7%)
Query: 323 KFFKRNGGLLLQQ--ELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM 380
+ + + L + + E + F + +G+G G V G
Sbjct: 154 EHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGD 213
Query: 381 LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIP 439
G VAVK K ++ + F+ E +++Q+ H N+V+LLG +E + L +V E++
Sbjct: 214 YR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270
Query: 440 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY 499
G+L Y+ ++ + + LL+ +++V A+ YL + HRD+ + N+L+ +
Sbjct: 271 KGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDN 326
Query: 500 RAKVSDFGTSRSVMVDQTHLTTK--VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 557
AKVSDFG ++ T T K V+ T PE + +F+ KSDV+SFG++L EI
Sbjct: 327 VAKVSDFGLTKE--ASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIY 380
Query: 558 T-GQKPIRAINTDEDKSLV--GY 577
+ G+ P I + V GY
Sbjct: 381 SFGRVPYPRIPLKDVVPRVEKGY 403
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 68/313 (21%), Positives = 123/313 (39%), Gaps = 44/313 (14%)
Query: 334 QQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVK--- 390
SS + F S ++ Y+ + +G GG V++ + +I A+K
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSVKG--RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN 61
Query: 391 KSKLVDETNVEQFINEVVILSQINHRN--IVKLLGCCLETEVPLLVYEFIPNGTLYQYIH 448
+ D ++ + NE+ L+++ + I++L + + +V E N L ++
Sbjct: 62 LEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK 119
Query: 449 NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 508
+ + + A+ +H I H D+K AN L+ D K+ DFG
Sbjct: 120 KK-KSIDP--WERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGI 172
Query: 509 SRSVMVDQTHLTTKVQ-GTFGYVDPEYFQSS-----------QFTEKSDVYSFGVVLVEI 556
+ + D T + Q GT Y+ PE + + + KSDV+S G +L +
Sbjct: 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232
Query: 557 LTGQKPIRAINTDEDKSLVGYFLQAI-NENRLFEILDARVLKEAKKEGIMTVATLAKRCL 615
G+ P + I K L AI + N E D K+ + + K CL
Sbjct: 233 TYGKTPFQQIINQISK------LHAIIDPNHEIEFPD-IPEKDLQD--------VLKCCL 277
Query: 616 NLNGKMRPTMKEV 628
+ K R ++ E+
Sbjct: 278 KRDPKQRISIPEL 290
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 366 RILGQGGQGTVYKGMLTDGR----IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVK 420
+I+G G G V G L VA+K K E F++E I+ Q +H NI++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 421 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 480
L G + ++V E++ NG+L ++ +F T L+ + V + YL
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF--TIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSS 538
+ HRD+ + N+L+D KVSDFG SR + D T G PE
Sbjct: 173 V---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 539 QFTEKSDVYSFGVVLVEILT-GQKP 562
F+ SDV+SFGVV+ E+L G++P
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 62/202 (30%), Positives = 112/202 (55%), Gaps = 13/202 (6%)
Query: 368 LGQGGQGTVYKGMLT--DGRI-VAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLG 423
LG G G+V +G+ +I VA+K K ++ + E+ + E I+ Q+++ IV+L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 483
C + +LV E G L++++ + EE + + +VS + YL +
Sbjct: 78 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYLEEKNFV-- 132
Query: 484 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYFQSSQFT 541
HRD+ + N+LL +++ AK+SDFG S+++ D ++ T + G + + PE +F+
Sbjct: 133 -HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 542 EKSDVYSFGVVLVEILT-GQKP 562
+SDV+S+GV + E L+ GQKP
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKP 213
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 59/273 (21%), Positives = 100/273 (36%), Gaps = 31/273 (11%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQI-NH 415
++ LG G G V+K DGR+ AVK+S + + + EV ++ H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 416 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 475
V+L E + L E +L Q+ P + + AL +L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPE--AQVWGYLRDTLLALAHL 173
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 535
HS + H D+K ANI L + R K+ DFG + +G Y+ PE
Sbjct: 174 HSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLV--ELGTAGAGEVQEGDPRYMAPELL 228
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595
Q + +DV+S G+ ++E+ + Q + + L A +
Sbjct: 229 Q-GSYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLPPEFTAGL 277
Query: 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
E + + L + K+R T + +
Sbjct: 278 SSELRS--------VLVMMLEPDPKLRATAEAL 302
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-38
Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 16/207 (7%)
Query: 366 RILGQGGQGTVYKGMLTDGRI-----VAVK--KSKLVDETNVEQFINEVVILSQINHRNI 418
+++G G G VYKGML VA+K K+ ++ V+ F+ E I+ Q +H NI
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNI 108
Query: 419 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 478
++L G + + +++ E++ NG L +++ + EF + L+ + ++ + YL +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEF--SVLQLVGMLRGIAAGMKYLANM 166
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQ 536
+ HRD+ + NIL++ KVSDFG SR + D T G PE
Sbjct: 167 NYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 537 SSQFTEKSDVYSFGVVLVEILT-GQKP 562
+FT SDV+SFG+V+ E++T G++P
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 67/238 (28%), Positives = 107/238 (44%), Gaps = 18/238 (7%)
Query: 366 RILGQGGQGTVYKGMLT-----DGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIV 419
R LG+G G V G VAVK K ++ E+ IL + H NIV
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 420 KLLGCCLETEVP--LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 477
K G C E L+ EF+P+G+L +Y+ + I + L+ AV++ + YL S
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 478 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF--GYVDPEYF 535
+ HRD+ + N+L++ +++ K+ DFG ++++ D+ + T K + PE
Sbjct: 145 RQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 536 QSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592
S+F SDV+SFGV L E+LT + + + RL L
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH--GQMTVTRLVNTLK 257
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 4e-38
Identities = 68/206 (33%), Positives = 104/206 (50%), Gaps = 18/206 (8%)
Query: 366 RILGQGGQGTVYKGMLTDGRI----VAVKKSKL-VDETNVEQFINEVVILSQINHRNIVK 420
RILG+G G VY+G+ T+ + VAVK K N E+F++E VI+ ++H +IVK
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 421 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 480
L+G E E ++ E P G L Y+ + L+ ++++ A+ YL S
Sbjct: 78 LIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLESINC 134
Query: 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT---FGYVDPEYFQS 537
+ HRDI NIL+ K+ DFG SR + + K T ++ PE
Sbjct: 135 V---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESINF 188
Query: 538 SQFTEKSDVYSFGVVLVEILT-GQKP 562
+FT SDV+ F V + EIL+ G++P
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 8e-38
Identities = 72/289 (24%), Positives = 125/289 (43%), Gaps = 37/289 (12%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
+ LG G G V+ VAVK K +VE F+ E ++ + H +VKL
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 426 LETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
T+ P+ ++ EF+ G+L ++ + E L+ + +++ + ++ I
Sbjct: 253 --TKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNYI--- 306
Query: 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSSQFTE 542
HRD+++ANIL+ K++DFG +R + ++ T + F PE FT
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTI 364
Query: 543 KSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQAINE--NRLFEILDARVLK 597
KSDV+SFG++L+EI+T G+ P ++ E + GY + L+
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN-------- 416
Query: 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGASILQQ 646
IM RC + RPT + + L T+T + +
Sbjct: 417 ------IM------MRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEI 453
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-37
Identities = 68/315 (21%), Positives = 124/315 (39%), Gaps = 43/315 (13%)
Query: 334 QQELSSNESNIEKTKLFTSKDLEKATDN---YNANRILGQGGQGTVYKGMLTDGRIVAVK 390
+Q + S + + +S E + Y+ + +G GG V++ + +I A+K
Sbjct: 27 RQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK 86
Query: 391 KSKL--VDETNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFIPNGTLYQY 446
L D ++ + NE+ L+++ I++L + + +V E N L +
Sbjct: 87 YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSW 145
Query: 447 IHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 506
+ + + + A+ +H I H D+K AN L+ D K+ DF
Sbjct: 146 LKKK-KSIDP--WERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDF 198
Query: 507 GTSRSVMVDQTHLTTKVQ-GTFGYVDPEYFQSS-----------QFTEKSDVYSFGVVLV 554
G + + D T + Q G Y+ PE + + + KSDV+S G +L
Sbjct: 199 GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258
Query: 555 EILTGQKPIRAINTDEDKSLVGYFLQAI-NENRLFEILDARVLKEAKKEGIMTVATLAKR 613
+ G+ P + I K L AI + N E D K+ + + K
Sbjct: 259 YMTYGKTPFQQIINQISK------LHAIIDPNHEIEFPD-IPEKDLQD--------VLKC 303
Query: 614 CLNLNGKMRPTMKEV 628
CL + K R ++ E+
Sbjct: 304 CLKRDPKQRISIPEL 318
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 66/285 (23%), Positives = 116/285 (40%), Gaps = 40/285 (14%)
Query: 361 NYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINH--R 416
Y+ + +G GG V++ + +I A+K L D ++ + NE+ L+++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 476
I++L + + +V E N L ++ + + + A+ +H
Sbjct: 70 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK-KSIDP--WERKSYWKNMLEAVHTIH 125
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ-GTFGYVDPEYF 535
I H D+K AN L+ D K+ DFG + + D T + Q GT Y+ PE
Sbjct: 126 QHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 536 Q-----------SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI-N 583
+ S+ + KSDV+S G +L + G+ P + I K L AI +
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK------LHAIID 235
Query: 584 ENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
N E D K+ + + K CL + K R ++ E+
Sbjct: 236 PNHEIEFPD-IPEKDLQD--------VLKCCLKRDPKQRISIPEL 271
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 2e-37
Identities = 44/210 (20%), Positives = 81/210 (38%), Gaps = 25/210 (11%)
Query: 362 YNANRILGQGGQGTVYKG--MLTDGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNI 418
Y + GG G +Y +GR V +K D + E L+++ H +I
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 419 VKLL-----GCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 473
V++ V +V E++ +L + + + +E+ AL
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALS 196
Query: 474 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 533
YLHS + + D+K NI+L ++ + K+ D G + + + GT G+ PE
Sbjct: 197 YLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI--NSFGY---LYGTPGFQAPE 247
Query: 534 YFQ-SSQFTEKSDVYSFGVVLVEILTGQKP 562
+ T +D+Y+ G L +
Sbjct: 248 --IVRTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-37
Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 366 RILGQGGQGTVYKGMLTDGR----IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVK 420
+++G G G V G L VA+K K+ E F+ E I+ Q +H NI++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 421 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 480
L G +++ ++V E++ NG+L ++ +F T L+ + ++ + YL
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMGY 168
Query: 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSS 538
+ HRD+ + NIL++ KVSDFG R + D T G PE
Sbjct: 169 V---HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 539 QFTEKSDVYSFGVVLVEILT-GQKP 562
+FT SDV+S+G+VL E+++ G++P
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-37
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 366 RILGQGGQGTVYKGMLTDGR----IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVK 420
R +G+G G V++G+ VA+K K ++ E+F+ E + + Q +H +IVK
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 421 LLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAAS 480
L+G E ++ E G L ++ + + L+ A ++S AL YL S
Sbjct: 81 LIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESKRF 137
Query: 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF 540
+ HRDI + N+L+ K+ DFG SR + + +K + ++ PE +F
Sbjct: 138 V---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 541 TEKSDVYSFGVVLVEILT-GQKP 562
T SDV+ FGV + EIL G KP
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-37
Identities = 56/239 (23%), Positives = 91/239 (38%), Gaps = 22/239 (9%)
Query: 333 LQQELSSNESNIEKTKLF-TSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK 390
L E NE + KL + + +G+G G V++ G AVK
Sbjct: 30 LGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK 89
Query: 391 KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI--H 448
K V E+V + ++ IV L G E + E + G+L Q I
Sbjct: 90 K---VRLEVFRV--EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM 144
Query: 449 NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFG 507
+ E + L + L YLH+ + H D+K+ N+LL RA + DFG
Sbjct: 145 GCLPE-----DRALYYLGQALEGLEYLHTRRIL---HGDVKADNVLLSSDGSRAALCDFG 196
Query: 508 TSRSVMVDQTHLTTK----VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
+ + D + + GT ++ PE K D++S +++ +L G P
Sbjct: 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 32/222 (14%)
Query: 366 RILGQGGQGTVYKGMLTDGR------IVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 419
R LG+G G V+ + +VAVK K + F E +L+ + H +IV
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFPITWELLLRIAV 466
K G C + + ++V+E++ +G L ++ + + + +L IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 526
+++ + YL AS HRD+ + N L+ K+ DFG SR V + +V G
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---RVGGH 194
Query: 527 FGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 562
+ PE +FT +SDV+SFGV+L EI T G++P
Sbjct: 195 -TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 366 RILGQGGQGTVYKGMLTDGR------IVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 419
LG+G G V+ + +VAVK K E+ + F E +L+ + H++IV
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQY------------IHNQIEEFPITWELLLRIAVE 467
+ G C E L+V+E++ +G L ++ + P+ LL +A +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 468 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 527
V+ + YL A + HRD+ + N L+ K+ DFG SR + +V G
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---YYRVGGR- 219
Query: 528 GYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 562
+ PE +FT +SDV+SFGVVL EI T G++P
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-36
Identities = 62/202 (30%), Positives = 112/202 (55%), Gaps = 13/202 (6%)
Query: 368 LGQGGQGTVYKGMLT--DGRI-VAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLG 423
LG G G+V +G+ +I VA+K K ++ + E+ + E I+ Q+++ IV+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 424 CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 483
C + +LV E G L++++ + EE P + + +VS + YL +
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIP--VSNVAELLHQVSMGMKYLEEKNFV-- 458
Query: 484 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY--VDPEYFQSSQFT 541
HR++ + N+LL +++ AK+SDFG S+++ D ++ T + G + PE +F+
Sbjct: 459 -HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 542 EKSDVYSFGVVLVEILT-GQKP 562
+SDV+S+GV + E L+ GQKP
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKP 539
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 65/276 (23%), Positives = 107/276 (38%), Gaps = 34/276 (12%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
Y R LG+GG ++ D + A K KS L+ E+ E+ I + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 416 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGAL 472
+++V G E + +V E +L + + E P L +I
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTE-PEARYYLRQIV----LGC 154
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532
YLH + HRD+K N+ L++ K+ DFG + V D + GT Y+ P
Sbjct: 155 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 210
Query: 533 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592
E + + DV+S G ++ +L G+ P E L + I +N + I
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF------ETSCLKETY-LRIKKNE-YSI-P 261
Query: 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ A L ++ L + RPT+ E+
Sbjct: 262 KHINPVAAS--------LIQKMLQTDPTARPTINEL 289
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 25/230 (10%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
+ + ILGQG V++G G + A+K + V+ + E +L ++NH
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66
Query: 416 RNIVKLLGC--CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 473
+NIVKL T +L+ EF P G+LY + + + L + +V G +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 474 YLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 529
+L I HR+IK NI+ D + K++DFG +R + D + GT Y
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVSLY-GTEEY 181
Query: 530 VDPEYFQSS--------QFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 571
+ P+ ++ + ++ D++S GV TG P R
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 68/283 (24%), Positives = 121/283 (42%), Gaps = 31/283 (10%)
Query: 352 SKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEV 407
+ + + +++ +LG+G VY+ + G VA+K K + V++ NEV
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 408 VILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLR-IA 465
I Q+ H +I++L E + LV E NG + +Y+ N+++ F E R
Sbjct: 63 KIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS---ENEARHFM 118
Query: 466 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 525
++ + YLHS I HRD+ +N+LL K++DFG + + + T + G
Sbjct: 119 HQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCG 174
Query: 526 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN 585
T Y+ PE S +SDV+S G + +L G+ P + ++ +
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF------DTDTVKNTL-NKVVLA 227
Query: 586 RLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ + + EAK L + L N R ++ V
Sbjct: 228 DY--EMPSFLSIEAKD--------LIHQLLRRNPADRLSLSSV 260
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 64/276 (23%), Positives = 106/276 (38%), Gaps = 34/276 (12%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
Y R LG+GG ++ D + A K KS L+ E+ E+ I + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 416 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGAL 472
+++V G E + +V E +L + + E P L +I
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTE-PEARYYLRQIV----LGC 128
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532
YLH + HRD+K N+ L++ K+ DFG + V D + GT Y+ P
Sbjct: 129 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 184
Query: 533 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592
E + + DV+S G ++ +L G+ P E L + I +N +
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF------ETSCLKETY-LRIKKNEY--SIP 235
Query: 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ A L ++ L + RPT+ E+
Sbjct: 236 KHINPVAAS--------LIQKMLQTDPTARPTINEL 263
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 60/301 (19%), Positives = 111/301 (36%), Gaps = 66/301 (21%)
Query: 366 RILGQGGQGTVYKGMLTDGRI--------VAVKKSKLVDETNVEQFINEVVILSQINHRN 417
LGQG ++KG+ + V +K E F ++S+++H++
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 418 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 477
+V G C+ + +LV EF+ G+L Y+ I W L +A +++ A+ +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEE 131
Query: 478 AASIPIYHRDIKSANILLDDKYR--------AKVSDFGTSRSVMVDQTHLTTKVQGTFGY 529
I H ++ + NILL + K+SD G S +V+
Sbjct: 132 NTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------IL 177
Query: 530 VDP---------EYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GY 577
+ E + +D +SFG L EI + G KP+ A+++ +
Sbjct: 178 QERIPWVPPECIENPK--NLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH 235
Query: 578 FLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRT 637
L A L ++ C++ RP+ + + +L + T
Sbjct: 236 QLPAPKAAELAN--------------LIN------NCMDYEPDHRPSFRAIIRDLNSLFT 275
Query: 638 S 638
Sbjct: 276 P 276
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 68/217 (31%), Positives = 99/217 (45%), Gaps = 17/217 (7%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
+++ R LG+G G VY I+A+K K++L Q EV I S + H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 416 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLR-IAVEVSGALF 473
NI++L G + L+ E+ P GT+Y+ + +F E E++ AL
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKL-SKFD---EQRTATYITELANALS 123
Query: 474 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 533
Y HS + HRDIK N+LL K++DFG SV + T GT Y+ PE
Sbjct: 124 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDLC-GTLDYLPPE 177
Query: 534 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+ EK D++S GV+ E L G+ P A E
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-36
Identities = 78/290 (26%), Positives = 126/290 (43%), Gaps = 33/290 (11%)
Query: 348 KLFTSKDLEKATDNYNANRILGQGGQGTVYKG-MLTDGRIVAVK---KSKLVDETNVEQF 403
+F +D Y R+LG+G G V G+ AVK K ++ +T+ E
Sbjct: 14 GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73
Query: 404 INEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLR 463
+ EV +L Q++H NI+KL + LV E G L+ I I + R
Sbjct: 74 LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAAR 130
Query: 464 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGTSRSVMVDQTHLT 520
I +V + Y+H I HRD+K N+LL+ K ++ DFG S + +
Sbjct: 131 IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MK 186
Query: 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ 580
K+ GT Y+ PE + + EK DV+S GV+L +L+G P N + L+
Sbjct: 187 DKI-GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILK 237
Query: 581 AINENRL-FEILD-ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ + + FE+ +V + AK L ++ L MR + ++
Sbjct: 238 KVEKGKYTFELPQWKKVSESAKD--------LIRKMLTYVPSMRISARDA 279
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-36
Identities = 35/299 (11%), Positives = 70/299 (23%), Gaps = 52/299 (17%)
Query: 366 RILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKL 421
L G + V+ + A+K + +E+ +++ + +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 422 LGCCLETEVP--------------------------LLVYEFIPNGTLYQYI----HNQI 451
LL+ + L +
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYV 186
Query: 452 EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511
L + ++ L S + H N+ + R + D
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 512 VMVDQTHLTTKVQGTFGYVDPEYFQSS--QFTEKSDVYSFGVVLVEILTGQKPIRAINTD 569
V Y E+ +S FT + + G+ + + P +
Sbjct: 244 V----GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 570 EDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
S L+ + L + K TL R LN + + R E
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVK--------TLIGRFLNFDRRRRLLPLEA 350
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-35
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 25/230 (10%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
+ + ILGQG V++G G + A+K + V+ + E +L ++NH
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66
Query: 416 RNIVKLLGC--CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 473
+NIVKL T +L+ EF P G+LY + + + L + +V G +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 474 YLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 529
+L I HR+IK NI+ D + K++DFG +R + D + GT Y
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVSLY-GTEEY 181
Query: 530 VDPEYFQSS--------QFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 571
+ P+ ++ + ++ D++S GV TG P R
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 70/298 (23%), Positives = 117/298 (39%), Gaps = 53/298 (17%)
Query: 366 RILGQGGQGTVYKGMLTDGR------IVAVK--KSKLVDETNVEQFINEVVILSQINHRN 417
R LG G G VY+G ++ VAVK ++ ++ F+ E +I+S+ NH+N
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 94
Query: 418 IVKLLGCCLETEVPLLVYEFIPNGTLYQYI----HNQIEEFPITWELLLRIAVEVSGALF 473
IV+ +G L++ ++ E + G L ++ + + LL +A +++
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 474 YLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 530
YL HRDI + N LL AK+ DFG +R + + +G +
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY----RKGGCAML 207
Query: 531 -----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV--GYFLQAI 582
PE F FT K+D +SFGV+L EI + G P + + E V G +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 267
Query: 583 NE--NRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638
++ IMT +C + RP + +
Sbjct: 268 KNCPGPVYR--------------IMT------QCWQHQPEDRPNFAIILERIEYCTQD 305
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-35
Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 18/227 (7%)
Query: 356 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK-SKLVDETNVEQFINEVVILSQI 413
+ + LG GG G V + + G VA+K+ + + N E++ E+ I+ ++
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 414 NHRNIVKLLGCCLETE-------VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV 466
NH N+V + +PLL E+ G L +Y++ + + +
Sbjct: 70 NHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGTSRSVMVDQTHLTTKV 523
++S AL YLH I HRD+K NI+L + K+ D G ++ + T V
Sbjct: 129 DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-ELDQGELCTEFV 184
Query: 524 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
GT Y+ PE + ++T D +SFG + E +TG +P
Sbjct: 185 -GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV 230
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 64/231 (27%), Positives = 107/231 (46%), Gaps = 41/231 (17%)
Query: 366 RILGQGGQGTVYKGMLTDGR------IVAVKKSK-LVDETNVEQFINEVVILSQINHRNI 418
+ LG+G G V K + VAVK K + + ++E +L Q+NH ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 419 VKLLGCCLETEVPLLVYEFIPNGTLYQY---------------------IHNQIEEFPIT 457
+KL G C + LL+ E+ G+L + + +E +T
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 458 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517
L+ A ++S + YL A + + HRD+ + NIL+ + + K+SDFG SR V + +
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 518 HLTTKVQGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 562
+ V+ + G + E +T +SDV+SFGV+L EI+T G P
Sbjct: 206 Y----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 74/366 (20%), Positives = 131/366 (35%), Gaps = 68/366 (18%)
Query: 313 KRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNAN------- 365
+I + + + Q S + + + T + ++
Sbjct: 9 HHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEV 68
Query: 366 --------RILGQGGQGTVYKGMLTDGR------IVAVK--KSKLVDETNVEQFINEVVI 409
R LG G G VY+G ++ VAVK ++ ++ F+ E +I
Sbjct: 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALI 127
Query: 410 LSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI----HNQIEEFPITWELLLRIA 465
+S+ NH+NIV+ +G L++ ++ E + G L ++ + + LL +A
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 466 VEVSGALFYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGTSRSVMVDQTHLTTK 522
+++ YL HRDI + N LL AK+ DFG +R + +
Sbjct: 188 RDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY---- 240
Query: 523 VQGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV- 575
+G + PE F FT K+D +SFGV+L EI + G P + + E V
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300
Query: 576 -GYFLQAINE--NRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632
G + ++ IMT +C + RP + +
Sbjct: 301 SGGRMDPPKNCPGPVYR--------------IMT------QCWQHQPEDRPNFAIILERI 340
Query: 633 GGIRTS 638
Sbjct: 341 EYCTQD 346
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-35
Identities = 73/311 (23%), Positives = 120/311 (38%), Gaps = 41/311 (13%)
Query: 334 QQELSSNESNIEKTK-------LFTSKDLEKATDNYNANRILGQGGQGTVYKG-MLTDGR 385
SS N+ +F + ++ Y + LG G G V
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 386 IVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGT 442
A+K K+ + + + + EV +L ++H NI+KL + LV E G
Sbjct: 64 ERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122
Query: 443 LYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK---Y 499
L+ I I I +V + YLH I HRD+K N+LL+ K
Sbjct: 123 LFDEI---IHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDA 176
Query: 500 RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTG 559
K+ DFG S + + ++ GT Y+ PE + + EK DV+S GV+L +L G
Sbjct: 177 LIKIVDFGLSAVFENQKK-MKERL-GTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAG 233
Query: 560 QKPIRAINTDEDKSLVGYFLQAINENRL-FEILD-ARVLKEAKKEGIMTVATLAKRCLNL 617
P E L+ + + + F+ + V + AK L K+ L
Sbjct: 234 YPPFGGQTDQE-------ILRKVEKGKYTFDSPEWKNVSEGAKD--------LIKQMLQF 278
Query: 618 NGKMRPTMKEV 628
+ + R + ++
Sbjct: 279 DSQRRISAQQA 289
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-35
Identities = 85/387 (21%), Positives = 146/387 (37%), Gaps = 83/387 (21%)
Query: 309 YKFVKRRKEI--KLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNA-- 364
+ + KL ++ R + + SS SN ++ T T
Sbjct: 7 HHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS 66
Query: 365 -------------------NRILGQGGQGTVYKGMLTDGR--------IVAVKKSK-LVD 396
+ LG+G G V VAVK K
Sbjct: 67 EYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 126
Query: 397 ETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTL------------ 443
E ++ ++E+ ++ I H+NI+ LLG C + ++ E+ G L
Sbjct: 127 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 186
Query: 444 -YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAK 502
Y Y N++ E +T++ L+ +++ + YL AS HRD+ + N+L+ + K
Sbjct: 187 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMK 243
Query: 503 VSDFGTSRSVMVDQTHLTTKVQGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEIL 557
++DFG +R + + + T G + PE +T +SDV+SFGV++ EI
Sbjct: 244 IADFGLARDINNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299
Query: 558 T-GQKPIRAINTDEDKSLV--GYFLQAINE--NRLFEILDARVLKEAKKEGIMTVATLAK 612
T G P I +E L+ G+ + N L+ +M +
Sbjct: 300 TLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM--------------MM------R 339
Query: 613 RCLNLNGKMRPTMKEVAFELGGIRTST 639
C + RPT K++ +L I T T
Sbjct: 340 DCWHAVPSQRPTFKQLVEDLDRILTLT 366
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 79/307 (25%), Positives = 122/307 (39%), Gaps = 60/307 (19%)
Query: 366 RILGQGGQGTVYKGMLTD------GRIVAVKKSK-LVDETNVEQFINEVVILSQI-NHRN 417
+ LG+G G V + R VAVK K + ++E+ IL I +H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 418 IVKLLGCCLETEVPLLV-YEFIPNGTL-------------YQYIHNQIEEFPITWELLLR 463
+V LLG C + PL+V EF G L Y+ + + +T E L+
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 464 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 523
+ +V+ + +L AS HRD+ + NILL +K K+ DFG +R + D + V
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----V 205
Query: 524 QGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGY 577
+ + PE +T +SDV+SFGV+L EI + G P Y
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--------------Y 251
Query: 578 FLQAINENRLFEILDARVL---KEAKKE--GIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632
I+E + + + E M C + RPT E+ L
Sbjct: 252 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM------LDCWHGEPSQRPTFSELVEHL 305
Query: 633 GGIRTST 639
G + +
Sbjct: 306 GNLLQAN 312
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 76/307 (24%), Positives = 129/307 (42%), Gaps = 60/307 (19%)
Query: 366 RILGQGGQGTVYKGMLTDGR--------IVAVKKSK-LVDETNVEQFINEVVILSQI-NH 415
+ LG+G G V VAVK K E ++ ++E+ ++ I H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 416 RNIVKLLGCCLETEVPLLVYEFIPNGTL-------------YQYIHNQIEEFPITWELLL 462
+NI+ LLG C + ++ E+ G L Y Y N++ E +T++ L+
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 463 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 522
+++ + YL AS HRD+ + N+L+ + K++DFG +R + +
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 213
Query: 523 VQGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV- 575
+ T G + PE +T +SDV+SFGV++ EI T G P I +E L+
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273
Query: 576 -GYFLQAINE--NRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632
G+ + N L+ +M + C + RPT K++ +L
Sbjct: 274 EGHRMDKPANCTNELYM--------------MM------RDCWHAVPSQRPTFKQLVEDL 313
Query: 633 GGIRTST 639
I T T
Sbjct: 314 DRILTLT 320
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-35
Identities = 57/279 (20%), Positives = 112/279 (40%), Gaps = 33/279 (11%)
Query: 361 NYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIV 419
++ +LG G +GT+ + D R VAVK+ + EV +L + + H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR---ILPECFSFADREVQLLRESDEHPNVI 81
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
+ + + + E TL +Y+ + ++F + + + + L +LHS
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 480 SIPIYHRDIKSANILLDDK-----YRAKVSDFGTSRSVMVDQTHLT--TKVQGTFGYVDP 532
I HRD+K NIL+ +A +SDFG + + V + + + V GT G++ P
Sbjct: 139 ---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 533 EYFQSSQF---TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589
E T D++S G V +++ + + L
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ------ANILLGACSLDC 249
Query: 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ + +E L ++ + ++ + RP+ K V
Sbjct: 250 LHPEKHEDVIARE-------LIEKMIAMDPQKRPSAKHV 281
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 17/217 (7%)
Query: 360 DNYNANRILGQGGQGTVYKG-MLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
D+++ R LG+G G VY + I+A+K KS+L E Q E+ I S + H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 416 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLR-IAVEVSGALF 473
NI+++ + L+ EF P G LY+ + F E E++ AL
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKH-GRFD---EQRSATFMEELADALH 128
Query: 474 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 533
Y H + HRDIK N+L+ K K++DFG SV T + GT Y+ PE
Sbjct: 129 YCHERK---VIHRDIKPENLLMGYKGELKIADFGW--SVHAPSLRRRT-MCGTLDYLPPE 182
Query: 534 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+ EK D++ GV+ E L G P + + E
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-34
Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 14/204 (6%)
Query: 366 RILGQGGQGTVYKGMLTDGR----IVAVK--KSKLVDETNVEQFINEVVILSQINHRNIV 419
R +G+G G V++G+ VA+K K+ D + F+ E + + Q +H +IV
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIV 454
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
KL+G E V ++ E G L ++ + + L+ A ++S AL YL S
Sbjct: 455 KLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLESKR 511
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 539
+ HRDI + N+L+ K+ DFG SR + + +K + ++ PE +
Sbjct: 512 FV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 540 FTEKSDVYSFGVVLVEILT-GQKP 562
FT SDV+ FGV + EIL G KP
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKP 592
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 51/220 (23%), Positives = 101/220 (45%), Gaps = 27/220 (12%)
Query: 366 RILGQGGQGTVYKGMLTDGR------IVAVKKSK-LVDETNVEQFINEVVILSQINHRNI 418
LG+ G VYKG L VA+K K + E+F +E ++ +++ H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 419 VKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFPITWELLLRIA 465
V LLG + + +++ + +G L+++ ++ + + + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 466 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 525
+++ + YL +S + H+D+ + N+L+ DK K+SD G R V +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY-KLLGNS 190
Query: 526 TF--GYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 562
++ PE +F+ SD++S+GVVL E+ + G +P
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 86/384 (22%), Positives = 148/384 (38%), Gaps = 86/384 (22%)
Query: 304 GIWWLYKFVKRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYN 363
G+ + YK K + +++ K +++ ++ + I+ T+L ++ E +N
Sbjct: 1 GVDYKYKQ-KPKYQVRWK----------IIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQ 49
Query: 364 ANRILGQGGQGTVYKGMLTDGR------IVAVKKSK-LVDETNVEQFINEVVILSQI-NH 415
+ LG G G V + VAVK K E ++E+ I+S + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 416 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQY-----------IHNQIEEFPITWELLLRI 464
NIV LLG C L++ E+ G L + I + LL
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 465 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ 524
+ +V+ + +L AS HRD+ + N+LL + + AK+ DFG +R +M D
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN------- 219
Query: 525 GTFGYVD------------PEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDED 571
Y+ PE +T +SDV+S+G++L EI + G P I +
Sbjct: 220 ----YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275
Query: 572 KSLVGYFLQAINE-NRLFEILDARVLKEAKKE--GIMTVATLAKRCLNLNGKMRPTMKEV 628
F + + + ++ A K IM + C L RPT +++
Sbjct: 276 ------FYKLVKDGYQM------AQPAFAPKNIYSIM------QACWALEPTHRPTFQQI 317
Query: 629 AFELGGIRTSTGASILQQNCEEID 652
L Q++ E D
Sbjct: 318 CSFLQ--------EQAQEDRRERD 333
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-34
Identities = 77/324 (23%), Positives = 132/324 (40%), Gaps = 67/324 (20%)
Query: 365 NRILGQGGQGTVYKGMLTD--------GRIVAVKKSK-LVDETNVEQFINEVVILSQI-N 414
+ LG+G G V VAVK K E ++ I+E+ ++ I
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 415 HRNIVKLLGCCLETEVPLLVYEFIPNGTL-------------YQYIHNQIEEFPITWELL 461
H+NI+ LLG C + ++ E+ G L Y Y + E ++ + L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 462 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT 521
+ A +V+ + YL AS HRD+ + N+L+ + K++DFG +R + +
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY--- 247
Query: 522 KVQGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLV 575
+ T G + PE +T +SDV+SFGV+L EI T G P + +E L+
Sbjct: 248 -KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306
Query: 576 --GYFLQAINE--NRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631
G+ + + N L+ +M + C + RPT K++ +
Sbjct: 307 KEGHRMDKPSNCTNELYM--------------MM------RDCWHAVPSQRPTFKQLVED 346
Query: 632 LGGIRTSTGASILQQNCEEIDFVD 655
L I T + +E+ +
Sbjct: 347 LDRIVALT-------SNQEMGYYH 363
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-34
Identities = 69/299 (23%), Positives = 123/299 (41%), Gaps = 50/299 (16%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNI 418
+ + +ILG G GTV GR VAVK+ + + + E+ +L++ +H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR---MLIDFCDIALMEIKLLTESDDHPNV 71
Query: 419 VKLLGCCLETEVPL-LVYEFIPNGTLYQYI---HNQIEEFPITWEL-LLRIAVEVSGALF 473
++ C T+ L + E N L + + E + E + + +++ +
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 474 YLHSAASIPIYHRDIKSANILLDDK-------------YRAKVSDFGTSRSVMVDQTHLT 520
+LH S+ I HRD+K NIL+ R +SDFG + + Q+
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 521 TKVQ---GTFGYVDPEYFQSSQF-------TEKSDVYSFGVVLVEILT-GQKPIRAINTD 569
T + GT G+ PE + S T D++S G V IL+ G+ P +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 570 EDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
E + G F + + + + D ++ EA L + ++ + RPT +V
Sbjct: 247 ESNIIRGIF----SLDEMKCLHDRSLIAEAT--------DLISQMIDHDPLKRPTAMKV 293
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 56/231 (24%), Positives = 100/231 (43%), Gaps = 41/231 (17%)
Query: 366 RILGQGGQGTVYKGMLTDGR------IVAVKKSK-LVDETNVEQFINEVVILSQINHRNI 418
R +G+G G V++ +VAVK K F E ++++ ++ NI
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 419 VKLLGCCLETEVPLLVYEFIPNGTLYQY---------------------IHNQIEEFPIT 457
VKLLG C + L++E++ G L ++ + P++
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 458 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517
L IA +V+ + YL + HRD+ + N L+ + K++DFG SR++
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 518 HLTTKVQGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 562
+ + PE +++T +SDV+++GVVL EI + G +P
Sbjct: 230 Y----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-34
Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 366 RILGQGGQGTVYKGMLTDG---RIVAVKKSK-LVDETNVEQFINEVVILSQI-NHRNIVK 420
++G+G G V K + A+K+ K + + F E+ +L ++ +H NI+
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 421 LLGCCLETEVPLLVYEFIPNGTLYQY-------------IHNQIEEFPITWELLLRIAVE 467
LLG C L E+ P+G L + ++ + LL A +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 468 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 527
V+ + YL + HRD+ + NIL+ + Y AK++DFG SR V V+ T
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKTM 200
Query: 528 GYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 562
G + E S +T SDV+S+GV+L EI++ G P
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-33
Identities = 82/320 (25%), Positives = 126/320 (39%), Gaps = 49/320 (15%)
Query: 334 QQELSSNESNIEKTKLFTSKDL------EKATDNYNANRILGQGGQGTVYKG-MLTDGRI 386
SS N+ + + + K ++Y R LG G G V
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 387 VAVK---KSKLVD----------ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433
A+K KS+ E E+ NE+ +L ++H NI+KL + + L
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123
Query: 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANI 493
V EF G L++ I I I ++ + YLH I HRDIK NI
Sbjct: 124 VTEFYEGGELFEQI---INRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENI 177
Query: 494 LLDDK---YRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFG 550
LL++K K+ DFG S D L ++ GT Y+ PE + + EK DV+S G
Sbjct: 178 LLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRL-GTAYYIAPEVLKKK-YNEKCDVWSCG 234
Query: 551 VVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL-FEILD-ARVLKEAKKEGIMTVA 608
V++ +L G P N + ++ + + + F+ D + EAK+
Sbjct: 235 VIMYILLCGYPPFGGQNDQD-------IIKKVEKGKYYFDFNDWKNISDEAKE------- 280
Query: 609 TLAKRCLNLNGKMRPTMKEV 628
L K L + R T +E
Sbjct: 281 -LIKLMLTYDYNKRCTAEEA 299
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 57/297 (19%), Positives = 108/297 (36%), Gaps = 56/297 (18%)
Query: 359 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQI-N 414
T ++ +G G G+V+K + DG I A+K+SK + + + EV + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 415 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI-HNQIEEFPITWELLLRIAVEVSGALF 473
H ++V+ E + L+ E+ G+L I N L + ++V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 474 YLHSAASIPIYHRDIKSANILLD-------------------DKYRAKVSDFGTSRSVMV 514
Y+HS + + H DIK +NI + +K K+ D G +
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 515 DQTHLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKS 573
Q +G ++ E Q + K+D+++ + +V + R +
Sbjct: 187 PQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----- 236
Query: 574 LVGYFLQAINENRLFEILDA--RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
I + RL I + E L K ++ + + RP+ +
Sbjct: 237 -----WHEIRQGRLPRIPQVLSQEFTE-----------LLKVMIHPDPERRPSAMAL 277
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 76/311 (24%), Positives = 121/311 (38%), Gaps = 67/311 (21%)
Query: 366 RILGQGGQGTVYKGMLTDGR------IVAVKKSK-LVDETNVEQFINEVVILSQI-NHRN 417
+ LG G G V + VAVK K T E ++E+ +LS + NH N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 418 IVKLLGCCLETEVPLLVYEFIPNGTLYQY---------------IHNQIEEFPITWELLL 462
IV LLG C L++ E+ G L + + +E + E LL
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 463 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 522
+ +V+ + +L AS HRD+ + NILL K+ DFG +R + D ++
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 523 -----VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVG 576
V+ PE + +T +SDV+S+G+ L E+ + G P + D
Sbjct: 206 NARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----- 256
Query: 577 YFLQAINE-NRLFEILDARVLKEAKKEG-------IMTVATLAKRCLNLNGKMRPTMKEV 628
F + I E R+ E IM K C + + RPT K++
Sbjct: 257 -FYKMIKEGFRM-----------LSPEHAPAEMYDIM------KTCWDADPLKRPTFKQI 298
Query: 629 AFELGGIRTST 639
+ + +
Sbjct: 299 VQLIEKQISES 309
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-33
Identities = 73/301 (24%), Positives = 126/301 (41%), Gaps = 39/301 (12%)
Query: 338 SSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKG-MLTDGRIVAVK---KSK 393
+ + + L+ + YN +LG+G G V K + AVK K+
Sbjct: 3 HHHHHSSGRENLYFQGTFA---ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS 59
Query: 394 LVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIE 452
++ + + EV +L +++H NI+KL E +V E G L+ I I+
Sbjct: 60 AKNK-DTSTILREVELLKKLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEI---IK 114
Query: 453 EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGTS 509
+ RI +V + Y+H I HRD+K NILL+ K K+ DFG S
Sbjct: 115 RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171
Query: 510 RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTD 569
+ + ++ GT Y+ PE + + + EK DV+S GV+L +L+G P N
Sbjct: 172 TCFQQNTK-MKDRI-GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY 228
Query: 570 EDKSLVGYFLQAINENRL-FEILD-ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKE 627
+ L+ + + F++ + +AK L ++ L + +R T +
Sbjct: 229 D-------ILKRVETGKYAFDLPQWRTISDDAKD--------LIRKMLTFHPSLRITATQ 273
Query: 628 V 628
Sbjct: 274 C 274
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 65/327 (19%), Positives = 122/327 (37%), Gaps = 46/327 (14%)
Query: 350 FTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVV 408
F + +E R+L +GG VY+ + GR A+K+ +E I EV
Sbjct: 18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVC 77
Query: 409 ILSQI-NHRNIVKLLGCCLETEVP-------LLVYEFIPNGTLYQYIHNQIEEFPITWEL 460
+ ++ H NIV+ + L+ + G L +++ P++ +
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 461 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520
+L+I + A+ ++H PI HRD+K N+LL ++ K+ DFG++ ++ +
Sbjct: 138 VLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196
Query: 521 TKVQ-----------GTFGYVDPEYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAI 566
+ + T Y PE EK D+++ G +L + Q P
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF--- 253
Query: 567 NTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMK 626
ED + + I + L + L +N + R ++
Sbjct: 254 ---EDGAKL-----RIVNGKYSIPPHDTQYTVFHS--------LIRAMLQVNPEERLSIA 297
Query: 627 EV---AFELGGIRTSTGASILQQNCEE 650
EV E+ R S + + E+
Sbjct: 298 EVVHQLQEIAAARNVNPKSPITELLEQ 324
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 63/240 (26%), Positives = 103/240 (42%), Gaps = 41/240 (17%)
Query: 366 RILGQGGQGTVYKGMLTDGR------IVAVKKSK-LVDETNVEQFINEVVILSQI-NHRN 417
++LG G G V VAVK K D + E ++E+ +++Q+ +H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 418 IVKLLGCCLETEVPLLVYEFIPNGTLYQY--------------------IHNQIEEFPIT 457
IV LLG C + L++E+ G L Y + + + +T
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 458 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517
+E LL A +V+ + +L HRD+ + N+L+ K+ DFG +R +M D
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 518 HLTTKVQGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDED 571
+ V + PE +T KSDV+S+G++L EI + G P I D +
Sbjct: 228 Y----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 283
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 67/249 (26%), Positives = 110/249 (44%), Gaps = 19/249 (7%)
Query: 326 KRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDG 384
L Q + ++E ++ + ++ +G+G G V G
Sbjct: 13 LGTENLYFQSGVVTHEQFKAALRMVVDQ--GDPRLLLDSYVKIGEGSTGIVCLAREKHSG 70
Query: 385 RIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLY 444
R VAVK L + E NEVVI+ H N+V++ L E ++ EF+ G L
Sbjct: 71 RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130
Query: 445 QYI-HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV 503
+ ++ E I + V AL YLH+ I HRDIKS +ILL R K+
Sbjct: 131 DIVSQVRLNEEQIA-----TVCEAVLQALAYLHAQGVI---HRDIKSDSILLTLDGRVKL 182
Query: 504 SDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ--- 560
SDFG + D + V GT ++ PE S + + D++S G++++E++ G+
Sbjct: 183 SDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241
Query: 561 ---KPIRAI 566
P++A+
Sbjct: 242 FSDSPVQAM 250
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 68/226 (30%), Positives = 111/226 (49%), Gaps = 13/226 (5%)
Query: 339 SNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDE 397
S+E +EK + S Y +GQG GTVY M + G+ VA+++ L +
Sbjct: 1 SDEEILEKLRSIVSV--GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 398 TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-NQIEEFPI 456
E INE++++ + + NIV L L + +V E++ G+L + ++E I
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 118
Query: 457 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516
+ E AL +LHS I HRDIKS NILL K++DFG + +Q
Sbjct: 119 A-----AVCRECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170
Query: 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
+ +T V GT ++ PE + K D++S G++ +E++ G+ P
Sbjct: 171 SKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 56/254 (22%), Positives = 110/254 (43%), Gaps = 33/254 (12%)
Query: 334 QQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVK--- 390
+++ SN SN+ + + +K ++Y R L QG + + A+K
Sbjct: 6 MKDILSNYSNLIYLNKYVKEK-DKYINDYRIIRTLNQGKFNKIILCEKD-NKFYALKKYE 63
Query: 391 KSKLV--------------DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVY 435
KS L ++ + F NE+ I++ I + + G + + ++Y
Sbjct: 64 KSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIY 122
Query: 436 EFIPNGTLYQYIH-----NQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKS 490
E++ N ++ ++ ++ I +++ I V + Y+H+ +I HRD+K
Sbjct: 123 EYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI--CHRDVKP 180
Query: 491 ANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT--EKSDVYS 548
+NIL+D R K+SDFG S + + GT+ ++ PE+F + K D++S
Sbjct: 181 SNILMDKNGRVKLSDFGE--SEYMVDKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWS 237
Query: 549 FGVVLVEILTGQKP 562
G+ L + P
Sbjct: 238 LGICLYVMFYNVVP 251
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 45/255 (17%), Positives = 82/255 (32%), Gaps = 29/255 (11%)
Query: 333 LQQELSSNESNIEKT----KLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD----- 383
L + +SS + E + + + + + +LG+G VY+ D
Sbjct: 34 LSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAK 93
Query: 384 -GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGT 442
+ +K K + + L +K L +LV E GT
Sbjct: 94 NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153
Query: 443 LYQYI--HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR 500
L I + E + L++ A+ + + +H I H DIK N +L + +
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFL 210
Query: 501 A-----------KVSDFGTSR--SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 547
+ D G S + T T K T G+ E + + + D +
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC-ETSGFQCVEMLSNKPWNYQIDYF 269
Query: 548 SFGVVLVEILTGQKP 562
+ +L G
Sbjct: 270 GVAATVYCMLFGTYM 284
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 359 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRN 417
+ ++ LG+G G+VYK + G+IVA+K+ + + +++ I E+ I+ Q + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85
Query: 418 IVKLLGCCLETEVPLLVYEFIPNGT---LYQYIHNQIEEFPITWELLLRIAVEVSGALFY 474
+VK G + +V E+ G+ + + + + E I I L Y
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIA-----TILQSTLKGLEY 140
Query: 475 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 534
LH I HRDIK+ NILL+ + AK++DFG + + T + GT ++ PE
Sbjct: 141 LHFMRKI---HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEV 196
Query: 535 FQSSQFTEKSDVYSFGVVLVEILTGQ------KPIRAI 566
Q + +D++S G+ +E+ G+ P+RAI
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI 234
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 72/268 (26%), Positives = 120/268 (44%), Gaps = 30/268 (11%)
Query: 313 KRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGG 372
K+ +E++L ++ KR L Q++ K D EK LG G
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQ---------KVGELKDDDFEKI-------SELGAGN 45
Query: 373 QGTVYKGMLT-DGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEV 430
G V+K G ++A K L + Q I E+ +L + N IV G
Sbjct: 46 GGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105
Query: 431 PLLVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDI 488
+ E + G+L Q + +I E ++L ++++ V L YL I HRD+
Sbjct: 106 ISICMEHMDGGSLDQVLKKAGRIPE-----QILGKVSIAVIKGLTYLREKHKI--MHRDV 158
Query: 489 KSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 548
K +NIL++ + K+ DFG S + + + V GT Y+ PE Q + ++ +SD++S
Sbjct: 159 KPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWS 215
Query: 549 FGVVLVEILTGQKPIRAINTDEDKSLVG 576
G+ LVE+ G+ PI + E + + G
Sbjct: 216 MGLSLVEMAVGRYPIPPPDAKELELMFG 243
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 12/207 (5%)
Query: 359 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNVEQFINEVVILSQINHR 416
+ + +G+G G V+KG+ ++VA+K L E +E E+ +LSQ +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ-IEEFPITWELLLRIAVEVSGALFYL 475
+ K G L+ ++ E++ G+ + ++E I I E+ L YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-----ILREILKGLDYL 135
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 535
HS I HRDIK+AN+LL + K++DFG + + Q T V GT ++ PE
Sbjct: 136 HSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVI 191
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKP 562
+ S + K+D++S G+ +E+ G+ P
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 81/294 (27%), Positives = 133/294 (45%), Gaps = 53/294 (18%)
Query: 351 TSKDLEKATDNYNANRILGQGGQGTVYKG--MLTDGRIVAVK---KSKLVDETNVEQFIN 405
+ D + NY + +G+G V +LT GR VA+K K++L + T++++
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQL-NPTSLQKLFR 63
Query: 406 EVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLL 462
EV I+ +NH NIVKL +ETE L L+ E+ G ++ Y+ H +++E +
Sbjct: 64 EVRIMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKE-----KEAR 117
Query: 463 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 522
++ A+ Y H I HRD+K+ N+LLD K++DFG S + L
Sbjct: 118 SKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFS-NEFTVGGKLDAF 173
Query: 523 VQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQA 581
G Y PE FQ ++ + DV+S GV+L +++G P N E
Sbjct: 174 C-GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE----------- 221
Query: 582 INENRLFE-ILDAR------VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
L E +L + + + + L KR L LN R T++++
Sbjct: 222 -----LRERVLRGKYRIPFYMSTDCEN--------LLKRFLVLNPIKRGTLEQI 262
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 29/236 (12%), Positives = 63/236 (26%), Gaps = 42/236 (17%)
Query: 366 RILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQ--------- 412
+LGQ + G V ++ ++Q EV+ L
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 413 -------------INHRNIVKLLGCCLETEVPLLVYEFIP-------NGTLYQYIHNQIE 452
+ K++ L+ ++ F T + + +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 453 EF-PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511
+ L++ ++V L LH + H ++ +I+LD + ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 512 VMVDQTHLTTKVQGTFGYVDPEYFQSSQ-----FTEKSDVYSFGVVLVEILTGQKP 562
+ Q T D ++ G+ + I P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 359 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRN 417
+ + LG G G VYK G + A K + E +E +I E+ IL+ +H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 418 IVKLLGCCLETEVPLLVYEFIPNGT---LYQYIHNQIEEFPITWELLLRIAVEVSGALFY 474
IVKLLG ++ EF P G + + + E I + ++ AL +
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-----VCRQMLEALNF 132
Query: 475 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY----- 529
LHS I HRD+K+ N+L+ + +++DFG S + + + GT Y
Sbjct: 133 LHSKRII---HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GT-PYWMAPE 187
Query: 530 -VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
V E + + + K+D++S G+ L+E+ + P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 76/306 (24%), Positives = 133/306 (43%), Gaps = 50/306 (16%)
Query: 338 SSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSK 393
+ +++ TKL K+ E Y +LG GG G+VY G+ ++D VA+K K +
Sbjct: 21 MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR 80
Query: 394 LVDETNVEQFIN---EVVILSQINHR--NIVKLLGCCLETEVPL-LVYEFI-PNGTLYQY 446
+ D + EVV+L +++ +++LL E L+ E P L+ +
Sbjct: 81 ISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDF 139
Query: 447 I--HNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKV 503
I ++E EL +V A+ + H+ + HRDIK NIL+D ++ K+
Sbjct: 140 ITERGALQE-----ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 191
Query: 504 SDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKP 562
DFG+ ++ T T GT Y PE+ + ++ + V+S G++L +++ G P
Sbjct: 192 IDFGSGA--LLKDTVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
Query: 563 IRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMR 622
+++ + G RV E + L + CL L R
Sbjct: 249 FE----HDEEIIRGQV-----------FFRQRVSSECQH--------LIRWCLALRPSDR 285
Query: 623 PTMKEV 628
PT +E+
Sbjct: 286 PTFEEI 291
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 60/339 (17%), Positives = 117/339 (34%), Gaps = 91/339 (26%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRN 417
++ + +G+GG G V++ D A+K+ +L + E E+ + EV L+++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 418 IVKLLGCCLETEVPLL-------------------------------------------- 433
IV+ LET
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 434 -VYEFIPNGTLY---QYIHN---------QIEEFPITWELLLRIAVEVSGALFYLHSAAS 480
+ P LY Q + + L I ++++ A+ +LHS
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184
Query: 481 IPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQ-----------GTFGY 529
+ HRD+K +NI KV DFG ++ D+ T GT Y
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 530 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589
+ PE + ++ K D++S G++L E+L +T ++ + + + +
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYS------FSTQMERVRI---ITDVRNLKFPL 293
Query: 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ + +E + + L+ + RP ++
Sbjct: 294 LFTQKYPQEHM---------MVQDMLSPSPTERPEATDI 323
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 60/249 (24%), Positives = 97/249 (38%), Gaps = 41/249 (16%)
Query: 338 SSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLV- 395
+ + + + +LF D E ++ R +G G G VY + + +VA+KK
Sbjct: 35 AGSLKDPDVAELFFKDDPE---KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG 91
Query: 396 --DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNG--TLYQYIHNQI 451
+ I EV L ++ H N ++ GC L LV E+ L + +
Sbjct: 92 KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPL 151
Query: 452 EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG---- 507
+E I + L YLHS I HRD+K+ NILL + K+ DFG
Sbjct: 152 QEVEIAA-----VTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASI 203
Query: 508 -TSRSVMVDQTHLTTKVQGTFGYVDPE---YFQSSQFTEKSDVYSFGVVLVEILTGQ--- 560
+ V GT ++ PE Q+ K DV+S G+ +E+ +
Sbjct: 204 MAPANSFV----------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253
Query: 561 ---KPIRAI 566
+ A+
Sbjct: 254 FNMNAMSAL 262
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-29
Identities = 69/289 (23%), Positives = 115/289 (39%), Gaps = 44/289 (15%)
Query: 359 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLV-----DETNVEQFINEVVI 409
D Y ++ LG G G V + VA++ K K + E+ I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 410 LSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVE 467
L ++NH I+K+ + E +V E + G L+ + + +++E ++
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKE-ATCKLYFYQML-- 249
Query: 468 VSGALFYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTHLTTKVQ 524
A+ YLH I HRD+K N+LL ++ K++DFG S+ ++ + + + T
Sbjct: 250 --LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRTLC- 302
Query: 525 GTFGYVDPEYFQSSQF---TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQA 581
GT Y+ PE S D +S GV+L L+G P T
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQ 356
Query: 582 INENRL-FEILD-ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
I + F A V ++A L K+ L ++ K R T +E
Sbjct: 357 ITSGKYNFIPEVWAEVSEKALD--------LVKKLLVVDPKARFTTEEA 397
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNVEQFINEVVILSQINHRN 417
D+Y ++G G V VA+K+ L +T++++ + E+ +SQ +H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 418 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELL--LRIAV---EVSGAL 472
IV + + LV + + G++ I + + + +L IA EV L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF-G--- 528
YLH I HRD+K+ NILL + +++DFG S + KV+ TF G
Sbjct: 135 EYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 529 YVDPEYF-QSSQFTEKSDVYSFGVVLVEILTGQKP 562
++ PE Q + K+D++SFG+ +E+ TG P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 75/294 (25%), Positives = 124/294 (42%), Gaps = 52/294 (17%)
Query: 352 SKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFIN-- 405
KD E Y +LG+GG GTV+ G LTD VA+K +++++ + + +
Sbjct: 23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 406 -EVVILSQIN----HRNIVKLLGCCLETEVPL-LVYEF-IPNGTLYQYI--HNQIEEFPI 456
EV +L ++ H +++LL ET+ LV E +P L+ YI + E
Sbjct: 83 LEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGE--- 138
Query: 457 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRSVMVD 515
+V A+ + HS + HRDIK NIL+D + AK+ DFG+ ++
Sbjct: 139 --GPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGA--LLH 191
Query: 516 QTHLTTKVQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL 574
T GT Y PE+ Q+ + V+S G++L +++ G P + + L
Sbjct: 192 DEPYTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE----RDQEIL 246
Query: 575 VGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
A V + L +RCL RP+++E+
Sbjct: 247 EAEL-----------HFPAHVSPDCCA--------LIRRCLAPKPSSRPSLEEI 281
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 25/209 (11%), Positives = 62/209 (29%), Gaps = 44/209 (21%)
Query: 368 LGQGGQGTVYKGMLTD---GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKL 421
G ++ D R VA+ ++ + +++ ++ + LS+I+ + ++
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 422 LGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASI 481
L L+V E+I G+L + + + +R ++ A H A
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 482 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 541
+ + + + ++ T
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATMPDA----------------------------N 180
Query: 542 EKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+ D+ G L +L + P+
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRS 209
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 47/221 (21%), Positives = 78/221 (35%), Gaps = 25/221 (11%)
Query: 359 TDNYNANRILGQGGQ--GTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQI 413
Y ++G+G + TV G V V++ L V E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 414 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEE-FPITWELLLRIAV---EVS 469
NH NIV + +V F+ G+ I + IA V
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVL 138
Query: 470 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 529
AL Y+H + HR +K+++IL+ + +S ++ S++
Sbjct: 139 KALDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 530 VD------PEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKP 562
V PE Q + + KSD+YS G+ E+ G P
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 38/338 (11%), Positives = 84/338 (24%), Gaps = 74/338 (21%)
Query: 336 ELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---K 391
L S +L + +LGQ + G V
Sbjct: 49 SLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYF 108
Query: 392 SKLVDETNVEQFINEVVILSQI-------------------------NHRNIVKLLGCCL 426
++ ++Q EV+ L + + ++++
Sbjct: 109 TERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDER 168
Query: 427 ETEVPLLVYEF-IPNGTLYQYI----HNQIEEFPITWELLLRIAVEVSGALFYLHSAASI 481
+ V + + L + + + L++ ++V L LH
Sbjct: 169 DMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 226
Query: 482 PIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ-- 539
+ H ++ +I+LD + ++ F + G+ PE
Sbjct: 227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV-----SSVSRGFEPPELEARRATI 280
Query: 540 ---------FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590
T D ++ G+V+ I PI + + I +
Sbjct: 281 SYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQ------ 334
Query: 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ L + L + R +
Sbjct: 335 -------PVRA--------LLEGFLRYPKEDRLLPLQA 357
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 68/270 (25%), Positives = 119/270 (44%), Gaps = 31/270 (11%)
Query: 368 LGQGGQGTVYKGMLT-DGRIVAVKKSKL-VDETNVEQFINEV-VILSQINHRNIVKLLGC 424
LG+G G V K G+I+AVK+ + V+ ++ + ++ + + ++ V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 425 CL-ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPI 483
E +V + E + Y + I ++L +IAV + AL +LHS S+ I
Sbjct: 75 LFREGDV-WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV-I 132
Query: 484 YHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE----YFQSSQ 539
HRD+K +N+L++ + K+ DFG S +VD G Y+ PE
Sbjct: 133 -HRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDIDA-GCKPYMAPERINPELNQKG 189
Query: 540 FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEA 599
++ KSD++S G+ ++E+ + P + T + L+ + E + L
Sbjct: 190 YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ------LKQVVEE------PSPQLPAD 237
Query: 600 K--KEGIMTVATLAKRCLNLNGKMRPTMKE 627
K E + + +CL N K RPT E
Sbjct: 238 KFSAEFVDFTS----QCLKKNSKERPTYPE 263
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 75/301 (24%), Positives = 128/301 (42%), Gaps = 33/301 (10%)
Query: 340 NESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDE 397
+ + K K+ + + ++ +G+G G+V K + G+I+AVK+ + VDE
Sbjct: 2 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61
Query: 398 TNVEQFINEV-VILSQINHRNIVKLLGCCL-ETEVPLLVYEFIPNG--TLYQYIHNQIEE 453
+Q + ++ V++ + IV+ G E + + E + Y+Y+++ +++
Sbjct: 62 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC-WICMELMSTSFDKFYKYVYSVLDD 120
Query: 454 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513
I E+L +I + AL +L I HRDIK +NILLD K+ DFG S +
Sbjct: 121 -VIPEEILGKITLATVKALNHLKENLKI--IHRDIKPSNILLDRSGNIKLCDFGIS-GQL 176
Query: 514 VDQTHLTTKVQGTFGYVDPEYFQSSQ----FTEKSDVYSFGVVLVEILTGQKPIRAINTD 569
VD T G Y+ PE S + +SDV+S G+ L E+ TG+ P N+
Sbjct: 177 VDSIAKTRDA-GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235
Query: 570 EDKSLVGYFLQAINEN---RLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMK 626
D L + + +L + CL + RP K
Sbjct: 236 FD------QLTQVVKGDPPQLSNSEEREFSPSFI--------NFVNLCLTKDESKRPKYK 281
Query: 627 E 627
E
Sbjct: 282 E 282
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 73/295 (24%), Positives = 127/295 (43%), Gaps = 37/295 (12%)
Query: 343 NIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKG-MLTDGRIVAVK---KSKLVDET 398
+ + L+ + YN +LG+G G V K + AVK K+ ++
Sbjct: 8 SSGRENLYFQGTFA---ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK- 63
Query: 399 NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITW 458
+ + EV +L +++H NI+KL ++ +V E G L+ I I+ +
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSE 120
Query: 459 ELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVD 515
RI +V + Y+H I HRD+K NILL+ K + K+ DFG S
Sbjct: 121 HDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQ 176
Query: 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 575
T + ++ GT Y+ PE + + + EK DV+S GV+L +L+G P N +
Sbjct: 177 NTKMKDRI-GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYD----- 229
Query: 576 GYFLQAINENRL-FEILD-ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
L+ + + F++ + +AK L ++ L + +R T +
Sbjct: 230 --ILKRVETGKYAFDLPQWRTISDDAKD--------LIRKMLTFHPSLRITATQC 274
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 72/291 (24%), Positives = 116/291 (39%), Gaps = 60/291 (20%)
Query: 359 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 414
+ +LG G V+ G++ A+K KS ++++E NE+ +L +I
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIK 64
Query: 415 HRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 473
H NIV L E+ LV + + G L+ I +E T + + +V A+
Sbjct: 65 HENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRI---LERGVYTEKDASLVIQQVLSAVK 120
Query: 474 YLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 530
YLH I HRD+K N+L ++ + ++DFG S M ++T GT GYV
Sbjct: 121 YLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGL--SKMEQNGIMSTAC-GTPGYV 174
Query: 531 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY--FLQAINENRLF 588
PE +++ D +S GV+ IL L GY F E++LF
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITY-IL----------------LCGYPPF-YEETESKLF 216
Query: 589 E-ILDAR----------VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
E I + + + AK L + R T ++
Sbjct: 217 EKIKEGYYEFESPFWDDISESAKD--------FICHLLEKDPNERYTCEKA 259
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 64/244 (26%), Positives = 112/244 (45%), Gaps = 22/244 (9%)
Query: 338 SSNESNIEKTKLFTS-KDLEKATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL- 394
SS S + L + + ++ +G G G V+K G ++AVK+ +
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61
Query: 395 VDETNVEQFINEV-VILSQINHRNIVKLLGCCL-ETEVPLLVYEFIPNGT--LYQYIHNQ 450
++ ++ + ++ V+L + IV+ G + T+V + E + L + +
Sbjct: 62 GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQGP 120
Query: 451 IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510
I E +L ++ V + AL+YL + I HRD+K +NILLD++ + K+ DFG S
Sbjct: 121 IPE-----RILGKMTVAIVKALYYLKEKHGV-I-HRDVKPSNILLDERGQIKLCDFGIS- 172
Query: 511 SVMVDQTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRA 565
+VD G Y+ PE + ++DV+S G+ LVE+ TGQ P +
Sbjct: 173 GRLVDDKAKDRSA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231
Query: 566 INTD 569
TD
Sbjct: 232 CKTD 235
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-28
Identities = 68/296 (22%), Positives = 116/296 (39%), Gaps = 40/296 (13%)
Query: 349 LFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDET--NVEQ 402
L + D D Y ++G+G V + + G+ AVK +K + E
Sbjct: 13 LDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 403 FINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE-- 459
E I + H +IV+LL ++ L +V+EF+ L I + + + E
Sbjct: 73 LKREASICHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131
Query: 460 --LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMV 514
+R +E AL Y H I HRD+K +LL K + K+ FG + +
Sbjct: 132 ASHYMRQILE---ALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 185
Query: 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL 574
+V GT ++ PE + + + DV+ GV+L +L+G P + L
Sbjct: 186 SGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY----GTKERL 240
Query: 575 VGYFLQAINENRL-FEILD-ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ I + + + + + AK L +R L L+ R T+ E
Sbjct: 241 ----FEGIIKGKYKMNPRQWSHISESAKD--------LVRRMLMLDPAERITVYEA 284
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 74/344 (21%), Positives = 125/344 (36%), Gaps = 72/344 (20%)
Query: 338 SSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSK 393
+ S+ + F L + Y+ +GQG G V + I A+K K+K
Sbjct: 4 HHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNK 63
Query: 394 L--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQI 451
+ ++ +VE+ EV ++ +++H NI +L + + LV E G L ++ I
Sbjct: 64 IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 452 EEFPITWELLL-------------------------------------RIAVEVSGALFY 474
++ + + I ++ AL Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 475 LHSAASIPIYHRDIKSANILLDDK--YRAKVSDFGTSRSV----MVDQTHLTTKVQGTFG 528
LH+ I HRDIK N L + K+ DFG S+ + +TTK GT
Sbjct: 184 LHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPY 239
Query: 529 YVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR 586
+V PE ++ + K D +S GV+L +L G P +N + + + +
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD-------TISQVLNKK 292
Query: 587 L-FEILD-ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
L FE + + A+ L LN N R
Sbjct: 293 LCFENPNYNVLSPLARD--------LLSNLLNRNVDERFDAMRA 328
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 71/296 (23%), Positives = 118/296 (39%), Gaps = 43/296 (14%)
Query: 346 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYKG-MLTDGRIVAVK---KSKLVDETNVE 401
+ L+ ++ D + R LG G G V+ + G +K K + + +E
Sbjct: 11 RENLYFQGTID---DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPME 65
Query: 402 QFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE- 459
Q E+ +L ++H NI+K+ E + +V E G L + I + E
Sbjct: 66 QIEAEIEVLKSLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124
Query: 460 ---LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVM 513
L++ + AL Y HS + H+D+K NIL D K+ DFG + +
Sbjct: 125 YVAELMKQMMN---ALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE-LF 177
Query: 514 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKS 573
H T GT Y+ PE F+ T K D++S GVV+ +LTG P + +E
Sbjct: 178 KSDEHSTNAA-GTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--- 232
Query: 574 LVGYFLQAINENRL-FEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
Q + + + +A L K+ L + + RP+ +V
Sbjct: 233 ----VQQKATYKEPNYAVECRPLTPQAVD--------LLKQMLTKDPERRPSAAQV 276
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 68/283 (24%), Positives = 106/283 (37%), Gaps = 38/283 (13%)
Query: 356 EKATDNYNANRILGQGGQGTVYKG-MLTDGRIVAVK---KSKLVDETNVEQFINEVVILS 411
Y +G+G G V A K K + D V++F E+ I+
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMK 61
Query: 412 QINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 470
++H NI++L E + LV E G L++ + + + RI +V
Sbjct: 62 SLDHPNIIRLYETF-EDNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLS 117
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGTSRSVMVDQTHLTTKVQGTF 527
A+ Y H + HRD+K N L K+ DFG + + TKV GT
Sbjct: 118 AVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMMRTKV-GTP 172
Query: 528 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 587
YV P+ + + + D +S GV++ +L G P A E + I E
Sbjct: 173 YYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VMLKIREGTF 224
Query: 588 -FEILD-ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
F D V +A+ L +R L + K R T +
Sbjct: 225 TFPEKDWLNVSPQAES--------LIRRLLTKSPKQRITSLQA 259
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-27
Identities = 69/295 (23%), Positives = 117/295 (39%), Gaps = 64/295 (21%)
Query: 359 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 414
T+ Y LG+G V + + + G+ A KL + ++ E I +
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLK 68
Query: 415 HRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLRIAVEVS 469
H NIV+L E L+++ + G L++ I + + E ++ +E
Sbjct: 69 HPNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDI---VAREYYS-EADASHCIQQILE-- 121
Query: 470 GALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTKVQGT 526
A+ + H + HR++K N+LL K + K++DFG + V +Q GT
Sbjct: 122 -AVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GT 176
Query: 527 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY--FLQAINE 584
GY+ PE + + + D+++ GV+L IL LVGY F ++
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILY-IL----------------LVGYPPF-WDEDQ 218
Query: 585 NRLFE-ILDAR----------VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+RL++ I V EAK L + L +N R T E
Sbjct: 219 HRLYQQIKAGAYDFPSPEWDTVTPEAKD--------LINKMLTINPSKRITAAEA 265
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 70/307 (22%), Positives = 117/307 (38%), Gaps = 74/307 (24%)
Query: 356 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLV-----DETNVEQFINE 406
+ D Y ++ LG G G V + VA+K K K + E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 407 VVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYI--HNQIEEFPITWELLLRI 464
+ IL ++NH I+K+ + E +V E + G L+ + + +++E
Sbjct: 66 IEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKE---------AT 115
Query: 465 AVE----VSGALFYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGTSRSVMVDQT 517
+ A+ YLH I HRD+K N+LL + K++DFG S+ ++ + +
Sbjct: 116 CKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETS 171
Query: 518 HLTTKVQGTFGYVDPEYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSL 574
+ T GT Y+ PE S + D +S GV+L I L
Sbjct: 172 LMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-IC----------------L 213
Query: 575 VGY--FLQAINENRLFE-ILDAR----------VLKEAKKEGIMTVATLAKRCLNLNGKM 621
GY F + + L + I + V ++A L K+ L ++ K
Sbjct: 214 SGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALD--------LVKKLLVVDPKA 265
Query: 622 RPTMKEV 628
R T +E
Sbjct: 266 RFTTEEA 272
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 76/316 (24%), Positives = 126/316 (39%), Gaps = 65/316 (20%)
Query: 338 SSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSK 393
+ + + F K +DNY+ LG+G V + + T G A K K
Sbjct: 7 MTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK 66
Query: 394 LVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIE 452
L + ++ E I ++ H NIV+L + E LV++ + G L++ I +
Sbjct: 67 LSAR-DFQKLEREARICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDI---VA 121
Query: 453 EFPITWE----LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSD 505
+ E ++ +E ++ Y HS I HR++K N+LL K + K++D
Sbjct: 122 REFYS-EADASHCIQQILE---SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD 174
Query: 506 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 565
FG + + D GT GY+ PE + +++ D+++ GV+L IL
Sbjct: 175 FGLAI-EVNDSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILY-IL-------- 223
Query: 566 INTDEDKSLVGY--FLQAINENRLFE-ILDAR----------VLKEAKKEGIMTVATLAK 612
LVGY F +++RL+ I V EAK L
Sbjct: 224 --------LVGYPPF-WDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS--------LID 266
Query: 613 RCLNLNGKMRPTMKEV 628
L +N K R T +
Sbjct: 267 SMLTVNPKKRITADQA 282
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 6e-27
Identities = 72/291 (24%), Positives = 118/291 (40%), Gaps = 57/291 (19%)
Query: 359 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 414
+DNY+ LG+G V + + T G A K KL + ++ E I ++
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ 63
Query: 415 HRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 473
H NIV+L + E LV++ + G L++ I + + ++ ++
Sbjct: 64 HPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIA 119
Query: 474 YLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTKVQGTFGYV 530
Y HS I HR++K N+LL K + K++DFG + + D GT GY+
Sbjct: 120 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWHGFA-GTPGYL 174
Query: 531 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY--FLQAINENRLF 588
PE + +++ D+++ GV+L IL LVGY F +++RL+
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILY-IL----------------LVGYPPFW-DEDQHRLY 216
Query: 589 E-ILDAR----------VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
I V EAK L L +N K R T +
Sbjct: 217 AQIKAGAYDYPSPEWDTVTPEAKS--------LIDSMLTVNPKKRITADQA 259
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 73/286 (25%), Positives = 110/286 (38%), Gaps = 50/286 (17%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
++++ + LG+G G V + VAVK + VD E E+ I +NH
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNH 64
Query: 416 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEE------FPITWELLLRIAV 466
N+VK G L E+ G L+ I + E F +L+ V
Sbjct: 65 ENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---HQLM--AGV 118
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT---HLTTKV 523
YLH I HRDIK N+LLD++ K+SDFG + +V L
Sbjct: 119 V------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERLLNKMC 168
Query: 524 QGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 582
GT YV PE + +F E DV+S G+VL +L G+ P + S
Sbjct: 169 -GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDW 221
Query: 583 NENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
E + + ++ L + L N R T+ ++
Sbjct: 222 KEKKTYLNPWKKIDSAPLA--------LLHKILVENPSARITIPDI 259
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 361 NYNANRILGQGGQGTVYKG--MLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
+Y LG G G V G LT G VAVK + K+ V + E+ L H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLT-GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 416 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGAL 472
+I+KL + T +V E++ G L+ YI H ++EE R+ ++ A+
Sbjct: 71 PHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEE-----MEARRLFQQILSAV 124
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532
Y H + HRD+K N+LLD AK++DFG S ++M D L T G+ Y P
Sbjct: 125 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GSPNYAAP 179
Query: 533 EYFQSSQFT-EKSDVYSFGVVLVEILTGQKP 562
E + + D++S GV+L +L G P
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 54/226 (23%), Positives = 99/226 (43%), Gaps = 26/226 (11%)
Query: 356 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILS 411
D Y+ LG G G V++ + GR+ K +D+ V+ NE+ I++
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMN 103
Query: 412 QINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLRIAV 466
Q++H ++ L E + + L+ EF+ G L+ I E++ ++ E +R A
Sbjct: 104 QLHHPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAA--EDYKMS-EAEVINYMRQAC 159
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGTSRSVMVDQTHLTTKVQ 524
E L ++H + I H DIK NI+ + K + K+ DFG + ++ +
Sbjct: 160 E---GLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLAT--KLNPDEIVKVTT 211
Query: 525 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
T + PE +D+++ GV+ +L+G P + E
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 257
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 25/216 (11%)
Query: 361 NYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKL-----VDETNVEQFINEVVILS 411
Y+ LG G G V+ + + V VK K K+ +++ + + E+ ILS
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 412 QINHRNIVKLLGCCLETEVPL-LVYEFIPNGT-LYQYI--HNQIEEFPITWELLLRIAVE 467
++ H NI+K+L E + LV E +G L+ +I H +++E L I +
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE-----PLASYIFRQ 138
Query: 468 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 527
+ A+ YL I HRDIK NI++ + + K+ DFG++ + + T GT
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA-AYLERGKLFYTFC-GTI 193
Query: 528 GYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKP 562
Y PE + + + +++S GV L ++ + P
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 15/212 (7%)
Query: 366 RILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKL 421
+ILG+G TV R A+K K ++ E V E ++S+++H VKL
Sbjct: 36 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 422 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAA 479
+ + L + NG L +YI F E R E+ AL YLH
Sbjct: 96 YFTF-QDDEKLYFGLSYAKNGELLKYIRKI-GSFD---ETCTRFYTAEIVSALEYLHGKG 150
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK-VQGTFGYVDPEYFQSS 538
I HRD+K NILL++ +++DFGT++ + + GT YV PE
Sbjct: 151 ---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 539 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+ SD+++ G ++ +++ G P RA N
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 73/286 (25%), Positives = 110/286 (38%), Gaps = 50/286 (17%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
++++ + LG+G G V + VAVK + VD E E+ I +NH
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNH 64
Query: 416 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEE------FPITWELLLRIAV 466
N+VK G L E+ G L+ I + E F +L+ V
Sbjct: 65 ENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---HQLM--AGV 118
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT---HLTTKV 523
YLH I HRDIK N+LLD++ K+SDFG + +V L
Sbjct: 119 V------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERLLNKMC 168
Query: 524 QGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 582
GT YV PE + +F E DV+S G+VL +L G+ P + S
Sbjct: 169 -GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDW 221
Query: 583 NENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
E + + ++ L + L N R T+ ++
Sbjct: 222 KEKKTYLNPWKKIDSAPLA--------LLHKILVENPSARITIPDI 259
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-26
Identities = 62/252 (24%), Positives = 104/252 (41%), Gaps = 20/252 (7%)
Query: 332 LLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVK 390
L Q + ++ + + K++ D++ +++G+G V + G++ A+K
Sbjct: 33 LAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMK 92
Query: 391 ---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQY 446
K ++ V F E +L + R I +L + E L LV E+ G L
Sbjct: 93 IMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTL 151
Query: 447 IHNQIEEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 505
+ E P + R E+ A+ +H + HRDIK NILLD +++D
Sbjct: 152 LSKFGERIP---AEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLAD 205
Query: 506 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY-------SFGVVLVEILT 558
FG+ + D T + GT Y+ PE Q+ + Y + GV E+
Sbjct: 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
Query: 559 GQKPIRAINTDE 570
GQ P A +T E
Sbjct: 266 GQTPFYADSTAE 277
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 8e-26
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 11/219 (5%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
D + R+LG+GG G V+ + G++ A K K +L + + E IL++++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 416 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALF 473
R IV L ET+ L LV + G + +I+N E+ P E ++ L
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 474 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPE 533
+LH I +RD+K N+LLDD ++SD G + + QT GT G++ PE
Sbjct: 304 HLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE 359
Query: 534 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 572
++ D ++ GV L E++ + P RA +
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 398
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 61/237 (25%), Positives = 99/237 (41%), Gaps = 19/237 (8%)
Query: 339 SNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDE 397
+++S L + ++G G G VYKG + G++ A+K +
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TG 61
Query: 398 TNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPL------LVYEFIPNGTLYQYIHNQ 450
E+ E+ +L + +HRNI G ++ P LV EF G++ I N
Sbjct: 62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 121
Query: 451 IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510
+ E + I E+ L +LH I HRDIK N+LL + K+ DFG S
Sbjct: 122 KGN-TLKEEWIAYICREILRGLSHLHQHKVI---HRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 511 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTE-----KSDVYSFGVVLVEILTGQKP 562
+ T + GT ++ PE + + KSD++S G+ +E+ G P
Sbjct: 178 QLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 69/291 (23%), Positives = 112/291 (38%), Gaps = 39/291 (13%)
Query: 352 SKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEV 407
+ D ++ LG+G K + + AVK K E+
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEI 56
Query: 408 VILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWE----LLL 462
L H NIVKL + LV E + G L++ I + + F E ++
Sbjct: 57 TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK-KHFS---ETEASYIM 112
Query: 463 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHL 519
R V A+ ++H + HRD+K N+L D+ K+ DFG +R D L
Sbjct: 113 RKLVS---AVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166
Query: 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL 579
T T Y PE + + E D++S GV+L +L+GQ P ++ + + +
Sbjct: 167 KTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM 225
Query: 580 QAINENRL-FEILD-ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ I + FE V +EAK L + L ++ R M +
Sbjct: 226 KKIKKGDFSFEGEAWKNVSQEAK--------DLIQGLLTVDPNKRLKMSGL 268
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 74/299 (24%), Positives = 121/299 (40%), Gaps = 64/299 (21%)
Query: 353 KDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK-SKLVDETNVEQFINEVVIL 410
+ + +D + LG+G VY+ + A+K K VD+ V E+ +L
Sbjct: 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR---TEIGVL 102
Query: 411 SQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLRIA 465
+++H NI+KL ET + LV E + G L+ I +E+ + E ++
Sbjct: 103 LRLSHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRI---VEKGYYS-ERDAADAVKQI 157
Query: 466 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLTTK 522
+E A+ YLH I HRD+K N+L K++DFG S +V+ L
Sbjct: 158 LE---AVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLS--KIVEHQVLMKT 209
Query: 523 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY--FLQ 580
V GT GY PE + + + D++S G++ IL L G+ F
Sbjct: 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITY-IL----------------LCGFEPFYD 252
Query: 581 AINENRLFE-ILDAR----------VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ +F IL+ V AK L ++ + L+ K R T +
Sbjct: 253 ERGDQFMFRRILNCEYYFISPWWDEVSLNAKD--------LVRKLIVLDPKKRLTTFQA 303
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 55/269 (20%), Positives = 103/269 (38%), Gaps = 26/269 (9%)
Query: 313 KRRKEIKLKQKFFKRNGGLLLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGG 372
+R ++ + K + G + + + + + D+Y+ + LG G
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169
Query: 373 QGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLET 428
G V++ G A K D+ V E+ +S + H +V L E
Sbjct: 170 FGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLVNLHDAF-ED 225
Query: 429 EVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLRIAVEVSGALFYLHSAASIPI 483
+ + ++YEF+ G L++ + ++ + E +R + L ++H
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADEHNKMS---EDEAVEYMRQVCK---GLCHMHENN---Y 276
Query: 484 YHRDIKSANILLDDK--YRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT 541
H D+K NI+ K K+ DFG + +D GT + PE +
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTA--HLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 542 EKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+D++S GV+ +L+G P N DE
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGENDDE 363
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 55/231 (23%), Positives = 92/231 (39%), Gaps = 29/231 (12%)
Query: 356 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETN---VEQFINEVV 408
+K D Y+ LG G V K + G A K K + E+ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 409 ILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLR 463
IL Q+ H N++ L E + L+ E + G L+ ++ ++ ++ E ++
Sbjct: 68 ILRQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFL---AQKESLS-EEEATSFIK 122
Query: 464 IAVEVSGALFYLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGTSRSVMVDQTHL 519
++ + YLH+ I H D+K NI+L K+ DFG + + D
Sbjct: 123 QILD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF 175
Query: 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
GT +V PE ++D++S GV+ +L+G P E
Sbjct: 176 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-25
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 361 NYNANRILGQGGQGTVYKG--MLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
+Y LG G G V G LT G VAVK + K+ V + E+ L H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELT-GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 416 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEE------FPITWELLLRIAV 466
+I+KL + T + +V E++ G L+ YI + +++E F ++L V
Sbjct: 76 PHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF---QQILS--GV 129
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 526
+ Y H + HRD+K N+LLD AK++DFG S ++M D L T G+
Sbjct: 130 D------YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GS 178
Query: 527 FGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKP 562
Y PE + + D++S GV+L +L G P
Sbjct: 179 PNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 70/291 (24%), Positives = 114/291 (39%), Gaps = 46/291 (15%)
Query: 356 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE---TNVEQFINEVV 408
E D Y+ LG G V K + G A K K + + E EV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 409 ILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLR 463
IL +I H N++ L E + + L+ E + G L+ ++ E+ +T E L+
Sbjct: 67 ILKEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFL---AEKESLT-EEEATEFLK 121
Query: 464 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA----KVSDFGTSRSVMVDQTHL 519
+ ++YLHS I H D+K NI+L D+ K+ DFG + +D +
Sbjct: 122 QILN---GVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNE 173
Query: 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL 579
+ GT +V PE ++D++S GV+ +L+G P E L
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TL 226
Query: 580 QAINENRL-FEILD-ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
++ FE + AK +R L + K R T+++
Sbjct: 227 ANVSAVNYEFEDEYFSNTSALAKD--------FIRRLLVKDPKKRMTIQDS 269
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 65/300 (21%), Positives = 110/300 (36%), Gaps = 64/300 (21%)
Query: 356 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDE---TNVEQFINEVV 408
+K D Y+ LG G V K + G A K K + E+ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 409 ILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLR 463
IL Q+ H NI+ L E + L+ E + G L+ ++ ++ ++ E ++
Sbjct: 68 ILRQVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFL---AQKESLS-EEEATSFIK 122
Query: 464 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK----YRAKVSDFGTSRSVMVDQTHL 519
++ + YLH+ I H D+K NI+L DK K+ DFG + ++
Sbjct: 123 QILD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVE 174
Query: 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFL 579
+ GT +V PE ++D++S GV+ +L+G P FL
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FL 219
Query: 580 QAINENRLFE-ILDAR----------VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ I + AK ++ L + R T++E
Sbjct: 220 -GDTKQETLANITAVSYDFDEEFFSQTSELAKD--------FIRKLLVKETRKRLTIQEA 270
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 56/222 (25%), Positives = 88/222 (39%), Gaps = 35/222 (15%)
Query: 361 NYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFIN-EVVILSQINH 415
Y +LG+G G V + + AVK K KL N E + E+ +L ++ H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 416 RNIVKLLG-CCLETEVPL-LVYEFIPNGT--LYQYI-HNQIEE------FPITWELLLRI 464
+N+++L+ E + + +V E+ G + + + F +L+
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF---CQLID-- 120
Query: 465 AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR--SVMVDQTHLTTK 522
+E YLHS I H+DIK N+LL K+S G + T
Sbjct: 121 GLE------YLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT- 170
Query: 523 VQGTFGYVDPEYFQSSQFTE--KSDVYSFGVVLVEILTGQKP 562
QG+ + PE K D++S GV L I TG P
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 70/297 (23%), Positives = 108/297 (36%), Gaps = 64/297 (21%)
Query: 359 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETN---VEQFINEVVILS 411
D+Y LG G V K G+ A K K +L E+ EV IL
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 412 QINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLRIAV 466
+I H NI+ L E + + L+ E + G L+ ++ E+ +T E L+ +
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFL---AEKESLT-EDEATQFLKQIL 118
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA----KVSDFGTSRSVMVDQTHLTTK 522
+ + YLHS I H D+K NI+L DK K+ DFG + +
Sbjct: 119 D---GVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEFKNI 171
Query: 523 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 582
GT +V PE ++D++S GV+ +L+G P FL
Sbjct: 172 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FL-GE 214
Query: 583 NENRLFE-ILDAR----------VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ I + AK +R L + K R T+ +
Sbjct: 215 TKQETLTNISAVNYDFDEEYFSNTSELAKD--------FIRRLLVKDPKRRMTIAQS 263
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 66/248 (26%), Positives = 108/248 (43%), Gaps = 51/248 (20%)
Query: 338 SSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDE 397
+ + + K K E+ Y +++G G G V++ L + VA+KK D
Sbjct: 18 LDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-D- 75
Query: 398 TNVEQFIN-EVVILSQINHRNIVKLLGCCLET-----EVPL-LVYEFIPNGTLYQYI-HN 449
++F N E+ I+ + H N+V L EV L LV E++P T+Y+ H
Sbjct: 76 ---KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHY 131
Query: 450 QIEEFPITWEL-------LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRA 501
+ + L LLR +L Y+HS I HRDIK N+LLD
Sbjct: 132 AKLKQTMPMLLIKLYMYQLLR-------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVL 181
Query: 502 KVSDFGTSRSVMVDQ--THLTTKVQGTFGYV------DPE-YFQSSQFTEKSDVYSFGVV 552
K+ DFG+++ ++ + Y+ PE F ++ +T D++S G V
Sbjct: 182 KLIDFGSAKILIAGEPNVS----------YICSRYYRAPELIFGATNYTTNIDIWSTGCV 231
Query: 553 LVEILTGQ 560
+ E++ GQ
Sbjct: 232 MAELMQGQ 239
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 16/220 (7%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
+ + R+LG+GG G V + G++ A K K ++ +NE IL ++N
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 416 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEE-FPITWELLLRI-AVEVSGAL 472
R +V L ET+ L LV + G L +I++ + FP E A E+ L
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARAVFYAAEICCGL 299
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532
LH I +RD+K NILLDD ++SD G + V QT GT GY+ P
Sbjct: 300 EDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAP 354
Query: 533 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK 572
E ++ ++T D ++ G +L E++ GQ P + +
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 394
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 28/226 (12%)
Query: 350 FTSKDLEKATDNYNANR--ILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQF 403
+ Y ++ ILG G G V+K G +A K + D E+
Sbjct: 77 IVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEV 133
Query: 404 INEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE--- 459
NE+ +++Q++H N+++L E++ + LV E++ G L+ I ++ E
Sbjct: 134 KNEISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDRIIDESYNLT---ELDT 189
Query: 460 -LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGTSRSVMVDQ 516
L ++ E + ++H I H D+K NIL ++ K+ DFG +R +
Sbjct: 190 ILFMKQICE---GIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243
Query: 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
L GT ++ PE + +D++S GV+ +L+G P
Sbjct: 244 K-LKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 58/250 (23%), Positives = 107/250 (42%), Gaps = 18/250 (7%)
Query: 332 LLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVK 390
L +++ K K + +++ +++G+G G V L + ++ A+K
Sbjct: 46 LRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMK 105
Query: 391 ---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQY 446
K +++ F E +L + + I L + + L LV ++ G L
Sbjct: 106 ILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTL 164
Query: 447 IHNQIEEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 505
+ + P E + R E+ A+ +H + HRDIK NIL+D +++D
Sbjct: 165 LSKFEDRLP---EEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLAD 218
Query: 506 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-----DVYSFGVVLVEILTGQ 560
FG+ +M D T ++ GT Y+ PE Q+ + + D +S GV + E+L G+
Sbjct: 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
Query: 561 KPIRAINTDE 570
P A + E
Sbjct: 279 TPFYAESLVE 288
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-24
Identities = 69/231 (29%), Positives = 108/231 (46%), Gaps = 53/231 (22%)
Query: 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQINHR 416
+Y +++G G G VY+ L D G +VA+KK ++F N E+ I+ +++H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 417 NIVKLLGCCLET-----EVPL-LVYEFIPNGTLYQYI-HNQIEEFPITWEL-------LL 462
NIV+L + EV L LV +++P T+Y+ H + + L
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 463 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQ--THL 519
R +L Y+HS I HRDIK N+LLD D K+ DFG+++ ++ +
Sbjct: 167 R-------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS- 215
Query: 520 TTKVQGTFGYV------DPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
Y+ PE F ++ +T DV+S G VL E+L GQ PI
Sbjct: 216 ---------YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 67/294 (22%), Positives = 114/294 (38%), Gaps = 60/294 (20%)
Query: 356 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK--KSKLVDETNVEQFINEVVILSQ 412
++ + Y LG+G G V++ + + + K K K D+ V+ E+ IL+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNI 57
Query: 413 INHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLRIAVE 467
HRNI+ L E+ L +++EFI +++ I+ F + E + E
Sbjct: 58 ARHRNILHLHESF-ESMEELVMIFEFISGLDIFERINT--SAFELN-EREIVSYVHQVCE 113
Query: 468 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGTSRSVMVDQTHLTTKVQG 525
AL +LHS I H DI+ NI+ + + K+ +FG +R + +
Sbjct: 114 ---ALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR--QLKPGDNFRLLFT 165
Query: 526 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN 585
Y PE Q + +D++S G ++ +L+G P FL A
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP---------------FL-AETNQ 209
Query: 586 RLFE-ILDAR----------VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
++ E I++A + EA R L K R T E
Sbjct: 210 QIIENIMNAEYTFDEEAFKEISIEAMD--------FVDRLLVKERKSRMTASEA 255
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 65/293 (22%), Positives = 104/293 (35%), Gaps = 61/293 (20%)
Query: 359 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 414
TD Y +G G + + AVK KSK +E ++L
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE------ILLRYGQ 74
Query: 415 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWE----LLLRIAVEVSG 470
H NI+ L + + +V E + G L I Q + F E +L +
Sbjct: 75 HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ-KFFS---EREASAVLFTITK--- 127
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDKYRA----KVSDFGTSRSVMVDQTHLTTKVQGT 526
+ YLH+ + HRD+K +NIL D+ ++ DFG ++ + + L T T
Sbjct: 128 TVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YT 183
Query: 527 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR 586
+V PE + + D++S GV+L +LTG P D
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-------------TPEE 230
Query: 587 LFE-ILDAR----------VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ I + V AK L + L+++ R T V
Sbjct: 231 ILARIGSGKFSLSGGYWNSVSDTAKD--------LVSKMLHVDPHQRLTAALV 275
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 75/306 (24%), Positives = 113/306 (36%), Gaps = 74/306 (24%)
Query: 352 SKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEV 407
+ +D Y+ + +G G G +VAVK + +DE NV++ E+
Sbjct: 12 DMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQR---EI 67
Query: 408 VILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEE------FPITW 458
+ + H NIV+ + T L ++ E+ G LY+ I + E F
Sbjct: 68 INHRSLRHPNIVRFKEV-ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFF---Q 123
Query: 459 ELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY--RAKVSDFGTSRSVMVDQ 516
+LL V Y HS I HRD+K N LLD R K+ DFG S V
Sbjct: 124 QLL--SGVS------YCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLH 171
Query: 517 THLTTKVQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 575
+ + V GT Y+ PE ++ + +DV+S GV L +L G P ED
Sbjct: 172 SQPKSTV-GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF------EDP--- 221
Query: 576 GYFLQAINENRLFEILDARVLK-------------EAKKEGIMTVATLAKRCLNLNGKMR 622
E R + R+L E L R + R
Sbjct: 222 -------EEPRDYRKTIQRILSVKYSIPDDIRISPECCH--------LISRIFVADPATR 266
Query: 623 PTMKEV 628
++ E+
Sbjct: 267 ISIPEI 272
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 59/306 (19%)
Query: 359 TDNYNANR-ILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQI 413
D Y +LG+G V + L + AVK K + V EV +L Q
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF---REVEMLYQC 67
Query: 414 -NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWE----LLLRIAVEV 468
HRN+++L+ E + LV+E + G++ +IH + F E ++++ +V
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR-RHFN---ELEASVVVQ---DV 120
Query: 469 SGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSV-------MVDQTH 518
+ AL +LH+ I HRD+K NIL + + K+ DF + +
Sbjct: 121 ASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 519 LTTKVQGTFGYVDPE-----YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKS 573
L T G+ Y+ PE ++S + ++ D++S GV+L +L+G P D
Sbjct: 178 LLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG-RCGSDCG 235
Query: 574 LVGYFLQAINENRLFE-ILDAR----------VLKEAKKEGIMTVATLAKRCLNLNGKMR 622
+N LFE I + + + AK L + L + K R
Sbjct: 236 WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAK--------DLISKLLVRDAKQR 287
Query: 623 PTMKEV 628
+ +V
Sbjct: 288 LSAAQV 293
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 69/301 (22%), Positives = 112/301 (37%), Gaps = 66/301 (21%)
Query: 359 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNV------EQFINEVV 408
+NY ILG+G V + + + AVK + + E + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 409 ILSQIN-HRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAV 466
IL +++ H NI++L ET LV++ + G L+ Y+ E+ ++ + +I
Sbjct: 76 ILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMR 131
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 526
+ + LH I HRD+K NILLDD K++DFG S + L GT
Sbjct: 132 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKLREVC-GT 186
Query: 527 FGYVDPEYFQSSQF------TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY--F 578
Y+ PE + S ++ D++S GV++ L L G F
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY-TL----------------LAGSPPF 229
Query: 579 LQAINENRLFE-ILDAR----------VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKE 627
+ + I+ K L R L + + R T +E
Sbjct: 230 W-HRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD--------LVSRFLVVQPQKRYTAEE 280
Query: 628 V 628
Sbjct: 281 A 281
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 69/304 (22%), Positives = 119/304 (39%), Gaps = 73/304 (24%)
Query: 359 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKL-----VDETNVEQFINEVVI 409
Y+ ++G+G V + + G AVK + E E E I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 410 LSQI-NHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWE----LLLR 463
L Q+ H +I+ L+ E+ + LV++ + G L+ Y+ E+ ++ E ++R
Sbjct: 153 LRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYL---TEKVALS-EKETRSIMR 207
Query: 464 IAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKV 523
+E A+ +LH+ I HRD+K NILLDD + ++SDFG S + L
Sbjct: 208 SLLE---AVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSC-HLEPGEKLRELC 260
Query: 524 QGTFGYVDPEYFQSSQF------TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY 577
GT GY+ PE + S ++ D+++ GV+L L L G
Sbjct: 261 -GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF-TL----------------LAGS 302
Query: 578 --FLQAINENRLFE-ILDAR----------VLKEAKKEGIMTVATLAKRCLNLNGKMRPT 624
F + + I++ + K L R L ++ + R T
Sbjct: 303 PPFW-HRRQILMLRMIMEGQYQFSSPEWDDRSSTVKD--------LISRLLQVDPEARLT 353
Query: 625 MKEV 628
++
Sbjct: 354 AEQA 357
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 27/223 (12%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQF----INEVVILSQINH 415
+ Y +G+G G VYK + GRIVA+K+ +L E E I E+ +L +++H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED--EGIPSTAIREISLLKELHH 78
Query: 416 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAVEVS 469
NIV L+ LV+EF+ L + + ++LL
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLR------- 130
Query: 470 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 529
+ + H I HRD+K N+L++ K++DFG +R+ + T +V T Y
Sbjct: 131 -GVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWY 185
Query: 530 VDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 571
P+ S +++ D++S G + E++TG KP+ TD+D
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVTDDD 227
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 56/235 (23%), Positives = 94/235 (40%), Gaps = 42/235 (17%)
Query: 361 NYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLV--------------------- 395
Y +G+G G V D A+K K KL+
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 396 --DETNVEQFINEVVILSQINHRNIVKL---LGCCLETEVPLLVYEFIPNGTLYQYIHNQ 450
+EQ E+ IL +++H N+VKL L E + +V+E + G + + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLK 132
Query: 451 IEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510
P++ + ++ + YLH I HRDIK +N+L+ + K++DFG S
Sbjct: 133 ----PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 511 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFT---EKSDVYSFGVVLVEILTGQKP 562
L + GT ++ PE ++ + DV++ GV L + GQ P
Sbjct: 186 -EFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 361 NYNANRILGQGGQGTVYKG--MLTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
Y LG+G G V T + VA+K + L + E+ L + H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKT-QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68
Query: 416 RNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYI--HNQIEEFPITWELLLRIAVEVSGAL 472
+I+KL + T + +V E+ G L+ YI ++ E + R ++ A+
Sbjct: 69 PHIIKLYDV-ITTPTDIVMVIEYA-GGELFDYIVEKKRMTE-----DEGRRFFQQIICAI 121
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532
Y H I HRD+K N+LLDD K++DFG S ++M D L T G+ Y P
Sbjct: 122 EYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTSC-GSPNYAAP 176
Query: 533 EYFQSSQFT-EKSDVYSFGVVLVEILTGQKP 562
E + + DV+S G+VL +L G+ P
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 63/247 (25%), Positives = 112/247 (45%), Gaps = 21/247 (8%)
Query: 334 QQELSSNESNIEKTKLFTSKDLEKAT-DNYNANRILGQGGQGTVYKGML----TDGRIVA 388
+ S+ S E+ ++ +K + T + + ++LG+G G V +L GR A
Sbjct: 121 RSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYA 177
Query: 389 VK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLY 444
+K K +V + V + E +L H + L +T L V E+ G L+
Sbjct: 178 MKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELF 236
Query: 445 QYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV 503
++ + F E R E+ AL YLHS ++ +Y RD+K N++LD K+
Sbjct: 237 FHLSRE-RVFS---EDRARFYGAEIVSALDYLHSEKNV-VY-RDLKLENLMLDKDGHIKI 290
Query: 504 SDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
+DFG + + D + T GT Y+ PE + + + D + GVV+ E++ G+ P
Sbjct: 291 TDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349
Query: 564 RAINTDE 570
+ ++
Sbjct: 350 YNQDHEK 356
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 52/216 (24%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVILSQIN 414
Y +G+G GTV+K IVA+K+ +L D+ E + E+ +L ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELK 59
Query: 415 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAVEV 468
H+NIV+L + LV+EF L +Y + + ++LL
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLK------ 112
Query: 469 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 528
L + HS + HRD+K N+L++ K+++FG +R+ + + +V T
Sbjct: 113 --GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLW 166
Query: 529 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
Y P+ F + ++ D++S G + E+ +P+
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 64/249 (25%), Positives = 110/249 (44%), Gaps = 19/249 (7%)
Query: 332 LLQQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYK-GMLTDGRIVAVK 390
L + + N + K + +DL ++Y +++G+G G V + ++ A+K
Sbjct: 41 LRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK 100
Query: 391 ---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQY 446
K +++ ++ F E I++ N +V+L + + L +V E++P G L
Sbjct: 101 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNL 159
Query: 447 IHNQIEEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 505
+ N + P E R EV AL +HS + HRD+K N+LLD K++D
Sbjct: 160 MSNY--DVP---EKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 211
Query: 506 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS----SQFTEKSDVYSFGVVLVEILTGQK 561
FGT + + GT Y+ PE +S + + D +S GV L E+L G
Sbjct: 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
Query: 562 PIRAINTDE 570
P A +
Sbjct: 272 PFYADSLVG 280
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 4e-23
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 27/215 (12%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQF----INEVVILSQINH 415
+ Y+ +G+G G VYK G A+KK +L E E I E+ IL ++ H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED--EGIPSTTIREISILKELKH 59
Query: 416 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAVEVS 469
NIVKL + +LV+E + L + + +LL
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLN------- 111
Query: 470 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 529
+ Y H + HRD+K N+L++ + K++DFG +R+ + T ++ T Y
Sbjct: 112 -GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWY 166
Query: 530 VDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
P+ S +++ D++S G + E++ G P+
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPL 200
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 6e-23
Identities = 63/246 (25%), Positives = 113/246 (45%), Gaps = 21/246 (8%)
Query: 334 QQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVK-- 390
Q+ + S++ ++ ++++ +RI+G+GG G VY D G++ A+K
Sbjct: 163 QKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL 222
Query: 391 -KSKLVDETNVEQFINEVVILSQIN---HRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQ 445
K ++ + +NE ++LS ++ IV + T L + + + G L+
Sbjct: 223 DKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHY 281
Query: 446 YIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVS 504
++ F E +R A E+ L ++H+ + +RD+K ANILLD+ ++S
Sbjct: 282 HLSQH-GVFS---EADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS 334
Query: 505 DFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPI 563
D G + + H V GT GY+ PE Q + S D +S G +L ++L G P
Sbjct: 335 DLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391
Query: 564 RAINTD 569
R T
Sbjct: 392 RQHKTK 397
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 23/211 (10%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFIN--EVVILSQINHR 416
+ Y +G+G G V+K G+IVA+KK ++ V + I E+ +L Q+ H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAVEVSG 470
N+V LL LV+E+ + T+ + P ITW+ L
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQ-------- 113
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 530
A+ + H HRD+K NIL+ K+ DFG +R + + +V T Y
Sbjct: 114 AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYR 169
Query: 531 DPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 560
PE +Q+ DV++ G V E+L+G
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 29/224 (12%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVILSQIN 414
+ Y LG+G TVYKG +VA+K+ +L E E I EV +L +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLK 58
Query: 415 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAVEV 468
H NIV L + LV+E++ L QY+ + ++LL
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL------- 110
Query: 469 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 528
L Y H + HRD+K N+L++++ K++DFG +R+ + +V T
Sbjct: 111 -RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLW 165
Query: 529 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 571
Y P+ S+ ++ + D++ G + E+ TG +P+ +T E+
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPLFPGSTVEE 208
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFIN--EVVILSQINHR 416
+ Y ++G+G G V K GRIVA+KK D+ + + I E+ +L Q+ H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWELLLRIAVEVSG 470
N+V LL C + + LV+EF+ + T+ + ++++
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIIN-------- 135
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 530
+ + HS I HRDIK NIL+ K+ DFG +R++ +V T Y
Sbjct: 136 GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYR 191
Query: 531 DPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 560
PE ++ + DV++ G ++ E+ G+
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 51/231 (22%), Positives = 98/231 (42%), Gaps = 26/231 (11%)
Query: 346 KTKLFTSKDLEKATDNYN-ANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNV 400
T+ + +E + Y ++ LG+G V + + + G+ A K K + +
Sbjct: 14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD-CR 72
Query: 401 EQFINEVVILSQINHR-NIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITW 458
+ ++E+ +L ++ L E + L+ E+ G ++ ++ E ++
Sbjct: 73 AEILHEIAVLELAKSCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEM-VS- 129
Query: 459 E----LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY---RAKVSDFGTSRS 511
E L++ +E ++YLH I H D+K NILL Y K+ DFG SR
Sbjct: 130 ENDVIRLIKQILE---GVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR- 182
Query: 512 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 562
+ ++ GT Y+ PE T +D+++ G++ +LT P
Sbjct: 183 -KIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 8e-22
Identities = 58/232 (25%), Positives = 104/232 (44%), Gaps = 43/232 (18%)
Query: 356 EKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQIN 414
K D + R+ GQG GTV G G VA+KK + D + + + L+ ++
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLH 77
Query: 415 HRNIVKLL------GCCLETEVPL-LVYEFIPNGTLYQYI-HNQIEEFPITWEL------ 460
H NIV+L G ++ L +V E++P+ TL++ + + L
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 461 -LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTH 518
L+R ++ LH S+ + HRDIK N+L++ K+ DFG+++ + + +
Sbjct: 137 QLIR-------SIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 519 LTTKVQGTFGYV------DPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
+ Y+ PE F + +T D++S G + E++ G+ PI
Sbjct: 189 V--------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PI 231
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 62/236 (26%), Positives = 99/236 (41%), Gaps = 40/236 (16%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVILSQIN 414
Y +GQG G V+K G+ VA+KK + +E E F + E+ IL +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLK 74
Query: 415 HRNIVKLLGCCLETEVPL--------LVYEFIPNGTLYQYIHNQIEEFP------ITWEL 460
H N+V L+ C P LV++F + L + N + +F + L
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQML 133
Query: 461 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS----VMVDQ 516
L L+Y+H I HRD+K+AN+L+ K++DFG +R+
Sbjct: 134 L--------NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 517 THLTTKVQGTFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 571
T +V T Y PE + D++ G ++ E+ T PI NT++
Sbjct: 183 NRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGNTEQH 236
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 64/233 (27%), Positives = 99/233 (42%), Gaps = 27/233 (11%)
Query: 352 SKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFIN----- 405
+ D++ Y LG+G TVYK +IVA+KK KL + + IN
Sbjct: 2 ALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61
Query: 406 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP------ITWE 459
E+ +L +++H NI+ LL LV++F+ L I +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLM 120
Query: 460 LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519
L L YLH I HRD+K N+LLD+ K++DFG ++S
Sbjct: 121 TLQ--------GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169
Query: 520 TTKVQGTFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 571
T +V T Y PE F + + D+++ G +L E+L P ++D D
Sbjct: 170 THQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDSDLD 220
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 64/292 (21%), Positives = 112/292 (38%), Gaps = 55/292 (18%)
Query: 359 TDNYNANR-ILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQI 413
TD+Y ++ +LG G G V + G+ A+K S + EV Q
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ--------EVDHHWQA 78
Query: 414 -NHRNIVKLLGCCLETEVP----LLVYEFIPNGTLYQYIHNQIEEF-------PITWELL 461
+IV +L L++ E + G L+ I + ++ I ++
Sbjct: 79 SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138
Query: 462 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTH 518
A+ +LHS I HRD+K N+L K + K++DFG ++ Q
Sbjct: 139 --------TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNA 185
Query: 519 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF 578
L T T YV PE ++ + D++S GV++ +L G P + +
Sbjct: 186 LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM--- 241
Query: 579 LQAINENRL-FEILD-ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ I + F + + V ++AK L + L + R T+ +
Sbjct: 242 KRRIRLGQYGFPNPEWSEVSEDAK--------QLIRLLLKTDPTERLTITQF 285
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 19/225 (8%)
Query: 366 RILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKL 421
R +G+G G V D ++ A+K K K V+ V E+ I+ + H +V L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 422 LGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYLHSAA 479
+ E + +V + + G L ++ Q F E +++ E+ AL YL +
Sbjct: 81 W-YSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFK---EETVKLFICELVMALDYLQNQR 135
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 539
I HRD+K NILLD+ ++DF + + + T + GT Y+ PE F S +
Sbjct: 136 ---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSSRK 190
Query: 540 FTEKS---DVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQA 581
S D +S GV E+L G++P ++ K +V F
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT 235
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 18/223 (8%)
Query: 358 ATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVILSQ 412
++ + LG G TVYKG+ T G VA+K+ KL E E I E+ ++ +
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKE 59
Query: 413 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF---PITWELLLRIAVEVS 469
+ H NIV+L LV+EF+ N L +Y+ ++ + L+ ++
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 470 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 529
L + H I HRD+K N+L++ + + K+ DFG +R+ + +++V T Y
Sbjct: 119 QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWY 174
Query: 530 VDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 571
P+ S ++ D++S G +L E++TG KP+ DE+
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPLFPGTNDEE 216
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 26/214 (12%)
Query: 359 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHR 416
D+Y R LG+G V++ + +T+ V VK K V + ++ E+ IL +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGP 91
Query: 417 NIVKLLGCCL--ETEVPLLVYEFIPNGTLYQYIHNQIEEFPI---TWELLLRIAVEVSGA 471
NI+ L + P LV+E + N Q + ++ I +E+L A
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-TLTDYDIRFYMYEILK--------A 142
Query: 472 LFYLHSAASIPIYHRDIKSANILLDDKYRA-KVSDFGTSRSVMVDQTHLTTKVQGTFGYV 530
L Y HS I HRD+K N+++D ++R ++ D+G + Q +V + +
Sbjct: 143 LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRV-ASRYFK 197
Query: 531 DPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPI 563
PE Q + S D++S G +L ++ ++P
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 61/227 (26%), Positives = 92/227 (40%), Gaps = 36/227 (15%)
Query: 359 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKK--SKLVDETNVEQFIN---------EV 407
Y R + G G V G+ ++G VA+K+ + + D V + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 408 VILSQINHRNIVKLLGCCLETEVPL-----LVYEFIPNGTLYQYIHNQ---IEEFPITWE 459
+L+ +H NI+ L + E P LV E + L Q IH+Q I I +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF 139
Query: 460 L--LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517
+ +L L LH A + HRD+ NILL D + DF +R D
Sbjct: 140 MYHILL-------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA- 188
Query: 518 HLTTKVQGTFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
+ T V Y PE Q FT+ D++S G V+ E+ K +
Sbjct: 189 NKTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KAL 233
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 55/262 (20%), Positives = 104/262 (39%), Gaps = 80/262 (30%)
Query: 355 LEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN-EVVILSQ 412
LE ++ Y+ + LG G G V + + G+ A+KK ++ N E+ I+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-----LQDPRYKNRELDIMKV 56
Query: 413 INHRNIVKLLGC-------------------------------------CLETEVPL-LV 434
++H NI+KL+ L ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 435 YEFIPNGTLYQYIHNQIEEF-PITWEL-------LLRIAVEVSGALFYLHSAASIPIYHR 486
E++P+ TL++ + + I I L L R A+ ++HS I HR
Sbjct: 117 MEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFR-------AVGFIHSLG---ICHR 165
Query: 487 DIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV------DPE-YFQSS 538
DIK N+L++ K+ DFG+++ ++ + + Y+ PE ++
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV--------AYICSRFYRAPELMLGAT 217
Query: 539 QFTEKSDVYSFGVVLVEILTGQ 560
++T D++S G V E++ G+
Sbjct: 218 EYTPSIDLWSIGCVFGELILGK 239
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 60/240 (25%), Positives = 104/240 (43%), Gaps = 23/240 (9%)
Query: 340 NESNIEKTKLFTSKDLEKAT-DNYNANRILGQGGQGTVYKGML----TDGRIVAVK---K 391
++ + K + + A D ++ + LG G G V ML G A+K K
Sbjct: 20 AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDK 76
Query: 392 SKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQI 451
K+V +E +NE IL +N +VKL + +V E++ G ++ ++
Sbjct: 77 QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI- 135
Query: 452 EEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510
F E R A ++ YLHS + +RD+K N+L+D + +V+DFG ++
Sbjct: 136 GRFS---EPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 511 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
V T + GT + PE S + + D ++ GV++ E+ G P A +
Sbjct: 190 RV----KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 21/220 (9%)
Query: 360 DNYNANRILGQGGQGTVYKGML----TDGRIVAVK---KSKLVDETNVEQFINEVVILSQ 412
++++ ++LG+G G V +L GR A+K K ++ + V + E +L
Sbjct: 5 NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 413 INHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSG 470
H + L +T L V E+ G L+ ++ + F E R E+
Sbjct: 62 TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRE-RVFT---EERARFYGAEIVS 116
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 530
AL YLHS + +RDIK N++LD K++DFG + + D GT Y+
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYL 172
Query: 531 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
PE + + + D + GVV+ E++ G+ P + +
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 22/223 (9%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVILSQIN 414
D Y LG+G G VYK + VA+K+ +L E E I EV +L ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE--EGVPGTAIREVSLLKELQ 91
Query: 415 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 474
HRNI++L L++E+ N L +Y+ ++ ++ ++ + +
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNF 147
Query: 475 LHSAASIPIYHRDIKSANILLDDKYRA-----KVSDFGTSRSVMVDQTHLTTKVQGTFGY 529
HS HRD+K N+LL + K+ DFG +R+ + T ++ T Y
Sbjct: 148 CHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWY 203
Query: 530 VDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 571
PE S ++ D++S + E+L P+ +++ D
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPLFPGDSEID 245
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 6e-20
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 366 RILGQGGQGTVY---KGMLTD-GRIVAVK---KSKLVDETN-VEQFINEVVILSQINHRN 417
R+LG+GG G V+ K + G+I A+K K+ +V E IL ++ H
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 418 IVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYL 475
IV L+ +T L L+ E++ G L+ + + F E E+S AL +L
Sbjct: 83 IVDLI-YAFQTGGKLYLILEYLSGGELFMQLERE-GIFM---EDTACFYLAEISMALGHL 137
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 535
H I +RD+K NI+L+ + K++DFG + + D +T GT Y+ PE
Sbjct: 138 HQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD-GTVTHTFCGTIEYMAPEIL 193
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
S D +S G ++ ++LTG P N +
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK 228
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 8e-20
Identities = 65/247 (26%), Positives = 107/247 (43%), Gaps = 22/247 (8%)
Query: 341 ESNIEKTKLFTSKDLEKAT-DNYNANRILGQGGQGTVY----KGMLTDGRIVAVK---KS 392
E + EK +N+ ++LG G G V+ G++ A+K K+
Sbjct: 34 TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA 93
Query: 393 KLVDETN-VEQFINEVVILSQINHRN-IVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHN 449
+V + E E +L I +V L +TE L L+ ++I G L+ ++
Sbjct: 94 TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQ 152
Query: 450 QIEEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 508
+ E F E ++I E+ AL +LH I +RDIK NILLD ++DFG
Sbjct: 153 R-ERFT---EHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205
Query: 509 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPIRAI 566
S+ + D+T GT Y+ P+ + + D +S GV++ E+LTG P
Sbjct: 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265
Query: 567 NTDEDKS 573
++
Sbjct: 266 GEKNSQA 272
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 8e-20
Identities = 72/242 (29%), Positives = 116/242 (47%), Gaps = 22/242 (9%)
Query: 341 ESNIEKTKL--FTSKDLEKAT-DNYNANRILGQGGQGTVY----KGMLTDGRIVAVK--- 390
E +I++ + + EKA + ++LGQG G V+ ++ A+K
Sbjct: 2 EGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK 61
Query: 391 KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHN 449
K+ L V E IL ++NH IVKL +TE L L+ +F+ G L+ +
Sbjct: 62 KATLKVRDRVRT-KMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSK 119
Query: 450 QIEEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 508
+ F E ++ E++ AL +LHS I +RD+K NILLD++ K++DFG
Sbjct: 120 E-VMFT---EEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGL 172
Query: 509 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINT 568
S+ + D GT Y+ PE T+ +D +SFGV++ E+LTG P + +
Sbjct: 173 SKESI-DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR 231
Query: 569 DE 570
E
Sbjct: 232 KE 233
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 9e-20
Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINH 415
Y + +G G QG V R VA+KK ++T+ ++ E+V++ +NH
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 416 RNIVKLLGCCLETEVPL------LVYEFIPNGTLYQYIHNQIEEFPITWEL--LLRIAVE 467
+NI+ LL + +V E + L Q I +++ +++ L +L
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLC---- 138
Query: 468 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 527
+ +LHSA I HRD+K +NI++ K+ DFG +R+ + + T T
Sbjct: 139 ---GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTR 190
Query: 528 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
Y PE + E D++S G ++ E++ G +
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVL 225
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 58/228 (25%), Positives = 89/228 (39%), Gaps = 36/228 (15%)
Query: 357 KATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFIN-----EVVIL 410
AT Y +G G GTVYK G VA+K ++ + + EV +L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 411 SQIN---HRNIVKLLGCCLETEVPL-----LVYEFIPNGTLYQYIHNQIEEF-------P 455
++ H N+V+L+ C + LV+E + L Y+
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 456 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515
+ + L L +LH+ I HRD+K NIL+ K++DFG +R
Sbjct: 125 LMRQFLR--------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173
Query: 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
LT V T Y PE S + D++S G + E+ KP+
Sbjct: 174 MA-LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPL 218
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 53/223 (23%), Positives = 92/223 (41%), Gaps = 40/223 (17%)
Query: 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINH 415
Y + +G G G+V + G VA+KK E ++ E+++L + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 416 RNIVKLLGCCLETEVPL------LVYEFIPNGTLYQYIHNQIEEFPITWEL--LLRIAVE 467
N++ LL LV F+ L + + + E I + + +L+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLK---- 137
Query: 468 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 527
L Y+HSA + HRD+K N+ +++ K+ DFG +R + T
Sbjct: 138 ---GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT---------- 181
Query: 528 GYVD------PE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
GYV PE + + D++S G ++ E+LTG K +
Sbjct: 182 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTL 223
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 6e-19
Identities = 68/290 (23%), Positives = 113/290 (38%), Gaps = 50/290 (17%)
Query: 359 TDNYN-ANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQI 413
D+Y +++LG G G V + A+K EV + +
Sbjct: 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA 111
Query: 414 -NHRNIVKLLGCCLETEVP-----LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 467
+IV+++ E L+V E + G L+ I ++ ++ T E R A E
Sbjct: 112 SQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FT-E---REASE 165
Query: 468 V----SGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGTSRSVMVDQTHLT 520
+ A+ YLHS I I HRD+K N+L K K++DFG ++ + LT
Sbjct: 166 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 221
Query: 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQ 580
T T YV PE ++ + D++S GV++ +L G P + + +
Sbjct: 222 TPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KT 277
Query: 581 AINENRL-FEILD-ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
I + F + + V +E K L + L R T+ E
Sbjct: 278 RIRMGQYEFPNPEWSEVSEEVK--------MLIRNLLKTEPTQRMTITEF 319
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 64/247 (25%), Positives = 116/247 (46%), Gaps = 30/247 (12%)
Query: 360 DNYNANRILGQGGQGTVYKGML----TDGRIVAVK---KSKLVDETNVEQFINEVVILSQ 412
+++ R++G+G V +L RI A+K K + D+ +++ E + Q
Sbjct: 9 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 413 I-NHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVS 469
NH +V L C +TE L V E++ G L ++ Q + P E R + E+S
Sbjct: 66 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLP---EEHARFYSAEIS 120
Query: 470 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 529
AL YLH I +RD+K N+LLD + K++D+G + + T+ GT Y
Sbjct: 121 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTFCGTPNY 176
Query: 530 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589
+ PE + + D ++ GV++ E++ G+ P + + ++ E+ LF+
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-------DQNTEDYLFQ 229
Query: 590 -ILDARV 595
IL+ ++
Sbjct: 230 VILEKQI 236
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 366 RILGQGGQGTVYKGML----TDGRIVAVK---KSKLVDETNVEQFINEVVILSQ-INHRN 417
+++G+G G V +L + AVK K ++ + + ++E +L + + H
Sbjct: 44 KVIGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 418 IVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGALFYL 475
+V L +T L V ++I G L+ ++ + F E R A E++ AL YL
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGELFYHLQRE-RCFL---EPRARFYAAEIASALGYL 155
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 535
HS I +RD+K NILLD + ++DFG + + + T+ GT Y+ PE
Sbjct: 156 HSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS-TTSTFCGTPEYLAPEVL 211
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+ D + G VL E+L G P + NT E
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 246
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 57/263 (21%), Positives = 110/263 (41%), Gaps = 34/263 (12%)
Query: 351 TSKDLEKATDNYN-ANRILGQGGQGTVYKGM---LTDGRIVAVKKSKL--VDETNVEQFI 404
S + E+ D + +G+G G VYK D + A+K+ + + +
Sbjct: 11 LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA----C 66
Query: 405 NEVVILSQINHRNIVKLLGCCLE-TEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLL 462
E+ +L ++ H N++ L L + + L++++ + L+ I + L
Sbjct: 67 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQL 125
Query: 463 RIAVEVS------GALFYLHSAASIPIYHRDIKSANILLDDKYRA----KVSDFGTSRSV 512
+ S + YLH+ + HRD+K ANIL+ + K++D G +R
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 513 MV---DQTHLTTKVQGTFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINT 568
L V TF Y PE + +T+ D+++ G + E+LT +PI
Sbjct: 183 NSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQ 240
Query: 569 DEDKSLVGYFLQAINENRLFEIL 591
++ K+ Y + +R+F ++
Sbjct: 241 EDIKTSNPYHHDQL--DRIFNVM 261
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 2e-18
Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINH 415
Y + +G G QG V R VA+KK ++T+ ++ E+V++ +NH
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 416 RNIVKLL-----GCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWEL--LLRIAVE 467
+NI+ LL LE + LV E + L Q I +++ +++ L +L
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLC---- 175
Query: 468 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF 527
+ +LHSA I HRD+K +NI++ K+ DFG +R+ +T V T
Sbjct: 176 ---GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV-VTR 227
Query: 528 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
Y PE + E D++S G ++ E++ K +
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KIL 262
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 63/247 (25%), Positives = 116/247 (46%), Gaps = 30/247 (12%)
Query: 360 DNYNANRILGQGGQGTVYKGML----TDGRIVAVK---KSKLVDETNVEQFINEVVILSQ 412
+++ R++G+G V +L RI A++ K + D+ +++ E + Q
Sbjct: 52 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 413 I-NHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVS 469
NH +V L C +TE L V E++ G L ++ Q + P E R + E+S
Sbjct: 109 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLP---EEHARFYSAEIS 163
Query: 470 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 529
AL YLH I +RD+K N+LLD + K++D+G + + T+ GT Y
Sbjct: 164 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTFCGTPNY 219
Query: 530 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589
+ PE + + D ++ GV++ E++ G+ P + + ++ E+ LF+
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-------DQNTEDYLFQ 272
Query: 590 -ILDARV 595
IL+ ++
Sbjct: 273 VILEKQI 279
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 38/228 (16%)
Query: 357 KATDNYNANRILGQGGQGTVYKG--MLTDGRIVAVKKSKLVDETNVEQF----INEVVIL 410
+A Y +G+G G V+K + GR VA+K+ ++ +T E I EV +L
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIREVAVL 65
Query: 411 SQIN---HRNIVKLLGCCLETEVPL-----LVYEFIPNGTLYQYIHNQIEEF-------P 455
+ H N+V+L C + LV+E + L Y+ E
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 456 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515
+ ++LL L +LHS + HRD+K NIL+ + K++DFG +R
Sbjct: 125 MMFQLLR--------GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173
Query: 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
LT+ V T Y PE S + D++S G + E+ KP+
Sbjct: 174 MA-LTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPL 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 76/240 (31%), Positives = 111/240 (46%), Gaps = 22/240 (9%)
Query: 341 ESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGML----TDGRIVAVK---KSK 393
ES+ E + + DN+ R+LG+G G V ML G + AVK K
Sbjct: 4 ESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKV---MLARVKETGDLYAVKVLKKDV 60
Query: 394 LVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQI 451
++ + +VE + E ILS NH + +L CC +T L V EF+ G L +I
Sbjct: 61 ILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKS- 118
Query: 452 EEFPITWELLLRI-AVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510
F E R A E+ AL +LH I +RD+K N+LLD + K++DFG +
Sbjct: 119 RRFD---EARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172
Query: 511 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+ + T GT Y+ PE Q + D ++ GV+L E+L G P A N D+
Sbjct: 173 EGICNGV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD 231
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 2e-18
Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 16/218 (7%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQIN- 414
++N +LG+G G V + AVK K ++ + +VE + E +L+
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 415 HRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGAL 472
+ +L C +T L V E++ G L +I F E A E++ L
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFK---EPHAVFYAAEIAIGL 455
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532
F+L S I +RD+K N++LD + K++DFG + + D T GT Y+ P
Sbjct: 456 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-TKTFCGTPDYIAP 511
Query: 533 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
E + + D ++FGV+L E+L GQ P + DE
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 32/224 (14%)
Query: 360 DNYNANRILGQGGQGTVYKGML----TDGRIVAVK---KSKLVDETNVEQFINEVVILSQ 412
++ R LG G G V L +GR A+K K +V VE +E ++LS
Sbjct: 6 QDFQILRTLGTGSFGRV---HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 413 INHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSG 470
+ H I+++ G + + ++ ++I G L+ + + FP + + A EV
Sbjct: 63 VTHPFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLLRKS-QRFP---NPVAKFYAAEVCL 117
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTF-G- 528
AL YLHS I +RD+K NILLD K++DFG ++ V D T+ T G
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTY-------TLCGT 166
Query: 529 --YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
Y+ PE + + + D +SFG+++ E+L G P NT +
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 54/234 (23%), Positives = 93/234 (39%), Gaps = 50/234 (21%)
Query: 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFIN---------EVV 408
+ ++ +LG+G G V G IVA+KK +E F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61
Query: 409 ILSQINHRNIVKLLGCCLETEVPL-----LVYEFIPNGT-LYQYIHNQI-EEFPITWEL- 460
IL H NI+ + ++ E + T L++ I Q+ + I + +
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQYFIY 119
Query: 461 -LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519
LR A+ LH + + HRD+K +N+L++ KV DFG +R +
Sbjct: 120 QTLR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 520 TTKVQGTF---GYVD------PEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
+ +V PE S++++ DV+S G +L E+ +PI
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPI 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 41/224 (18%)
Query: 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINH 415
Y + +G G G V + G VA+KK E ++ E+ +L + H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 416 RNIVKLLGCCLETEVPL------LVYEFIPNGTLYQYIHNQI-EEFPITWEL--LLRIAV 466
N++ LL E LV F+ L + + ++ E I + + +L+
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLK--- 139
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 526
L Y+H+A I HRD+K N+ +++ K+ DFG +R + T
Sbjct: 140 ----GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT--------- 183
Query: 527 FGYVD------PEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
GYV PE ++T+ D++S G ++ E++TG K +
Sbjct: 184 -GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKK-SKLVDETNVEQFINEVVILSQINHR 416
Y +G+G G V VA+KK S +T ++ + E+ IL + H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 417 NIVKLLGCCLETEVPL-----LVYEFIPNGT-LYQYIHNQI-EEFPITWEL--LLRIAVE 467
NI+ + + +V + + T LY+ + Q I + L +LR
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHICYFLYQILR---- 139
Query: 468 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH---LTTKVQ 524
L Y+HSA + HRD+K +N+LL+ K+ DFG +R D H LT V
Sbjct: 140 ---GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV- 192
Query: 525 GTFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
T Y PE S +T+ D++S G +L E+L+ +PI
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 38/229 (16%)
Query: 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRN 417
Y + LG GG G V+ + D + VA+KK L D +V+ + E+ I+ +++H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 418 IVKLL------GCCLETEVPL--------LVYEFIPNGT-LYQYIH-NQIEEFPITWEL- 460
IVK+ G L +V +V E++ T L + + E +
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPLLEEHARLFMY 127
Query: 461 -LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGTSRSVMVDQTH 518
LLR L Y+HSA + HRD+K AN+ ++ + K+ DFG +R + +H
Sbjct: 128 QLLR-------GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 519 ---LTTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
L+ + T Y P + +T+ D+++ G + E+LTG K +
Sbjct: 178 KGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTL 224
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 16/218 (7%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVVILSQI-N 414
++N +LG+G G V + AVK K ++ + +VE + E +L+
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 415 HRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVSGAL 472
+ +L C +T L V E++ G L +I F E A E++ L
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFK---EPHAVFYAAEIAIGL 134
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532
F+L S I +RD+K N++LD + K++DFG + + D T GT Y+ P
Sbjct: 135 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GVTTKTFCGTPDYIAP 190
Query: 533 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
E + + D ++FGV+L E+L GQ P + DE
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 53/224 (23%), Positives = 90/224 (40%), Gaps = 41/224 (18%)
Query: 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINH 415
+ Y +G G G+V T G VAVKK + ++ E+ +L + H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 416 RNIVKLLGCCLETEVPL------LVYEFIPNGTLYQYIHNQI-EEFPITWEL--LLRIAV 466
N++ LL LV + L + Q + + + + +LR
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR--- 143
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 526
L Y+HSA I HRD+K +N+ +++ K+ DFG +R + T
Sbjct: 144 ----GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--------- 187
Query: 527 FGYVD------PE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
GYV PE + + D++S G ++ E+LTG + +
Sbjct: 188 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTL 229
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 360 DNYNANRILGQGGQGTVYKGML----TDGRIVAVK---KSKLVDETNVEQFINEVVILSQ 412
+++ +++LG+G G V L + A+K K ++ + +VE + E +LS
Sbjct: 17 EDFILHKMLGKGSFGKV---FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 413 -INHRNIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRI-AVEVS 469
H + + C +T+ L V E++ G L +I + +F A E+
Sbjct: 74 AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFD---LSRATFYAAEII 128
Query: 470 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 529
L +LHS I +RD+K NILLD K++DFG + M+ T GT Y
Sbjct: 129 LGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDY 184
Query: 530 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE 570
+ PE ++ D +SFGV+L E+L GQ P + +E
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 225
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 34/205 (16%)
Query: 444 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV 503
+ + + +T E L+ + +V+ + +L AS HRD+ + NILL +K K+
Sbjct: 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 234
Query: 504 SDFGTSRSVMVDQTHLTTKVQGTFGYVD-----PEYFQSSQFTEKSDVYSFGVVLVEILT 558
DFG +R + D + V+ + PE +T +SDV+SFGV+L EI +
Sbjct: 235 CDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
Query: 559 -GQKPIRAINTDEDKSLVGYFLQAINE-NRLFEILDARVLKEAKKE--GIMTVATLAKRC 614
G P + DE+ F + + E R+ R E M C
Sbjct: 291 LGASPYPGVKIDEE------FCRRLKEGTRM------RAPDYTTPEMYQTM------LDC 332
Query: 615 LNLNGKMRPTMKEVAFELGGIRTST 639
+ RPT E+ LG + +
Sbjct: 333 WHGEPSQRPTFSELVEHLGNLLQAN 357
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 9e-17
Identities = 49/233 (21%), Positives = 90/233 (38%), Gaps = 55/233 (23%)
Query: 362 YNANRILGQGGQGTVYKGM-LTDGRIVAVK--KSKLVDETNVEQFINEVVILSQIN---- 414
Y R LG G TV+ + + VA+K + + E +E+ +L ++N
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADN 77
Query: 415 -------HRNIVKLLGC-----------CLETEVPLL---VYEFIPNGTLYQYIHNQIEE 453
+I+KLL + E +L + I +
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALI--------KKYEHRG 127
Query: 454 FPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA------KVSDFG 507
P+ + +I+ ++ L Y+H I I H DIK N+L++ K++D G
Sbjct: 128 IPL--IYVKQISKQLLLGLDYMHRRCGI-I-HTDIKPENVLMEIVDSPENLIQIKIADLG 183
Query: 508 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 560
+ D+ H T +Q Y PE + + +D++S ++ E++TG
Sbjct: 184 NAC--WYDE-HYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 50/246 (20%), Positives = 93/246 (37%), Gaps = 47/246 (19%)
Query: 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINH 415
DNY ++G+G G VY + + VA+KK + D + ++ + E+ IL+++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 416 RNIVKLLGCCLETEVPL-----LVYEFIPNGT-LYQYIH--NQIEEFPITWEL--LLRIA 465
I++L + ++ +V E + L + + E I L LL
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPIFLTEEHIKTILYNLLL-- 140
Query: 466 VEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQG 525
++H + I HRD+K AN LL+ KV DFG +R++ ++
Sbjct: 141 -----GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 526 TFGYVDP----------EY------------FQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
P + +T+ D++S G + E+L +
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252
Query: 564 RAINTD 569
T+
Sbjct: 253 INDPTN 258
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 6e-16
Identities = 58/279 (20%), Positives = 105/279 (37%), Gaps = 61/279 (21%)
Query: 334 QQELSSNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKS 392
+++ S++ + + + D Y ++G G G V + + R+VA+KK
Sbjct: 30 RKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI 86
Query: 393 KLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-----LVYEFIPNGT-LY 444
V D + ++ + E+ IL+++NH ++VK+L + +V +V E +
Sbjct: 87 LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFK 144
Query: 445 QYIHNQIEEFPITWEL-------LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD 497
+ + +T LL + Y+HSA I HRD+K AN L++
Sbjct: 145 KLFRTPV---YLTELHIKTLLYNLLV-------GVKYVHSAG---ILHRDLKPANCLVNQ 191
Query: 498 KYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP---------------EY-------- 534
KV DFG +R+V + + +
Sbjct: 192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRA 251
Query: 535 ----FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTD 569
+TE DV+S G + E+L K A + D
Sbjct: 252 PELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 66/242 (27%), Positives = 108/242 (44%), Gaps = 56/242 (23%)
Query: 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQIN- 414
Y + LG+G G V+K + G +VAVKK + T+ ++ E++IL++++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 415 HRNIVKLLGCCLETEVPL--------LVYEFIPNGT-LYQYIHNQI-EEFPITWEL--LL 462
H NIV LL V LV++++ T L+ I I E + + L+
Sbjct: 68 HENIVNLL------NVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVYQLI 119
Query: 463 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK 522
+ + YLHS + HRD+K +NILL+ + KV+DFG SRS + +
Sbjct: 120 K-------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 523 VQGTFGYVDP---------EY------------FQSSQFTEKSDVYSFGVVLVEILTGQK 561
+ +Y S+++T+ D++S G +L EIL G K
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-K 228
Query: 562 PI 563
PI
Sbjct: 229 PI 230
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 43/220 (19%)
Query: 362 YNANRILGQGGQGTVYKGM-LTDGRIVAVK--KSKLVDETNVEQFINEVVILSQINHR-- 416
Y +++G+G G V K + VA+K +++ + Q E+ IL + +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDK 155
Query: 417 ----NIVKLLGC-------CLETEVPLL---VYEFIPNGTLYQYIHNQIEEFPITWELLL 462
N++ +L C+ E LL +YE I N+ + F + L+
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKK--------NKFQGFSLP--LVR 203
Query: 463 RIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGTSRSVMVDQTHLT 520
+ A + L LH I H D+K NILL + R+ KV DFG+S + +
Sbjct: 204 KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVY 257
Query: 521 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 560
T +Q F Y PE +++ D++S G +L E+LTG
Sbjct: 258 TYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 61/228 (26%), Positives = 94/228 (41%), Gaps = 45/228 (19%)
Query: 356 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQF----INEVVIL 410
EK D Y + ++G+G G V K + VA+K K N + F EV +L
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-----NKKAFLNQAQIEVRLL 104
Query: 411 SQINHR------NIVKLLGC-------CLETEVPLL---VYEFIPNGTLYQYIHNQIEEF 454
+N IV L CL E +L +Y+ + N
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLLRN--------TNFRGV 154
Query: 455 PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGTSRSV 512
+ L + A ++ AL +L + + I H D+K NILL + R+ K+ DFG+S
Sbjct: 155 SLN--LTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--C 209
Query: 513 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 560
+ Q +Q F Y PE + D++S G +LVE+ TG+
Sbjct: 210 QLGQRI-YQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 59/285 (20%), Positives = 94/285 (32%), Gaps = 91/285 (31%)
Query: 359 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK--KSKLVDETNVEQFINEVVILSQI-- 413
Y+ R LG G TV+ + + VA+K KS E E ++E+ +L +
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRN 92
Query: 414 ------NHRNIVKLLGC-----------CLETEVPLLVYEFIPNG-TLYQYIHNQIEEFP 455
N +V+LL C+ V+E G L ++I
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICM-------VFE--VLGHHLLKWIIKS-NYQG 142
Query: 456 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL-------------------- 495
+ + +I +V L YLH+ I H DIK NILL
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRII--HTDIKPENILLSVNEQYIRRLAAEATEWQRS 200
Query: 496 -----------------------------DDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 526
+K + K++D G + V H T +Q T
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV---HKHFTEDIQ-T 256
Query: 527 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED 571
Y E S + +D++S + E+ TG + +E
Sbjct: 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEY 301
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 61/305 (20%), Positives = 96/305 (31%), Gaps = 84/305 (27%)
Query: 350 FTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFIN 405
K D +++LG G G V + A+K
Sbjct: 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-------- 59
Query: 406 EVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRI 464
EV + + +IV+++ VYE + G I + E EL RI
Sbjct: 60 EVELHWRASQCPHIVRIVD----------VYENLYAGRKCLLI---VMECLDGGELFSRI 106
Query: 465 ------------AVEV----SGALFYLHSAASIPIYHRDIKSANILLDDKYRA---KVSD 505
A E+ A+ YLHS I HRD+K N+L K K++D
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTD 163
Query: 506 FGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 565
FG + G Y + D++S GV++ +L G P +
Sbjct: 164 FG-----------FAKETTGE-KY-----------DKSCDMWSLGVIMYILLCGYPPFYS 200
Query: 566 INTDEDKSLVGYFLQAINENRL-FEILD-ARVLKEAKKEGIMTVATLAKRCLNLNGKMRP 623
+ + I + F + + V +E K L + L R
Sbjct: 201 NHGLAISPGM---KTRIRMGQYEFPNPEWSEVSEEVKM--------LIRNLLKTEPTQRM 249
Query: 624 TMKEV 628
T+ E
Sbjct: 250 TITEF 254
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 53/243 (21%), Positives = 87/243 (35%), Gaps = 65/243 (26%)
Query: 359 TDNYNANRILGQGGQGTVYKGM--LTDGRIVAVKKSKLVDETNVEQFIN----EVVILSQ 412
+ Y LG+G G V + + VA+K + NV ++ E+ +L +
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-----NVGKYREAARLEINVLKK 72
Query: 413 INHR------NIVKLLGC-------CLETEVPLL---VYEFIPNGTLYQYIHNQIEEFPI 456
I + V + C+ E LL +EF+ N + +P+
Sbjct: 73 IKEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKE--------NNFQPYPL 122
Query: 457 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA--------------- 501
+ +A ++ AL +LH H D+K NIL +
Sbjct: 123 --PHVRHMAYQLCHALRFLHENQLT---HTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177
Query: 502 ----KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 557
+V+DFG++ D H TT V Y PE + + DV+S G +L E
Sbjct: 178 NTSIRVADFGSA---TFDHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYY 233
Query: 558 TGQ 560
G
Sbjct: 234 RGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 62/244 (25%), Positives = 89/244 (36%), Gaps = 69/244 (28%)
Query: 362 YNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFIN----EVVILSQINHR 416
+ R +G G G V + + + AVK + N++++ E IL +I +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-----NIKKYTRSAKIEADILKKIQND 91
Query: 417 -----NIVKLLGC-------CLETEVPLL---VYEFIPNGTLYQYIHNQIEEFPITWELL 461
NIVK G CL E L +YE I N F I E +
Sbjct: 92 DINNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITR--------NNYNGFHI--EDI 139
Query: 462 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA-------------------- 501
+E+ AL YL + H D+K NILLDD Y
Sbjct: 140 KLYCIEILKALNYLRKMSLT---HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 502 -----KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEI 556
K+ DFG + H + + Y PE + + SD++SFG VL E+
Sbjct: 197 KSTGIKLIDFGCA--TFKSDYH-GSIINTRQ-YRAPEVILNLGWDVSSDMWSFGCVLAEL 252
Query: 557 LTGQ 560
TG
Sbjct: 253 YTGS 256
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 59/240 (24%), Positives = 93/240 (38%), Gaps = 65/240 (27%)
Query: 362 YNANRILGQGGQGTVYKG--MLTDGRIVAVKKSKLVDETNVEQFIN----EVVILSQINH 415
Y LG+G G V + GR VAVK K NV+++ E+ +L +N
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-----NVDRYCEAARSEIQVLEHLNT 70
Query: 416 R------NIVKLLGC-------CLETEVPLL---VYEFIPNGTLYQYIHNQIEEFPITWE 459
V++L C+ E LL Y+FI N F + +
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKE--------NGFLPFRL--D 118
Query: 460 LLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILL-DDKYRA----------------- 501
+ ++A ++ ++ +LHS H D+K NIL Y
Sbjct: 119 HIRKMAYQICKSVNFLHSNKLT---HTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 502 -KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 560
KV DFG++ D+ H +T V Y PE + +++ DV+S G +L+E G
Sbjct: 176 IKVVDFGSA--TYDDEHH-STLVSTRH-YRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 49/232 (21%), Positives = 93/232 (40%), Gaps = 24/232 (10%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRN 417
+ + R +G G G +Y G + VA+K + +T Q + E I +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTG 64
Query: 418 IVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 476
I + +E + +LV + + P+ L + + + + +L +A ++ + ++H
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLLGPS--LEDLFNFCSRKLSL--KTVLMLADQMINRVEFVH 120
Query: 477 SAASIPIYHRDIKSANILLDDKYRAK---VSDFGTSRSVMVDQTHL------TTKVQGTF 527
S + + HRDIK N L+ RA + DFG ++ TH + GT
Sbjct: 121 SKSFL---HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 528 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP---IRAINTDEDKSLVG 576
Y + + + D+ S G VL+ L G P ++A + +
Sbjct: 178 RYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 40/165 (24%), Positives = 70/165 (42%), Gaps = 15/165 (9%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH-RN 417
+ Y R +G G G +Y G + G VA+K + +T Q E I +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 66
Query: 418 IVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 476
I + C E + ++V E + P+ L + +F + + +L +A ++ + Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELLGPS--LEDLFNFCSRKFSL--KTVLLLADQMISRIEYIH 122
Query: 477 SAASIPIYHRDIKSANILL---DDKYRAKVSDFGTSRSVMVDQTH 518
S I HRD+K N L+ + DFG ++ +TH
Sbjct: 123 SKNFI---HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 7e-09
Identities = 30/204 (14%), Positives = 63/204 (30%), Gaps = 54/204 (26%)
Query: 358 ATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNV--------EQFINEVVI 409
T+ +G+G G V++ + D VA+K + V E+ + E++I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 410 LSQI---------NHRNIVKLLGCCL----------------------ETEVPL------ 432
++ + L + P
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 433 --LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKS 490
+V EF G + + ++ + I +++ +L + S+ HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKL----SSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190
Query: 491 ANILLDDKYRAKVSDFGTSRSVMV 514
N+LL K+ +S +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTI 214
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 39/183 (21%), Positives = 62/183 (33%), Gaps = 36/183 (19%)
Query: 361 NYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSK--------LVDETNVEQFINEVVILS 411
+ + +G GG G +Y A K L E Q + + +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 412 QINHRNIVKLLGCCLETEVPLLVY--EFIPNGTLY------------QYIHNQIEEFPIT 457
+ R + LG +PL G Y Q I Q F
Sbjct: 98 KWIERKQLDYLG------IPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKK- 150
Query: 458 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV--SDFGTSRSVMVD 515
+L++ + + L Y+H + H DIK+AN+LL K +V +D+G S +
Sbjct: 151 -STVLQLGIRMLDVLEYIHENEYV---HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206
Query: 516 QTH 518
H
Sbjct: 207 GNH 209
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 46/241 (19%), Positives = 87/241 (36%), Gaps = 40/241 (16%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRN 417
+Y R +G+G G +++G L + + VA+K ++ Q +E +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 67
Query: 418 IVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 476
I + E +LV + + P+ L + +F + + + A ++ + +H
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLGPS--LEDLLDLCGRKFSV--KTVAMAAKQMLARVQSIH 123
Query: 477 SAASIPIYHRDIKSANILLDDKYRAK-----VSDFGTSRSVMVDQTHL------TTKVQG 525
+ + +RDIK N L+ V DFG + T + G
Sbjct: 124 EKSLV---YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 526 TFGYVDPEYFQSS----QFTEKS---DVYSFGVVLVEILTGQKP---IRAINTDEDKSLV 575
T Y S E+S D+ + G V + L G P ++A + +
Sbjct: 181 TARY-------MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233
Query: 576 G 576
G
Sbjct: 234 G 234
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 2e-07
Identities = 41/312 (13%), Positives = 85/312 (27%), Gaps = 98/312 (31%)
Query: 76 LLGSPFIFSNIS-------NRFAAIGCDDYDTVDIN--NSTVSGGCLSISTCDPTSKRGC 126
L +P S I+ + D++ V+ + + + S++ +P R
Sbjct: 323 LTTNPRRLSIIAESIRDGLATW-----DNWKHVNCDKLTTIIE---SSLNVLEPAEYRKM 374
Query: 127 YDFLCALSP---NITH----IFNADLSYFYSQNISQKCRSVSVVEENWVGSK------YL 173
+D L ++ P +I + D+ + K S+VE+ S YL
Sbjct: 375 FDRL-SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYL 433
Query: 174 ENPRVLKQQARGIPAM----LDWGEEIGSCFEEFSSYSTICGDRENGCSIKLSSGYICRC 229
E LK + A+ +D Y+ + Y
Sbjct: 434 E----LKVKLENEYALHRSIVD-------------HYNIPKTFDSDDLIPPYLDQYFY-- 474
Query: 230 DAGFYRPHGLCSGTLLCISGHNCSKCPYGYF---------RYPRNSTDCYGGTA------ 274
+ H L + + + R+ + + G
Sbjct: 475 ---SHIGHHLKN----IEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQL 527
Query: 275 --YYSYFTRKSRVKYIIIGCSGGLGLLFLLVGIWWLYKFVKRRKEIKLKQKFFKRNGGLL 332
Y Y ++ + F+ + +E + K+ L
Sbjct: 528 KFYKPYICDNDPKYERLVNA---------------ILDFLPKIEENLICSKYTD-----L 567
Query: 333 LQQELSSNESNI 344
L+ L + + I
Sbjct: 568 LRIALMAEDEAI 579
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 1e-05
Identities = 56/312 (17%), Positives = 88/312 (28%), Gaps = 86/312 (27%)
Query: 286 KYIII-GCSGGLG--LLFLLV------------GIWWLYKFVKRRKE---IKLKQKFFKR 327
K ++I G G G + L V I+WL +++ QK +
Sbjct: 151 KNVLIDG-VLGSGKTWVALDVCLSYKVQCKMDFKIFWL-NLKNCNSPETVLEMLQKLLYQ 208
Query: 328 NGGLLLQQ-------ELSSNESNIEKTKLFTSKDLEKA---TDN-YNAN---------RI 367
+ +L + E +L SK E N NA +I
Sbjct: 209 IDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI 268
Query: 368 LGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLE 427
L T +K +TD + A + + + + + LL L+
Sbjct: 269 L----LTTRFKQ-VTD-FLSAATTTHISLDHHSMTL----------TPDEVKSLLLKYLD 312
Query: 428 TEV---PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIY 484
P V P I I + TW+ + H +
Sbjct: 313 CRPQDLPREVLTTNP--RRLSIIAESIRDGLATWD-------------NWKHV--NCDKL 355
Query: 485 HRDIK-SANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 543
I+ S N+L +YR SV H+ T + + D K
Sbjct: 356 TTIIESSLNVLEPAEYRKMFDRL----SVFPPSAHIPTILLSLI-WFDVIKSDVMVVVNK 410
Query: 544 SDVYSFGVVLVE 555
YS LVE
Sbjct: 411 LHKYS----LVE 418
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 2e-04
Identities = 63/404 (15%), Positives = 121/404 (29%), Gaps = 112/404 (27%)
Query: 381 LTDGRIVAVKKSKLV---DETNVEQFINEVV-------ILSQINHRNIVKLLGCCLETEV 430
I++V + V D +V+ ++ I+ + + L L ++
Sbjct: 16 YQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQ 75
Query: 431 PLLVYEFI-----PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYH 485
+V +F+ N Y+++ + I+ ++ R+ +E L+ + Y+
Sbjct: 76 EEMVQKFVEEVLRIN---YKFLMSPIKTEQRQPSMMTRMYIEQRDRLY--NDNQVFAKYN 130
Query: 486 --R-----DIKSANILLDDKYRAKVS---DFGTSRSVMVDQTHLTTKVQGTFGY------ 529
R ++ A LL+ + V G+ ++ + L+ KVQ +
Sbjct: 131 VSRLQPYLKLRQA--LLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLN 188
Query: 530 --------------------VDPEYFQ--SSQFTEKSDVYSFGVVLVEILTGQ------- 560
+DP + K ++S L +L +
Sbjct: 189 LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL 248
Query: 561 --------KPIRAIN-------TDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIM 605
K A N T K + FL A + + L + + +
Sbjct: 249 VLLNVQNAKAWNAFNLSCKILLTTRFKQVTD-FLSAATTTHISLDHHSMTLTPDEVKSL- 306
Query: 606 TVATLAKRCLNLN-GKMRPTMKEVA-FELGGIRTSTGASI----------LQQNCEEIDF 653
L K L+ + + L I SI NC+++
Sbjct: 307 ----LLK-YLDCRPQDLPREVLTTNPRRLSII----AESIRDGLATWDNWKHVNCDKLT- 356
Query: 654 VDGDISGHSLETGSSSTGMSILNSSSAFSIDAH-P--LLSNKWG 694
I SL + + + S F AH P LLS W
Sbjct: 357 ---TIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWF 397
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 32/158 (20%), Positives = 61/158 (38%), Gaps = 17/158 (10%)
Query: 361 NYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNI 418
N+ + +G G G + G L VA+K + ++ Q E Q+ + I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRFYKQLGSGDGI 67
Query: 419 VKLLGCCLETEVPLLVYEFI-PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 477
++ + +V E + P+ L F + + +L IA+++ + Y+HS
Sbjct: 68 PQVYYFGPCGKYNAMVLELLGPS--LEDLFDLCDRTFSL--KTVLMIAIQLISRMEYVHS 123
Query: 478 AASIPIYHRDIKSANILLDDKYRAKVS-----DFGTSR 510
I +RD+K N L+ DF ++
Sbjct: 124 KNLI---YRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 29/180 (16%), Positives = 65/180 (36%), Gaps = 27/180 (15%)
Query: 361 NYNANRILGQGGQGTVYKGM---------LTDGRIVAVK----KSKLVDETNVEQF---- 403
+ + QG +Y+ + ++K +L +E N Q
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 404 --INEVVILSQINHRNIVKLLGC-CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL 460
+N+ L I +G + + LV + G Q + + ++
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERS 160
Query: 461 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV--SDFGTSRSVMVDQTH 518
+L++A + AL +LH + H ++ + NI +D + +++V + +G + H
Sbjct: 161 VLQVACRLLDALEFLHENEYV---HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 33/182 (18%), Positives = 63/182 (34%), Gaps = 31/182 (17%)
Query: 361 NYNANRILGQGGQGTVYKGMLTDGRIVAVKK-----------SKLVDETNVEQFINEVVI 409
+ +GQGG G +Y + V L E Q +
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 410 LSQINHRNIVKLLG-----CCLETEVPLLVYEFI------PNGTLYQYIHNQIEEFPITW 458
+ + +K LG + Y F+ + L + + F
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSD--LQKIYEANAKRFSR-- 151
Query: 459 ELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV--SDFGTSRSVMVDQ 516
+ +L++++ + L Y+H + H DIK++N+LL+ K +V D+G + +
Sbjct: 152 KTVLQLSLRILDILEYIHEHEYV---HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 517 TH 518
H
Sbjct: 209 VH 210
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 694 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-70 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-69 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-65 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-64 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-63 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-58 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-58 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-55 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-52 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-51 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-51 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-49 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-46 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-45 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-41 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 1e-70
Identities = 72/289 (24%), Positives = 118/289 (40%), Gaps = 21/289 (7%)
Query: 354 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQI 413
D E + +G G GTVYKG V + ++ F NEV +L +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 414 NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALF 473
H NI+ +G +V ++ +LY ++H E L+ IA + + +
Sbjct: 62 RHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMD 118
Query: 474 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ-THLTTKVQGTFGYVDP 532
YLH+ I HRD+KS NI L + K+ DFG + +H ++ G+ ++ P
Sbjct: 119 YLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 533 EYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589
E + ++ +SDVY+FG+VL E++TGQ P IN + + + L
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLSP 229
Query: 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638
L K + L CL RP ++ + + S
Sbjct: 230 DLSKVRSNCPKA-----MKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (573), Expect = 5e-69
Identities = 65/280 (23%), Positives = 120/280 (42%), Gaps = 21/280 (7%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 419
+ LG G G V+ G VAVK K + + F+ E ++ Q+ H+ +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
+L + + ++ E++ NG+L ++ +T LL +A +++ + ++
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 539
HRD+++ANIL+ D K++DFG +R + ++ + + PE
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 540 FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEA 599
FT KSDV+SFG++L EI+T + T+ + +Q + D +E
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGYRMVRPD-NCPEEL 239
Query: 600 KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639
+ L + C + RPT + L T+T
Sbjct: 240 YQ--------LMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 3e-68
Identities = 73/303 (24%), Positives = 125/303 (41%), Gaps = 37/303 (12%)
Query: 355 LEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL-VDETNVEQFINEVVILSQ 412
+E D++ LG G G V+K G ++A K L + Q I E+ +L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 413 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 472
N IV G + E + G+L Q + I ++L ++++ V L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGL 117
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532
YL I HRD+K +NIL++ + K+ DFG S ++ + GT Y+ P
Sbjct: 118 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 533 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED--------------------- 571
E Q + ++ +SD++S G+ LVE+ G+ PI + E
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 572 --KSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAK----RCLNLNGKMRPTM 625
+ L Y + + +FE+LD V + K + + +CL N R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 626 KEV 628
K++
Sbjct: 293 KQL 295
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-65
Identities = 72/279 (25%), Positives = 122/279 (43%), Gaps = 21/279 (7%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 419
+ +G G G V+ G + VA+K + + E FI E ++ +++H +V
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
+L G CLE LV+EF+ +G L Y+ Q E LL + ++V + YL A
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA- 120
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 539
+ HRD+ + N L+ + KVSDFG +R V+ DQ +T + + PE F S+
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 540 FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEA 599
++ KSDV+SFGV++ E+ + K + + + + E +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKI---------------PYENRSNSEVVEDISTGFRLYK 223
Query: 600 KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638
+ V + C + RP + +L I S
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 2e-65
Identities = 73/277 (26%), Positives = 121/277 (43%), Gaps = 25/277 (9%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHR 416
++Y +G G G K +DG+I+ K+ + E + ++EV +L ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 417 NIVKLLGCCLETE--VPLLVYEFIPNGTLYQYIHNQIEEF-PITWELLLRIAVEVSGALF 473
NIV+ ++ +V E+ G L I +E + E +LR+ +++ AL
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 474 YLH--SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 531
H S + HRD+K AN+ LD K K+ DFG +R + D + GT Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMS 182
Query: 532 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591
PE + EKSD++S G +L E+ P A + E I E + F +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGK-FRRI 234
Query: 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
R E + + R LNL RP+++E+
Sbjct: 235 PYRYSDELNE--------IITRMLNLKDYHRPSVEEI 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 2e-65
Identities = 69/279 (24%), Positives = 130/279 (46%), Gaps = 27/279 (9%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 419
+ +G+G G V G G VAVK + ++ + F+ E +++Q+ H N+V
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLV 63
Query: 420 KLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 478
+LLG +E + L +V E++ G+L Y+ ++ + + LL+ +++V A+ YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 479 ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSS 538
HRD+ + N+L+ + AKVSDFG ++ Q + + PE +
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREK 175
Query: 539 QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598
+F+ KSDV+SFG++L EI + + +D + + + + D
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPD-GCPPA 228
Query: 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRT 637
+ + K C +L+ MRP+ ++ +L I+T
Sbjct: 229 VYE--------VMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (544), Expect = 1e-64
Identities = 77/290 (26%), Positives = 126/290 (43%), Gaps = 21/290 (7%)
Query: 354 DLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQ 412
E + LG G G VY+G+ VAVK K D VE+F+ E ++ +
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 69
Query: 413 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 472
I H N+V+LLG C ++ EF+ G L Y+ ++ +LL +A ++S A+
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAM 128
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532
YL HRD+ + N L+ + + KV+DFG SR + D + + P
Sbjct: 129 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 533 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592
E ++F+ KSDV++FGV+L EI T I+ ++++E+L+
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLE 230
Query: 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGAS 642
E + V L + C N RP+ E+ + + S
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 280
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 3e-64
Identities = 62/280 (22%), Positives = 117/280 (41%), Gaps = 21/280 (7%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 419
++ LGQG G V+ G VA+K K + E F+ E ++ ++ H +V
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
+L E + +V E++ G+L ++ + ++ L+ +A +++ + Y+
Sbjct: 76 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLR-LPQLVDMAAQIASGMAYVERM- 132
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 539
HRD+++ANIL+ + KV+DFG +R + ++ + + PE +
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 540 FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEA 599
FT KSDV+SFG++L E+ T + + + L + +
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYRMPC-PPECPESL 243
Query: 600 KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639
L +C + RPT + + L TST
Sbjct: 244 HD--------LMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 3e-63
Identities = 77/291 (26%), Positives = 131/291 (45%), Gaps = 25/291 (8%)
Query: 339 SNESNIEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDE 397
S+E +EK + S Y +GQG GTVY M + G+ VA+++ L +
Sbjct: 1 SDEEILEKLRSIVSVG--DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 398 TNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPIT 457
E INE++++ + + NIV L L + +V E++ G+L + +
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMD 114
Query: 458 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517
+ + E AL +LHS + HRDIKS NILL K++DFG + +Q+
Sbjct: 115 EGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171
Query: 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY 577
+T V GT ++ PE + K D++S G++ +E++ G+ P N
Sbjct: 172 KRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------ 224
Query: 578 FLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
L I N E+ + L ++ RCL+++ + R + KE+
Sbjct: 225 -LYLIATNGTPELQNPEKLSAIFRD-------FLNRCLDMDVEKRGSAKEL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 6e-62
Identities = 75/273 (27%), Positives = 113/273 (41%), Gaps = 30/273 (10%)
Query: 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
+++ R LG+G G VY I+A+K K++L Q EV I S + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 416 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 475
NI++L G + L+ E+ P GT+Y+ + + E++ AL Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 535
HS + HRDIK N+LL K++DFG S + + GT Y+ PE
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMI 176
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595
+ EK D++S GV+ E L G+ P A E + I+ V
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEF--TFPDFV 227
Query: 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ A+ L R L N RP ++EV
Sbjct: 228 TEGARD--------LISRLLKHNPSQRPMLREV 252
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 6e-62
Identities = 75/288 (26%), Positives = 132/288 (45%), Gaps = 30/288 (10%)
Query: 353 KDLEKATDNYN-ANRILGQGGQGTVYKGML---TDGRIVAVKK-SKLVDETNVEQFINEV 407
K L DN A+ LG G G+V +G+ VA+K + ++ + E+ + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 408 VILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVE 467
I+ Q+++ IV+L+G C + E +LV E G L++++ + EE P + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIP--VSNVAELLHQ 117
Query: 468 VSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK--VQG 525
VS + YL HRD+ + N+LL +++ AK+SDFG S+++ D ++ T + +
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 526 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINE 584
+ PE +F+ +SDV+S+GV + E L+ GQKP + + E + I +
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQ 227
Query: 585 NRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632
+ E E L C + RP V +
Sbjct: 228 GKRMECPP-ECPPELYA--------LMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (526), Expect = 8e-62
Identities = 66/291 (22%), Positives = 111/291 (38%), Gaps = 36/291 (12%)
Query: 345 EKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNV 400
+ +LF D EK ++ R +G G G VY + + +VA+K S
Sbjct: 3 DVAELFFKDDPEK---LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 401 EQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWEL 460
+ I EV L ++ H N ++ GC L LV E+ ++ P+
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVE 116
Query: 461 LLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT 520
+ + L YLHS + HRD+K+ NILL + K+ DFG++
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS-----IMAPA 168
Query: 521 TKVQGTFGYVDPEYFQSS---QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY 577
GT ++ PE + Q+ K DV+S G+ +E+ + P+ +N
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------ 222
Query: 578 FLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
L I +N + + + CL + RPT + +
Sbjct: 223 -LYHIAQNESPALQSGHWSEYFRN--------FVDSCLQKIPQDRPTSEVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 8e-62
Identities = 68/269 (25%), Positives = 115/269 (42%), Gaps = 21/269 (7%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV 419
+ + LG G G V G VA+K K + ++FI E ++ ++H +V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
+L G C + ++ E++ NG L Y+ F + LL + +V A+ YL S
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ--TQQLLEMCKDVCEAMEYLESK- 119
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 539
HRD+ + N L++D+ KVSDFG SR V+ D+ + + + PE S+
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 540 FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEA 599
F+ KSD+++FGV++ EI + K + + E + +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAEHIAQGLRLYR 222
Query: 600 KKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
V T+ C + RPT K +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKIL 251
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 3e-61
Identities = 80/286 (27%), Positives = 136/286 (47%), Gaps = 29/286 (10%)
Query: 362 YNANRILGQGGQGTVYKGMLTD----GRIVAVKK-SKLVDETNVEQFINEVVILSQINHR 416
+ N ++G+G G VY G L D AVK +++ D V QF+ E +I+ +H
Sbjct: 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 88
Query: 417 NIVKLLGCCLETE-VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 475
N++ LLG CL +E PL+V ++ +G L +I N E T + L+ ++V+ + +L
Sbjct: 89 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFL 146
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV---MVDQTHLTTKVQGTFGYVDP 532
S HRD+ + N +LD+K+ KV+DFG +R + D H T + ++
Sbjct: 147 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 533 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592
E Q+ +FT KSDV+SFGV+L E++T P D + + + RL
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-----YPDVNTFDITVYLLQGRRLL--QP 256
Query: 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638
+ + +C + +MRP+ E+ + I ++
Sbjct: 257 EYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 5e-61
Identities = 61/272 (22%), Positives = 118/272 (43%), Gaps = 30/272 (11%)
Query: 365 NRILGQGGQGTVYKGMLTD-GRIVAVKK--SKLVDETNVEQFINEVVILSQINHRNIVKL 421
+ +G+G TVYKG+ T+ VA + + + ++ ++F E +L + H NIV+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 422 LGCCLET----EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 477
T + +LV E + +GTL Y+ + ++L ++ L +LH+
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT 130
Query: 478 AASIPIYHRDIKSANILLDDK-YRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 536
+ PI HRD+K NI + K+ D G + + + V GT ++ PE ++
Sbjct: 131 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAPEMYE 186
Query: 537 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596
++ E DVY+FG+ ++E+ T + P + + D +
Sbjct: 187 E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPASFDKVAI 239
Query: 597 KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
E K+ + + C+ N R ++K++
Sbjct: 240 PEVKE--------IIEGCIRQNKDERYSIKDL 263
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 5e-61
Identities = 76/336 (22%), Positives = 138/336 (41%), Gaps = 51/336 (15%)
Query: 331 LLLQQELSSNESN---IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLTD---- 383
L + Q S+++ ++ + E +N ++LG G G V
Sbjct: 5 LQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKT 64
Query: 384 --GRIVAVKK-SKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIP 439
VAVK + D + E ++E+ +++Q+ +H NIV LLG C + L++E+
Sbjct: 65 GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC 124
Query: 440 NGTLYQYIHNQIEEF--------------------PITWELLLRIAVEVSGALFYLHSAA 479
G L Y+ ++ E+F +T+E LL A +V+ + +L
Sbjct: 125 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK- 183
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT-TKVQGTFGYVDPEYFQSS 538
HRD+ + N+L+ K+ DFG +R +M D ++ + ++ PE
Sbjct: 184 --SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 241
Query: 539 QFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597
+T KSDV+S+G++L EI + G P I D + F + I + +
Sbjct: 242 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN------FYKLIQNGFKMDQ-PFYATE 294
Query: 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633
E + + C + + RP+ + LG
Sbjct: 295 EIYI--------IMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (519), Expect = 6e-61
Identities = 68/305 (22%), Positives = 122/305 (40%), Gaps = 40/305 (13%)
Query: 350 FTSKDLEKATDN---------YNANRILGQGGQGTVYKGMLT----DGRIVAVKK-SKLV 395
FT +D +A +++G G G V G L VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 396 DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFP 455
E F++E I+ Q +H N++ L G ++ +++ EF+ NG+L ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--Q 124
Query: 456 ITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515
T L+ + ++ + YL HRD+ + NIL++ KVSDFG SR + D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 516 QTHLTTK----VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 570
+ T + + PE Q +FT SDV+S+G+V+ E+++ G++P + +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
Query: 571 DKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAF 630
+ AI ++ + L C + RP ++
Sbjct: 242 -------VINAIEQDYRLPP-PMDCPSALHQ--------LMLDCWQKDRNHRPKFGQIVN 285
Query: 631 ELGGI 635
L +
Sbjct: 286 TLDKM 290
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 7e-61
Identities = 72/276 (26%), Positives = 125/276 (45%), Gaps = 31/276 (11%)
Query: 365 NRILGQGGQGTVYKGMLTD---GRIVAVK--KSKLVDETNVEQFINEVVILSQINHRNIV 419
++ LG G GTV KG + VAVK K++ D ++ + E ++ Q+++ IV
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
+++G C E E +LV E G L +Y+ + + ++ + +VS + YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES- 126
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTK--VQGTFGYVDPEYFQS 537
HRD+ + N+LL ++ AK+SDFG S+++ D+ + + + + PE
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 538 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596
+F+ KSDV+SFGV++ E + GQKP R + E + + A
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMGC-PAGCP 236
Query: 597 KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632
+E L C + + RP V L
Sbjct: 237 REMYD--------LMNLCWTYDVENRPGFAAVELRL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 9e-61
Identities = 60/298 (20%), Positives = 114/298 (38%), Gaps = 29/298 (9%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCC 425
+G+G G V++G G VAVK +E + E+ + H NI+ +
Sbjct: 9 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAAD 66
Query: 426 LETE----VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA-- 479
+ LV ++ +G+L+ Y++ +T E ++++A+ + L +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 480 ---SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL---TTKVQGTFGYVDPE 533
I HRD+KS NIL+ ++D G + + GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 534 YFQSS------QFTEKSDVYSFGVVLVEILTGQKPIRAINTDE----DKSLVGYFLQAIN 583
S + +++D+Y+ G+V EI + D ++ +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 584 ENRLFEILDARVLKEAK-KEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTG 640
+ + L + + E + +A + + C NG R T + L + G
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-60
Identities = 68/276 (24%), Positives = 106/276 (38%), Gaps = 26/276 (9%)
Query: 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRN 417
D + LG G G VYK + + A K E +E ++ E+ IL+ +H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 418 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 477
IVKLL ++ EF G + + E P+T + + + AL YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHD 128
Query: 478 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS 537
I HRD+K+ NIL K++DFG S + + GT ++ PE
Sbjct: 129 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMC 184
Query: 538 SQ-----FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592
+ K+DV+S G+ L+E+ + P +N L+
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAKSEPPTLAQP 238
Query: 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+R K K+CL N R T ++
Sbjct: 239 SRWSSNFKD--------FLKKCLEKNVDARWTTSQL 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (517), Expect = 1e-60
Identities = 64/312 (20%), Positives = 120/312 (38%), Gaps = 47/312 (15%)
Query: 353 KDLEKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVDETNVEQFIN 405
LE +N R +G+G G V++ +VAVK + F
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65
Query: 406 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF----------- 454
E ++++ ++ NIVKLLG C + L++E++ G L +++ +
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 455 ----------PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVS 504
P++ L IA +V+ + YL HRD+ + N L+ + K++
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIA 182
Query: 505 DFGTSRSVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
DFG SR++ D ++ PE +++T +SDV+++GVVL EI +
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242
Query: 564 RAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRP 623
E+ + + + + + E L + C + RP
Sbjct: 243 YYGMAHEE------VIYYVRDGNILACPE-NCPLELYN--------LMRLCWSKLPADRP 287
Query: 624 TMKEVAFELGGI 635
+ + L +
Sbjct: 288 SFCSIHRILQRM 299
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 6e-59
Identities = 70/273 (25%), Positives = 110/273 (40%), Gaps = 24/273 (8%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK-SKLVDETNVEQFINEVVILSQINHRN 417
++++ + LG+G G V + VAVK E E+ I +NH N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 418 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 477
+VK G E + L E+ G L+ I I + R ++ + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG 121
Query: 478 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD-QTHLTTKVQGTFGYVDPEYFQ 536
I HRDIK N+LLD++ K+SDFG + + + L K+ GT YV PE +
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 537 SSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595
+F E DV+S G+VL +L G+ P + S E + + ++
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
L + L N R T+ ++
Sbjct: 233 DSAPLA--------LLHKILVENPSARITIPDI 257
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 3e-58
Identities = 69/287 (24%), Positives = 115/287 (40%), Gaps = 26/287 (9%)
Query: 354 DLEKATDNYNANRILGQGGQGTVYKGMLTD----GRIVAVKK-SKLVDETNVEQFINEVV 408
D E + R +G+G G V++G+ VA+K ++ E+F+ E +
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 409 ILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 468
+ Q +H +IVKL+G E V ++ E G L ++ + + + L+ A ++
Sbjct: 61 TMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQL 117
Query: 469 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 528
S AL YL S HRDI + N+L+ K+ DFG SR + + +K +
Sbjct: 118 STALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 529 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 588
++ PE +FT SDV+ FGV + EIL + D + I
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERL 228
Query: 589 EILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635
+ L +C + RP E+ +L I
Sbjct: 229 PMPP-NCPPTLYS--------LMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 3e-58
Identities = 68/316 (21%), Positives = 124/316 (39%), Gaps = 41/316 (12%)
Query: 344 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVD 396
I+ T+L E + + + LG G G V + VAVK
Sbjct: 7 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66
Query: 397 ETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF- 454
T E ++E+ +LS + NH NIV LLG C L++ E+ G L ++ + + F
Sbjct: 67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 455 --------------PITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYR 500
+ E LL + +V+ + +L S HRD+ + NILL
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI 183
Query: 501 AKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTG 559
K+ DFG +R + D + + + ++ PE + +T +SDV+S+G+ L E+ +
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 560 QKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNG 619
+ K ++++ + + + + K C + +
Sbjct: 244 GSSPYPGMPVDSK--------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289
Query: 620 KMRPTMKEVAFELGGI 635
RPT K++ +
Sbjct: 290 LKRPTFKQIVQLIEKQ 305
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 4e-58
Identities = 67/278 (24%), Positives = 114/278 (41%), Gaps = 28/278 (10%)
Query: 356 EKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILS 411
+K +++ +ILG+G TV L R A+K K ++ E V E ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 412 QINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGA 471
+++H VKL + E + NG L +YI E+ A
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSA 120
Query: 472 LFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD-QTHLTTKVQGTFGYV 530
L YLH I HRD+K NILL++ +++DFGT++ + + + GT YV
Sbjct: 121 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 531 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590
PE + SD+++ G ++ +++ G P RA N Q I +
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IFQKIIKLEY--D 228
Query: 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ +A+ L ++ L L+ R +E+
Sbjct: 229 FPEKFFPKARD--------LVEKLLVLDATKRLGCEEM 258
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 5e-58
Identities = 67/291 (23%), Positives = 123/291 (42%), Gaps = 28/291 (9%)
Query: 356 EKATDNYNANRILGQGGQGTVYKGMLTDG-----RIVAVKK-SKLVDETNVEQFINEVVI 409
E +++G G G VYKGML VA+K E F+ E I
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 410 LSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVS 469
+ Q +H NI++L G + + +++ E++ NG L +++ + EF L+ + ++
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS--VLQLVGMLRGIA 120
Query: 470 GALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ--THLTTKVQGTF 527
+ YL + HRD+ + NIL++ KVSDFG SR + D T+ T+ +
Sbjct: 121 AGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 528 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 587
+ PE +FT SDV+SFG+V+ E++T + ++ + +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELSNHEV 222
Query: 588 FEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638
+ ++ + + L +C RP ++ L + +
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 9e-58
Identities = 69/319 (21%), Positives = 122/319 (38%), Gaps = 38/319 (11%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTDG---RIVAVKK-SKLVDETNVEQFINEVVILSQI-N 414
++ ++G+G G V K + A+K+ + + + F E+ +L ++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 415 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF-------------PITWELL 461
H NI+ LLG C L E+ P+G L ++ ++ + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 462 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT 521
L A +V+ + YL HRD+ + NIL+ + Y AK++DFG SR V T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 522 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQA 581
+ ++ E S +T SDV+S+GV+L EI++
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYCG 229
Query: 582 INENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGA 641
+ L+E L E V L ++C RP+ ++ L +
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
Query: 642 SILQQNCEEIDFVDGDISG 660
+ E+ + D S
Sbjct: 290 YVNTTLYEKFTYAGIDCSA 308
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 195 bits (496), Expect = 5e-57
Identities = 56/274 (20%), Positives = 111/274 (40%), Gaps = 27/274 (9%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 418
D+Y+ + LG G G V++ G A K E++ E E+ +S + H +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 419 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 478
V L + +++YEF+ G L++ + ++ ++ + + +V L ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 479 ASIPIYHRDIKSANILLDDKY--RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 536
H D+K NI+ K K+ DFG + + Q+ T GT + PE +
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAE 198
Query: 537 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN--RLFEILDAR 594
+D++S GV+ +L+G P N DE L+ + + + +
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWNMDDSAFSG 251
Query: 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ ++ K ++ L + R T+ +
Sbjct: 252 ISEDGKD--------FIRKLLLADPNTRMTIHQA 277
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 4e-56
Identities = 60/283 (21%), Positives = 125/283 (44%), Gaps = 29/283 (10%)
Query: 357 KATDNYNANRILGQGGQGTVYKGMLTD-----GRIVAVKK-SKLVDETNVEQFINEVVIL 410
K T+ + ++LG G GTVYKG+ VA+K+ + ++ ++E ++
Sbjct: 7 KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 411 SQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 470
+ +++ ++ +LLG CL + V L+ + +P G L Y+ + I + LL V+++
Sbjct: 66 ASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAK 122
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT-HLTTKVQGTFGY 529
+ YL + HRD+ + N+L+ K++DFG ++ + ++ + + +
Sbjct: 123 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 530 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589
+ E +T +SDV+S+GV + E++T I + +
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISS 224
Query: 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFEL 632
IL+ + V + +C ++ RP +E+ E
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-55
Identities = 68/279 (24%), Positives = 113/279 (40%), Gaps = 31/279 (11%)
Query: 360 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETNVEQFINEVVILSQ 412
+ LG G G V +G VAVK L ++ FI EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 413 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 472
++HRN+++L G L + +V E P G+L + + L R AV+V+ +
Sbjct: 68 LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH--LTTKVQGTFGYV 530
YL S HRD+ + N+LL + K+ DFG R++ + H + + F +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 531 DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFE 589
PE ++ F+ SD + FGV L E+ T GQ+P +N + L I++
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-------ILHKIDKEGERL 234
Query: 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
++ + +C + RPT +
Sbjct: 235 PRPEDCPQDIYN--------VMVQCWAHKPEDRPTFVAL 265
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 185 bits (471), Expect = 2e-54
Identities = 77/289 (26%), Positives = 117/289 (40%), Gaps = 30/289 (10%)
Query: 359 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQIN 414
+D Y ILG GG V+ L R VAVK D + +F E + +N
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 415 HRNIVKLLGCCLETE----VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 470
H IV + +P +V E++ TL +H + P+T + + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQ 122
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL--TTKVQGTFG 528
AL + H I HRD+K ANI++ KV DFG +R++ + T V GT
Sbjct: 123 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 529 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 588
Y+ PE + +SDVYS G VL E+LTG+ P S V Q + E+ +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF------TGDSPVSVAYQHVREDPIP 233
Query: 589 EILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRP-TMKEVAFELGGIR 636
L + + L N + R T E+ +L +
Sbjct: 234 PSARHEGLSADLDA-------VVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-53
Identities = 75/325 (23%), Positives = 136/325 (41%), Gaps = 41/325 (12%)
Query: 344 IEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKK-SKLVD 396
++ + E A + +R LGQG G VY+G+ VA+K ++
Sbjct: 4 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63
Query: 397 ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------N 449
+F+NE ++ + N ++V+LLG + + L++ E + G L Y+ N
Sbjct: 64 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 123
Query: 450 QIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS 509
P + ++++A E++ + YL++ HRD+ + N ++ + + K+ DFG +
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 180
Query: 510 RSVM-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINT 568
R + D K ++ PE + FT SDV+SFGVVL EI T + +
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240
Query: 569 DEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+E L+ + E L + D + L + C N KMRP+ E+
Sbjct: 241 NEQ------VLRFVMEGGLLDKPD-NCPDMLFE--------LMRMCWQYNPKMRPSFLEI 285
Query: 629 AFELGGIRTSTGASILQQNCEEIDF 653
+ ++ E+ F
Sbjct: 286 ISSIKE--------EMEPGFREVSF 302
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 185 bits (471), Expect = 2e-53
Identities = 56/274 (20%), Positives = 105/274 (38%), Gaps = 27/274 (9%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 418
D Y+ LG G G V++ + GR+ K + NE+ I++Q++H +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 419 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 478
+ L + +L+ EF+ G L+ I + ++ ++ ++ + L ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 479 ASIPIYHRDIKSANILLD--DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 536
I H DIK NI+ + K+ DFG + ++ + T + PE
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTTATAEFAAPEIVD 201
Query: 537 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN--RLFEILDAR 594
+D+++ GV+ +L+G P + E LQ + E +
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWEFDEDAFSS 254
Query: 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
V EAK K L + R T+ +
Sbjct: 255 VSPEAKD--------FIKNLLQKEPRKRLTVHDA 280
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (461), Expect = 1e-52
Identities = 75/299 (25%), Positives = 120/299 (40%), Gaps = 40/299 (13%)
Query: 360 DNYNANRILGQGGQGTVYKGM------LTDGRIVAVKK-SKLVDETNVEQFINEVVILSQ 412
D + LG+G G V + R VAVK + + ++E+ IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 413 INHR-NIVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHNQIEEF-------------PIT 457
I H N+V LLG C + PL ++ EF G L Y+ ++ EF +T
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 458 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517
E L+ + +V+ + +L S HRD+ + NILL +K K+ DFG +R + D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 518 HL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVG 576
++ + ++ PE +T +SDV+SFGV+L EI + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVKIDE 244
Query: 577 YFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635
F + + E D E + C + RPT E+ LG +
Sbjct: 245 EFCRRLKEGTRMRAPD-YTTPEMYQ--------TMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (462), Expect = 1e-52
Identities = 63/278 (22%), Positives = 107/278 (38%), Gaps = 20/278 (7%)
Query: 353 KDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK-SKLVDETNVEQFINEVVIL 410
K E D Y+ +LG G V ++VA+K +K E NE+ +L
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 411 SQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 470
+I H NIV L L+ + + G L+ I + T R+ +V
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLD 118
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 530
A+ YLH + + LD+ + +SDFG S+ M D + + GT GYV
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTACGTPGYV 176
Query: 531 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590
PE +++ D +S GV+ +L G P N + F Q + F+
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQILKAEYEFDS 230
Query: 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ ++ K+ + + + + R T ++
Sbjct: 231 PYWDDISDSAKD-------FIRHLMEKDPEKRFTCEQA 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-52
Identities = 61/272 (22%), Positives = 106/272 (38%), Gaps = 24/272 (8%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 418
+ Y LG+G G V++ + + + K K+ T+ E+ IL+ HRNI
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNI 63
Query: 419 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 478
+ L E ++++EFI +++ I+ F + ++ +V AL +LHS
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH 121
Query: 479 ASIPIYHRDIKSANILLDDK--YRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 536
I H DI+ NI+ + K+ +FG +R + + Y PE Q
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQAR--QLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 537 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596
+ +D++S G ++ +L+G P A + ++ I D
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEY--TFDEEAF 227
Query: 597 KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
KE E + R L K R T E
Sbjct: 228 KEISIEAM----DFVDRLLVKERKSRMTASEA 255
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 4e-51
Identities = 68/300 (22%), Positives = 119/300 (39%), Gaps = 42/300 (14%)
Query: 360 DNYNANRILGQGGQGTVYKGMLT--------DGRIVAVKKSKL-VDETNVEQFINEVVIL 410
D + LG+G G V VAVK K E ++ I+E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 411 SQI-NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQ-------------IEEFPI 456
I H+NI+ LLG C + ++ E+ G L +Y+ + E +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 457 TWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516
+ + L+ A +V+ + YL S HRD+ + N+L+ + K++DFG +R +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 517 THLTTKVQ-GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV 575
+ T ++ PE +T +SDV+SFGV+L EI T
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------- 236
Query: 576 GYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635
+ LF++L + + + + C + RPT K++ +L I
Sbjct: 237 --PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 176 bits (447), Expect = 5e-51
Identities = 68/286 (23%), Positives = 116/286 (40%), Gaps = 38/286 (13%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK---------SKLVDETNVEQFINEVVI 409
+NY ILG+G V + + + AVK S + E + EV I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 410 LSQIN-HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 468
L +++ H NI++L LV++ + G L+ Y+ ++ ++ + +I +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRAL 119
Query: 469 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFG 528
+ LH I HRD+K NILLDD K++DFG S +D +V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVCGTPS 174
Query: 529 YVDPEYFQSSQ------FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 582
Y+ PE + S + ++ D++S GV++ +L G P +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMIM 228
Query: 583 NENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ N F + + K+ L R L + + R T +E
Sbjct: 229 SGNYQFGSPEWDDYSDTVKD-------LVSRFLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 4e-49
Identities = 66/273 (24%), Positives = 111/273 (40%), Gaps = 29/273 (10%)
Query: 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVK---KSKLVDETNVEQFINEVVILS-QIN 414
+++ +++LG+G G V+ + A+K K ++ + +VE + E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 415 HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFY 474
H + + E V E++ G L +I + A E+ L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQF 118
Query: 475 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 534
LHS I +RD+K NILLD K++DFG + M+ T GT Y+ PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI 174
Query: 535 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594
++ D +SFGV+L E+L GQ P + +E +I + F
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPF--YPRW 225
Query: 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKE 627
+ KEAK L + + R ++
Sbjct: 226 LEKEAKD--------LLVKLFVREPEKRLGVRG 250
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 168 bits (425), Expect = 9e-48
Identities = 58/283 (20%), Positives = 108/283 (38%), Gaps = 20/283 (7%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRN 417
+ Y+ +G+G G VYK G A+KK +L DE I E+ IL ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 418 IVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 477
IVKL + +LV+E + E + +++ + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 478 AASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQS 537
+ HRD+K N+L++ + K++DFG +R+ + T ++ + S
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 538 SQFTEKSDVYSFGVVLVEILTGQKP------------IRAINTDEDKSLVGYFLQAINEN 585
+++ D++S G + E++ G I I + + +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 586 RLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
F + + + K + L + L L+ R T K+
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (430), Expect = 2e-47
Identities = 60/280 (21%), Positives = 113/280 (40%), Gaps = 31/280 (11%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVK---KSKLVDETNVEQFINEVV---ILSQ 412
++++ +RI+G+GG G VY D G++ A+K K ++ + +NE + ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 413 INHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 472
+ IV + + + + + G L+ ++ + + A E+ L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGL 120
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDP 532
++H+ + +RD+K ANILLD+ ++SD G + + H GT GY+ P
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAP 174
Query: 533 EYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591
E Q + +D +S G +L ++L G P R T + + L E L
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------L 228
Query: 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631
E + L + L + R +
Sbjct: 229 PDSFSPELRS--------LLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 167 bits (423), Expect = 4e-47
Identities = 69/276 (25%), Positives = 115/276 (41%), Gaps = 31/276 (11%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
++ R LG G G V+ +GR A+K K +V VE +E ++LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 416 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 475
I+++ G + + ++ ++I G L+ + + A EV AL YL
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYL 120
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 535
HS I +RD+K NILLD K++DFG ++ V +T + GT Y+ PE
Sbjct: 121 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVV 173
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595
+ + + D +SFG+++ E+L G P NT + + I L
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-------TYEKILNAEL--RFPPFF 224
Query: 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631
++ K L R + + R + E
Sbjct: 225 NEDVKD--------LLSRLITRDLSQRLGNLQNGTE 252
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 2e-46
Identities = 61/292 (20%), Positives = 111/292 (38%), Gaps = 25/292 (8%)
Query: 357 KATDNYNANRILGQGGQGTVYKG--MLTDGRIVAVK--KSKLVDETNVEQFINEVVILSQ 412
+A Y +G+G G V+K + GR VA+K + + +E I EV +L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 413 I---NHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQ---YIHNQIEEFPITWELLLRIAV 466
+ H N+V+L C + + + Q +++ E + E + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 467 EVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGT 526
++ L +LHS + HRD+K NIL+ + K++DFG +R T V T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVT 178
Query: 527 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE-- 584
Y PE S + D++S G + E+ + R + + + + E
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 585 --------NRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ F A+ +++ + L +CL N R +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-46
Identities = 56/289 (19%), Positives = 116/289 (40%), Gaps = 22/289 (7%)
Query: 359 TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK-SKLVDETNVEQFINEVVILSQINHR 416
Y +G+G G V + VA+KK S +T ++ + E+ IL + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 476
NI+ + + + ++ + ++ ++ ++ + + ++ L Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLT--TKVQGTFGYVDPEY 534
SA + HRD+K +N+LL+ K+ DFG +R D H T+ T Y PE
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 535 FQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDA 593
+S+ +T+ D++S G +L E+L+ + + + + + L + ++ L I++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 594 RVLKEAKKEGIMTVAT--------------LAKRCLNLNGKMRPTMKEV 628
+ L + L N R +++
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 2e-46
Identities = 60/284 (21%), Positives = 109/284 (38%), Gaps = 20/284 (7%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHR 416
+N+ +G+G G VYK G +VA+KK +L E I E+ +L ++NH
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 476
NIVKLL LV+EF+ + + P L+ ++ L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP--LPLIKSYLFQLLQGLAFCH 119
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 536
S + HRD+K N+L++ + K++DFG +R+ V T +V +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 537 SSQFTEKSDVYSFGVVLVEILTGQKP------------IRAINTDEDKSLVGYFLQAINE 584
++ D++S G + E++T + I D+ + +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 585 NRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
F + + +L + L+ + R + K
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 2e-46
Identities = 62/281 (22%), Positives = 107/281 (38%), Gaps = 25/281 (8%)
Query: 366 RILGQGGQGTVYKGMLT-DGRIVAVKKSKL-----VDETNVEQFINEVVILSQINHRNIV 419
LG+G TVYK +IVA+KK KL + + E+ +L +++H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 420 KLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA 479
LL LV++F+ N +T + + L YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 480 SIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQ 539
I HRD+K N+LLD+ K++DFG ++S T +V T Y PE ++
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176
Query: 540 -FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598
+ D+++ G +L E+L + + + + + L E + ++
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 599 AKKEGIMTVAT-----------LAKRCLNLNGKMRPTMKEV 628
K + + L + N R T +
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 7e-46
Identities = 59/279 (21%), Positives = 108/279 (38%), Gaps = 30/279 (10%)
Query: 360 DNYN-ANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHR 416
D+Y +++LG G G V + A+K + + + EV + +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCP 65
Query: 417 NIVKLLGCC----LETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 472
+IV+++ + L+V E + G L+ I ++ ++ T I + A+
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAI 124
Query: 473 FYLHSAASIPIYHRDIKSANILLDDKY---RAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 529
YLHS I HRD+K N+L K K++DFG ++ + T T Y
Sbjct: 125 QYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYY 179
Query: 530 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589
V PE ++ + D++S GV++ +L G P + + + + +
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIRMGQYEFPN 238
Query: 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ V +E K L + L R T+ E
Sbjct: 239 PEWSEVSEEVKM--------LIRNLLKTEPTQRMTITEF 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 6e-45
Identities = 69/291 (23%), Positives = 114/291 (39%), Gaps = 35/291 (12%)
Query: 349 LFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLV------DETNVE 401
+F ++++ D Y+ LG G V K + G A K K + E
Sbjct: 2 VFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58
Query: 402 QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELL 461
EV IL +I H N++ L +L+ E + G L+ ++ + +T E
Sbjct: 59 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEA 115
Query: 462 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDFGTSRSVMVDQT 517
++ ++YLHS I H D+K NI+L D K R K+ DFG + + D
Sbjct: 116 TEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFG 170
Query: 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY 577
+ + GT +V PE ++D++S GV+ +L+G P E
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLA 226
Query: 578 FLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ A+N E AK +R L + K R T+++
Sbjct: 227 NVSAVNYEFEDEYFS-NTSALAKD--------FIRRLLVKDPKKRMTIQDS 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 7e-45
Identities = 65/297 (21%), Positives = 116/297 (39%), Gaps = 44/297 (14%)
Query: 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 418
+Y +++G G G VY+ L D G +VA+KK + E+ I+ +++H NI
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNI 75
Query: 419 VKLLGCCLETEVP------LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGAL 472
V+L + LV +++P H + + + ++ +L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 473 FYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVD 531
Y+HS I HRDIK N+LLD D K+ DFG+++ ++ + +++ + +
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAP 191
Query: 532 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDE--------------------D 571
F ++ +T DV+S G VL E+L GQ + + +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 572 KSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
+ + I + ++ R EA L R L R T E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIA--------LCSRLLEYTPTARLTPLEA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 6e-44
Identities = 55/285 (19%), Positives = 108/285 (37%), Gaps = 22/285 (7%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHR 416
Y +G+G GTV+K IVA+K+ +L DE + E+ +L ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 417 NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLH 476
NIV+L + LV+EF + + E++ ++ L + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCH 118
Query: 477 SAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQ 536
S + HRD+K N+L++ K+++FG +R+ + + +V + F
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 537 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDED-------------KSLVGYFLQAIN 583
+ ++ D++S G + E+ +P+ N +D + + +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 584 ENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
L + T L + L N R + +E
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-43
Identities = 66/280 (23%), Positives = 115/280 (41%), Gaps = 42/280 (15%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK------SKLVDETNVEQFINEVVILSQ 412
Y +LG GG G+VY G+ ++D VA+K S + N + EVV+L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 413 IN--HRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 470
++ +++LL + +L+ E E + EL +V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLE 121
Query: 471 ALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGY 529
A+ + H+ + HRDIK NIL+D ++ K+ DFG+ + + + T GT Y
Sbjct: 122 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA---LLKDTVYTDFDGTRVY 175
Query: 530 VDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 588
PE+ + ++ + V+S G++L +++ G P I ++
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQV- 221
Query: 589 EILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
RV E + L + CL L RPT +E+
Sbjct: 222 -FFRQRVSSECQH--------LIRWCLALRPSDRPTFEEI 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-43
Identities = 61/276 (22%), Positives = 107/276 (38%), Gaps = 28/276 (10%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK---KSKLVDETNVEQFINEVVILSQINH 415
++++ ++LG+G G V GR A+K K ++ + V + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 416 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 475
+ L + V E+ G L+ ++ + T E E+ AL YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYL 121
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYF 535
HS + +RDIK N++LD K++DFG + + D + T GT Y+ PE
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL 177
Query: 536 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595
+ + + D + GVV+ E++ G+ P + + + I + +
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI--RFPRTL 228
Query: 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631
EAK L L + K R +
Sbjct: 229 SPEAKS--------LLAGLLKKDPKQRLGGGPSDAK 256
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (382), Expect = 1e-41
Identities = 51/280 (18%), Positives = 94/280 (33%), Gaps = 28/280 (10%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 418
+ Y R +G G G +Y G + G VA+K + +T Q E I +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 64
Query: 419 VKLLG-CCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS 477
+ + C E + ++V E + + + + +L +A ++ + Y+HS
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS 121
Query: 478 AASIPIYHRDIKSANIL---LDDKYRAKVSDFGTSRSVMVDQTH------LTTKVQGTFG 528
HRD+K N L + DFG ++ +TH + GT
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 529 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 588
Y + + + D+ S G VL+ G P + + + + +
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 237
Query: 589 EILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
E+L E C +L +P +
Sbjct: 238 EVLCKGYPSEFAT--------YLNFCRSLRFDDKPDYSYL 269
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-41
Identities = 55/305 (18%), Positives = 115/305 (37%), Gaps = 36/305 (11%)
Query: 350 FTSKDLEKAT----DNYNANRILGQGGQGTVYKGM-LTDGRIVAVK--KSKLVDETNVEQ 402
F +++ K Y + +G G G V + G VA+K E ++
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 403 FINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEF-PITWELL 461
E+ +L + H N++ LL E +F ++ + + + +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 462 LRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTT 521
+ ++ L Y+H+A I HRD+K N+ +++ K+ DFG +R + +T
Sbjct: 124 QFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTG 177
Query: 522 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLV------ 575
V + ++T+ D++S G ++ E++TG+ + + + +
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 576 --GYFLQAINENRLFEILD----------ARVLKEAKKEGIMTVATLAKRCLNLNGKMRP 623
F+Q + + + A +L A + L ++ L L+ + R
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV----NLLEKMLVLDAEQRV 293
Query: 624 TMKEV 628
T E
Sbjct: 294 TAGEA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (380), Expect = 8e-41
Identities = 58/247 (23%), Positives = 101/247 (40%), Gaps = 20/247 (8%)
Query: 334 QQELSSNESNIEKTKLFTSKDLEKAT------DNYNANRILGQGGQGTVYKGM-LTDGRI 386
E S + + K K K E + D ++ + LG G G V G
Sbjct: 9 GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 387 VAVK---KSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPNGTL 443
A+K K K+V +E +NE IL +N +VKL + +V E++ G +
Sbjct: 69 YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 444 YQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKV 503
+ ++ + A ++ YLHS + +RD+K N+L+D + +V
Sbjct: 129 FSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQV 182
Query: 504 SDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 563
+DFG ++ V + GT + PE S + + D ++ GV++ E+ G P
Sbjct: 183 TDFGFAKRVKGRTWT----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238
Query: 564 RAINTDE 570
A +
Sbjct: 239 FADQPIQ 245
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 57/299 (19%), Positives = 108/299 (36%), Gaps = 36/299 (12%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHR 416
Y +GQG G V+K G+ VA+KK + E + E+ IL + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 417 NIVKLLGCCLETEVP--------LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEV 468
N+V L+ C P LV++F + + + T + R+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQML 126
Query: 469 SGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT---HLTTKVQG 525
L L+ I HRD+K+AN+L+ K++DFG +R+ + + + T
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 526 TFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINE 584
T Y PE + + D++ G ++ E+ T ++ +L+ +I
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 585 NRLFEILDARVLKEAKKEGIMTVAT---------------LAKRCLNLNGKMRPTMKEV 628
+ + + ++ + L + L L+ R +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 142 bits (358), Expect = 2e-38
Identities = 43/281 (15%), Positives = 91/281 (32%), Gaps = 28/281 (9%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNI 418
+Y R +G+G G +++G L + + VA+K ++ Q +E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 62
Query: 419 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA 478
+ + + + ++ + +L + + + + A ++ + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 479 ASIPIYHRDIKSANILLDDKYR-----AKVSDFGTSRSVMVDQT------HLTTKVQGTF 527
+ +RDIK N L+ V DFG + T + GT
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 528 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 587
Y+ + + + D+ + G V + L G P + + +K R+
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY---------ERI 228
Query: 588 FEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEV 628
E + L+E NL P +
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 138 bits (348), Expect = 8e-37
Identities = 55/298 (18%), Positives = 112/298 (37%), Gaps = 45/298 (15%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRN 417
D+Y R LG+G V++ + +T+ V VK + ++ E+ IL + N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKILENLRGGPN 91
Query: 418 IVKLLGCCLE--TEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 475
I+ L + + P LV+E + N Q +T + E+ AL Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYC 145
Query: 476 HSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEY 534
HS I HRD+K N+++D + + ++ D+G + Q + + + PE
Sbjct: 146 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPEL 200
Query: 535 FQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDA 593
Q + D++S G +L ++ ++P + + D + + + L++ +D
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYIDK 258
Query: 594 RVLKEAKKEGIMTVAT-----------------------LAKRCLNLNGKMRPTMKEV 628
++ + + + L + + R T +E
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-36
Identities = 66/283 (23%), Positives = 112/283 (39%), Gaps = 30/283 (10%)
Query: 360 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVK---KSKLVDETN-VEQFINEVVILS 411
+N+ ++LG G G V+ G++ A+K K+ +V + E E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 412 QINHR-NIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 470
I +V L L+ ++I G L+ ++ + T + E+
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVL 140
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 530
AL +LH I +RDIK NILLD ++DFG S+ + D+T GT Y+
Sbjct: 141 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 531 DPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 588
P+ + + D +S GV++ E+LTG P D +K+ + I ++
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV---DGEKNSQAEISRRILKSEP- 253
Query: 589 EILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631
+ AK L +R L + K R +
Sbjct: 254 -PYPQEMSALAKD--------LIQRLLMKDPKKRLGCGPRDAD 287
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 6e-36
Identities = 63/303 (20%), Positives = 114/303 (37%), Gaps = 45/303 (14%)
Query: 360 DNYNANRILGQGGQGTVYKGM-LTDGRIVAVKK--SKLVDETNVEQFINEVVILSQINHR 416
Y + +G G QG V R VA+KK ++T+ ++ E+V++ +NH+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 417 NIVKLLGCCL------ETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSG 470
NI+ LL E + LV E + E + + ++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 471 ALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHLTTKVQGTFGYV 530
+ +LH S I HRD+K +NI++ K+ DFG +R+ + + T T Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 185
Query: 531 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN---------------TDEDKSLV 575
PE + E D++S G ++ E++ + + E +
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 576 GYFLQAINENRL------FEILDARVLKEAKKEGIMTVATLAK----RCLNLNGKMRPTM 625
++ ENR F L L A E A+ A+ + L ++ R ++
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 626 KEV 628
+
Sbjct: 306 DDA 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 2e-35
Identities = 59/305 (19%), Positives = 112/305 (36%), Gaps = 36/305 (11%)
Query: 350 FTSKDLEKA----TDNYNANRILGQGGQGTVYKGM-LTDGRIVAVK--KSKLVDETNVEQ 402
F ++L K + Y +G G G+V G VAVK + ++
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 403 FINEVVILSQINHRNIVKLLGCC-----LETEVPLLVYEFIPNGTLYQYIHNQIEEFPIT 457
E+ +L + H N++ LL LE + + + L + Q +T
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLT 119
Query: 458 WELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517
+ + + ++ L Y+HSA I HRD+K +N+ +++ K+ DFG +
Sbjct: 120 DDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDD 173
Query: 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY 577
+T V + + + D++S G ++ E+LTG+ + + L+
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
Query: 578 FLQAINENRLFEILDA------RVLKEAKKEGIMTVAT--------LAKRCLNLNGKMRP 623
+ L +I + L + K V L ++ L L+ R
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293
Query: 624 TMKEV 628
T +
Sbjct: 294 TAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (297), Expect = 9e-30
Identities = 57/318 (17%), Positives = 107/318 (33%), Gaps = 58/318 (18%)
Query: 362 YNANRILGQGGQGTVYKGM-LTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVK 420
Y R LG G TV+ + + VA+K + D+ E +E+ +L ++N + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 421 LLGCCLETEVPLLVY--EFIPNGTLYQYIH-----------NQIEEFPITWELLLRIAVE 467
+ LL + PNG + + E I + +I+ +
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 468 VSGALFYLHSAASIPIYHRDIKSANILLD------DKYRAKVSDFGTSRSVMVDQTHLTT 521
+ L Y+H I H DIK N+L++ + + K++D G + T+
Sbjct: 134 LLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN--- 188
Query: 522 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQA 581
T Y PE + + +D++S ++ E++TG + Q
Sbjct: 189 -SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
Query: 582 IN-------------------ENRLFEILDARVLKEAKKEGIMT------------VATL 610
I N + + LK E ++T ++
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307
Query: 611 AKRCLNLNGKMRPTMKEV 628
L L+ + R +
Sbjct: 308 LSPMLQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.1 bits (207), Expect = 3e-19
Identities = 25/157 (15%), Positives = 49/157 (31%), Gaps = 20/157 (12%)
Query: 366 RILGQGGQGTVYKGMLTDGRIVAVK----------KSKLVDETNVEQFINEVVILSQINH 415
+++G+G + V+ VK K K + F + ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 416 RNIVKLLGCCLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYL 475
R + KL G + Y + N L + I + + + +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVEN-PDEVLDMILEEVAKF 119
Query: 476 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 512
+ I H D+ N+L+ + + DF S V
Sbjct: 120 YHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 694 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.07 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.63 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.42 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.85 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.57 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.58 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 90.62 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 89.95 | |
| d3bpse1 | 40 | Low density lipoprotein (LDL) receptor, different | 88.83 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 87.65 | |
| d1kigl_ | 51 | Factor X, N-terminal module {Cow (Bos taurus) [Tax | 86.88 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 86.43 | |
| d1nt0a3 | 45 | Mannose-binding protein associated serine protease | 86.34 | |
| d1autl2 | 50 | Activated protein c (autoprothrombin IIa) {Human ( | 86.24 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 85.84 | |
| d2p3ua1 | 51 | Factor X, N-terminal module {Human (Homo sapiens) | 83.21 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 83.19 | |
| d1szba2 | 45 | Mannose-binding protein associated serine protease | 83.06 | |
| d1rfnb_ | 57 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 81.92 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 81.34 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=377.36 Aligned_cols=257 Identities=28% Similarity=0.447 Sum_probs=213.9
Q ss_pred CCCCCCCEEEEECCEEEEEEEECCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEEEECC
Q ss_conf 49886612432074799999982993999998235680209999999999963268761017759963792189998279
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP 439 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 439 (694)
++|++.+.||+|+||+||+|.+.+++.||||++... ....++|.+|+.++++++||||++++|++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 995888898208882999999889999999998788-6768999999999996689975653524315993379998369
Q ss_pred CCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCE
Q ss_conf 99967887403677788999999999999999999874499984404666460887799937993127852234477611
Q 005492 440 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519 (694)
Q Consensus 440 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 519 (694)
+|+|.+++..... .+++..++.++.|+|.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 84 ~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCCHHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCEE
T ss_conf 9918997520134--7889999999999999877653164---3104431532666688776865532100236887335
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHC-CCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHHHHHHHH
Q ss_conf 1123317898897211369988200277426889998849-998766787567617999999863040356620444313
Q 005492 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTG-QKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 520 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
.....||..|+|||++.+..++.++||||||+++|||+++ ++|+......+ +...+..+.. ..
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~-------~~~~i~~~~~---------~~ 222 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGFR---------LY 222 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH-------HHHHHHHTCC---------CC
T ss_pred ECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHHCCC---------CC
T ss_conf 0430017666785786079998403321059999999878988877899999-------9999980688---------89
Q ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 4299999999999981134999999988899999415014
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 638 (694)
.+...+..+.+|+.+||+.+|.+||+|.+++++|++++.+
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 9543679999999997657976891999999999999857
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=375.98 Aligned_cols=258 Identities=25% Similarity=0.432 Sum_probs=211.8
Q ss_pred CCCCCCCEEEEECCEEEEEEEECC-C---CEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEE
Q ss_conf 498866124320747999999829-9---3999998235-6802099999999999632687610177599637921899
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-G---RIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 434 (694)
++|++.+.||+|+||+||+|.+.. + ..||||.+.. ......+.|.+|+.++++++|||||+++|++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 04278569802788299999995799788999999978445989999999999999857998886189999628877999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 98279999678874036777889999999999999999998744999844046664608877999379931278522344
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~ 514 (694)
|||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEECCCCCCEEEECCCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCCEECCC
T ss_conf 972279853002104567--9999999999999999889885279---83576150448988999199888443157567
Q ss_pred CCCCE----EEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHHHCCHHH
Q ss_conf 77611----112331789889721136998820027742688999884-9998766787567617999999863040356
Q 005492 515 DQTHL----TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFE 589 (694)
Q Consensus 515 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (694)
..... .....|++.|+|||++.+..++.++||||||++||||+| |+.||......+ ....+..+..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-------~~~~i~~~~~-- 251 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-------VINAIEQDYR-- 251 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCC--
T ss_pred CCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHCCCC--
T ss_conf 7776536502566688300387888369978612144535789999867999999999999-------9999973788--
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 6204443134299999999999981134999999988899999415014
Q 005492 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 590 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 638 (694)
...+...+..+.+|+.+||+.+|.+||++.++++.|+.+.+.
T Consensus 252 -------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 252 -------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf -------999742269999999997587976892999999999998418
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=378.24 Aligned_cols=268 Identities=27% Similarity=0.392 Sum_probs=220.6
Q ss_pred HHHHHHHHCCCCCCCEEEEECCEEEEEEEECC-CCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCC
Q ss_conf 56688870498866124320747999999829-93999998235680209999999999963268761017759963792
Q 005492 352 SKDLEKATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEV 430 (694)
Q Consensus 352 ~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 430 (694)
+++++...++|++.+.||+|+||+||+|.+.. ++.||||++... ....++|.+|+.++++++|||||+++|++.+.+.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CCCCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCE
T ss_conf 765174579939865982088808999999999969999997776-1039999999999986799988267752745785
Q ss_pred CEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 18999827999967887403677788999999999999999999874499984404666460887799937993127852
Q 005492 431 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~ 510 (694)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEEEEECCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEE
T ss_conf 478763146760677753035-541579999999999999788898789---3057604576899899928983244546
Q ss_pred CCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHH
Q ss_conf 23447761111233178988972113699882002774268899988499987667875676179999998630403566
Q 005492 511 SVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590 (694)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (694)
....+.........|+..|+|||++.+..++.++||||||+++|||+++..|+....... .....+..+.
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~------~~~~~i~~~~---- 233 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDY---- 233 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHTTC----
T ss_pred ECCCCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHHCCC----
T ss_conf 537887221035566546669278727999810430217899999986799887742599------9999985588----
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 2044431342999999999999811349999999888999994150146
Q 005492 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTST 639 (694)
Q Consensus 591 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 639 (694)
....+...+..+.+|+.+||+.+|.+|||+.++++.|+.+....
T Consensus 234 -----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 234 -----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred -----CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf -----88887433099999999975779768939999999999998757
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.73 Aligned_cols=268 Identities=27% Similarity=0.421 Sum_probs=214.7
Q ss_pred HHHHHHCCCCCCCEEEEECCEEEEEEEECCCCEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCC
Q ss_conf 68887049886612432074799999982993999998235--6802099999999999632687610177599637921
Q 005492 354 DLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 431 (694)
Q Consensus 354 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 431 (694)
+++...++|++.+.||+|+||+||+|++. ..||||++.. .+....+.|.+|+.++++++||||++++|++.+ ...
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CCCCCCCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEE
T ss_conf 71315451899889830788589999999--989999997346998999999999999984799878645679715-589
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 89998279999678874036777889999999999999999998744999844046664608877999379931278522
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~ 511 (694)
+|||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred EEEEECCCCCCHHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEE
T ss_conf 999965899888999852357--8999999999999999988875099---95161478997981899788750022133
Q ss_pred CCCCCC-CEEEEEECCCCCCCCCCCCC---CCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCH
Q ss_conf 344776-11112331789889721136---99882002774268899988499987667875676179999998630403
Q 005492 512 VMVDQT-HLTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 587 (694)
Q Consensus 512 ~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (694)
...... .......||+.|+|||++.. ..++.++||||||++||||++|+.||.+..... .....+..+..
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~ 227 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYL 227 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSC
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHHCCCC
T ss_conf 355677631256655743179999950568999953151635999999997889989989699------99999965888
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 56620444313429999999999998113499999998889999941501469
Q 005492 588 FEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTG 640 (694)
Q Consensus 588 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 640 (694)
.+. ........+..+.+|+.+||+.+|.+|||+.+++++|+.++++.+
T Consensus 228 ~p~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 228 SPD-----LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CCC-----GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCC-----CHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf 986-----000365554999999999758897689299999999999997098
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.57 Aligned_cols=265 Identities=24% Similarity=0.383 Sum_probs=213.8
Q ss_pred HHHHHHHCCCCCCCEEEEECCEEEEEEEECCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCE
Q ss_conf 66888704988661243207479999998299399999823568020999999999996326876101775996379218
Q 005492 353 KDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 432 (694)
Q Consensus 353 ~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 432 (694)
++++...++|++.+.||+|+||+||+|.++++..||||++... ....+.|.+|+.++++++|||||+++|++.+ +..+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred CCEECCHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEE
T ss_conf 7700388993886798107982899999999999999998647-6888999999999986799988578731045-9769
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 99982799996788740367778899999999999999999987449998440466646088779993799312785223
Q 005492 433 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 512 (694)
Q Consensus 433 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~ 512 (694)
+||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||||++++.+||+|||+++..
T Consensus 84 iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEECCCCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEEC
T ss_conf 9999578982888875147-898878899999999999999997489---546756422515620244042341014773
Q ss_pred CCCCCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHH
Q ss_conf 44776111123317898897211369988200277426889998849998766787567617999999863040356620
Q 005492 513 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592 (694)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 592 (694)
............|++.|+|||++....++.++||||||+++|||+||..|+....... . ....+..+...
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-----~-~~~~i~~~~~~---- 229 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----E-VIQNLERGYRM---- 229 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----H-HHHHHHTTCCC----
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----H-HHHHHHHCCCC----
T ss_conf 5886442035677444458289837999824564525799999996898888888999-----9-99999706888----
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 4443134299999999999981134999999988899999415014
Q 005492 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 593 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 638 (694)
..+...+..+.+|+.+||+.+|++||||.+|++.|+.+..+
T Consensus 230 -----~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 230 -----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -----89655719999999997588976893999999986113213
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.86 Aligned_cols=261 Identities=28% Similarity=0.464 Sum_probs=213.3
Q ss_pred HHHHHCCCCCCCEEEEECCEEEEEEEECC-C-----CEEEEEECCC-CCHHHHHHHHHHHHHHHHC-CCCCCEEEEEEEE
Q ss_conf 88870498866124320747999999829-9-----3999998235-6802099999999999632-6876101775996
Q 005492 355 LEKATDNYNANRILGQGGQGTVYKGMLTD-G-----RIVAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLLGCCL 426 (694)
Q Consensus 355 l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~-----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 426 (694)
++...++|++.+.||+|+||+||+|.+.. + ..||+|.+.. ........+.+|+.++.++ +|||||++++++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 65778993970198307881999999857885542049999996633587899999999999997158996868778886
Q ss_pred ECCCCEEEEEECCCCCHHHHHHCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEC
Q ss_conf 37921899982799996788740367--------------------7788999999999999999999874499984404
Q 005492 427 ETEVPLLVYEFIPNGTLYQYIHNQIE--------------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHR 486 (694)
Q Consensus 427 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~ 486 (694)
+.+..++||||+++|+|.++|+.... ...+++..++.++.|++.||+|||+.+ |+||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred ECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEC
T ss_conf 2995899997279995999998625777510221000012220012577899999999999999999997399---0505
Q ss_pred CCCCCCEEECCCCCEEEEECCCCCCCCCCCCC-EEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHH-CCCCCC
Q ss_conf 66646088779993799312785223447761-1112331789889721136998820027742688999884-999876
Q 005492 487 DIKSANILLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIR 564 (694)
Q Consensus 487 Dikp~NIll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~ 564 (694)
||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||++||||++ |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCCHHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCC
T ss_conf 27032144345982898514222204577861562343578765783887279999633030003999999838999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 678756761799999986304035662044431342999999999999811349999999888999994
Q 005492 565 AINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELG 633 (694)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 633 (694)
+....+. +...+..+. ..+.+...+..+.+|+.+||+.+|++|||+.||+++|.
T Consensus 269 ~~~~~~~------~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDAN------FYKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSHH------HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHH------HHHHHHCCC---------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 9898999------999985699---------89988767899999999975889668939999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.24 Aligned_cols=250 Identities=26% Similarity=0.426 Sum_probs=209.5
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEEEEC
Q ss_conf 49886612432074799999982-99399999823568020999999999996326876101775996379218999827
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 438 (694)
++|++.+.||+|+||+||+|... +++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..+|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99996788740367778899999999999999999987449998440466646088779993799312785223447761
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 518 (694)
++|+|.+++.+. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.... .
T Consensus 100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (293)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred CCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC-C
T ss_conf 798089886415----9999999999999999999999879---7226776888688789968642515641321366-6
Q ss_pred EEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHHHHHHHH
Q ss_conf 11123317898897211369988200277426889998849998766787567617999999863040356620444313
Q 005492 519 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+ ........... .. .
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~~~-~~-------~ 237 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP-EL-------Q 237 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSC-CC-------S
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHHCCCC-CC-------C
T ss_conf 4444444777368266447998801203137299999804889989979999------99999857999-88-------8
Q ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 429999999999998113499999998889999
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.+...+..+.+|+.+||+.+|.+||++.|++++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 855379999999999866996689099999649
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.35 Aligned_cols=254 Identities=27% Similarity=0.422 Sum_probs=216.3
Q ss_pred CCCCCCCEEEEECCEEEEEEEECCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEEEECC
Q ss_conf 49886612432074799999982993999998235680209999999999963268761017759963792189998279
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIP 439 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 439 (694)
++|++.++||+|+||+||+|+++++..||||.++.. ....++|++|+.++++++||||++++|++.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 997996898207883999999889989999998747-5778999999999996689860158899850781699997048
Q ss_pred CCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCE
Q ss_conf 99967887403677788999999999999999999874499984404666460887799937993127852234477611
Q 005492 440 NGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL 519 (694)
Q Consensus 440 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 519 (694)
+|+|.+++..... .+++..+++++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 83 ~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCCHHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCEE
T ss_conf 9938886410246--7768999999999999999875468---4346654135887699847988614420235787225
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHHHHHHHH
Q ss_conf 112331789889721136998820027742688999884-9998766787567617999999863040356620444313
Q 005492 520 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLKE 598 (694)
Q Consensus 520 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 598 (694)
.....+|..|+|||.+....++.++||||||+++|||+| |+.||...+..+ ....+..+... .
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------~~~~i~~~~~~---------~ 221 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGLRL---------Y 221 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCCC---------C
T ss_pred ECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHH-------HHHHHHHCCCC---------C
T ss_conf 2465788775780786379988521033643246739755999988999999-------99999807978---------9
Q ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 4299999999999981134999999988899999415
Q 005492 599 AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 599 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 635 (694)
.+...+..+.+|+.+||+.+|++|||+.+++++|.++
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf 9654659999999997668976893999999874188
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=362.79 Aligned_cols=253 Identities=21% Similarity=0.297 Sum_probs=210.7
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEEEE
Q ss_conf 049886612432074799999982-9939999982356802099999999999632687610177599637921899982
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 359 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 437 (694)
.++|++.+.||+|+||.||++... +++.||+|++........+.+.+|+.++++++|||||++++++.+.+..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCCCCCCC
Q ss_conf 79999678874036777889999999999999999998744999844046664608877--9993799312785223447
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD--DKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DfGl~~~~~~~ 515 (694)
+++|+|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC
T ss_conf 799889999976237--8999999999999999999997569---76000154673641688986999545210442565
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHHHHH
Q ss_conf 76111123317898897211369988200277426889998849998766787567617999999863040356620444
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+ ....+...... .
T Consensus 180 --~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~------~ 244 (350)
T d1koaa2 180 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWN------M 244 (350)
T ss_dssp --SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC------S
T ss_pred --CCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHHCCCC------C
T ss_conf --43200068624218899758998726765546599999985989989979999-------99999847889------8
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 313429999999999998113499999998889999
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 942235899999999999756896679089998629
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.94 Aligned_cols=252 Identities=26% Similarity=0.358 Sum_probs=208.2
Q ss_pred CCCCCCCEEEEECCEEEEEEEECC-CCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEEEEC
Q ss_conf 498866124320747999999829-9399999823568020999999999996326876101775996379218999827
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFI 438 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 438 (694)
+.|++.+.||+|+||+||+|.... +..||+|.+........+.+.+|+.++++++|||||++++++.+.+..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99996788740367778899999999999999999987449998440466646088779993799312785223447761
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 518 (694)
++|+|.+++.+... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 92 ~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp TTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred CCCCHHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC-C
T ss_conf 99818899986289--9999999999999999999999889---8871407003148789998997161230357786-4
Q ss_pred EEEEEECCCCCCCCCCCC-----CCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHHH
Q ss_conf 111233178988972113-----699882002774268899988499987667875676179999998630403566204
Q 005492 519 LTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDA 593 (694)
Q Consensus 519 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 593 (694)
......||+.|+|||++. ...++.++||||||+++|||++|+.||...+..+ ....+.......+
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-------~~~~i~~~~~~~~--- 235 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSEPPTL--- 235 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHHHHHHSCCCCC---
T ss_pred CCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHCCCCCCC---
T ss_conf 100102562647999983202578888806657878999999820889999989999-------9999970799877---
Q ss_pred HHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 44313429999999999998113499999998889999
Q 005492 594 RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 594 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..+...+..+.+|+.+||+.+|.+|||+.|++++
T Consensus 236 ----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 ----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ----7656699999999999766996689199999629
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=363.31 Aligned_cols=253 Identities=21% Similarity=0.282 Sum_probs=210.7
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEEEE
Q ss_conf 049886612432074799999982-9939999982356802099999999999632687610177599637921899982
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 359 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 437 (694)
.++|++.+.||+|+||.||+|... +++.||+|.+..........+.+|+.++++++|||||++++++.+.+..+|||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCCCCCCC
Q ss_conf 79999678874036777889999999999999999998744999844046664608877--9993799312785223447
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD--DKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DfGl~~~~~~~ 515 (694)
+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 108 ~~gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf 899808888986389--9899999999999999999999779---26513144553113467884899525630343788
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHHHHH
Q ss_conf 76111123317898897211369988200277426889998849998766787567617999999863040356620444
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+....+ ....+...... .
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~~------~ 247 (352)
T d1koba_ 183 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWE------F 247 (352)
T ss_dssp --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHCCCC------C
T ss_pred --CCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHHCCCC------C
T ss_conf --72010047645348999747998976333898999999996889989979999-------99999847889------8
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 313429999999999998113499999998889999
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
........+..+.+|+.+||+.+|.+|||+.|++++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 930024799999999999756996689189999609
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.56 Aligned_cols=252 Identities=28% Similarity=0.413 Sum_probs=206.2
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEEEE
Q ss_conf 49886612432074799999982-99399999823568-02099999999999632687610177599637921899982
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 437 (694)
++|++.+.||+|+||+||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEEC
T ss_conf 46089989721748099999999999799999984566412799999999999857998884696540467436798864
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 79999678874036777889999999999999999998744999844046664608877999379931278522344776
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~~~~ 517 (694)
+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC
T ss_conf 58980899975379---9999999999999999999999759---83575468997887899879832314224046886
Q ss_pred -CEEEEEECCCCCCCCCCCCCCCC-CCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHHHHH
Q ss_conf -11112331789889721136998-8200277426889998849998766787567617999999863040356620444
Q 005492 518 -HLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 518 -~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
.......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ............
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~------~~~~~~~~~~~~------ 226 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEKKTYL------ 226 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH------HHHHHHTTCTTS------
T ss_pred CCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHCCCCCC------
T ss_conf 53111325574742872861899999710161737999999829978888985999------999986388878------
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 313429999999999998113499999998889999
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
......+..+.+|+.+||+.+|.+|||+.|++++
T Consensus 227 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 227 --NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --8644699999999999767996689099999619
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.85 Aligned_cols=265 Identities=26% Similarity=0.410 Sum_probs=208.5
Q ss_pred HHCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEE
Q ss_conf 7049886612432074799999982-9939999982356-8020999999999996326876101775996379218999
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 358 ~~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 435 (694)
..++|++.+.||+|+||+||+|... +++.||+|+++.. ......++.+|+.++++++|||||++++++.+.+..+|||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 75688897897127780999999989996999999875409789999999999998679999994999999899999999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 8279999678874036777889999999999999999998744-999844046664608877999379931278522344
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~ 514 (694)
||+++|+|.+++.+.. .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 7679986899874249---99999999999999999999998599---97144577994687899899954877625678
Q ss_pred CCCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHH-HHHHHH----------
Q ss_conf 776111123317898897211369988200277426889998849998766787567617999-999863----------
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGY-FLQAIN---------- 583 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~-~~~~~~---------- 583 (694)
. ......||..|+|||++.+..++.++|||||||++|||++|+.||...+..+....... ......
T Consensus 158 ~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp H---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred C---CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
T ss_conf 8---6211137714119468758998948889989999999998889989988789999998875177545774212333
Q ss_pred ------------HCCHHHHHHHHHHH----HHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf ------------04035662044431----3429999999999998113499999998889999
Q 005492 584 ------------ENRLFEILDARVLK----EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 584 ------------~~~~~~~~d~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.....+..+..... .........+.+|+.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 2211112223541347788766502687667644489999999999868994679089999609
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.58 Aligned_cols=257 Identities=28% Similarity=0.429 Sum_probs=209.2
Q ss_pred CCCCCCC-EEEEECCEEEEEEEECC---CCEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEE
Q ss_conf 4988661-24320747999999829---93999998235-6802099999999999632687610177599637921899
Q 005492 360 DNYNANR-ILGQGGQGTVYKGMLTD---GRIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 360 ~~f~~~~-~Lg~G~fg~Vy~~~~~~---~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 434 (694)
++|.+.+ +||+|+||+||+|.++. +..||||.++. ......++|.+|+.++++++|||||+++|++.+ +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf 4718878487306080999999960897689999998820397899999999999986799888068656036-807999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 98279999678874036777889999999999999999998744999844046664608877999379931278522344
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~ 514 (694)
|||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 mE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEECCCCCHHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCCCC
T ss_conf 980789968997521256--9999999999999999878998688---10576764660454688542033134211554
Q ss_pred CCCCE--EEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHH
Q ss_conf 77611--112331789889721136998820027742688999884-999876678756761799999986304035662
Q 005492 515 DQTHL--TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591 (694)
Q Consensus 515 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (694)
..... .....||+.|+|||++....++.++||||||+++|||++ |+.||......+ +...+..+...
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~~~~--- 231 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRM--- 231 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCC---
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHCCCCC---
T ss_conf 34321135621137433586887279999541232201789999938999999979999-------99999818999---
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 04443134299999999999981134999999988899999415014
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 638 (694)
..+...+..+.+|+.+||+.+|++||++.++++.|+....+
T Consensus 232 ------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 232 ------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf ------99976789999999997577976890999999999999998
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.34 Aligned_cols=259 Identities=26% Similarity=0.393 Sum_probs=210.4
Q ss_pred CCCCCCCEEEEECCEEEEEEEECCC-----CEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEE
Q ss_conf 4988661243207479999998299-----3999998235-680209999999999963268761017759963792189
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTDG-----RIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~~~-----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 433 (694)
+.|+..+.||+|+||+||+|.++.. ..||||++.. .......+|++|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf 99686159811779099999996899878799999998844596899999999999985689878323677833880389
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 99827999967887403677788999999999999999999874499984404666460887799937993127852234
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~ 513 (694)
||||+.+++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEECCCCCCHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHCCC
T ss_conf 9972135740222102345--4208999999999998541212123---4257656442788899849984551030035
Q ss_pred CCCC--CEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHH
Q ss_conf 4776--11112331789889721136998820027742688999884999876678756761799999986304035662
Q 005492 514 VDQT--HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591 (694)
Q Consensus 514 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (694)
.... .......||+.|+|||++....++.++||||||+++|||+++..|+....... .+...+..+.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~------~~~~~i~~~~----- 230 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKAINDGF----- 230 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTC-----
T ss_pred CCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH------HHHHHHHCCC-----
T ss_conf 78765267426777734348888704999973556344898999996798865568999------9999986357-----
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 04443134299999999999981134999999988899999415014
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 638 (694)
....+...+..+.+|+.+||+.+|++||+|.+|++.|+.+.+.
T Consensus 231 ----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 ----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ----8998504579999999997767976893999999999998669
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.38 Aligned_cols=264 Identities=24% Similarity=0.357 Sum_probs=215.7
Q ss_pred HHHCCCCCCCEEEEECCEEEEEEEECCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEEE
Q ss_conf 87049886612432074799999982993999998235680209999999999963268761017759963792189998
Q 005492 357 KATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 357 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 436 (694)
...++|++.+.||+|+||+||+|.++++..||||++... ....+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEE
T ss_conf 477997984699307980999999999999999998804-4888999999999986666788689999823-97599999
Q ss_pred ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 27999967887403677788999999999999999999874499984404666460887799937993127852234477
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~~~ 516 (694)
|+++|+|..++..... ..++|..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 92 y~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 92 YMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred ECCCCCHHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCC
T ss_conf 4479943542000035-53059999999999999999875411---4335312307999899929984425554256887
Q ss_pred CCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHHHHHH
Q ss_conf 61111233178988972113699882002774268899988499987667875676179999998630403566204443
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 596 (694)
........|++.|+|||++....++.++||||||+++|||++|..|+....... .+...+..+..
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~------~~~~~i~~~~~--------- 232 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGYR--------- 232 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCC---------
T ss_pred CEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHH------HHHHHHHHCCC---------
T ss_conf 335245455665458089837998917741323589999986899999888899------99999982689---------
Q ss_pred HHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 134299999999999981134999999988899999415014698
Q 005492 597 KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGA 641 (694)
Q Consensus 597 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~ 641 (694)
...+...++.+.+|+.+||+.+|++||+|.+|++.|+........
T Consensus 233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCCC
T ss_conf 999832379999999997566975891999999987666238999
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.84 Aligned_cols=246 Identities=29% Similarity=0.403 Sum_probs=206.7
Q ss_pred CCCCCCCEEEEECCEEEEEEEECC-CCEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEE
Q ss_conf 498866124320747999999829-939999982356---8020999999999996326876101775996379218999
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 435 (694)
++|++.+.||+|+||+||++.... ++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 82799996788740367778899999999999999999987449998440466646088779993799312785223447
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~~ 515 (694)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EECCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCCC
T ss_conf 5047985898875048---9999999999999999999999889---465220234414668998711555633544888
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHHHHH
Q ss_conf 76111123317898897211369988200277426889998849998766787567617999999863040356620444
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
......||+.|+|||++.+..++.++||||||++||||++|+.||...+..+ ....+.....
T Consensus 160 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~-------- 221 (263)
T d2j4za1 160 ---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEF-------- 221 (263)
T ss_dssp ---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC--------
T ss_pred ---CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHCCCC--------
T ss_conf ---5235578876349999758998931440467599999832999988899999-------9999971899--------
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 313429999999999998113499999998889999
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..+...++.+.+|+.+||+.+|.+|||+.|++++
T Consensus 222 --~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 222 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --9986689999999999764797689099999719
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.87 Aligned_cols=248 Identities=28% Similarity=0.436 Sum_probs=203.7
Q ss_pred CEEEEECCEEEEEEEECC---CCEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEEEECCC
Q ss_conf 124320747999999829---93999998235--6802099999999999632687610177599637921899982799
Q 005492 366 RILGQGGQGTVYKGMLTD---GRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFIPN 440 (694)
Q Consensus 366 ~~Lg~G~fg~Vy~~~~~~---~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 440 (694)
++||+|+||+||+|.+.+ ++.||||.+.. .+....++|.+|+.++++++|||||+++|++.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCE-
Q ss_conf 9967887403677788999999999999999999874499984404666460887799937993127852234477611-
Q 005492 441 GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTHL- 519 (694)
Q Consensus 441 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~~~~~~- 519 (694)
|+|.++++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCC
T ss_conf 96899975225---7899999999999999976687479---55677761131023567512341345331343234432
Q ss_pred -EEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHHHHHHH
Q ss_conf -112331789889721136998820027742688999884-999876678756761799999986304035662044431
Q 005492 520 -TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVLK 597 (694)
Q Consensus 520 -~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 597 (694)
.....||+.|+|||++....++.++||||||+++|||++ |+.||.+....+ ....+..+...
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~~--------- 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERM--------- 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCC---------
T ss_pred CCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHCCCCC---------
T ss_conf 24456778420391665379998434430340313289658999999989999-------99999828999---------
Q ss_pred HHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 342999999999999811349999999888999994150
Q 005492 598 EAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636 (694)
Q Consensus 598 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 636 (694)
..+...+..+.+|+.+||+.+|.+||++.+|++.|+...
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHH
T ss_conf 998656799999999975889768909899999852887
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.52 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=208.5
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC--CCCEEE
Q ss_conf 49886612432074799999982-9939999982356--802099999999999632687610177599637--921899
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLV 434 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 434 (694)
++|++.+.||+|+||+||++... +++.||+|.+... +....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EEECCCCCHHHHHHCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 98279999678874036-7778899999999999999999987449--99844046664608877999379931278522
Q 005492 435 YEFIPNGTLYQYIHNQI-EEFPITWELLLRIAVEVSGALFYLHSAA--SIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~ 511 (694)
|||+++|+|.+++.+.. ....+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf 95689993899998515457899999999999999999999997167788788586765425747888579800100032
Q ss_pred CCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHH
Q ss_conf 34477611112331789889721136998820027742688999884999876678756761799999986304035662
Q 005492 512 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591 (694)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (694)
...+. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+ ....+..+....+
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-------~~~~i~~~~~~~~- 234 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFRRI- 234 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCCCC-
T ss_pred CCCCC-CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHH-------HHHHHHCCCCCCC-
T ss_conf 24577-75566778823279999839999938988752789999801889989989999-------9999971899889-
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 0444313429999999999998113499999998889999
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+...+..+.+|+.+||+.+|.+||++.|++++
T Consensus 235 --------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 235 --------PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf --------74359999999999767995579189999729
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=359.97 Aligned_cols=265 Identities=24% Similarity=0.395 Sum_probs=217.2
Q ss_pred HHHHHHHCCCCCCCEEEEECCEEEEEEEEC------CCCEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCCEEEEEEE
Q ss_conf 668887049886612432074799999982------99399999823568-02099999999999632687610177599
Q 005492 353 KDLEKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCC 425 (694)
Q Consensus 353 ~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~ 425 (694)
.+++...++|++.+.||+|+||+||+|++. +++.||||++.... ....++|.+|+.++++++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEE
T ss_conf 31138988938867982078839999998887657788299999988210857999999999999966899765524666
Q ss_pred EECCCCEEEEEECCCCCHHHHHHCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEE
Q ss_conf 637921899982799996788740367---------------------77889999999999999999998744999844
Q 005492 426 LETEVPLLVYEFIPNGTLYQYIHNQIE---------------------EFPITWELLLRIAVEVSGALFYLHSAASIPIY 484 (694)
Q Consensus 426 ~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iv 484 (694)
.+....++++||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred CCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---EE
T ss_conf 059803899981589929999985275542100001110012103467889899999999999999855413578---68
Q ss_pred ECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC-CEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCC-CC
Q ss_conf 046664608877999379931278522344776-1111233178988972113699882002774268899988499-98
Q 005492 485 HRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ-KP 562 (694)
Q Consensus 485 H~Dikp~NIll~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~-~p 562 (694)
||||||+|||++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||+++. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCC
T ss_conf 54884011689899928983314421136776411157777676767989972688980563025236299998068999
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 76678756761799999986304035662044431342999999999999811349999999888999994150
Q 005492 563 IRAINTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIR 636 (694)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 636 (694)
|......+ ....+..+...++ +...+..+.+|+.+||+.+|.+||||.||++.|+++.
T Consensus 243 ~~~~~~~e-------~~~~v~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHEE-------VIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHHH-------HHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHHH-------HHHHHHCCCCCCC---------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 99989999-------9999973997888---------7325299999999974889657939999999999842
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.15 Aligned_cols=257 Identities=23% Similarity=0.480 Sum_probs=210.6
Q ss_pred CCCCCCCEEEEECCEEEEEEEECC-CC----EEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEE
Q ss_conf 498866124320747999999829-93----999998235-680209999999999963268761017759963792189
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GR----IVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 433 (694)
++|++.+.||+|+||+||+|.+.. ++ .||+|++.. .+....++|.+|+.++++++|||||+++|++.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf 999783198208992999999958998898999999965134979999999999999867998881589999619-8369
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 99827999967887403677788999999999999999999874499984404666460887799937993127852234
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~ 513 (694)
++|++.+++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEECCCCCCCCCCCCCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEECC
T ss_conf 9984268740101113345--7999999999999999999998769---5047621203116799875860255222335
Q ss_pred CCCCC-EEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHH
Q ss_conf 47761-1112331789889721136998820027742688999884-999876678756761799999986304035662
Q 005492 514 VDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591 (694)
Q Consensus 514 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (694)
..... ......||..|+|||++.+..++.++||||||+++|||+| |..||......+ +...+..+..
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-------~~~~i~~~~~---- 231 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGER---- 231 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-------HHHHHHHTCC----
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHCCCC----
T ss_conf 44453223651058644670887469998356544079999999977999999999899-------9999975998----
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 04443134299999999999981134999999988899999415014
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 638 (694)
...+...+..+.+|+.+||+.+|.+|||+.+++++|..+...
T Consensus 232 -----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 232 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -----999855689999999984789934691999999999998758
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=359.63 Aligned_cols=253 Identities=24% Similarity=0.308 Sum_probs=207.0
Q ss_pred HHCCCCCCCEEEEECCEEEEEEEECC-CCEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEE
Q ss_conf 70498866124320747999999829-9399999823568-020999999999996326876101775996379218999
Q 005492 358 ATDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVD-ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 358 ~~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 435 (694)
..+.|++.+.||+|+||+||++.... ++.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 76666998899406583999999999998999999815773128999999999998679989991989999899888988
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCCCC
Q ss_conf 8279999678874036777889999999999999999998744999844046664608877---9993799312785223
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGTSRSV 512 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DfGl~~~~ 512 (694)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEEC
T ss_conf 5268984888653036---7887899999999999987524130---556870463001104688824998315435872
Q ss_pred CCCCCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHH
Q ss_conf 44776111123317898897211369988200277426889998849998766787567617999999863040356620
Q 005492 513 MVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592 (694)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 592 (694)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+......
T Consensus 161 ~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~~---- 227 (307)
T d1a06a_ 161 DPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------LFEQILKAEYE---- 227 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHTTCCC----
T ss_pred CCC--CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHCCCCC----
T ss_conf 589--70440032842259188737999807873451599999985979999989999-------99998616877----
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 444313429999999999998113499999998889999
Q 005492 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 593 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.........++.+.+|+.+||+.+|.+|||+.|++++
T Consensus 228 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 --FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp --CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --7876666789999999999760897579189998629
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.24 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=198.7
Q ss_pred CCCCCEEEEECCEEEEEEEECC-CCEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC----CCCEEE
Q ss_conf 8866124320747999999829-939999982356--802099999999999632687610177599637----921899
Q 005492 362 YNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLET----EVPLLV 434 (694)
Q Consensus 362 f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----~~~~lv 434 (694)
|+..++||+|+||+||+|.+.. +..||+|.+... .....+.+.+|++++++++|||||++++++.+. ...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf 88516970082849999999999959999998512279899999999999998579998506999984033458889999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC-CCCCEEEEECCCCCCCC
Q ss_conf 98279999678874036777889999999999999999998744999844046664608877-99937993127852234
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DfGl~~~~~ 513 (694)
|||+++|+|.+++.+.. .+++..+..++.|++.||+|||+++ ++|+||||||+|||++ +++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEECC
T ss_conf 95789894899975135---5469999999999999999999789-9799687674351166799988980057654236
Q ss_pred CCCCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHHH
Q ss_conf 47761111233178988972113699882002774268899988499987667875676179999998630403566204
Q 005492 514 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDA 593 (694)
Q Consensus 514 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 593 (694)
. .......||+.|+|||++.+ .++.++||||||+++|||++|+.||....... .....+..+.....
T Consensus 167 ~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~------~~~~~i~~~~~~~~--- 233 (270)
T d1t4ha_ 167 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPAS--- 233 (270)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCGG---
T ss_pred C---CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHH------HHHHHHHCCCCCCC---
T ss_conf 8---76677553813008988478-99986711007999999987889998765599------99999973899865---
Q ss_pred HHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 44313429999999999998113499999998889999
Q 005492 594 RVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 594 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.....++.+.+|+.+||+.+|++|||+.|++++
T Consensus 234 -----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 234 -----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----675578999999999763797589299999677
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.24 Aligned_cols=260 Identities=27% Similarity=0.423 Sum_probs=214.9
Q ss_pred HHHCCCCCCCEEEEECCEEEEEEEECC----CCEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCC
Q ss_conf 870498866124320747999999829----939999982356-802099999999999632687610177599637921
Q 005492 357 KATDNYNANRILGQGGQGTVYKGMLTD----GRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 431 (694)
Q Consensus 357 ~~~~~f~~~~~Lg~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 431 (694)
...++|++.+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.++++++||||++++|++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred CCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEE
T ss_conf 688996987799307882999999936996449999999365668799999999999998689999856988995-3747
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 89998279999678874036777889999999999999999998744999844046664608877999379931278522
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~ 511 (694)
++||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEECCCCCHHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEE
T ss_conf 999984069807765422478--9999999999999987752302267---44141026553206789678765034213
Q ss_pred CCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHH
Q ss_conf 34477611112331789889721136998820027742688999884-99987667875676179999998630403566
Q 005492 512 VMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEI 590 (694)
Q Consensus 512 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (694)
.............||+.|+|||++....++.++||||||+++|||++ |.+||......+ +...+..+...+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-------~~~~i~~~~~~~- 229 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLP- 229 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCCCC-
T ss_pred CCCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHCCCCCC-
T ss_conf 367762330540058310326675169988745244424789999826999988899999-------999998189998-
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 204443134299999999999981134999999988899999415014
Q 005492 591 LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 591 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 638 (694)
.+...+..+.+|+.+||+.+|.+|||+.+|++.|+.+...
T Consensus 230 --------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 230 --------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf --------9877799999999997687976892999999999999778
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=358.74 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=201.5
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEE
Q ss_conf 49886612432074799999982-99399999823568---020999999999996326876101775996379218999
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD---ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 435 (694)
+.|+..+.||+|+||+||+|... +++.||||.+.... ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 82799996788740367778899999999999999999987449998440466646088779993799312785223447
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~~ 515 (694)
||+++|+|..++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EECCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCC-
T ss_conf 806999457899737---99999999999999999999998689---76667884217987999789844365334677-
Q ss_pred CCCEEEEEECCCCCCCCCCCCC---CCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHH
Q ss_conf 7611112331789889721136---9988200277426889998849998766787567617999999863040356620
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILD 592 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 592 (694)
.....||+.|+|||++.+ ..|+.++||||||+++|||++|+.||......+ .+.... .+......
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~------~~~~i~-~~~~~~~~- 235 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIA-QNESPALQ- 235 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH-HSCCCCCS-
T ss_pred ----CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-HCCCCCCC-
T ss_conf ----873134766368899834678886721454558999999987889999979999------999998-28999888-
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 444313429999999999998113499999998889999
Q 005492 593 ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 593 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
....++.+.+|+.+||+.+|.+|||+.|++++
T Consensus 236 -------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 236 -------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf -------78889999999999773796579189999719
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.29 Aligned_cols=249 Identities=25% Similarity=0.357 Sum_probs=208.0
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEE
Q ss_conf 49886612432074799999982-9939999982356---8020999999999996326876101775996379218999
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 435 (694)
++|++.+.||+|+||+||+|... +++.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 82799996788740367778899999999999999999987449998440466646088779993799312785223447
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~~ 515 (694)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf 7048987777653159---9999999999999999997621650---884767741236688853886032102422567
Q ss_pred CC-CEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHHHH
Q ss_conf 76-11112331789889721136998820027742688999884999876678756761799999986304035662044
Q 005492 516 QT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 516 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+ ....+.....
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~------- 227 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IFQKIIKLEY------- 227 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTCC-------
T ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHCCCC-------
T ss_conf 76433355567755258440026898966623045699999803889989959999-------9999971899-------
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 4313429999999999998113499999998889999
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..+......+.+||.+||+.+|.+|||+.|++++
T Consensus 228 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf ---9985479999999999855797689197897377
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.77 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=208.3
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEE
Q ss_conf 049886612432074799999982-9939999982356---802099999999999632687610177599637921899
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 359 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 434 (694)
.++|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 98279999678874036777889999999999999999998744999844046664608877999379931278522344
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~ 514 (694)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 00357986055553256---7759999999999965211343159---62246477784765899888820565200356
Q ss_pred CCCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHHHH
Q ss_conf 77611112331789889721136998820027742688999884999876678756761799999986304035662044
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+ ....+.....
T Consensus 158 ~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~i~~~~~------- 222 (337)
T d1o6la_ 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI------- 222 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-------
T ss_pred CC-CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHCCCC-------
T ss_conf 78-62055100889966665048988833310223067889987899999969999-------9999852899-------
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHH
Q ss_conf 431342999999999999811349999999-----8889999
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPT-----MKEVAFE 631 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 631 (694)
..+...+..+.+||.+||+.||.+||+ +.+++++
T Consensus 223 ---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCC
T ss_conf ---898668999999998666389344225652349999729
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.46 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=206.9
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC------HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCC
Q ss_conf 049886612432074799999982-99399999823568------02099999999999632687610177599637921
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD------ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 431 (694)
Q Consensus 359 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 431 (694)
.++|++.+.||+|+||+||+|... +++.||+|.+.... ....+.+.+|+.++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEEECC
Q ss_conf 89998279999678874036777889999999999999999998744999844046664608877999----37993127
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFG 507 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DfG 507 (694)
+|||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEECCCCCCCCCHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf 99998677864310010356---4215578999999999987666254---22113330127982589866646964334
Q ss_pred CCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCH
Q ss_conf 85223447761111233178988972113699882002774268899988499987667875676179999998630403
Q 005492 508 TSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 587 (694)
Q Consensus 508 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (694)
++...... .......|++.|+|||++.+..++.++||||||+++|||++|+.||.+.+..+ ....+.....
T Consensus 163 ~a~~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNY 233 (293)
T ss_dssp TCEECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTCC
T ss_pred HHHHCCCC--CCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHHCCC
T ss_conf 42105777--63122477774309999818999976652214099999970889988999999-------9999981688
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 56620444313429999999999998113499999998889999
Q 005492 588 FEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 588 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..........+..+.+|+.+||+.+|.+|||+.|++++
T Consensus 234 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 ------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ------88701047889999999999863896689199999619
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.19 Aligned_cols=260 Identities=26% Similarity=0.427 Sum_probs=211.3
Q ss_pred CCCCCCCEEEEECCEEEEEEEECC-CC--EEEEEECCC-CCHHHHHHHHHHHHHHHHC-CCCCCEEEEEEEEECCCCEEE
Q ss_conf 498866124320747999999829-93--999998235-6802099999999999632-687610177599637921899
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GR--IVAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 434 (694)
++|++.++||+|+||+||+|.+.+ +. .||||++.. ......+.+.+|+.++.++ +||||++++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCHHHHHHCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf 98279999678874036-------------77788999999999999999999874499984404666460887799937
Q 005492 435 YEFIPNGTLYQYIHNQI-------------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRA 501 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 501 (694)
|||+++|+|.++++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663089---5455505204898688763
Q ss_pred EEEECCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCC-CCCCCCCCCCCCCHHHHHHH
Q ss_conf 99312785223447761111233178988972113699882002774268899988499-98766787567617999999
Q 005492 502 KVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ-KPIRAINTDEDKSLVGYFLQ 580 (694)
Q Consensus 502 kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~ 580 (694)
||+|||+++...... ......||..|+|||.+....++.++||||||+++|||++|. +||...+..+ +..
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE 237 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHH
T ss_pred EECCCCCCCCCCCCC--CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHH-------HHH
T ss_conf 874344322444223--45530137755553875269999622153138899999836899999999999-------999
Q ss_pred HHHHCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 863040356620444313429999999999998113499999998889999941501469
Q 005492 581 AINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTG 640 (694)
Q Consensus 581 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 640 (694)
.+..+.. .+.+...+..+.+||.+||+.+|++||+|.+|+++|+.+....+
T Consensus 238 ~i~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 238 KLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp HGGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHHCCC---------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf 9982688---------88876678999999999767896689499999999999986186
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.97 Aligned_cols=270 Identities=28% Similarity=0.412 Sum_probs=214.3
Q ss_pred CHHHHHHHHCCCCCCCEEEEECCEEEEEEEECC------CCEEEEEECCC-CCHHHHHHHHHHHHHHHHC-CCCCCEEEE
Q ss_conf 856688870498866124320747999999829------93999998235-6802099999999999632-687610177
Q 005492 351 TSKDLEKATDNYNANRILGQGGQGTVYKGMLTD------GRIVAVKKSKL-VDETNVEQFINEVVILSQI-NHRNIVKLL 422 (694)
Q Consensus 351 ~~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~------~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 422 (694)
+.++++...++|++.+.||+|+||.||+|.+.. ++.||||++.. ......+.+..|...+.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEE
T ss_conf 98252616799798449841678399999986777555783999999860017178999999999988614998499741
Q ss_pred EEEEECC-CCEEEEEECCCCCHHHHHHCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCC
Q ss_conf 5996379-21899982799996788740367-------------778899999999999999999987449998440466
Q 005492 423 GCCLETE-VPLLVYEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDI 488 (694)
Q Consensus 423 g~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Di 488 (694)
+++.+.+ ..++||||+++|+|.++++.... ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCC
T ss_conf 15404797579999845899299999853666665322202332146899999999999999999887379---717867
Q ss_pred CCCCEEECCCCCEEEEECCCCCCCCCCCCC-EEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHC-CCCCCCC
Q ss_conf 646088779993799312785223447761-11123317898897211369988200277426889998849-9987667
Q 005492 489 KSANILLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTG-QKPIRAI 566 (694)
Q Consensus 489 kp~NIll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg-~~p~~~~ 566 (694)
||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||+++ ..||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCC
T ss_conf 73106577998289845752001135665222475166721020368646889966322136789999986889999899
Q ss_pred CCCCCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 875676179999998630403566204443134299999999999981134999999988899999415014
Q 005492 567 NTDEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 638 (694)
...+ .+...+..+...+ .+...++.+.+|+.+||+.+|.+|||+.+++++|+++..+
T Consensus 241 ~~~~------~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 241 KIDE------EFCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCSH------HHHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHH------HHHHHHHCCCCCC---------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 9899------9999996389888---------8865789999999997677966791999999999799867
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.88 Aligned_cols=267 Identities=27% Similarity=0.418 Sum_probs=215.8
Q ss_pred HHHHHHCCCCCCCEEEEECCEEEEEEEEC------CCCEEEEEECCCC-CHHHHHHHHHHHHHHHHC-CCCCCEEEEEEE
Q ss_conf 68887049886612432074799999982------9939999982356-802099999999999632-687610177599
Q 005492 354 DLEKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCC 425 (694)
Q Consensus 354 ~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 425 (694)
.++...++|++.+.||+|+||.||+|.+. .++.||||+++.. .......+.+|+.+++++ +|||||+++|++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEE
T ss_conf 26377899698549820688299999980664477886999999874248779999999999987626999887899898
Q ss_pred EECCCCEEEEEECCCCCHHHHHHCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf 637921899982799996788740367---------------77889999999999999999998744999844046664
Q 005492 426 LETEVPLLVYEFIPNGTLYQYIHNQIE---------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKS 490 (694)
Q Consensus 426 ~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp 490 (694)
.+.+..++||||+++|+|.++++.... ...+++..++.++.|++.||+|||+++ ++||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCC
T ss_conf 319978999973799879999985356654444453322233458899999999999999999887579---26662410
Q ss_pred CCEEECCCCCEEEEECCCCCCCCCCCC-CEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHH-CCCCCCCCCC
Q ss_conf 608877999379931278522344776-11112331789889721136998820027742688999884-9998766787
Q 005492 491 ANILLDDKYRAKVSDFGTSRSVMVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINT 568 (694)
Q Consensus 491 ~NIll~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~ 568 (694)
+|||++.++.+|++|||+++....... .......|++.|+|||++....++.++||||||+++|||++ |.+|+.....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred CCCCCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf 21000025752102340102336788615862013596876778861799997400102589999998589988778998
Q ss_pred CCCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 5676179999998630403566204443134299999999999981134999999988899999415014
Q 005492 569 DEDKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 638 (694)
.+. +...+..+. ....+...+..+.+|+.+||+.+|.+||+|.+++++|+++...
T Consensus 254 ~~~------~~~~i~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 254 DSK------FYKMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SHH------HHHHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH------HHHHHHCCC---------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 999------999986689---------8898543659999999997577965792999999999876534
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.83 Aligned_cols=252 Identities=25% Similarity=0.325 Sum_probs=206.6
Q ss_pred HCCCCCCCEEEEECCEEEEEEEECC-CCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEEEE
Q ss_conf 0498866124320747999999829-939999982356802099999999999632687610177599637921899982
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 359 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 437 (694)
.++|++.+.||+|+||+||++.... ++.||+|.+.... .....+.+|+.+|+.++||||+++++++.+.+..+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 010588789831778399999998999699999975786-6599999999999857997989098999889988999953
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEEECCCCCCCCCC
Q ss_conf 799996788740367778899999999999999999987449998440466646088779--993799312785223447
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD--KYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~--~~~~kl~DfGl~~~~~~~ 515 (694)
+++|+|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC
T ss_conf 899808899875389--9999999999999999999998769---97513554443443788518997644111003467
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHHHHH
Q ss_conf 76111123317898897211369988200277426889998849998766787567617999999863040356620444
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
.......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+ ....+...... ++
T Consensus 158 --~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-------~~~~i~~~~~~--~~--- 223 (321)
T d1tkia_ 158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYT--FD--- 223 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCC--CC---
T ss_pred --CCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHHCCCC--CC---
T ss_conf --75321223322234021048777840113027999999982899999989999-------99999838999--88---
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 313429999999999998113499999998889999
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.......+..+.+|+.+||..||.+||++.|++++
T Consensus 224 -~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 224 -EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -HHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -02236789999999999866996689099999639
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.26 Aligned_cols=257 Identities=30% Similarity=0.479 Sum_probs=207.4
Q ss_pred CCEEEEECCEEEEEEEECCC----CEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC-CCCEEEEEEC
Q ss_conf 61243207479999998299----3999998235-6802099999999999632687610177599637-9218999827
Q 005492 365 NRILGQGGQGTVYKGMLTDG----RIVAVKKSKL-VDETNVEQFINEVVILSQINHRNIVKLLGCCLET-EVPLLVYEFI 438 (694)
Q Consensus 365 ~~~Lg~G~fg~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv~e~~ 438 (694)
.++||+|+||+||+|.+.++ ..||||++.. .+....++|.+|++++++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99996788740367778899999999999999999987449998440466646088779993799312785223447761
Q 005492 439 PNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQTH 518 (694)
Q Consensus 439 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 518 (694)
++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ECCCHHHHHCCCCC--CCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf 06741442101345--4048999999999887652003367---625776687576779998899106523225566555
Q ss_pred ---EEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHHHHH
Q ss_conf ---11123317898897211369988200277426889998849998766787567617999999863040356620444
Q 005492 519 ---LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 519 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
......||..|+|||.+....++.++||||||+++|||++|..||.......+ . ...+..+... .
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~----~~~i~~g~~~--~---- 254 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--I----TVYLLQGRRL--L---- 254 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------C----HHHHHTTCCC--C----
T ss_pred CCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--H----HHHHHCCCCC--C----
T ss_conf 31002565556455676887437999745746619999999978999988899999--9----9999808988--9----
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 3134299999999999981134999999988899999415014698
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGA 641 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~ 641 (694)
.+...+..+.+|+.+||+.+|++||+|.||+++|+.+......
T Consensus 255 ---~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 255 ---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred ---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHH
T ss_conf ---9644759999999997688976893999999999999975201
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=344.76 Aligned_cols=245 Identities=22% Similarity=0.289 Sum_probs=205.3
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEE
Q ss_conf 49886612432074799999982-993999998235---68020999999999996326876101775996379218999
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKL---VDETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 435 (694)
++|++.+.||+|+||.||++..+ +++.||+|.+.. ......+.+.+|+.+++.++||||+++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 82799996788740367778899999999999999999987449998440466646088779993799312785223447
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~~ 515 (694)
||+.+|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf 2334662266675158---9899999999999999899998599---861767999936077897886101033322566
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHHHHH
Q ss_conf 76111123317898897211369988200277426889998849998766787567617999999863040356620444
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+... ....+......
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~i~~~~~~------- 256 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKVR------- 256 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC-------
T ss_pred ----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHCCCCC-------
T ss_conf ----643367635678899717998853311450078999975889989959999-------99998617988-------
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
Q ss_conf 3134299999999999981134999999-----98889999
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRP-----TMKEVAFE 631 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 631 (694)
.+...+..+.+|+.+||+.||.+|+ ++.+++++
T Consensus 257 ---~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 257 ---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCC
T ss_conf ---97668999999999983409986065534549999719
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=344.32 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=198.7
Q ss_pred CCCCCCCEEEEECCEEEEEEEECC-CCEEEEEECCCC---CHHHHHHHHH---HHHHHHHCCCCCCEEEEEEEEECCCCE
Q ss_conf 498866124320747999999829-939999982356---8020999999---999996326876101775996379218
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFIN---EVVILSQINHRNIVKLLGCCLETEVPL 432 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~---E~~~l~~l~h~niv~l~g~~~~~~~~~ 432 (694)
++|++.+.||+|+||.||+|.... ++.||+|.+... .......+.+ ++.+++.++||||+++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 99982799996788740367778899999999999999999987449998440466646088779993799312785223
Q 005492 433 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 512 (694)
Q Consensus 433 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~ 512 (694)
|||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEECCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEEEC
T ss_conf 9999148983899987325---5327899999999999999999779---622044422167858896798220102333
Q ss_pred CCCCCCEEEEEECCCCCCCCCCCCC-CCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHH
Q ss_conf 4477611112331789889721136-998820027742688999884999876678756761799999986304035662
Q 005492 513 MVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEIL 591 (694)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (694)
.... .....||+.|+|||++.. ..++.++|||||||+||||++|+.||......+... .........
T Consensus 158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----~~~~~~~~~----- 225 (364)
T d1omwa3 158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTMA----- 225 (364)
T ss_dssp SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH----HHHHSSSCC-----
T ss_pred CCCC---CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHHCCCCC-----
T ss_conf 7886---4331134554216876038999844104677899999985999888899899999----998604688-----
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHH
Q ss_conf 044431342999999999999811349999999-----8889999
Q 005492 592 DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPT-----MKEVAFE 631 (694)
Q Consensus 592 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 631 (694)
...+...+..+.+||.+||+.+|.+||+ +.+++++
T Consensus 226 -----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 226 -----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -----CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -----CCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf -----8788778999999999985669888088743579999749
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=345.67 Aligned_cols=245 Identities=28% Similarity=0.364 Sum_probs=204.8
Q ss_pred CCCCCCCEEEEECCEEEEEEEECC-CCEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEE
Q ss_conf 498866124320747999999829-939999982356---8020999999999996326876101775996379218999
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 435 (694)
++|++.+.||+|+||+||++..+. ++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 82799996788740367778899999999999999999987449998440466646088779993799312785223447
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVD 515 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~~ 515 (694)
||+++|+|..++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EECCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECCC
T ss_conf 5037863223432222---1110079999999987655412476---770556810503868998898317521671245
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHHHHH
Q ss_conf 76111123317898897211369988200277426889998849998766787567617999999863040356620444
Q 005492 516 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARV 595 (694)
Q Consensus 516 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 595 (694)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+ ....+.....
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~i~~~~~-------- 218 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-------TYEKILNAEL-------- 218 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHCCC--------
T ss_pred ----CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHH-------HHHHHHCCCC--------
T ss_conf ----643457634359999838999804304653336899975989999969999-------9999970898--------
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
Q ss_conf 3134299999999999981134999999-----98889999
Q 005492 596 LKEAKKEGIMTVATLAKRCLNLNGKMRP-----TMKEVAFE 631 (694)
Q Consensus 596 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 631 (694)
..+...+..+.+++.+||..+|.+|+ ++.+++++
T Consensus 219 --~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf --899778999999999995449976664310219999819
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.78 Aligned_cols=267 Identities=26% Similarity=0.442 Sum_probs=215.9
Q ss_pred HHHHHHHHCCCCCCCEEEEECCEEEEEEEEC------CCCEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEE
Q ss_conf 5668887049886612432074799999982------9939999982356-80209999999999963268761017759
Q 005492 352 SKDLEKATDNYNANRILGQGGQGTVYKGMLT------DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGC 424 (694)
Q Consensus 352 ~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~ 424 (694)
.++++...++|++.+.||+|+||+||+|.+. ++..||||++... .......|.+|+.++++++||||++++|+
T Consensus 12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred CCCEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 61004268991883598207881899999878644778968999998701286899999999999997699988412547
Q ss_pred EEECCCCEEEEEECCCCCHHHHHHCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC
Q ss_conf 963792189998279999678874036-------7778899999999999999999987449998440466646088779
Q 005492 425 CLETEVPLLVYEFIPNGTLYQYIHNQI-------EEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD 497 (694)
Q Consensus 425 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~ 497 (694)
+...+..++||||+++|+|.+++.... ....+++..+..++.|+|.||.|||+.+ |+||||||+|||++.
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 168 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred EECCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECC
T ss_conf 84288106777604899889998750332113444688799999999999999999876479---654328677540359
Q ss_pred CCCEEEEECCCCCCCCCCCCC-EEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCC-CCCCCCCCCCCCCHH
Q ss_conf 993799312785223447761-111233178988972113699882002774268899988499-987667875676179
Q 005492 498 KYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ-KPIRAINTDEDKSLV 575 (694)
Q Consensus 498 ~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~-~p~~~~~~~~~~~~~ 575 (694)
++.+||+|||+++........ ......|++.|+|||.+.+..++.++||||||+++|||++|. .||...+..+
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~----- 243 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ----- 243 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-----
T ss_pred CCEEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHH-----
T ss_conf 964999424542023577630313402316323788887369988333444378999999968999999989999-----
Q ss_pred HHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 99999863040356620444313429999999999998113499999998889999941501
Q 005492 576 GYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRT 637 (694)
Q Consensus 576 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 637 (694)
....+..+...++ +...+..+.+|+.+||+.+|++||+|.+|+++|+....
T Consensus 244 --~~~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 244 --VLRFVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp --HHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --HHHHHHHCCCCCC---------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf --9999980888888---------63353999999999757796589399999999787617
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.89 Aligned_cols=252 Identities=28% Similarity=0.483 Sum_probs=208.3
Q ss_pred HCCCCCCCEEEEECCEEEEEEEECCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC-CCCEEEEEE
Q ss_conf 0498866124320747999999829939999982356802099999999999632687610177599637-921899982
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLET-EVPLLVYEF 437 (694)
Q Consensus 359 ~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv~e~ 437 (694)
.++|++.+.||+|+||.||+|.++ +..||||+++. ....+.+.+|+.++++++||||++++|++.+. +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECC--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf 899488579820798089999999-90999999885--777999999999998678989854987887238928999963
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 79999678874036777889999999999999999998744999844046664608877999379931278522344776
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~~~~ 517 (694)
+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCC--
T ss_conf 69998999987457-888899999999999985232113376---553666567601468997763245600344787--
Q ss_pred CEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHHHHHH
Q ss_conf 11112331789889721136998820027742688999884-99987667875676179999998630403566204443
Q 005492 518 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFEILDARVL 596 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 596 (694)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||......+ +...+..+...
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-------~~~~i~~~~~~-------- 219 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKM-------- 219 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------HHHHHTTTCCC--------
T ss_pred --CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHCCCCC--------
T ss_conf --7655666467781787279888588777579999999978999999999999-------99999808999--------
Q ss_pred HHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 13429999999999998113499999998889999941501
Q 005492 597 KEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRT 637 (694)
Q Consensus 597 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 637 (694)
+.+...+..+.+|+.+||+.+|.+|||+.+++++|+.++.
T Consensus 220 -~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 220 -DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf -9976579999999999756697689399999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.38 Aligned_cols=264 Identities=27% Similarity=0.425 Sum_probs=214.8
Q ss_pred HHHHCCCCCCCEEEEECCEEEEEEEECC--------CCEEEEEECCCC-CHHHHHHHHHHHHHHHHC-CCCCCEEEEEEE
Q ss_conf 8870498866124320747999999829--------939999982356-802099999999999632-687610177599
Q 005492 356 EKATDNYNANRILGQGGQGTVYKGMLTD--------GRIVAVKKSKLV-DETNVEQFINEVVILSQI-NHRNIVKLLGCC 425 (694)
Q Consensus 356 ~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 425 (694)
+...++|++.+.||+|+||.||+|.... +..||||++... ......++.+|...+.++ +|||||++++++
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCC
T ss_conf 22589969700985167828999998578755566754999999881128688999999999999813999697346522
Q ss_pred EECCCCEEEEEECCCCCHHHHHHCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCC
Q ss_conf 637921899982799996788740367-------------7788999999999999999999874499984404666460
Q 005492 426 LETEVPLLVYEFIPNGTLYQYIHNQIE-------------EFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSAN 492 (694)
Q Consensus 426 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~N 492 (694)
.+....++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCC
T ss_conf 0188689999736999099999860677643222334574346799999999999999998766379---7863022102
Q ss_pred EEECCCCCEEEEECCCCCCCCCCCCC-EEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHH-CCCCCCCCCCCC
Q ss_conf 88779993799312785223447761-1112331789889721136998820027742688999884-999876678756
Q 005492 493 ILLDDKYRAKVSDFGTSRSVMVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDE 570 (694)
Q Consensus 493 Ill~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~ 570 (694)
||++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHH
T ss_conf 24547897676221110113555554314667888466326675179888255547758888874017989899999999
Q ss_pred CCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 76179999998630403566204443134299999999999981134999999988899999415014
Q 005492 571 DKSLVGYFLQAINENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTS 638 (694)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 638 (694)
....+..+... ..+...+..+.+|+.+||+.+|.+|||+.||++.|+++.+.
T Consensus 246 -------~~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 246 -------LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp -------HHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------HHHHHHCCCCC---------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -------99999728888---------98743529999999997667976793999999999888604
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=339.70 Aligned_cols=259 Identities=28% Similarity=0.372 Sum_probs=211.6
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCC----
Q ss_conf 049886612432074799999982-9939999982356---80209999999999963268761017759963792----
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEV---- 430 (694)
Q Consensus 359 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---- 430 (694)
.++|++.+.||+|+||+||+|... +++.||+|.+... +......+.+|+.+++.++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred CEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 18999827999967887403677788999999999999999999874499984404666460887799937993127852
Q 005492 431 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~ 510 (694)
.+|||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++..+|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEEHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf 999997788987101120358---9999999999999999999998579---5276346755665754320100344432
Q ss_pred CCCCCCC--CEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHH
Q ss_conf 2344776--11112331789889721136998820027742688999884999876678756761799999986304035
Q 005492 511 SVMVDQT--HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 588 (694)
Q Consensus 511 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (694)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+ .....+......
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCC
T ss_pred HHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHH------HHHHHHHCCCCC
T ss_conf 21235443333464257624369999839999966320265289999976979989969999------999998469999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHCCC
Q ss_conf 66204443134299999999999981134999999-9888999994150
Q 005492 589 EILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRP-TMKEVAFELGGIR 636 (694)
Q Consensus 589 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~~ 636 (694)
. .......+..+.+++.+||+.||.+|| +++++++.|.+++
T Consensus 234 ~-------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 P-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp G-------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred C-------CHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf 7-------10034789999999999866797677739999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.01 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=207.3
Q ss_pred CCCCCCCEEEEECCEEEEEEEECC--C--CEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCE
Q ss_conf 498866124320747999999829--9--39999982356---8020999999999996326876101775996379218
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD--G--RIVAVKKSKLV---DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 432 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 432 (694)
++|++.+.||+|+||+||+|.+.. + ..||||.+... .....++|.+|+.++++++||||++++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 99982799996788740367778899999999999999999987449998440466646088779993799312785223
Q 005492 433 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 512 (694)
Q Consensus 433 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~ 512 (694)
+||||+++|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEECCCCHHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHHC
T ss_conf 14654238612544421268--9999999999999999998752178---752056688815655654332561155530
Q ss_pred CCCCCC--EEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHHHCCHHH
Q ss_conf 447761--1112331789889721136998820027742688999884-9998766787567617999999863040356
Q 005492 513 MVDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINTDEDKSLVGYFLQAINENRLFE 589 (694)
Q Consensus 513 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (694)
...... ......|+..|+|||++.+..++.++||||||+++|||++ |+.||.+.+..+ ......+.+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~~~~i~~~~~~~- 234 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGERL- 234 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSCCCC-
T ss_pred CCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHHCCCCC-
T ss_conf 3588752654763257310799998379999421566148999999968999999969999------999998479999-
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 6204443134299999999999981134999999988899999415
Q 005492 590 ILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGI 635 (694)
Q Consensus 590 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 635 (694)
..+...+..+.+|+.+||+.+|++|||+.+|++.|++.
T Consensus 235 --------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 --------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf --------98544539999999997688966792999999999964
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.20 Aligned_cols=253 Identities=23% Similarity=0.284 Sum_probs=200.0
Q ss_pred HCCCCCCC-EEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHC-CCCCCEEEEEEEEE----CCCC
Q ss_conf 04988661-2432074799999982-9939999982356802099999999999632-68761017759963----7921
Q 005492 359 TDNYNANR-ILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQI-NHRNIVKLLGCCLE----TEVP 431 (694)
Q Consensus 359 ~~~f~~~~-~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~ 431 (694)
.++|.+.. .||+|+||+||+|... +++.||||.+.. ...+.+|+.++.++ +||||+++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 14879810796545486999999889998999999897-----4779999999998669999782989995034689789
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEECCC
Q ss_conf 899982799996788740367778899999999999999999987449998440466646088779---99379931278
Q 005492 432 LLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD---KYRAKVSDFGT 508 (694)
Q Consensus 432 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DfGl 508 (694)
+|||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 99997789984999998627-877579999999999999999999769---86444100220113555566311354551
Q ss_pred CCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHH
Q ss_conf 52234477611112331789889721136998820027742688999884999876678756761799999986304035
Q 005492 509 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 588 (694)
Q Consensus 509 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (694)
++...... ......||+.|+|||++.+..++.++||||||++||+|++|+.||.+....+... .+...+.....
T Consensus 161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~~~~- 234 (335)
T d2ozaa1 161 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQY- 234 (335)
T ss_dssp CEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS-
T ss_pred EEECCCCC--CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHH---HHHHHHHCCCC-
T ss_conf 23336888--6432267756379277748988888888764516778865889988988778899---99999853888-
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 6620444313429999999999998113499999998889999
Q 005492 589 EILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 589 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..........+..+.+|+.+||+.+|.+||++.|++++
T Consensus 235 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 -----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----88985434699999999999756996579099999709
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.35 Aligned_cols=247 Identities=25% Similarity=0.363 Sum_probs=203.5
Q ss_pred CCCCCCCEEEEECCEEEEEEEECC-CCEEEEEECCCC---CHHHHHHHHHHHHHHH-HCCCCCCEEEEEEEEECCCCEEE
Q ss_conf 498866124320747999999829-939999982356---8020999999999996-32687610177599637921899
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLV---DETNVEQFINEVVILS-QINHRNIVKLLGCCLETEVPLLV 434 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lv 434 (694)
++|++.+.||+|+||+||+|.... ++.||+|.+... .....+.+..|..++. .++||||+++++++.+.+..+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 98279999678874036777889999999999999999998744999844046664608877999379931278522344
Q 005492 435 YEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMV 514 (694)
Q Consensus 435 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~ 514 (694)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEECCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf 75037980899864047---8999999999999999999998689---34034765404444899630155530232356
Q ss_pred CCCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHHHHH
Q ss_conf 77611112331789889721136998820027742688999884999876678756761799999986304035662044
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEILDAR 594 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 594 (694)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+ ....+..... .
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~------~ 221 (320)
T d1xjda_ 156 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNP------F 221 (320)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC------C
T ss_pred CC-CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHCCCC------C
T ss_conf 65-33454578777689999827998832320112278989873889999989999-------9999971899------8
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHH
Q ss_conf 43134299999999999981134999999988-8999
Q 005492 595 VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMK-EVAF 630 (694)
Q Consensus 595 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-evl~ 630 (694)
.+...+..+.+|+.+||..+|.+||++. ++++
T Consensus 222 ----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf ----975679999999999654489878388999980
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.94 Aligned_cols=269 Identities=22% Similarity=0.325 Sum_probs=203.8
Q ss_pred CCCCCCCEEEEECCEEEEEEEECCCCEEEEEECCCCCHHHHHHHHH--HHHHHHHCCCCCCEEEEEEEEECC----CCEE
Q ss_conf 4988661243207479999998299399999823568020999999--999996326876101775996379----2189
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFIN--EVVILSQINHRNIVKLLGCCLETE----VPLL 433 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~g~~~~~~----~~~l 433 (694)
+.|.+.+.||+|+||+||+|++ +++.||||++... ....+.. |+..+.+++||||+++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCC---CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 6899988982078819999999-9989999998720---04679999999999627998683268899837986048999
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf 9982799996788740367778899999999999999999987449-----99844046664608877999379931278
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA-----SIPIYHRDIKSANILLDDKYRAKVSDFGT 508 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-----~~~ivH~Dikp~NIll~~~~~~kl~DfGl 508 (694)
||||+++|+|.+++++. .++|..++.++.|+|.||+|||+.. .++|+||||||+||||+.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEECCCCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCC
T ss_conf 99646698989998658----99989999999999999999887665204689866153173135786887768876386
Q ss_pred CCCCCCCCCC---EEEEEECCCCCCCCCCCCCCC------CCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCC-------
Q ss_conf 5223447761---111233178988972113699------882002774268899988499987667875676-------
Q 005492 509 SRSVMVDQTH---LTTKVQGTFGYVDPEYFQSSQ------FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDK------- 572 (694)
Q Consensus 509 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~il~elltg~~p~~~~~~~~~~------- 572 (694)
++........ ......||+.|+|||++.... ++.++||||||++||||++|..|+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCC
T ss_conf 62346777620013552503547678221056545467776750122015999999962899887663112410122556
Q ss_pred -CHHHHHHHHHHHCCHHHHHHHHHHHH-HHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf -17999999863040356620444313-429999999999998113499999998889999941501469
Q 005492 573 -SLVGYFLQAINENRLFEILDARVLKE-AKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTG 640 (694)
Q Consensus 573 -~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 640 (694)
..............+. +.+... ...+.+..+.+|+.+||+.+|.+|||+.||++.|+++....+
T Consensus 235 ~~~~~~~~~~~~~~~~~----p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLR----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp SCCHHHHHHHHTTSCCC----CCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHCCCCC----CCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCC
T ss_conf 43099999987502468----8877655776899999999999760698589599999999998888659
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=336.74 Aligned_cols=251 Identities=26% Similarity=0.382 Sum_probs=204.8
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCH---------HHHHHHHHHHHHHHHCC-CCCCEEEEEEEEEC
Q ss_conf 49886612432074799999982-993999998235680---------20999999999996326-87610177599637
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE---------TNVEQFINEVVILSQIN-HRNIVKLLGCCLET 428 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~ 428 (694)
++|++.+.||+|+||+||++... +++.+|||.+..... ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf 63888528841768499999999999899999996244641147888999999999999999850799747997621467
Q ss_pred CCCEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf 92189998279999678874036777889999999999999999998744999844046664608877999379931278
Q 005492 429 EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGT 508 (694)
Q Consensus 429 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 508 (694)
+..+|||||+++|+|.++++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCEEEEEECCCCCHHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCHH
T ss_conf 60599997689866899998659---9999999999999999999998759---94323462548986899838712403
Q ss_pred CCCCCCCCCCEEEEEECCCCCCCCCCCCC------CCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 52234477611112331789889721136------998820027742688999884999876678756761799999986
Q 005492 509 SRSVMVDQTHLTTKVQGTFGYVDPEYFQS------SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAI 582 (694)
Q Consensus 509 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 582 (694)
++..... .......||..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+ ....+
T Consensus 157 a~~~~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~i 227 (277)
T d1phka_ 157 SCQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMI 227 (277)
T ss_dssp CEECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH
T ss_pred EEECCCC--CCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHH-------HHHHH
T ss_conf 1672688--72134524678889888605344567889923318565602310322888988999999-------99999
Q ss_pred HHCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 3040356620444313429999999999998113499999998889999
Q 005492 583 NENRLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 583 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..+... .........++.+.+|+.+||+.+|.+||++.|++++
T Consensus 228 ~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHCCCC------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 818988------8985434689999999999765896689199999739
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.49 Aligned_cols=258 Identities=23% Similarity=0.249 Sum_probs=197.4
Q ss_pred CCCEEEEECCEEEEEEEECC-CCEEEEEECCCCCHH-----HHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEEEE
Q ss_conf 66124320747999999829-939999982356802-----099999999999632687610177599637921899982
Q 005492 364 ANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDET-----NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 364 ~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 437 (694)
..++||+|+||+||+|.... ++.||||++...... ..+.+.+|+.++++++|||||++++++.+.+..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 79999678874036777889999999999999999998744999844046664608877999379931278522344776
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~~~~ 517 (694)
+.++++..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred HCCHHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC
T ss_conf 3450776554126---67789999999999999998863163---55035776258853778411465761000578755
Q ss_pred CEEEEEECCCCCCCCCCCCC-CCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHHH-----
Q ss_conf 11112331789889721136-998820027742688999884999876678756761799999986304035662-----
Q 005492 518 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEIL----- 591 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 591 (694)
......||+.|+|||++.. ..++.++||||||+++|||++|+.||......+. ...+.............
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSSTTSS
T ss_pred -CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHH---HHHHHHHCCCCCHHHCCCHHCC
T ss_conf -433020473336399972677888056436304289999859699999999999---9999985189972545210002
Q ss_pred ---------HHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf ---------0444313429999999999998113499999998889999
Q 005492 592 ---------DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 592 ---------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.............+.+.+|+.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 1344303478988678565689999999999763894569089999679
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.76 Aligned_cols=263 Identities=24% Similarity=0.344 Sum_probs=201.2
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEEE
Q ss_conf 49886612432074799999982-99399999823568--0209999999999963268761017759963792189998
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVD--ETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 436 (694)
++|++.+.||+|+||+||+|... +++.||+|++.... ....+++.+|+.++++++||||+++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 27999967887403677788999999999999999999874499984404666460887799937993127852234477
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~~~ 516 (694)
|+.+ .+..++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.+..+||+|||+++......
T Consensus 82 ~~~~-~~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSE-EHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ECCC-CHHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCCC
T ss_conf 2377-445554420-2568888999999999999999865288---9921357114011346762103578613436886
Q ss_pred CCEEEEEECCCCCCCCCCCCCCC-CCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCC---HHHHH-
Q ss_conf 61111233178988972113699-88200277426889998849998766787567617999999863040---35662-
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR---LFEIL- 591 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~- 591 (694)
.......|++.|+|||++.... ++.++||||||+++|+|++|+.||...+..+. ............ .....
T Consensus 157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGG
T ss_pred -CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHH---HHHHHHHCCCCCHHHCCCCCC
T ss_conf -4100103652154112213665777422103333134279668799898899999---999998328983331444222
Q ss_pred --H------HH---HHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf --0------44---4313429999999999998113499999998889999
Q 005492 592 --D------AR---VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 592 --d------~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+ .. ............+.+|+.+||+.+|.+|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 421243454322220444166789999999999763995579189999678
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=330.92 Aligned_cols=262 Identities=22% Similarity=0.305 Sum_probs=203.9
Q ss_pred CCCCCCCEEEEECCEEEEEEEECCCCEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEEEE
Q ss_conf 498866124320747999999829939999982356--802099999999999632687610177599637921899982
Q 005492 360 DNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 437 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 437 (694)
++|++.++||+|+||+||+|.+++++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 79999678874036777889999999999999999998744999844046664608877999379931278522344776
Q 005492 438 IPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQT 517 (694)
Q Consensus 438 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~~~~ 517 (694)
+.++.+..+.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EHHHHHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCC-
T ss_conf 0045678998604---77514456899999999999860574---8826787750568689978732366430114676-
Q ss_pred CEEEEEECCCCCCCCCCCCCC-CCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHHH------
Q ss_conf 111123317898897211369-9882002774268899988499987667875676179999998630403566------
Q 005492 518 HLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFEI------ 590 (694)
Q Consensus 518 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 590 (694)
.......+++.|+|||.+... .++.++||||||+++|||++|+.||...+..+. ................
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGS
T ss_pred CCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHH---HHHHHHHHCCCCHHHCCCHHHH
T ss_conf 5410102431101378871788888410021117589999779799898898999---9999986389971104212333
Q ss_pred ---------HHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf ---------20444313429999999999998113499999998889999
Q 005492 591 ---------LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 591 ---------~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
................+.+|+.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 22143333356764666512589999999999866896689099998569
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.13 Aligned_cols=263 Identities=24% Similarity=0.335 Sum_probs=197.1
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC-C-CCEEEEEECCCC--CHHHHHHHHHHHHHHHHC---CCCCCEEEEEEEEEC---
Q ss_conf 049886612432074799999982-9-939999982356--802099999999999632---687610177599637---
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-D-GRIVAVKKSKLV--DETNVEQFINEVVILSQI---NHRNIVKLLGCCLET--- 428 (694)
Q Consensus 359 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~--- 428 (694)
.++|++.+.||+|+||+||+|.+. + ++.||||++... .......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred --CCCEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf --921899982799996788740367778899999999999999999987449998440466646088779993799312
Q 005492 429 --EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 506 (694)
Q Consensus 429 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 506 (694)
...++++|+++++.+........ ..+++..+..++.|++.||+|||+.+ |+||||||+|||++..+.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCEEEEEEEECCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECCH
T ss_conf 6746999997405871444443037--89998999999999999999997588---983579862789858997542100
Q ss_pred CCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 78522344776111123317898897211369988200277426889998849998766787567617999999863040
Q 005492 507 GTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR 586 (694)
Q Consensus 507 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 586 (694)
|+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.+..+. ...+........
T Consensus 161 g~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~ 235 (305)
T d1blxa_ 161 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPG 235 (305)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCC
T ss_pred HHHHHHCCC--CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHHCCCC
T ss_conf 010110023--457776548511483100179888111000328999999878799899898999---999998407996
Q ss_pred HHHH-------------HHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 3566-------------20444313429999999999998113499999998889999
Q 005492 587 LFEI-------------LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 587 ~~~~-------------~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.... ..............+.+.+|+.+||+.||.+|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 1105321111033302234564544044589999999999874896679189999669
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.08 Aligned_cols=263 Identities=21% Similarity=0.314 Sum_probs=201.0
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC----CCE
Q ss_conf 049886612432074799999982-9939999982356-8020999999999996326876101775996379----218
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV-DETNVEQFINEVVILSQINHRNIVKLLGCCLETE----VPL 432 (694)
Q Consensus 359 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~ 432 (694)
+++|++.+.||+|+||+||+|... +++.||||++... .....+.+++|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 99982799996788740367778899999999999999999987449998440466646088779993799312785223
Q 005492 433 LVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSV 512 (694)
Q Consensus 433 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~ 512 (694)
++++++.+|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEECCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 999962598656644058----9999999999999999999999789---867778764378879997787545705650
Q ss_pred CCCCCC--EEEEEECCCCCCCCCCCCC-CCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHH
Q ss_conf 447761--1112331789889721136-9988200277426889998849998766787567617999999863040356
Q 005492 513 MVDQTH--LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589 (694)
Q Consensus 513 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (694)
...... ......|++.|+|||++.. ..++.++||||+|+++++|++|+.||......+.... ............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH---ILGILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHHH
T ss_pred CCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHH---HHHHCCCCCHHH
T ss_conf 47776410101102652000387860478887410100467013377669799788888999998---765206997566
Q ss_pred --------HHH-----HH----HHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf --------620-----44----4313429999999999998113499999998889999
Q 005492 590 --------ILD-----AR----VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 590 --------~~d-----~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
... +. ............+.+|+.+||+.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 42343322220244677557787778378999999999999764895679089998619
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.14 Aligned_cols=259 Identities=25% Similarity=0.330 Sum_probs=192.9
Q ss_pred CCCCCCEEEEECCEEEEEEEECC-CCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC------CCEE
Q ss_conf 98866124320747999999829-9399999823568020999999999996326876101775996379------2189
Q 005492 361 NYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVKLLGCCLETE------VPLL 433 (694)
Q Consensus 361 ~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~l 433 (694)
.|+..++||+|+||+||+|++.. ++.||||++..... ...+|+.++++++|+||+++++++.... ..+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 76751698217683999999999997999999881606----89999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCCCC
Q ss_conf 998279999678874036777889999999999999999998744999844046664608877999-3799312785223
Q 005492 434 VYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRSV 512 (694)
Q Consensus 434 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfGl~~~~ 512 (694)
||||++++.+............+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 9841688607888863103689999999999999999999998668---7645788603787358971167336605440
Q ss_pred CCCCCCEEEEEECCCCCCCCCCCCC-CCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCC---HH
Q ss_conf 4477611112331789889721136-9988200277426889998849998766787567617999999863040---35
Q 005492 513 MVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR---LF 588 (694)
Q Consensus 513 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 588 (694)
.... ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ...+........ +.
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~---l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ---LVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH---HHHHHHHHCCCCHHHHH
T ss_pred CCCC--CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHH---HHHHHHHHCCCHHHHHH
T ss_conf 4776--532002555556827764046888210002465277855028799898799999---99999974898177654
Q ss_pred HH------------HHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 66------------20444313429999999999998113499999998889999
Q 005492 589 EI------------LDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 589 ~~------------~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.. ..............+.+.+|+.+||..||.+|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 3062101103554456744443156899999999999765895579299999669
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.41 Aligned_cols=257 Identities=22% Similarity=0.328 Sum_probs=199.7
Q ss_pred HCCCCCCCEEEEECCEEEEEEEECC-CCEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC------
Q ss_conf 0498866124320747999999829-93999998235--68020999999999996326876101775996379------
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLETE------ 429 (694)
Q Consensus 359 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 429 (694)
.++|++.+.||+|+||+||+|.... ++.||||++.. ......+.+.+|+.+|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred CCEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 21899982799996788740367778899999999999999999987449998440466646088779993799312785
Q 005492 430 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS 509 (694)
Q Consensus 430 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~ 509 (694)
..++||||+ +.+|..+++.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEECC-CCCHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf 599998405-52189998740----2269999999999999999987378---764566851111210012211343102
Q ss_pred CCCCCCCCCEEEEEECCCCCCCCCCCCC-CCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHH
Q ss_conf 2234477611112331789889721136-998820027742688999884999876678756761799999986304035
Q 005492 510 RSVMVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 588 (694)
Q Consensus 510 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (694)
+..... .+...|++.|+|||++.+ ..++.++||||||+++|+|++|+.||...+...... .......... .
T Consensus 169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~---~~~~~~~~~~-~ 240 (346)
T d1cm8a_ 169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK---EIMKVTGTPP-A 240 (346)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCC-H
T ss_pred ECCCCC----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHH---HHHHCCCCCC-H
T ss_conf 206876----3102455333588998178789965010300389999997869988897689999---9985037884-8
Q ss_pred HHH------------------HHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 662------------------0444313429999999999998113499999998889999
Q 005492 589 EIL------------------DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 589 ~~~------------------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
+.. ...............+.+|+.+||..||.+|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8886530003443311578666556677556899999999999772995579299999639
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=319.44 Aligned_cols=265 Identities=20% Similarity=0.260 Sum_probs=202.9
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEE-EEEEEEECCCCEEEEE
Q ss_conf 049886612432074799999982-99399999823568020999999999996326876101-7759963792189998
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIVK-LLGCCLETEVPLLVYE 436 (694)
Q Consensus 359 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~g~~~~~~~~~lv~e 436 (694)
.++|++.+.||+|+||.||+|.+. +++.||||.+.... ...++..|+++++.++|++++. +.++..+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf 888999689850788099999998899899999972100--588899999999970389960179999951987789998
Q ss_pred ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCCCCC
Q ss_conf 279999678874036777889999999999999999998744999844046664608877---99937993127852234
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGTSRSVM 513 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DfGl~~~~~ 513 (694)
|+ +++|...+..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++ .+..+||+|||+++.+.
T Consensus 84 ~~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EC-CCCHHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEECC
T ss_conf 73-8713332443068--8768999999999999999999799---4426678766064335777615650467513425
Q ss_pred CCCCC------EEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCH
Q ss_conf 47761------111233178988972113699882002774268899988499987667875676179999998630403
Q 005492 514 VDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 587 (694)
Q Consensus 514 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (694)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||................... +
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~----~ 233 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK----M 233 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH----H
T ss_pred CCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCC----C
T ss_conf 544554100013577678735329999918998983218861778999984987665530577999999852356----7
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 56620444313429999999999998113499999998889999941501469
Q 005492 588 FEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTG 640 (694)
Q Consensus 588 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 640 (694)
... ........+.++.+++.+||+.+|++||++.++.+.|+.+.....
T Consensus 234 -~~~----~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 234 -STP----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp -HSC----HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -CCC----HHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCC
T ss_conf -898----357534788999999999843995579199999999999999769
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.40 Aligned_cols=264 Identities=23% Similarity=0.321 Sum_probs=198.7
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC-------
Q ss_conf 049886612432074799999982-9939999982356--802099999999999632687610177599637-------
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLET------- 428 (694)
Q Consensus 359 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------- 428 (694)
.++|++.+.||+|+||+||+|.+. +++.||||++... ......++.+|+.+|++++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred -CCCEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf -9218999827999967887403677788999999999999999999874499984404666460887799937993127
Q 005492 429 -EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 507 (694)
Q Consensus 429 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 507 (694)
...++|||++.++.+..+.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEECCCCCCCCHHHHCC---CCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEECC
T ss_conf 76389998535787410122203---44330899999999999998852299---8856767222036689968763135
Q ss_pred CCCCCCCCCCC---EEEEEECCCCCCCCCCCCCC-CCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 85223447761---11123317898897211369-988200277426889998849998766787567617999999863
Q 005492 508 TSRSVMVDQTH---LTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAIN 583 (694)
Q Consensus 508 l~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 583 (694)
+++........ ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+.... +.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~---i~~~~~ 239 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL---ISQLCG 239 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHC
T ss_pred EEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHH---HHHHCC
T ss_conf 00223554443211356602497874289970799989178700678646617448799899899999999---998418
Q ss_pred HCC-----------HHHHHHH------HHHHHH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 040-----------3566204------443134-29999999999998113499999998889999
Q 005492 584 ENR-----------LFEILDA------RVLKEA-KKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 584 ~~~-----------~~~~~d~------~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
... ....... ...... .......+.+|+.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 998255344320344433201334455503340444599899999999873896589099999749
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=316.06 Aligned_cols=266 Identities=17% Similarity=0.179 Sum_probs=209.8
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCC-CCCEEEEEEEEECCCCEEEEE
Q ss_conf 049886612432074799999982-993999998235680209999999999963268-761017759963792189998
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQINH-RNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 359 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e 436 (694)
.++|++.+.||+|+||+||+|.+. +++.||+|.+.... ....+.+|++.++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 980699799841788299999998899799999975025--829999999999996489998779999601881179999
Q ss_pred ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEEECCCCCC
Q ss_conf 2799996788740367778899999999999999999987449998440466646088779-----99379931278522
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-----KYRAKVSDFGTSRS 511 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~DfGl~~~ 511 (694)
|+ +++|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++. .+.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EC-CCCHHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf 64-8887999975203--1106899999999999999999779---6626677131523475434479568723660577
Q ss_pred CCCCCCC------EEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf 3447761------1112331789889721136998820027742688999884999876678756761799999986304
Q 005492 512 VMVDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINEN 585 (694)
Q Consensus 512 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 585 (694)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred CCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCC
T ss_conf 14676654111024676277510267989648888869998983199999986987678853021999999997056799
Q ss_pred CHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 03566204443134299999999999981134999999988899999415014698
Q 005492 586 RLFEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFELGGIRTSTGA 641 (694)
Q Consensus 586 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~ 641 (694)
. ..+.....++++.+++..|+..+|++||+++.+.+.|+++......
T Consensus 236 ~---------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 236 P---------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp C---------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred C---------HHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCC
T ss_conf 9---------5896579989999999998439930085999999999999997599
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.98 Aligned_cols=240 Identities=26% Similarity=0.429 Sum_probs=194.9
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCH------HHHHHHHHHHHHHHHCC--CCCCEEEEEEEEECCC
Q ss_conf 49886612432074799999982-993999998235680------20999999999996326--8761017759963792
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDE------TNVEQFINEVVILSQIN--HRNIVKLLGCCLETEV 430 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~ 430 (694)
++|++.+.||+|+||+||+|... +++.||||.+..... ....++.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf 83799679840878399999999999799999985688443345567999999999999743589881279999830996
Q ss_pred CEEEEEECCC-CCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-CCCEEEEECCC
Q ss_conf 1899982799-996788740367778899999999999999999987449998440466646088779-99379931278
Q 005492 431 PLLVYEFIPN-GTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGT 508 (694)
Q Consensus 431 ~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DfGl 508 (694)
.++||||+.+ +++.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEECCCCCHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCCCC
T ss_conf 8999983368622899986158---9999999999999999999998779---755667611147744788489775465
Q ss_pred CCCCCCCCCCEEEEEECCCCCCCCCCCCCCCC-CCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCH
Q ss_conf 52234477611112331789889721136998-82002774268899988499987667875676179999998630403
Q 005492 509 SRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRL 587 (694)
Q Consensus 509 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (694)
++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ..... ..
T Consensus 158 a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~-~~ 221 (273)
T d1xwsa_ 158 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRG-QV 221 (273)
T ss_dssp CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHC-CC
T ss_pred CEECCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH------------HHHHC-CC
T ss_conf 3532444---55665658774799998489978865332554034536756889988736------------77615-44
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 56620444313429999999999998113499999998889999
Q 005492 588 FEILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 588 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.. +...+..+.+|+.+||+.+|.+|||+.|++++
T Consensus 222 --~~--------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 --FF--------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --CC--------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CC--------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --77--------87799999999999760897589399998539
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.91 Aligned_cols=262 Identities=22% Similarity=0.291 Sum_probs=201.5
Q ss_pred HCCCCCCCEEEEECCEEEEEEEECC-CCEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC------C
Q ss_conf 0498866124320747999999829-93999998235--6802099999999999632687610177599637------9
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLTD-GRIVAVKKSKL--VDETNVEQFINEVVILSQINHRNIVKLLGCCLET------E 429 (694)
Q Consensus 359 ~~~f~~~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~ 429 (694)
.++|++.++||+|+||+||+|.+.. ++.||||++.. .+......+.+|+.++++++||||+++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 37759988962175859999999999989999998823369799999999999998648987648998970256434576
Q ss_pred CCEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 21899982799996788740367778899999999999999999987449998440466646088779993799312785
Q 005492 430 VPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTS 509 (694)
Q Consensus 430 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~ 509 (694)
..++||||+.++. .+.+.. .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~l-~~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANL-CQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEH-HHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEEEEECCCHHH-HHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHHH
T ss_conf 2699984144677-876503-----8999999999999999998865221---124567763211365443132010232
Q ss_pred CCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH-----------
Q ss_conf 223447761111233178988972113699882002774268899988499987667875676179999-----------
Q 005492 510 RSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF----------- 578 (694)
Q Consensus 510 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~----------- 578 (694)
+.... ........+|..|+|||++.+..++.++||||+|+++++|++|+.||.+.+...........
T Consensus 167 ~~~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred HCCCC--CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 11466--6553322146555581331477778774333566257898659899888977889999997205898799987
Q ss_pred -----HHHHHHC------CHHHHHHHHH---HHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf -----9986304------0356620444---313429999999999998113499999998889999
Q 005492 579 -----LQAINEN------RLFEILDARV---LKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 579 -----~~~~~~~------~~~~~~d~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
....... .......... ...........+.+|+.+||..||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 6566777764175435666421264333543210133379999999999876994579089999669
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=320.69 Aligned_cols=253 Identities=25% Similarity=0.330 Sum_probs=205.0
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC----CCCEEEEEECCCC----CHHHHHHHHHHHHHHHHCCC-CCCEEEEEEEEECCC
Q ss_conf 49886612432074799999982----9939999982356----80209999999999963268-761017759963792
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT----DGRIVAVKKSKLV----DETNVEQFINEVVILSQINH-RNIVKLLGCCLETEV 430 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~ 430 (694)
++|++.+.||+|+||+||+|... .++.||+|.+... +....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred CEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 18999827999967887403677788999999999999999999874499984404666460887799937993127852
Q 005492 431 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~ 510 (694)
.++++||+.+|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEEECCCCCHHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf 001231234117999987304---5437888888999999998851499---8965477320124699988874132022
Q ss_pred CCCCCCCCEEEEEECCCCCCCCCCCCCC--CCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHH
Q ss_conf 2344776111123317898897211369--98820027742688999884999876678756761799999986304035
Q 005492 511 SVMVDQTHLTTKVQGTFGYVDPEYFQSS--QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLF 588 (694)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (694)
.+............|++.|++||.+... .++.++||||||++||+|++|+.||......+..... ........
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i---~~~~~~~~-- 252 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---SRRILKSE-- 252 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH---HHHHHHCC--
T ss_pred HHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---HHHCCCCC--
T ss_conf 2034444322122233333106876057768871325177779999997689998888777799999---98335689--
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHH
Q ss_conf 662044431342999999999999811349999999-----8889999
Q 005492 589 EILDARVLKEAKKEGIMTVATLAKRCLNLNGKMRPT-----MKEVAFE 631 (694)
Q Consensus 589 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 631 (694)
...+...+..+.+|+.+||+++|.+||+ ++|++++
T Consensus 253 --------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 253 --------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --------CCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCC
T ss_conf --------9886547999999999974458988199974509999749
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=315.33 Aligned_cols=256 Identities=22% Similarity=0.309 Sum_probs=196.3
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEEC--CCCEEEE
Q ss_conf 49886612432074799999982-99399999823568020999999999996326-87610177599637--9218999
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLET--EVPLLVY 435 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lv~ 435 (694)
++|++.++||+|+||+||+|+.. +++.||+|+++. ...+++.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 671897898317481999999889997999999888---99999999999998515799876799999816877126888
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCCCCCC
Q ss_conf 8279999678874036777889999999999999999998744999844046664608877999-379931278522344
Q 005492 436 EFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGTSRSVMV 514 (694)
Q Consensus 436 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfGl~~~~~~ 514 (694)
||+++++|..+.+ .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EECCCCCHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf 6317985899746------8999999999999999998876433---443456441237748998366415654266468
Q ss_pred CCCCEEEEEECCCCCCCCCCCCCC-CCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHH----
Q ss_conf 776111123317898897211369-988200277426889998849998766787567617999999863040356----
Q 005492 515 DQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE---- 589 (694)
Q Consensus 515 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 589 (694)
.. ......+|..|+|||.+.+. .++.++||||+|+++++|++|+.||.......+.. ..+...........
T Consensus 183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~--~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 183 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL--VRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH--HHHHHHHCHHHHHHHHHH
T ss_pred CC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHHHHCCCHHHHHHHH
T ss_conf 87--44432248642476102688888845232335455587604889998876018999--999998788415555542
Q ss_pred -----------HH--------HHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf -----------62--------0444313429999999999998113499999998889999
Q 005492 590 -----------IL--------DARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 590 -----------~~--------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
.. ...............+.+|+.+||+.||.+|||++|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2544474300000333433112115521124489999999999866995689089999649
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.89 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=203.5
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCEEEEE
Q ss_conf 49886612432074799999982-9939999982356--80209999999999963268761017759963792189998
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 436 (694)
++|++.++||+|+||+||+|++. +++.||||+++.. ......++.+|+.+++.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 27999967887403677788999999999999999999874499984404666460887799937993127852234477
Q 005492 437 FIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSRSVMVDQ 516 (694)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~~~~~~ 516 (694)
++.+++|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.+..+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ECCCCCCCCCCCCCC---CCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC
T ss_conf 023322211212356---5403678999999999987743399---8600146761211337826652046011046887
Q ss_pred CCEEEEEECCCCCCCCCCCCCCC-CCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCC---H---HH
Q ss_conf 61111233178988972113699-88200277426889998849998766787567617999999863040---3---56
Q 005492 517 THLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENR---L---FE 589 (694)
Q Consensus 517 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~---~~ 589 (694)
. ......++..|+|||.+.... ++.++||||||+++|||++|+.||.......+ ....+........ . ..
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGG
T ss_pred C-CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHH--HHHHHHHHCCCCCHHHHHHHHH
T ss_conf 5-100103443101466750698888044402654188998518999988999999--9999986118997355134432
Q ss_pred HHH---------HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 620---------444313429999999999998113499999998889999
Q 005492 590 ILD---------ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 590 ~~d---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
..+ ............+.+.+|+.+||+.||.+|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 221133444544310433065689999999999864996689099999649
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=315.20 Aligned_cols=258 Identities=22% Similarity=0.309 Sum_probs=198.9
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC-----CC
Q ss_conf 049886612432074799999982-9939999982356--802099999999999632687610177599637-----92
Q 005492 359 TDNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLV--DETNVEQFINEVVILSQINHRNIVKLLGCCLET-----EV 430 (694)
Q Consensus 359 ~~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~ 430 (694)
.++|++.+.||+|+||+||+|... +++.||||++... +....+++.+|+.++++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred CEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 18999827999967887403677788999999999999999999874499984404666460887799937993127852
Q 005492 431 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~ 510 (694)
.+++++++.+|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEEEECCCCHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHC
T ss_conf 49999962588623200224----5309999999999999999997388---7651667763345543220013210001
Q ss_pred CCCCCCCCEEEEEECCCCCCCCCCCCCC-CCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHCCHHH
Q ss_conf 2344776111123317898897211369-988200277426889998849998766787567617999999863040356
Q 005492 511 SVMVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYFLQAINENRLFE 589 (694)
Q Consensus 511 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (694)
.... ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+...... .+........ .+
T Consensus 170 ~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~---~i~~~~~~~~-~~ 241 (348)
T d2gfsa1 170 HTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK---LILRLVGTPG-AE 241 (348)
T ss_dssp CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCC-HH
T ss_pred CCCC----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHHHHCCCCC-HH
T ss_conf 2575----44443454355583553377567855124320589999976889978898899999---9997307997-57
Q ss_pred HHH-----------HH-------HHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 620-----------44-------4313429999999999998113499999998889999
Q 005492 590 ILD-----------AR-------VLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKEVAFE 631 (694)
Q Consensus 590 ~~d-----------~~-------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 631 (694)
... .. ............+.+|+.+||..||.+|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 732001024454443035578755566267899999999999775883459389998559
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=281.57 Aligned_cols=264 Identities=20% Similarity=0.201 Sum_probs=194.7
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCHHHHHHHHHHHHHHHHCC-----------CCCCEEEEEEEEE
Q ss_conf 49886612432074799999982-99399999823568020999999999996326-----------8761017759963
Q 005492 360 DNYNANRILGQGGQGTVYKGMLT-DGRIVAVKKSKLVDETNVEQFINEVVILSQIN-----------HRNIVKLLGCCLE 427 (694)
Q Consensus 360 ~~f~~~~~Lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~ 427 (694)
.+|++.++||+|+||+||+|+.. +++.||||++... ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC-CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 8579989975077818999999999979999998343-133689999999999840145555542276764789987631
Q ss_pred C--CCCEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCC-----
Q ss_conf 7--9218999827999967887403677788999999999999999999874-4999844046664608877999-----
Q 005492 428 T--EVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHS-AASIPIYHRDIKSANILLDDKY----- 499 (694)
Q Consensus 428 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~----- 499 (694)
. ...++++++...+..............+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCCCC
T ss_conf 2565202343200035420000012234678689999999999999888764058---6465677057056305765644
Q ss_pred -CEEEEECCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
Q ss_conf -3799312785223447761111233178988972113699882002774268899988499987667875676179999
Q 005492 500 -RAKVSDFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINTDEDKSLVGYF 578 (694)
Q Consensus 500 -~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~ 578 (694)
.+|++|||.+..... ......|+..|+|||++....++.++||||+|+++++|++|+.||...............
T Consensus 169 ~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred CEEEEEECCCCCCCCC----CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
T ss_conf 3056753144212344----542236652105713214667776432012378999998788998987554321026899
Q ss_pred HHHH---HHCCH---------HHHHH-------------------HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 9986---30403---------56620-------------------44431342999999999999811349999999888
Q 005492 579 LQAI---NENRL---------FEILD-------------------ARVLKEAKKEGIMTVATLAKRCLNLNGKMRPTMKE 627 (694)
Q Consensus 579 ~~~~---~~~~~---------~~~~d-------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e 627 (694)
...+ ..... ....+ ..............+.+|+.+||..||.+|||+.|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 99999837998788624532200013201220243235776444210001567435899999999987799457908999
Q ss_pred HHHH
Q ss_conf 9999
Q 005492 628 VAFE 631 (694)
Q Consensus 628 vl~~ 631 (694)
++++
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HHCC
T ss_conf 9669
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.2e-26 Score=166.16 Aligned_cols=170 Identities=16% Similarity=0.156 Sum_probs=119.2
Q ss_pred CCCCEEEEECCEEEEEEEECCCCEEEEEECCCCC------------------HHHHHHHHHHHHHHHHCCCCCCEEEEEE
Q ss_conf 8661243207479999998299399999823568------------------0209999999999963268761017759
Q 005492 363 NANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVD------------------ETNVEQFINEVVILSQINHRNIVKLLGC 424 (694)
Q Consensus 363 ~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~g~ 424 (694)
.+.++||+|+||+||+|...+++.||||..+... .........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EEECCCCEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf 96379218999827999967887403677788999999999999999999874499984404666460887799937993
Q 005492 425 CLETEVPLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAASIPIYHRDIKSANILLDDKYRAKVS 504 (694)
Q Consensus 425 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 504 (694)
. ..+++|||+++..+.+ ++......++.|++.+|+|||..+ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred C----CCEEEEEEECCCCCCC----------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEEEE
T ss_conf 2----8889999504565420----------015789999999999999982688---8983689036114289-89998
Q ss_pred ECCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEEEEEEHHHHHH
Q ss_conf 12785223447761111233178988972113699882002774268899
Q 005492 505 DFGTSRSVMVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLV 554 (694)
Q Consensus 505 DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ 554 (694)
|||++.....+..... ...+... ..+ +....|+.++|+||+.--++
T Consensus 145 DFG~a~~~~~~~~~~~--l~rd~~~-~~~-~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWREI--LERDVRN-IIT-YFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHHHH--HHHHHHH-HHH-HHHHHHCCCCCHHHHHHHHH
T ss_pred ECCCCCCCCCCCCHHH--HHHHHHH-HHH-HHCCCCCCCCCHHHHHHHHH
T ss_conf 7788430899870999--9877999-999-97578998446899999874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.07 E-value=1e-09 Score=69.98 Aligned_cols=151 Identities=15% Similarity=0.116 Sum_probs=102.7
Q ss_pred HHHHHHHHCCCCCCCEEEEECCEEEEEEEECCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEECCC
Q ss_conf 566888704988661243207479999998299399999823568020999999999996326-8761017759963792
Q 005492 352 SKDLEKATDNYNANRILGQGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQIN-HRNIVKLLGCCLETEV 430 (694)
Q Consensus 352 ~~~l~~~~~~f~~~~~Lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~ 430 (694)
..++......|+..+..+.+....||+... ++..+++|+...........+.+|...+..+. +--+.+++.+..+.+.
T Consensus 6 ~~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 6 SPELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp CHHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred CHHHHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCC
T ss_conf 799997513527997678998771899990-8986999984887653255699999999987606998728999750896
Q ss_pred CEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------
Q ss_conf 1899982799996788740367778899999999999999999987449-------------------------------
Q 005492 431 PLLVYEFIPNGTLYQYIHNQIEEFPITWELLLRIAVEVSGALFYLHSAA------------------------------- 479 (694)
Q Consensus 431 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~------------------------------- 479 (694)
.++||+++++.++.+..... .. ...++.+++..|+.||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEEECCCCCCCCCCCCC-----CC---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_conf 49999860433435433440-----26---99999989999999855684214357644656555778998776555543
Q ss_pred -------------------------CCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -------------------------99844046664608877999379931278522
Q 005492 480 -------------------------SIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 480 -------------------------~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~ 511 (694)
.+.++|+|+.+.|||++++...-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 033232005799999999844986781789860047642364996599960231441
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.63 E-value=2.3e-07 Score=56.52 Aligned_cols=130 Identities=16% Similarity=0.145 Sum_probs=84.0
Q ss_pred EEEEC-CEEEEEEEECCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCC--CCCEEEEEEEEECCCCEEEEEECCCCCHH
Q ss_conf 43207-4799999982993999998235680209999999999963268--76101775996379218999827999967
Q 005492 368 LGQGG-QGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFIPNGTLY 444 (694)
Q Consensus 368 Lg~G~-fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 444 (694)
+..|. ...||+....++..+++|....... ..+..|...++.+.. -.+.+++++..+.+..++||+++++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CCCCCCCCEEEEEEECCCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCCC
T ss_conf 6786547758999938987899995896677---6899999999999865999886132224566159998744135543
Q ss_pred HHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q ss_conf 887403677788999999999999999999874-----------------------------------------------
Q 005492 445 QYIHNQIEEFPITWELLLRIAVEVSGALFYLHS----------------------------------------------- 477 (694)
Q Consensus 445 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~----------------------------------------------- 477 (694)
+.. ... ...+.+++..|+-||.
T Consensus 95 ~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 95 SSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred CCC--------CCH---HHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHH
T ss_conf 221--------268---999999999999873688544887554124688999999875411011340112137999999
Q ss_pred ----C----CCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf ----4----999844046664608877999379931278522
Q 005492 478 ----A----ASIPIYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 478 ----~----~~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~~ 511 (694)
. ..+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 998718765795678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.42 E-value=3.4e-06 Score=49.92 Aligned_cols=77 Identities=17% Similarity=0.209 Sum_probs=49.9
Q ss_pred CCEEEEECCEEEEEEEECC-CCEEEEEECCC----C---CHHHHHHHHHHHHHHHHCC-C--CCCEEEEEEEEECCCCEE
Q ss_conf 6124320747999999829-93999998235----6---8020999999999996326-8--761017759963792189
Q 005492 365 NRILGQGGQGTVYKGMLTD-GRIVAVKKSKL----V---DETNVEQFINEVVILSQIN-H--RNIVKLLGCCLETEVPLL 433 (694)
Q Consensus 365 ~~~Lg~G~fg~Vy~~~~~~-~~~vavK~~~~----~---~~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~~~~~l 433 (694)
.+.||.|....||+....+ ++.+++|.... . .+....+...|...|+.+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEEECCCCCH
Q ss_conf 9982799996
Q 005492 434 VYEFIPNGTL 443 (694)
Q Consensus 434 v~e~~~~gsL 443 (694)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.85 E-value=8e-05 Score=42.14 Aligned_cols=73 Identities=19% Similarity=0.248 Sum_probs=46.8
Q ss_pred CEEEEECCEEEEEEEECCC--------CEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCC-EEEEEEEEECCCCEEEEE
Q ss_conf 1243207479999998299--------3999998235680209999999999963268761-017759963792189998
Q 005492 366 RILGQGGQGTVYKGMLTDG--------RIVAVKKSKLVDETNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVYE 436 (694)
Q Consensus 366 ~~Lg~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e 436 (694)
+.|+.|-.-.+|++...++ +.+.++... . ........+|..+++.+.-.++ +++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-C-CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEEE
T ss_conf 991785334348999688775445789817999659-9-61165899999999999757999808998189----56999
Q ss_pred ECCCCCHH
Q ss_conf 27999967
Q 005492 437 FIPNGTLY 444 (694)
Q Consensus 437 ~~~~gsL~ 444 (694)
|+++.+|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EECCCCCC
T ss_conf 73455488
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.57 E-value=0.00021 Score=39.71 Aligned_cols=136 Identities=18% Similarity=0.157 Sum_probs=72.2
Q ss_pred CEEEEEEEECCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCE--EEE-----EEEEECCCCEEEEEECCCCCHH-
Q ss_conf 47999999829939999982356802099999999999632687610--177-----5996379218999827999967-
Q 005492 373 QGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINHRNIV--KLL-----GCCLETEVPLLVYEFIPNGTLY- 444 (694)
Q Consensus 373 fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~l~-----g~~~~~~~~~lv~e~~~~gsL~- 444 (694)
-..||++...+|..+++|..... ....+++..|...+..|....+. ..+ .........+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred CCEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCC
T ss_conf 20269998389997999984787-78899999999999999855998787520689805665347999986527768899
Q ss_pred ----HH---------HHCCC------CCCCCCH----------------------HHHHHHHHHHHHHHHHHH-HCCCCC
Q ss_conf ----88---------74036------7778899----------------------999999999999999987-449998
Q 005492 445 ----QY---------IHNQI------EEFPITW----------------------ELLLRIAVEVSGALFYLH-SAASIP 482 (694)
Q Consensus 445 ----~~---------l~~~~------~~~~l~~----------------------~~~~~i~~qia~aL~~LH-~~~~~~ 482 (694)
.+ +|... .+..+++ ......+.++...+.-+- ......
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCE
T ss_conf 99999999899999988630357865567789788766568999874769988989999999999999998454568712
Q ss_pred EEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 44046664608877999379931278522
Q 005492 483 IYHRDIKSANILLDDKYRAKVSDFGTSRS 511 (694)
Q Consensus 483 ivH~Dikp~NIll~~~~~~kl~DfGl~~~ 511 (694)
++|+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred EECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 0247888042878389--35886520146
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.58 E-value=0.013 Score=29.53 Aligned_cols=158 Identities=12% Similarity=0.051 Sum_probs=78.4
Q ss_pred CCHHHHHHHHCCCCCCCEEE-----EECCEEEEEEEECCCCEEEEEECCCCCHHHHHHHHHHHHHHHHCCC-----CCCE
Q ss_conf 68566888704988661243-----2074799999982993999998235680209999999999963268-----7610
Q 005492 350 FTSKDLEKATDNYNANRILG-----QGGQGTVYKGMLTDGRIVAVKKSKLVDETNVEQFINEVVILSQINH-----RNIV 419 (694)
Q Consensus 350 ~~~~~l~~~~~~f~~~~~Lg-----~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----~niv 419 (694)
.+.++++....+|.+.+... .|---+.|+....+++ +++|...... ..+++..|+.++..+.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCCC-EEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 89999999998679998568523788852673899978972-8999807899--98899999999875430255545564
Q ss_pred EEE-E--EEEECCCCEEEEEECCCCCHHH--------------HHHCCCCCC------------------------CCCH
Q ss_conf 177-5--9963792189998279999678--------------874036777------------------------8899
Q 005492 420 KLL-G--CCLETEVPLLVYEFIPNGTLYQ--------------YIHNQIEEF------------------------PITW 458 (694)
Q Consensus 420 ~l~-g--~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~~------------------------~l~~ 458 (694)
... | ..........++.+..+..... .++...... ....
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCC
T ss_conf 10489762134125502453114655333204678888899876454443202453101110120024567777653114
Q ss_pred HHHHHHHHHHHHHHHHHHHCC-CCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 999999999999999987449-9984404666460887799937993127852
Q 005492 459 ELLLRIAVEVSGALFYLHSAA-SIPIYHRDIKSANILLDDKYRAKVSDFGTSR 510 (694)
Q Consensus 459 ~~~~~i~~qia~aL~~LH~~~-~~~ivH~Dikp~NIll~~~~~~kl~DfGl~~ 510 (694)
......+......+...+... ...++|+|+.+.||+++++...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 12799999998764204855454503337863656402045412674222123
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=90.62 E-value=0.045 Score=26.52 Aligned_cols=28 Identities=29% Similarity=0.714 Sum_probs=20.7
Q ss_pred CCCCCCCCCCCCCCCCCEEEECCCCCCCCCC
Q ss_conf 4358998841116998658970174001798
Q 005492 208 TICGDRENGCSIKLSSGYICRCDAGFYRPHG 238 (694)
Q Consensus 208 ~aC~s~~s~C~~~~~~gy~C~C~~g~~~~~g 238 (694)
-.|.. +..|.+..+ +|.|.|++||++ +|
T Consensus 7 ~~C~~-~A~C~Nt~G-sy~C~C~~Gy~G-dG 34 (40)
T d1gl4a2 7 HQCSV-HAECRDYAT-GFCCRCVANYTG-NG 34 (40)
T ss_dssp GGSCT-TEEEEECSS-CEEEEECTTEEE-CS
T ss_pred CCCCC-CCEEECCCC-CEEEECCCCCCC-CC
T ss_conf 88899-989665899-928589999747-98
|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement protease C1R species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.95 E-value=0.081 Score=25.06 Aligned_cols=19 Identities=26% Similarity=0.754 Sum_probs=15.4
Q ss_pred CCCCCCCCCEEEECCCCCCC
Q ss_conf 41116998658970174001
Q 005492 216 GCSIKLSSGYICRCDAGFYR 235 (694)
Q Consensus 216 ~C~~~~~~gy~C~C~~g~~~ 235 (694)
.|+|+.|+ |+|.|..||.+
T Consensus 25 ~C~Nt~Gs-Y~C~C~~Gy~l 43 (53)
T d1apqa_ 25 LCHNYVGG-YFCSCRPGYEL 43 (53)
T ss_dssp EEEEETTE-EEEECSTTCEE
T ss_pred EEECCCCC-EEEECCCCCEE
T ss_conf 81738998-18589999749
|
| >d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.83 E-value=0.082 Score=25.03 Aligned_cols=22 Identities=32% Similarity=0.560 Sum_probs=16.1
Q ss_pred CCCCCCCCCEEEECCCCCCCCCC
Q ss_conf 41116998658970174001798
Q 005492 216 GCSIKLSSGYICRCDAGFYRPHG 238 (694)
Q Consensus 216 ~C~~~~~~gy~C~C~~g~~~~~g 238 (694)
.|.+.. .+|+|.|..||.+.++
T Consensus 15 ~C~n~~-g~~~C~C~~Gy~L~d~ 36 (40)
T d3bpse1 15 VCNDLK-IGYECLCPDGFQLVAQ 36 (40)
T ss_dssp EEEECS-SSEEEECCTTCCEETT
T ss_pred EEECCC-CCEEEECCCCCEECCC
T ss_conf 977599-9778789999898998
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.65 E-value=0.2 Score=22.88 Aligned_cols=26 Identities=27% Similarity=0.598 Sum_probs=13.5
Q ss_pred CCCCCCCCCCEEEECCCCCCCCCCCCC
Q ss_conf 841116998658970174001798634
Q 005492 215 NGCSIKLSSGYICRCDAGFYRPHGLCS 241 (694)
Q Consensus 215 s~C~~~~~~gy~C~C~~g~~~~~g~c~ 241 (694)
..|.|..|+ |.|.|..||.+.+..|+
T Consensus 17 ~~C~Nt~Gs-y~C~C~~Gy~~~g~~C~ 42 (43)
T d1emoa1 17 GQCINTDGS-YRCECPFGYILAGNECV 42 (43)
T ss_dssp SCCCCCSSC-CCCCCCTTEEESSSCEE
T ss_pred CEEECCCCC-EEEECCCCCCCCCCCCC
T ss_conf 886888999-48679999526898430
|
| >d1kigl_ g.3.11.1 (L:) Factor X, N-terminal module {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Cow (Bos taurus) [TaxId: 9913]
Probab=86.88 E-value=0.085 Score=24.93 Aligned_cols=30 Identities=23% Similarity=0.413 Sum_probs=19.0
Q ss_pred CCCCCCCCCEEEECCCCCCCC-CCC-CCCCCCC
Q ss_conf 411169986589701740017-986-3464233
Q 005492 216 GCSIKLSSGYICRCDAGFYRP-HGL-CSGTLLC 246 (694)
Q Consensus 216 ~C~~~~~~gy~C~C~~g~~~~-~g~-c~~~~~c 246 (694)
.|++. ..+|+|.|..||.+. ++. |..+++|
T Consensus 11 ~C~~~-~~~~~C~C~~Gy~L~~D~~tC~~~~~~ 42 (51)
T d1kigl_ 11 FCREE-RSEVRCSCAHGYVLGDDSKSCVSTERF 42 (51)
T ss_dssp CCCEE-TTEECCCCCTTEEECTTSSCEEECSSS
T ss_pred EEECC-CCCEEEECCCCCEECCCCCCCCCCCCC
T ss_conf 75848-996796819999899898945168853
|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.43 E-value=0.2 Score=22.79 Aligned_cols=24 Identities=33% Similarity=0.973 Sum_probs=17.7
Q ss_pred CCCCCCCCCCCCCCCCEEEECCCCCCC
Q ss_conf 358998841116998658970174001
Q 005492 209 ICGDRENGCSIKLSSGYICRCDAGFYR 235 (694)
Q Consensus 209 aC~s~~s~C~~~~~~gy~C~C~~g~~~ 235 (694)
.|. .+ .|+|..|+ |+|.|..||.+
T Consensus 12 ~c~-~~-~C~Nt~Gs-y~C~C~~Gy~l 35 (43)
T d1uzka2 12 LCQ-GG-KCINTFGS-FQCRCPTGYYL 35 (43)
T ss_dssp GGB-TS-EEEECSSC-EEEECCTTCCB
T ss_pred CCC-CC-EEECCCCC-EEEECCCCCEE
T ss_conf 867-88-87888999-68678999829
|
| >d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Mannose-binding protein associated serine protease 2, MASP2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=86.34 E-value=0.16 Score=23.44 Aligned_cols=23 Identities=30% Similarity=0.768 Sum_probs=16.7
Q ss_pred CCCCCCCCCCEEEECCCCCCC-CCC
Q ss_conf 841116998658970174001-798
Q 005492 215 NGCSIKLSSGYICRCDAGFYR-PHG 238 (694)
Q Consensus 215 s~C~~~~~~gy~C~C~~g~~~-~~g 238 (694)
..|.+..+ ||+|.|.+||.+ .+|
T Consensus 16 ~~C~Nt~g-sy~C~C~~Gy~L~~d~ 39 (45)
T d1nt0a3 16 HYCHNYLG-GYYCSCRVGYILHQNK 39 (45)
T ss_dssp SEEEEETT-EEEEECCTTEEECTTS
T ss_pred CEEECCCC-CEEEECCCCCEECCCC
T ss_conf 88423799-8787389997799998
|
| >d1autl2 g.3.11.1 (L:97-146) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.24 E-value=0.19 Score=22.96 Aligned_cols=28 Identities=21% Similarity=0.460 Sum_probs=17.6
Q ss_pred CCCCCCCCCEEEECCCCCCCC-CCC-CCCCC
Q ss_conf 411169986589701740017-986-34642
Q 005492 216 GCSIKLSSGYICRCDAGFYRP-HGL-CSGTL 244 (694)
Q Consensus 216 ~C~~~~~~gy~C~C~~g~~~~-~g~-c~~~~ 244 (694)
.|.+.. .+|+|.|..||.+. ++. |+..+
T Consensus 12 ~C~~~~-g~~~C~C~~Gy~L~~D~~tC~~~~ 41 (50)
T d1autl2 12 YCLEEV-GWRRCSCAPGYKLGDDLLQCHPAV 41 (50)
T ss_dssp EEEECS-SSEEEECCTTEEECTTSSCEEECS
T ss_pred EEECCC-CCEEEECCCCCEECCCCCCCCCCC
T ss_conf 756599-974877899988999999603388
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.84 E-value=0.16 Score=23.39 Aligned_cols=22 Identities=27% Similarity=0.647 Sum_probs=16.4
Q ss_pred CCCCCCCCCCCEEEECCCCCCCC
Q ss_conf 88411169986589701740017
Q 005492 214 ENGCSIKLSSGYICRCDAGFYRP 236 (694)
Q Consensus 214 ~s~C~~~~~~gy~C~C~~g~~~~ 236 (694)
+..|++..+ ||+|.|..||.+.
T Consensus 14 ~~~C~Nt~G-~y~C~C~~Gy~l~ 35 (43)
T d1uzka1 14 SGNCVNTPG-SYICDCPPDFELN 35 (43)
T ss_dssp TSEEEEETT-EEEEECCTTCEEC
T ss_pred CCEEECCCC-CEEEECCCCCEEC
T ss_conf 788687799-7787569997799
|
| >d2p3ua1 g.3.11.1 (A:87-137) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.21 E-value=0.21 Score=22.76 Aligned_cols=28 Identities=25% Similarity=0.560 Sum_probs=17.6
Q ss_pred CCCCCCCCCEEEECCCCCCC-CCCC-CCCCC
Q ss_conf 41116998658970174001-7986-34642
Q 005492 216 GCSIKLSSGYICRCDAGFYR-PHGL-CSGTL 244 (694)
Q Consensus 216 ~C~~~~~~gy~C~C~~g~~~-~~g~-c~~~~ 244 (694)
.|.+.. .+|+|.|..||.+ .++. |...+
T Consensus 13 ~C~n~~-g~~~C~C~~Gy~L~~D~~tC~~~~ 42 (51)
T d2p3ua1 13 FCHEEQ-NSVVCSCARGYTLADNGKACIPTG 42 (51)
T ss_dssp EEEEET-TEEEEECCTTEEECTTSSCEEESS
T ss_pred EEECCC-CCEEEECCCCCEECCCCCCCCCCC
T ss_conf 856589-976968299998999999101088
|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.19 E-value=0.27 Score=22.12 Aligned_cols=31 Identities=32% Similarity=0.897 Sum_probs=20.8
Q ss_pred CCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf 35899884111699865897017400179863464
Q 005492 209 ICGDRENGCSIKLSSGYICRCDAGFYRPHGLCSGT 243 (694)
Q Consensus 209 aC~s~~s~C~~~~~~gy~C~C~~g~~~~~g~c~~~ 243 (694)
-|. +++.|++. ..+|+|.|..||.+.. |+..
T Consensus 8 pC~-ngg~C~~~-~~~y~C~C~~g~~G~~--Ce~~ 38 (40)
T d1g1sa2 8 SCS-KQGECLET-IGNYTCSCYPGFYGPE--CEYV 38 (40)
T ss_dssp GGG-GSEEEEEC-SSSEEEEECTTEESTT--SCEE
T ss_pred CCC-CCCEEECC-CCCEEEECCCCCCCCC--CCCC
T ss_conf 489-99598789-9986883899965898--7888
|
| >d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Mannose-binding protein associated serine protease 2, MASP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.06 E-value=0.28 Score=22.01 Aligned_cols=20 Identities=35% Similarity=0.921 Sum_probs=15.2
Q ss_pred CCCCCCCCCEEEECCCCCCCC
Q ss_conf 411169986589701740017
Q 005492 216 GCSIKLSSGYICRCDAGFYRP 236 (694)
Q Consensus 216 ~C~~~~~~gy~C~C~~g~~~~ 236 (694)
.|.++.+ ||+|.|..||.+.
T Consensus 17 ~C~Nt~G-sy~C~C~~Gy~l~ 36 (45)
T d1szba2 17 HCHNHLG-GFYCSCRAGYVLH 36 (45)
T ss_dssp EEEEETT-EEEEECCTTEEEC
T ss_pred CCCCCCC-CEEEECCCCCEEC
T ss_conf 8735899-8587799998599
|
| >d1rfnb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.92 E-value=0.51 Score=20.52 Aligned_cols=29 Identities=17% Similarity=0.532 Sum_probs=18.7
Q ss_pred CCCCCCCCCEEEECCCCCCCC-CCC-CCCCC
Q ss_conf 411169986589701740017-986-34642
Q 005492 216 GCSIKLSSGYICRCDAGFYRP-HGL-CSGTL 244 (694)
Q Consensus 216 ~C~~~~~~gy~C~C~~g~~~~-~g~-c~~~~ 244 (694)
.|++..+.+|+|.|..||.+. ++. |..++
T Consensus 13 ~C~~~~~~~~~C~C~~Gy~L~~D~~tC~~~~ 43 (57)
T d1rfnb_ 13 FCKNSADNKVVCSCTEGYRLAENQKSCEPAV 43 (57)
T ss_dssp EEEECTTSCEEEECCTTEEECTTSSSEEECS
T ss_pred EEEECCCCCEEEECCCCCEECCCCCCCCCCC
T ss_conf 7350899976828999998998999252588
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.34 E-value=0.3 Score=21.84 Aligned_cols=24 Identities=29% Similarity=0.681 Sum_probs=18.1
Q ss_pred CCCCCCCCCCCCCCCCEEEECCCCCCC
Q ss_conf 358998841116998658970174001
Q 005492 209 ICGDRENGCSIKLSSGYICRCDAGFYR 235 (694)
Q Consensus 209 aC~s~~s~C~~~~~~gy~C~C~~g~~~ 235 (694)
.|. +..|.|..|+ |+|.|..||.+
T Consensus 11 ~C~--~~~C~Nt~Gs-y~C~C~~Gy~l 34 (42)
T d1lmja2 11 LCR--GGVCHNTEGS-YRCECPPGHQL 34 (42)
T ss_dssp TTT--TSEEEEETTE-EEEESCTTSCC
T ss_pred CCC--CCEEECCCCC-EEEECCCCCEE
T ss_conf 889--9985889999-58758999839
|